,ApplicationId,SubprojectId,FiscalYear,OrganisationName,OrganisationCity,OrganisationState,DepartmentType,ProjectNumber,ProjectSerialNumber,OrganisationCountry,ActivityCode,AwardAmount,IsActive,ProgramOfficers,AgencyICFundig,ProjectStartDate,ProjectEndDate,FundingOpportunityAnnouncements,AbstractText,ProjectTitle,PHRText,ProjectInvestigatorsName,ProjectInvestigatorsId
0,6752762,,2004,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32DK007120-30,DK007120,UNITED STATES,T32,392032,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
1,6767707,,2004,HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),BOSTON,MA,PUBLIC HEALTH & PREV MEDICINE,5T32HL007118-29,HL007118,UNITED STATES,T32,450489,False,Ann E. Rothgeb,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,Lung Biology and Respiratory Disease,,Joseph D Brain,1889196
2,6766938,,2004,UNIVERSITY OF WASHINGTON,SEATTLE,WA,DENTISTRY,5T32DE007023-28,DE007023,UNITED STATES,T32,541010,False,Kevin S Hardwick,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"
DESCRIPTION (provided by applicant):   
This Research Training Grant renewal application is an extensively revised resubmission of our initial proposal to support cross-disciplinary and comprehensive dental science research training at the School of Dentistry at the University of Washington. The application constitutes the competing renewal of the former Oral Biology-Salivary Research Training and the Bacterially Induced Chronic Inflammation Research Training grants. The revised application consists of a single research training facility and program, focused on using molecular and cell biology and bioengineering approaches to study the basic biology of the oral tissues and their reactions to microbial pathogens and inert materials. The Program is administered by a Program Coordinator, and directed by a Program Oversight Committee. The collaborating Training Faculty include individuals from the Schools of Dentistry, Medicine, Public Health and the Department of Bioengineering; and are organized into 12 groups based on research interests. The proposed training program consists of two phases: 1) All trainees will receive coursework in the major competency areas cited in the PA including: genomics, molecular biology and molecular epidemiology, gene-mediated diagnosis and therapeutics, cell biology, bioinformatics, biomaterials, biomimetics, nanotechnology, tissue engineering and bioimaging technology. Coursework will also include experimental design and data analysis, and dental sciences. PhD students will receive the most training; MS and short-term trainees will receive less. 2) All trainees will learn to perform biological experiments using molecular and cell biology and/or bioengineering approaches by designing and performing experiments under the direction of a Research Mentor chosen from the proposed training faculty. A total of 12.75 training positions are requested, of which 6 are postdoctoral and 5 are predoctoral long term positions, 1.5 are short term positions for dental students, and 0.25 are short term positions for new and midcareer dental school faculty. Although long term trainees may elect to matriculate in a PhD or MS (dentists only) programs in 6 departments, Oral Biology and Bioengineering are expected to have highest enrollments. Courses to be taken in conjunction with this training are described in some detail.",Cross-Disciplinary Dental Science Research Training,,Kenneth T Izutsu,1877343
3,6766756,,2004,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007106-30,HL007106,UNITED STATES,T32,337783,False,Ann E. Rothgeb,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-12-31T05:00:00Z,,,"Pulmonary, Critical Care, and Molecular Training",,Richard Charles Boucher,1860172
4,6763108,,2004,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,BIOCHEMISTRY,5T32GM007215-29,GM007215,UNITED STATES,T32,1335444,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,GRADUATE TRAINING IN MOLECULAR BIOSCIENCES,,DAVID A BROW,1927890
5,6763093,,2004,UNIVERSITY OF CHICAGO,CHICAGO,IL,GENETICS,5T32GM007183-30,GM007183,UNITED STATES,T32,1478783,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,Molecular and Cellular Biology Training Grant,,HARINDER  SINGH,1978275
6,6762375,,2004,VANDERBILT UNIVERSITY,NASHVILLE,TN,INTERNAL MEDICINE/MEDICINE,5T32DK007061-31,DK007061,UNITED STATES,T32,315038,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
7,6752442,,2004,UNIVERSITY OF IOWA,IOWA CITY,IA,INTERNAL MEDICINE/MEDICINE,5T32HL007121-30,HL007121,UNITED STATES,T32,829869,False,Beth  Schucker,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-04-30T04:00:00Z,,,Interdisciplinary Cardiovascular Research Fellowship,,FRANCOIS M ABBOUD,1864622
8,6751030,,2004,STANFORD UNIVERSITY,STANFORD,CA,BIOLOGY,2T32GM007276-29,GM007276,UNITED STATES,T32,1613059,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2009-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  Our program will direct predoctoral training in cellular and molecular biology at Stanford University.  Exceptional students will be provided with a common training experience that includes:1. Formal course work from a menu of biology foundational and specialized courses taught collaboratively by the training faculty; 2. Seminars and journal clubs; and 3. Exciting thesis research opportunities with exceptional faculty preceptors.  These elements are woven together to provide all trainees with a common training experience.  In addition to the common program elements mentioned above, there are 3 programmatic components exclusively for our trainees.  We have initiated a CBM Research Symposium, a CMB Literature/Seminar course and a CMB Science/Social.  These ""enrichment"" components will enhance program identity and cohesiveness.  
  
The Program Directors and the Executive Committee assure that all committee meetings, course requirements, and exams are completed on schedule and that thesis progress is satisfactory.  They will carefully monitor student progress and compliance with programmatic schedules.  It is our expectation that close monitoring reduce the time necessary to complete the work for a Ph.D.  
  
We expect that our students will continue to be highly successful in careers in biomedical research and many will become leaders.  
      

",Cellular and Molecular Biology Training Program,,ROBERT D SIMONI,1859078
9,6748560,,2004,UNIVERSITY OF CHICAGO,CHICAGO,IL,GENETICS,5T32GM007197-30,GM007197,UNITED STATES,T32,850280,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,," DESCRIPTION: (Taken from the Application) The Genetics and Regulation training     
 program at The University of Chicago is a broad interdisciplinary program at       
 training Ph.D. scholars in advanced rationales and methods of genetic analysis     
 for careers as independent scientists in basic and applied biomedical research     
 and education. The training faculty are comprised of tenure-track members of       
 five basic science departments: Biochemistry and Molecular Biology, Ecology and    
 Evolution, Human Genetics, Molecular Genetics and Cell Biology, and Organismal     
 Biology and Anatomy, plus selected faculty in the Departments of Medicine,         
 Psychiatry, Radiation Oncology and Surgery. Most of the trainers also have         
 secondary appointments in the Committee on Genetics. The Director and a            
 Steering Committee of trainers in the major participating departments,             
 representing various sub disciplines of genetics administer the training grant.    
 Trainees are selected from students admitted to various Departments and            
 degree-granting Committees, on the basis of previous academic record slid          
 specific interest in genetics. They take courses in molecular, transmission and    
 population genetics and meet uniform program standards. Individual                 
 Departmental/Committee advisory committees and the Genetics and Regulation         
 Training Grant Steering Committee monitor progress on a regular basis. Common      
 features of the program are course work, laboratory rotations, teaching and        
 assisting in courses, seminar programs, journal clubs, joint research meetings,    
 student seminar programs and Mini-Symposia focused on areas of current interest    
 in genetics. A total of 18 increasing to 24 trainees is proposed for the next      
 five-year period.                                                                  
                                                                                    
",GENETICS AND REGULATION (NRSA),,LUCIA B. B ROTHMAN-DENES,1888982
10,6746886,,2004,UNIVERSITY OF GEORGIA (UGA),ATHENS,GA,GENETICS,5T32GM007103-30,GM007103,UNITED STATES,T32,331448,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,GRADUATE TRAINING IN GENETICS,,Michael T. Bender,1887620
11,6746880,,2004,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007057-29,HL007057,UNITED STATES,T32,298777,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Applicant's Abstract) The purpose of the Training Program in Transfusion Medicine and Related Areas is to provide research training in transfusion medicine and the scientific disciplines related to it in order to develop academically oriented physician-scientists and nonphysician scientists with expertise in the performance of both basic and clinical research.  Upon completion of this program, each trainee will be qualified to assume a medical school faculty position and conduct an independent program of clinical or laboratory investigation in one of the fields of study included in this program, including transfusion medicine, immunohematology, and immunology (Track I); hemoglobin, hematopoiesis and cellular therapy (Track II); hemostasis and thrombosis (Track III); and molecular biology, molecular signaling, and DNA repair (Track IV).  In each of these tracks, exposure to the clinical aspects of the area selected (comprising less than 20 percent of the total trainee time during the tenure of this fellowship) will be provided to permit the trainee to understand the clinical context in which the research which he or she is to undertake is placed.  The reminder of the time (at least 80 percent) will be spend in a defined tutorial research program with a preceptor in one of the laboratories or clinical investigation areas described in this grant proposal.  The trainees in all tracks will also take part in inter- and intradepartmental seminars and conferences, and will be expected to report orally and in writing on the research being performed.  The trainee will be able to take whatever course work at Duke University is necessary for the satisfactory completion of his or her work.  Trainees in areas of clinical investigation will be encouraged to pursue either a masters in public health degree (at the University of North Carolina at Chapel Hill) or a masters in health sciences in clinical research degree granted by the Duke University Clinical Research Training Program (formerly the Biometry Training Program); at a minimum, they will be expected to complete an introductory course in statistics.  The training program funded by this award will be offered to qualified persons holding either the M.D. or Ph.D. degree with interests in research training in transfusion medicine and related areas.  Persons from minority groups and women will be encouraged to enter the program.  No predoctoral or primarily clinical competence training will be funded by this grant.  The facilities for research training will be based at the various. research laboratories and clinics of Duke University and the allied Veterans' Administration Medical Centers in Durham., North Carolina.  Fulfillment of the training goals of this program will meet present and future needs for scientists and physician-scientists who can conduct high caliber research in both basic and clinical sciences related to transfusion medicine and who can apply the rapidly growing knowledge in this field to the care of patients with hematopoietic and other disorders requiring blood product and stem cell therapy. ",Transfusion Medicine and Related Areas,,Marilyn J Telen,1885877
12,6764167,,2004,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,5T32GM007240-28,GM007240,UNITED STATES,T32,1117276,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant): The Cell, Molecular, and Genetics (CMG)
Training Program at the University of California, San Diego is currently in its
25th year. This program is the foundation of the Ph.D. training effort in the
biological sciences at UCSD, as it supports the very best graduate students
from the Biology-Salk and Chemistry-Biochemistry Ph.D. programs. The mission of
the CMG Training Program is to provide rigorous basic research training in cell
biology, molecular biology, and genetics to outstanding young biomedical
researchers in the earlier years of their doctoral studies. Specific emphasis
is placed upon the creativity, quality, and impact of the research, the ethical
conduct of research, the achievement of racial diversity among biomedical
researchers, the ability of the trainees to communicate their results
effectively, and the promotion of cooperation and collaboration among
scientists.  While the new director has already made an impressive
impact and demonstrates significant potential for leading this program to a
greater level of accomplishment, more time is needed to correct the weaknesses
mentioned above. Thus, funding for three years at the current slot level is
recommended to provide for a timelier reassessment of progress.
The CMG Program Director is Dr. Jim Kadonaga. He has been a member of the
Biology Department/Division at UCSD since 1988, and is currently Professor and
Vice Chair of the Molecular Biology Section. Dr. Kadonaga works with an
Advisory Committee for the CMG Training Program that consists of Drs. Lorraine
Pillus, Steve Wasserman, Bart Sefton, Elizabeth Komives, and Bill McGinnis.
There are currently 98 training faculty from the UCSD Division of Biology, Salk
Institute, UCSD Department of Chemistry and Biochemistry, and Department of
Cellular and Molecular Medicine at the UCSD Medical School. The CMG Training
Program provides support for 45 outstanding Ph.D. students that are selected
from a five-fold larger pool of eligible students (currently, 224 eligible
students). The trainees fulfill the general requirements of their respective
graduate programs and additionally participate in CMG-specific training
activities, which include biannual CMG Training Program Symposia, annual
One-on-One Conferences with the Program Director, and CMG Career Development
Workshops. Over the past 10 years, 124 CMG trainees have successfully completed
their Ph.D. thesis. Past and present CMG trainees have contributed an enormous
wealth of fascinating and important knowledge to the biological sciences
through a total of 411 publications (not including abstracts). With the
projected growth of biology at UCSD, we envision the implementation of an even
stronger CMG Training Program over the next five years.","Cell, Molecular and Genetics Training Program",,Randolph Y. Hampton,1924909
13,6735605,,2004,MAYO CLINIC,ROCHESTER,MN,,5T32DK007013-27,DK007013,UNITED STATES,T32,189776,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2007-11-30T05:00:00Z,,,Kidney Disease Research Training Program,,Vicente E Torres,1877235
14,6731098,,2004,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007101-29,HL007101,UNITED STATES,T32,231608,False,Beth  Schucker,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-03-31T05:00:00Z,,"DESCRIPTION (Applicant's Abstract) Duke University Medical Center has been engaged in the training of clinicians and scientists in the area of cardiovascular diseases -for over 40 years. Much of this success can be attributed to 25 years of funding of the Cardiovascular Training Program Grant.  This application is a competitive renewal for our Cardiovascular Training Program Grant, which was last funded in 1996.  The cardiovascular training program represents the integrated efforts of the Departments of Medicine, Surgery, Cell Biology, Pediatrics, Pharmacology, Engineering, and Genetics to train postdoctoral cardiovascular physician-scientists.  This will be accomplished by providing a multidisciplinary faculty and environment to trainees in order to foster and develop excellence in biomedical research related to the cardiovascular system.  The underlying philosophy of this program will be to integrate training and research by creating an environment that facilitates the natural linkages among programs and departments throughout the University.  An extended period of research (2 years or more) will be provided to trainees under the mentorship of program faculty who will closely supervise and direct the academic career development of the trainee.  This program will provide an important mechanism for supporting trainees during a critical period of postgraduate medical training and provide an environment conducive to a research-oriented career.  During this time, trainees will be ""protected"" from clinical responsibilities and immersed in research to obtain the background and experience necessary to establish themselves an independent investigators in academic institutions.  The individual mentor will provide skills such as experimental design, data analysis, and manuscript and grant preparation during the training period. The goal of this program is to continue this history of productivity by creating an environment that will ensure that Duke will continue to contribute to the development of young investigators capable of pursuing successful research careers in cardiovascular fields.  The current application will describe the modifications and improvements that have been recently implemented and will discuss Duke""s ongoing commitment to train the next generation of cardiovascular researchers.  The training program emphasizes the training of physician-scientists, and to this end, approximately 90% of the trainees will be MDs or MD/PhDs. ",Multidisciplinary Heart and Vascular Diseases,,Howard A Rockman,1882946
15,6740187,,2004,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32CA009140-30,CA009140,UNITED STATES,T32,624495,False,LESTER S. GORELIC,National Cancer Institute,1975-07-01T04:00:00Z,2005-04-30T04:00:00Z,,,IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES,,YVONNE J PATERSON,1877881
16,6945902,,2005,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PEDIATRICS,5T32AI007007-27,AI007007,UNITED STATES,T32,116133,False,Lawrence J. Prograis,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,2009-08-31T04:00:00Z,,"DESCRIPTION (provided by applicant): This training program has been designed to create a critical mass of faculty who can train Pediatricians to address the problems of allergic and immunologic diseases in children both in the laboratory and in the clinical setting.  The program is based in the Division of Allergy and Immunology in the Department of Pediatrics. The Division is located in the Children's Center of The Johns Hopkins Hospital.  All of the laboratories and offices are contiguous and consist of 7 separate, fully equipped laboratories, 6 faculty offices, 2 secretaries' offices, a Fellows' office, and a library/conference room.  The division is uniquely suited to offer fellowship training in that it is composed of 5 full-time and one 1/2 time investigators with balanced interests; 3 are primarily interested in allergy and 3 are primarily interested in immunology.  In addition, it utilizes the faculty and facilities of other divisions within the University's immunology community, such the Graduate Program in Immunology, the Division of Rheumatology and the Division of Clinical Immunology in the Department of Medicine.  
The program provides 3 years of balanced training in basic and clinical immunology to Pediatricians who will pursue an academic career.  Candidates will have completed a 2-4 year residency in Pediatrics.  They will be selected primarily based upon their commitment to an academic career and their interest in research in the allergic and immunologic diseases of children. Each trainee spends the majority of his/her time in laboratory research (80%), supplemented with course work and limited clinical responsibilities.  A single faculty member acts as the preceptor for a given fellow, supervising his/her laboratory work, helping to select formal course work, and designing a program of clinical activities. The laboratory work focuses on one of the areas in which the faculty is actively involved and includes immunology and Epidemiology of Childhood Asthma (Drs. Eggleston, Wood, Matsui, Lederman, Bochner and Adkinson), the role of immune system in host defense and inflammation (Drs. Lederman, Bochner, Rosen, Sule and Desiderio) and the Primary Immunodeficiency Diseases, (Drs. Lederman, Winkelstein, Sule, Rosen and Desiderio).  Course work includes both a core curriculum designed to give the fellow a strong foundation in basic immunology and elective courses aimed at meeting the special needs of the fellow.  Clinical training focuses on Allergy and Immunology but also includes limited experience in Rheumatology, Pulmonology, and ENT, and is in accord with that specified by the Board of Allergy and Clinical Immunology.",Research Training in Pediatric Allergy and Immunology,,ROBERT A WOOD,6785863
17,7059509,,2005,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,MISCELLANEOUS,3T32HD007014-30S1,HD007014,UNITED STATES,T32,311693,False,Rebecca L Clark,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,2006-04-30T04:00:00Z,,,DEMOGRAPHY AND ECOLOGY,,ALBERTO B. PALLONI,1903062
18,6778215,,2004,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,PEDIATRICS,5T32DK007087-31,DK007087,UNITED STATES,T32,125607,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY,,S. Michael Mauer,2295322
19,6896797,,2005,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007057-30,HL007057,UNITED STATES,T32,238799,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Applicant's Abstract) The purpose of the Training Program in Transfusion Medicine and Related Areas is to provide research training in transfusion medicine and the scientific disciplines related to it in order to develop academically oriented physician-scientists and nonphysician scientists with expertise in the performance of both basic and clinical research.  Upon completion of this program, each trainee will be qualified to assume a medical school faculty position and conduct an independent program of clinical or laboratory investigation in one of the fields of study included in this program, including transfusion medicine, immunohematology, and immunology (Track I); hemoglobin, hematopoiesis and cellular therapy (Track II); hemostasis and thrombosis (Track III); and molecular biology, molecular signaling, and DNA repair (Track IV).  In each of these tracks, exposure to the clinical aspects of the area selected (comprising less than 20 percent of the total trainee time during the tenure of this fellowship) will be provided to permit the trainee to understand the clinical context in which the research which he or she is to undertake is placed.  The reminder of the time (at least 80 percent) will be spend in a defined tutorial research program with a preceptor in one of the laboratories or clinical investigation areas described in this grant proposal.  The trainees in all tracks will also take part in inter- and intradepartmental seminars and conferences, and will be expected to report orally and in writing on the research being performed.  The trainee will be able to take whatever course work at Duke University is necessary for the satisfactory completion of his or her work.  Trainees in areas of clinical investigation will be encouraged to pursue either a masters in public health degree (at the University of North Carolina at Chapel Hill) or a masters in health sciences in clinical research degree granted by the Duke University Clinical Research Training Program (formerly the Biometry Training Program); at a minimum, they will be expected to complete an introductory course in statistics.  The training program funded by this award will be offered to qualified persons holding either the M.D. or Ph.D. degree with interests in research training in transfusion medicine and related areas.  Persons from minority groups and women will be encouraged to enter the program.  No predoctoral or primarily clinical competence training will be funded by this grant.  The facilities for research training will be based at the various. research laboratories and clinics of Duke University and the allied Veterans' Administration Medical Centers in Durham., North Carolina.  Fulfillment of the training goals of this program will meet present and future needs for scientists and physician-scientists who can conduct high caliber research in both basic and clinical sciences related to transfusion medicine and who can apply the rapidly growing knowledge in this field to the care of patients with hematopoietic and other disorders requiring blood product and stem cell therapy. ",TRANSFUSION MEDICINE AND RELATED AREAS,,Marilyn J Telen,1885877
20,6906544,,2005,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,BIOCHEMISTRY,5T32GM007215-30,GM007215,UNITED STATES,T32,1335444,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,GRADUATE TRAINING IN MOLECULAR BIOSCIENCES,,DAVID A BROW,1927890
21,6898279,,2005,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007196-31,GM007196,UNITED STATES,T32,349148,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):  This training grant will support 17 graduate students usually for their first two years.  The goal of this program is to give the students the widest possible education in genetics and provide opportunities to work in many of the major areas of genetics research, including plant, microbial, yeast, Drosophila, C. elegans, Zebrafish, human genetics, genomics and bioinformatics and other areas.  The Training Grant sponsors regular genetics research presentations by more senior graduate students and three student-invited outside genetics seminar speakers.  Students are selected for the grant before matriculating on the basis of their interests and their agreement to take an introductory and an advanced genetic course.  Their progress is followed by faculty advisors who are members of the Training Grant and by the Director this Grant.  These students will be part of the Biological and Biomedical Sciences program which includes the following components: 1) Advising throughout their graduate career by a faculty member of the Training Grant; 2) a set of four core courses in genetics and other core subjects, a critical reading course, and advanced courses.  The total required number of courses is 8; 3) a regular fall poster session, regular faculty talks, student-organized fall retreat, Mini-Symposia on specialized topics and Departmental activities all of which introduce students to the range of lab research subjects available; 4) a program and course in Conduct of Science and a seminar speaker on social issues in genetics; 5) laboratory rotations during the first 12 months allowing students to try out three labs; 6) forums on careers in academic science and in alternative careers; 7) a qualifying examination and a thesis advisory committee to follow the progress of the student; 8) regular seminars on genetic subjects in Medical School basic science Departments.",Regul. of Gene Expression in Prokaryotes and Eukaryotes,,FRED M. WINSTON,1863326
22,6911728,,2005,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,BIOCHEMISTRY,5T32GM007185-31,GM007185,UNITED STATES,T32,1015072,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"                                                                                    
 DESCRIPTION: (provided by applicant) This proposal seeks renewal for UCLA's        
 predoctoral Cellular and Molecular Biology Training Program. Now in its 26th       
 year, the program has trained more than 350 Ph.D. candidates for careers in        
 biomedical research and education. The program is interdepartmental and            
 includes faculty and students in the Departments of Chemistry and Biochemistry     
 and Molecular, Cell and Developmental Biology in the College of Letters and        
 Sciences, the Departments of Biological Chemistry, Microbiology, Immunology and    
 Molecular Genetics, and Neurobiology in the School of Medicine, as well as the     
 Interdepartmental Program in Molecular Biology. There are currently 84 training    
 faculty with primary appointments in 10 departments. Major research areas          
 include biochemistry, cell biology, developmental biology, gene expression,        
 macromolecular structure, molecular and cellular immunology, neurobiology,         
 virology and microbial pathology.                                                  
                                                                                    
 Representatives of each of the six major Ph.D. degree programs involved            
 nominate trainees for the program. Students are selected on a highly               
 competitive basis using the criteria of their academic and research                
 achievements. Appointments are made for a maximum period of three years. A         
 small number of students enter the training program as first year students;        
 however, the bulk of them come in after a year of graduate work when they have     
 chosen their dissertation research director. In addition to meeting the            
 University and Departmental or Program requirements for their degrees, trainees    
 participate in a research ethics course, as well as in seminars and conferences    
 organized by the Training Program. This proposal requests stipends for 45          
 trainees.                                                                          
                                                                                    
 The facilities are those of a major undergraduate and graduate campus of           
 approximately 33,000 students that includes a medical school faculty. All of       
 the departments involved in this program are in close proximity to each other      
 and to the interdepartmental Molecular Biology Institute, which facilitates        
 interactions of both students and faculty.                                         
                                                                                    
",RESEARCH TRAINING IN CELLULAR AND MOLECULAR BIOLOGY,,STEVEN G CLARKE,1863373
23,6894072,,2005,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,ANATOMY/CELL BIOLOGY,5T32GM007067-31,GM007067,UNITED STATES,T32,966443,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,DAVID A HARRIS,1893159
24,6893953,,2005,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOMEDICAL ENGINEERING,2T32GM007057-31,GM007057,UNITED STATES,T32,495217,False,Alison E. Cole,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant): The Biomedical Engineering Doctoral training program at the Johns Hopkins University aims to train talented students from engineering and other quantitative sciences for careers in biological and medical research. The program is interdisciplinary and interdepartmental in nature. Program faculty are drawn from a wide range of departments. This includes but is not limited to the departments of Biomedical Engineering, Neuroscience, Otolaryngology-Head and Neck Surgery, and Radiology in the School of Medicine, and the departments of Applied Mathematics and Statistics, Chemical and Biomolecular Engineering, Electrical and Computer Engineering, Material Science and Engineering and Mechanical Engineering in the Whiting School of Engineering. The faculty are engineers, applied mathematicians, neuroscientists, physiologists, cell biologists, and molecular biologists with both experimental and theoretical/computational research programs. A unique aspect of the program is that students are free to do research in any laboratory of the University, subject to program approval. Support is requested for 12 pre-doctoral trainees. The usual duration of the program is 5-6 years. Students are drawn mainly from engineering schools, although they also come from mathematics, physics, chemistry, and biology. Program coursework includes graduate level courses in life sciences plus advanced courses in engineering, mathematics, and biology. The core of the program is research training in the research laboratories of the Program faculty.      

",Biomedical Engineering Training Program,,RAIMOND Lester WINSLOW,1865780
25,6886797,,2005,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,PSYCHOLOGY,5T32MH014257-31,MH014257,UNITED STATES,T32,256456,False,Debra K. Wynne,National Institute of Mental Health,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,PA00103,"DESCRIPTION (provided by applicant):  This program provides predoctoral (4 positions) and postdoctoral (3 positions) research training for psychologists specializing in research design, measurement, statistical methods, decision making, psychological scaling, and assessment of individual differences, with an emphasis on application of these methods in investigations of behavioral and mental disorders. During their careers these specialists (a) continue to train students in all areas of behavioral and social sciences by their research and teaching activities, and/or (b) act as principal investigators or consultants in research on basic processes, psychopathology, and related problems. Predoctoral trainees receive Ph.D. degrees in Psychology; some having joint majors in quantitative methods and substantive problem areas such as clinical, developmental, or cognitive psychology. Other trainees major in quantitative methods and receive M.S. degrees in Applied Statistics with specialization in psychological  assessment, behavioral statistics (more broadly defined), and modeling with the aim of developing new methods, or improving existing methods for investigating psychological phenomena of all kinds, including basic cognitive, affective, social, and psychophysiological processes. Course and seminars are designed to advance trainees' knowledge of quantitative statistics that enables them to manipulate research data in psychologically meaningful ways. Research projects include: adolescent coping and neighborhood violence, social networks of at risk adolescent girls, reactions towards Arab Ethnic groups following the terrorist attacks on America, emotional and attentional mechanisms of high anxiety-sensitive individuals using fMRI neuroimaging and emotional Stroop paradigm, and cognitive and affective processes in pathological gambling. Research on methodological problems includes; effects of feedback on calibration, meta-analytic treatment of research results, alternatives to exploratory factor analysis, and models for the description and analysis of social networks.",Quantitative Methods for Behavioral Research,,Michel  Regenwetter,8586997
26,6886794,,2005,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,5T32AR007019-30,AR007019,UNITED STATES,T32,187758,False,Carl  Baker,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2007-04-30T04:00:00Z,,"
 DESCRIPTION: (Taken from the applicant's abstract) The purpose of the training     
 program in dermatology is to provide advanced training in basic science            
 research as it relates to the study of the skin. The program is directed           
 towards the training of physician-scientists for academic careers, but will        
 also include Ph.D.'s committed to dermatology and to the study of skin-related     
 problems. The training faculty group have particular expertise in the study of:    
 1 ) morphologic and biochemical assessment of cutaneous development and repair;    
 2) keratinocyte-specific proteins and function, 3 ) extracellular matrix           
 metabolism and, 4) structural proteins of the extracellular matrix including       
 elastin, proteoglycans, and collagens. The areas under investigation in these      
 laboratories utilize a variety of approaches involving cell biology,               
 enzymology, protein chemistry, modern molecular biology, gene transfection,        
 immunology, and cell culture. Specialized training in areas not offered by our     
 the staff will be open to the trainees through the close association with the      
 faculty of other departments in the medical school e.g., Dr. Peter Byers,          
 Professor, Dept. of Pathology, Dr. William Carter, Professor, Dept. of             
 Pathobiology and Fred Hutchinson Cancer Research Center (FHCRC), Karen             
 Stephens, Research Associate Professor, Dept. of Medicine, Division of Medical     
 Genetics, Dr. Curtis Omiecinski, Professor, Dept. of Environmental Health, Dr.     
 Buddy Ratner, Professor Dept. of Chemical Engineering, Dr. Nicole Gibran,          
 Associate Professor, Dept. of Surgery and Dr. Mark Bothwell, Professor, Dept.      
 of Physiology and Biophysics. There are research seminars presented by the         
 division as well as seminars offered in a number of associated basic science       
 departments including Biological Structure.                                        
                                                                                    
 The dermatology training grant program is intended to train individuals with a     
 strong commitment to pursue a full-time academic research career. Continued        
 support is requested for 3 postdoctoral trainees who have received the degree      
 of either M.D. or Ph.D. Candidates are selected from the clinical training         
 program and/or from outside applicants applying directly to the research           
 program. The training program has developed a program for expanding the pool of    
 qualified minority applicants as well as recruiting and retaining those            
 applicants. Likewise, a program is in place for teaching research integrity.       
                                                                                    
",DERMATOLOGY TRAINING,,JOHN Everett OLERUD,1894262
27,6845185,,2005,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,2T32GM007200-31,GM007200,UNITED STATES,T32,2446788,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The purpose of Washington University's Medical Scientist Training Program is to provide in-depth training in the techniques of modern biomedical research and clinical medicine for students who wish to join faculties of clinical or preclinical departments at medical schools throughout the country. Its goal is to ensure that each student acquires thorough knowledge in a chosen scientific discipline in addition to the diverse education gained in medical school. This training is available to students within the interdepartmental graduate programs of the Department of Biomedical Engineering and the Division of Biology and Biomedical Sciences, which includes the programs in Developmental Biology, Immunology, Molecular Biophysics, Biochemistry, Chemical Biology, Molecular Cell Biology, Molecular Genetics, Molecular Microbiology and Microbial Pathogenesis, and Neurosciences. Students may also do biomedically relevant doctoral work in other departments, such as Physics or Anthropology. The basic components of the MSTP are: 1) two years of the medical school curriculum; 2) a minimum of three years of biomedically related doctoral research; and 3) 15-24 months of Clinical training. The M.D. and Ph.D. degrees are awarded jointly at the successful completion of these components. This program, which features a high degree of flexibility, may be modified and adjusted to provide highly individualized training and meet specific career goals.      

",National Research Science Award - Medical Scientist,,Daniel E. Goldberg,1930486
28,6845060,,2005,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,BIOLOGY,2T32GM007092-31,GM007092,UNITED STATES,T32,294302,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  This application requests continued support for predoctoral student training in genetics and molecular biology. Students who receive support are enrolled in the Curriculum in Genetics and Molecular Biology, and interdepartmental predoctoral training program. The goal of this program is to train students to be creative, sophisticated research scientists in the disciplines of genetics and molecular biology. The emphasis of this training is the acquisition of a foundation of knowledge, the accumulation of laboratory skills, and the development of the ability to formulate experimental approaches to solving contemporary problems in the biological sciences. The Curriculum Director, Robert J. Duronio, serves as the Program Director for this NRSA award. The 75 training faculty have appointments in the School of Medicine and the Department of Biology. They participate in student training by acting as dissertation sponsors, serving on dissertation committees, teaching in Curriculum sponsored courses, inviting speakers for the Curriculum's seminar series, and serving on administrative committees such as the Admissions Committee. There are currently 71 students enrolled in the Curriculum and they are training in 35 laboratories in 9 departments on the UNC-CH campus and one laboratory at the NIH Sciences. Student research includes the generation and characterization of mouse models of human diseases, the characterization of molecular mechanisms of replication, recombination and repair, the control of gene expression, and the genetic basis of cancer. The training program requires all students to take courses in genetics and molecular biology, to attend sessions on responsible conduct of research, to attend Curriculum seminars, to act as teaching assistants for one semester, to participate and present in a student seminar series, to present a poster for the Annual Research Day, and to pass a written qualifying exam, an oral preliminary exam, and a final oral exam and written dissertation. Essentially all students publish their dissertation research in peer-reviewed journals.      

",NRSA in Genetics,,ROBERT J DURONIO,1866381
29,6844955,,2005,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,2T32GM007229-30,GM007229,UNITED STATES,T32,609525,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The Cell and Molecular Biology Training Program at the University of Pennsylvania is a University-wide, interdepartmental and interschool program whose mission is to provide a multifaceted doctoral program to prepare students for careers in cell and molecular biology in academia, industry, or government. The training program's goal is to provide broad-based training in modern methods of cell and molecular biology and in-depth didactic exposure to cell and molecular biology, while at the same time matching the Trainees' specific interests. These goals are achieved through general and specialized courses, literature survey courses, laboratory rotations, a qualifying examination, thesis research with oversight from an advising committee, training in bioethics, and training grant-specific activities. Trainee-specific activities include a biweekly Trainee Seminar Series during which junior Trainers present a research seminar or Trainees present a short talk on their rotation/thesis research; attendance at the annual Cell and Molecular Biology Retreat; attending the Annual Trainee Organized Invited Lectures; participating in Alumni Day in which a former Trainee who has completed their Ph.D. and left Penn is invited back to give a seminar and meet with the Trainees; and the Current and Former Trainee Lunch in which 2-3 former Trainees now pursuing their thesis research meet with current Trainees and discuss their research. Incoming students are appointed for two years and are selected annually by an open and democratic process. Trainers come from the Schools of Medicine, Veterinary Medicine, and Biology and have active research programs in cell and molecular biology and a commitment to graduate education. The training program has formal mechanisms to monitor trainees both during and after their training grant support. In addition, the training program has formal mechanisms to monitor trainers, as well as to resolve any conflicts between trainees and trainers. Last, the training program has specific initiatives to recruit under-represented minorities both locally and nationally.  
      

",Training Program in Cell and Molecular Biology,,RICHARD M SCHULTZ,1876102
30,8501472,,2013,YALE UNIVERSITY,NEW HAVEN,CT,ANATOMY/CELL BIOLOGY,5T32GM007205-39,GM007205,UNITED STATES,T32,2085492,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2015-06-30T04:00:00Z,PA08226,"  
DESCRIPTION (provided by applicant): The Medical Scientist Training Program at Yale is designed to train physician-scientists who will translate basic and clinical research to problems of human pathobiology. About 12 students each year enter our MSTP and make up -12% of the medical school class. The strength of our Program is the flexibility of the Yale System of medical education and the breadth and depth of the graduate programs at Yale. These programs of medical and graduate education allow MSTP students to customize their educational paths. Graduate training at Yale provide students with opportunities in many biomedical tracks including Cell Biology, Physiology, Genetics, Immunology, Microbiology, Molecular Biophysics & Biochemistry, Neuroscience, Pharmacology, Molecular Cellular & Developmental Biology, and Chemistry. We accommodate students in nontraditional areas such as epidemiology and public health, psychology, computer sciences, sociology and anthropology. New programs in Translational Research (e.g... Clinical Immunology and Cancer Biology), and in Biomedical Engineering provide new opportunities for MSTP students. The Program requires ~8 years to complete but emphasizes interdisciplinary training and correlation with clinical disciplines. Students spend the first two years studying basic sciences of which some courses can be taken for graduate school credit. Clinical medicine is introduced in the 2nd year and emphasizes systems approaches to disease. All students complete 6 months of clerkships in medicine, pads and psychiatry before beginning thesis work. This prepares them for participation in weekly longitudinal clinics in ambulatory medicine, designed for MSTP students during the research years. Students are thus able to relate research training to clinical medicine without compromising lab time. Approximately 74% of our graduates now in academic positions are in clinical departments while 26% are in basic science departments. Our goal of preparing physician-scientists for academic careers has been successful in that -90% of our graduates have peer reviewed research grants. Over the past 36 years the Program has been in existence, > 8,000 publications in top journals have appeared.   
  
RELEVANCE: Basic and translational/clinical research form the basis for all advances in health. We are now at a crossroads in basic science with our understanding of the human genome and our ability to decipher the cellular and molecular basis of normal and pathophysiological processes, and design rational approaches to alleviating disease. The future of medicine depends on the marriage of basic and clinical disciplines: MSTP nhvsician-scienti.sts will lead these endeavors.   
    

",Medical Scientist Training Program,,JAMES Douglas JAMIESON,1866407
31,8501470,,2013,UNIVERSITY OF WASHINGTON,SEATTLE,WA,SURGERY,5T32GM007037-39,GM007037,UNITED STATES,T32,260220,False,Scott D. Somers,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2015-06-30T04:00:00Z,PA08226,"  
DESCRIPTION (provided by applicant): The program trains physician-scientists and post-doctoral PhD scientists in aspects of the pathophysiological processes that occur after traumatic injury and critical illness. Over the past 4 years we have successfully recruited to fill our positions and have addressed a key concern that was raised in our previous competitive renewal regarding diversity in our program. We have paid particular attention to identifying and recruiting strong under-represented minority candidates.  Our previous competitive renewal also focused upon the ""key initiatives"", defined by the leaders at the National Institutes of Health and termed the ""NIH Roadmap"". This had direct bearing on the structure and direction of this training program. Briefly, the key initiatives or themes are: (1) New Pathways to Discovery, (2) Research Teams of the Future and (3) Reengineering the Clinical Research Enterprise. We propose to continue to educate trainees in established molecular biology techniques and will expand their training to include cutting edge research and analysis (i.e. biomedical computing) techniques. Through collaborations with basic scientists and integration with the available research education programs at the University of Washington, we will expose trainees to broad-based research teams and programs. Trainee education and experience will continue to include concepts of translational research, whereby basic observations will be evaluated as potential diagnostic and therapeutic benefit for critically ill patients.  In summary, we aim to prepare a diverse group of interested scientists for academic careers as independent investigators and educators. Through a multidisciplinary and collaborative effort, trainees learn how to identify important research questions, how to design, conduct and analyze experiments that will address these questions and how to translate their findings into clinically relevant interventions. RELEVANCE:  Trauma remains an important public health problem. Injuries are responsible for a high proportion of deaths in people of all ages and medical care for injury victims is costly. Our training program has successfully educated surgeons, physicians and post-doctoral students in aspects of the applied biology of injury and inflammation. Graduates from our program have demonstrated a commitment to understanding the biology of injury and to the care of critically ill injury victims.   
    

",POSTDOCTORAL TRAINING,,GRANT E O'KEEFE,7040005
32,8481555,,2013,UNIVERSITY OF CHICAGO,CHICAGO,IL,GENETICS,5T32GM007197-39,GM007197,UNITED STATES,T32,803782,False,Anthony D. Carter,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"  
DESCRIPTION (provided by applicant):  The aim of this program is to educate well-trained scholars with an advanced appreciation of genetic rationales and methods to 1) perform basic and applied biomedical research, 2) provide future educators in this discipline, and 3) fulfill health- related positions, both academic and in industry, requiring a sophisticated understanding of genetics and genomics. The training faculty is comprised of fifty-five distinguished and respected members of the scientific community. Their specific strengths are focused in the areas of: chromosome organization and behavior, gene expression and developmental genetics, genetics of model organisms, population and evolutionary genetics, systems biology, and the genetics of human diseases with special emphasis on genetic alterations in cancer, diabetes, cardiac disorders and asthma. Diverse systems including viruses, bacteria, Arabidopsis, yeast, ciliates, Drosophila, nematodes, zebrafish, mice, humans, and a variety of other plant and animal species. Research is also characterized by the use of interdisciplinary approaches.    
  
",Genetics and Regulation," The aim of this program is to educate well-trained scholars with an advanced appreciation of genetic rationales and methods to 1) perform basic and applied biomedical research, 2) provide future educators in this discipline, and 3) fulfill health- related positions, both academic and in industry, requiring a sophisticated understanding of genetics and genomics.  
  
    

",LUCIA B. B ROTHMAN-DENES,1888982
33,8490405,,2013,UNIV OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007149-37,HL007149,UNITED STATES,T32,338588,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2017-06-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant): The long standing Hematology T32 Training Grant at the University of North Carolina at Chapel Hill (UNC-CH) remains committed to training both MD physician-scientists and PhD scientists for careers in academic hematology and hematology research. This program will continue to train adult and pediatric hematology fellows and PhD post- doctoral candidates in areas of traditional institutional research strengths encompassing benign hematology. Both basic bench and clinical research tracks are available, with carefully selected didactic coursework to complement the training experience. In this competitive renewal application, scientific and educational interactions between MD and PhD trainees in the form of conferences, journal clubs, and symposia have been emphasized. Following 2 years of training on the T32 grant, trainees will be encouraged to apply for individual or institutional K series awards, and/or other sources of independent funding.    
   
      

",Research Training in Hematology at UNC Chapel Hill,"
Project Narrative:
For over 35 years, the training program in academic hematology at the University of North
Carolina at Chapel Hill (UNC-CH) has benefitted from support by the Ruth L. Kirschstein
National Research Service Award. This program, which encompasses disorders of the
blood, vasculature or immune system, has been extraordinarily successful in its mission
to train clinical and bench researchers in hematology. The cornerstones of training
include a mentored research project, focused seminars and conferences, training in the
responsible conduct of research, and didactic coursework in clinical research, laboratory
methodology, grantsmanship, and the academic community. Both MD and PhD
postdoctoral candidates are recruited from intramural and extramural sources, and their
frequent interaction during the 2-year period of support engenders a mutual respect and
understanding of the ultimate goals of biomedical research in hematologic disorders.",Nigel S. Key,1887365
34,8490347,,2013,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32DK007066-39,DK007066,UNITED STATES,T32,411807,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2015-06-30T04:00:00Z,PA08226,"  
DESCRIPTION (provided by applicant): The University of Pennsylvania Gl Training Program has been instrumental in the development of academic research careers for gastroenterology trainees since 1963. During the last 10 years, there has been tremendous expansion of biomedical research. The Penn Training Program has increased its base of basic science faculty coupled with impressive growth and maturation of the adult and pediatric Gl divisions. Trainees have outstanding opportunities to pursue molecular and cellular biology in the field of gastroenterology. Direction: The Program Director and Associate Directors have an administrative structure that oversees the needs of the Training Program, assisted by an internal Executive Committee and an External Advisory Board. They are complemented by rigorous individual trainee research advisory committees. Faculty: Research faculty from the Adult and Pediatric Gl divisions and basic science departments are selected based upon experience with trainees, independent and externally funded laboratories, and relevant projects in digestive, liver and pancreatic diseases. The faculty are grouped by research interests: 1) Cell growth and differentiation; 2) Immunobiology and host responses; and 3) Developmental biology and genetics. Proposed Training: The cornerstone of the Program is an intensive laboratory-based research experience, which entails close interaction with a training program faculty mentor. This laboratory work is supplemented by an educational curriculum that includes an introductory course in molecular and cellular biology, selected University courses, research seminars and lectures, written and oral research presentations, and seminars on extramural funding and the ethics of scientific research. Candidates: Outstanding trainees with MD or MD-PhD degrees postdoctoral fellows) enter the Program from the Adult and Pediatric Gl Fellowship Programs after being selected through a nationally competitive application process. Additionally, there has been growth in Penn's Physician-Scientist Residency Pathway, and new avenues have emerged to identify future trainees in gastroenterology, including through our NIDDK R25 undergraduate training grant and our medical student training grant supplements.   
  
PUBLIC HEALTH RELEVANCE: The overarching objective of this Training Program is to provide the experience and expertise for physician- scientists and selected PhD scientists to develop independent research careers in the investigation of important questions in digestive, liver and pancreatic diseases.   
    

",Training program in gastrointestinal sciences,,Anil K Rustgi,1868587
35,8500305,,2013,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,GENETICS,5T32GM007067-39,GM007067,UNITED STATES,T32,937746,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"  
DESCRIPTION (provided by applicant): This application requests continuing support for a successful interdisciplinary program in Cellular and Molecular Biology at Washington University in St. Louis. The mission of the program is to provide interdisciplinary training to graduate students from four distinct yet related fields of cell and molecular biology (Developmental Biology, Genetics, Cell Biology, and Microbiology). Our program is highly integrated and introduces students to the core concepts and methods of cell and molecular biology. It has an organizational structure specifically designed to foster student and faculty interactions that span programmatic and departmental boundaries, to maintain effective communication and cooperation among the faculty and steering committees of four individual doctoral programs, and to oversee a centralized admissions process. In this renewal, we are implementing three training grant-specific activities to foster a group identity among training grant-supported students: a student-hosted research seminar, a series of sponsored lunches for first- and second-year students, and a set of first-year student talks. We identify students for support based on eight parameters and support them for their first three years because this is when they are most involved in the unifying didactic components of the program. In addition, by supporting students in their first year, we supplement university funds and are able to matriculate more students than would otherwise be possible. We have successfully continued our efforts at recruiting students from under-represented groups in science and disadvantaged backgrounds, and are expanding these efforts to include students with disabilities. The Cellular and Molecular Biology Training Grant itself serves as a powerful unifying force that interconnects students and faculty from all four programs around the shared responsibility of graduate training. And, our graduate training program seeks to enable our students to pursue careers at the vanguard of scientific research and education by helping them to establish a broad-based scientific foundation of knowledge and network of colleagues as they initiate their scientific career.  
  
",Training Program in Cellular and Molecular Biology," 8. Public Health Relevance Statement Most human diseases arise due to disruptions in basic cellular and molecular processes caused by mutations in one's own DNA or the presence of a pathogen in one's body. Our program trains students in the core concepts and methods of cell and molecular biology, and thus provides them with the knowledge and skills required to identify the molecular basis of, and develop more effective treatments for, human disease.  
    

",James Benjamin Skeath,1902990
36,8499386,,2013,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007057-38,HL007057,UNITED STATES,T32,496288,False,LISBETH A WELNIAK,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"  
DESCRIPTION (provided by applicant): The purpose of the Training Program in Transfusion Medicine and Hematology is to provide research training in transfusion medicine and the scientific disciplines related to Hematology in order to develop academically oriented physician-scientists and nonphysician scientists with expertise in the performance of both basic and clinical research. Upon completion of this program, each trainee will be qualified to assume a medical school faculty position and conduct an independent program of clinical or laboratory investigation in one of the fields of study included in this program, including Immunohematology and Transfusion Medicine (Track I); Hemoglobin, Hematopoiesis and Cellular Therapy (Track II); Coagulation and Thrombosis (Track III); and Molecular Biology, Molecular Signaling, and Genetics (Track IV). In each of these tracks, exposure to the clinical aspects of the area selected (comprising less than 20 per cent of the total trainee time during the tenure of this fellowship) will be provided to permit the trainee to understand the clinical context in which the research which he or she is to undertake is placed. The remainder of the time (at least 80%) will be spent in a defined tutorial research program with a preceptor in one of the laboratories or clinical investigation areas described in this grant proposal. The trainees in all tracks will also take part in an inter- and intradepartmental didactic program, including both standardized curricular content as well as topical seminars and conferences. Each trainee will be expected to report orally and in writing on the research being performed at regular intervals. The trainee will also be encouraged to take additional course work at Duke University it that will enhance his/her ability to achieve satisfactory completion of his/her work. Trainees in areas of clinical investigation will be encouraged to pursue a masters in health sciences in clinical research degree granted by the Duke University Clinical Research Training Program; at a minimum, they will be expected to complete an introductory course in statistics and attend the training program's own course in clinical investigation. The training program funded by this award will be offered to qualified persons holding either the M.D. or Ph.D. degree with interests in research training in transfusion medicine and hematology; at least one trainee will be recruited specifically into the field of genomics and hemoglobinopathies. Persons from minority groups and women will be encouraged to enter the program. No predoctoral or primarily clinical competence training will be funded by this grant. The facilities for research training will be based at the various research laboratories and clinics of Duke University and the allied Veterans' Administration Medical Centers in Durham, North Carolina. Fulfillment of the training goals of this program will meet present and future needs for scientists and physician-scientists who can conduct high caliber research in both basic and clinical sciences related to transfusion medicine and hematology and who can translate the rapidly growing knowledge in these fields to improvements in the care of patients with hematologic disorders and other conditions requiring blood product and stem cell therapy.  
  
    

",TRANSFUSION MEDICINE AND HEMATOLOGY,"
Project Narrative: Relevance
This training program will provide basic and clinical research training to physicians and PhD scientists focused
on problems related to hematologic diseases and their treatment, including the science of transfusion and
cellular therapy, including hematopoietic stem cell transplantation. Advances in these fields are needed in
order to improve the health of millions of people with inherited and acquired blood disorders.",Marilyn J Telen,1885877
37,8496783,,2013,UNIVERSITY OF WISCONSIN-MADISON,MADISON,WI,GENETICS,5T32GM007133-39,GM007133,UNITED STATES,T32,677481,False,Anthony D. Carter,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2014-06-30T04:00:00Z,PA06468,"  
DESCRIPTION (provided by applicant): The goal of this proposal is to train predoctoral students broadly in the discipline of genetics. Graduate students admitted to the University of Wisconsin doctoral program in Genetics will be supported in the initial years of their graduate training. The Genetics doctoral program presently consists of 73 faculty representing 20 different departments in the biological sciences and 65 students studying with 33 different faculty trainers. The collective research interests of program faculty and students encompass virtually the entire breadth and depth of contemporary genetics. Trainees are selected based on prior academic achievements, research experience, and personal interviews conducted before acceptance into the program. Accepted students identify Genetics as their primary academic pursuit and choose thesis advisors based on their individual research interests. The Genetics doctoral program is a campus-wide training program administered by the Laboratory of Genetics, which is housed in two adjacent modern research buildings. Supported students complete a rigorous academic program consisting of both formal coursework and individualized mentoring in genetics; Formal coursework includes a core curriculum of required genetics courses, specialized electives identified by students together with their Thesis Advisory Committee, and a course in the ethical conduct of science. Students gain teaching and communication experience by (i) serving for one semester as a Teaching Assistant for an undergraduate Genetics course and (ii) presenting their thesis research in formal settings before faculty and students of the program. Student performance is evaluated by a two-part qualifying examination that tests their understanding of broad genetic principles and their ability to propose, accomplish, and defend a thesis research project. Student progress is monitored annually by a Thesis Advisory Committee. The Genetics Training Grant develops young investigators as independent scientists by providing a rigorous and broad education in the science of genetics. Our graduates bring the methods and logic of genetic analysis to bear on contemporary research problems.  
    

",Predoctoral Training Program in Genetics,,Philip  Anderson,1893729
38,8494650,,2013,UNIVERSITY OF COLORADO DENVER,Aurora,CO,INTERNAL MEDICINE/MEDICINE,5T32HL007085-39,HL007085,UNITED STATES,T32,846271,False,Sandra  Colombini-Hatch,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2015-06-30T04:00:00Z,PA08226,"  
DESCRIPTION (provided by applicant):   
The renewal application represents years 35 - 40 of the institutional training grant in pulmonary diseases from the University of Colorado Denver. The continuing goal of the program, is to prepare l\/ID and PhD trainees for careers in the translational research of lung diseases. The program incorporates a multidisciplinary and interdisciplinary approach highlighting opportunities for either clinical-translational or basic translational T32 trainees. This is accomplished by recruiting exceptional and committed applicants and exposing them to an environment which features dedicated, experienced, and well funded mentors. To adapt to the current research environment and to facilitate cross fertilization, collaboration and the incorporation of new high throughput platforms we have reorganized the research activity into four firms: Injury, Repair, Remodeling; Vascular Biology; Host Defense, Immunology; and Epithelial Cell Biology. The program plan for both MD and PhD trainees includes oversight by the PD/PI, a programmatic research oversight committee, individual trainee research committees, and trainee mentor(s) in the School of Public Health and the Clinical Science Program of the CTSA. There are also postgraduate degree programs for clinical-translational research trainees (MPH, PhD) and advanced course work for basic translational researchers. The trainees are made aware of their responsibilities when accepting a T32 position, including timelines for accomplishments, and the expectation for application for further fellowship or advanced career development awards. Significant new resources have been obtained for the pulmonary research environment at both the University of Colorado Denver and its affiliated institute. National Jewish Health. The proposed research training is three years, four positions each in post graduate years 5, 6, 7. We maintain our goal of preparing the next generation of pulmonary investigators.   
    

",Multidisciplinary Research Training in Respiratory Disease,,"MARK W GERACI,Marvin I Schwarz","1887562,1963090"
39,8492089,,2013,YALE UNIVERSITY,NEW HAVEN,CT,PHARMACOLOGY,5T32GM007324-37,GM007324,UNITED STATES,T32,357236,False,Richard T. Okita,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2017-06-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant):  The objectives of this program are to train graduate students for a research career in academia, pharmaceutical companies, or government research agencies in the general area of pharmacology, with a focus on signal transduction, structural biology, neuropharmacology, and drug discovery. The program is designed to adapt to students' interest a will provide a strong biochemical, neuroscience, biophysical, and physiological background that will enable the student (1) to understand the molecular basis of currently used therapeutics; (2) to design experiments (a) to identify potential targets; and (b) t elucidate signal transduction mechanisms of new physiological agents or new therapeutics, (c) to solve macromolecular structures of interest in pharmacology, and (d) use modern tools for drug discovery. To achieve these ends, the pharmacology program at Yale was changed with new faculty and courses. Modern techniques in molecular pharmacology, cell and molecular biology, structural biology, chemistry, biochemistry, physiology and biophysics will be available to the trainee to achieve these goals. The trainee will have constant exposure to a variety of research programs of the faculty and over one hundred senior postdoctoral fellows who provide an additional resource for the trainees.     
   
",Institutional National Research Service Award," The training program is designed to produce high-quality independent scientists with expertise in the general area of pharmacology and signal transduction.     
      

",William C Sessa,1862877
40,8475019,,2013,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,2T32GM007281-39,GM007281,UNITED STATES,T32,893782,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2018-06-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant): The Medical Scientist Training Program (MSTP) is committed to training the next generation of scholars and leaders in the biomedical sciences by providing students with access to the very best resources of the University of Chicago. Chicago's distinctive interdisciplinary approach encourages students to explore their medical and research interests in the broadest possible terms in medicine, biology, the social sciences and the physical sciences. The University of Chicago was among the first schools to obtain federal funding in 1967 for a MSTP. Currently, we are in our 45th year of uninterrupted funding and have graduated 255 physician scientists. Our trainees have made many fundamental contributions to our understanding of biology and human disease resulting in numerous papers in Nature, Science, Cell, Immunity and the Proceedings of the National Academy of Sciences. Our graduates have gone on to lead important departments and academic units including the MSTPs at UCSF, Stanford, Harvard and Emory. Two of our trainees have been elected to the National Academy of Sciences. Currently 57 individuals, from all over the country, are enrolled in the program of which 37% are women and 7% are URMs. However, we have initiated several programs to enhance diversity and 3 of our 11 incoming students, or 27%, are URMs. In 2012, we had a large applicant pool of 438 students from which we successfully recruited students of outstanding academic promise. Therefore, we are requesting 35 NIH-supported trainee slots for years 39-43. This level of support, in conjunction with substantial and ongoing support from the University of Chicago Biological Sciences Division, will ensure that at least 10% of the total incoming Pritzker Medical School Class are trained as physician scientists. Relative to our institutional support, the requested NIH investment would be reasonable, constituting only 27% of our anticipated budget. Since the last funding submission in 2009, significant changes in the University of Chicago MSTP have been implemented. This proposal details how the MSTP administration has been completely overhauled to improve student recruitment, mentoring and student involvement in governance. As described, several new initiates have been undertaken to enhance the rigor and productivity of graduate training, fully integrate the graduate and medical school curriculums, lessen the time to degree and to enhance both the recruitment and retention of URMs. We also provide compelling and detailed evidence on the superb quality of our students and the outstanding research environment at The University of Chicago that is uniquely configured to support interdisciplinary programs such as the MSTP.   
   
",Medical Scientist National Research Service Award,"PUBLIC HEALTH RELEVANCE: The University of Chicago Medical Scientist Training Program is designed for students who wish to pursue broad careers in research relevant to human health and disease. Overall, the MSTP seeks to fulfill a national need for individuals who will apply clinical and research experience to biomedical investigation and will catalyze the application of multidisciplinary approaches to solve the most pressing problems in medical science. The Medical Scientist Training Program is committed to training the next generation of scholars and leaders in the biomedical sciences by providing students with access to the very best resources of the University of Chicago. Chicago's distinctive interdisciplinary approach encourages students to explore their medical and research interests in the broadest possible terms in medicine, biology, and the physical sciences.   
      

",Marcus Ramsay Clark,6298240
41,8474817,,2013,HARVARD SCHOOL OF PUBLIC HEALTH,BOSTON,MA,PUBLIC HEALTH & PREV MEDICINE,5T32HL007118-38,HL007118,UNITED STATES,T32,616920,False,Xenia  Tigno,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"  
DESCRIPTION (provided by applicant): The breadth of interdisciplinary research teams is expanding dramatically. At the intersection of environment and health, in particular, teams increasingly need strong grounding in basic biology and genetics while at the same time need increasingly sophisticated analyses of disease models. Only then will they be prepared to study the interaction of susceptibility genes with environmental exposures. For that reason we have adopted the approach that the modern trainee cannot be expected to do it all; rather, to succeed he or she will need to be prepared with the strongest possible disciplinary foundation together with the tools needed to work effectively with others outside their own discipline. From a large and talented pool of applicants, we select outstanding BS and DVM trainees who seek the PhD or ScD degree, and outstanding PhD, MD, and DVM trainees who make a 3-year commitment to postdoctoral training in interdisciplinary pulmonary sciences. Trainees with backgrounds in biology, medicine, engineering, and physics work side-by-side on problems at the intersection of pulmonary sciences and environmental exposures. These trainees benefit from working with each other, working with trainees not supported by this T32, and working with a well-funded interdisciplinary faculty. This faculty addresses three main problems: air pollution, lung infection, and asthma. The theme of pulmonary inflammation spans these foci. Another theme is a strong emphasis on engineering and physical sciences. Bridging the gap between the life sciences and the physical / engineering sciences has been a longstanding goal of our program. These themes foster exceptional levels of collaboration among a faculty with unusually diverse expertise and interests. They form the faculty into a cohesive interdisciplinary team elucidating basic mechanisms of lung disease. Our Program offers access to excellent facilities and unique nanotechnologies, and is designed so that trainees will: 1) master modern technologies of cell and molecular biology as well as integrative physiology; 2) learn the relative strengths and weaknesses of different approaches, 3) design experiments effectively and interpret data critically, 4) adapt well to change, and 5) build successful careers as responsible members of the scientific community. In the past 34 years of our T32 we have never had an unfilled slot. In the past 10 years of our T32, 6 of our trainees were underrepresented minorities and 27 have completed training. 25 are currently working in science, including 7 in industry and 18 in academia at the rank of assistant professor or higher.  
  
  
  
    

",Training in Interdisciplinary Pulmonary Sciences,"
PROJECT NARRATIVE
Our training program addresses three main problems: air pollution, lung infection, and asthma. The theme of
pulmonary inflammation certainly spans these problems, as does a strong interdisciplinary emphasis on
bridging the gap between the biological sciences and the physical sciences. These bridging themes form our
faculty into a cohesive interdisciplinary training program elucidating basic mechanisms of lung disease.",Jeffrey J Fredberg,1887476
42,8414456,,2013,MAYO CLINIC ROCHESTER,ROCHESTER,MN,,2T32HL007111-36,HL007111,UNITED STATES,T32,385688,False,Wayne C. Wang,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2018-07-31T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant): The ""Cardiovasology"" Post-doctoral Training Program at Mayo Clinic, in this renewal, requests continuation of support for years 36 to 40. Through four decades of mentored career development, the Program has realized the mission of preparing physicians and scientists for independent research careers in cardiovascular medicine and biology. Trainees have acquired rigorous scientific proficiency, excelled in productivity, established track- records in research support, and secured academic placements contributing to the nation's diverse workforce. Accomplishments have included strong recruitment and retention, interactive mentoring with outstanding NIH- funded faculty, robust infrastructure and cooperative environment ensuring launch of competitive careers. The renewal spans science-education-practice intersections to best equip next generation investigators. Mapped to draw from highest educational standards and cutting-edge technological platforms, the Program is customized to match the background and career path of each trainee, while widening interests and capabilities in pursuit of evolving scientific advances. Heart failure - with focus on translation from the bench to the bedside to populations - is the central theme, reflecting national morbidity and mortality trends. The Program actuates the NHLBI Strategic Plan by implementing training for the better understanding of molecular and clinical mechanisms of heart failure aimed at improved prevention, diagnosis, and treatment of individuals and the public-at-large. Leveraging major initiatives at Mayo Clinic, including the NIH Center for Translational Science Activities, Department of Health and Human Services Southeast Minnesota Beacon Program, NHLBI Heart Failure Clinical Research Network, NIH Pharmacogenomics Research Network, NHLBI Cardiovascular Cell Therapy Research Network, and Minnesota Partnership for Biotechnology and Medical Genomics, the Program assembles collaborative and complementary teams of mentors across the discovery-translation- application continuum interconnected with local/regional/national centers of excellence. Committed to NHLBI programmatic emphases, the renewal integrates multidisciplinary training to achieve competencies in evolving areas of scientific need. The renewal capitalizes on degree-granting programs; community-based heart failure registries and biobanks; enabling biotechnology platforms; and rolled-out diagnostics/therapeutics pipelines. Aligned with Mayo Clinic Strategic Priorities of Individualized Medicine, Regenerative Medicine, and Science of Health Care Delivery, offerings have been enriched to include curricula in personalized medicine and Pharmacogenomics; regenerative medicine; systems biology and bioinformatics; molecular imaging; genetic epidemiology; comparative effectiveness; and health disparities research. A fellow-to-faculty career development program is in place to foster faculty transition, and a minority recruitment and responsible conduct of research plans are implemented to ensure consistent success. The renewal underscores the vision of the ""Cardiovasology"" Program to provide most advanced training at the vanguard of cardiovascular research. (End of Abstract)   
      

",Cardiovasology,"
Project Health Relevance Statement
Cardiovascular disease is the leading cause of global mortality, accounting for 1 of every 3 deaths in the
United States. The ""Cardiovasology"" Training Program offers post-graduate training to best equip next
generations of physicians and scientists committed to cardiovascular research careers in advancing
prevention, diagnosis, and treatment of heart failure in patients and populations.",ANDRE  TERZIC,6195276
43,8333807,,2013,UNIVERSITY OF WASHINGTON,SEATTLE,WA,BIOCHEMISTRY,2T32GM007270-39,GM007270,UNITED STATES,T32,981728,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2018-06-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant): This proposal requests continued funding of the predoctoral Training Program in Cell and Molecular Biology at the University of Washington and Fred Hutchinson Cancer Center (UW/FHCRC). Trainees in the program are chosen by a rigorous selection process that picks the top graduate students from three interdisciplinary programs and eight departmental programs. The major goal of this program is to train students in cell and molecular biology during their graduate career by exposing them to the wide range of research in this area. Students in the Training Program receive training beyond the standard graduate program through a monthly student presentation series that includes all of the trainees, an annual retreat that includes the trainees and their advisors, and through lectures supported by this program. This program plays an important role in training the next generation of scientists for academia and industry. The trainees have a strong record of success as shown by their publications in graduate school and the career choices they make after they leave graduate school.   
   
",Training in Molecular and Cellular Biology,"PUBLIC HEALTH RELEVANCE: The Training Program in Cell and Molecular Biology is designed to train the top graduate students at the University of Washington and Fred Hutchinson Cancer Center in the general areas of cell biology and molecular biology, both of which are of major importance for the prevention, detection and treatment of a wide variety of human diseases. This training program plays a special role because it brings together graduate students from a wide variety of biomedical disciplines, allowing these future leaders of academia and industry to broaden their scientific horizons well beyond what they would normally learn in graduate school. The regular meetings of this training program allow for an important exchange of ideas across disciplines, allowing the trainees to place their studies in a broader context and to consider new applications and approaches to their research.   
      

",John D Scott,1898302
44,8676319,,2013,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,3T32GM007229-37S1,GM007229,UNITED STATES,T32,304325,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2014-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant): The Cell and Molecular Biology Training Program at the University of Pennsylvania is a University-wide, interdepartmental and interschool program whose mission is to provide a multifaceted doctoral program to prepare students for careers in cell and molecular biology in academia, industry, or government. The training program's goal is to provide broad-based training in modern methods of cell and molecular biology and in-depth didactic exposure to cell and molecular biology, while at the same time matching the Trainees' specific interests. These goals are achieved through general and specialized courses, literature survey courses, laboratory rotations, a qualifying examination, thesis research with oversight from an advising committee, training in bioethics, and training grant-specific activities. Trainee-specific activities include an annual oral presentation of ongoing thesis research; attending the annual Cell and Molecular Biology Retreat; attending the Annual Trainee Organized Invited Lectures; participating in Alumni Day in which a former Trainee who has completed their Ph.D. and left Penn is invited back to give a seminar and meet with the Trainees; and the Current and Former Trainee Lunch in which 2 former Trainees present a talk on their thesis research. Students completing their first year of graduate studies are appointed for two years and are selected annually by the Executive Committee. Trainers come from the Schools of Medicine, Veterinary Medicine and Arts and Sciences, and the Wistar Institute, have active research programs in cell and molecular biology, and a commitment to graduate education. The training program has formal mechanisms to monitor trainees both during and after their training grant support. In addition, the training program has formal mechanisms to monitor trainers, as well as to resolve any conflicts between trainees and trainers. Last, Trainers participate in a number of efforts to recruit under-represented minorities both locally and nationally.  
    

",Training Program in Cell and Molecular Biology,,RICHARD M SCHULTZ,1876102
45,8526450,,2013,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,5T32DK007011-39,DK007011,UNITED STATES,T32,154853,False,Arthur  Castle,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"  
DESCRIPTION (provided by applicant): The present Training Program in Endocrinology at the University of Chicago aims to produce scientists who are trained to investigate endocrine disease and endocrine physiology from newborn to old age using a wide variety of modern experimental techniques and who are able to integrate investigations of cellular and molecular biology with organ system pathophysiology. The Training Faculty numbers 33 senior investigators from six University departments (Medicine, Pediatrics, Biochemistry and Molecular Biology, Human Genetics, Molecular Genetics and Cell Biology, Pathology) who carry out a broad range of endocrine-related research supported by a substantial base of NIH and other peer reviewed research grants. Each training faculty member is an established investigator. In addition to the training faculty, the program is aided by the participation of 21 Senior and 12 Associate Faculty from the Departments of Medicine, Pediatrics, Ob/Gyn and Health Studies. These faculty make important contributions to the training experience by providing training in clinical endocrinology and clinical research or statistical analysis of data. Trainees are selected on the basis of prior individual accomplishments including prior research training and experience as well as commitment to an academic research career. Trainees select a faculty preceptor(s) and the trainee and preceptor jointly identify a research project. Trainees then undergo at least 3 years of training in the research laboratory of the preceptor during which time trainees assume a progressively greater responsibility for developing research hypotheses, designing experiments, analyzing the data and preparing abstracts and scientific manuscripts. In the final year of training, an area of research is identified which is sufficiently different from the research of the preceptor to allow the trainee to submit an independent research grant proposal. This research training occurs within the framework of a required core curriculum consisting of courses which describe and review current research methodology and research advances as well as statistical analysis of research data. As a result of this intensive training, a substantial proportion of trainees from this program assume academic positions upon completion of their training and remain active in research.  
",Integrated Clinical and Basic Endocrinology Research," Diseases of the endocrine system constitute major public health problem in the US and worldwide. The objective of this Program is to prepare young scientists to pursue research careers addressing mechanisms and treatment of human disease, with focus on the endocrine system. We expect that trainees from this Program will identify disease mechanisms and develop and implement new effective treatments, whose applications will improve human health.    

",Samuel  Refetoff,1872745
46,8529239,,2013,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,5T32AR007108-35,AR007108,UNITED STATES,T32,289073,False,Marie  Mancini,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2015-06-30T04:00:00Z,PA06468,"See instructions):
This program trains physicians and basic scientists for research in rheumatology and contributes to the availability of
investigators in rheumatic diseases. Persons with an MD or MD, PhD degree who have completed their trainingin
internal medicineor pediatrics, and persons with a PhD degree will be considered for the program if they have a
commitment to an investigative career. Trainees will be provided theoretical and practical experience in biomedical
research related to rheumatic diseases. Trainees will participate in seminars, lectures and selected courses to further
theoretical knowledge. Trainees with MD degrees will gain expertise in diagnosis and treatment of rheumatic diseases,
providing them with teaching abilities in this field and focusing their evolving research expertise on rheumatic diseases.
Trainees devote at least 40 hours per week to trainingin research. Areas of research training will be related to
immunobiology, genetics, vascular pathology, clinical epidemiology, or outcomes of rheumatic diseases. Preceptors
will be members of the Division of Rheumatology, Immunology-Rheumatologyin the Department of Pediatrics,or
basic science departments includingImmunology, Orthopedics, Genome Sciences and Pathology. The facilities consist
of research laboratories of participating faculty members. The outstanding research milieu of the UW is an important
factor in overall training. The period of training will be three years. Upon completion of training, career options
include academic appointments in schools of medicine for research, or teaching in rheumatology. Six postdoctoral
positions are requested, one or two being from Pediatric Rheumatology.
RELEVANCE (See instructions):",Research Training in Rheumatology,,Keith B. Elkon,1864069
47,8668122,,2014,UNIV OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,PUBLIC HEALTH & PREV MEDICINE,5T32HL007055-38,HL007055,UNITED STATES,T32,332784,False,Lorraine M Silsbee,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2017-05-31T04:00:00Z,PA10036,"   
DESCRIPTION (provided by applicant):    
   
ABSTRACT This competing continuation application builds on seven successful five-year cycles of NRSA/NHLBI supported academic and applied research training and mentoring in cardiovascular disease (CVD) epidemiology at the Department of Epidemiology, University of North Carolina (UNC), Gillings School of Global Public Health. The goal of the program is to train innovative and effective researchers in the field of CVD epidemiology, to channel qualified scientists into a workforce capable to address the national and worldwide burden of CVD, who possess competencies that can place research at the interface between disciplines and the ability to incorporate innovation into the formulation and conduct of research. Historical strengths of the program include: engaged mentoring and numerous opportunities for active participation in research for pre- and postdoctoral trainees in environmental, behavioral, social and genetic epidemiology of CVD, subclinical atherosclerosis and community-based surveillance of CVD; integration of collaborating mentors from biostatistics, cardiology, nephrology, dental ecology, health policy, nutrition, neurology, genetics, and sociology; ongoing programmatic self-assessment and evaluation; and development of trainees from minority groups under-represented in the biomedical sciences (9 minority trainees supported in past 10 years). A process of close mentoring encourages trainees to develop individual training paths and career development models. Career development competencies and measurable outcomes are built into the yearly goals for both pre-doctoral and post-doctoral trainees. The 28 former trainees who completed predoctoral and/or postdoctoral training funded by this program since the year 2000 published 495 manuscripts (199 in first-author positions), including graduates now in academia, industry or governmental agencies. Enhancements to the program in the last five years include the promotion of peer-mentoring, the establishment of co-mentoring (a primary mentor and an associated mentor), periodic goal setting by each trainee and fellow with their mentors; and yearly evaluations of trainer and trainee. We propose to retain these components as well as introduce three new features to the training program. New elements include (1) expanded leadership structure of the program to include a Program Steering Committee, Career Development team, and Research Support team; (2) creation of an External Advisory Board; and (3) introduction of two new core research areas based on active research (vascular origins of cognitive impairment and dementia, and CVD outcomes research). We propose continuation of our four predoctoral and four postdoctoral trainees.   
   
",Cardiovascular Epidemiology Training Grant,"PUBLIC HEALTH RELEVANCE:    
   
Project narrative Through engaged mentoring, numerous active research areas, and ongoing self- assessment and innovation the Cardiovascular Disease (CVD) Epidemiology Training Program at the University of North Carolina trains innovative and effective researchers in the field of CVD epidemiology. The program seeks to meet the demands of a growing national and global burden of CVD by channeling qualified scientists into a workforce who possess competencies that can place research at the interface between disciplines and the ability to incorporate creativity into the formulation and conduct of research.   
      

",Wayne D. Rosamond,7995491
48,8666414,,2014,UNIVERSITY OF CHICAGO,CHICAGO,IL,PEDIATRICS,2T32HD007009-39A1,HD007009,UNITED STATES,T32,297055,False,Melissa  Parisi,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,2019-04-30T04:00:00Z,PA11184,"
Project Summary
The University of Chicago Growth, Development and Disabilities MD/PhD Training Program is designed to
provide basic science and translational research training for a highly selective group of medical students in a
combined-degree program. The Program is based on the premise that a commitment to complete both the MD
and PhD degrees and to establish and maintain a research-focused career is only developed after some time
in medical school (hence no attrition from this training program since 1978). Students are chosen on the basis
of outstanding academic credentials, demonstrated ability in basic science, and devotion to pursuit of a
research-oriented career. All students fulfill the requirements of a PhD in a particular discipline and complete
the same requirements for the MD as other medical students. They are continuously and longitudinally advised
by the Program Director and staff, a Student Advisory Committee, a newly-formed External Advisory
Committee, and Mentors who have outstanding records of promoting the training, education and career
advancement of biomedical scientists. The Program has undergone a restructuring to more closely align its
training goals with the mission of NICHD to foster training in the areas of growth, development, and disabilities
research and clinical specialties in pediatrics and related areas. The overall Program, its elements, and the
participants are assessed via multiple evaluation tools through the year. The ultimate success is measured by
the impact of the trainees' thesis research, the completion of both the MD and PhD degrees, and their long-
term success as physician-scientists.",Graduate Training in Growth and Development,"PUBLIC HEALTH RELEVANCE: The long-standing goal of the University of Chicago MD/PhD training program in Growth, Development and Disabilities is to train outstanding physician-scientists. Formal training is provided for each degree, supplemented with ample, dedicated mentoring and advising to assure the attainment of this goal. The participants' progress is followed throughout their time in the training program and their subsequent career trajectories.   
      

",NANCY B SCHWARTZ,1871366
49,8666397,,2014,UNIVERSITY OF WISCONSIN-MADISON,MADISON,WI,GENETICS,2T32GM007133-40,GM007133,UNITED STATES,T32,718061,False,Susan R. Haynes,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant): The proposed Research Training Program will train predoctoral students broadly in the discipline of genetics at the University of Wisconsin - Madison. Students admitted to the Genetics graduate program at Wisconsin will be supported for two years of graduate studies: the first year and a subsequent year after completing all required coursework and qualifying examinations. The Genetics graduate program presently consists of 79 faculty representing 20 different departments in the biological sciences and 53 students studying with 28 different faculty trainers. The collective research interests of program faculty and students encompass virtually the entire breadth and depth of contemporary genetics.  Trainees are selected based on prior academic achievements, research experience, and personal interviews conducted before acceptance into the program. Accepted students identify Genetics as their primary academic pursuit and choose thesis advisors based on their individual research interests The Genetics doctoral program is a campus-wide training program administered by the Laboratory of Genetics, which is housed in a modern state-of-the-art research facility.  Supported students complete a rigorous academic program consisting of both formal coursework and individualized mentoring in genetics. Formal coursework includes a core curriculum of required genetics courses, specialized electives identified by students together with their Thesis Advisory Committee, a course in the responsible conduct of research (RCR), and continuing exposure to RCR-related issues throughout the graduate career. Students gain teaching and communication experience by serving for one semester as a Teaching Assistant for an undergraduate Genetics course and by presenting their research in formal settings before faculty and students of the program. Student performance is evaluated by a two-part qualifying examination that tests understanding of broad genetic principles and an ability to propose, execute, and defend a thesis research project. Each student's progress is monitored annually by a Thesis Advisory Committee.  The Genetics Training Grant develops young investigators as independent scientists by providing a rigorous and broad education in the science of genetics. Our graduates bring the methods and logic of genetic analysis to bear on contemporary research problems. Our long range goal is to educate new generations of professional geneticists who will advance the biological research sciences using genetic approaches and methodologies.   
   
",Predoctoral Training Program in Genetics,"PUBLIC HEALTH RELEVANCE: Genetics is a fundamental discipline of contemporary biomedical research. It is both a tool for discovery and an consistent logic for in-depth understanding of biological mechanisms, especially those that relate to inherited human disease. The University of Wisconsin graduate program in Genetics trains young investigators broadly in the science of genetics and, by doing so, develops future generations of professional biomedical researchers.   
   
   
      

",Philip  Anderson,1893729
0,8507591,,2013,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PEDIATRICS,5T32AI007007-35,AI007007,UNITED STATES,T32,189895,False,Lawrence J. Prograis,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,2014-08-31T04:00:00Z,,"  
DESCRIPTION (provided by applicant): This program has been constructed to provide a training environment that will afford trainees with all the skills needed to succeed in an academic career. This has been accomplished by assembling a critical mass of faculty with a broad range of research interests, and by creating an environment that fosters each trainees' development though intensive mentoring. The Allergy and Immunology Division is comprised of 3 full time and two part time faculty and the program in total consists of 18 faculty, including ten professors and six associate professors, 5 women and 2 minorities. These other faculty are based in Pediatric Pulmonary, Clinical Immunology and Pulmonary in the Department of Medicine, the Institute of Genetic Medicine, and the School of Public Health. The faculty are all well funded and solidly committed to this program. The program provides 3 years of balanced training in allergy and basic and clinical immunology to pediatricians, and in some cases PhD candidates. Prospective trainees are selected based on their commitment to and potential for success in an academic career. Each trainee spends the majority of his/her time in clinical, laboratory, or translational research, supplemented with course work and required clinical responsibilities. The PI/PD oversees all fellows and a single faculty member acts as preceptor for each fellow, supervising laboratory work and helping to select formal course work. Research opportunities are diverse, including clinical, laboratory, epidemiologic, and translational investigations in food allergy, asthma, and immune deficiency, as well as basic studies in both allergy and immunology. Course work includes both a core curriculum and elective courses, up to and including a Masters degree. Clinical training is outstanding and well balanced, with all of our graduates capable of caring for the world's most complicated patients. The program is based in the Division of Allergy and Immunology in the Department of Pediatrics and located in the Children's Center of The Johns Hopkins Hospital in space that was fully renovated in 2006. Space included 5 separate, fully equipped laboratories, 5 faculty offices, 3 administrative offices, a Fellows' office, a conference room equipped for teleconferencing, and offices for the division's 24 research staff.   
RELEVANCE: The importance of allergic and immunologic disease in children is enormous and growing. Allergic diseases now represent about 25% of pediatric ""sick"" visits, asthma is the leading cause of emergency admissions to the hospital, and food allergies now affect over 5% of children. The need for physicians and Ph.D.'s with expertise in both research and patient care in allergy and immunology is therefore greater than ever.  
  
    

",Research Training in Pediatric Allergy and Immunology,,ROBERT A WOOD,6785863
1,8508081,,2013,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32DK007006-40,DK007006,UNITED STATES,T32,355681,False,Krystyna E Rys-Sikora,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2015-06-30T04:00:00Z,PA08226,"  
DESCRIPTION (provided by applicant): The purpose of this grant is to furnish basic and clinical research training for postdoctoral renal fellows with M.D. or M.D./Ph.D. degrees that wish to pursue biomedical research careers. Trainees entering our research laboratories will usually have completed a medical residency and one year of clinical nephrology. Selection for appointment is based on the aptitude of the applicant and their commitment to a career in biomedical research. Trainees are normally appointed for two years. Our program teaches a rigorous approach to scientific inquiry in basic science or/and clinical investigation. The faculty of this training program are all members of the University of Pennsylvania. Together they form a close and well-integrated collaborative entity dedicated to research training and investigation. The core basic research program emphasizes the areas of immunology/inflammation, transplantation, kidney development and structural biology, whereas the core clinical research programs focus on the epidemiology of chronic kidney disease and hypertension, and health care economics. Trainees may elect to work with investigators outside the Renal Electrolyte and Hypertension Division, as long as they are working in renal-related areas. In either scenario, cross-fertilization and development of skills to prepare trainees for a life long investigative career are emphasized. Each trainee will develop a carefully crafted research project under the close supervision of a faculty trainer. This intensively structured research experience will be supplemented by research seminars, attendance at scientific meetings, and by formal course work in molecular genetics, immunology, biochemistry, cell biology, statistics, bioethics, environmental health, radiation safety and experimental design. The Renal Research Training Committee made up of the Program Directors will carefully monitor the evolving progress of each trainee. Upon completion of this comprehensive experience, it is anticipated that each graduate will be equipped to effectively compete for further individual training support, or for independent funding at an entry-level faculty position in academic nephrology.   
  
PUBLIC HEALTH RELEVANCE: Kidney disease is a leading cause of illness and death in the United States. This application is for a program to train young physicians to conduct research into developing new strategies and treatments for kidney disease.   
    

",Renal Research Training Program,,LAWRENCE B. HOLZMAN,1861879
2,10229115,,2020,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,3T32DK007012-42S1,DK007012,UNITED STATES,T32,54302,True,Arthur  Castle,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2024-06-30T04:00:00Z,PA18403,"Project Summary/Abstract
The Endocrinology and Metabolism Research Training Program (T32) at Duke University Medical Center is
centered on clinical and basic science investigators in the Division of Endocrinology, as well as collaborators
working in other divisions and departments. The broad goal of this program is to train the next generation of
biomedical scientists working in Diabetes, Metabolism and related diseases. Post-doctoral participants in this
program will be either board- eligible or board-certified physicians with training in Internal Medicine or
Pediatrics, or PhD scientists pursuing careers in endocrine/metabolic research.
The Duke Endocrinology T32 has a long track record of training successful investigators in diabetes,
metabolic bone disease, and other areas of endocrine/metabolic research. A substantial majority (80% of
trainees over the past two cycles of the grant) are in academic positions at major medical centers across
the US and abroad. Most are in positions with substantial research components, supported by federal,
foundation, or industry grants, and the remainder have significant teaching responsibilities.
The program includes training opportunities in clinical, translational, and basic research. Mentors associated
with this grant have funded research programs ranging from basic science (islet biology, mitochondrial
function and energetics, metabolic flux, transcriptional regulation of metabolism), to preclinical physiology
using mouse genetic models, clinical physiology in humans (insulin secretion, incretin function, exercise and
metabolism, bariatric surgery) to implementation science (novel approaches to diabetes care and weight
management), and outcomes research (clinical trials and epidemiology). Trainees will choose primary
mentors, but have access to the full breadth of the mentorship team through collaborations, didactic teaching
and seminars. Training is aimed at identifying important research questions, formulating incisive hypotheses
and learning to design simple but dispositive experiments; technical and analytic proficiency will also be
stressed. Individuals who complete the program will be capable of independent investigation and able to
translate research accomplishments into significant advances with clinical relevance.",Endocrinology and Metabolism Training Program,"Narrative
 Diabetes and related conditions are a public health scourge, with a prevalence approaching 10%
worldwide, causing significant complications and co-morbidities and enormous cost to health care systems. To
meet the growing clinical needs of people affected by diabetes and other endocrine disorders, and to develop
new and more effective treatments and therapeutic strategies, it is critical to train more academic
Endocrinologists who have the capacity to assess and change the course of clinical diabetes through
discovery, analysis, and development of new strategies. The Duke University T32 Research Training Program
in Endocrinology and Metabolism has a mission to recruit and train outstanding physicians and other medical
scientists for careers in endocrine/metabolic research in an outstanding multifaceted environment.",DAVID A. D'ALESSIO,1882148
3,9996496,,2020,RESEARCH INST OF FOX CHASE CAN CTR,PHILADELPHIA,PA,,5T32CA009035-45,CA009035,UNITED STATES,T32,640130,True,Susan E Lim,National Cancer Institute,1975-07-01T04:00:00Z,2021-08-31T04:00:00Z,PA14015,"PROJECT SUMMARY/ABSTRACT
The inter-disciplinary Training Program in Cancer Research at Fox Chase Cancer Center, currently in its 40th
year, focuses on preparing a cadre of outstanding cancer scientists through rigorous research and impactful,
targeted mentoring. Continued funds are requested to support 10 postdoctoral trainees. The highly collaborative
participating faculty consist of 50 Cancer Center members of the Fox Chase Cancer Center and Temple Health.
Collectively, these faculty possess interests that span the cancer spectrum, including cell growth control, signal
transduction, inflammation, epigenetics, cancer prevention, bio-behavioral cancer research, and developmental
therapeutics. The postdoctoral pool is extremely strong; there is an average of 3-4 applicants per open slot, and
the majority of applicants received graduate training at outstanding institutions, and published in high-impact
journals. The program offers diverse training in areas relevant to cancer research, with a combination of didactic
and laboratory-based training, including seminar series and journal clubs, scientific writing courses, career
development seminars, and individualized development plans. Input from the postdoctoral pool is extensive and
highly valued in shaping this program; trainee satisfaction is best exemplified by our long-standing placement in
the Top 20 Best Places in the United States for Postdoctoral Training, as published in The Scientist magazine
(through 2012). Trainee slots are highly competitive, all slots have been continuously filled for the last 3 funding
cycles, and >75% of trainees who have completed training report that they are still doing research directly
relevant to cancer. Appointments are made for one year, with an option to renew for a second year of support.
A chief objective of our Research Training Plan is to equip our trainees with the skills needed to transition to
impactful careers in cancer biology and medicine, recognizing that fundamental contributions to the cancer effort
can be achieved in a wide array of career paths. In summary, this proposal continues a long history of excellence
in training in cancer biology at Fox Chase.",Training Program in Cancer Research,"PROJECT NARRATIVE
This grant application seeks funds to support the training of postdoctoral fellows in the fields of cancer biology,
prevention, and control. Fox Chase Cancer Center is a national leader in the study and treatment of cancer, and
we have a long-standing and successful track record of training highly productive postdoctoral fellows who
dedicate their professional careers to cancer research.",JONATHAN D. CHERNOFF,1882056
4,9935792,,2020,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,2T32DK007074-47,DK007074,UNITED STATES,T32,504117,True,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2025-06-30T04:00:00Z,PA18403,"PROJECT SUMMARY/ABSTRACT
This proposal entitled Training for Discovery and Scholarship in Digestive Health and Diseases is for
continuation of a long-standing, highly successful research training program for pre- and postdoctoral
candidates and GI fellows in Digestive Health and Diseases (DHD) at the University of Chicago. This program
provides rigorous scientific training to highly qualified and promising individuals for careers in basic,
translational, and clinical investigation. It has successfully prepared generations of leaders in biomedical
research, academia, and other walks of life. The training faculty are comprised of funded, highly successful,
multidisciplinary, and collaborative investigators from the University of Chicago and its two affiliates, Argonne
National Lab and the Marine Biological Lab. A recently defined group of Associate Mentors that include early
stage investigators representing the next generation of mentors and leaders, important resource experts, or
full-time clinicians without research support, will assist full mentors. The program is strategically located in the
heart of the biomedical research complex that includes state-of-the-art research and clinical facilities. These
facilities offer technologies such as mouse genetic engineering, gnotobiotic, single cell genomics, mass
cytometry, advanced imaging, advanced `omic' technologies such as next generation DNA sequencing and
other quantitative data sciences for systems biology and integration. A robust clinical research pipeline capable
of generating highly curated clinical metadata and biospecimens for translational investigators in DHD is
available through the NIDDK P30 DDRCC. Currently, the program supports the training of two predoctoral and
five postdoctoral trainees drawn from a large pool of highly qualified candidates, particularly with the recent
influx of MD/PhD and research-intensive MDs from the Physician Scientist Development Program of the
Department of Medicine. However, with the increased demand for training in DHD, especially in the areas of
the gut microbiome, host-microbe interactions, data sciences, metabolism, immunology and IBD, we are
requesting the addition of a third pre-doctoral training position. Our DHDT32 curriculum is notable in using a
combination of didactic, formal coursework, problem-based, and hands-on training approaches that
continuously adapt to the everchanging landscape of knowledge, technology, and clinical practice to insure the
competitiveness, productivity, and success of all trainees. Their progress and career development will be
monitored closely by faculty advisory and program oversight committees. Trainees will be taught how to think
critically and creatively, and receive instruction in academic skills (e.g. grant and MS writing, etc) and the
responsible conduct of research. The program is also stepping up its efforts to promote diversity among its
selected candidates through the recent creation of the Diversity and Inclusion Committee. Collectively, these
efforts will continue to produce high quality investigators who are well prepared to become independent
investigators, future mentors, and leaders in academia, clinical research, and other biomedical fields.",Digestive Health and Diseases (DHD) Training Grant,"PROJECT NARRATIVE
Digestive diseases that have immunological, metabolic, microbial, and developmental bases represent a
significant burden of disease and public health problem in the US and worldwide. The objective of this Program
is to prepare the next generation of leaders, scholars and educators performing cutting edge research in
Digestive Health and Diseases.",EUGENE  CHANG,1858734
5,9936503,,2020,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,ENGINEERING (ALL TYPES),2T32ES007020-46,ES007020,UNITED STATES,T32,684012,True,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2025-06-30T04:00:00Z,PA18403,"Project Summary/Abstract
The goal of this training program in environmental toxicology is to produce scientists and engineers
professionally qualified to make original contributions to improved understanding of the impacts of
environmental agents, especially hazardous chemicals, on human health. This program has supported 112
predoctoral and 94 postdoctoral Trainees since its inception in 1975. During that same time period, 356 PhD
or ScD degrees have been awarded to all students in the MIT toxicology program (Trainees plus non-
Trainees). Of our pre-doctoral and post-doctoral Trainees over the past 15 years, 8 out of 66 (12%) are in
academic positions and 42 (64%) are in industry or government, with the balance continuing in training.
Trainees pick projects from the following areas: (1) analysis of genome-, proteome- and glycome-level
responses to toxins and toxicants; (2) characterization of mutagenic responses to carcinogens as expressed
hierarchically at the genome, cell, tissue, organism and population levels of organization; (3) construction of
novel animal models for determining the effects of exposure of mammals to environmental agents; (4) systems
biology of kinase-mediated signaling cascades triggered in response to toxic agents, and during neoplastic
transformation; (5) characterization of the chemistry underlying the reaction of toxins and toxicants with cellular
macromolecules and other targets; (6) mechanistic assessment of the contribution of DNA damage to genetic
disease, and identification of the cellular defenses (e.g., DNA repair strategies) that protect against heritable
damage; (7) engineering-based design of novel model systems for evaluating responses to toxic agents; (8)
unraveling the underlying biology of environmental chemical-infectious agent interactions; and (9) development
of analytical methods for monitoring hazardous chemicals in the environment, and determining of how those
agents chemically change over time. In the previous period of support, 29% of the PhD students supported
were from underrepresented groups, and 59% were female. Regarding postdocs, 18.2% were from
underrepresented groups, and 55% of the cohort was female. More than 600 students apply for the pre-
doctoral program annually, allowing for good program selectivity.
Highlights of the program are a well-structured and constantly updated academic toxicology Certificate
Program taken by PhD students, a pre- and post-doctoral mentoring program, numerous toxicology-focused
seminar programs and a large emphasis on research collaboration. We created a course entitled
Fundamentals of Toxicology and Environmental Health to cross-train our diverse group of engineers and
scientists. It includes formal toxicology lectures, training in responsible conduct of research, authentication of
reagents, rigor and reproducibility, data science and community outreach.
This proposal requests funding for seven predoctoral and six postdoctoral trainees.",Training Grant in Environmental Toxicology,"Project Narrative
This training program comes from MIT researchers working at the interface of science and engineering. Using
and developing state-of-the-art technology, the trainees address cutting edge problems in environmental health.
Our approaches involve measurement of risk, mining of complex biological data, modeling of systems exposed
to environmental agents, and manipulation of systems to modulate risk.",JOHN M ESSIGMANN,1864810
6,9938538,,2020,UNIVERSITY OF COLORADO DENVER,Aurora,CO,INTERNAL MEDICINE/MEDICINE,5T32DK007038-45,DK007038,UNITED STATES,T32,156316,True,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2021-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): There is a long-documented and continuing shortage of well-trained MD and PhD investigators in Gastroenterology & Hepatology. This issue was further highlighted as an urgent national need in the NIH authorized National Commission on Digestive Diseases Report (March 2009). The overall goal of this program is to provide a diverse group of post-doctoral trainees with an exceptional supervised training and mentoring experience in order to allow them to develop or enhance their research skills and knowledge in preparation for a successful gastroenterology- and hepatology-related research career. This program is intended for post- doctoral MD or PhD trainees and will provide support for 2 or 3 years (currently 2 fellows per year). Success in academic medicine requires not only developing one's own research program but also developing collaborations. Collaborations stimulate ideas, facilitate translational application and provide stimulus for program projects. We have identified research areas involving multiple investigators. Fellows interested in these topics are asked to meet with mentors from these topics. In turn, we encourage collaborative interactions between the various investigative groups that have common research themes. The salient point is that there are many exceptional opportunities for education of trainees in pivotal areas of gastrointestinal/hepatic research, and there is direct access to investigators with complementary skills potentially beyond the realm of the primary mentor; clearly, some of the accomplished faculty members fall into more than one theme category. The faculty of the T32 can be grouped into main 6 research groups: Mucosal Inflammation Program; Immunology of the Liver; Nutrition, Metabolic Syndrome, and Gut Microbiota; Gastroenterology and Hepatology Health Outcomes Policy and Economics Center; Gastrointestinal and Hepatic Cell and Molecular Biology; Carcinogenesis. In addition to the in-person evaluations of the trainee by the mentor and mentorship committee, the Research and Career Development Committee meets quarterly to review all of the trainees based on their personal interaction and the evaluations provided by the mentor and mentorship committees. As mentioned, this Committee not only evaluates the progress of the Trainees, but also of the program in general. The group discusses both how the trainee is doing in terms of their research project, their interaction with their primary mentor, their productivity in writing, their ability to write grants, their short-term and long-term goals,and whether they are on-track to becoming an independent investigator.",Gastrointestinal Diseases Training Grant,"PUBLIC HEALTH RELEVANCE   
Pervasive public health concerns specific to gastroenterology and liver diseases include hepatitis, inflammatory bowel disease, cancer, and obesity, among others. The cutting-edge and collaborative research environment this project provides for young investigators aims to find clinical and research solutions for these common health disorders",Sean P Colgan,1877113
7,9937714,,2020,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32DK007012-42,DK007012,UNITED STATES,T32,255648,True,Arthur  Castle,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2024-06-30T04:00:00Z,PA18403,"Project Summary/Abstract
The Endocrinology and Metabolism Research Training Program (T32) at Duke University Medical Center is
centered on clinical and basic science investigators in the Division of Endocrinology, as well as collaborators
working in other divisions and departments. The broad goal of this program is to train the next generation of
biomedical scientists working in Diabetes, Metabolism and related diseases. Post-doctoral participants in this
program will be either board- eligible or board-certified physicians with training in Internal Medicine or
Pediatrics, or PhD scientists pursuing careers in endocrine/metabolic research.
The Duke Endocrinology T32 has a long track record of training successful investigators in diabetes,
metabolic bone disease, and other areas of endocrine/metabolic research. A substantial majority (80% of
trainees over the past two cycles of the grant) are in academic positions at major medical centers across
the US and abroad. Most are in positions with substantial research components, supported by federal,
foundation, or industry grants, and the remainder have significant teaching responsibilities.
The program includes training opportunities in clinical, translational, and basic research. Mentors associated
with this grant have funded research programs ranging from basic science (islet biology, mitochondrial
function and energetics, metabolic flux, transcriptional regulation of metabolism), to preclinical physiology
using mouse genetic models, clinical physiology in humans (insulin secretion, incretin function, exercise and
metabolism, bariatric surgery) to implementation science (novel approaches to diabetes care and weight
management), and outcomes research (clinical trials and epidemiology). Trainees will choose primary
mentors, but have access to the full breadth of the mentorship team through collaborations, didactic teaching
and seminars. Training is aimed at identifying important research questions, formulating incisive hypotheses
and learning to design simple but dispositive experiments; technical and analytic proficiency will also be
stressed. Individuals who complete the program will be capable of independent investigation and able to
translate research accomplishments into significant advances with clinical relevance.",Endocrinology and Metabolism Training Program,"Narrative
 Diabetes and related conditions are a public health scourge, with a prevalence approaching 10%
worldwide, causing significant complications and co-morbidities and enormous cost to health care systems. To
meet the growing clinical needs of people affected by diabetes and other endocrine disorders, and to develop
new and more effective treatments and therapeutic strategies, it is critical to train more academic
Endocrinologists who have the capacity to assess and change the course of clinical diabetes through
discovery, analysis, and development of new strategies. The Duke University T32 Research Training Program
in Endocrinology and Metabolism has a mission to recruit and train outstanding physicians and other medical
scientists for careers in endocrine/metabolic research in an outstanding multifaceted environment.",DAVID A. D'ALESSIO,1882148
8,9952376,,2020,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32GM007171-46,GM007171,UNITED STATES,T32,1276934,True,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2022-06-30T04:00:00Z,PA16152,"7. PROJECT SUMMARY/ABSTRACT
The Duke Medical Scientist Training Program (MSTP) is one of three original MSTPs funded by NIGMS in
1966, and it has been continuously funded since that time. This competing continuation application requests
funding for 28 trainees, an increase of one position over the current level of support. The goal of the Duke
MSTP is to prepare young physician-scientists for careers in biomedical research and academic medicine by
providing comprehensive training in both scientific research and clinical medicine through completion of both
the MD and PhD degrees. The program's mission is to provide an intellectual foundation that will allow trainees
from diverse backgrounds to become the future thought leaders in biomedical science and academic medicine
in the US. To accomplish these goals, the Program is built on a unique medical school curriculum that
integrates medical education with original scholarly investigation. The defining feature of the Duke curriculum is
that all medical students engage in significant scholarly activity in the third year. As a consequence, the core
medical education takes place over three years, rather than four, with the preclinical basic sciences condensed
into the first year and core clinical clerkships taught in the second year. This curriculum is therefore ideally
suited to MSTP trainees, as it provides comprehensive clinical training prior to PhD training, allowing students
to align their research interests with their long-term clinical interests as well as shortening the time to the dual
degree. Over the past 5 years, the Duke MSTP has undergone a number of major changes and improvements
after it came under new directorship in 2006: 1) The admissions process was revamped to ensure recruitment
of top tier applicants while also addressing the problem of unacceptably high attrition rates; 2) Program
administration has been modified to ensure adequate oversight of the director and to provide enhanced input
from a broader range of outstanding faculty; 3) Improved trainee oversight has been incorporated at multiple
stages of the program; 4) Numerous program activities have been added to ensure adequate program-wide
training opportunities and to foster program unity; 5) An accelerated rotation structure has been added to allow
time for trainees to take Step 1 of the USMLE and to transition to their thesis labs by the middle of first-year of
graduate school; 6) Activities to ensure that clinical skills are not lost during the PhD years have been added;
7) Institutional support has improved dramatically; and 8) Multiple opportunities for trainees to influence their
own career development have been incorporated. These new program initiatives have built on the Duke
MSTP's tradition of excellent MD-PhD training to substantially improve and revitalize the program, preparing it
for growth over the next 5 years to a new steady state of approximately 88 students.",Medical Scientist Training Program,"8. PROJECT NARRATIVE
There is a need to train physician-scientists with an excellent foundation in both biomedical research and
clinical medicine in order to gain a more detailed understanding of disease. The Duke Medical Scientist
Training Program seeks to train MD-PhD candidates in both medicine and science through a unique curriculum
that provides students with comprehensive clinical training prior to their PhD training. Through this program,
Duke MSTP students will be poised to translate scientific discoveries into therapies for human disease.",Christopher D Kontos,1902570
9,9965025,,2019,UNIVERSITY OF UTAH,SALT LAKE CITY,UT,INTERNAL MEDICINE/MEDICINE,3T32DK007115-44S1,DK007115,UNITED STATES,T32,48417,False,VICTORIA MARIE Spruance,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2021-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is an amended application for the University of Utah's Research Training in Hematology Program, a program established in 1943 by Dr. M.M. Wintrobe. Eighteen faculty members serve as research preceptors for trainees, and the faculty consists of both physician-scientists and basic scientists from the Departments of Medicine, Biochemistry, Human Genetics, Oncological Sciences, Pathology, and Pediatrics. Research groups participating in the Training Program are the Molecular Regulation of Iron and Heme Metabolism Group and the Hematopoiesis and Stem Cell Group. The special attribute of this multidisciplinary training program is the training faculty that includes both basic and clinical investigators with whom trainees will interact. The unifying element is the objective to train postdoctoral fellows and graduate students who can conduct innovative hematologic research using state of the art technology. Physician-trainees interact with basic science post- doctoral trainees and graduate students in our program, and this interaction promotes an expanded view of hematologic research for all trainees. This amended application expands our program to include newly added faculty with expertise in genetics and genomics. The application requests support for four predoctoral trainees and three postdoctoral fellows.",Research Training in Hematology,"PUBLIC HEALTH RELEVANCE: Hematology has led medical sciences into an era of unprecedented advances in understanding the cellular and molecular basis of many diseases. The leading role of hematology is explained, in part, by the ease of access to blood and bone marrow cells. An expanded core of investigators trained to integrate clinical and basic science investigation is required to exploit new opportunities afforded by advances in technology, and the Hematology Research Training Program at the University of Utah is designed to train these investigators","Elizabeth Ann Leibold,JOSEF T PRCHAL","1887691,1881539"
10,9964990,,2019,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,INTERNAL MEDICINE/MEDICINE,3T32GM007309-45S1,GM007309,UNITED STATES,T32,157983,False,JOSEPH G GINDHART,"Eunice Kennedy Shriver National Institute of Child Health and Human Development,National Institute of Neurological Disorders and Stroke",1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is an application for renewal of The Johns Hopkins University School of Medicine Medical Scientist Training Program, which is now in its 39th year. The Program seeks to train MD-PhD students for positions of leadership in academic medicine and medical research. Since our last submission in 2009, completed AMCAS applications have remained high, averaging 436 per year. Interviews are extended to approximately 15% of those applicants who complete both the AMCAS and Hopkins Secondary applications. Applicants invited for interviews have outstanding academic records (mean GPA 3.92), excellent MCAT scores (average total 38), significant laboratory research experience, and high motivation for careers in biomedical research and clinical medicine. Approximately 10-12 students enter the Program each year and on average 10 students receive MSTP awards. The average length of study for the combined degrees is 8 years (which is also the national average). There are currently 116 MD-PhD students in the Program; 96 have MSTP awards. Currently, 21.3% of the 116 students enrolled in the Hopkins Program are underrepresented in medicine. Students generally take two years of preclinical science courses in medical school and then enroll in one of 30 available graduate programs for approximately four years. Students in the Hopkins Program have a pool of over 1000 Hopkins faculty from which to select a potential mentor. During this time, students take advanced courses and complete thesis research, publishing an average of 6.1 peer-reviewed papers, before returning to the final required clinical clerkships and electives in medical school. In 2013, Andrea Cox, M.D., Ph.D. was appointed as Co- Director of the Hopkins MSTP. She is an Associate Professor of Medicine and Oncology, an active research scientist, and a board certified and practicing infectious disease specialist. Therefore, Dr. Cox brings to the MD-PhD leadership team a perspective on clinical medicine as well as basic research. From this point forward, Drs. Cox and Siliciano will co-direct the MD-PhD Program. Dr. Robert Siliciano, has been Director of the Program since 1999 and will continue co-directing the Program with Dr. Cox. The Co-Directors head a 26-member MD-PhD Committee that admits applicants and formulates policies for the Program. The committee members also assist the Co-Directors in advising trainees and evaluating student progress. The Program has been highly successful in fulfilling the goals initially set fort by the NIH. Since the inception of the Hopkins MSTP grant (1980-first graduates), 350 MD-PhD students have graduated from the Program. Of the 270 graduates who have completed postgraduate training and begun their careers, 83% are in medical research positions. This includes those in academic medicine (67%), those at research institutes such as the NIH (6%) and those in the pharmaceutical or biotech industries (10%).",Medical Scientist Training Program,"PUBLIC HEALTH RELEVANCE: MSTP Project Narrative Progress towards solving major health problems will require a steady source of well-trained new investigators who have the clinical background to appreciate major medical issues and the research skills to tackle them. Over the years, MD-PhD programs have proven to be a highly effective way to train such investigators. We seek here funding to continue a highly successful MD-PhD Program at The Johns Hopkins University School of Medicine.",ANDREA L COX,7289265
11,9941081,,2020,TUFTS UNIVERSITY BOSTON,BOSTON,MA,BIOCHEMISTRY,5T32GM007310-43,GM007310,UNITED STATES,T32,206711,True,Michael T. Bender,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2021-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): Continued support is requested for five years for five predoctoral trainees per year for an interdepartmental training program focused on the molecular genetics of basic cell functions. The emphasis is on rigorous training using the power of molecular genetics to study basic cell processes, such as chromosome replication, recombination, and segregation; evolution of genes and genomes; genome organization; gene function; regulation of transcription and translation; RNA processing; cell-to-cell communication; signal recognition and transduction; and membrane fusion. This training program has strongly benefited from continuous support from NIGMS since 1975. Students are supported in their second, third, or fourth year based on their commitment to in-depth genetics training in the context of thesis research. The training faculty, from the Departments of Molecular Biology & Microbiology, Developmental, Molecular & Chemical Biology, Integrative Physiology & Pathobiology, Medicine, and Chemistry, is highly interactive and dedicated to close, joint supervision and mentoring of graduate students. Importantly, the mentoring faculty has increased dramatically in the last three years because of recruitment of outstanding young faculty members and more senior investigators from a variety of disciplines that have genetics at the core of their research. Our training program, based in the Graduate Program in Molecular Microbiology, has a pool of 80-100 applicants and annually enrolls 5-7 new students, nearly all of whom are eligible for training grant support. The program has been successful in attracting a significant number of students from underrepresented groups (including six of the 33 students enrolled during the 2014-2015 academic year); all have been supported by this training grant. The majority of past trainees have obtained high-quality postdoctoral appointments and those who have completed this training are active members of the biomedical workforce with the majority pursuing careers as researchers in academia or industry. Others are high school science teachers, biotechnology-focused patent attorneys, or pursuing other science-related professions. Supported students take required courses that provide a strong grounding in genetics and are selected based on the relevance of their research to fundamental questions in molecular genetics. In addition to strong didactic training in genetics, all students are required o complete courses focused on scientific ethics and participate in teaching of medical or dental students and many have opportunities to mentor undergraduates in research activities. Students are also exposed to the range of career available to biomedical science PhD graduates and use an Individual Development Plan to guide their career preparation. Our faculty is strongly dedicated to graduate education and mentors the PhD students in terms of both their research activities and career goals.",Molecular Genetics of Basic Cell Function,"PUBLIC HEALTH RELEVANCE   
The power of genetics to define gene function, to pinpoint the roles of proteins and their individual amino acids, and to predict susceptibility to disease lies at the heart of modern biomedical science. The training offered by our program prepares young scientists to take full advantage of genetic approaches to solve difficult, but important problems in biomedical science and human disease.",Andrew  Camilli,1923823
12,9725971,,2019,BAYLOR COLLEGE OF MEDICINE,HOUSTON,TX,OPHTHALMOLOGY,5T32EY007001-43,EY007001,UNITED STATES,T32,127397,False,neeraj  agarwal,National Eye Institute,1975-07-01T04:00:00Z,2022-06-30T04:00:00Z,PA16152,"Project Summary/Abstract
 This is a revised competing renewal application of the Visual Sciences Training (VST) Grant from
Baylor College of Medicine (BCM, T32 EY007001) which was first awarded by the National Institutes of Health
in 1975. Since that time, this program has trained 67 predoctoral students and 83 postdoctoral fellows, and
many of them have become leaders in vision and ophthalmic research. During the past 10 years, trainees of
this Program have written 275 research papers (143 during the past 5 years, abstracts not included), and 12
trainees have received their own grant support. The VST program has 22 preceptors from 10 departments and
12 graduate PhD programs in BCM, carrying 21 active qualifying (+1 pending and 1 NCE) RO1 grants
supported from the National Eye Institute and 9 grants from other federal research agencies or foundations.
The Program is directed by Samuel M. Wu, PhD, who has been a preceptor on this training grant for 34 years,
and has been the Principal Investigator and Program Director since 1994. Dr. Wu is assisted by a training
grant coordinator, Kim Harano, and three committees, the Steering Committee, Recruitment/Admissions
Committee and Academic Progress Committee. The objective of this training program is to train competent
basic and translational vision researchers, and to equip them with cutting edge scientific ideas and techniques
to face scientific and medical challenges of the 21st century. Trainees are required to take a number of didactic
vision, neuroscience, genetics and ethics courses, and expected to acquire comprehensive knowledge of the
entire visual system and the associate diseases, and to learn state-of-the-art experimental techniques.
Additionally, a trainee will be guided by his/her preceptors (and other members of the program) into at least
one special area of the visual system, one research discipline and one disease in great depth, so that he/she
can initiate an independent research project after training.",Research Training in Visual Sciences,"Project Narrative
This is a competing renewal application from 22 preceptors in Baylor College of Medicine, carrying 21 active
qualifying NEI-RO1 grants. This Training Program started in 1975 and has trained a large number of vision
researchers who have made significant impacts to the field. The Program will continue to provide high-quality
training for predoctoral students and postdoctoral fellows, and to equip them with comprehensive knowledge of
the visual system and state-of-the-art experimental skills, enabling them to become successful researchers in
the battle to fight blinding diseases.",Samuel M Wu,7354218
13,9724481,,2019,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,BIOLOGY,5T32GM007287-45,GM007287,UNITED STATES,T32,1480278,True,Ronald  Adkins,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2021-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This proposal is for continuing support of the pre-doctoral training grant in biology at the Massachusetts Institute of Technology (MIT). This training grant (in its 40th year) continues to be the most important source of support for graduate students studying biological science at MIT. The mission of this program is to train the next generation of biological/biomedical scientists, many of whom will be innovators and leaders in research and education. Specifically, in this training program we strive to educate our students: to understand the fundamental underlying principles of modern biology including genetics, biochemistry, cell biology, molecular biology and quantitative data analysis; to be ethical decision makers; to flexibly adapt to the rapidly changing modern biomedical sciences landscape; to become creative, effective, rigorous researchers; to become excellent communicators of science, and to become thoughtful teachers and mentors. We seek out, recruit and train talented students from majority, underrepresented minority, and disadvantaged populations, and help them initiate successful research careers. Trainees admitted to our program have outstanding undergraduate academic records and have demonstrated strong motivation to pursue research. A key feature of our program is an intensive, focused curriculum required of all first-semester students. Students work together in lecture and discussion-style courses taught by dedicated faculty to master a fundamental set of approaches that underpin all modern molecular biological science. The training program exposes students to the research interests of all faculty members in the Biology Department prior to the critical choice of a thesis
lab and topic. Responsible conduct in research is taught in three phases, including an intense mini-course for 2nd year students. We aim to support 46 predoctoral students per year, primarily in their first and second years of training; the complete Ph.D. program takes trainees approximately 5.8 years to complete. Students' progress through the program is monitored in regular thesis committee meetings with faculty members, with oversight provided by the graduate committee. Our students perform research of outstanding quality, and most trainees go on to careers in biomedical research. Many of our former trainees are now leaders in their chosen fields.",Pre-Doctoral Training in Biological Sciences,"PUBLIC HEALTH RELEVANCE: The MIT Department of Biology trains some of the world's most talented young scientists to unravel biology complexities fundamental to human health and disease. Our program provides training in the foundational approaches to biological research and a deep research experience in a student's chosen area. We also educate students about the basis of ethical and humane decision-making, and prepare diverse individuals for leadership positions in a range of biomedical careers.","Stephen P. Bell,AMY E KEATING","1893710,2118679"
14,9517941,,2018,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,PATHOLOGY,5T32GM007308-42,GM007308,UNITED STATES,T32,1303248,False,Stefan  Maas,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is a competing renewal application for T32GM007308-39, which funds the Medical Scientist Training Program (MSTP) at NYU School of Medicine (NYUSOM). The purpose of the MSTP is to train physician-scientists who will be capable of moving seamlessly between the realms of rigorous scientific inquiry and the holistic approach required for patient care. Students who successfully complete the MSTP graduate with both an MD and PhD degree. The MSTP at NYUSOM was one of the first three programs to be funded by NIGMS in 1964 and has been NIH funded ever since. Many of the 314 graduates have had illustrious careers and are counted among the leaders of academic medicine in the United States. The training begins with a summer research rotation, followed by three semesters of pre-clinical medical education punctuated by a second summer research rotation. Students then select a thesis lab and begin graduate work under the auspices of the Sackler Institute of Graduate Biomedical Sciences. Graduate training is offered in thirteen interdisciplinary training programs that include Biomedical Imaging, Biomedical Informatics, Cellular & Molecular Biology, Computational Biology, Developmental Genetics, Immunology and Inflammation, Microbiology, Molecular Biophysics, Molecular Oncology & Tumor Immunology, Molecular Pharmacology, Neuroscience & Physiology, Pathobiology, and Stem Cell Biology. Upon completion of a PhD thesis, the trainees return to medical school for the clinical portion of the curriculum, participating in all required clerkships as well as clinical electives. Trainees ar expected to complete the training in eight years or less. Over the past 5-year grant cycle, the median time-to-degree was 8.1 years. Mark Philips, MD, who runs an active molecular cell biology laboratory and who has trained 10 MSTP students, serves as the eighth director of the NYU MSTP and is assisted by two Co-Directors, Mitchell Chesler and Jennifer Philips, both MD/PhDs. A Faculty Operating Committee (FOC) and a full-time administrative staff assist the Co-directors. The training faculty consists of 121 full-time, tenure-track faculty who are selected
by the Co-directors for the quality of their research programs and their skills as mentors. Admission to the NYU MSTP is highly competitive. Over the past 5-year grant cycle 1883 students applied, 517 were interviewed, 197 (10.5%) were offered admission, and 47 matriculated. Significant effort is made to enhance the diversity of MSTP students. Of the 71 students currently enrolled in the MSTP, 10 (14%) are members of underrepresented minorities, one is disabled, and three are economically disadvantaged. The competitiveness of the NYU MSTP with regard to recruiting top candidates has improved over the past 5-year grant cycle both as a consequence of reorganization of the MSTP and the sharp rise of NYUSOM in the national rankings of research medical schools (37th to 19th). The Administration of NYUSOM supports the MSTP with substantial funding: in 2013 the Administration contributed $3,967,369 (57% of the total cost). At the last competing renewal, T32GM007308-34 received an outstanding priority score and 29 training slots were funded. The government sequester in 2012 reduced the funding to 25 slots. In accord with the recent academic success of the MSTP and of NYUSOM in general, we seek to expand the MSTP from 8-10 students per year to 10-12 and therefore request funding for 35 trainees.",Medical Scientist Research Service Award,"PUBLIC HEALTH RELEVANCE: This proposal seeks to renew funding for the NYU Medical Scientist Training Program (MSTP), one of 44 such programs funded by the National Institutes of Health. The dual MD/PhD degrees conferred on MSTP trainees equip them with the skills required to function both as a physician and a scientist. The MSTP thereby produces a class of professionals ideally positioned to become leaders in academic medicine and to perform rigorous, patient-oriented research designed to improve human health.",MARK Reid PHILIPS,1888869
15,9517956,,2018,UNIV OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,BIOLOGY,5T32GM007092-44,GM007092,UNITED STATES,T32,372175,False,Michael T. Bender,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): The Curriculum in Genetics and Molecular Biology (the Genetics Curriculum) is a well-established and highly-ranked interdepartmental PhD program at the University of North Carolina at Chapel Hill (UNC-CH). Throughout the 50-year life of the program we have provided diverse and cutting-edge research opportunities to trainees. In addition to our ongoing expertise in key areas in genetics (e.g., genetics of model microbes, plants, and animals) and molecular biology (e.g., signal transduction, gene expression, and virology), we have added strengths in epigenetics, clinical and translational genetics, systems genetics, quantitative genetics, computational genetics, and genomics. Extensive interaction between researchers in diverse areas is promoted by the interdepartmental and inter-school nature of the Genetics Curriculum and many faculty centers, and is facilitated by the physical proximity of the different units, all of which are on the same campus.  We strive to maintain a modern and innovative training program. The curriculum includes features common in similar programs, like coursework, written and oral qualifying exams, seminars, and retreats. Several years ago we introduced an innovative feature wherein selection of student and postdoctoral speakers for the annual Genetics Scientific Retreat are made by a mock study section at which training grant-appointed students score and discuss submitted abstracts. We've also innovated in coursework by transitioning to focused, modular courses that meet for a third of a semester and can be taken a la carte. This gives students greater flexibility choosing the most appropriate topics of study and allows faculty to teach withi their areas of greatest expertise. We now partner with the Department of Biology to expand teaching assistantship opportunities to include undergraduate courses at the introductory and advanced levels. The Office of Graduate Education has developed unique programs that enhance the training experience and promote career development.  We compete nationally for the top students and have successfully recruited a diverse group, with about 25% belonging to one of the NIH-defined diversity groups. Our students are successful in obtain competitive external funding, and every student publishes at least one first-authored research paper in a peer-reviewed journal (the mean is almost 4 publications). The vast majority of our students remain in scientific careers after they graduate. Most initially do postdoctoral research in academia, government labs, or private research foundations. Some remain in academic/government research, but others go into private corporations, science teaching, or science policy.",NRSA in Genetics,"PUBLIC HEALTH RELEVANCE: Genetics and genomics are among the most important fields in basic biomedical research, contributing to essentially all medical applications. The Curriculum in Genetics and Molecular Biology is a highly-ranked doctoral program that trains students broadly in these fields; this proposal seeks to continue NIH support for training these students for a careers and academic, government, and private research, clinical settings, teaching, and other scientific fields.",JEFF J. SEKELSKY,1925859
16,9517950,,2018,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-44,GM007200,UNITED STATES,T32,2293716,False,Stefan  Maas,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is a renewal application to support the Medical Scientist Training Program (MSTP) at Washington University in St. Louis. The overarching goal of the MSTP is to provide in-depth pre-doctoral training in clinical medicine and biomedical research for individuals desiring careers as physician-scientists. The applicant pool is strong and in the past funding period, the MSTP made significant strides in recruiting diversity students. Medical training is provided by the School of Medicine and research training is carried out in the interdisciplinary graduate programs of the Division of Biology and Biomedical Sciences, and in the Departments of Biomedical Engineering and Anthropology. Together, these graduate programs encompass nearly all contemporary areas of biomedical research. The basic components of the MSTP are: 1) Two years of the preclinical medical school curriculum; 2) Coursework in a biomedically relevant discipline; 3) Three or more years of original, hypothesis-driven research leading to completion of a doctoral thesis; 4) At least 15 months of clinical training; and 5) A wealth of academic and social programs designed to enhance the program and cohesiveness of the student body. The M.D. and Ph.D. degrees are awarded jointly at the successful completion of both components which typically takes 7-8 years, a period shortened by integrating both curricula. Upon completion of subsequent postgraduate training, MSTP alumni will be prepared to enter the workforce as physician-scientists. Based on the track record of this program, the vast majority will join the faculty of te nation's medical schools while others will contribute to the nation's biomedical research enterprise in government laboratories, biotechnology firms, and the pharmaceutical industry. Regardless of their position, their MSTP training will allow them to bridge the gap between the basic laboratory and the clinic. The success of this program is due to strong institutional support
and continued funding of this grant. Thus, this renewal application seeks continued support for 55 students annually for 36 months each with the goal of graduating 20-25 MSTP students each year over the period of this grant.",National Research Science Award - Medical Scientist,"PUBLIC HEALTH RELEVANCE: The Medical Scientist Training Program at Washington University is a pre-doctoral program that trains future physician-scientists for careers where they
will have the abilities to treat patients, teach medical students and scientists, and conduct cutting-edge research that improves human health and eradicates disease. They will be uniquely qualified to help bridge the gap between the research laboratory and the clinic.",Wayne M. Yokoyama,8404502
17,9503044,,2018,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007151-40,HL007151,UNITED STATES,T32,293981,False,Henry  Chang,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): The New York University School of Medicine has a long established record of training academic hematologists. In large part, this record has been fostered by the continuous support, since 1962, of a NIH Training Grant (T32) which supports 6 M.D., M.D., PhD, and PhD Trainees. The long term goal of the Training Program is to prepare Hematology Trainees for future careers in academic medicine. The interaction of both M.D., M.D./PhD, and PhD Trainees in a unified Training Program serves to increase the number of physicians and scientists committed to a career in research. The Training Program exposes Trainees to rigorous mentored lab based hematology research, a detailed curriculum, seminar series, a journal club, a clinical management conference, and the opportunity to participate (for M.D Trainees) or observe (for PhD Trainees) the practice of clinical hematology relevant to the Trainee's laboratory investigation. Trainees are selected from the ACGME accredited adult and pediatric hematology/medical oncology fellowship programs and from eligible post- doctoral PhD fellows in participating faculty member's laboratories. The program, led by a Director with three well qualified Associate Directors, is specifically dedicated to actively recruiting underrepresented minorities. Our 15 Mentors have experience in mentoring and documented productivity, and their laboratories are highly interactive and use a variety of model systems to study 1) benign hematology including PNH, platelet biology and Fanconi anemia; 2) the genetics of leukemia; 3) JAK/STAT and Ras signaling mechanisms in hematopoietic stem cells, lymphopoieis, leukemia and lymphoma; 4) lymphopoiesis and lymphocyte activation (including GVHD); 5) mechanisms of myeloid and lymphoid trafficking; 6) ubiquitination in hematopoietic stem cell biology, lymphopoiesis, and leukemia/lymphoma; and 7) the epigenetic and molecular basis of normal and abnormal hematopoiesis. Past graduates of our program have achieved the highest ranks of academia and have made lasting contributions to the field of hematology, and a high proportion of our recent graduates remain in academia, using the research skills gained as Trainees in careers as researchers, academic teachers and trialists. Over the last 10 years the majority of our graduates have obtained positions in academic institutions, have published their findings in the highest tier of journals, and have received multiple NIH and foundation awards.",Research in the Pathogenesis of Hematologic Disorders,"Project Narrative
Hematological disorders represent a major cause of death in the U.S. Insights into many diseases have also
come from laboratory-based research of hematological disorders and hematopoiesis. Well trained physicians
and scientists will lead the way to new treatments for these disorders through fundamental and translational
research, education, and clinical trials.",Samer  Al-Homsi,14677471
18,9497811,,2018,UNIVERSITY OF COLORADO DENVER,Aurora,CO,INTERNAL MEDICINE/MEDICINE,5T32HL007085-44,HL007085,UNITED STATES,T32,946207,False,Roya  Kalantari,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"DESCRIPTION (provided by applicant): This application is a competitive renewal of the Colorado Multidisciplinary Research Training Program in Respiratory Disease (CTP), currently in the 39th year. The program proposes to train 12 post-doctoral Trainees (MD and PhD) per year. The mission is to train exceptional MD and PhD scientists for leadership in investigative careers. The future of American medicine will be dependent on the comprehensive investigation of T1-T4 research [basic translation (T1) through implementation science (T4)] with the goal to the betterment of patient care and patient health. In order to position the future generation for this goal, our training program (CTP) is designed to enable Trainees to have a comprehensive, integrative, and formal career development experience with the goal of positioning them to become the next generation of leaders in Pulmonary and Critical Care research. The CTP stresses translational science, incorporating the newest scientific platforms and didactic training
integrated with cell, animal model, and human tissue research with established clinical research programs. Formal graduate school training is available through the Colorado Clinical and Translational Sciences Institute (CCTSI). There are 53 Faculty Mentors and 18 Emerging Mentors from 3 Schools and 6 Departments. The inclusion of 18 emerging mentors (EM) is to provide the continuum of mentorship and leadership development for the CTP. The Pulmonary Division at the University of Colorado is designed around selected thematic research firms. Within each of these research firms, specific disease teams have comprehensive, translational research programs. The four research firms include; 1) Lung Injury and Repair, with specific disease team focus on acute lung injury (ALI), and idiopathic pulmonary fibrosis (IPF); 2) Pulmonary Vascular Diseases, including both adult and pediatric presentations of disease; 3) Airway Biology, with disease teams in asthma, COPD, cystic fibrosis and lung carcinogenesis, and 4) Host Defense and Immunology with a focus on granulomatous lung diseases and infectious lung diseases. T1 - T4 methodologies transcend the research efforts of each Firm. The Firms organize thematic research seminars, and are empowered to provide pilot funding for disease-specific Teams. For a sustainable workforce, we will use a conceptual model of academic persistence as our theoretical framework. Between 2004-2014, 65 T32 Trainees completed their training, or are in process (53 MD, 4 MD/PhD, 8 PhD), and 82% remain in academic medicine or related fields. This group has been awarded 10 fellowship awards and 20 career development awards. Eight faculty have recently achieved ""K to R"" transition over the past 5 years. The Trainees are highly diverse, with 43% women and 15% persons from URM or underserved backgrounds. All of these factors enable the University of Colorado to be an ideal site for training future leaders in respiratory diseases.  (End of Abstract)",Multidisciplinary Research Training in Respiratory Disease,"PROJECT NARRATIVE
Pulmonary diseases account for approximately four million deaths per year in the United States. There is an
acute need to train dedicated scientists who will form the future workforce empowered to make discoveries
which lead to the reduction in death and disability from pulmonary disease. The University of Colorado School
of Medicine Multidisciplinary Research Training in Respiratory Disease provides state-of-the-art research
training for M.D. and Ph.D. scientists in both laboratory-based and clinical studies, with the goal of training the
next generation of leaders in the field of pulmonary disease research.","David Albert Schwartz,Marvin I Schwarz","9419318,1963090"
19,9485354,,2018,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PUBLIC HEALTH & PREV MEDICINE,5T32HL007024-44,HL007024,UNITED STATES,T32,733068,False,Lorraine M Silsbee,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This application is for a five year renewal, years 41-45, of an institutional training grant in cardiovascular disease epidemiology. The aims of the training program are to develop creative and independent investigators who will contribute to our knowledge of cardiovascular disease, its pathogenesis, complications and prevention. Both the training program and trainees will evolve in response to the changing needs of benefits from close ties with other population and clinically-oriented departments at The Johns Hopkins cardiovascular epidemiology and science. The program is based in the Department of Epidemiology but Medical Institutions as well as several affiliated community-based research units. The 53 trainees in the past 10 years have been extremely successful; to date their CVs show a total of 907 total publications with nearly all doing research (30 in an academic setting and 11 are in government or industry) with 10 still training and only 2 not doing any research. Time to degree completion is on target (mean 4.2 for pre-docs and 2 for Masters) and productivity is high (pre-doc and post-doc average of 17.6 and 20.3; medians of 9.5 and 15 total recruitment efforts are robust and successful. Pre-doctoral candidates will enroll in the PhD program. Post- publications including 37 first author publications cited >50 times). All slots were
filled and minority doctoral candidates without a previous degree in epidemiology will enroll in a 2-year thesis bearing master's series, and a program-specific research-in-progress meeting, 3) ""hands-on"" analysis of an existing data set degree. Trainees will participate in 1) a structured schedule of didactic course work, 2) journal club, seminar and 4) thesis research project.  A Program Director, a co-director, 18 core, 5 junior participating, and 14 Affiliate excellence, mult-disciplinary collaboration, innovation and life-long learning. Faculty Members serve as potential support and mentors for the trainees. The program will maintain a focus on",Cardiovascular Epidemiology Institutional Training,"PROJECT NARRATIVE:
This grant trains future leaders in studying risk factors for developing heart disease with rigorous training in
statistics and epidemiology to study strategies to improve disease prevention. The faculty and trainees
emphasize innovative methods including genetic risk factors and radiological imaging of blood vessels as well
as prevention research and efforts to decrease disparities in health outcomes.",JOSEF  CORESH,1877194
20,9477345,,2017,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,3T32DK007126-41S1,DK007126,UNITED STATES,T32,6255,False,Krystyna E Rys-Sikora,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2018-06-30T04:00:00Z,PA16287,"DESCRIPTION (provided by applicant): This revised competing renewal application for training grant T32 DK07126 requests continued support for the post-doctoral training (up to 3 years) of four board-eligible or board-certified internists and basic scientists (MD, PhD or MD/PhD) for careers as independent investigators committed to studying kidney disease. The Renal Division at Washington University (WU) has maintained an active and formally organized fellowship program since 1956. The purpose of this training effort is the preparation of carefully selected candidates for full time careers in academic medicine. In the course of our training program we provide highly-motivated carefully-selected individuals with in-depth experience and direction in the philosophy, methodology, and details of execution of controlled investigations in areas related to renal function in health and disease. WU offers a resource-rich environment. Interaction between individuals based in clinical and basic departments occurs as a matter of routine through their common association with the multidisciplinary Division of Biology and Biomedical Sciences and Institute of Clinical and Translational Sciences. Patient-based investigation is facilitated by participation in and access to the clinical practice at WU and Barnes Jewish Hospital (BJH) and St. Louis Children's Hospital (SLCH). The WU Renal Division owns, operates and staffs four outpatient dialysis facilities. The kidney transplant program at WU/BJH is one of the oldest in the USA. The WU George M. O'Brien Center for Kidney Disease Research provides core services to support a wide range of research endeavors including organ culture and transplantation (organogenesis); provides expertise and advice for investigators wishing to study diverse aspects of renal development, function and disease; generates non-genetic (injury) models of kidney disease in mice and rats; generates transgenic and knockout mice for the study of genes involved in renal development, function, and disease; provides a battery of renal chemistry assays of blood and urine to aid in the analysis of animal models of genetic and acquired kidney diseases; provides equipment and support for analyzing renal development, morphology and histopathology by fluorescence, light, and transmission electron microscopy; maintains a repository of kidneys from animal models of kidney disease; and a repository of curated kidney patient serum, DNA and tissues. Its administrative core supports a series of topical conferences by internationally recognized scientists relating to developmental biology published in the journal Organogenesis. Continued interdisciplinary training of young internists and basic scientists in state-of-the-art approaches to the analysis and cure of kidney diseases is consistent with the longstanding commitment of WU School of Medicine to provide leadership in biomedical investigation. Twenty-five individuals who trained in Nephrology at WU have gone on to head Renal Divisions in the United States and abroad. The WU Renal Division has a longstanding commitment to train individuals from minority groups and several are longstanding members of its faculty.",Renal Disease,The incidence and prevalence of kidney disease is increasing yearly in the United States. The training of individuals well versed in all aspects of renal scienc is essential to maintaining the public health in terms of reducing the incidence and prevalence and limiting the morbidity and mortality of renal diseases,BENJAMIN D. HUMPHREYS,1902627
21,9570006,,2018,UNIVERSITY OF WASHINGTON,SEATTLE,WA,BIOCHEMISTRY,2T32GM007270-44A1,GM007270,UNITED STATES,T32,753238,False,DESIREE LYNN Salazar,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2021-06-30T04:00:00Z,PA16152,"Abstract
The Cellular and Molecular Biology (CMB) training program offers doctoral candidates a broad-based
education in molecular and cellular biology at institutions located within the Seattle biomedical corridor.
Administered out of the University of Washington (UW), this interdisciplinary program also supports predoctoral
trainees at the Fred Hutchinson Cancer Research Center (Fred Hutch) and partner institutions mostly located
in the South Lake Union region of the city. The primary objectives of the CMB program are to recruit
enthusiastic and motivated students who are passionate about the biomedical sciences and to provide
personalized training across a range of disciplines pertaining to basic and translational aspects of molecular
and cellular biology. These talented individuals have the opportunity to be mentored by 68 faculty members
who are experts in a range of disciplines that include Biochemistry, Biophysical Structure and Design,
Immunology, Microbiology, Molecular and Cellular Biology, Neuroscience, Pathology, Pharmacology, and
Physiology and Biophysics. CMB trainees enter the program in years 2-4 of graduate school and are selected
on academic record and performance in the written and oral components of the annual application competition.
Trainees complete mandatory coursework in biostatistics and fundamentals of molecular biology; participate in
the Biomedical Research Integrity Lecture series; attend a monthly student organized research conference
with speaking and networking opportunities; and take part in the annual CMB Training Grant retreat.
Traditionally, the CMB program has successfully partnered with several minority advocacy groups to promote
diversity on all campuses. We continue to expand the under-represented minority (URM) footprint and are now
emphasizing the recruitment and retention of students who are the first in their families to attend college (first
generation) and students with disabilities. This innovative graduate training environment encourages trainees
to pursue scientific excellence and endorses peer mentorship and the exploration of alternative career paths.
The intended outcome is to nurture a diverse close-knit group of students who are equipped to become the
next generation of scientific leaders.",Training in Cellular and Molecular Biology,"Narrative
This program trains students to understand both the life of a cell at the molecular level and how this relates to
human health. This is achieved through a combination of formal lectures, laboratory-based research, and
group -learning experiences. The anticipated outcome of this educational experience is to nurture a diverse,
close-knit group of students who are equipped to become the next generation of scientific leaders.",David W Raible,1929733
22,9396150,,2017,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,3T32DK007074-43S1,DK007074,UNITED STATES,T32,3175,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA16287,"   
DESCRIPTION (provided by applicant): This is a proposal for continuation of a long-standing, highly successful research training program for pre- and postdoctoral candidates in Digestive Health, Diseases, and Nutrition (DHD&N) at the University of Chicago. This program has had a tradition of providing rigorous scientific training to highly qualified and promising individuals fr careers in basic, translational, and clinical investigation. As a result, the program has successfully prepared generations of leaders in biomedical research and academia. The training faculty is highly multidisciplinary, collaborative, and stable, with almost all participating in mentoring past and current trainees over the past two funding cycles. The program enjoys strong institutional support that includes the selection of the DHD&N area in 2009 by the Division of Biological Sciences as one of five high priority areas to be promoted over the next decade. Accordingly, the program has been provided with state-of-the-art research and clinical facilities that are strategically located in the heart of the biomedical research complex that offes enabling technologies such as mouse genetic engineering and gnotobiotic facilities, next generation DNA sequencing, advanced `omic' technologies, light and digital imaging resources, computational resources for systems biology and integration, and a robust infrastructure designed to provide highly curated clinical metadata and biospecimens for translational investigators in the area of DHD&N. The program's curriculum is custom designed for training predoctoral and postdoctoral trainees, and includes both didactic, formal coursework and problem-based and hands-on training. At the same time, the curriculum adapts to the everchanging landscape of knowledge, technology, and clinical practice to insure the competitiveness, productivity, and success of all our trainees. Cross-cutting themes such as the gut microbiome, host-microbe interactions, personalized medicine, epigenetics, and mucosal immunology are the underpinnings of the program, promoting collaborative science, scholarship, and discovery. During the course of training, the progress and career development of all candidate are monitored closely by faculty advisory and program oversight committees. Trainees are taught how to think critically and creatively, and receive instruction in academic skills (e.g. grant and MS writing, instruction in mentorship, etc) and the responsible conduct of research. The program also proactively promotes diversity among its selected candidates and has developed a strong retention plan. Collectively, these efforts have resulted in a high success rate in producing high quality investigators who are well prepared to become independent investigators, future mentors, and academic leaders.","Research Training in Digestive Health, Diseases, and Nutrition","PUBLIC HEALTH RELEVANCE: Digestive and nutritional/metabolic diseases represent a significant burden of disease and public health problem in the US and worldwide. The objective of this Program is to prepare next generation of young scientists and clinicians as future mentors, scholars, and leaders in Digestive Health, Diseases, and Nutrition.",EUGENE  CHANG,1858734
23,9387619,,2017,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,ENGINEERING (ALL TYPES),3T32ES007020-42S1,ES007020,UNITED STATES,T32,4425,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2017-06-30T04:00:00Z,PA16287,"   
DESCRIPTION (provided by applicant)   
   
The goal of this training program in environmental toxicology is to produce scientists professionally qualified to make original contributions to improved understanding of the impacts of environmental agents, especially hazardous chemicals, on human health. Trainees pick projects from the following areas: (1) analysis of genome-, proteome- and glycome-level responses to toxins and toxicants; (2) characterization of mutagenic responses to carcinogens as expressed hierarchically at the genome, cell, tissue, organism and population levels of organization; (3) construction of novel animal models for determining the effects of exposure of mammals to environmental agents; (4) investigation of intra-cellular kinase-mediated signaling cascades triggered in response to toxic agents, and during neoplastic transformation and endometriosis; (5) characterization of the chemistry underlying the reaction of toxins and toxicants with cellular macromolecules and other targets; (6) mechanistic assessment of the contribution of specific DNA adducts to genetic disease, and identification of the cellular defenses (e.g., DNA repair strategies) that protect against DNA damage; (7) engineering-based design of novel model systems for evaluating responses to toxic agents; (8) design of novel sensing systems to track pollutants; and, (9) measurement of pollution distribution in the environment. A central theme that has developed during the past five years, which links all nineteen research groups, is the interplay between environmental chemicals and infectious agents in human disease. Highlights of the program are a well-structured and constantly updated academic program taken by pre-doctoral students, a postdoctoral mentoring program, numerous toxicology-focused seminar programs and a large emphasis on research collaboration. More than 400 students apply for the pre-doctoral program annually, allowing for good program selectivity.    
   
This program supports seven pre-doctoral and six postdoctoral trainees. It has supported 100 pre-doctoral and 80 postdoctoral trainees since its inception in 1975. During that same time period, 251 Ph.D. or Sc.D. degrees have been awarded to all students in the MIT toxicology program (trainees plus non-trainees). Of the pre-doctoral and postdoctoral graduates over the past 10 years, 7 out of 20 (35%) are in academic or postdoctoral positions and 13 of 20 (65%) are in industry. Of the 251 degrees awarded, 37 recipients have become professors and 6 are in other forms of teaching.",Training Grant in Environmental Toxicology,"PUBLIC HEALTH RELEVANCE: This training program comes from the interface of science and engineering. Using and developing state-of-the-art technology, the trainees address cutting edge problems in environmental health. The approaches involve measurement of risk, mining of complex biological data, modeling of systems exposed to environmental agents, and manipulation of systems to modulate risk.",JOHN M ESSIGMANN,1864810
24,9052767,,2016,UNIV OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,PHARMACOLOGY,5T32GM007040-42,GM007040,UNITED STATES,T32,302865,False,Sailaja  Koduri,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This Pharmacological Sciences Training Program (PSTP) is dedicated to training outstanding scientists in the pharmacological sciences. A highly productive and well-funded faculty provide a broad diversity of research areas for trainees that builds on our traditional strengths in receptors and signal transduction, cancer and protein kinases, and neuropharmacology with emerging areas in chemical biology, nanotechnology, genomics and proteomics, stem cells, RNA biology, bioinformatics and systems biology. Students apply to the Biological and Biomedical Sciences Program (BBSP), an admissions portal/first year program for 14 degree-granting departments/curricula in the School of Medicine, Biology and the biological division of Chemistry in the College of Liberal Arts & Sciences, and the Divisions of Chemical Biology & Medicinal Chemistry and Molecular Pharmaceutics in the School of Pharmacy. This umbrella program oversees recruitment and training of first- year graduate students in the biomedical sciences. Last year, the BBSP brought in 88 students, 16 of which were underrepresented minorities (18%). Students carry out three research rotations, take basic first year courses, and, at the end of their first year, choose a mentor and a PhD program for their thesis research. Students joining the PSTP choose from 45-core faculty for their dissertation research. A very strong Medical Scientist Training Program (MSTP) also brings in ~8-9 students per year, 1-3 of which join the PSTP per year. The PSTP consists of formal courses, seminar courses focusing on scientific communication skills, and original doctoral research. Basic courses in cell biology or neurobiology, introductory and advanced courses in pharmacology and physiology, and elective specialized courses are required and are taken in the first and second years. A rigorous and intensive grant-writing course develops skills for identifying an important and innovative research question and hypotheses and formulating a strong set of Specific Aims that test these hypotheses. Presentation courses and a student seminar series provide students with many opportunities to hone their research presentation skills and gain confidence in public speaking. Quantitative skills are developed through strong emphasis on biostatistics, biocomputation, and ligand-receptor binding theory and analysis. Individual Development Plans are drafted for all students, and also are used to identify quantitative skills classes germane to the students' research projects. A robust advisory system oversees the thesis research years of students.",Predoctoral Training in Pharmacological Sciences,"PUBLIC HEALTH RELEVANCE: Students who complete this predoctoral training program will have acquired basic knowledge of pharmacology and related fields, in-depth knowledge of an important area of biomedical research, skill in planning and executing a valuable research project in the pharmacological sciences, and exceptional ability to analyze, interpret and communicate results. These skills provide a sound basis for scientific careers in academia, government, or industry.",ROBERT A NICHOLAS,1899037
25,8897279,,2015,UNIVERSITY OF WISCONSIN-MADISON,MADISON,WI,INTERNAL MEDICINE/MEDICINE,5T32CA009135-38,CA009135,UNITED STATES,T32,412369,False,Susan N Perkins,National Cancer Institute,1975-07-01T04:00:00Z,2016-07-31T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): Our grant for ""Training in Cancer Biology"" has supported predoctoral training in the McArdle Laboratory for Cancer Research, and more recently, the University of Wisconsin Carbone Cancer Center (UWCCC), for 35 years, and is the educational core for cancer research at the University of Wisconsin-Madison. This competitive renewal seeks to continue our mission of providing the best training environment for the next generation of cancer researchers. This is a broad-based training program in experimental cancer research that is implemented by 38 UW faculty members with research programs focused on both basic and translational cancer research. Our trainers are highly committed to providing substantive training and mentoring for our trainees and they have a record of success. All trainers in the program are funded with peer-reviewed grants, supported by the NIH, DOD, and/or the ACS. They are engaged in multiple intra-programmatic collaborations which support collaborative grants and joint publications. Our grant currently supports 15 predoctoral trainees and we are requesting continued support for the same number of slots. Trainees represent students from a variety of graduate programs at UW-Madison, such as Cancer Biology, Cellular and Molecular Biology, and Molecular and Cellular Pharmacology. Students are eligible for a position on this grant upon passing their qualifying exam and achieving dissertator status. Importantly, they must demonstrate a clear commitment to cancer research. This training grant can boast a number of accomplishments during the last 5 years, including well-funded and interactive trainers, a productive publication record of trainees, and successful employment of trainees in cancer-research related activities. We have greatly increased the diversity of our trainee cohort and we will continue to prioritize recruitment efforts of students from traditionall under-represented groups. The program will be led by Dr. Bill Sugden who has been PI of this grant since 1987. Drs. Alarid and Loeb have been working with Dr. Sugden for the past two years and will continue to do so as Assistant Directors. Both investigators have a clear and demonstrated commitment to predoctoral training of cancer researchers. It is anticipated that they will evolve to become the co-Directors of this grant over its next funding period. This grant has supported the training of more than 450 scientists in cancer biology, initiating their careers in academia and industry to carry out robust cancer research throughout America. We seek to continue this excellent training of young scientists with this grant, which is the only training grnt on our campus dedicated to the predoctoral training of cancer researchers.",Training In Cancer Biology,"PUBLIC HEALTH RELEVANCE: This grant, entitled Training in Cancer Biology, has supported the training of cancer researchers at the University of Wisconsin-Madison for 35 years. The goal of this grant is to limit cancer maximally as a disease by educating the next generation of cancer researchers to be as committed and competent as is humanly possible. We shall both build on our past success and evolve this program to lead training in cancer research optimally into the future.",WILLIAM M. SUGDEN,1884478
26,8897278,,2015,RESEARCH INST OF FOX CHASE CAN CTR,PHILADELPHIA,PA,,5T32CA009035-40,CA009035,UNITED STATES,T32,565626,False,Susan E Lim,National Cancer Institute,1975-07-01T04:00:00Z,2016-08-31T04:00:00Z,PA10036,"DESCRIPTION (provided by applicant): Support is requested for years 35-40 of a long-standing training program in cancer research for postdoctoral fellows at the Fox Chase Cancer Center. The Training Faculty consists of 47 Mentors (11 Assistant Professor, 15 Associate Professor, 21 Full Professor) with diverse interests in cell growth control, signal transduction, oncogenes and tumor suppressor genes, angiogenesis, epigenetics, cancer prevention, programmed cell death, bio-behavioral cancer research, immunology, mouse models of cancer, and developmental therapeutics. The well-funded and highly collaborative Training Faculty come from five different research programs: Immune Cell Development and Host Defense, Cancer Biology, Developmental Therapeutics, Women's Cancer, and Cancer Prevention and Control. The postdoctoral pool is extremely strong; there are 4 applicants per open slot, and the majority of applicants received graduate training at outstanding Institutions and are published in high- impact journals. The program offers diverse training in areas relevant to cancer research, with a combination of didactic and laboratory-based training, including seminar series, journal clubs, grant- writing workshops, and educational series. Input from the postdoctoral pool is extensive and highly valued; trainee satisfaction is best exemplified by our placement, every year for the past seven years, in the Top 20 ""Best Places in the United States for Postdoctoral Training"", as determined by anonymous survey and published in The Scientist magazine. Funding for 10 trainees per year is requested; this is less than one quarter the citizenship-eligible trainees in the labs of the training faculty. Trainee slots are highly competitive and have been continuously filled for the last 2 funding cycles. Finally, 82% of trainees who have completed training and left this program report that they are still doing research directly relevant to cancer, indicating that we are fulfilling our goal of training the future of cancer research. Finally, this training program serves as the nucleus of our postdoctoral program. Its continued success is vital to the mission of Fox Chase Cancer Center.",Training Program in Cancer Research,"Cancer continues to be a major health issue in the United States. With a highly collaborative faculty, a diverse and rigorous training program, an outstanding pool of postdoctoral fellows and cutting-edge research questions, this training program seeks to train the future scientists in cancer research.",JONATHAN D. CHERNOFF,1882056
27,8929249,,2015,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,OPHTHALMOLOGY,5T32EY007026-40,EY007026,UNITED STATES,T32,223779,False,neeraj  agarwal,National Eye Institute,1975-07-01T04:00:00Z,2017-08-31T04:00:00Z,PA10036,"DESCRIPTION (provided by applicant): This is a resubmission of a competing renewal application for an NRSA Research Training Grant (T32- EY007026). The Vision Science Training Program (VSTP) has its home in the Jules Stein Eye Institute (JSEI), University of California, Los Angeles (UCLA) School of Medicine, and has been continuously active for 35 years. The Program covers the training of both Pre-doctoral and Post- doctoral Fellows. Training takes place in the laboratories of 20 faculty mentors who work at JSEI. These vision scientists possess expertise in a wide range of disciplines and hold academic appointments in 15 departments at UCLA. Applicants for Pre-doctoral Fellowships must first gain acceptance to one of the accredited graduate programs at UCLA. The majority of Pre-doctoral Fellows are recruited from the ACCESS umbrella program. Accordingly, the VSTP has established formal ties with ACCESS. VSTP faculty is playing a larger role in the recruitment and selection of ACCESS applicants. Applicants for Post-doctoral fellowships are recruited directly by VSTP faculty members. The VSTP curriculum is comprised of several components. For Pre-doctoral Fellows, it includes the first- and second-year curriculum of the degree-granting graduate program. Pre-doctoral and Post-doctoral Fellows in the VSTP are required to take Fundamentals of Vision Research, a quarter-long course organized and taught by members of the VSTP faculty. This course provides trainees with an overview of vision science and an understanding of the important unanswered questions in vision research. Another offering of the VSTP is Career Development, which covers issues such as career trajectories, scientific writing, grantsmanship, and laboratory management, from a vision-science perspective. Still another VSTP course offering is Fundamentals of Clinical Ophthalmology, which provides Pre-doctoral and Post-doctoral fellows with an overview of ophthalmologic diseases, current diagnostic tools, and accepted treatments. This course is to encourage VSTP Fellows in the direction of translational research. Other teaching offerings of the VSTP include a Vision Science Seminar Series, a Vision Science Journal Club, a Stem Cell Works-in- Progress Meeting, the JSEI Annual Clinical and Research Seminar, and the Annual Vision Science Retreat. With regards to diversity, the VSTP benefits from the highly effective and institution-wide commitment to the recruitment of under-represented minorities at UCLA. VSTP faculty members participate directly in these recruiting efforts. Pre- and Post-doctoral Fellows in the VSTP are required to take the course M234 on Ethics and Accountability in Biomedical Research, in addition to the mini-course on scientific ethics offered during the JSEI Vision Science Annual Retreat. The VSTP has been highly successful at recruiting and retaining Pre-doctoral and Post-doctoral Fellows. In fact, we have had more qualified Pre-doctoral and Post-doctoral applicants than positions every year since the last competing renewal. Continued funding of this application will permit JSEI to carry on its critical mission of training the next generation of first-rate basic and clinical vision scientists.",Vision Research Training Grant,"Vision science is entering a phase where many 'untreatable' blinding diseases will become amenable to treatment, given further research. However, the development of breakthrough therapies will require a new generation of vision scientists with experience in the areas of stem-cell technology, gene delivery, and biochemical pathogenesis. The Vision Science Training Program at Jules Stein Eye Institute, with its world-class faculty and outstanding facilities, seeks to continue training leaders in the field of vision science.",GABRIEL H TRAVIS,1893848
28,9061018,,2016,YALE UNIVERSITY,NEW HAVEN,CT,PSYCHIATRY,4T32MH014276-42,MH014276,UNITED STATES,T32,291390,False,Mark  Chavez,National Institute of Mental Health,1975-07-01T04:00:00Z,2018-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant):  The main purpose of the Biological Sciences Training Program in the Department of Psychiatry at Yale is to train postdoctoral fellows in biological and behavioral sciences relevant to mental illness and health. To attain this goal, the program recruits two groups of postdoctoral trainees: 1) psychiatrists, generally after completing two or three years of clinical residency, and 2) individuals with a Ph.D. degree in a basic science. To help fill a nationally recognized need, the aim of the program is to both increase the number of research psychiatrists with a grounding in basic biological sciences and to develop the interest of basic scientists in clinical problems as well as in interdisciplinary aspects of thir own basic research. Thus, the overall aim is to promote cross-fertilization between basic researchers and individuals who are experienced clinically. Extensive research collaboration between training program faculty members further contributes to interdisciplinary experience of the trainee. It is expected that trainees coming out of this program will be able to bridge the gap
between basic and clinical neuroscience in psychiatry.  There are 29 faculty members in the program consisting of both basic and clinical researcher scientists. The number of postdoctoral training slots requested is five, the same number as the current grant. The program typically involves training for approximately 2 years in one primary discipline but usually includes direct or collaborative interactions with other disciplines. Laboratory training is offered in the followig fundamental areas of research: neurochemistry, molecular biology, biochemistry, proteomics, electrophysiology, systems neurobiology, and behavior. Clinical research training is offered in behavioral assessment, genetic analysis, biological measurements, and imaging techniques. In addition to specific research training, there are courses in Clinical Neuroscience and Neuropharmacology as well as seminars and regular Workshops in which Fellows present ongoing research to the entire group of faculty and trainees.  The training proposal is directly relevant to the research objectives of NIMH by fostering the training of researchers to elucidate the neurobiology of mental disorders and maladaptive behavior. Thus, basic and clinical research is carried out in areas related to anxiety (e.g., panic and post- traumatic stress disorder), obsessive-compulsive disorder, schizophrenia, affective illnesses (depression and bipolar disorder), and substance abuse. The basic research conducted by the faculty and trainees during their time at Yale and later in their careers will lead to identification and development of novel and more effective therapeutic strategies.",Research Training - Biological Sciences,"PUBLIC HEALTH RELEVANCE:  The Biological Sciences Training Program at Yale trains postdoctoral fellows in biological and behavioral sciences relevant to mental illness and health. The aim is to increase both the number of research psychiatrists with grounding in basic biological sciences and to develop the interest of basic scientists in clinical problems as well as
in interdisciplinary aspects of their own basic research. The training program helps to fill a nationally recognized need by teaching researchers to elucidate the neurobiology of mental disorders and maladaptive behavior and to identify novel and more effective treatment strategies.",RONALD S. DUMAN,1865048
29,9060328,,2016,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,ANATOMY/CELL BIOLOGY,5T32GM007229-40,GM007229,UNITED STATES,T32,461061,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): We propose to continue a flexible interdisciplinary Training Program in Cell and Molecular Biology, currently in its 37th year at the University of Pennsylvania. The training program is a University-wide, interdepartmental and interschool program whose mission is to provide a multifaceted doctoral program to prepare students for careers in cell and molecular biology in academia, industry, or government. The training program's goal is to provide broad-based training in modern methods of cell and molecular biology and in-depth didactic exposure to cell and molecular biology, while at the same time matching the Trainees' specific interests. These goals are achieved through general and specialized courses, literature survey courses, laboratory rotations, a qualifying examination, thesis research with oversight from an advising committee, training in bioethics, and training grant-specific activities. Trainee-specific activities include an annual oral presentation of ongoing thesis research; attending the annual Cell and Molecular Biology Retreat; attending the Annual Trainee Organized Invited Lectures; participating in Alumni Day in which a former Trainee who has completed their Ph.D. and left Penn is invited back to give a seminar and meet with the Trainees; group attendance of Trainees/Trainer at the annual meeting of the American Society for Cell Biology meeting and the Current and Former Trainee Lunch in which 2 former Trainees present a talk on their thesis research. Students completing their second year of graduate studies are appointed for two years and are selected annually by the Executive Committee. Trainers come from the Schools of Medicine, Veterinary Medicine, Arts and Science, and Engineering and Applied Science, and the Wistar Institute and not only have active research programs in cell and molecular biology but also a commitment to graduate education. The training program has formal mechanisms to monitor trainees both during and after their training grant support. In addition, the training program has formal mechanisms to monitor trainers, as well as to resolve any conflicts between trainees and trainers. Last, Trainers
participate in a number of efforts to recruit under-represented minorities both locally and nationally. Direct management of the Training Program is done by an Executive Committee that sets and reviews policy and selects trainees. Based on the number of potential trainees, we request support for 14 predoctoral trainees/year for the next 5 years; this number is the same as that currently supported by the training grant.",Training Program in Cell and Molecular Biology,"PUBLIC HEALTH RELEVANCE: This Predoctoral Training Program includes education and research opportunities to investigate the molecular and cellular basis of fundamental biological processes that range from cell signaling to gene expression, employing a wide array of model systems.","MARISA S. BARTOLOMEI,RICHARD M SCHULTZ","1883128,1876102"
30,9060175,,2016,UNIVERSITY OF WISCONSIN-MADISON,MADISON,WI,MISCELLANEOUS,4T32HD007014-40,HD007014,UNITED STATES,T32,243652,False,Rebecca L Clark,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,2017-04-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant): This application requests five additional years of support for training in population research at the Center for Demography and Ecology, University of Wisconsin-Madison. Although we have expanded our interdisciplinary activities and the breadth of our training, we are requesting the same number of predoctoral (8) and postdoctoral (1) stipends. The Center for Demography and Ecology has for nearly 50 years offered a world-class program of training in population science. Its graduates are among the most renowned demographers and population scientists. The training program is based on four critical ingredients: outstanding and diverse faculty conducting innovative research; capable and committed graduate students; high-quality resources for faculty and student research and study; and a well-designed and fully implemented curriculum combining course work and research experience. Since 2009 CDE has been an independent unit in the College of Letters & Science, raising its visibility and facilitating the development of intellectual linkages across campus. New
and stronger ties across departments and disciplines enhance students' interdisciplinary training experiences. The international components of CDE's research portfolio have grown extensively in the past five years, producing a diverse set of international projects and research networks through which students can develop their own international research agenda. The 45 members of the CDE training faculty offer a rich curriculum and extraordinary opportunities for students to
participate on a wide variety of research projects. Research resources provided to students from CDE's infrastructure grant, individual grants, and university support are outstanding. Together with a demanding curriculum and an intensive apprenticeship system, CDE's human and material resources produce one of the best available environments for pre- and postdoctoral training in population research.   
   
",Demography and Ecology," The Center for Demography and Ecology offers state-of-the-art instruction and training in demographic processes including fertility, health and mortality, an migration. Our students predominately enter research careers in academic and government institutions and agencies. Their research increases the understanding of basic behavioral processes and influence national policies that affect the health and well-being of all groups of the American population.   
      

",JAMES M RAYMO,1954499
31,9102055,,2016,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32DK007066-42,DK007066,UNITED STATES,T32,476018,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): The University of Pennsylvania Perelman School of Medicine (Penn) Gastroenterology (GI) Training Program has been instrumental in the development of academic research careers for gastroenterology trainees since 1963. During the last 15 years, there has been a tremendous expansion of biomedical research. The Penn GI Training Program has increased its base of basic science faculty coupled with impressive growth and maturation of the adult and pediatric GI divisions. Trainees have outstanding opportunities to pursue molecular and cellular biology in the field of gastroenterology, including hepatology and pancreatology. Direction: The Program Director (Dr. Anil Rustgi) and Associate Director (Dr. Gary Wu) have an administrative structure that oversees the needs of the Training Program, assisted by an Internal Advisory Board and an External Advisory Board. They are complemented by rigorous individual trainee research advisory committees. Faculty: Research faculty from the Adult and Pediatric GI divisions and basic science departments are selected based upon experience with trainees, independent and externally funded laboratories, and relevant projects in digestive, liver and pancreatic diseases. The faculty is grouped by research interests; we refer to them as affinity or thematic groups: 1) Developmental biology and genetics; 2) Immunobiology and host responses; and 3) Cell growth and differentiation. Proposed Training: The cornerstone of the Program is an intensive laboratory-based research experience (basic and translational), which entails close interaction with a training program faculty mentor and close oversight by a research advisory committee and the administrative structure. This laboratory work is supplemented by an educational curriculum that includes an introductory course in molecular and cellular biology, selected University courses, research seminars and lectures, journal clubs, written and oral research presentations, and seminars on extramural funding and the bioethics of scientific research. Candidates: Outstanding trainees with MD or MD-PhD degrees (postdoctoral fellows) or occasionally PhD degrees enter the Program from the Adult and Pediatric GI Fellowship Programs after being selected through a nationally competitive application process. Additionally, there has been growth in Penn's Physician-Scientist Residency Pathway (short-track internal medicine residents pursuing GI fellowship) and new avenues have emerged to identify future trainees in gastroenterology, including through our NIDDK R25 undergraduate training grant and our medical student T32 training grant supplements.",Training Program in Gastrointestinal Sciences,"PUBLIC HEALTH RELEVANCE: Gastroenterology is a multidisciplinary field including approaches in basic science and translational medicine. It is vital to improve diagnosis and therapy of gastrointestinal diseases and disorders through research discoveries. The future of gastroenterology is predicated upon the development and growth of young physician-scientists and basic scientists. The University of Pennsylvania Perelman School of Medicine Gastroenterology Training Program has had historic success, and continues to be on the leading edge of nurturing young researchers and ensuring their maturation as leading investigators.",Anil K Rustgi,1868587
32,9100736,,2016,UNIVERSITY OF WISCONSIN-MADISON,MADISON,WI,INTERNAL MEDICINE/MEDICINE,4T32ES007015-39,ES007015,UNITED STATES,T32,553915,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2018-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant)   
   
The Molecular and Environmental Toxicology Center Training Grant (METC-TG) involves 34 trainers that have outstanding training records and well-funded research programs. These trainers cover a variety of research areas such as developmental toxicology, predictive toxicology, structural biology, high throughput toxicology, stem cell toxicology, mammalian genetics, molecular biology and biochemistry. Pre-doctoral trainees come from the METC graduate program and other Ph.D. graduate programs such as M.D./Ph.D., Cancer Biology, Cellular and Molecular Pathology, Molecular and Cellular Pharmacology, Biomolecular Chemistry, and Pharmaceutical Sciences. Candidates are considered for support for a period of two to three years. Postdoctoral trainees are also supported for two years, but will be required to
submit an Individual NRSA application in their first six months. The selection of trainees and oversight of the grant will be carried out by the Training Grant Leadership (TGL) which consists of the Director and two co-Deputy Directors.  In addition, four subcommittees monitor student progress, curriculum, recruitment and trainee input. The METC will be reviewed by an External Advisory Board composed of nationally recognized toxicologists at the midpoint of the next funding cycle. This application seeks continued support for eight pre-doctoral and four postdoctoral positions.  All pre-doctoral trainees take a METC-TG core curriculum comprised of courses in basic mechanistic toxicology, the environment and human disease, research ethics and career development. They are also required to attend a weekly toxicology research seminar, and complete additional courses required by their Trainee. Pre- and postdoctoral trainees will also be mentored in grant writing, ethics, managing techniques and teaching. A preliminary examination qualifies predoctoral trainees for the final research phase and thesis examination, although laboratory research is continuous from the first semester. Pre-doctoral trainee progress is monitored by Research Advisory Committees for each trainee and by the TGL.  Postdoctoral training is facilitated by appointment of a Postdoctoral Career Advisory Committee (two faculty mentors in addition to a trainer) that will recommend selected didactic continuing education courses, collaborations and professional development credits. The recruitment of minorities to the Program is given high priority and is facilitated by a NIEHS-funded Summer Minority Research Program for undergraduates. The University provides two-year special fellowships for minority and disadvantaged students. Upon completion of the training program, graduates usually undertake a period of postdoctoral training, after which they are well qualified to assume responsible career positions in toxicology in academic, governmental, or other public or private research institutions, or industrial laboratories.",Molecular & Environmental Toxicology Pre-& Postdoctoral Training Program,Public Health Relevance: The human chemical environment influences a significant fraction of human morbidity and mortality. This application is designed to train the next generation of scientists to take leadership positions in the arena of human oriented environmental health research. Training of such scientists is essential if we are to understand how our environment impacts our health and if we are to properly identify and regulate those important causal chemicals.,CHRISTOPHER A BRADFIELD,1877011
33,9113061,,2016,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007151-38,HL007151,UNITED STATES,T32,409925,False,Henry  Chang,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): The New York University School of Medicine has a long established record of training academic hematologists. In large part, this record has been fostered by the continuous support, since 1962, of a NIH Training Grant (T32) which supports 6 M.D., M.D., PhD, and PhD Trainees. The long term goal of the Training Program is to prepare Hematology Trainees for future careers in academic medicine. The interaction of both M.D., M.D./PhD, and PhD Trainees in a unified Training Program serves to increase the number of physicians and scientists committed to a career in research. The Training Program exposes Trainees to rigorous mentored lab based hematology research, a detailed curriculum, seminar series, a journal club, a clinical management conference, and the opportunity to participate (for M.D Trainees) or observe (for PhD Trainees) the practice of clinical hematology relevant to the Trainee's laboratory investigation. Trainees are selected from the ACGME accredited adult and pediatric hematology/medical oncology fellowship programs and from eligible post- doctoral PhD fellows in participating faculty member's laboratories. The program, led by a Director with three well qualified Associate Directors, is specifically dedicated to actively recruiting underrepresented minorities. Our 15 Mentors have experience in mentoring and documented productivity, and their laboratories are highly interactive and use a variety of model systems to study 1) benign hematology including PNH, platelet biology and Fanconi anemia; 2) the genetics of leukemia; 3) JAK/STAT and Ras signaling mechanisms in hematopoietic stem cells, lymphopoieis, leukemia and lymphoma; 4) lymphopoiesis and lymphocyte activation (including GVHD); 5) mechanisms of myeloid and lymphoid trafficking; 6) ubiquitination in hematopoietic stem cell biology, lymphopoiesis, and leukemia/lymphoma; and 7) the epigenetic and molecular basis of normal and abnormal hematopoiesis. Past graduates of our program have achieved the highest ranks of academia and have made lasting contributions to the field of hematology, and a high proportion of our recent graduates remain in academia, using the research skills gained as Trainees in careers as researchers, academic teachers and trialists. Over the last 10 years the majority of our graduates have obtained positions in academic institutions, have published their findings in the highest tier of journals, and have received multiple NIH and foundation awards.",Research in the Pathogenesis of Hematologic Disorders,"Project Narrative
Hematological disorders represent a major cause of death in the U.S. Insights into many diseases have also
come from laboratory-based research of hematological disorders and hematopoiesis. Well trained physicians
and scientists will lead the way to new treatments for these disorders through fundamental and translational
research, education, and clinical trials.",LAWRENCE Benjamin GARDNER,2053992
34,9088463,,2016,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-42,GM007200,UNITED STATES,T32,2248668,False,Stefan  Maas,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is a renewal application to support the Medical Scientist Training Program (MSTP) at Washington University in St. Louis. The overarching goal of the MSTP is to provide in-depth pre-doctoral training in clinical medicine and biomedical research for individuals desiring careers as physician-scientists. The applicant pool is strong and in the past funding period, the MSTP made significant strides in recruiting diversity students. Medical training is provided by the School of Medicine and research training is carried out in the interdisciplinary graduate programs of the Division of Biology and Biomedical Sciences, and in the Departments of Biomedical Engineering and Anthropology. Together, these graduate programs encompass nearly all contemporary areas of biomedical research. The basic components of the MSTP are: 1) Two years of the preclinical medical school curriculum; 2) Coursework in a biomedically relevant discipline; 3) Three or more years of original, hypothesis-driven research leading to completion of a doctoral thesis; 4) At least 15 months of clinical training; and 5) A wealth of academic and social programs designed to enhance the program and cohesiveness of the student body. The M.D. and Ph.D. degrees are awarded jointly at the successful completion of both components which typically takes 7-8 years, a period shortened by integrating both curricula. Upon completion of subsequent postgraduate training, MSTP alumni will be prepared to enter the workforce as physician-scientists. Based on the track record of this program, the vast majority will join the faculty of te nation's medical schools while others will contribute to the nation's biomedical research enterprise in government laboratories, biotechnology firms, and the pharmaceutical industry. Regardless of their position, their MSTP training will allow them to bridge the gap between the basic laboratory and the clinic. The success of this program is due to strong institutional support
and continued funding of this grant. Thus, this renewal application seeks continued support for 55 students annually for 36 months each with the goal of graduating 20-25 MSTP students each year over the period of this grant.",National Research Science Award - Medical Scientist,"PUBLIC HEALTH RELEVANCE: The Medical Scientist Training Program at Washington University is a pre-doctoral program that trains future physician-scientists for careers where they
will have the abilities to treat patients, teach medical students and scientists, and conduct cutting-edge research that improves human health and eradicates disease. They will be uniquely qualified to help bridge the gap between the research laboratory and the clinic.",Wayne M. Yokoyama,8404502
35,9088462,,2016,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,PATHOLOGY,5T32GM007308-40,GM007308,UNITED STATES,T32,1277652,False,Stefan  Maas,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is a competing renewal application for T32GM007308-39, which funds the Medical Scientist Training Program (MSTP) at NYU School of Medicine (NYUSOM). The purpose of the MSTP is to train physician-scientists who will be capable of moving seamlessly between the realms of rigorous scientific inquiry and the holistic approach required for patient care. Students who successfully complete the MSTP graduate with both an MD and PhD degree. The MSTP at NYUSOM was one of the first three programs to be funded by NIGMS in 1964 and has been NIH funded ever since. Many of the 314 graduates have had illustrious careers and are counted among the leaders of academic medicine in the United States. The training begins with a summer research rotation, followed by three semesters of pre-clinical medical education punctuated by a second summer research rotation. Students then select a thesis lab and begin graduate work under the auspices of the Sackler Institute of Graduate Biomedical Sciences. Graduate training is offered in thirteen interdisciplinary training programs that include Biomedical Imaging, Biomedical Informatics, Cellular & Molecular Biology, Computational Biology, Developmental Genetics, Immunology and Inflammation, Microbiology, Molecular Biophysics, Molecular Oncology & Tumor Immunology, Molecular Pharmacology, Neuroscience & Physiology, Pathobiology, and Stem Cell Biology. Upon completion of a PhD thesis, the trainees return to medical school for the clinical portion of the curriculum, participating in all required clerkships as well as clinical electives. Trainees ar expected to complete the training in eight years or less. Over the past 5-year grant cycle, the median time-to-degree was 8.1 years. Mark Philips, MD, who runs an active molecular cell biology laboratory and who has trained 10 MSTP students, serves as the eighth director of the NYU MSTP and is assisted by two Co-Directors, Mitchell Chesler and Jennifer Philips, both MD/PhDs. A Faculty Operating Committee (FOC) and a full-time administrative staff assist the Co-directors. The training faculty consists of 121 full-time, tenure-track faculty who are selected
by the Co-directors for the quality of their research programs and their skills as mentors. Admission to the NYU MSTP is highly competitive. Over the past 5-year grant cycle 1883 students applied, 517 were interviewed, 197 (10.5%) were offered admission, and 47 matriculated. Significant effort is made to enhance the diversity of MSTP students. Of the 71 students currently enrolled in the MSTP, 10 (14%) are members of underrepresented minorities, one is disabled, and three are economically disadvantaged. The competitiveness of the NYU MSTP with regard to recruiting top candidates has improved over the past 5-year grant cycle both as a consequence of reorganization of the MSTP and the sharp rise of NYUSOM in the national rankings of research medical schools (37th to 19th). The Administration of NYUSOM supports the MSTP with substantial funding: in 2013 the Administration contributed $3,967,369 (57% of the total cost). At the last competing renewal, T32GM007308-34 received an outstanding priority score and 29 training slots were funded. The government sequester in 2012 reduced the funding to 25 slots. In accord with the recent academic success of the MSTP and of NYUSOM in general, we seek to expand the MSTP from 8-10 students per year to 10-12 and therefore request funding for 35 trainees.",Medical Scientist Research Service Award,"PUBLIC HEALTH RELEVANCE: This proposal seeks to renew funding for the NYU Medical Scientist Training Program (MSTP), one of 44 such programs funded by the National Institutes of Health. The dual MD/PhD degrees conferred on MSTP trainees equip them with the skills required to function both as a physician and a scientist. The MSTP thereby produces a class of professionals ideally positioned to become leaders in academic medicine and to perform rigorous, patient-oriented research designed to improve human health.",MARK Reid PHILIPS,1888869
36,8875693,,2015,BRANDEIS UNIVERSITY,WALTHAM,MA,BIOLOGY,5T32GM007122-40,GM007122,UNITED STATES,T32,305733,False,Susan R. Haynes,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"DESCRIPTION (provided by applicant): This project supports the training of nine students annually at Brandeis University in the field of genetics, who will be appointed in the second year of their Ph. D. training. This grant has played a central role in the education of a highly productive group of interactive graduate students actively involved in genetics research in problems relating to molecular, cell, and developmental biology and neuroscience, with relevance to the mechanisms and treatment of human disease. The Training Grant Faculty are drawn from highly collaborative and interdisciplinary researchers in the Departments of Biology and Biochemistry. Students work in well-funded and productive laboratories that are supported by recently upgraded core facilities in DNA and protein analysis, proteomics, genomics, microscopy and mouse and viral transgenics. The proposed program emphasizes rigorous training to develop research and other professional skills including scientific literacy, writing and oral communication and quantitative approaches. The Ph. D. program has a core curriculum of molecular biology, cell biology and ethics and advanced genetics courses, which includes molecular genetics, neurogenetics, population genetics and genomics, epigenetics and human genetics. These core courses are supplemented by elective courses in biochemistry, structural biology, developmental biology, mathematical modeling or neuroscience and courses concerning human diseases such as cancer, infectious disease, neurological and development disorders. Trainees are appointed based on the strength of their academic records and research potential and are supported for two to three years. Progress of the students is closed monitored by a committee of Training Grant Faculty selected for each student. Qualifying examinations at the end of the first and second years provide a means to evaluate each student's ability to frame questions and propose research solutions in their emerging area of expertise and in an outside field. The training of students is supplemented by seminars and journal clubs, featuring a wide variety of successful investigators in diverse areas of biological research. A number of professional development activities feature valuable personal discussions that assist each student's career planning. Special opportunities for Trainees include enhanced personal interactions with speakers and participation in an annual Genetics Symposium. In addition, Trainees work with Training faculty in the planning and implementation of these activities. The program is assessed yearly through online surveys and personal discussions with Trainees. This, and the small size and interconnectedness of students and faculty, provides training responsive to the needs of each student in a first-class research setting.",Genetic and Biochemical Mechanisms of Regulation,"This project trains nine Ph. D. students yearly in the field of genetics at Brandeis University. Along with intensive coursework and research training, students work on basic mechanisms of disease and its treatment, including neurodegeneration, developmental disorders, heart disease, cancer and infectious disease. This training features the development of skills necessary for students to become productive and independent contributors in the fields of scientific and medical research.",SUSAN THOMAS LOVETT,1883094
37,8875664,,2015,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",SAN FRANCISCO,CA,INTERNAL MEDICINE/MEDICINE,5T32DK007007-41,DK007007,UNITED STATES,T32,189132,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"DESCRIPTION (provided by applicant): Training creative and productive academicians is a critical mission of gastroenterology programs. Emerging discoveries in related fields ranging from human genetics to molecular and cellular biology, microbiology and epidemiology have had major impacts on the understanding of pathophysiology of gastrointestinal diseases. The UCSF Division of Gastroenterology has been a leader in gastrointestinal research for over 40 years. In addition, allied Divisions and Departments at UCSF augment the training program by providing complementary and synergistic training experiences. During the past funding cycle, we have renewed our selection and training procedures to optimize the success of our trainees. The enhanced pool of applicants and trainees in our program attests to the success of our efforts. In this application, we propose to continue our training of innovative and creative academic investigators in gastroenterology.",INRSA Training Grant in Gastroenterology,"This application is for support of four training positions in an established program in digestive diseases that has been funded since 1975 at the Division of Gastroenterology, University of California, San Francisco. The Program's goal is preparing trainees for careers in academic luminal gastroenterology, and its track record in this regard is outstanding, with numerous graduates of the program now in leadership positions. The training environment is broadly interdisciplinary, reflecting the synergistic relationships of the Division of Gastroenterology with the IBD Center, the Immunology Program, the Cancer Center, the Institute of Molecular Medicine, and the graduate programs for Biomedical Sciences and Biological Sciences. These broadly interdisciplinary setting provides an ideal training environment for academic gastroenterologists of the future.  
  
NOTE: The criteria scores and the critiques given below were provided by the reviewers assigned to this application. These do not necessarily reflect the positions of the reviewers at the close of the group discussion or the final majority opinion of the group, although the reviewers were asked to amend their criteria scores and critiques if their positions changed during the discussion. Please note that the criteria scores are not averaged in arriving at the final overall impact scores. If the reviewers have not changed their criteria scores after the discussion, those shown in the critiques may reflect the opinion of the reviewers before the meeting. The Resume and other initial sections of the summary statement are the authoritative representations of the final outcome of the group discussion. If there is any discrepancy between the reviewers' commentaries and the priority/impact score on the face page of this summary statement, the priority/impact score should be considered the most accurate representation of the final outcome of the group discussion.",AVERIL I MA,1872380
38,8867216,,2015,YALE UNIVERSITY,NEW HAVEN,CT,INTERNAL MEDICINE/MEDICINE,5T32DK007058-41,DK007058,UNITED STATES,T32,390985,False,Arthur  Castle,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): This proposal seeks continued support for the Yale research-training program in Diabetes Mellitus and Disorders of Metabolism. This program serves as the core source of support for postdoctoral research training in diabetes and endocrinology at the Yale School of Medicine. A major goal of the program is to provide physician-scientists with the research expertise required to pursue clinical, basic and translational research careers in an academic setting. Physician trainees entering the program will have M.D. or M.D./Ph.D. degrees and at least 2-3 years of clinical training in internal medicine or pediatrics. Ph.D. scientists are also recruited into the program since we believe an integrated training experience bringing together adult endocrinologists,  pediatric endocrinologists and endocrine scientists is necessary to prepare our trainees to participate in  modern multidisciplinary research groups. Trainees are selected based on their aptitude and commitment to a  research career. The duration of the training period is three years to ensure an in-depth training experience.  The cornerstone of the curriculum is the participation of each trainee in a specific research project under the supervision of a designated preceptor and guided by a progress committee composed of 2-3 other members of  the training faculty. Potential projects run the gamut from clinical to basic research in 3 primary areas of emphasis: 1) type 1 diabetes, 2) type 2 diabetes, and 3) bone and mineral metabolism. Within these areas, trainees have the opportunity to work with mentors in several basic science departments as well as those in  Pediatrics and Medicine. Close interaction among preceptors and trainees within each programmatic area and  within several multidisciplinary and interdepartmental research centers administered within the Endocrine  Section further enrich the training experience. Multiple educational opportunities including two degree-granting  (MS, PhD) programs are available to trainees through the CTSA-funded Yale Center for Clinical Investigation.  Instruction is also provided through organized lectures, research seminars and journal clubs. The application  requests an additional training slot per year for a total of 6 stipends. This is based
on our decision to fully  integrate Yale's pediatric and internal medicine training programs in diabetes and metabolism and, therefore,  not to seek renewal of the pediatric T32 (DK63703). It is also based on our ongoing track record of attracting an outstanding applicant pool, the high level of research productivity of our training faculty, the expanded  research opportunities provided by our diverse faculty and the continued shortage of physician-scientists in  both medicine and pediatrics dedicated to research careers in diabetes and metabolic diseases.",Diabetes Mellitus and Disorders of Metabolism,"PUBLIC HEALTH RELEVANCE: Obesity, diabetes and osteoporosis represent a spectrum of increasingly prevalent metabolic diseases that are  responsible for a great burden of suffering and death in the US and throughout the world. Academic endocrine  researchers are needed to better understand these disorders and to translate research findings into new  therapies. Our training program in diabetes and disorders of metabolism is dedicated to providing young  physicians and scientists with the research training necessary to tackle these important health problems.","ROBERT S SHERWIN,WILLIAM V TAMBORLANE,John J Wysolmerski","1882029,1901638,1872589"
39,8856252,,2015,UNIVERSITY OF GEORGIA,ATHENS,GA,GENETICS,5T32GM007103-40,GM007103,UNITED STATES,T32,273682,False,Susan R. Haynes,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): This proposal is a competitive renewal of a successful and established predoctoral training program whose objective is to broadly train high quality research scientists in basic genetic approaches to the study of biology at the molecular, cellular, organismal, and population level. Funds are requested to support eight trainees each year. Students enter the training program upon admission to the Department of Genetics based on merit and potential for success in scientific careers. Students are rigorously trained in cuttin-edge genetic and biochemical research and data analysis through laboratory research, classes, and attendance at seminars. In addition, they gain written and oral communication skills through preliminary and qualifying examinations; presentations in an annual seminar class, at lab meetings and journal clubs; attendance at national and international meetings; and preparation of manuscripts for publication. Students obtain teaching experience through a requirement to serve as teaching assistants in undergraduate introductory genetics or evolutionary biology for at least one semester in their second or third year. During their first year, students complete three laboratory research rotations as well as participate in lecture courses. All students are required to take at least one course in each of the three broad areas of molecular genetics, genomics and population genetics. The unusual breadth of genetics that students are exposed to throughout their training is a major strength of the program. At the end of their first year, students enter the lab where they will do their dissertation research, choosing from 33 training faculty in nine departments representing a very wide range of genetic disciplines. In years 2-5, students also enroll in seminars, advanced electives and special topics courses. To insure that students complete degree requirements in a timely manner, progress is monitored twice yearly, once by the Graduate Affairs Committee and once by students' dissertation committees. Written and oral examinations and major courses are normally completed by the end of the fifth semester. Graduates from this training program over the past 35+ years have been highly successful in careers in academia, government, and industry. The training program is dynamic and will continue to produce broadly trained leaders in genetics as it embraces the exciting genetic developments of the 21st Century.",T32 Predoctoral training grant in genetics,"PUBLIC HEALTH RELEVANCE: This project provides funds to annually support eight Ph.D. students in the field of genetics. It will considerably strengthen the entire graduate program in Genetics at its host institution, the University of Georgia. It will also contribute to public healh in the U.S. by helping train scientists with an exceptionally broad background that includes molecular, population and genomic approaches to genetics.",DAVID W. HALL,9305345
40,8877550,,2015,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,5T32GM007127-40,GM007127,UNITED STATES,T32,509268,False,Susan R. Haynes,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2017-06-30T04:00:00Z,PA10036,"DESCRIPTION (provided by applicant):  The enclosed proposal presents a revised training program in genetics at UC Berkeley. The program spans four separate administrative units on the Berkeley campus: the Departments of Molecular & Cell Biology (MCB), Plant & Molecular Biology (PMB), Integrative Biology (IB), and the School of Public Health (PH). The program includes 43 training faculty, all prominent researchers in their respective areas of study (10 are members of the National Academy of Sciences). Training faculty represent three major areas of genetics research: developmental genetics, cell & systems-level analysis, and population genetics & evolution. Funds are requested to support the research activities of 15 graduate student trainees (per year) in genetics-oriented laboratories located within the four aforementioned administrative units. Trainees will be appointed by a steering committee composed of prominent faculty from each of the participating administrative units. This committee is also responsible for renewing the appointments of training faculty and appointing new faculty to the training program. In addition, the committee will review the efficacy of the training program by soliciting comments from past and present trainees and faculty. A number of mechanisms have been established to ensure that the proposed genetics training program offers a unique educational experience that is distinct from other programs on the Berkeley campus, such as genomics, cell & molecular biology, and immunology. First, genetics trainees are required to present their current research findings at an annual retreat that is restricted to trainees and their mentors. Second, all trainees will be required to enroll in at least one advanced genetics course, such as MCB 240. Third, all trainees are required to attend the annual Genetics, Genomics, and Development (GGD) retreat regardless of their departmental affiliations. And fourth, all trainees must participate in at least one additional genetics-oriented forum, such as the weekly GGD seminar series or regularly scheduled journal clubs and research meetings focused on topics in genetic analysis. A variety of outreach strategies will be employed to ensure that members of under- represented minorities, women, and disabled or otherwise disadvantaged students are given the opportunity to obtain training in this program and thereby gain access to the wonderful world of genetics.",Postgraduate Training Program in Genetics,"Our genes shape who we are. Our health, our susceptibility to disease, and our response to medicines are all affected by our genes. The training of scientists with a firm foundation in formal genetic analysis is essential for understanding how our genes contribute to health and disease.",Andrew G Dillin,1902647
41,8871748,,2015,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,INTERNAL MEDICINE/MEDICINE,5T32HL007035-40,HL007035,UNITED STATES,T32,686370,False,Sandra  Colombini-Hatch,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA10036,"DESCRIPTION (provided by applicant):   
  
 The goal of this program is to train 6 pre-doctoral PhD candidates and 12 PhD and MD post doctoral fellows per year in the research disciplines of greatest importance for identifying and solving the problems of lung health maintenance and disease. Since the last submission, our program has grown to 40 faculty and evolved permitting us to re-organize our scientific focus groups (SFGs) to specifically address the strategic areas of importance defined by NHLBI. We offer training in: 1. Development and Regenerative Medicine (including gene therapy and matrix biology); 2. Immunology and Inflammation (including innate immunity, cytokine biology, vaccine development and emerging airborne infectious diseases) and; 3. Population Sciences (including Genetics, Genomics, Epidemiology, and Bioinformatics /Systems Biology). Each of these disciplines has a critical mass of experienced senior and junior faculty mentors which represent a broad range of expertise for trainees, such that every trainee gets the advantage of the group expertise in weekly meetings. Each group has laboratories that offer basic, translational and clinical science experiences, purposely integrated to provide a learning experience for every trainee. This continues our 34 year tradition of placing pre- doctoral students and post-doctoral PhD and MD fellows in integrated environments to provide a full spectrum of translational experiences. We will provide traditional laboratory based research opportunities for pre-doctoral students interested in studying lung sciences after completion of course work from either of 2 formal degree granting pathways Bioinformatics/Systems Biology or Molecular Medicine. For MD post-doctoral trainees we provide unique, integrated and customized post doctoral Masters degree programs in Statistics/ Epidemiology, Public Health, Bioinformatics and Clinical Investigation combined with traditional laboratory based experiences in laboratories within the three SFGs; and similar lab based experiences for PhD post-doctoral trainees.  This award has supported over 75 doctoral students and over 140 MD and PhD post- doctoral fellows over the past 34 years in multiple disciplines related to lung diseases. Our graduates include many Chiefs of Pulmonary Medicine, 2 Chairs in Medicine, 3 Associate Deans and numerous Professors and national leaders in every field of Pulmonary Science with high profile funded research programs. The breadth and depth of the training portfolio we now offer is the most superior research experience in our 34 years and is specifically designed to address all the major areas of strategic interest of the Division of Lung Diseases of NHLBI.",Biology of the Lung: A Multidisciplinary Program,,"DAVID M. CENTER,JOSEPH P MIZGERD","1864129,1917012"
42,8853092,,2015,BOSTON MEDICAL CENTER,BOSTON,MA,,2T32DK007053-42,DK007053,UNITED STATES,T32,184816,False,Krystyna E Rys-Sikora,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): This is a competitive renewal of the nephrology training grant at Boston University. This vibrant and successful program has been active continuously for 41 years. Its primary goals are to identify, inspire and train promising postdoctoral candidates for translational research careers focused on kidney diseases and to assist qualified trainees in obtaining suitable research positions. The program is designed to provide physicians heading for careers in academic nephrology the thorough scientific grounding necessary for a successful research career and to attract recent PhD graduates and provide them postdoctoral training in kidney-related research. Training is closely aligned with the NCATS Advisory Council Working Group recommendations to prepare the next generation of biomedical scientists for translational research careers. Research training will continue for at
least two years. On average, three new trainees will enter the program each year. The principal mechanism for training is direct performance of research under the personal supervision of one or more of the training staff comprised of nine nephrologists and five basic scientists. Outstanding, interdisciplinary training staff provides translational training in autoimmunity, ischemic and toxic renal injury, immunopathology, gene regulation related to renal cancer and developmental biology, and vascular disease and thrombosis in chronic kidney disease and clinical epidemiology of cardiovascular relevant to kidney diseases. Well-established collaborative arrangements allow each trainee to acquire a broad research experience and focus a variety of skills on a specific research protocol. Trainees assume graded responsibility for the design, conduct and interpretation of experiments, progressively becoming more independent. All trainees and staff meet frequently for a rich menu of seminars, journal clubs and other formal group teaching exercises. Coursework leading to a PhD in Translational and Molecular Medicine is available, and formal training in clinical research is provided through the BU School of Public Health. Trainees work in a modern, well-equipped laboratory in the Evans Biomedical Research Center and laboratories of basic science faculty. These are in close proximity to core facilities, modern animal care quarters supervised by a full-time veterinarian, and the BUSPH. Collaboration and team building are emphasized throughout the training period. In this renewal we have taken advantage of substantial progress on the BU medical campus in bioinformatics, career development, evaluation, networking and tracking programs to enhance the training experience beyond the laboratory bench or research database. An Office of Postdoctoral Affairs supported by the Provost's office, and programs in Development and Diversity and Interdisciplinary Research add to the richness of the training environment and help promote a healthy work/life balance.   
",Research Training in Nephrology,"PUBLIC HEALTH RELEVANCE: This program is designed to provide research training for physicians and scientists to investigate the causes and consequences of kidney diseases; to identify ways to prevent diseases of the kidney from progressing to kidney failure and to improve the quality and duration of the lives of those who do develop end stage kidney failure.      

",DAVID J SALANT,1883548
43,8852419,,2015,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,2T32DK007120-41,DK007120,UNITED STATES,T32,707595,False,Arthur  Castle,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant):    
This competitive renewal application represents the merger of two successful diabetes research training programs at Washington University, DK007120 (based in the Department of Medicine) and KD007296 (based in the Department of Pathology & Immunology), into a single program entitled Diabetes and Related Metabolic Diseases (DK007120). For more than 35 years, these two T32 programs have trained a large number of biomedical scientists who have generated important insights into diabetes. To continue training outstanding scientists and physicians capable of developing novel approaches to address the striking increase in diabetes and its complications, we have integrated these two longstanding programs into one. The goal of this merged program is to provide mentoring expertise spanning model systems to outcomes research within a nurturing, structured environment that will produce independent diabetes scientists likely to change the landscape of research in diabetes and its complications. The program is directed by two PIs with complementary skill sets, one in immunology, the other in metabolism, to facilitate training opportunities in the emerging field of immunometabolism. The merged program represents the only NIH-supported mechanism for postdoctoral training in diabetes research at Washington University.   The program is continually evolving in response to our ongoing assessment of its effectiveness, the needs of our trainees, and the dynamic nature of diabetes research. It is multidisciplinary and team-oriented. We propose to continue to train MD, MD PhD, and PhD scientists for 2-3 years through a structured program that leverages numerous strengths that include but are not limited to:   An exceptional pool of 29 mentors focused on diabetes. These scientists are pursuing research in basic mechanisms, proof of principle T1 translation, T2/T3 translation to patients and practice, and T3/T4 translatio to practice and populations. This group includes two members of the National Academy of Sciences and one member of the Institute of Medicine, each having mentored trainees during this most recent funding period, and several new members representing a broad spectrum of career stage and diversity.   A core curriculum in diabetes science required of all trainees to ensure that individuals with different backgrounds establish a standard knowledge base.  Training with a clinical context for PhD scientists as well as those with clinical degrees in order
to inform translational efforts.   Clearly defined metrics of success that are monitored by a personalized Career Development Committee for each trainee.  A series of mechanisms to assess quality and effectiveness of the program as well as established procedures to take action in response to the results of these assessment tools.  A dynamically integrated short-term research training program operated in close collaboration with our NIDDK Diabetes Research Center.  Well-established mechanisms for enhancing diversity.     Our trainees are productive, having published more than 250 papers that have been cited more than 8000 times in the past 10 years. They are successful in terms of obtaining grant support for their research that includes (in the past 10 years) two R01s, several R01 equivalents (in the EU), three K01s, two K12s, two KL2s, one K99/R00, several pilot and feasibility awards, awards from the American Diabetes Association and the American Heart Association, and others. They are successful in terms of achieving productive scientific careers since our trainees enter academics (in the past 10 years) at a rate ~50-100% greater (depending on degree) than the biomedical workforce based on data cited by NIH. Our integration of two programs has achieved synergies leading to improvements in the mentor pool, enhancements in recruitment and mentoring strategies, and expanded efforts to increase diversity that collectively perpetuate a culture of multidisciplinary training with a very high likelihood of exerting a sustained and powerful influence on diabetes research.     
",Diabetes and Related Metabolic Diseases,"PUBLIC HEALTH RELEVANCE: Diabetes in the United States is increasing in prevalence at an alarming rate. This increase affects all ages and all ethnic groups, and in children and adolescents both type 1 diabetes and type 2 diabetes are increasing. Certain overwhelming complications of the disease, in particular stroke, amputations, and end stage renal disease are also increasing. The burden of diabetes is emotionally as well as economically devastating, and current therapies are less than ideal. This application is relevant to public health since its goalis to rigorously train scientists in a broad spectrum of approaches to diabetes and its complications in order to translate new observations into new therapies with the potential of decreasing the burden of diabetes.      

",Clay F. Semenkovich,1860060
44,8999824,,2015,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,PATHOLOGY,2T32CA009140-41A1,CA009140,UNITED STATES,T32,520632,False,Susan E Lim,National Cancer Institute,1975-07-01T04:00:00Z,2020-08-31T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): The major goal of this training program, which completes its 40th year in May 2015, is to successfully train young investigators in a career in biomedical research pertaining to lymphocyte biology, ranging from cancer immunotherapy to neoplastic transformation. This competitive application is especially timely given that results from Penn-based immunotherapy trials were markedly effective in treating leukemia, a result that contributed to Cancer Immunotherapy being chosen as the 2013 Scientific Breakthrough of the Year by Science Magazine. The Penn training program sits at the nexus of the NCI-designated Abramson Cancer Center and the Institute for Immunology to offer multi-disciplinary training in both basic and translational research related to cancer immunobiology. Drs. Pear (Program Director) and Vonderheide (Program Co-Director) will provide the sustained leadership required for continued development of top-tier cancer immunobiology training at Penn and have an administrative structure that oversees the needs of the training program, assisted by an Internal Executive Committee and an External Advisory Board and complemented by individual research trainee advisory committees. Our training faculty are in multiple departments campus-wide, including the University of Pennsylvania School of Medicine, School of Veterinary Medicine, Children's Hospital of Philadelphia and the Wistar Institute, and have diverse interests that are focused on cancer immunobiology. Common among our trainers is successful mentoring, independent funding, continued productivity and projects relevant to cancer immunobiology. Our 2 predoctoral and 8 postdoctoral trainees are competitively selected and are expected to meet high standards of competence, motivation and perseverance, and have a commitment to a research career in cancer immunobiology. Recruitment of qualified, under-represented minorities is high priority. The training program is anchored in an intensive laboratory experience with a rigorous mentor. The laboratory experience is complemented by basic lecture courses in immunology and related disciplines, advanced seminar courses in various aspects of cancer immunobiology, cancer biology and bioethics, seminars from visiting scientists and Penn faculty, research conferences, workshops and retreats. Programs developed specifically for our trainees include monthly trainee meetings focused on cancer immunobiology, a weekly cancer immunobiology research-in-progress forum, training grant and cancer immunobiology retreats, a visiting scholar/seminar program, and training in the responsible conduct of research. Goals of this training program will be accomplished through two specific aims. Aim 1: To support the research and training of young scientists with new or established interests in cancer immunobiology. Aim 2: To provide a rich and rigorous training environment in cancer immunobiology that provides multi-disciplinary training in cancer biology and immunology.   
   
",IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES,"PUBLIC HEALTH RELEVANCE:  This program provides training to develop future leaders in cancer immunobiology research. As a catalyst for developing the next generation of principal investigators, this training program will impact directly on improving cancer treatment, decreasing costs, and most importantly, improving the lives of cancer patients, all of which are directly relevant to public health   
      

",WARREN S PEAR,2106040
45,8843916,,2015,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007151-37,HL007151,UNITED STATES,T32,392053,False,Henry  Chang,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): The New York University School of Medicine has a long established record of training academic hematologists. In large part, this record has been fostered by the continuous support, since 1962, of a NIH Training Grant (T32) which supports 6 M.D., M.D., PhD, and PhD Trainees. The long term goal of the Training Program is to prepare Hematology Trainees for future careers in academic medicine. The interaction of both M.D., M.D./PhD, and PhD Trainees in a unified Training Program serves to increase the number of physicians and scientists committed to a career in research. The Training Program exposes Trainees to rigorous mentored lab based hematology research, a detailed curriculum, seminar series, a journal club, a clinical management conference, and the opportunity to participate (for M.D Trainees) or observe (for PhD Trainees) the practice of clinical hematology relevant to the Trainee's laboratory investigation. Trainees are selected from the ACGME accredited adult and pediatric hematology/medical oncology fellowship programs and from eligible post- doctoral PhD fellows in participating faculty member's laboratories. The program, led by a Director with three well qualified Associate Directors, is specifically dedicated to actively recruiting underrepresented minorities. Our 15 Mentors have experience in mentoring and documented productivity, and their laboratories are highly interactive and use a variety of model systems to study 1) benign hematology including PNH, platelet biology and Fanconi anemia; 2) the genetics of leukemia; 3) JAK/STAT and Ras signaling mechanisms in hematopoietic stem cells, lymphopoieis, leukemia and lymphoma; 4) lymphopoiesis and lymphocyte activation (including GVHD); 5) mechanisms of myeloid and lymphoid trafficking; 6) ubiquitination in hematopoietic stem cell biology, lymphopoiesis, and leukemia/lymphoma; and 7) the epigenetic and molecular basis of normal and abnormal hematopoiesis. Past graduates of our program have achieved the highest ranks of academia and have made lasting contributions to the field of hematology, and a high proportion of our recent graduates remain in academia, using the research skills gained as Trainees in careers as researchers, academic teachers and trialists. Over the last 10 years the majority of our graduates have obtained positions in academic institutions, have published their findings in the highest tier of journals, and have received multiple NIH and foundation awards.",Research in the Pathogenesis of Hematologic Disorders,"Project Narrative
Hematological disorders represent a major cause of death in the U.S. Insights into many diseases have also
come from laboratory-based research of hematological disorders and hematopoiesis. Well trained physicians
and scientists will lead the way to new treatments for these disorders through fundamental and translational
research, education, and clinical trials.",LAWRENCE Benjamin GARDNER,2053992
46,8860219,,2015,UNIV OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007149-39,HL007149,UNITED STATES,T32,353661,False,Henry  Chang,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2016-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant): The long standing Hematology T32 Training Grant at the University of North Carolina at Chapel Hill (UNC-CH) remains committed to training both MD physician-scientists and PhD scientists for careers in academic hematology and hematology research. This program will continue to train adult and pediatric hematology fellows and PhD post- doctoral candidates in areas of traditional institutional research strengths encompassing benign hematology. Both basic bench and clinical research tracks are available, with carefully selected didactic coursework to complement the training experience. In this competitive renewal application, scientific and educational interactions between MD and PhD trainees in the form of conferences, journal clubs, and symposia have been emphasized. Following 2 years of training on the T32 grant, trainees will be encouraged to apply for individual or institutional K series awards, and/or other sources of independent funding.",Research Training in Hematology at UNC Chapel Hill,"Project Narrative:
For over 35 years, the training program in academic hematology at the University of North
Carolina at Chapel Hill (UNC-CH) has benefitted from support by the Ruth L. Kirschstein
National Research Service Award. This program, which encompasses disorders of the
blood, vasculature or immune system, has been extraordinarily successful in its mission
to train clinical and bench researchers in hematology. The cornerstones of training
include a mentored research project, focused seminars and conferences, training in the
responsible conduct of research, and didactic coursework in clinical research, laboratory
methodology, grantsmanship, and the academic community. Both MD and PhD
postdoctoral candidates are recruited from intramural and extramural sources, and their
frequent interaction during the 2-year period of support engenders a mutual respect and
understanding of the ultimate goals of biomedical research in hematologic disorders.",Nigel S. Key,1887365
47,8855744,,2015,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,2T32DK007066-41,DK007066,UNITED STATES,T32,464396,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2020-06-30T04:00:00Z,PA14015,"   
DESCRIPTION (provided by applicant): The University of Pennsylvania Perelman School of Medicine (Penn) Gastroenterology (GI) Training Program has been instrumental in the development of academic research careers for gastroenterology trainees since 1963. During the last 15 years, there has been a tremendous expansion of biomedical research. The Penn GI Training Program has increased its base of basic science faculty coupled with impressive growth and maturation of the adult and pediatric GI divisions. Trainees have outstanding opportunities to pursue molecular and cellular biology in the field of gastroenterology, including hepatology and pancreatology. Direction: The Program Director (Dr. Anil Rustgi) and Associate Director (Dr. Gary Wu) have an administrative structure that oversees the needs of the Training Program, assisted by an Internal Advisory Board and an External Advisory Board. They are complemented by rigorous individual trainee research advisory committees. Faculty: Research faculty from the Adult and Pediatric GI divisions and basic science departments are selected based upon experience with trainees, independent and externally funded laboratories, and relevant projects in digestive, liver and pancreatic diseases. The faculty is grouped by research interests; we refer to them as affinity or thematic groups: 1) Developmental biology and genetics; 2) Immunobiology and host responses; and 3) Cell growth and differentiation. Proposed Training: The cornerstone of the Program is an intensive laboratory-based research experience (basic and translational), which entails close interaction with a training program faculty mentor and close oversight by a research advisory committee and the administrative structure. This laboratory work is supplemented by an educational curriculum that includes an introductory course in molecular and cellular biology, selected University courses, research seminars and lectures, journal clubs, written and oral research presentations, and seminars on extramural funding and the bioethics of scientific research. Candidates: Outstanding trainees with MD or MD-PhD degrees (postdoctoral fellows) or occasionally PhD degrees enter the Program from the Adult and Pediatric GI Fellowship Programs after being selected through a nationally competitive application process. Additionally, there has been growth in Penn's Physician-Scientist Residency Pathway (short-track internal medicine residents pursuing GI fellowship) and new avenues have emerged to identify future trainees in gastroenterology, including through our NIDDK R25 undergraduate training grant and our medical student T32 training grant supplements.   
",Training Program in Gastrointestinal Sciences,"PUBLIC HEALTH RELEVANCE: Gastroenterology is a multidisciplinary field including approaches in basic science and translational medicine. It is vital to improve diagnosis and therapy of gastrointestinal diseases and disorders through research discoveries. The future of gastroenterology is predicated upon the development and growth of young physician-scientists and basic scientists. The University of Pennsylvania Perelman School of Medicine Gastroenterology Training Program has had historic success, and continues to be on the leading edge of nurturing young researchers and ensuring their maturation as leading investigators.      

",Anil K Rustgi,1868587
48,7460830,,2008,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32DK007126-34,DK007126,UNITED STATES,T32,189355,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2011-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
This resubmission for competitive renewal application for training grant T32 DK07126 requests continued support for the post-doctoral training of eight board-eligible or board-certified internists and basic scientists (MD, PhD or MD/PhD) for careers as independent investigators committed to studying kidney disease. Training of individuals to pursue investigations in renal disease is an investment that is essential to serve the present and future health care needs of the nation. The Renal Division at Washington University has maintained an active and formally organized fellowship program since 1961. The purpose of this training effort is the preparation of carefully selected candidates for full time careers in academic medicine. In the course of our training program we provide highly-motivated carefully-selected individuals with in-depth experience and direction in the philosophy, methodology, and details of execution of controlled investigations in areas related to renal function in health and disease. Washington University offers a resource-rich environment. Interaction between individuals based in clinical and basic departments occurs as a matter of routine through their common association with the multidisciplinary Division of Biology and Biomedical Sciences. Patient-based investigation is facilitated by participation in and access to the clinical practice at Washington University. Currently four NIH or NIH/VA multi-center studies (Frequent Hemodialysis Clinical Trials; Vascular Access Clinical Trials Consortium; Intensive versus Conventional Renal Support in Acute Renal Failure; Folic Acid Vascular Outcomes Research in Transplantation -F.A.V.O.R.I.T) include a Washington University site. Continued interdisciplinary training of young internists and basic scientists in state-of-the-art approaches to the analysis and cure of kidney diseases is consistent with the longstanding commitment of Washington University School of Medicine to provide leadership in biomedical investigation. Twenty-two individuals who trained in Nephrology at Washington University have gone on to head Renal Divisions in the United States and abroad. The incidence and prevelance of kidney disease is increasing yearly in the United States. The training of individuals well versed in all aspects of renal science is essential to maintaining the public health in terms of reducing the incidence and prevalence and limiting the morbidity and mortality of renal diseases.    

",Renal Disease,,Marc Randall Hammerman,1888256
49,7452357,,2008,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,5T32GM007127-34,GM007127,UNITED STATES,T32,487016,False,Clifton A. Poodry,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The enclosed proposal represents a competitive renewal of an established graduate training program in Genetics at UC Berkeley. We request funds to support 17 graduate trainees in the areas of Developmental Genetics and Genomics, Cell & Systems Genetics, and Population Genetics and Evolution. Students enter this inter-disciplinary training program after gaining admission into one of four Departments on campus. Two of the Departments, Molecular and Cell Biology (MCB) and Integrative Biology (IB), are located within the College of Letters and Sciences. A third Department, Plant and Microbial Biology (PMB), is located in the College of Natural Resources. Students can also enter the training program through the School of Public Health (SPH). Students are selected into the program based on an interest in one of the broadly defined areas of genetics that are sponsored by this training grant. They are also selected based on merit and future promise as independent investigators. Despite their diverse backgrounds, the training program includes a number of mechanisms to ensure that all of the graduate students obtain rigorous training in genetics. Once they enter the program, students are free to select any one of 41 different faculty mentors located in the four aforementioned performance sites. These faculty employ a variety of genetic and genomic methods to study a broad spectrum of problems in cell, developmental, and evolutionary biology, including metazoan and plant patterning, embryogenesis, sex determination, cell determination and differentiation, morphogenesis, and organogenesis. The study of cellular processes in the areas of signal transduction, DNA replication, transcription, cell trafficking and the cytoskeleton, transcription, and DNA replication are the focus of many faculty. Other faculty use genetic approaches to study evolutionary processes such as the evolution of chordates and patterning in invertebrates. In the first year of the program, trainees complete advanced lecture, laboratory, and seminar courses. Students in PMB and MCB are also required to complete three 10-week laboratory rotations with potential dissertation mentors. All students commence their dissertation research by the beginning of the second year. They are also required to complete an oral qualifying exam that is administered by four faculty from at least two different departments within the training program. All students are required to complete at least two semesters of teaching as graduate instructors during the second and third years of the training program. In addition to formal course offerings in the different areas of genetics, students are expected to participate in a variety of seminar programs, joint lab meetings, journal clubs, and retreats that are sponsored by the Genetics Training Program.        

",Postgraduate Training Program in Genetics,,"GIAN  GARRIGA,HENK  ROELINK","1911524,2098825"
0,7457892,,2008,CASE WESTERN RESERVE UNIVERSITY,CLEVELAND,OH,PATHOLOGY,5T32GM007250-33,GM007250,UNITED STATES,T32,1242534,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2009-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):    
  
Nationally known for its pioneering curriculum that integrates basic and clinical sciences, Case Western Reserve University School of Medicine (CWRU SOM) has provided superior MD/Ph.D. training since 1956.  The NIH-funded CWRU Medical Scientist Training Program (MSTP) was started in 1975 (T32 GM07250).  The CWRU MSTP curriculum integrates scientific and clinical instruction with both Ph. D. and MD course work during the first two years, personalized clinical instruction during the Ph.D. research years, and elective time for research and clinical experiences in the final year.  The program emphasizes development of leadership skills through student governance, faculty mentoring, and student-led group activities like dinner seminars and MSTP retreats.  Criteria for acceptance include superior academic performance (average GPA and MCAT of 3 7 and 34, respectively, over the past three years) and evidence of strong propensity for research.  Acceptance by the MSTP automatically qualifies a student for admission to the School of Medicine and any basic science Ph.D. program in the SOM, plus Biomedical Engineering, Biology and Chemistry Ph.D. mentors provide individualized research training and are student-selected (subject to approval by the MSTP Steering Committee).  The 137 MSTP research trainers include junior and established investigators who are well supported by NIH research grants and other funding sources.  Research training occurs in laboratories at the CWRU home campus and affiliated institutions (University Hospitals of Cleveland, Cleveland Clinic Foundation and MetroHealth Medical Center).  These sites are well equipped for modern biomedical research Clinical training occurs at the SOM and affiliated teaching hospitals (University Hospitals of Cleveland, Metro Health Medical Center, Cleveland Clinic Foundation and Louis Stokes Cleveland Veteran's Administration Hospital).  All CWRU MSTP students receive full financial support for stipend, tuition and health fees for all phases of the program, and the program provides laptop computers and travel awards for students to attend national research meetings.  Overall, the program integrates clinical and scientific training of physician scientists.  Our mission is to endow students with the skills necessary for a lifetime of scholarly accomplishment in medical science      

",Medical Scientist Training Program,,Clifford V Harding,1888529
1,7452357,,2008,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,5T32GM007127-34,GM007127,UNITED STATES,T32,487016,False,Clifton A. Poodry,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The enclosed proposal represents a competitive renewal of an established graduate training program in Genetics at UC Berkeley. We request funds to support 17 graduate trainees in the areas of Developmental Genetics and Genomics, Cell & Systems Genetics, and Population Genetics and Evolution. Students enter this inter-disciplinary training program after gaining admission into one of four Departments on campus. Two of the Departments, Molecular and Cell Biology (MCB) and Integrative Biology (IB), are located within the College of Letters and Sciences. A third Department, Plant and Microbial Biology (PMB), is located in the College of Natural Resources. Students can also enter the training program through the School of Public Health (SPH). Students are selected into the program based on an interest in one of the broadly defined areas of genetics that are sponsored by this training grant. They are also selected based on merit and future promise as independent investigators. Despite their diverse backgrounds, the training program includes a number of mechanisms to ensure that all of the graduate students obtain rigorous training in genetics. Once they enter the program, students are free to select any one of 41 different faculty mentors located in the four aforementioned performance sites. These faculty employ a variety of genetic and genomic methods to study a broad spectrum of problems in cell, developmental, and evolutionary biology, including metazoan and plant patterning, embryogenesis, sex determination, cell determination and differentiation, morphogenesis, and organogenesis. The study of cellular processes in the areas of signal transduction, DNA replication, transcription, cell trafficking and the cytoskeleton, transcription, and DNA replication are the focus of many faculty. Other faculty use genetic approaches to study evolutionary processes such as the evolution of chordates and patterning in invertebrates. In the first year of the program, trainees complete advanced lecture, laboratory, and seminar courses. Students in PMB and MCB are also required to complete three 10-week laboratory rotations with potential dissertation mentors. All students commence their dissertation research by the beginning of the second year. They are also required to complete an oral qualifying exam that is administered by four faculty from at least two different departments within the training program. All students are required to complete at least two semesters of teaching as graduate instructors during the second and third years of the training program. In addition to formal course offerings in the different areas of genetics, students are expected to participate in a variety of seminar programs, joint lab meetings, journal clubs, and retreats that are sponsored by the Genetics Training Program.        

",Postgraduate Training Program in Genetics,,"GIAN  GARRIGA,HENK  ROELINK","1911524,2098825"
2,7254939,,2007,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,BIOCHEMISTRY,5T32GM007185-33,GM007185,UNITED STATES,T32,1126704,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2011-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  This proposal seeks renewal for UCLA's predoctoral Cellular and Molecular Biology Training Program. Now in its 30th year, the program has trained 414 Ph.D. candidates for careers in biomedical research and education. These students have gone on to make discoveries that have improved human health and we expect that future trainees will also follow in their footsteps with the training received here. The program is interdepartmental and includes faculty and students in both the UCLA College and the School of Medicine, including the Departments of Chemistry and Biochemistry; Molecular, Cell and Developmental Biology; Microbiology, Immunology and Molecular Genetics; Biological Chemistry; and Neurobiology, as well as, the Interdepartmental Program in Molecular Biology. There are currently 40 training faculty with primary appointments in nine departments, including those listed above and Pathology and Laboratory Medicine; Physiological Sciences; Medicine; and Urology. Major research areas include biochemistry, cell biology, developmental biology, gene expression, macromolecular structure, molecular and cellular immunology, neurobiology, virology and microbial pathology.  
  
Trainees are self-nominated from each of the six major Ph.D. programs involved. Students are selected on a highly competitive basis using the criteria of their academic and research achievements. Appointments are made for a maximum period of three years. A small number of students enter the Training Program as first year Ph.D. students; the majority, however, come in after a year of graduate work when they have chosen their dissertation research director. In addition to meeting the University and Departmental or Program requirements for their degrees, trainees participate in a research ethics course, as well as in seminars and conferences organized by the Training Program. This proposal requests stipends for 45 trainees.  
  
The facilities are those of a major undergraduate and graduate campus of approximately 33,000 students that includes a medical school faculty. All of the departments involved in this program are in close proximity to each other and to the interdepartmental Molecular Biology Institute, which facilitates interactions of both students and faculty.  
    

",Research Training in Cellular and Molecular Biology,,STEVEN G CLARKE,1863373
3,7254629,,2007,MASSACHUSETTS GENERAL HOSP,BOSTON,MA,,5T32DK007028-33,DK007028,UNITED STATES,T32,575334,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
The postdoctoral research training program in Endocrinology and Diabetes at the Massachusetts General Hospital is intended to provide intensive research experience in basic or clinical investigation, complemented by didactic research training in basic sciences pertinent to endocrinology and diabetes. The trainees are primarily M.D.'s and M.D./Ph.D.'s who desire a career in investigative endocrinology and academic medicine, as well as Ph.D.'s who want further research training. The trainees are selected from a large applicant pool on the basis of prior academic and/or research achievement, and evidence of strong commitment to a career in biomedical investigation. The Program director (J. Avruch) is a senior academician/endocrine investigator who governs in conjunction with a committee of experienced endocrine scientists (Habener, Kronenberg, Crowley, Neer, Freeman and Klibanski). The training faculty consists of 46 active, well-funded scientists, whose interests range broadly across the subdisciplines of endocrinology, and from clinical investigation to the regulation of gene expression, protein structural analysis, transmembrane signaling mechanisms, etc. The trainees are supervised closely by a primary faculty mentor, and interact extensively with junior faculty, who often serve as secondary mentors. A carefully evolved and extensive program of didactic sessions complements the research activity. The training period is 2-3 years but may include several years additional experience at junior faculty status, so as to permit consolidation of skills and maximal competitiveness for independent support. The productivity of past trainees during training has been very high overall, as judged by the number and quality of trainee publications. Among the program graduates since 1990 supported by this grant, the majority remain in academia and a substantial number are in the biotechnology/pharmaceutical industry. Among those in academia, about one quarter have achieved independent support equivalent to an RO-1 and nearly one third have achieved transitional independent support, a usual precursor to RO-1 support. The facilities at the MGH are extensive, including an active GCRC, an Institutional Clinical Research Support Program, access to a very large base of endocrine/diabetes patients, and over 40,000 square feet of fully equipped modern laboratory dedicated to our training faculty. The institutional training grant represents the central stabilizing financial element in this program, and is especially critical in enabling M.D. trainees to achieve careers in biomedical investigation      

",Training Program in Endocrinology and Diabetes,,JOSEPH  AVRUCH,1888259
4,7253467,,2007,UNIVERSITY OF CALIFORNIA,LA JOLLA,CA,BIOLOGY,5T32GM007240-31,GM007240,UNITED STATES,T32,1314194,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The Cell, Molecular, and Genetics (CMG) Training Program at the University of California, San Diego is currently in its 29th year.  This program is a cornerstone of the Ph.D. training effort in the biological sciences at UCSD, as it supports the very best graduate students from the Biology-Salk and Chemistry-Biochemistry Ph.D. programs.  The mission of the CMG Training Program is to provide rigorous basic research training in cell biology, molecular biology, and genetics to outstanding young biomedical researchers in the earlier years of their doctoral studies. Specific emphasis is placed upon the creativity, quality, and impact of the research, the ethical conduct of research, the achievement of racial diversity among biomedical researchers, the ability of the trainees to communicate their results effectively, and the promotion of cooperation and collaboration among scientists.      
  
The CMG Program Director is Dr. Randolph Hampton. He has been a member of the UCSD Division of Biological Sciences since 1995, and is currently Associate Professor and holder of the Paul Saltman Chair for Scientific Education. Dr. Hampton works with an Advisory Committee for the CMG Training Program that consists of Drs. Lorraine Pillus, Tracy Johnson, Bart Sefton, Elizabeth Komives, and Bill McGinnis.  There are currently 110 training faculty from the UCSD Division of Biology, Salk Institute, UCSD Department of Chemistry and Biochemistry, and Department of Cellular and Molecular Medicine at the UCSD Medical School.   
  
The CMG Training Program provides support for 39 outstanding Ph.D. students that are selected from a current total group of 264. The trainees fulfill the general requirements of their respective graduate programs and additionally participate in CMG-specific training activities, which include, training in responsible conduct in research, Fall Reception and Poster Session, biannual CMG Training Program Symposia, annual one-on-one Conferences with the Program Director, CMG Sponsored Workshops, annual Idea and Input Lunch, CMG Hosted Biology Divisional Speaker, CMG-Hosted Informal Events, and participation in Trainee Committees to steer and organize these activities. Over the past 10 years, 126 CMG trainees have successfully completed their Ph.D. theses.  Past and present CMG trainees have contributed an enormous wealth of fascinating and important knowledge to the biological sciences in over 400 publications (not including abstracts).  With the projected growth of biology at UCSD, we envision the implementation of an even stronger CMG Training Program over the next five years.          

",Cell and Molecular Genetic Training Grant,,Randolph Y. Hampton,1924909
5,7253273,,2007,UNIVERSITY OF WASHINGTON,SEATTLE,WA,BIOCHEMISTRY,5T32GM007270-33,GM007270,UNITED STATES,T32,1059184,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,,"
DESCRIPTION (provided by applicant):  The proposal requests continued funding of the predoctoral Training Program in Molecular and Cellular Biology at the University of Washington and the Fred Hutchinson Cancer Research Center (UW/FHCRC).  Trainees in the program are chosen by a rigorous selection process that picks the top graduate students from three interdisciplinary programs and nine departmental programs.   

The major goal of this program is to train students in cell and molecular biology during their graduate careers by exposing them to a wide range of research in this area.  Students in the Training Program receive training beyond the standard graduate program through a monthly student presentation series that includes all of the trainees, an annual retreat that includes the trainees and their advisors, and through lectures and symposia supported by this grant   

This program plays an important role in training the next generation of scientists for academia and industry.  The trainees have a strong record of success as shown by their publications in graduate school and the career choices they make after they leave graduate school.   

",TRAINING IN MOLECULAR AND CELLULAR BIOLOGY,,David  Kimelman,1895252
6,7236989,,2007,UNIVERSITY OF GEORGIA,ATHENS,GA,GENETICS,2T32GM007103-32A1,GM007103,UNITED STATES,T32,259763,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2012-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  This proposal is a revision of a competitive renewal of a successful and established predoctoral training program whose objective is to broadly train high quality research scientists in basic genetic approaches to the study of biology at the molecular, cellular, organismal, and population level. Funds are requested to support 10 trainees each year. Students enter the training program upon admission to the Department of Genetics based on merit and potential for success in scientific careers. Students are rigorously trained in cutting-edge genetic and biochemical research and data analysis through laboratory research, classes, and attendance at seminars. In addition, they gain written and oral communication skills through preliminary and qualifying examinations; presentations at lab meetings, seminars, and journal clubs; attendance at national and international meetings; and preparation of manuscripts for publication. Students obtain teaching experience through a requirement to serve as teaching assistants in undergraduate introductory genetics or evolutionary biology for at least one semester in their second or third year. During their first year, students participate in lecture courses in either a molecular or a population and evolutionary genetics track, and they complete 3-4 laboratory research rotations. They then begin dissertation research and in years 2-5 enroll in seminars, advanced electives and special topics courses. To ensure that students complete degree requirements in a timely manner, progress is monitored twice yearly by the Graduate Affairs Committee and students' dissertation committees. Written and oral examinations and major courses must be completed by the end of the fifth semester, and students meet at least once annually with their dissertation committees. A major strength of the program is the interdisciplinary training students receive in molecular, population and evolutionary genetics from 33 training faculty representing a wide range of genetic disciplines. Students in each curriculum track take at least one major course in the other track. In addition, attendance is expected at departmental seminars and symposia. Graduates from this training program over the past 33 years have been highly successful in careers in academia, government, and industry. The training program is dynamic and will continue to produce broadly trained leaders in genetics as it embraces the exciting genetic developments of the 21st Century.   
    

",Graduate Training in Genetics,,Michael T. Bender,1887620
7,7252637,,2007,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,CORAL GABLES,FL,PHYSIOLOGY,5T32NS007044-32,NS007044,UNITED STATES,T32,317942,False,Stephen J Korn,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,2011-06-30T04:00:00Z,PA02109,"  
DESCRIPTION (provided by applicant)  
  
This is a renewal application for a long-standing, highly focused training program that provides predoctoral and postdoctoral trainees with intensive research experience in the areas of synapses, ion channels, and transduction, while ensuring that the trainees have a thorough grounding in the basic neurosciences. The approaches involve the use of advanced molecular biological, physical, chemical, electrical, mathematical, and computational techniques to study fundamental questions in these focused areas of cellular and molecular neuroscience in which the 20 training faculty have expertise. Predoctoral trainees will enter the program after taking an interdisciplinary group of graduate courses and specialized courses tailored to their needs and interests. Under a mentor's direction they will do original research culminating in a Ph.D. degree. Postdoctoral trainees are offered a choice of research projects from which they develop their own independent research. All trainees receive much individual attention from program and allied faculty. Training involves a broad variety of research activities including presentations and participation in seminars and journal clubs with a large and closely interacting group of neuroscientists. The trainees also take part in career and ethics workshops and gain some teaching experience. The aim of this training program is to produce scientists of high quality, capable of working at the forefront of their research area, broadly knowledgeable in the basic neurosciences, and able to communicate effectively. The trainees will be qualified for diverse advanced positions in the biomedical sciences, ranging from the traditional academic to those in private industry and government. In keeping with the rigorous nature of the program, we seek first- rate applicants. Predoctoral candidates must be strong academically, with demonstrated interest in, and aptitude for, scientific inquiry. Postdoctoral candidates with Ph.D.s must have completed a high quality research project in a relevant discipline; individuals with M.D. degrees are actively recruited. Support is requested for 2 pre- and 2 postdoctoral trainees and short-term training for 4 medical students. The focused training forms the basis for understanding many diseases and disorders of the nervous system, including neurodegeneration, channelopathies, and dysfunction from genetic mutation. By training neuroscientists for research in these critical areas, the program is expected to contribute substantially to public health.  
    

","Synapses,Channels, and Transduction in Neuroscience",,Kenneth J Muller,7684521
8,7252111,,2007,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32DK007130-34,DK007130,UNITED STATES,T32,253366,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
The goals of this training program in academic gastroenterology are to train, nurture and develop both physician scientists (MD, MD/PhD) and PhD scientists for productive and sustaining careers as academic investigators in the broad field of digestive and liver diseases. The overarching objectives are to train individuals in preparation for independent careers in basic, translational and clinical investigation through mentored interactions supplemented by course work and guided study. The training program in academic gastroenterology draws upon the institutional resources within the Division of Biology and Biomedical Sciences with over half the core faculty preceptor group (6/11) having joint appointments in clinical (Medicine) as well as basic science departments, including Pharmacology and Molecular Biology (3), Cell Biology (1), Biochemistry and Biophysics (1), Molecular Microbiology (1). In addition, 5 of 7 collaborating faculty preceptors have joint appointments in clinical and basic science departments, including Cell Biology (2), Genetics (1), and Immunology (2). Other features of this training program include the intellectual enrichment emanating from two NIH funded centers, including a Digestive Disease Research Core Center and a Clinical Nutrition Research Unit. This depth and range of interaction between basic science departments, academic programs and laboratories insures that our trainees are exposed to the most vigorous research and training opportunities in fields including molecular genetics, cell and molecular biology, immunology and developmental biology. In addition to these programs in basic science, our trainees have opportunities in clinical translational investigation, including metabolic studies in obesity, nonalcoholic fatty liver disease, viral hepatitis, esophageal motor physiology, inflammatory bowel disease and colon cancer genetics. Formal coursework is expected of our clinical investigator trainees, who will work towards an MPH degree. We propose to select three trainees each year, each of whom will be funded for two years by this training grant      

",Clinical/Laboratory Training Academic Gastroenterology,,Nicholas O. Davidson,8179452
9,7227457,,2007,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,INTERNAL MEDICINE/MEDICINE,5T32HL007035-32,HL007035,UNITED STATES,T32,1123538,False,Sandra  Colombini-Hatch,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2011-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):   
  
The goal of this program is to train scientists in fields related to lung diseases. We propose to accomplish this by providing formal course work, doctoral and post-doctoral degree programs, and laboratory based training in six major disciplines related to lung biology: Pulmonary Vascular biology, Developmental Biology of the Airways and Lung Vasculature, Lung Matrix Biology, Immunology and Inflammation, Genetics and Epidemiology of Lung Diseases, and Bioinformatics/Systems Biology. In this 6th renewal (31st year) we have developed a new comprehensive program in Systems Biology, building on our existing strengths in genomics and bioinformatics to add proteomics and an integrated approach to lung cell biology. In that regard, we have expanded the formal degree granting curricula and added outstanding senior faculty in Bio-informatics, genomics and proteomics and vascular biology to complement our existing programs. These new faculty interact with all our core disciplines to provide an integrated approach to Systems Biology of each research program. Predoctoral students in the M.D./PhD. Medical School Program, Biochemistry, Pathology, Immunology (either Microbiology or Pathology) and Engineering (Bioinformatics/Systems Biology) Ph.D. graduate programs are offered support for directed study through course work and thesis mentorship with Pulmonary Training Grant faculty. Post-doctoral M.D. trainees accepted into our Clinical Pulmonary Fellowship who express interest in pursuing careers in science participate in three to four years of research post-doctoral fellowship in one of the disciplines noted. During that time, they may elect any of three formal training programs: an M.P.H. degree program in Lung epidemiology or genetics sponsored by the School of Public Health; enrollment in our CREST program in translational medicine or a new Masters in Bio-Informatics. This renewal also provides a pathway to capture Ph.D. post-doctoral fellows who seek training in lung related biology. This award has trained over 60 doctoral students in Biochemistry, Pathology, Immunology and Engineering and 130 post-doctoral fellows over the past 29 years in disciplines related to lung diseases. Our graduates include 8 current or former Academic Chiefs of Pulmonary Medicine, three Chairs in Medicine, numerous Professors of Medicine and national leaders in every field of Pulmonary Science. (End of Abstract)  
    

",Biology of the Lung: A Multidisciplinary Program,,DAVID M. CENTER,1864129
10,7240479,,2007,UNIVERSITY OF CALIFORNIA,LA JOLLA,CA,PHARMACOLOGY,5T32GM007198-33,GM007198,UNITED STATES,T32,1083909,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):  This multi-disciplinary program is designed to enhance the learning of clinical medicine and biomedical science and has as its goal the training of physician-scientists who, because of their simultaneous and rigorous educations, are especially well-equipped biomedical investigators. The University of California, San Diego (UCSD) is a campus of unusual strength in the biomedical sciences. The strong ties between the School of Medicine (SOM), the adjoining General Campus and nearby research institutes (e.g., Salk Institute for Biological Studies, the Scripps Research Institute [TSRI], the Burnham Institute), as well as within the San Diego biomedical community creates an academic environment highly suited for this program by increasing the interdigitation of basic science, biomedical research and medical practice. The education is integrated: in the first two years, the students take the preclinical curriculum and utilize elective time to explore research opportunities and fulfill academic requirements in Graduate Programs. Students choose a Graduate Program toward the end of the preclinical curriculum. The site of advanced research training depends upon the research area chosen by the student. Graduate training programs include Anthropology, Biology, Biomedical Sciences, Bioengineering, Bioinformatics, Biophysics, Chemistry/Biochemistry, Epidemiology, Molecular Pathology, Neuroscience, Physics, and the TSRI Program in Chemical and Biological Sciences. Advanced research work in a Graduate Programs leads to the Ph.D. degree and completion of clinical clerkships in the SOM, leads to the M.D. degree. Flexibility of curriculum design is stressed and each student's program is individualized. The caliber of the students is excellent, with graduates from leading University throughout the US. Current areas of student's research include cutting edge of biomedical sciences. Virtually every one of our graduates since 1990 has continued to pursue research, almost all in academic positions. This Program has grown by virtue of expanded research opportunities at UCSD and neighboring institutions and by a growing pool of high quality applicants and faculty. Recent changes include development of an MSTP SURF, revamping of admissions and curricula and growing support from UCSD and its La Jolla neighbors. In this application we seek support for additional positions for this highly successful MSTP.",Medical Scientist Training Program,,PAUL A INSEL,1881196
11,6894529,,2005,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,2T32HL007093-31,HL007093,UNITED STATES,T32,500751,False,Henry  Chang,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):   
The Hematology Research Training Program at the University of Washington is designed to provide intensive post-doctoral research training in investigative hematology. The program emphasizes cell and molecular biology, with particular strengths in: stem cells and hematopoiesis, cell and gene therapy, platelets and hemostasis, vascular biology, hematologic malignancies, cancer biology, transplantation biology, and molecular medicine. Program faculty include established investigators with strong independent research programs from both basic science and clinical departments at the University of Washington, Fred Hurtchinson Cancer Research Center, and nearby affiliated institutions. The goal of the Training Program is to develop the research, presentation, and fund-raising skills that trainees will need to establish independent research careers, and to train future leaders in the field of research hematology. Trainees have M.D., M.D.-Ph.D., or Ph.D. degrees. Many have completed clinical training in hematology, but others are basic researchers wishing to work in the field. Trainees are chosen through an application process and interactions with program faculty. They obtain laboratory experience by working with a mentor, and are assisted in laboratory techniques, publishing papers, presentation skills, and acquiring independent grant support. Trainees typically receive 2 years of funding from the Program, but often continue their training longer under separate funding mechanisms. Training progress is monitored by the faculty mentor, a separate faculty adivsor, the Program Directors, and the Division of Hematology faculty through regular research presentations and meetings with each trainee. 
The main strengths of the Program include: diverse research opportunities, a qualified senior faculty, and a long track record, spanning over three decades, of graduates obtaining junior faculty positions and becoming independent and distinguished investigators.",Research Training in Hematology,,David W Russell,1885915
12,6894072,,2005,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,ANATOMY/CELL BIOLOGY,5T32GM007067-31,GM007067,UNITED STATES,T32,966443,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,DAVID A HARRIS,1893159
13,6893953,,2005,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOMEDICAL ENGINEERING,2T32GM007057-31,GM007057,UNITED STATES,T32,495217,False,Alison E. Cole,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant): The Biomedical Engineering Doctoral training program at the Johns Hopkins University aims to train talented students from engineering and other quantitative sciences for careers in biological and medical research. The program is interdisciplinary and interdepartmental in nature. Program faculty are drawn from a wide range of departments. This includes but is not limited to the departments of Biomedical Engineering, Neuroscience, Otolaryngology-Head and Neck Surgery, and Radiology in the School of Medicine, and the departments of Applied Mathematics and Statistics, Chemical and Biomolecular Engineering, Electrical and Computer Engineering, Material Science and Engineering and Mechanical Engineering in the Whiting School of Engineering. The faculty are engineers, applied mathematicians, neuroscientists, physiologists, cell biologists, and molecular biologists with both experimental and theoretical/computational research programs. A unique aspect of the program is that students are free to do research in any laboratory of the University, subject to program approval. Support is requested for 12 pre-doctoral trainees. The usual duration of the program is 5-6 years. Students are drawn mainly from engineering schools, although they also come from mathematics, physics, chemistry, and biology. Program coursework includes graduate level courses in life sciences plus advanced courses in engineering, mathematics, and biology. The core of the program is research training in the research laboratories of the Program faculty.      

",Biomedical Engineering Training Program,,RAIMOND Lester WINSLOW,1865780
14,6898279,,2005,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007196-31,GM007196,UNITED STATES,T32,349148,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):  This training grant will support 17 graduate students usually for their first two years.  The goal of this program is to give the students the widest possible education in genetics and provide opportunities to work in many of the major areas of genetics research, including plant, microbial, yeast, Drosophila, C. elegans, Zebrafish, human genetics, genomics and bioinformatics and other areas.  The Training Grant sponsors regular genetics research presentations by more senior graduate students and three student-invited outside genetics seminar speakers.  Students are selected for the grant before matriculating on the basis of their interests and their agreement to take an introductory and an advanced genetic course.  Their progress is followed by faculty advisors who are members of the Training Grant and by the Director this Grant.  These students will be part of the Biological and Biomedical Sciences program which includes the following components: 1) Advising throughout their graduate career by a faculty member of the Training Grant; 2) a set of four core courses in genetics and other core subjects, a critical reading course, and advanced courses.  The total required number of courses is 8; 3) a regular fall poster session, regular faculty talks, student-organized fall retreat, Mini-Symposia on specialized topics and Departmental activities all of which introduce students to the range of lab research subjects available; 4) a program and course in Conduct of Science and a seminar speaker on social issues in genetics; 5) laboratory rotations during the first 12 months allowing students to try out three labs; 6) forums on careers in academic science and in alternative careers; 7) a qualifying examination and a thesis advisory committee to follow the progress of the student; 8) regular seminars on genetic subjects in Medical School basic science Departments.",Regul. of Gene Expression in Prokaryotes and Eukaryotes,,FRED M. WINSTON,1863326
15,6896797,,2005,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007057-30,HL007057,UNITED STATES,T32,238799,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Applicant's Abstract) The purpose of the Training Program in Transfusion Medicine and Related Areas is to provide research training in transfusion medicine and the scientific disciplines related to it in order to develop academically oriented physician-scientists and nonphysician scientists with expertise in the performance of both basic and clinical research.  Upon completion of this program, each trainee will be qualified to assume a medical school faculty position and conduct an independent program of clinical or laboratory investigation in one of the fields of study included in this program, including transfusion medicine, immunohematology, and immunology (Track I); hemoglobin, hematopoiesis and cellular therapy (Track II); hemostasis and thrombosis (Track III); and molecular biology, molecular signaling, and DNA repair (Track IV).  In each of these tracks, exposure to the clinical aspects of the area selected (comprising less than 20 percent of the total trainee time during the tenure of this fellowship) will be provided to permit the trainee to understand the clinical context in which the research which he or she is to undertake is placed.  The reminder of the time (at least 80 percent) will be spend in a defined tutorial research program with a preceptor in one of the laboratories or clinical investigation areas described in this grant proposal.  The trainees in all tracks will also take part in inter- and intradepartmental seminars and conferences, and will be expected to report orally and in writing on the research being performed.  The trainee will be able to take whatever course work at Duke University is necessary for the satisfactory completion of his or her work.  Trainees in areas of clinical investigation will be encouraged to pursue either a masters in public health degree (at the University of North Carolina at Chapel Hill) or a masters in health sciences in clinical research degree granted by the Duke University Clinical Research Training Program (formerly the Biometry Training Program); at a minimum, they will be expected to complete an introductory course in statistics.  The training program funded by this award will be offered to qualified persons holding either the M.D. or Ph.D. degree with interests in research training in transfusion medicine and related areas.  Persons from minority groups and women will be encouraged to enter the program.  No predoctoral or primarily clinical competence training will be funded by this grant.  The facilities for research training will be based at the various. research laboratories and clinics of Duke University and the allied Veterans' Administration Medical Centers in Durham., North Carolina.  Fulfillment of the training goals of this program will meet present and future needs for scientists and physician-scientists who can conduct high caliber research in both basic and clinical sciences related to transfusion medicine and who can apply the rapidly growing knowledge in this field to the care of patients with hematopoietic and other disorders requiring blood product and stem cell therapy. ",TRANSFUSION MEDICINE AND RELATED AREAS,,Marilyn J Telen,1885877
16,6886797,,2005,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,PSYCHOLOGY,5T32MH014257-31,MH014257,UNITED STATES,T32,256456,False,Debra K. Wynne,National Institute of Mental Health,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,PA00103,"DESCRIPTION (provided by applicant):  This program provides predoctoral (4 positions) and postdoctoral (3 positions) research training for psychologists specializing in research design, measurement, statistical methods, decision making, psychological scaling, and assessment of individual differences, with an emphasis on application of these methods in investigations of behavioral and mental disorders. During their careers these specialists (a) continue to train students in all areas of behavioral and social sciences by their research and teaching activities, and/or (b) act as principal investigators or consultants in research on basic processes, psychopathology, and related problems. Predoctoral trainees receive Ph.D. degrees in Psychology; some having joint majors in quantitative methods and substantive problem areas such as clinical, developmental, or cognitive psychology. Other trainees major in quantitative methods and receive M.S. degrees in Applied Statistics with specialization in psychological  assessment, behavioral statistics (more broadly defined), and modeling with the aim of developing new methods, or improving existing methods for investigating psychological phenomena of all kinds, including basic cognitive, affective, social, and psychophysiological processes. Course and seminars are designed to advance trainees' knowledge of quantitative statistics that enables them to manipulate research data in psychologically meaningful ways. Research projects include: adolescent coping and neighborhood violence, social networks of at risk adolescent girls, reactions towards Arab Ethnic groups following the terrorist attacks on America, emotional and attentional mechanisms of high anxiety-sensitive individuals using fMRI neuroimaging and emotional Stroop paradigm, and cognitive and affective processes in pathological gambling. Research on methodological problems includes; effects of feedback on calibration, meta-analytic treatment of research results, alternatives to exploratory factor analysis, and models for the description and analysis of social networks.",Quantitative Methods for Behavioral Research,,Michel  Regenwetter,8586997
17,6886794,,2005,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,5T32AR007019-30,AR007019,UNITED STATES,T32,187758,False,Carl  Baker,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2007-04-30T04:00:00Z,,"
 DESCRIPTION: (Taken from the applicant's abstract) The purpose of the training     
 program in dermatology is to provide advanced training in basic science            
 research as it relates to the study of the skin. The program is directed           
 towards the training of physician-scientists for academic careers, but will        
 also include Ph.D.'s committed to dermatology and to the study of skin-related     
 problems. The training faculty group have particular expertise in the study of:    
 1 ) morphologic and biochemical assessment of cutaneous development and repair;    
 2) keratinocyte-specific proteins and function, 3 ) extracellular matrix           
 metabolism and, 4) structural proteins of the extracellular matrix including       
 elastin, proteoglycans, and collagens. The areas under investigation in these      
 laboratories utilize a variety of approaches involving cell biology,               
 enzymology, protein chemistry, modern molecular biology, gene transfection,        
 immunology, and cell culture. Specialized training in areas not offered by our     
 the staff will be open to the trainees through the close association with the      
 faculty of other departments in the medical school e.g., Dr. Peter Byers,          
 Professor, Dept. of Pathology, Dr. William Carter, Professor, Dept. of             
 Pathobiology and Fred Hutchinson Cancer Research Center (FHCRC), Karen             
 Stephens, Research Associate Professor, Dept. of Medicine, Division of Medical     
 Genetics, Dr. Curtis Omiecinski, Professor, Dept. of Environmental Health, Dr.     
 Buddy Ratner, Professor Dept. of Chemical Engineering, Dr. Nicole Gibran,          
 Associate Professor, Dept. of Surgery and Dr. Mark Bothwell, Professor, Dept.      
 of Physiology and Biophysics. There are research seminars presented by the         
 division as well as seminars offered in a number of associated basic science       
 departments including Biological Structure.                                        
                                                                                    
 The dermatology training grant program is intended to train individuals with a     
 strong commitment to pursue a full-time academic research career. Continued        
 support is requested for 3 postdoctoral trainees who have received the degree      
 of either M.D. or Ph.D. Candidates are selected from the clinical training         
 program and/or from outside applicants applying directly to the research           
 program. The training program has developed a program for expanding the pool of    
 qualified minority applicants as well as recruiting and retaining those            
 applicants. Likewise, a program is in place for teaching research integrity.       
                                                                                    
",DERMATOLOGY TRAINING,,JOHN Everett OLERUD,1894262
18,6895007,,2005,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PHYSIOLOGY,2T32GM007108-31,GM007108,UNITED STATES,T32,459513,False,Alison E. Cole,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The program described in this training grant application provides support for predoctoral (Ph. D.) students in neurobiology at the University of Washington.  Fifty-two University of Washington faculty members from the Graduate Program in Neurobiology & Behavior serve as training grant faculty.  All of the training faculty direct active, externally-funded research programs and are committed to training graduate students, postdoctoral fellows and visiting scientists.  The extensive publication records of training grant faculty are detailed in their biographical sketches.  The training grant faculty provides a breadth of neuroscience research areas extending from molecular biology to behavioral neurobiology.  Further, this is a highly collaborative faculty.  The large number of training grant faculty provides the opportunity for trainees to learn many different techniques and approaches to research through their lab rotations, journal clubs, seminar series and course work.      

",Institutional Grant for Neurobiology,,MARC D BINDER,1862647
19,6911728,,2005,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,BIOCHEMISTRY,5T32GM007185-31,GM007185,UNITED STATES,T32,1015072,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"                                                                                    
 DESCRIPTION: (provided by applicant) This proposal seeks renewal for UCLA's        
 predoctoral Cellular and Molecular Biology Training Program. Now in its 26th       
 year, the program has trained more than 350 Ph.D. candidates for careers in        
 biomedical research and education. The program is interdepartmental and            
 includes faculty and students in the Departments of Chemistry and Biochemistry     
 and Molecular, Cell and Developmental Biology in the College of Letters and        
 Sciences, the Departments of Biological Chemistry, Microbiology, Immunology and    
 Molecular Genetics, and Neurobiology in the School of Medicine, as well as the     
 Interdepartmental Program in Molecular Biology. There are currently 84 training    
 faculty with primary appointments in 10 departments. Major research areas          
 include biochemistry, cell biology, developmental biology, gene expression,        
 macromolecular structure, molecular and cellular immunology, neurobiology,         
 virology and microbial pathology.                                                  
                                                                                    
 Representatives of each of the six major Ph.D. degree programs involved            
 nominate trainees for the program. Students are selected on a highly               
 competitive basis using the criteria of their academic and research                
 achievements. Appointments are made for a maximum period of three years. A         
 small number of students enter the training program as first year students;        
 however, the bulk of them come in after a year of graduate work when they have     
 chosen their dissertation research director. In addition to meeting the            
 University and Departmental or Program requirements for their degrees, trainees    
 participate in a research ethics course, as well as in seminars and conferences    
 organized by the Training Program. This proposal requests stipends for 45          
 trainees.                                                                          
                                                                                    
 The facilities are those of a major undergraduate and graduate campus of           
 approximately 33,000 students that includes a medical school faculty. All of       
 the departments involved in this program are in close proximity to each other      
 and to the interdepartmental Molecular Biology Institute, which facilitates        
 interactions of both students and faculty.                                         
                                                                                    
",RESEARCH TRAINING IN CELLULAR AND MOLECULAR BIOLOGY,,STEVEN G CLARKE,1863373
20,6909039,,2005,ALBERT EINSTEIN COL OF MED YESHIVA UNIV,BRONX,NY,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007288-31,GM007288,UNITED STATES,T32,1534090,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine (AECOM) has been in continuous existence since 1963.  Its mission has always been to train physician-scientists who are equipped to address biomedical and bioethical challenges and opportunities over the ensuing decades of their professional life.  The MSTP has graduated 229 trainees; over 90% remain in academic medicine; over 85% of those who have completed postdoctoral training remain in investigative work.  Based on our: 1) commitment to adapt continuously the MSTP curriculum to the changing needs of future physician-scientists; 2) enhanced research programs, faculty, funding and facilities; 3) success with minority recruitment and retention; and 4) record of training successful physician-scientists, we request funding for 38 MSTP positions.  
",Medical Scientist Training Program,,Myles H. Akabas,1859306
21,7278618,,2007,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PEDIATRICS,5T32AI007007-29,AI007007,UNITED STATES,T32,177322,False,Lawrence J. Prograis,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,2009-08-31T04:00:00Z,,"DESCRIPTION (provided by applicant): This training program has been designed to create a critical mass of faculty who can train Pediatricians to address the problems of allergic and immunologic diseases in children both in the laboratory and in the clinical setting.  The program is based in the Division of Allergy and Immunology in the Department of Pediatrics. The Division is located in the Children's Center of The Johns Hopkins Hospital.  All of the laboratories and offices are contiguous and consist of 7 separate, fully equipped laboratories, 6 faculty offices, 2 secretaries' offices, a Fellows' office, and a library/conference room.  The division is uniquely suited to offer fellowship training in that it is composed of 5 full-time and one 1/2 time investigators with balanced interests; 3 are primarily interested in allergy and 3 are primarily interested in immunology.  In addition, it utilizes the faculty and facilities of other divisions within the University's immunology community, such the Graduate Program in Immunology, the Division of Rheumatology and the Division of Clinical Immunology in the Department of Medicine.  
The program provides 3 years of balanced training in basic and clinical immunology to Pediatricians who will pursue an academic career.  Candidates will have completed a 2-4 year residency in Pediatrics.  They will be selected primarily based upon their commitment to an academic career and their interest in research in the allergic and immunologic diseases of children. Each trainee spends the majority of his/her time in laboratory research (80%), supplemented with course work and limited clinical responsibilities.  A single faculty member acts as the preceptor for a given fellow, supervising his/her laboratory work, helping to select formal course work, and designing a program of clinical activities. The laboratory work focuses on one of the areas in which the faculty is actively involved and includes immunology and Epidemiology of Childhood Asthma (Drs. Eggleston, Wood, Matsui, Lederman, Bochner and Adkinson), the role of immune system in host defense and inflammation (Drs. Lederman, Bochner, Rosen, Sule and Desiderio) and the Primary Immunodeficiency Diseases, (Drs. Lederman, Winkelstein, Sule, Rosen and Desiderio).  Course work includes both a core curriculum designed to give the fellow a strong foundation in basic immunology and elective courses aimed at meeting the special needs of the fellow.  Clinical training focuses on Allergy and Immunology but also includes limited experience in Rheumatology, Pulmonology, and ENT, and is in accord with that specified by the Board of Allergy and Clinical Immunology.",Research Training in Pediatric Allergy and Immunology,,ROBERT A WOOD,6785863
22,7277690,,2007,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,INTERNAL MEDICINE/MEDICINE,5T32DK007007-33,DK007007,UNITED STATES,T32,175917,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2011-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
This revised application is for support of four training positions in an established program in digestive diseases at the University of California, San Francisco. Its focus is mucosal biology and clinical research in luminal gastroenterology and pancreas; training in hepatology is a separate program. The mentor group comprises 9 members of the UCSF Division of Gastroenterology and 8 investigators from affiliated Departments and programs who are actively involved in collaborative research with faculty of the Gl Division. All have independent research programs and a record of successful mentoring. The training environment is broadly interdisciplinary, reflecting the involvement of Gl Division faculty in the graduate program for Biomedical Sciences, the Immunology Program, and the Cancer Center. Changes to the Program since the 1999 competing renewal application include: (1) Creation of a comprehensive program in inflammatory bowel diseases, the UCSF Center for Colitis and Crohn's Disease, which encompasses fundamental, translational and clinical research as well as state-of-the-art clinical care; (2) implementation of a program in cancer of the pancreas and another for cancer risk assessment, focused mainly on colon cancer; and (3) a K30 award to the UCSF Department of Epidemiology and Biostatistics, to expand its didactic program in clinical research methods with a Master's degree in Clinical Research. In the year since the initial submission of this renewal proposal, a program in outcomes and health services research has been formally constituted under the direction of John Inadomi, MD. Also, the School of Medicine received an institutional K12 award for training of both fellows and junior faculty in translational research. Subspecialty fellows selected for support under this training grant generally will hold an MD or MD/PhD and will have completed both a program in Internal Medicine and 12 months of intensive training in clinical gastroenterology. Highly qualified PhD recipients, whose research is focused on the Gl tract and has translational potential, also may apply. The duration of research training is three years, except for fellows with exceptionally strong prior experience who may do two years only. Program graduates will have a well-defined research focus and the tools needed for success with a career in biomedical investigation in the field of gastroenterology.  
    

",INRSA Training Grant in Gastroenterology,,AVERIL I MA,1872380
23,7246868,,2006,UNIVERSITY OF CHICAGO,CHICAGO,IL,GENETICS,3T32GM007183-31S1,GM007183,UNITED STATES,T32,739391,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,,Molecular and Cellular Biology Training Grant,,HARINDER  SINGH,1978275
24,7008293,,2006,HARVARD UNIVERSITY,BOSTON,MA,BIOCHEMISTRY,2T32GM007306-31,GM007306,UNITED STATES,T32,342710,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2011-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  This is an application for renewal of a longstanding program for predoctoral training in Pharmacological Sciences. Eight training slots are requested to support students in their first two years. The program seeks to meet the need for well-trained scientists who can maintain rapid progress in applying advances in biology to medicine. Rigorous training in molecular biology, genetics, biochemistry, structural biology, and cell biology, as well as pharmacology, forms the foundation of the program. These many disciplines are reflected in the research activities and classes offered to the students. The training program is conducted under the aegis of the Biological and Biomedical Sciences (BBS) graduate program at Harvard Medical School. BBS draws its faculty members from various basic science departments and their affiliates, and the training program faculty is a subset of this group. The central department for this program is Biological Chemistry and Molecular Pharmacology, although faculty members from other departments play important roles in the training program.  The various departments and the training grant faculty are highly interactive. The research activities of the training grant faculty span a broad spectrum of pharmacological sciences with multiple areas of research strength. Students in the program are closely advised and monitored. In their first year, they take core courses covering multiple disciplines in basic biomedical sciences including pharmacological sciences, and a course that stresses reading original research papers and critical thinking. They are then required to take an advanced pharmacology course. Other courses offered include advanced courses in pharmacological sciences and/or human biology, which also stress critical thinking and the primary literature. Full time thesis research follows course work, laboratory rotations, and qualifying examinations. Students receive training in teaching, and participate in multiple other training activities including a yearly Science Day, seminars, journal clubs, and data presentation. This training plan should ensure the strengthening of a program that aims to train students who can play leadership roles in pharmacological sciences.        

",PHARMACOLOGICAL SCIENCES,,DONALD M COEN,1888951
25,7007809,,2006,UNIVERSITY OF COLORADO DENVER,AURORA,CO,INTERNAL MEDICINE/MEDICINE,2T32DK007038-31,DK007038,UNITED STATES,T32,149422,False,Christine L Densmore,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2010-11-30T05:00:00Z,,"  
DESCRIPTION (provided by applicant):  
Purpose: The Training Program in Gastroenterology and Hepatology at the University of Colorado Health Sciences Center is committed to preparing highly motivated post-doctoral candidates for investigative careers in gastrointestinal research. Building on a 29 year background of sustained scientific accomplishment, the program has embarked on an exciting period of new growth and expansion of training opportunities since this application was last reviewed. This growth is marked by the recruitment of new research faculty, the successful competition for new NIH (and other) grants, and the development of programs that utilize sophisticated molecular and biophysical technologies to address basic issues in gastrointestinal research. Further, the availability of-formal coursework has been expanded; clinical, translational and outcomes research opportunities have been increased and significant new research programs have been developed to enhance the breadth and quality of training. These intellectual and capital resources contribute to an outstanding environment for career development of two new trainees per year. We propose to extend the period of training from 2 to 3 years for each trainee to accommodate the coursework and research experience that is necessary for a committed trainee to be successful in an academic career.  
Resources: The nucleus of the program is provided by 32 distinguished faculty members (19 MD, 3 MD PhD, and 10PhD) with research interests centered around three major themes, including i) cell and molecular biology of gastrointestinal and liver tissues ii) nutrition and carcinogenesis and iii) clinical trials and outcomes in hepatitis, liver transplantation and gastrointestinal endoscopy. The expertise of the faculty ranges from fundamental basic science to clinical, translational, outcomes and behavioral investigation. The training faculty participate in 7 major center, 6 project, and 93 individual extramural grants. These resources allow trainees an opportunity to approach gastrointestinal diseases from clinical, behavioral, epidemiologic, physiologic, biochemical, molecular and genetic perspectives. Trainees may elect to earn a Certificate, Masters or PhD degree during their training.  
Program: With the advice of the leadership of the adult and pediatric Divisions of Gastroenterology, the Executive Committee provides the overall direction and strategic planning for the program. The faculty draws broadly from nationally recognized research and training programs in other Divisions and Departments to provide the best training opportunities possible. Each year, two trainees are recruited from fellowship and doctoral programs in both clinical and basic science disciplines. Selection is based upon a confirmed commitment to a research-oriented career, an integrated research training plan, and the support of appropriate faculty with established credentials in the field of interest to ensure optimal scientific and career mentoring. The long-term goal of this program is to identify and support new investigators committed to rigorous training in gastrointestinal research, and to continue to develop the scientific and academic leaders for the future.    

",Gastrointestinal Diseases Training Grant,,DENNIS J AHNEN,1888571
26,6948994,,2005,MASSACHUSETTS GENERAL HOSPITAL,BOSTON,MA,,2T32DK007028-31,DK007028,UNITED STATES,T32,573901,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
The postdoctoral research training program in Endocrinology and Diabetes at the Massachusetts General Hospital is intended to provide intensive research experience in basic or clinical investigation, complemented by didactic research training in basic sciences pertinent to endocrinology and diabetes. The trainees are primarily M.D.'s and M.D./Ph.D.'s who desire a career in investigative endocrinology and academic medicine, as well as Ph.D.'s who want further research training. The trainees are selected from a large applicant pool on the basis of prior academic and/or research achievement, and evidence of strong commitment to a career in biomedical investigation. The Program director (J. Avruch) is a senior academician/endocrine investigator who governs in conjunction with a committee of experienced endocrine scientists (Habener, Kronenberg, Crowley, Neer, Freeman and Klibanski). The training faculty consists of 46 active, well-funded scientists, whose interests range broadly across the subdisciplines of endocrinology, and from clinical investigation to the regulation of gene expression, protein structural analysis, transmembrane signaling mechanisms, etc. The trainees are supervised closely by a primary faculty mentor, and interact extensively with junior faculty, who often serve as secondary mentors. A carefully evolved and extensive program of didactic sessions complements the research activity. The training period is 2-3 years but may include several years additional experience at junior faculty status, so as to permit consolidation of skills and maximal competitiveness for independent support. The productivity of past trainees during training has been very high overall, as judged by the number and quality of trainee publications. Among the program graduates since 1990 supported by this grant, the majority remain in academia and a substantial number are in the biotechnology/pharmaceutical industry. Among those in academia, about one quarter have achieved independent support equivalent to an RO-1 and nearly one third have achieved transitional independent support, a usual precursor to RO-1 support. The facilities at the MGH are extensive, including an active GCRC, an Institutional Clinical Research Support Program, access to a very large base of endocrine/diabetes patients, and over 40,000 square feet of fully equipped modern laboratory dedicated to our training faculty. The institutional training grant represents the central stabilizing financial element in this program, and is especially critical in enabling M.D. trainees to achieve careers in biomedical investigation      

",Training Program in Endocrinology and Diabetes,,JOSEPH  AVRUCH,1888259
27,6945902,,2005,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PEDIATRICS,5T32AI007007-27,AI007007,UNITED STATES,T32,116133,False,Lawrence J. Prograis,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,2009-08-31T04:00:00Z,,"DESCRIPTION (provided by applicant): This training program has been designed to create a critical mass of faculty who can train Pediatricians to address the problems of allergic and immunologic diseases in children both in the laboratory and in the clinical setting.  The program is based in the Division of Allergy and Immunology in the Department of Pediatrics. The Division is located in the Children's Center of The Johns Hopkins Hospital.  All of the laboratories and offices are contiguous and consist of 7 separate, fully equipped laboratories, 6 faculty offices, 2 secretaries' offices, a Fellows' office, and a library/conference room.  The division is uniquely suited to offer fellowship training in that it is composed of 5 full-time and one 1/2 time investigators with balanced interests; 3 are primarily interested in allergy and 3 are primarily interested in immunology.  In addition, it utilizes the faculty and facilities of other divisions within the University's immunology community, such the Graduate Program in Immunology, the Division of Rheumatology and the Division of Clinical Immunology in the Department of Medicine.  
The program provides 3 years of balanced training in basic and clinical immunology to Pediatricians who will pursue an academic career.  Candidates will have completed a 2-4 year residency in Pediatrics.  They will be selected primarily based upon their commitment to an academic career and their interest in research in the allergic and immunologic diseases of children. Each trainee spends the majority of his/her time in laboratory research (80%), supplemented with course work and limited clinical responsibilities.  A single faculty member acts as the preceptor for a given fellow, supervising his/her laboratory work, helping to select formal course work, and designing a program of clinical activities. The laboratory work focuses on one of the areas in which the faculty is actively involved and includes immunology and Epidemiology of Childhood Asthma (Drs. Eggleston, Wood, Matsui, Lederman, Bochner and Adkinson), the role of immune system in host defense and inflammation (Drs. Lederman, Bochner, Rosen, Sule and Desiderio) and the Primary Immunodeficiency Diseases, (Drs. Lederman, Winkelstein, Sule, Rosen and Desiderio).  Course work includes both a core curriculum designed to give the fellow a strong foundation in basic immunology and elective courses aimed at meeting the special needs of the fellow.  Clinical training focuses on Allergy and Immunology but also includes limited experience in Rheumatology, Pulmonology, and ENT, and is in accord with that specified by the Board of Allergy and Clinical Immunology.",Research Training in Pediatric Allergy and Immunology,,ROBERT A WOOD,6785863
28,7059509,,2005,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,MISCELLANEOUS,3T32HD007014-30S1,HD007014,UNITED STATES,T32,311693,False,Rebecca L Clark,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,2006-04-30T04:00:00Z,,,DEMOGRAPHY AND ECOLOGY,,ALBERTO B. PALLONI,1903062
29,6949293,,2005,BOSTON MEDICAL CENTER,BOSTON,MA,,2T32DK007053-32,DK007053,UNITED STATES,T32,148002,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
The goals of this program are to identify, inspire and train promising candidates for research careers in academic nephrology and to assist qualified trainees in obtaining suitable academic positions. The program is designed to provide physicians heading for careers in academic nephrology the thorough scientific grounding necessary for a successful research career and to attract recent PhD graduates and provide them postdoctoral research training in a scientific discipline relevant to nephrology. Research training will continue for at least two years. On average, three new trainees will enter the program each year.  
The principal mechanism for training is direct performance of research under the personal supervision of one or more of the training staff comprised of nine nephrologists and seven basic scientists. Experienced, interdisciplinary training staff provide training in immunopathology, autoimmunity, renal cell physiology, ischemic and toxic renal injury, gene regulation related to renal cancer and developmental biology, and clinical research relevant to kidney diseases. Well-established collaborative arrangements allow each trainee to acquire a broad research experience and focus a variety of skills on a specific research protocol. Trainees assume graded responsibility for the design, conduct and interpretation of experiments, progressively becoming more independent but always remaining under the supervision of the preceptor. All trainees and staff meet frequently for seminars, journal clubs and other formal group teaching exercises. Coursework leading to a PhD is available in the Graduate Program in Molecular Medicine, and formal training in clinical research is provided through the BU School of Public Health and Division of Graduate Medical Sciences.  
Trainees work in modern, well-equipped laboratory space in the Evans Biomedical Research Center and laboratories of basic science faculty. These are in close proximity to core facilities, modern animal care quarters supervised by a full-time veterinarian, and the BUSPH. The General Clinical Research Center at Boston Medical Center is available for clinical studies      

",RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
30,7082136,,2006,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32DK007012-29,DK007012,UNITED STATES,T32,334485,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
The Endocrinology and Metabolism Training Program at Duke University Medical Center consists of an interactive matrix of several basic science and clinical divisions and departments This program is designed to prepare physicians or medical scientists for research careers in Endocrinology and Metabolism The trainees will be either board-eligible or certified physicians who have trained in internal medicine, pediatrics, or obstetrics/gynecology, or non-physician graduates of science who wish to pursue careers in endocrine/metabolic research Recently, we have instituted changes in the program that include 1) expansion of both basic and clinical research training opportunities, 2) development of separate research training modules, 3) introduction of a program of joint mentorship of trainees, and 4) establishment of didactic programs for both clinical and basic science trainees (the Clinical Research Training Program and the Medical Genomics Training Program) The training modules are designed to expose trainees to some of the most important areas in Endocrinology research today, and afford the opportunity for training with outstanding scientists and mentors These modules range from those solely devoted to basic science (Receptor Signaling and Pharmacology, G Protein-Coupled Receptors) to those with basic and translational/clinical arms (Bone and Mineral Metabolism, Diabetes, Obesity and Nutrient Metabolism, Reproductive Endocrinology and Infertility, Pediatric Endocrinology) and those with a purely clinical orientation (Women's Health, Chronic Disease Management, Hypertension) Training is aimed at promoting the understanding, design and use of biochemical, physiological and molecular biological approaches to endocrine and metabolic problems, as well as proficiency in laboratory and clinical investigation techniques Individuals who complete the program will be capable of independent investigation and translating research accomplishments into important advances with clinical relevanc      

",Endocrinology and Metabolism Training Program,,MARK N FEINGLOS,2058822
31,7092212,,2006,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,PEDIATRICS,5T32DK007087-33,DK007087,UNITED STATES,T32,178134,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  
This application is for renewal of the Prefaculty Training in Pediatric Nephrology program, formally established at the University of Minnesota (U of MN) in 1965. The program's aim is to prepare pediatric nephrologists for academic careers. 1- 3 post-doctoral trainees are selected annually from a pool of candidates who have completed residency in Pediatrics or Pediatrics/Medicine. Training is for 3 or more years. At least 80% of the trainees time is devoted to research under close faculty supervision. The faculty consists of 11 pediatric nephrologists who are all actively engaged in research. Six are principal investigators of NIH grants. Research interests of the group are broad, including renal development, renal cell-matrix interactions, diabetic nephropathy, epidemiology of hypertension and childhood ESRD, drug adherence after renal transplantation, Alport syndrome and glomerular podocyte pathobiology. Laboratories are equipped for studies in molecular biology, electron microscopy, immunohistochemistry, morphometry, cell and organ culture, animal models of renal disease and renal development, epidemiology, and clinical data base management, and are staffed by scientists and technicians who participate in training fellows to perform laboratory procedures. Trainees are schooled in abstract preparation and presentation, and manuscript and grant writing. The program offers numerous research conferences and didactic lectures, and access to the Master of Science Degree Program in Clinical Research. There is a wide range of opportunities for interaction with basic science laboratories throughout the Medical School. Our 3 current fellows and 2 incoming fellows are women. The program has graduated 7 fellows since 1994. All practice Pediatric Nephrology full time, 6 have full time academic faculty appointments, 2 have national funding and 2 have local funding. The program remains deeply committed to the development of academic pediatric nephrologists, who continue to be in short supply throughout the nation, and to the preparation of women and minorities for these positions      

",Prefaculty Training in Pediatric Nephrology,,Clifford E. Kashtan,1874414
32,7080396,,2006,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,GENETICS,5T32GM007133-32,GM007133,UNITED STATES,T32,785838,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2009-06-30T04:00:00Z,,,Predoctoral Training Program in Genetics,,Philip  Anderson,1893729
33,7059927,,2006,UNIVERSITY OF COLORADO DENVER,AURORA,CO,INTERNAL MEDICINE/MEDICINE,5T32HL007085-32,HL007085,UNITED STATES,T32,892350,False,Sandra  Colombini-Hatch,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2010-06-30T04:00:00Z,PA02109,,Multidisciplinary Research Training Respiratory Disease,,Marvin I Schwarz,1963090
34,7058831,,2006,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,BIOCHEMISTRY,5T32GM007135-32,GM007135,UNITED STATES,T32,440395,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2008-06-30T04:00:00Z,,,Creative Training in Molecular Biology,,Kenneth S Krauter,1963175
35,7071246,,2006,STANFORD UNIVERSITY,STANFORD,CA,BIOLOGY,5T32GM007276-31,GM007276,UNITED STATES,T32,1603190,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2009-06-30T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  Our program will direct predoctoral training in cellular and molecular biology at Stanford University.  Exceptional students will be provided with a common training experience that includes:1. Formal course work from a menu of biology foundational and specialized courses taught collaboratively by the training faculty; 2. Seminars and journal clubs; and 3. Exciting thesis research opportunities with exceptional faculty preceptors.  These elements are woven together to provide all trainees with a common training experience.  In addition to the common program elements mentioned above, there are 3 programmatic components exclusively for our trainees.  We have initiated a CBM Research Symposium, a CMB Literature/Seminar course and a CMB Science/Social.  These ""enrichment"" components will enhance program identity and cohesiveness.  
  
The Program Directors and the Executive Committee assure that all committee meetings, course requirements, and exams are completed on schedule and that thesis progress is satisfactory.  They will carefully monitor student progress and compliance with programmatic schedules.  It is our expectation that close monitoring reduce the time necessary to complete the work for a Ph.D.  
  
We expect that our students will continue to be highly successful in careers in biomedical research and many will become leaders.  
      

",Cellular and Molecular Biology Training Program,,ROBERT D SIMONI,1859078
36,2414038,,1997,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32CA009140-23,CA009140,UNITED STATES,T32,503803,False,,National Cancer Institute,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,,IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES,,YVONNE J PATERSON,1877881
37,2409348,,1997,YALE UNIVERSITY,NEW HAVEN,CT,PSYCHIATRY,5T32MH014276-23,MH014276,UNITED STATES,T32,182485,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,RESEARCH TRAINING - BIOLOGICAL SCIENCES,,RONALD S. DUMAN,1865048
38,2379517,,1997,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-22,NS007044,UNITED STATES,T32,230793,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,NEUROSCIENCE TRAINING GRANT,,Kenneth J Muller,7684521
39,2331712,,1997,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,BIOCHEMISTRY,5T32GM007185-23,GM007185,UNITED STATES,T32,623549,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,RESEARCH TRAINING IN CELLULAR AND MOLECULAR BIOLOGY,,STEVEN G CLARKE,1863373
40,2331707,,1997,UNIVERSITY OF CHICAGO,CHICAGO,IL,PHARMACOLOGY,5T32GM007151-23,GM007151,UNITED STATES,T32,171946,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,RICHARD J MILLER,6232691
41,2331702,,1997,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PHYSIOLOGY,5T32GM007108-23,GM007108,UNITED STATES,T32,188857,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,INSTITUTIONAL GRANT FOR NEUROBIOLOGY,,WAYNE E. CRILL,1901429
42,2332142,,1997,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,SOCIAL SCIENCES,5T32HD007014-23,HD007014,UNITED STATES,T32,175976,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,,DEMOGRAPHY AND ECOLOGY,,FRANKLIN D. WILSON,6606405
43,2331741,,1997,PRINCETON UNIVERSITY,PRINCETON,NJ,BIOCHEMISTRY,5T32GM007312-23,GM007312,UNITED STATES,T32,465195,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,THOMAS E SHENK,1894197
44,2331736,,1997,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,MISCELLANEOUS,5T32GM007287-23,GM007287,UNITED STATES,T32,1828693,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCES,,FRANK E SOLOMON,1883096
45,2331716,,1997,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-23,GM007200,UNITED STATES,T32,1342403,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTIST,,Daniel E. Goldberg,1930486
46,2331735,,1997,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,BIOCHEMISTRY,5T32GM007283-23,GM007283,UNITED STATES,T32,455234,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,David M. Kranz,1879633
47,2332144,,1997,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,ANATOMY/CELL BIOLOGY,5T32HD007029-23,HD007029,UNITED STATES,T32,114023,False,STEVEN  KLEIN,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,1999-06-30T04:00:00Z,,,DEVELOPMENTAL MECHANISMS UNDERLYING CONGENITAL DEFECTS,,HANS R BODE,1955156
48,2331708,,1997,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOCHEMISTRY,5T32GM007170-23,GM007170,UNITED STATES,T32,1332571,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,Glen N. Gaulton,2432778
49,2331528,,1997,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,PUBLIC HEALTH & PREV MEDICINE,5T32ES007015-20,ES007015,UNITED STATES,T32,249403,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY PREDOCTORAL AND POSTDOCTORAL,,COLIN ROBERT JEFCOATE,6695885
0,6498637,,2002,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,BIOLOGY,5T32GM007287-28,GM007287,UNITED STATES,T32,2557944,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,PRE-DOCTORAL TRAINING GRANT IN THE BIOLOGICAL SCIENCES,,ALAN D GROSSMAN,1859694
1,6498605,,2002,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,BIOCHEMISTRY,5T32GM007215-27,GM007215,UNITED STATES,T32,1202932,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,GRADUATE TRAINING IN MOLECULAR BIOSCIENCES,,DAVID A BROW,1927890
2,6498602,,2002,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,PHARMACOLOGY,5T32GM007198-28,GM007198,UNITED STATES,T32,868601,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,PAUL A INSEL,1881196
3,6498597,,2002,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,ANATOMY/CELL BIOLOGY,5T32GM007226-28,GM007226,UNITED STATES,T32,558089,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,," DESCRIPTION: (provided by applicant) This application is a request for funds to    
 continue to support the training of graduate students in Cell and Developmental    
 Biology at Harvard Medical School. Trainee support under this grant is             
 primarily for first and second year students, but under unusual circumstances      
 is used to support advanced students. These students are selected based on         
 their potential for cell and developmental biology research. The program           
 outlined in this proposal will support the graduate training of 23 Ph.D.           
 students (about 13% of the enrolled first and second year students). Research      
 activities in cell and developmental biology focuses on understanding the          
 properties that enable cells of higher organisms to grow tissues and organs and    
 the molecular processes that underlie the development of complex organisms. The    
 program in Cell and Developmental Biology of Harvard Medical School is one of      
 the major components of the Biological and Biomedical Sciences program (BBS).      
 This is a transdepartmental graduate program with 299 graduate students and 230    
 faculty. Our student pool has improved markedly in their preparation and           
 qualifications. Our faculty members are from the departments of Biological         
 Chemistry and Molecular Pharmacology, Cell Biology, Genetics, Microbiology and     
 Molecular Genetics, and Pathology at Harvard Medical School. The research          
 activities of the program faculty on this training grant are concentrated in       
 the following areas: development in metazoans and differentiation of cells (16     
faculty), the cell cycle (14 faculty), cell death (3 faculty), signal              
 transduction in developing systems (29 faculty), trafficking, the cytoskeleton,    
 and cell asymmetry (15 faculty), proteolysis during the cell cycle and cell        
 morphogenesis (3 faculty). The training program utilizes a multi-disciplinary      
 approach based on class work, an extensive seminar and meeting program, and a      
 vigorous research environment to educate students. Students admitted to the        
 program have previous training in biology, biochemistry, molecular biology,        
 genetics, microbiology, cell biology, or chemistry. This graduate research         
 program leads to the awarding of a Doctorate of Philosophy. Students               
 participate in both required and elective courses in the first and second years    
 of training. Courses are selected in consultation with faculty preceptors who      
 advise and direct students until they have their own advisory committees.          
 Students in the program are required to take eight graduate courses and to         
 conduct three rotations in different laboratories. Before starting their thesis    
 work the students must acquire a strong background in biochemistry and cell        
 biology and they must pass a qualifying examination in which they write and        
 defend a research proposal.",CELLULAR AND DEVELOPMENTAL BIOLOGY,,MARC Wallace KIRSCHNER,1863369
4,6498591,,2002,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOMEDICAL ENGINEERING,5T32GM007057-28,GM007057,UNITED STATES,T32,469362,False,Alison E. Cole,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING TRAINING PROGRAM,,Eric Daniel Young,1877392
5,6498585,,2002,UNIVERSITY OF WASHINGTON,SEATTLE,WA,SURGERY,5T32GM007037-28,GM007037,UNITED STATES,T32,224924,False,Scott D. Somers,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING,,Ronald Vitt Maier,1898321
6,6498220,,2002,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,INTERNAL MEDICINE/MEDICINE,5T32ES007020-28,ES007020,UNITED STATES,T32,412888,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGY,,JOHN M ESSIGMANN,1864810
7,6498577,,2002,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32GM007170-28,GM007170,UNITED STATES,T32,1667949,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,LAWRENCE F BRASS,6125110
8,6498574,,2002,UNIVERSITY OF CHICAGO,CHICAGO,IL,GENETICS,5T32GM007183-28,GM007183,UNITED STATES,T32,1394024,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,Molecular and Cellular Biology Training Grant,,HARINDER  SINGH,1978275
9,6498570,,2002,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,BIOCHEMISTRY,5T32GM007185-28,GM007185,UNITED STATES,T32,917769,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"                                                                                    
 DESCRIPTION: (provided by applicant) This proposal seeks renewal for UCLA's        
 predoctoral Cellular and Molecular Biology Training Program. Now in its 26th       
 year, the program has trained more than 350 Ph.D. candidates for careers in        
 biomedical research and education. The program is interdepartmental and            
 includes faculty and students in the Departments of Chemistry and Biochemistry     
 and Molecular, Cell and Developmental Biology in the College of Letters and        
 Sciences, the Departments of Biological Chemistry, Microbiology, Immunology and    
 Molecular Genetics, and Neurobiology in the School of Medicine, as well as the     
 Interdepartmental Program in Molecular Biology. There are currently 84 training    
 faculty with primary appointments in 10 departments. Major research areas          
 include biochemistry, cell biology, developmental biology, gene expression,        
 macromolecular structure, molecular and cellular immunology, neurobiology,         
 virology and microbial pathology.                                                  
                                                                                    
 Representatives of each of the six major Ph.D. degree programs involved            
 nominate trainees for the program. Students are selected on a highly               
 competitive basis using the criteria of their academic and research                
 achievements. Appointments are made for a maximum period of three years. A         
 small number of students enter the training program as first year students;        
 however, the bulk of them come in after a year of graduate work when they have     
 chosen their dissertation research director. In addition to meeting the            
 University and Departmental or Program requirements for their degrees, trainees    
 participate in a research ethics course, as well as in seminars and conferences    
 organized by the Training Program. This proposal requests stipends for 45          
 trainees.                                                                          
                                                                                    
 The facilities are those of a major undergraduate and graduate campus of           
 approximately 33,000 students that includes a medical school faculty. All of       
 the departments involved in this program are in close proximity to each other      
 and to the interdepartmental Molecular Biology Institute, which facilitates        
 interactions of both students and faculty.                                         
                                                                                    
",RESEARCH TRAINING IN CELLULAR AND MOLECULAR BIOLOGY,,STEVEN G CLARKE,1863373
10,6634790,,2003,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32DK007120-29,DK007120,UNITED STATES,T32,445943,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
11,6632559,,2003,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,INTERNAL MEDICINE/MEDICINE,5T32AR007055-29,AR007055,UNITED STATES,T32,133359,False,Deborah N Ader,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2006-04-30T04:00:00Z,," DESCRIPTION: (Taken from the applicant's abstract) The purpose of the Program      
 is to train postdoctoral fellows for full-time academic careers in rheumatology    
 research. Trainees will be prepared for research and teaching in the               
 subspecialty. The training will primarily revolve around laboratory or clinical    
 investigation and didactic training in rheumatology research to provide a          
 background for a career in academic rheumatology investigation. Currently the      
 Training Program has a faculty of 18 persons from the Departments of Internal      
 Medicine, Dermatology, Immunology, Pediatrics and Orthopedics. There are           
 currently 17 postdoctoral fellows in training. Research training in immunology,    
 molecular biology, cell biology and clinical trial design is available.            
 Trainees are assigned to one of the full-time faculty members for direct           
 supervision of research progress. Each trainee works closely with his              
 supervisor for day-to-day guidance in the design of experiments, utilization of    
 appropriate methodology, and data analysis. The training director provides         
 overall supervision for the direction of the research by maintaining close         
 contact both with the trainee and with his/her supervisor. In addition to          
 his/her research activity, the trainee will receive clinical training, when        
 appropriate in both outpatient and inpatient environments. He/she will also        
 attend a weekly research-in-progress conference, and a weekly basic science        
 journal club. In addition, regular seminars and clinical conferences of the        
 Department of Internal Medicine and research seminars and conferences of the       
 Immunology Program are available. Trainees will have M.D. or Ph.D. degrees. The    
 Training Program will be carried out in the laboratories of the Rheumatic          
 Diseases Division of the Department of Internal Medicine and the Harold C.         
 Simmons Arthritis Research Center, University of Texas Southwestern Medical        
 Center.",Basic and Clinical Rheumatology,,JOEL D TAUROG,1866799
12,6635597,,2003,BAYLOR COLLEGE OF MEDICINE,HOUSTON,TX,OPHTHALMOLOGY,5T32EY007001-28,EY007001,UNITED STATES,T32,131881,False,CHYREN  HUNTER,National Eye Institute,1975-07-01T04:00:00Z,2006-02-28T05:00:00Z,," DESCRIPTION: (Applicant's Abstract) Sixteen vision researchers at Baylor           
 College of Medicine with 14 active and 7 pending NEI grants apply for              
 continuation of a training program for visual sciences begun in 1975. The          
 objective of this program is to provide a laboratory-based research experience     
 to predoctoral students (4 per year) and postdoctoral fellows (2 per year) who     
 are interested in pursuing careers in vision research. Trainees will have          
 opportunities to do research in the broad disciplines of molecular biology,        
 biochemistry, developmental biology, structural and computational biology, cell    
 biology, neurophysiology, and psychophysics. The sixteen preceptors have           
 research interests covering almost the entire visual system (lens and cornea,      
 retina, LGN and cortex, and visual system development). The emphasis of this       
 training program is to create an interacting training environment so that          
 trainees can receive multi-disciplinary training and comprehensive knowledge of    
 the entire visual system. Predoctoral trainees are recruited to vision research    
 labs through seven Ph.D. graduate student programs (total enrollment of 243).      
 Each trainee participates in vigorous and comprehensive training programs          
 including formal courses, qualifying exams, lab rotations, seminars, journal       
 clubs and research. There are 323 postdoctoral trainees in the eight               
 participating departments of this Training Grant, and they participate in many     
 organized postdoctoral training activities including active inter-departmental     
 collaborations, seminars, vision research courses, grand rounds and journal        
 clubs. Dr Samuel Wu, who is assisted by three committees (the Steering             
 Committee, Recruitment/Ad mission Committee, and the Academic Progress             
 Committee) directs the Training Program. The 16 vision research labs occupy        
 over, 25,000 sq. ft. All 16 preceptors and. their trainees are members of an       
 NEI-funded Core grant (EY02520), which consists of three modules (Confocal and     
 Digital Imaging, Electron Microscopy and Histology, and Machine Shop) located      
 at the Cullen Eye Institute (about 2,900 sq. ft.) within 3 minutes walk from       
 all labs. Additionally, there are large core animal facilities (including          
 primate, mouse and xenopus facilities) available for vision researchers in this    
 Training Program. Our goal is to produce outstanding vision researchers to face    
 scientific and medical challenges in the 21st century.",RESEARCH TRAINING IN VISUAL SCIENCES,,Samuel M Wu,7354218
13,6644211,,2003,UNIVERSITY OF WASHINGTON,SEATTLE,WA,DENTISTRY,5T32DE007023-27,DE007023,UNITED STATES,T32,438479,False,Kevin S Hardwick,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"
DESCRIPTION (provided by applicant):   
This Research Training Grant renewal application is an extensively revised resubmission of our initial proposal to support cross-disciplinary and comprehensive dental science research training at the School of Dentistry at the University of Washington. The application constitutes the competing renewal of the former Oral Biology-Salivary Research Training and the Bacterially Induced Chronic Inflammation Research Training grants. The revised application consists of a single research training facility and program, focused on using molecular and cell biology and bioengineering approaches to study the basic biology of the oral tissues and their reactions to microbial pathogens and inert materials. The Program is administered by a Program Coordinator, and directed by a Program Oversight Committee. The collaborating Training Faculty include individuals from the Schools of Dentistry, Medicine, Public Health and the Department of Bioengineering; and are organized into 12 groups based on research interests. The proposed training program consists of two phases: 1) All trainees will receive coursework in the major competency areas cited in the PA including: genomics, molecular biology and molecular epidemiology, gene-mediated diagnosis and therapeutics, cell biology, bioinformatics, biomaterials, biomimetics, nanotechnology, tissue engineering and bioimaging technology. Coursework will also include experimental design and data analysis, and dental sciences. PhD students will receive the most training; MS and short-term trainees will receive less. 2) All trainees will learn to perform biological experiments using molecular and cell biology and/or bioengineering approaches by designing and performing experiments under the direction of a Research Mentor chosen from the proposed training faculty. A total of 12.75 training positions are requested, of which 6 are postdoctoral and 5 are predoctoral long term positions, 1.5 are short term positions for dental students, and 0.25 are short term positions for new and midcareer dental school faculty. Although long term trainees may elect to matriculate in a PhD or MS (dentists only) programs in 6 departments, Oral Biology and Bioengineering are expected to have highest enrollments. Courses to be taken in conjunction with this training are described in some detail.",Cross-Disciplinary Dental Science Research Training,,Kenneth T Izutsu,1877343
14,6190727,,2000,VANDERBILT UNIVERSITY,NASHVILLE,TN,INTERNAL MEDICINE/MEDICINE,2T32DK007061-27,DK007061,UNITED STATES,T32,221003,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
15,6315149,,2000,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,3T32HL007151-21S1,HL007151,UNITED STATES,T32,51076,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,,RESEARCH IN THE PATHOGENESIS OF HEMATOLOGIC DISORDERS,,SIMON  KARPATKIN,1857754
16,6314680,,2000,MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,3T32AA007275-21S1,AA007275,UNITED STATES,T32,49726,False,ERNESTINE  VANDERVEEN,National Institute on Alcohol Abuse and Alcoholism,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,PATHOGENESIS AND TREATMENT OF ALCOHOL INDUCED DISEASES,,CHARLES S LIEBER,1878147
17,6409841,,2002,YALE UNIVERSITY,NEW HAVEN,CT,PHARMACOLOGY,2T32GM007324-26,GM007324,UNITED STATES,T32,234627,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"
DESCRIPTION (provided by applicant): The purpose of the training program is to
provide education in the pharmacological sciences and to train students in the
philosophies, strategies and techniques of modern biological research.
Graduates of this program in the past have obtained postdoctoral research
experiences and then taken position at universities, government laboratories or
industrial research laboratories. There are twenty-five faculty associated with
the program and thirty-five students currently in the graduate program in
pharmacological sciences. When a student has completed the requirements for the
Ph.D. degree, he or she will:
1 Have a basic understanding of areas closely allied to pharmacological
sciences including physiology, molecular biology and biochemistry.
2 Have broad background knowledge in pharmacological sciences.
3 Possess advanced knowledge in the specialty of the pharmacological
sciences concerned with is or her dissertation research.
4 Have demonstrated the ability to design and perform research of high
quality and communicate the results to others in a lucid manner.
The program is characterized by the size and excellence of its faculty, the
breadth and depth of research training opportunities and an exceptionally rich
environment for education and research in the biological sciences.",Institutional National Research Service Award,,William C Sessa,1862877
18,6380224,,2001,YALE UNIVERSITY,NEW HAVEN,CT,INTERNAL MEDICINE/MEDICINE,5T32DK007058-27,DK007058,UNITED STATES,T32,241982,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,"This proposal seeks continued support for the Yale research training program in Diabetes Mellitus and Disorders of Metabolism. The application seeks maintenance of the current level of funding (5 stipends per year) to serve as the core source of support for postdoctoral research training in diabetes and endocrinology at the Yale School of Medicine. The request is based on our record of attracting a strong applicant pool for this program, the high level of research productivity of the training faculty, and the continuing shortage of physician-scientists in both adult and pediatric endocrinology/diabetes. A major goal of the program is to develop physician-scientists who possess the requisite laboratory skills to pursue and compete effectively in academic medicine. Physician trainees entering the program will have an M.D. or M.D./Ph.D. degree and at least 2-3 years of clinical training in medicine or pediatrics. Ph.D. scientists are also recruited to the program since we believe their participation is critical to the training environment. Heavy emphasis in the selection process is given to those applications demonstrating potential and desiring research training for a career in clinical investigation. The duration of the training period is three years so as to provide a more in-depth training experience. The cornerstone of the curriculum involves the participation by the trainee in a specific laboratory project under the direction of a designated preceptor. The research projects offered span the gamut from clinical investigation to basic science and are designed to develop the laboratory skills required for a faculty appointment in internal medicine, pediatrics, or in a basic science department. The scope of the program has been expanded to provide the trainees with greater exposure to state-of-the-art laboratory techniques. Research opportunities are available in three major areas: 1) pathophysiology of diabetes, 2) immunology of diabetes, and 3) developmental and bone biology. Trainees have the opportunity to participate in ongoing projects involving collaborations with basic science departments in genetics, cell biology and immunobiology. Close interactions among preceptors within each programmatic area serve to further enrich the training experience. Instruction is also provided by means of an organized series of lectures, research seminars, and journal clubs. ",DIABETES MELLITUS AND DISORDERS OF METABOLISM,,ROBERT S SHERWIN,1882029
19,6380223,,2001,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,INTERNAL MEDICINE/MEDICINE,5T32DK007053-28,DK007053,UNITED STATES,T32,138058,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
20,6538387,,2002,YALE UNIVERSITY,NEW HAVEN,CT,PUBLIC HEALTH & PREV MEDICINE,5T32MH014235-28,MH014235,UNITED STATES,T32,252016,False,Mark  Chavez,National Institute of Mental Health,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,"
 DESCRIPTION (Adapted from the Applicant's Abstract): The present application is    
 for continued support for Research Training in Mental Health Epidemiology          
 (originally, Research Training in Psychosocial Epidemiology). The major goal of    
 the program is to provide rigorous training in the application of epidemiologic    
 methods to psychosocial and psychiatric research. Since its inception in 1975,     
 this program has had an unusual degree of stability in its core training           
 faculty and overall objectives. Students who have participated in this program     
 have demonstrated outstanding success in developing careers with important         
 contributions to psychiatric and psychosocial epidemiology. Dr. Stan Kasl has      
 been the Principal Investigator since 1975; however, Dr. Kathleen Merikangas       
 now will take over as Program Director and Dr. Kasl will become Co-Director.       
 The major components of the training include faculty mentoring, formal course      
 work in epidemiology, applied research experience, and clinical practica, where    
 relevant. The present application requests support for 4 pre-doctoral and 4        
 post-doctoral trainees. Trainees will be recruited to represent the following      
 focal areas: psychosocial epidemiology, psychiatric epidemiology, genetic          
 epidemiology, and biostatistics. The substantive areas of expertise in this        
 program include links between psychosocial risk factors, psychopathology and       
 chronic diseases, comorbidity of psychiatric disorders and substance abuse,        
 genetic epidemiology of behavioral and emotional disorders, and a new future       
 direction of prevention. Faculty interests cover all stages of the life span       
 ranging from childhood to late life. Strengths of this program include: (1) the    
 availability of an excellent formal academic program in the Department of          
 Epidemiology and Public Health including programs in Chronic Disease               
 Epidemiology, Biostatistics, and strong links with other departments including     
 Psychiatry, Psychology and Genetics; (2) an extensive network of ongoing           
 research in diverse areas and across all levels of epidemiology including          
 descriptive, analytic and intervention to provide direct experience in research    
 in psychiatric epidemiology; (3) an interdisciplinary faculty with extensive       
 experience in domains of relevance to psychiatric research including               
 epidemiology, biostatistics, genetics, health policy and services, clinical        
 psychiatry, clinical psychology, developmental psychology and sociology; and       
 (4) focus on four disciplinary areas and four specialty areas that are of          
 critical importance to advances in contemporary psychiatry. Formal training,       
 mentorship, and extensive research experience will provide trainees with the       
 requisite methodologic and substantive tools to conduct high quality research      
 in psychiatry. Exposure to diverse specialty areas both within and between the     
 current program and other ongoing training initiatives will provide a broader      
 perspective on the substantive areas of psychiatric research and appreciation      
 of the need for an interdisciplinary approach that is critical to future           
 progress in understanding the pathogenesis and impact of mental disorders.         
                                                                                    
                                                                                    
                                                                                    
",RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
21,6665309,,2003,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,PEDIATRICS,5T32DK007087-30,DK007087,UNITED STATES,T32,121349,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY,,S. Michael Mauer,2295322
22,6391843,,2001,YALE UNIVERSITY,NEW HAVEN,CT,PUBLIC HEALTH & PREV MEDICINE,5T32MH014235-27,MH014235,UNITED STATES,T32,267950,False,Mark  Chavez,National Institute of Mental Health,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,"
 DESCRIPTION (Adapted from the Applicant's Abstract): The present application is    
 for continued support for Research Training in Mental Health Epidemiology          
 (originally, Research Training in Psychosocial Epidemiology). The major goal of    
 the program is to provide rigorous training in the application of epidemiologic    
 methods to psychosocial and psychiatric research. Since its inception in 1975,     
 this program has had an unusual degree of stability in its core training           
 faculty and overall objectives. Students who have participated in this program     
 have demonstrated outstanding success in developing careers with important         
 contributions to psychiatric and psychosocial epidemiology. Dr. Stan Kasl has      
 been the Principal Investigator since 1975; however, Dr. Kathleen Merikangas       
 now will take over as Program Director and Dr. Kasl will become Co-Director.       
 The major components of the training include faculty mentoring, formal course      
 work in epidemiology, applied research experience, and clinical practica, where    
 relevant. The present application requests support for 4 pre-doctoral and 4        
 post-doctoral trainees. Trainees will be recruited to represent the following      
 focal areas: psychosocial epidemiology, psychiatric epidemiology, genetic          
 epidemiology, and biostatistics. The substantive areas of expertise in this        
 program include links between psychosocial risk factors, psychopathology and       
 chronic diseases, comorbidity of psychiatric disorders and substance abuse,        
 genetic epidemiology of behavioral and emotional disorders, and a new future       
 direction of prevention. Faculty interests cover all stages of the life span       
 ranging from childhood to late life. Strengths of this program include: (1) the    
 availability of an excellent formal academic program in the Department of          
 Epidemiology and Public Health including programs in Chronic Disease               
 Epidemiology, Biostatistics, and strong links with other departments including     
 Psychiatry, Psychology and Genetics; (2) an extensive network of ongoing           
 research in diverse areas and across all levels of epidemiology including          
 descriptive, analytic and intervention to provide direct experience in research    
 in psychiatric epidemiology; (3) an interdisciplinary faculty with extensive       
 experience in domains of relevance to psychiatric research including               
 epidemiology, biostatistics, genetics, health policy and services, clinical        
 psychiatry, clinical psychology, developmental psychology and sociology; and       
 (4) focus on four disciplinary areas and four specialty areas that are of          
 critical importance to advances in contemporary psychiatry. Formal training,       
 mentorship, and extensive research experience will provide trainees with the       
 requisite methodologic and substantive tools to conduct high quality research      
 in psychiatry. Exposure to diverse specialty areas both within and between the     
 current program and other ongoing training initiatives will provide a broader      
 perspective on the substantive areas of psychiatric research and appreciation      
 of the need for an interdisciplinary approach that is critical to future           
 progress in understanding the pathogenesis and impact of mental disorders.         
                                                                                    
                                                                                    
                                                                                    
",RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
23,6452432,,2001,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,3T32GM007229-26S1,GM007229,UNITED STATES,T32,1,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGY,,RICHARD M SCHULTZ,1876102
24,6343314,,2001,UNIVERSITY OF CALIFORNIA DAVIS,DAVIS,CA,INTERNAL MEDICINE/MEDICINE,5T32HL007013-24,HL007013,UNITED STATES,T32,112365,False,Ann E. Rothgeb,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,TRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINE,,CARROLL E CROSS,6999203
25,6343316,,2001,WEILL MEDICAL COLLEGE OF CORNELL UNIV,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007029-27,HL007029,UNITED STATES,T32,118203,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY,,Roy L Silverstein,1893827
26,6350941,,2001,CASE WESTERN RESERVE UNIVERSITY,CLEVELAND,OH,PHARMACOLOGY,5T32GM007250-26,GM007250,UNITED STATES,T32,1125517,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,Clifford V Harding,1888529
27,6350936,,2001,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-27,GM007200,UNITED STATES,T32,2096328,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,NATIONAL RESEARCH SCIENCE AWARD - MEDICAL SCIENTIST,,Daniel E. Goldberg,1930486
28,6350930,,2001,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32GM007170-27,GM007170,UNITED STATES,T32,1897300,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,LAWRENCE F BRASS,6125110
29,6350929,,2001,STANFORD UNIVERSITY,STANFORD,CA,BIOLOGY,5T32GM007149-25,GM007149,UNITED STATES,T32,197052,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,PREDOCTORAL PHARMACOLOGY TRAINING PROGRAM,,HELEN M BLAU,1858519
30,6350925,,2001,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,5T32GM007127-27,GM007127,UNITED STATES,T32,424677,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,POSTGRADUATE TRAINING PROGRAM IN GENETICS,,Michael Steven Levine,1880328
31,6350921,,2001,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,PATHOLOGY,5T32GM007092-27,GM007092,UNITED STATES,T32,233944,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,NRSA IN GENETICS,,Susan T Lord,7944013
32,6350913,,2001,ALBANY MEDICAL COLLEGE,ALBANY,NY,PHYSIOLOGY,5T32GM007033-25,GM007033,UNITED STATES,T32,116009,False,Scott D. Somers,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,"DESCRIPTION:  The program will now offer two years of basic science training for surgical  residents who have completed at least two or three years of their residencies,  with the highest priority given to qualified physicians from approved surgical  residency programs at other institutions and lower priority given to AMC  surgical candidates.  Recruitment of qualified surgery residents will be achieved through the extensive network that Dr. Saba and the former trainees  from this program have established with surgical programs throughout the  country.  Qualified applicants recommended by the advisory committee and whose  research interests match those of the faculty members will be invited to AMC  for interviews.  The advisory committee, in conjunction with Drs. Saba and  McKeown- Longo, will offer traineeships to selected candidates. ",BASIC SCIENCE TRAUMA RESEARCH TRAINING,,THOMAS G SABA,1895251
33,6350761,,2001,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,INTERNAL MEDICINE/MEDICINE,5T32ES007020-27,ES007020,UNITED STATES,T32,447678,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGY,,JOHN M ESSIGMANN,1864810
34,6350758,,2001,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,PUBLIC HEALTH & PREV MEDICINE,5T32ES007015-24,ES007015,UNITED STATES,T32,345706,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,"DESCRIPTION: The environmental toxicology training program at the University of Wisconsin at Madison has been receiving support for the past 21 years. The training grant is administered by the Environmental Toxicology Center which is directed by Dr. Colin R. Jefcoate. The training program is actively managed by Dr. Jefcoate, the Program Director, and the Training Grant Committee. The committee is made up of six members selected from the 19 trainers from the program to serve three-year terms on a rotation basis. The committee also represents the special interest of the training grant with the Environmental Toxicology Center with respect to important training issues. The standing committees in the Center are responsible for standardized admission and curriculum activities. The standing committees are: Admission Committee, Graduate Achievement and Curriculum Committee and Steering Committee. The training faculty of the program consists of 19 individuals from 10 departments. All but four of them are also members of the Environmental Toxicology Center. In addition, most of them are also members of the proposed NIEHS Center for Developmental and Molecular Toxicology. The trainees will be educated in a curriculum involving biochemistry, genetics and cell biology disciplines. In addition to identifying immunotoxicology and neurotoxicology as new areas of toxicology during the last grant application, developmental toxicology will be developed as a new educational component for the trainees in this application. The application requests funding for eight predoctoral and two postdoctoral positions for five years. After admission to the program, predoctoral students typically select a mentor during the first semester rotation through three laboratories. The selection is based mainly on matching the interest between the student and the faculty as well as the funding support of the faculty. After selection of a laboratory, trainees typically work alongside a senior graduate student or postdoctoral associate who is working on a related topic. A research advisory committee will then be set up for each student. Trainees meet with advisors regularly, at least once per week to discuss course work and research. The curriculum for the NIEHS predoctoral trainees is being revised. Each of the required core courses: Toxicology I and II, Ecotoxicology and Chemicals in the Environment, has been or being revised. Each course is being established in a modular format with three one-credit modules. This revision is supposed to provide more flexibility for Ph.D. students. For example, it is under review that the NIEHS predoctoral trainees may take all modules of the two courses in Toxicology but only four or six modules from the other two core courses. The trainees will also take advanced courses: a two credit advanced course on Molecular Approaches to Toxicant Metabolism and two one credit Advanced Workshop courses. A new advanced course in Developmental Toxicology is being developed and the trainees are expected to take this course also. The remaining requirements for the trainees are six credits of Biochemistry and one credit/semester of Toxicology seminar. After completion of the courses, trainees will take a rigorous three-part Preliminary Examination. Their progress in research will be supervised by the Research Advisory Committee. A special training experience for the NIEHS postdoctoral trainees is that they meet regularly with a group of trainers and must write a proposal early in the support period for external support. These trainees present their research on a regular basis at the Environmental Toxicology Center evening meetings and at least once in the regular program seminar series. In addition, they submit a brief annual report on their research progress which stresses the toxicological relevance of the research. ",ENVIRONMENTAL TOXICOLOGY PREDOCTORAL AND POSTDOCTORAL,,B LYNN ALLEN-HOFFMANN,1877749
35,2872400,,1999,STANFORD UNIVERSITY,STANFORD,CA,INTERNAL MEDICINE/MEDICINE,5T32GM007065-25,GM007065,UNITED STATES,T32,15894,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN CLINICAL PHARMACOLOGY,,TERRENCE FRANCIS BLASCHKE,1955228
36,2872274,,1999,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,PUBLIC HEALTH & PREV MEDICINE,5T32ES007015-22,ES007015,UNITED STATES,T32,315979,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,"DESCRIPTION: The environmental toxicology training program at the University of Wisconsin at Madison has been receiving support for the past 21 years. The training grant is administered by the Environmental Toxicology Center which is directed by Dr. Colin R. Jefcoate. The training program is actively managed by Dr. Jefcoate, the Program Director, and the Training Grant Committee. The committee is made up of six members selected from the 19 trainers from the program to serve three-year terms on a rotation basis. The committee also represents the special interest of the training grant with the Environmental Toxicology Center with respect to important training issues. The standing committees in the Center are responsible for standardized admission and curriculum activities. The standing committees are: Admission Committee, Graduate Achievement and Curriculum Committee and Steering Committee. The training faculty of the program consists of 19 individuals from 10 departments. All but four of them are also members of the Environmental Toxicology Center. In addition, most of them are also members of the proposed NIEHS Center for Developmental and Molecular Toxicology. The trainees will be educated in a curriculum involving biochemistry, genetics and cell biology disciplines. In addition to identifying immunotoxicology and neurotoxicology as new areas of toxicology during the last grant application, developmental toxicology will be developed as a new educational component for the trainees in this application. The application requests funding for eight predoctoral and two postdoctoral positions for five years. After admission to the program, predoctoral students typically select a mentor during the first semester rotation through three laboratories. The selection is based mainly on matching the interest between the student and the faculty as well as the funding support of the faculty. After selection of a laboratory, trainees typically work alongside a senior graduate student or postdoctoral associate who is working on a related topic. A research advisory committee will then be set up for each student. Trainees meet with advisors regularly, at least once per week to discuss course work and research. The curriculum for the NIEHS predoctoral trainees is being revised. Each of the required core courses: Toxicology I and II, Ecotoxicology and Chemicals in the Environment, has been or being revised. Each course is being established in a modular format with three one-credit modules. This revision is supposed to provide more flexibility for Ph.D. students. For example, it is under review that the NIEHS predoctoral trainees may take all modules of the two courses in Toxicology but only four or six modules from the other two core courses. The trainees will also take advanced courses: a two credit advanced course on Molecular Approaches to Toxicant Metabolism and two one credit Advanced Workshop courses. A new advanced course in Developmental Toxicology is being developed and the trainees are expected to take this course also. The remaining requirements for the trainees are six credits of Biochemistry and one credit/semester of Toxicology seminar. After completion of the courses, trainees will take a rigorous three-part Preliminary Examination. Their progress in research will be supervised by the Research Advisory Committee. A special training experience for the NIEHS postdoctoral trainees is that they meet regularly with a group of trainers and must write a proposal early in the support period for external support. These trainees present their research on a regular basis at the Environmental Toxicology Center evening meetings and at least once in the regular program seminar series. In addition, they submit a brief annual report on their research progress which stresses the toxicological relevance of the research. ",ENVIRONMENTAL TOXICOLOGY PREDOCTORAL AND POSTDOCTORAL,,B LYNN ALLEN-HOFFMANN,1877749
37,2857584,,1999,UNIVERSITY OF IOWA,IOWA CITY,IA,INTERNAL MEDICINE/MEDICINE,5T32HL007121-25,HL007121,UNITED STATES,T32,394323,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,INTERDISCIPLINARY CARDIOVASCULAR RESEARCH FELLOWSHIP,,FRANCOIS M ABBOUD,1864622
38,2857583,,1999,WAKE FOREST UNIVERSITY HEALTH SCIENCES,WINSTON-SALEM,NC,PATHOLOGY,5T32HL007115-25,HL007115,UNITED STATES,T32,180618,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,CARDIOVASCULAR PATHOLOGY,,Richard W ST CLAIR,1884537
39,2857577,,1999,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,ENGINEERING (ALL TYPES),5T32HL007089-25,HL007089,UNITED STATES,T32,247010,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-05-31T04:00:00Z,,,CARDIOVASCULAR BIOENGINEERING SCIENCE,,SHU  CHIEN,1876594
40,2857571,,1999,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,PUBLIC HEALTH & PREV MEDICINE,5T32HL007055-23,HL007055,UNITED STATES,T32,266675,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2002-05-31T04:00:00Z,,,CARDIOVASCULAR  EPIDEMIOLOGY TRAINING,,Gerardo  Heiss,1876480
41,2857570,,1999,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,INTERNAL MEDICINE/MEDICINE,5T32HL007035-24,HL007035,UNITED STATES,T32,641473,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,BIOLOGY OF THE LUNG: A MULTIDISCIPLINARY PROGRAM,,Jerome S Brody,1903039
42,2857565,,1999,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,INTERNAL MEDICINE/MEDICINE,5T32HL007022-24,HL007022,UNITED STATES,T32,336362,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,"The purpose of this NHLBI Institutional Research Training Program at            
UCSD, which has maintained a positive record over some 20 years, remains        
unchanged. The goal is to prepare carefully selected physicians of high         
investigative potential, who have completed their clinical training, for        
productive research careers. The centerpiece of this training effort is         
direct involvement by trainees in research, under the preceptorship of          
experienced scientists who have a record of productive, well-funded             
investigation and a demonstrated devotion to research training. Trainees        
participate actively in all phases of the investigative process:                
formulation of sound hypotheses, mastery of fundamental concepts and            
technics, background reading, didactic offerings, hands-on experience at        
the bench and discussions with preceptors and collaborating                     
investigators. Rigorous attention to experimental design, including             
biostatistical considerations, is emphasized, as are the writing of             
protocols; direct performance of the research; data analysis and                
interpretation; ethical considerations in research; and the preparation         
of verbal and written presentations and publications. Trainees                  
investigative activities are reviewed by the Preceptor, collaborating           
investigators, at Divisional Research Conferences, by visiting                  
consultants and, twice each year, by the Divisions Education Committee.         
The outcomes of trainees who have completed this Training Program have          
been, and continue to be, positive. The majority of our graduates have          
entered productive academic-investigative careers at institutions               
throughout the United States; and a number have achieved leadership             
positions in Pulmonary Medicine.                                                
",INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARD (NHLBI),,ANDREW L RIES,1889459
43,2855746,,1999,MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32AA007275-21,AA007275,UNITED STATES,T32,194491,False,VISHNU  PUROHIT,National Institute on Alcohol Abuse and Alcoholism,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,"APPLICANT'S ABSTRACT:  This request is for continuation of a research training program for 5 qualified post-doctoral U.S. fellows (with M.D. or Ph.D.). The members of our interdisciplinary team (10 M.D.'s and 6 Ph.D.'s) with expertise in ethanol metabolism, hepatology, gastroenterology, pharmacology, biochemistry, pathology, nutrition, immunology, anatomy, psychiatry and psychology, conduct studies on patients as well as experimental models of alcoholic injury; their objective is to investigate the biochemical and structural mechanism of the pathological effects of ethanol in order to improve diagnosis and treatment and to allow for early recognition through the development of biological markers and biochemical tests.  The trainees will be given the opportunity to acquire special skills in both clinical and basic research and to learn advanced techniques in biochemistry, molecular biology, pharmacology, electron microscopy, immunology, immuno cytochemistry, cell culture and experimental psychology.  In a 2-3 year apprenticeship with one or more of the senior investigators, the trainees will participate in projects selected on the basis of their interest and the relevance and interdisciplinary value of the question raised.  The trainees will attend and give seminars and special lectures in the field, contribute to literature (journal club) and manuscript reviews as well as grant applications, present papers at scientific meetings and acquire the skills needed to publish the research findings in reputable peer reviewed journals. These activities are carried out in an intellectual environment enriched by the presence of a score of international fellows, visiting professors and scientists on sabbaticals. The trainees will be selected on the basis of scholastic achievements, commitment to research in alcoholism and academic orientation.  The MD's will usually enter the program at the end of their clinical training (residencies in internal medicine or psychiatry).  This program is designed to encourage talented young individuals to enter the field of research on alcoholism and should prepare them to contribute successfully to the understanding and ability to handle alcohol problems.  Graduate students with clinical training will be allowed to spend 20 % of their time in clinical activities selected to allow them to maintain their acquired clinical skills. The trainees will have office and laboratory space at the Alcohol Research Center (Bronx Veterans Administration Medical Center), the Annenberg building of the Mount Sinai Medical Center and the laboratory of Dr. S. Fisher, North Shore Hospital, New York.  They will have access to a ten bed Medical Detoxification Unit (including an outpatient clinic), a Rehabilitation Unit (with a 20 bed ward and a clinic), supporting GI, Liver and Nutrition Units, as well as fully equipped biochemistry, pharmacology, immunology, molecular biology and electron microscopy laboratories.  Extensive animal facilities are available with rabbits, mice, rats, deermice, hamsters, baboons and common surgical suites and culture rooms. There are excellent library, computer and statistics support facilities at the Alcohol Research Ctr., the Bronx VA Medical Ctr., the North Shore Medical Ctr. and the Mount Sinai School of Medicine. ",PATHOGENESIS AND TREATMENT OF ALCOHOL INDUCED DISEASES,,CHARLES S LIEBER,1878147
44,2838014,,1999,"MAYO CLINIC COLL OF MEDICINE, ROCHESTER",ROCHESTER,MN,,5T32DK007013-22,DK007013,UNITED STATES,T32,91030,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2002-11-30T05:00:00Z,,,KIDNEY DISEASE RESEARCH TRAINING GRANT,,KARL A. NATH,1890747
45,2801473,,1999,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PATHOLOGY,2T32GM007266-25,GM007266,UNITED STATES,T32,739789,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,"Our purpose is to continue and to enhance the Medical Scientist Training Program at the University of Washington. This program provides an opportunity for a group of highly qualified students, selected from a national pool, to pursue the M.D. and Ph.D. degrees concurrently. The overall aim of the program is to provide training for outstanding future medical researchers. Each student is trained in the methodology and logic of basic research as well as the disciplines of medicine. Our expectation is that our trainees will enter careers in medical research and make significant advances in the understanding of human disease processes. A major goal of this program is to achieve a sufficiently large number of MSTP students in each medical school class to establish medical research as major career objectives at the University of Washington. There are several unique features of the program: (1) Our program emphasizes training in molecular biology and bioengineering. (2) New students begin a period of laboratory rotations prior to beginning the fist year medical school curriculum. (3) The second year medical school curriculum occupies mainly afternoons, leaving some mornings free for graduate courses. (4) MSTP students meet regularly on a monthly basis at the school or at faculty homes to present their research and to discuss their future directions. In this program the MSTP student is able to pursue an in-depth research project and medical school studies. Being more intense than either a medical or graduate school program, this experience provides a unique perspective and orientation to medical research. Our overall goal is to train a coterie of excellent students to translate basic molecular research into important medical discoveries. ",MEDICAL SCIENTIST TRAINING PROGRAM,,LAWRENCE A LOEB,1860313
46,6800955,,2003,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,3T32DK007126-30S1,DK007126,UNITED STATES,T32,56446,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RENAL DISEASE,,Marc Randall Hammerman,1888256
47,6603903,,2003,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,5T32HL007028-28,HL007028,UNITED STATES,T32,247662,False,Beth  Schucker,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,"NUTRITION, LIPID METABOLISM & ATHEROSCLEROSIS TRAINING",,ALAN  CHAIT,1863672
48,6603801,,2003,DUKE UNIVERSITY,DURHAM,NC,PATHOLOGY,5T32GM007171-29,GM007171,UNITED STATES,T32,1547332,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"
 DESCRIPTION (provided by applicant): This is a renewal application for years       
 28-32 of GM07171 which supports the Medical Scientist Training Program (MSTP)      
 at Duke University. One of the first MSTP's, this Program has been continually     
 funded by the National Institutes of General Medical Sciences, the first ten       
 years as GM01678 (1966-1975) and the subsequent 26 years as GM07171                
 (1975-2001). The Program currently has an award of 36 funded positions and is      
 requesting the same number of slots in this renewal. However, the Program has      
 grown significantly since the previous application in 1996 when there were 42      
 students. Currently, there are 57 students and the Program will reach a new        
 steady state of 70-84 students. This number represents 10 to 12% of the Medical    
 School class. The additional funding is provided by the Medical and Graduate       
 Schools, the Duke Medical Alumni Association, and the Duke Endowment. In           
 addition, an $800,000 reserve fund has been created to cover unexpected            
 financial needs by the Program. As of this writing, 14 of 16 applicants            
 accepted by the Program have indicated their intention to matriculate here. The    
 current Program student body is quite diverse with 17.6% underrepresented          
 minority enrollment and a gender distribution that is 44% female. A large pool     
 of applicants (200-300 per year) has allowed us to recruit an outstanding group    
 of students. The structure of the Program is unchanged since the prior             
 application. It consists of a basic science core year, a clinical core year,       
 graduate school, and return to a final clinical year. The average program          
 length is 7.2 years. Students may spend their graduate years in the traditional    
 Medical School basic sciences, Chemistry, Zoology, and Biomedical Engineering.     
 Greater flexibility is now available to our students who may also opt a new        
 Biostatistics and Bioinformatics department, Economics, or Cognitive               
 Neuroscience/Psychology.                                                           
                                                                                    
",Medical Scientist Training Program,,Salvatore V Pizzo,1871037
49,6593292,,2003,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,MICROBIOLOGY/IMMUN/VIROLOGY,2T32GM007196-29,GM007196,UNITED STATES,T32,349028,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):  This training grant will support 17 graduate students usually for their first two years.  The goal of this program is to give the students the widest possible education in genetics and provide opportunities to work in many of the major areas of genetics research, including plant, microbial, yeast, Drosophila, C. elegans, Zebrafish, human genetics, genomics and bioinformatics and other areas.  The Training Grant sponsors regular genetics research presentations by more senior graduate students and three student-invited outside genetics seminar speakers.  Students are selected for the grant before matriculating on the basis of their interests and their agreement to take an introductory and an advanced genetic course.  Their progress is followed by faculty advisors who are members of the Training Grant and by the Director this Grant.  These students will be part of the Biological and Biomedical Sciences program which includes the following components: 1) Advising throughout their graduate career by a faculty member of the Training Grant; 2) a set of four core courses in genetics and other core subjects, a critical reading course, and advanced courses.  The total required number of courses is 8; 3) a regular fall poster session, regular faculty talks, student-organized fall retreat, Mini-Symposia on specialized topics and Departmental activities all of which introduce students to the range of lab research subjects available; 4) a program and course in Conduct of Science and a seminar speaker on social issues in genetics; 5) laboratory rotations during the first 12 months allowing students to try out three labs; 6) forums on careers in academic science and in alternative careers; 7) a qualifying examination and a thesis advisory committee to follow the progress of the student; 8) regular seminars on genetic subjects in Medical School basic science Departments.",Regul. of Gene Expression in Prokaryotes and Eukaryotes,,FRED M. WINSTON,1863326
0,6516819,,2002,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32DK007006-29,DK007006,UNITED STATES,T32,304727,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RENAL RESEARCH TRAINING PROGRAM,,MICHAEL P MADAIO,1896913
1,6452432,,2001,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,3T32GM007229-26S1,GM007229,UNITED STATES,T32,1,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGY,,RICHARD M SCHULTZ,1876102
2,6498577,,2002,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32GM007170-28,GM007170,UNITED STATES,T32,1667949,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,LAWRENCE F BRASS,6125110
3,6490319,,2002,VANDERBILT UNIVERSITY,NASHVILLE,TN,INTERNAL MEDICINE/MEDICINE,5T32HL007123-28,HL007123,UNITED STATES,T32,589228,False,Sandra  Colombini-Hatch,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,PATHOPHYSIOLOGY OF THE PULMONARY MICROCIRCULATION,,Gordon R Bernard,1859896
4,6490317,,2002,HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),BOSTON,MA,PUBLIC HEALTH & PREV MEDICINE,5T32HL007118-27,HL007118,UNITED STATES,T32,537528,False,Ann E. Rothgeb,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,LUNG BIOLOGY AND RESPIRATORY DISEASE,,Joseph D Brain,1889196
5,6490310,,2002,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,ENGINEERING (ALL TYPES),5T32HL007089-28,HL007089,UNITED STATES,T32,858851,False,Michael  Commarato,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2005-05-31T04:00:00Z,,,CARDIOVASCULAR ENGINEERING SCIENCE,,SHU  CHIEN,1876594
6,6490303,,2002,WEILL MEDICAL COLLEGE OF CORNELL UNIV,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007029-28,HL007029,UNITED STATES,T32,309544,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY,,Roy L Silverstein,1893827
7,6490300,,2002,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PUBLIC HEALTH & PREV MEDICINE,5T32HL007024-28,HL007024,UNITED STATES,T32,543120,False,Lorraine M Silsbee,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2005-05-31T04:00:00Z,,,CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAINING,,JOSEF  CORESH,1877194
8,6490299,,2002,UNIVERSITY OF CALIFORNIA DAVIS,DAVIS,CA,INTERNAL MEDICINE/MEDICINE,5T32HL007013-25,HL007013,UNITED STATES,T32,151733,False,Ann E. Rothgeb,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,,TRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINE,,CARROLL E CROSS,6999203
9,6453886,,2002,DUKE UNIVERSITY,DURHAM,NC,PATHOLOGY,2T32GM007171-28,GM007171,UNITED STATES,T32,1440033,False,Bert I. Shapiro,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2007-06-30T04:00:00Z,,"
 DESCRIPTION (provided by applicant): This is a renewal application for years       
 28-32 of GM07171 which supports the Medical Scientist Training Program (MSTP)      
 at Duke University. One of the first MSTP's, this Program has been continually     
 funded by the National Institutes of General Medical Sciences, the first ten       
 years as GM01678 (1966-1975) and the subsequent 26 years as GM07171                
 (1975-2001). The Program currently has an award of 36 funded positions and is      
 requesting the same number of slots in this renewal. However, the Program has      
 grown significantly since the previous application in 1996 when there were 42      
 students. Currently, there are 57 students and the Program will reach a new        
 steady state of 70-84 students. This number represents 10 to 12% of the Medical    
 School class. The additional funding is provided by the Medical and Graduate       
 Schools, the Duke Medical Alumni Association, and the Duke Endowment. In           
 addition, an $800,000 reserve fund has been created to cover unexpected            
 financial needs by the Program. As of this writing, 14 of 16 applicants            
 accepted by the Program have indicated their intention to matriculate here. The    
 current Program student body is quite diverse with 17.6% underrepresented          
 minority enrollment and a gender distribution that is 44% female. A large pool     
 of applicants (200-300 per year) has allowed us to recruit an outstanding group    
 of students. The structure of the Program is unchanged since the prior             
 application. It consists of a basic science core year, a clinical core year,       
 graduate school, and return to a final clinical year. The average program          
 length is 7.2 years. Students may spend their graduate years in the traditional    
 Medical School basic sciences, Chemistry, Zoology, and Biomedical Engineering.     
 Greater flexibility is now available to our students who may also opt a new        
 Biostatistics and Bioinformatics department, Economics, or Cognitive               
 Neuroscience/Psychology.                                                           
                                                                                    
",Medical Scientist Training Program,,Salvatore V Pizzo,1871037
10,6452670,,2002,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,2T32GM007229-27A1,GM007229,UNITED STATES,T32,773823,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,"
DESCRIPTION (provided by applicant): The Cell and Molecular Biology Predoctoral
Training Program at the University of Pennsylvania is a University-wide,
interdepartmental and interschool program for careers in modern biology. The
group of trainers consists of approximately 300 senior and younger faculty from
many parts of the University. These faculty are members of the Cell and
Molecular Biology Graduate Group. Graduate Groups, which are interdepartmental
and interschool in membership and fully responsible for graduate education, are
not the same as or coextensive with Departments. Individual Graduate Groups set
requirements for degrees, admit and monitor the progress of students and
eventually certify their degrees. This somewhat unusual arrangement, whereby
graduate education is handled by Graduate Groups rather than Departments,
promotes interaction among the many faculty having common interests in cell and
molecular biology, and contributes strongly to the interdisciplinary spirit of
graduate training and collaborative research in these areas at the University
of Pennsylvania. The mission of the training grant is to support students with
broadly defined interests in cell and/or molecular biology during the first two
years of graduate training while they explore and refine their research
interests. In general, incoming students are appointed for two years, and
second year students are appointed for one year. Trainees are selected annually
by an open and democratic process. Trainees are required to take a rigorous
course in Cell Biology and Molecular Biology, attend the annual retreat of the
Cell and Molecular Biology Graduate Group, and participate in a weekly meeting
in which each trainee presents a seminar once a year on either their rotation
or thesis research. In addition, junior trainers present research seminars to
the trainees. Trainees also choose a topic for and organize an annual
symposium. The training program has formal mechanisms to monitor trainees both
during and after their support from the training grant. In addition, the
training program has formal mechanisms to monitor trainers, as well as to
resolve any conflicts between trainees and trainers.",Training Program in Cell and Molecular Biology,,RICHARD M SCHULTZ,1876102
11,6380224,,2001,YALE UNIVERSITY,NEW HAVEN,CT,INTERNAL MEDICINE/MEDICINE,5T32DK007058-27,DK007058,UNITED STATES,T32,241982,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,"This proposal seeks continued support for the Yale research training program in Diabetes Mellitus and Disorders of Metabolism. The application seeks maintenance of the current level of funding (5 stipends per year) to serve as the core source of support for postdoctoral research training in diabetes and endocrinology at the Yale School of Medicine. The request is based on our record of attracting a strong applicant pool for this program, the high level of research productivity of the training faculty, and the continuing shortage of physician-scientists in both adult and pediatric endocrinology/diabetes. A major goal of the program is to develop physician-scientists who possess the requisite laboratory skills to pursue and compete effectively in academic medicine. Physician trainees entering the program will have an M.D. or M.D./Ph.D. degree and at least 2-3 years of clinical training in medicine or pediatrics. Ph.D. scientists are also recruited to the program since we believe their participation is critical to the training environment. Heavy emphasis in the selection process is given to those applications demonstrating potential and desiring research training for a career in clinical investigation. The duration of the training period is three years so as to provide a more in-depth training experience. The cornerstone of the curriculum involves the participation by the trainee in a specific laboratory project under the direction of a designated preceptor. The research projects offered span the gamut from clinical investigation to basic science and are designed to develop the laboratory skills required for a faculty appointment in internal medicine, pediatrics, or in a basic science department. The scope of the program has been expanded to provide the trainees with greater exposure to state-of-the-art laboratory techniques. Research opportunities are available in three major areas: 1) pathophysiology of diabetes, 2) immunology of diabetes, and 3) developmental and bone biology. Trainees have the opportunity to participate in ongoing projects involving collaborations with basic science departments in genetics, cell biology and immunobiology. Close interactions among preceptors within each programmatic area serve to further enrich the training experience. Instruction is also provided by means of an organized series of lectures, research seminars, and journal clubs. ",DIABETES MELLITUS AND DISORDERS OF METABOLISM,,ROBERT S SHERWIN,1882029
12,6380223,,2001,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,INTERNAL MEDICINE/MEDICINE,5T32DK007053-28,DK007053,UNITED STATES,T32,138058,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
13,6731098,,2004,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32HL007101-29,HL007101,UNITED STATES,T32,231608,False,Beth  Schucker,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-03-31T05:00:00Z,,"DESCRIPTION (Applicant's Abstract) Duke University Medical Center has been engaged in the training of clinicians and scientists in the area of cardiovascular diseases -for over 40 years. Much of this success can be attributed to 25 years of funding of the Cardiovascular Training Program Grant.  This application is a competitive renewal for our Cardiovascular Training Program Grant, which was last funded in 1996.  The cardiovascular training program represents the integrated efforts of the Departments of Medicine, Surgery, Cell Biology, Pediatrics, Pharmacology, Engineering, and Genetics to train postdoctoral cardiovascular physician-scientists.  This will be accomplished by providing a multidisciplinary faculty and environment to trainees in order to foster and develop excellence in biomedical research related to the cardiovascular system.  The underlying philosophy of this program will be to integrate training and research by creating an environment that facilitates the natural linkages among programs and departments throughout the University.  An extended period of research (2 years or more) will be provided to trainees under the mentorship of program faculty who will closely supervise and direct the academic career development of the trainee.  This program will provide an important mechanism for supporting trainees during a critical period of postgraduate medical training and provide an environment conducive to a research-oriented career.  During this time, trainees will be ""protected"" from clinical responsibilities and immersed in research to obtain the background and experience necessary to establish themselves an independent investigators in academic institutions.  The individual mentor will provide skills such as experimental design, data analysis, and manuscript and grant preparation during the training period. The goal of this program is to continue this history of productivity by creating an environment that will ensure that Duke will continue to contribute to the development of young investigators capable of pursuing successful research careers in cardiovascular fields.  The current application will describe the modifications and improvements that have been recently implemented and will discuss Duke""s ongoing commitment to train the next generation of cardiovascular researchers.  The training program emphasizes the training of physician-scientists, and to this end, approximately 90% of the trainees will be MDs or MD/PhDs. ",Multidisciplinary Heart and Vascular Diseases,,Howard A Rockman,1882946
14,6789827,,2003,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,3T32DK007120-29S2,DK007120,UNITED STATES,T32,28374,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
15,6330787,,2000,UNIVERSITY OF WASHINGTON,SEATTLE,WA,DENTISTRY,3T32DE007023-25S1,DE007023,UNITED STATES,T32,249146,False,James A Lipton,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,DE9304,,ORAL BIOLOGY TRAINING - SALIVARY SECRETIONS,,Kenneth T Izutsu,1877343
16,6343314,,2001,UNIVERSITY OF CALIFORNIA DAVIS,DAVIS,CA,INTERNAL MEDICINE/MEDICINE,5T32HL007013-24,HL007013,UNITED STATES,T32,112365,False,Ann E. Rothgeb,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,TRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINE,,CARROLL E CROSS,6999203
17,6343316,,2001,WEILL MEDICAL COLLEGE OF CORNELL UNIV,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007029-27,HL007029,UNITED STATES,T32,118203,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY,,Roy L Silverstein,1893827
18,6375523,,2001,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PATHOLOGY,5T32CA009437-20,CA009437,UNITED STATES,T32,552616,False,DAVID J ECKSTEIN,National Cancer Institute,1975-07-01T04:00:00Z,2003-05-31T04:00:00Z,,,MOLECULAR TRAINING PROGRAM IN CANCER RESEARCH - COMPETIN,,LAWRENCE A LOEB,1860313
19,6313920,,2001,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,INTERNAL MEDICINE/MEDICINE,2T32HL007152-26,HL007152,UNITED STATES,T32,200741,False,Traci  Mondoro,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Applicant's Abstract) The goal of this program is to provide the postdoctoral training needed for a successful investigative career in Hematology.  This training program was begun in 1975 and has provided training to 52 current or past postdoctoral scientists and physicians.  Of these, a large proportion are in academic medicine and many continue in clinical or basic science research.  During the current funding period, six trainees have been supported.  Of four who completed their training, two currently have academic positions and one has accepted a position for the beginning of the next academic year.  The program is centered in the Vascular Medicine Unit at the University of Rochester Medical Center but is interdepartmental with faculty from adult and pediatric Hematology/Oncology, Biochemistry and Biophysics, and Pharmacology and Physiology.  The program will be directed by Dr. Charles Francis, Chief of the Vascular Medicine Unit, assisted by an Executive Committee comprised of three of the faculty.  It will offer an intensive, focused, two or three year training experience in hematology research that will include didactic course work, lectures, informal seminars, a close mentoring relationship with a faculty member and a research project.  All trainees will complete a didactic training program provided by the Rochester Clinical Research Curriculum supported by a K30 award that will include principles of scientific writing; issues related to technology transfer, funding and industrial relations; and grant writing skills.  Trainees with an M.D. degree may pursue patient- oriented research and additional didactic course work in biostatistics, epidemiology, and outcomes research is available.  Either Ph.D. or M.D. trainees may pursue basic research in the laboratory of one of the faculty. Each trainee's program will be approved by the Executive Committee and monitored by the Training Committee.  The mentor relationship between faculty and trainee is emphasized, and the faculty are committed to providing necessary support, encouragement, and resources necessary to begin an independent investigative career.  Trainee candidates are typically recruited from the Hematology/Oncology fellowship programs and from Ph.D. candidates in the departments of Pathology, Biochemistry and Biophysics, and Pharmacology and Physiology.  The University of Rochester Medical Center is a research-intensive institution with a new major commitment to further increasing research and offers an ideal environment for this training program. ",GRADUATE TRAINING HEMATOLOGY RESEARCH,,Charles W. Francis,1860669
20,6313917,,2001,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,2T32HL007101-26,HL007101,UNITED STATES,T32,446801,False,Beth  Schucker,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2006-03-31T05:00:00Z,,"DESCRIPTION (Applicant's Abstract) Duke University Medical Center has been engaged in the training of clinicians and scientists in the area of cardiovascular diseases -for over 40 years. Much of this success can be attributed to 25 years of funding of the Cardiovascular Training Program Grant.  This application is a competitive renewal for our Cardiovascular Training Program Grant, which was last funded in 1996.  The cardiovascular training program represents the integrated efforts of the Departments of Medicine, Surgery, Cell Biology, Pediatrics, Pharmacology, Engineering, and Genetics to train postdoctoral cardiovascular physician-scientists.  This will be accomplished by providing a multidisciplinary faculty and environment to trainees in order to foster and develop excellence in biomedical research related to the cardiovascular system.  The underlying philosophy of this program will be to integrate training and research by creating an environment that facilitates the natural linkages among programs and departments throughout the University.  An extended period of research (2 years or more) will be provided to trainees under the mentorship of program faculty who will closely supervise and direct the academic career development of the trainee.  This program will provide an important mechanism for supporting trainees during a critical period of postgraduate medical training and provide an environment conducive to a research-oriented career.  During this time, trainees will be ""protected"" from clinical responsibilities and immersed in research to obtain the background and experience necessary to establish themselves an independent investigators in academic institutions.  The individual mentor will provide skills such as experimental design, data analysis, and manuscript and grant preparation during the training period. The goal of this program is to continue this history of productivity by creating an environment that will ensure that Duke will continue to contribute to the development of young investigators capable of pursuing successful research careers in cardiovascular fields.  The current application will describe the modifications and improvements that have been recently implemented and will discuss Duke""s ongoing commitment to train the next generation of cardiovascular researchers.  The training program emphasizes the training of physician-scientists, and to this end, approximately 90% of the trainees will be MDs or MD/PhDs. ",MULTIDISCIPLINARY HEART AND VASCULAR DISEASES,,Howard A Rockman,1882946
21,6323566,,2001,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,2T32CA009179-26A1,CA009179,UNITED STATES,T32,207794,False,LESTER S. GORELIC,National Cancer Institute,1975-07-01T04:00:00Z,2006-06-30T04:00:00Z,,,Molecular Immunology & Tumor Biology,,JAMES P ALLISON,1888724
22,2909739,,1999,UNIVERSITY OF IOWA,IOWA CITY,IA,ORTHOPEDICS,5T32AR007075-25,AR007075,UNITED STATES,T32,74874,False,James S. Panagis,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2001-04-30T04:00:00Z,,"The long term objective of the University of Iowa Research Training             
Program in Skeletal Disorders is to improve treatment of musculoskeletal        
injuries and diseases including fractures, joint injuries, arthritis and        
skeletal deformities by increasing the number of investigators who will         
advance understanding of the musculoskeletal system. The specific aims          
include attracting talented postdoctoral trainees with either M.D. or           
Ph.D. degrees to careers in musculoskeletal research, stimulating them to       
investigate clinically important musculoskeletal problems, providing them       
with high quality research education that will prepare them to be               
productive investigators and promoting collaborative research among M.D.        
and Ph.D. scientists with different areas of expertise. During their            
research training program the individuals selected for this program will        
learn specific research skills, design and perform research projects, and       
apply their research skills to advance understanding of clinical problems       
of the musculoskeletal system. Trainees will first develop detailed             
research protocols with the assistance of a senior investigator. The            
protocols will then be reviewed by a committee consisting of Joseph             
Buckwalter, M.D., Richard Brand, M.D., Thomas Brown, Ph.D. and Reginald         
Cooper, M.D. Following this review the protocol will be refined and the         
individual will proceed with their research program with guidance from a        
senior investigator for one to three years. They will work in one of the        
four Orthopaedic departmental laboratories (i.e., the biomechanics              
laboratory, the cell and molecular biology laboratory, the morphology and       
ultrastructure laboratory or the bone healing laboratory). Trainees may         
also spend part of their time in a laboratory in another department within      
the University, or less frequently travel to a laboratory at another            
institution to learn a specific research technique. The emphasis is placed      
on trainees learning to develop and conduct their own research programs so      
that at the end of their training program they are prepared to function as      
productive independent investigators and to collaborate with other              
scientists. The senior investigator and the Departmental Research               
Committee will monitor the trainee's progress to ensure that at the             
completion of training they will have the skills and knowledge to pursue        
independent investigations of the highest quality that will have                
significant impact on important clinical problems of the musculoskeletal        
system.                                                                         
",RESEARCH TRAINING IN SKELETAL DISORDERS,,JOSEPH A. BUCKWALTER,1866797
23,2909736,,1999,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32AR007033-26,AR007033,UNITED STATES,T32,200266,False,William J. Sharrock,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,"DESCRIPTION (taken from the application): The overall goal of this training grant is to provide advanced training in research to qualified individuals with M.D., Ph.D. or equivalent degrees who plan to pursue academic careers with vested interests in the biology/physiology/function of bone cells, and skeletal homeostasis. The trainees will have the opportunity to develop original research protocols in the laboratories of faculty members with vested interests in these topics utilizing techniques which encompass the field of molecular and cellular biology, cell culture, cellular and molecular immunology, pharmacology, immunopathology and genetics. Independent research undertakings are supplemented by a variety of hourly/weekly seminars designed for either the presentation of research accomplishments by the trainee, or a review of the most recent literature by both trainees and faculty members. Clinical (M.D.) trainees are also assigned rotations in outpatient clinics of patients with either acquired or inherited skeletal disorders and attendance at a weekly bone biopsy review seminar. The Bone and Mineral Disease research milieu at the Washington University Medical Center and the clinical-research facilities of The Shriners' Hospital for Crippled Children offer a dynamic and unique situation wherein faculty members can interact and collaborate to insure the success of the research undertaking and the programmed development of the trainees. ",MINERAL AND SKELETAL METABOLISM,,ROBERTO  PACIFICI,1885666
24,2896938,,1999,UNIVERSITY OF WASHINGTON,SEATTLE,WA,DENTISTRY,5T32DE007023-25,DE007023,UNITED STATES,T32,41684,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,DE9304,"DESCRIPTION: This is an application for renewal  of an on-going oral biology NRSA training program in salivary  secretions, under the continuing directorship of Dr. Kenneth Izutsu.  The  purpose of the program is to provide multi-disciplinary  training in salivary secretion biology  as it  relates to oral  health and disease.  The goal is to train researchers, primarily at the postdoctoral level, to become effective investigators of both basic mechanisms of secretion and the  pathology associated with  different diseases involving oral tissues. Twenty-two training faculty, with expertise in a wide range of disciplines that converge on oral health and disease, are involved in the training program. It is designed  to   support  postdoctoral  trainees predominantly, with a minor component of training for research oriented undergraduate dental students. The majority of postdoctoral candidates will have  the DDS  degree and  will pursue PhD or MSD  degrees. The  remainder will be  PhD degree investigators particularly interested in salivary secretions or other oral biology research. PhD candidates  will  predominantly matriculate in the Department of Oral Biology although selection of another department represented by a training faculty member will be available. MSD candidates would matriculate  in oral pathology or oral medicine. All trainees would pursue the oral biology core curriculum plus  additional formal  classwork based  on  individual goals and interests. The program is to be administered  through the program director who will  work closely with the  Oral Biology Department Chairman, a co-program director for the program.  A steering committee, consisting of the full members of the Oral Biology  Department, will advise on accepting new  students and  recruitment activities, and will periodically review  each trainee's  progress and  make suggestions as appropriate. ",ORAL BIOLOGY TRAINING - SALIVARY SECRETIONS,,Kenneth T Izutsu,1877343
25,6146776,,2000,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,2T32DK007130-27,DK007130,UNITED STATES,T32,165659,False,"JUDITH M, PODSKALNY",National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGY,,Nicholas O. Davidson,8179452
26,6149259,,2000,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,INTERNAL MEDICINE/MEDICINE,2T32DK007007-26,DK007007,UNITED STATES,T32,286590,False,"JUDITH M, PODSKALNY",National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,NIH NIDDK INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARD,,RICHARD A. WEISIGER,1861063
27,6023996,,2000,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,PHARMACOLOGY,2T32GM007040-26,GM007040,UNITED STATES,T32,323688,False,Peter  Preusch,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCES,,ROBERT L ROSENBERG,1868988
28,6022005,,2000,STANFORD UNIVERSITY,STANFORD,CA,INTERNAL MEDICINE/MEDICINE,2T32GM007065-26,GM007065,UNITED STATES,T32,148421,False,Alison E. Cole,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,TRAINING PROGRAM IN CLINICAL PHARMACOLOGY,,BRIAN B HOFFMAN,3154678
29,6190727,,2000,VANDERBILT UNIVERSITY,NASHVILLE,TN,INTERNAL MEDICINE/MEDICINE,2T32DK007061-27,DK007061,UNITED STATES,T32,221003,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
30,6169468,,2000,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PEDIATRICS,5T32AI007007-22,AI007007,UNITED STATES,T32,141120,False,Lawrence J. Prograis,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,2004-08-31T04:00:00Z,,,RESEARCH TRAINING IN PEDIATRIC ALLERGY AND IMMUNOLOGY,,Jerry A Winkelstein,1899134
31,6080208,,2000,BRANDEIS UNIVERSITY,WALTHAM,MA,BIOLOGY,2T32GM007122-26,GM007122,UNITED STATES,T32,348048,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,GENETIC AND BIOCHEMICAL MECHANISMS OF REGULATION,,JEFFREY C HALL,1895708
32,6080206,,2000,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOMEDICAL ENGINEERING,2T32GM007057-26,GM007057,UNITED STATES,T32,391092,False,Alison E. Cole,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING TRAINING PROGRAM,,Eric Daniel Young,1877392
33,6079273,,2000,YALE UNIVERSITY,NEW HAVEN,CT,PUBLIC HEALTH & PREV MEDICINE,2T32MH014235-26,MH014235,UNITED STATES,T32,300853,False,Lisa J. Colpe,National Institute of Mental Health,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,"
 DESCRIPTION (Adapted from the Applicant's Abstract): The present application is    
 for continued support for Research Training in Mental Health Epidemiology          
 (originally, Research Training in Psychosocial Epidemiology). The major goal of    
 the program is to provide rigorous training in the application of epidemiologic    
 methods to psychosocial and psychiatric research. Since its inception in 1975,     
 this program has had an unusual degree of stability in its core training           
 faculty and overall objectives. Students who have participated in this program     
 have demonstrated outstanding success in developing careers with important         
 contributions to psychiatric and psychosocial epidemiology. Dr. Stan Kasl has      
 been the Principal Investigator since 1975; however, Dr. Kathleen Merikangas       
 now will take over as Program Director and Dr. Kasl will become Co-Director.       
 The major components of the training include faculty mentoring, formal course      
 work in epidemiology, applied research experience, and clinical practica, where    
 relevant. The present application requests support for 4 pre-doctoral and 4        
 post-doctoral trainees. Trainees will be recruited to represent the following      
 focal areas: psychosocial epidemiology, psychiatric epidemiology, genetic          
 epidemiology, and biostatistics. The substantive areas of expertise in this        
 program include links between psychosocial risk factors, psychopathology and       
 chronic diseases, comorbidity of psychiatric disorders and substance abuse,        
 genetic epidemiology of behavioral and emotional disorders, and a new future       
 direction of prevention. Faculty interests cover all stages of the life span       
 ranging from childhood to late life. Strengths of this program include: (1) the    
 availability of an excellent formal academic program in the Department of          
 Epidemiology and Public Health including programs in Chronic Disease               
 Epidemiology, Biostatistics, and strong links with other departments including     
 Psychiatry, Psychology and Genetics; (2) an extensive network of ongoing           
 research in diverse areas and across all levels of epidemiology including          
 descriptive, analytic and intervention to provide direct experience in research    
 in psychiatric epidemiology; (3) an interdisciplinary faculty with extensive       
 experience in domains of relevance to psychiatric research including               
 epidemiology, biostatistics, genetics, health policy and services, clinical        
 psychiatry, clinical psychology, developmental psychology and sociology; and       
 (4) focus on four disciplinary areas and four specialty areas that are of          
 critical importance to advances in contemporary psychiatry. Formal training,       
 mentorship, and extensive research experience will provide trainees with the       
 requisite methodologic and substantive tools to conduct high quality research      
 in psychiatry. Exposure to diverse specialty areas both within and between the     
 current program and other ongoing training initiatives will provide a broader      
 perspective on the substantive areas of psychiatric research and appreciation      
 of the need for an interdisciplinary approach that is critical to future           
 progress in understanding the pathogenesis and impact of mental disorders.         
                                                                                    
                                                                                    
                                                                                    
",RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,KATHLEEN R MERIKANGAS,1861672
34,6078614,,2000,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,BIOCHEMISTRY,2T32GM007311-26,GM007311,UNITED STATES,T32,278566,False,MARION M. ZATZ,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,SYNTHESIS AND STRUCTURE OF BIOLOGICAL MACROMOLECULES,,Timothy F Osborne,1918292
35,6076750,,2000,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,2T32DK007126-27,DK007126,UNITED STATES,T32,350124,False,TRACY L RANKIN,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,RENAL DISEASE,,Marc Randall Hammerman,1888256
36,2872446,,1999,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOCHEMISTRY,5T32GM007309-25,GM007309,UNITED STATES,T32,1621049,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,ROBERT F SILICIANO,1880560
37,2872443,,1999,YESHIVA UNIVERSITY,BRONX,NY,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007288-25,GM007288,UNITED STATES,T32,1140385,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,Betty  Diamond,1862435
38,2872441,,1999,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,BIOCHEMISTRY,5T32GM007283-25,GM007283,UNITED STATES,T32,524181,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,"Program Goal.  The goal of the training program is to prepare highly            
qualified students for research careers in cellular and molecular biology.      
The program offers its trainees a large and diverse group of faculty            
research mentors (80) with projects in a number of cutting edge areas. It       
is organized to provide students with the collegiality and support of a         
departmental environment but also the flexibility to move easily across         
department lines and to choose research mentors from among all program          
faculty. Trainee research is supported by the outstanding facilities            
available at the University of Illinois.                                        
                                                                                
Students. The training program has proved to be an extremely valuable           
recruiting tool in attracting a highly qualified and geographically             
diverse group of students. We have significantly improved the                   
representation of minority students in the program and added a large new        
pool of students through a new department, Cell and Structural Biology.         
                                                                                
Faculty. We have maintained strength in the areas in which we have been         
strong traditionally and increased our strength in cell biology. An             
outstanding group of new faculty have been added to the program since the       
last renewal and we project continued faculty growth in cell and molecular      
biology.                                                                        
                                                                                
Program Design. The program would provide three years of support for 27         
students. The program has functioned to allow students full access to all       
the relevant faculty and facilities of the institution while providing          
them with the supportive atmosphere of relatively small departments. The        
program sets certain course requirements for all its students. It also          
mandates that all its students carry out research rotations and requires        
that at least one rotation be outside the major department. Students also       
organize and run an annual symposium and a monthly seminar series.              
                                                                                
Facilities. There has been a dramatic increase in the research space            
devoid to cell and molecular biology at UIUC. The Chemistry-Life Sciences       
Building (to be occupied in 1996) will provide new space to many more. We       
offer our trainees world class research support facilities in the               
Biotechnology Center (oligonucleotide and peptide synthesis, nucleotide         
and protein sequencing, amino acid analysis, production of hybridomas,          
polyclonal antibodies and transgenic animals, flow cytometry, fermentation      
and electron microscopy facilities), Chemical Sciences Laboratories (NMR,       
ESR, mass spectrometry, etc.), imaging (Beckman Institute), and computing       
(NCSA, SOLS network) facilities.                                                
",CELLULAR AND MOLECULAR BIOLOGY,,David M. Kranz,1879633
39,2872440,,1999,UNIVERSITY OF CHICAGO,CHICAGO,IL,PATHOLOGY,5T32GM007281-25,GM007281,UNITED STATES,T32,1233714,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,MEDICAL SCIENTIST NATIONAL RESEARCH SERVICE AWARD,,Jose Ramon Quintans,1955225
40,2872436,,1999,UNIVERSITY OF WASHINGTON,SEATTLE,WA,BIOCHEMISTRY,5T32GM007270-25,GM007270,UNITED STATES,T32,796192,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,TRAINING IN MOLECULAR AND CELLULAR BIOLOGY,,David  Kimelman,1895252
41,2872430,,1999,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,5T32GM007229-25,GM007229,UNITED STATES,T32,1014937,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,"The Cell and Molecular Biology Predoctoral Training Program at the              
University of Pennsylvania is a University-wide, interdepartmental and          
interschool program for careers in modern biology.  The group of trainers       
consists of more than 100 senior and younger faculty from many parts of         
the University.  These faculty members, and the training they provide,          
are organized into Graduate Groups according to disciplines of interest.        
These Graduate Groups, which are interdepartmental and interschool in           
membership and fully responsible for graduate education, are not the same       
as or coextensive with Departments. Individual Graduate Groups set              
requirements for degrees, admit and monitor the progress of students, and       
eventually certify their degrees.  organizationally, two of the Graduate        
Groups that participate in this program are in the School of Arts and           
Sciences (Biology and Chemistry), and the remaining 10 Groups come under        
Biomedical Graduate Studies in the School of Medicine, which provides a         
central point for processing applications, keeping records, coordinating        
curricula and other activities of the individual Graduate Groups, and           
through which considerable University funding for student support is            
channeled.  This somewhat unusual arrangement, whereby graduate education       
is handled by Graduate Groups rather than Departments, promotes                 
interaction among the many faculty having common interests in cell and          
molecular biology, and, contributes strongly to the interdisciplinary           
spirit of graduate training and collaborative research in these areas at        
the University of Pennsylvania.  The Training Program in Cell and               
Molecular Biology is an important component in attempts to maximize             
interaction among students and faculty of various Departments.  Trainees        
meet together periodically and, approximately once per year, choose a           
topic for a special 1-2 day seminar, select and invite speakers, and            
otherwise organize all aspects of the seminar. only students working            
toward the Ph.D. degree are supported by this Training Program. In total,       
34 students were supported for part or all of the present year, out of          
a total pool of more than 300 matriculated Ph.D. students interested in         
cell and molecular biology.  Individual Graduate Groups differ somewhat         
in their procedures and methods used in training.  All use a mix of             
formal courses, pre-thesis laboratory rotations, seminars, and individual       
laboratory research work leading to a thesis.  Examination and                  
supervision of research progress are done by faculty committees,                
sometimes with the addition of persons from outside the University              
",TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGY,,LEE D PEACHEY,1870979
42,2872425,,1999,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-25,GM007200,UNITED STATES,T32,1661756,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,"This is a renewal application for support of graduate training in Cellular      
and Molecular Biology within the Division of Biology and Biomedical             
Sciences at Washington University.  Since 1973, all predoctoral education       
in the biological sciences at Washington University has been provided by        
the Division of Biology and Biomedical Sciences. The Division is a unique       
and nationally recognized administrative structure, the key feature of          
which is the absence of any departmental predoctoral programs: all              
predoctoral programs and degree-granting units in the biological sciences       
at this university are both interdisciplinary and interdepartmental. The        
Division was established with its own endowment more than 20 years ago in       
recognition of the increasingly interrelated nature of all aspects of           
research in the biomedical and biological sciences, and in order to             
facilitate cooperation among faculty in the interdisciplinary training of       
prospective biological scientists.                                              
                                                                                
It is in such a tradition that the current training grant is rooted; we         
intend to use the continuation of this training grant to promote the            
professional growth of students whose research interests lie in an              
interdisciplinary area of rapidly growing importance and productivity:          
cellular and molecular biology. In parallel we hope to foster interactions      
among faculty which in turn will provide unique research opportunities for      
students.                                                                       
",NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTIST,,Daniel E. Goldberg,1930486
43,2872420,,1999,DUKE UNIVERSITY,DURHAM,NC,NEUROSCIENCES,5T32GM007184-25,GM007184,UNITED STATES,T32,817075,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,ORGANIZATION AND FUNCTION OF CELLULAR STRUCTURE,,DAVID R MC CLAY,1896395
44,2872418,,1999,COLUMBIA UNIVERSITY HEALTH SCIENCES,NEW YORK,NY,PHARMACOLOGY,5T32GM007182-25,GM007182,UNITED STATES,T32,128748,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN PHARMACOLOGICAL SCIENCES,,RICHARD B ROBINSON,1899763
45,2872403,,1999,COLUMBIA UNIVERSITY HEALTH SCIENCES,NEW YORK,NY,GENETICS,5T32GM007088-25,GM007088,UNITED STATES,T32,286704,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,PREDOCTORAL TRAINING GRANT IN GENETICS AND DEVELOPMENT,,VIRGINIA E. PAPAIOANNOU,1955125
46,2872400,,1999,STANFORD UNIVERSITY,STANFORD,CA,INTERNAL MEDICINE/MEDICINE,5T32GM007065-25,GM007065,UNITED STATES,T32,15894,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN CLINICAL PHARMACOLOGY,,TERRENCE FRANCIS BLASCHKE,1955228
47,2872274,,1999,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,PUBLIC HEALTH & PREV MEDICINE,5T32ES007015-22,ES007015,UNITED STATES,T32,315979,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,"DESCRIPTION: The environmental toxicology training program at the University of Wisconsin at Madison has been receiving support for the past 21 years. The training grant is administered by the Environmental Toxicology Center which is directed by Dr. Colin R. Jefcoate. The training program is actively managed by Dr. Jefcoate, the Program Director, and the Training Grant Committee. The committee is made up of six members selected from the 19 trainers from the program to serve three-year terms on a rotation basis. The committee also represents the special interest of the training grant with the Environmental Toxicology Center with respect to important training issues. The standing committees in the Center are responsible for standardized admission and curriculum activities. The standing committees are: Admission Committee, Graduate Achievement and Curriculum Committee and Steering Committee. The training faculty of the program consists of 19 individuals from 10 departments. All but four of them are also members of the Environmental Toxicology Center. In addition, most of them are also members of the proposed NIEHS Center for Developmental and Molecular Toxicology. The trainees will be educated in a curriculum involving biochemistry, genetics and cell biology disciplines. In addition to identifying immunotoxicology and neurotoxicology as new areas of toxicology during the last grant application, developmental toxicology will be developed as a new educational component for the trainees in this application. The application requests funding for eight predoctoral and two postdoctoral positions for five years. After admission to the program, predoctoral students typically select a mentor during the first semester rotation through three laboratories. The selection is based mainly on matching the interest between the student and the faculty as well as the funding support of the faculty. After selection of a laboratory, trainees typically work alongside a senior graduate student or postdoctoral associate who is working on a related topic. A research advisory committee will then be set up for each student. Trainees meet with advisors regularly, at least once per week to discuss course work and research. The curriculum for the NIEHS predoctoral trainees is being revised. Each of the required core courses: Toxicology I and II, Ecotoxicology and Chemicals in the Environment, has been or being revised. Each course is being established in a modular format with three one-credit modules. This revision is supposed to provide more flexibility for Ph.D. students. For example, it is under review that the NIEHS predoctoral trainees may take all modules of the two courses in Toxicology but only four or six modules from the other two core courses. The trainees will also take advanced courses: a two credit advanced course on Molecular Approaches to Toxicant Metabolism and two one credit Advanced Workshop courses. A new advanced course in Developmental Toxicology is being developed and the trainees are expected to take this course also. The remaining requirements for the trainees are six credits of Biochemistry and one credit/semester of Toxicology seminar. After completion of the courses, trainees will take a rigorous three-part Preliminary Examination. Their progress in research will be supervised by the Research Advisory Committee. A special training experience for the NIEHS postdoctoral trainees is that they meet regularly with a group of trainers and must write a proposal early in the support period for external support. These trainees present their research on a regular basis at the Environmental Toxicology Center evening meetings and at least once in the regular program seminar series. In addition, they submit a brief annual report on their research progress which stresses the toxicological relevance of the research. ",ENVIRONMENTAL TOXICOLOGY PREDOCTORAL AND POSTDOCTORAL,,B LYNN ALLEN-HOFFMANN,1877749
48,2857584,,1999,UNIVERSITY OF IOWA,IOWA CITY,IA,INTERNAL MEDICINE/MEDICINE,5T32HL007121-25,HL007121,UNITED STATES,T32,394323,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,INTERDISCIPLINARY CARDIOVASCULAR RESEARCH FELLOWSHIP,,FRANCOIS M ABBOUD,1864622
49,2857583,,1999,WAKE FOREST UNIVERSITY HEALTH SCIENCES,WINSTON-SALEM,NC,PATHOLOGY,5T32HL007115-25,HL007115,UNITED STATES,T32,180618,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,CARDIOVASCULAR PATHOLOGY,,Richard W ST CLAIR,1884537
0,2331528,,1997,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,PUBLIC HEALTH & PREV MEDICINE,5T32ES007015-20,ES007015,UNITED STATES,T32,249403,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY PREDOCTORAL AND POSTDOCTORAL,,COLIN ROBERT JEFCOATE,6695885
1,2331735,,1997,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,BIOCHEMISTRY,5T32GM007283-23,GM007283,UNITED STATES,T32,455234,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,David M. Kranz,1879633
2,2331727,,1997,UNIVERSITY OF OREGON,EUGENE,OR,NEUROSCIENCES,5T32GM007257-23,GM007257,UNITED STATES,T32,145221,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,SYSTEMS PHYSIOLOGY TRAINING PROGRAM,,JANIS CHRISTINE WEEKS,1887121
3,2331712,,1997,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,BIOCHEMISTRY,5T32GM007185-23,GM007185,UNITED STATES,T32,623549,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,RESEARCH TRAINING IN CELLULAR AND MOLECULAR BIOLOGY,,STEVEN G CLARKE,1863373
4,2332142,,1997,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,SOCIAL SCIENCES,5T32HD007014-23,HD007014,UNITED STATES,T32,175976,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,,DEMOGRAPHY AND ECOLOGY,,FRANKLIN D. WILSON,6606405
5,2331741,,1997,PRINCETON UNIVERSITY,PRINCETON,NJ,BIOCHEMISTRY,5T32GM007312-23,GM007312,UNITED STATES,T32,465195,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,THOMAS E SHENK,1894197
6,2331736,,1997,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,MISCELLANEOUS,5T32GM007287-23,GM007287,UNITED STATES,T32,1828693,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCES,,FRANK E SOLOMON,1883096
7,2331716,,1997,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-23,GM007200,UNITED STATES,T32,1342403,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTIST,,Daniel E. Goldberg,1930486
8,2414038,,1997,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32CA009140-23,CA009140,UNITED STATES,T32,503803,False,,National Cancer Institute,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,,IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES,,YVONNE J PATERSON,1877881
9,2331707,,1997,UNIVERSITY OF CHICAGO,CHICAGO,IL,PHARMACOLOGY,5T32GM007151-23,GM007151,UNITED STATES,T32,171946,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,RICHARD J MILLER,6232691
10,2331702,,1997,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PHYSIOLOGY,5T32GM007108-23,GM007108,UNITED STATES,T32,188857,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,INSTITUTIONAL GRANT FOR NEUROBIOLOGY,,WAYNE E. CRILL,1901429
11,2409348,,1997,YALE UNIVERSITY,NEW HAVEN,CT,PSYCHIATRY,5T32MH014276-23,MH014276,UNITED STATES,T32,182485,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,RESEARCH TRAINING - BIOLOGICAL SCIENCES,,RONALD S. DUMAN,1865048
12,6646278,,2002,YALE UNIVERSITY,NEW HAVEN,CT,INTERNAL MEDICINE/MEDICINE,3T32DK007058-27S1,DK007058,UNITED STATES,T32,23916,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2004-06-30T04:00:00Z,,,DIABETES MELLITUS AND DISORDERS OF METABOLISM,,ROBERT S SHERWIN,1882029
13,6618495,,2002,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,3T32DK007120-28S1,DK007120,UNITED STATES,T32,43912,False,JAMES F HYDE,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2005-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
14,2020391,,1997,YALE UNIVERSITY,NEW HAVEN,CT,PHARMACOLOGY,2T32GM007324-21,GM007324,UNITED STATES,T32,141188,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARD,,PRISCILLA S DANNIES,1880393
15,2020389,,1997,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,BIOCHEMISTRY,2T32GM007315-21A1,GM007315,UNITED STATES,T32,151672,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY AT MICHIGAN,,DAVID R ENGELKE,1872783
16,2020388,,1997,TUFTS UNIVERSITY BOSTON,BOSTON,MA,BIOCHEMISTRY,2T32GM007310-21,GM007310,UNITED STATES,T32,133218,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,MOLECULAR GENETICS OF BASIC CELL FUNCTIONS,,CATHERINE L SQUIRES,1898450
17,2020383,,1997,DUKE UNIVERSITY,DURHAM,NC,PATHOLOGY,2T32GM007171-23,GM007171,UNITED STATES,T32,932982,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,Salvatore V Pizzo,1871037
18,2020380,,1997,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,MICROBIOLOGY/IMMUN/VIROLOGY,2T32GM007104-21A2,GM007104,UNITED STATES,T32,185167,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING PROGRAM IN GENETIC MECHANISMS AT U,,ROBERT W SIMONS,1876779
19,2177897,,1996,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,5R01GM035437-12,GM035437,UNITED STATES,R01,45000,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-07-31T04:00:00Z,,,DORSAL-VENTRAL PATTERN OF THE DROSOPHILA EMBRYO,,Kathryn V Anderson,1885388
20,2166461,,1996,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOCHEMISTRY,5T32GM007309-22,GM007309,UNITED STATES,T32,1288723,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,STEPHEN V DESIDERIO,1926905
21,2166456,,1996,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NEW YORK,NY,ANATOMY/CELL BIOLOGY,5T32GM007308-22,GM007308,UNITED STATES,T32,813875,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,MEDICAL SCIENTIST RESEARCH SERVICE AWARD,,DAVID D SABATINI,1871376
22,2166357,,1996,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOLOGY,2T32GM007231-22,GM007231,UNITED STATES,T32,675913,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,RICHARD E MCCARTY,1955226
23,2166236,,1996,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,BIOCHEMISTRY,5T32GM007135-22,GM007135,UNITED STATES,T32,374234,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,CREATIVE TRAINING IN MOLECULAR BIOLOGY,,WILLIAM B WOOD,1871377
24,2166170,,1996,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,PEDIATRICS,5T32GM007085-20,GM007085,UNITED STATES,T32,76639,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING IN MEDICAL GENETICS,,Charles J Epstein,1865075
25,2166141,,1996,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOMEDICAL ENGINEERING,5T32GM007057-22,GM007057,UNITED STATES,T32,270316,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING TRAINING PROGRAM,,LAWRENCE P SCHRAMM,1890370
26,2212013,,1996,WAKE FOREST UNIVERSITY,WINSTON-SALEM,NC,PATHOLOGY,5T32HL007115-22,HL007115,UNITED STATES,T32,269506,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,CARDIOVASCULAR PATHOLOGY,,Richard W ST CLAIR,1884537
27,2211934,,1996,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,2T32HL007057-21,HL007057,UNITED STATES,T32,199486,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,TRANSFUSION MEDICINE AND RELATED AREAS,,Marilyn J Telen,1885877
28,2211898,,1996,WEILL MEDICAL COLLEGE OF CORNELL UNIV,NEW YORK,NY,INTERNAL MEDICINE/MEDICINE,5T32HL007029-22,HL007029,UNITED STATES,T32,187168,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY,,Roy L Silverstein,1893827
29,2211865,,1996,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PITTSBURGH,PA,PUBLIC HEALTH & PREV MEDICINE,5T32HL007011-22,HL007011,UNITED STATES,T32,201927,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,CARDIOVASCULAR EPIDEMIOLOGY TRAINING PROGRAM,,LEWIS H KULLER,1861036
30,2562671,,1997,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,PUBLIC HEALTH & PREV MEDICINE,5T32HL007024-23,HL007024,UNITED STATES,T32,303619,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,2000-05-31T04:00:00Z,,,CARDIOVASCULAR EPIDEMIOLOGY INSTITUTIONAL TRAINING,,PAUL K WHELTON,2040693
31,6375523,,2001,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PATHOLOGY,5T32CA009437-20,CA009437,UNITED STATES,T32,552616,False,DAVID J ECKSTEIN,National Cancer Institute,1975-07-01T04:00:00Z,2003-05-31T04:00:00Z,,,MOLECULAR TRAINING PROGRAM IN CANCER RESEARCH - COMPETIN,,LAWRENCE A LOEB,1860313
32,2872446,,1999,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOCHEMISTRY,5T32GM007309-25,GM007309,UNITED STATES,T32,1621049,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,ROBERT F SILICIANO,1880560
33,2872443,,1999,YESHIVA UNIVERSITY,BRONX,NY,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007288-25,GM007288,UNITED STATES,T32,1140385,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,Betty  Diamond,1862435
34,2872441,,1999,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,BIOCHEMISTRY,5T32GM007283-25,GM007283,UNITED STATES,T32,524181,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,"Program Goal.  The goal of the training program is to prepare highly            
qualified students for research careers in cellular and molecular biology.      
The program offers its trainees a large and diverse group of faculty            
research mentors (80) with projects in a number of cutting edge areas. It       
is organized to provide students with the collegiality and support of a         
departmental environment but also the flexibility to move easily across         
department lines and to choose research mentors from among all program          
faculty. Trainee research is supported by the outstanding facilities            
available at the University of Illinois.                                        
                                                                                
Students. The training program has proved to be an extremely valuable           
recruiting tool in attracting a highly qualified and geographically             
diverse group of students. We have significantly improved the                   
representation of minority students in the program and added a large new        
pool of students through a new department, Cell and Structural Biology.         
                                                                                
Faculty. We have maintained strength in the areas in which we have been         
strong traditionally and increased our strength in cell biology. An             
outstanding group of new faculty have been added to the program since the       
last renewal and we project continued faculty growth in cell and molecular      
biology.                                                                        
                                                                                
Program Design. The program would provide three years of support for 27         
students. The program has functioned to allow students full access to all       
the relevant faculty and facilities of the institution while providing          
them with the supportive atmosphere of relatively small departments. The        
program sets certain course requirements for all its students. It also          
mandates that all its students carry out research rotations and requires        
that at least one rotation be outside the major department. Students also       
organize and run an annual symposium and a monthly seminar series.              
                                                                                
Facilities. There has been a dramatic increase in the research space            
devoid to cell and molecular biology at UIUC. The Chemistry-Life Sciences       
Building (to be occupied in 1996) will provide new space to many more. We       
offer our trainees world class research support facilities in the               
Biotechnology Center (oligonucleotide and peptide synthesis, nucleotide         
and protein sequencing, amino acid analysis, production of hybridomas,          
polyclonal antibodies and transgenic animals, flow cytometry, fermentation      
and electron microscopy facilities), Chemical Sciences Laboratories (NMR,       
ESR, mass spectrometry, etc.), imaging (Beckman Institute), and computing       
(NCSA, SOLS network) facilities.                                                
",CELLULAR AND MOLECULAR BIOLOGY,,David M. Kranz,1879633
35,2872436,,1999,UNIVERSITY OF WASHINGTON,SEATTLE,WA,BIOCHEMISTRY,5T32GM007270-25,GM007270,UNITED STATES,T32,796192,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,TRAINING IN MOLECULAR AND CELLULAR BIOLOGY,,David  Kimelman,1895252
36,2872430,,1999,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,BIOLOGY,5T32GM007229-25,GM007229,UNITED STATES,T32,1014937,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,"The Cell and Molecular Biology Predoctoral Training Program at the              
University of Pennsylvania is a University-wide, interdepartmental and          
interschool program for careers in modern biology.  The group of trainers       
consists of more than 100 senior and younger faculty from many parts of         
the University.  These faculty members, and the training they provide,          
are organized into Graduate Groups according to disciplines of interest.        
These Graduate Groups, which are interdepartmental and interschool in           
membership and fully responsible for graduate education, are not the same       
as or coextensive with Departments. Individual Graduate Groups set              
requirements for degrees, admit and monitor the progress of students, and       
eventually certify their degrees.  organizationally, two of the Graduate        
Groups that participate in this program are in the School of Arts and           
Sciences (Biology and Chemistry), and the remaining 10 Groups come under        
Biomedical Graduate Studies in the School of Medicine, which provides a         
central point for processing applications, keeping records, coordinating        
curricula and other activities of the individual Graduate Groups, and           
through which considerable University funding for student support is            
channeled.  This somewhat unusual arrangement, whereby graduate education       
is handled by Graduate Groups rather than Departments, promotes                 
interaction among the many faculty having common interests in cell and          
molecular biology, and, contributes strongly to the interdisciplinary           
spirit of graduate training and collaborative research in these areas at        
the University of Pennsylvania.  The Training Program in Cell and               
Molecular Biology is an important component in attempts to maximize             
interaction among students and faculty of various Departments.  Trainees        
meet together periodically and, approximately once per year, choose a           
topic for a special 1-2 day seminar, select and invite speakers, and            
otherwise organize all aspects of the seminar. only students working            
toward the Ph.D. degree are supported by this Training Program. In total,       
34 students were supported for part or all of the present year, out of          
a total pool of more than 300 matriculated Ph.D. students interested in         
cell and molecular biology.  Individual Graduate Groups differ somewhat         
in their procedures and methods used in training.  All use a mix of             
formal courses, pre-thesis laboratory rotations, seminars, and individual       
laboratory research work leading to a thesis.  Examination and                  
supervision of research progress are done by faculty committees,                
sometimes with the addition of persons from outside the University              
",TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGY,,LEE D PEACHEY,1870979
37,2872425,,1999,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32GM007200-25,GM007200,UNITED STATES,T32,1661756,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,"This is a renewal application for support of graduate training in Cellular      
and Molecular Biology within the Division of Biology and Biomedical             
Sciences at Washington University.  Since 1973, all predoctoral education       
in the biological sciences at Washington University has been provided by        
the Division of Biology and Biomedical Sciences. The Division is a unique       
and nationally recognized administrative structure, the key feature of          
which is the absence of any departmental predoctoral programs: all              
predoctoral programs and degree-granting units in the biological sciences       
at this university are both interdisciplinary and interdepartmental. The        
Division was established with its own endowment more than 20 years ago in       
recognition of the increasingly interrelated nature of all aspects of           
research in the biomedical and biological sciences, and in order to             
facilitate cooperation among faculty in the interdisciplinary training of       
prospective biological scientists.                                              
                                                                                
It is in such a tradition that the current training grant is rooted; we         
intend to use the continuation of this training grant to promote the            
professional growth of students whose research interests lie in an              
interdisciplinary area of rapidly growing importance and productivity:          
cellular and molecular biology. In parallel we hope to foster interactions      
among faculty which in turn will provide unique research opportunities for      
students.                                                                       
",NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTIST,,Daniel E. Goldberg,1930486
38,2872420,,1999,DUKE UNIVERSITY,DURHAM,NC,NEUROSCIENCES,5T32GM007184-25,GM007184,UNITED STATES,T32,817075,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,ORGANIZATION AND FUNCTION OF CELLULAR STRUCTURE,,DAVID R MC CLAY,1896395
39,2872418,,1999,COLUMBIA UNIVERSITY HEALTH SCIENCES,NEW YORK,NY,PHARMACOLOGY,5T32GM007182-25,GM007182,UNITED STATES,T32,128748,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN PHARMACOLOGICAL SCIENCES,,RICHARD B ROBINSON,1899763
40,2872403,,1999,COLUMBIA UNIVERSITY HEALTH SCIENCES,NEW YORK,NY,GENETICS,5T32GM007088-25,GM007088,UNITED STATES,T32,286704,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,PREDOCTORAL TRAINING GRANT IN GENETICS AND DEVELOPMENT,,VIRGINIA E. PAPAIOANNOU,1955125
41,2872440,,1999,UNIVERSITY OF CHICAGO,CHICAGO,IL,PATHOLOGY,5T32GM007281-25,GM007281,UNITED STATES,T32,1233714,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,MEDICAL SCIENTIST NATIONAL RESEARCH SERVICE AWARD,,Jose Ramon Quintans,1955225
42,2379517,,1997,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-22,NS007044,UNITED STATES,T32,230793,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,NEUROSCIENCE TRAINING GRANT,,Kenneth J Muller,7684521
43,2896938,,1999,UNIVERSITY OF WASHINGTON,SEATTLE,WA,DENTISTRY,5T32DE007023-25,DE007023,UNITED STATES,T32,41684,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,2002-06-30T04:00:00Z,DE9304,"DESCRIPTION: This is an application for renewal  of an on-going oral biology NRSA training program in salivary  secretions, under the continuing directorship of Dr. Kenneth Izutsu.  The  purpose of the program is to provide multi-disciplinary  training in salivary secretion biology  as it  relates to oral  health and disease.  The goal is to train researchers, primarily at the postdoctoral level, to become effective investigators of both basic mechanisms of secretion and the  pathology associated with  different diseases involving oral tissues. Twenty-two training faculty, with expertise in a wide range of disciplines that converge on oral health and disease, are involved in the training program. It is designed  to   support  postdoctoral  trainees predominantly, with a minor component of training for research oriented undergraduate dental students. The majority of postdoctoral candidates will have  the DDS  degree and  will pursue PhD or MSD  degrees. The  remainder will be  PhD degree investigators particularly interested in salivary secretions or other oral biology research. PhD candidates  will  predominantly matriculate in the Department of Oral Biology although selection of another department represented by a training faculty member will be available. MSD candidates would matriculate  in oral pathology or oral medicine. All trainees would pursue the oral biology core curriculum plus  additional formal  classwork based  on  individual goals and interests. The program is to be administered  through the program director who will  work closely with the  Oral Biology Department Chairman, a co-program director for the program.  A steering committee, consisting of the full members of the Oral Biology  Department, will advise on accepting new  students and  recruitment activities, and will periodically review  each trainee's  progress and  make suggestions as appropriate. ",ORAL BIOLOGY TRAINING - SALIVARY SECRETIONS,,Kenneth T Izutsu,1877343
44,2443800,,1997,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32DK007120-23,DK007120,UNITED STATES,T32,261171,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
45,2443795,,1997,VANDERBILT UNIVERSITY,NASHVILLE,TN,PHYSIOLOGY,5T32DK007061-24,DK007061,UNITED STATES,T32,193575,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
46,2443792,,1997,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,INTERNAL MEDICINE/MEDICINE,5T32DK007053-24,DK007053,UNITED STATES,T32,124239,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
47,2443787,,1997,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,5T32DK007011-24,DK007011,UNITED STATES,T32,188459,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,INTEGRATED CLINICAL AND BASIC ENDOCRINOLOGY RESEARCH,,KENNETH S POLONSKY,1873910
48,2547255,,1998,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,PSYCHOLOGY,2T32MH014257-24,MH014257,UNITED STATES,T32,164894,False,DELLA M. HANN,National Institute of Mental Health,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,QUANTITATIVE METHODS FOR BEHAVIORAL RESEARCH,,LAWRENCE E JONES,1871718
49,2654727,,1998,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,BIOCHEMISTRY,5T32GM007306-23,GM007306,UNITED STATES,T32,226631,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,DONALD M COEN,1888951
0,2084726,,1995,INSTITUTE FOR CANCER RESEARCH,PHILADELPHIA,PA,,2T32CA009035-21,CA009035,UNITED STATES,T32,341578,False,,National Cancer Institute,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,,TRAINING PROGRAM IN CANCER RESEARCH,,CHARLES P. EMERSON,1884969
1,2260234,,1995,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-20,NS007044,UNITED STATES,T32,237323,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1996-09-19T04:00:00Z,,,NEUROSCIENCE TRAINING GRANT,,Kenneth J Muller,7684521
2,2260228,,1995,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,PEDIATRICS,5T32NS007027-20,NS007027,UNITED STATES,T32,137452,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,Steven Mark Rothman,8902205
3,2260218,,1995,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,BIOLOGY,2T32NS007009-21,NS007009,UNITED STATES,T32,169914,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,Gerald D Fischbach,1877448
4,2129471,,1995,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,DENTISTRY,5T32DE007034-20,DE007034,UNITED STATES,T32,28209,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,DE8907,,TRAINING PROGRAM IN PERIODONTAL DISEASE,,Robert J Genco,1883720
5,2129451,,1995,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,DENTISTRY,5T32DE007010-20,DE007010,UNITED STATES,T32,250650,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,DE8907,,RESEARCH TRAINING IN PERIODONTAL DISEASES,,T. HOWARD HOWELL,1967091
6,2129436,,1995,UNIVERSITY OF SOUTHERN CALIFORNIA,LOS ANGELES,CA,OTHER BASIC SCIENCES,5T32DE007006-19,DE007006,UNITED STATES,T32,84749,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,TRAINING PROGRAM IN CRANIOFACIAL BIOLOGY (CBY),,Michael  Melnick,3095428
7,2700280,,1998,STANFORD UNIVERSITY,STANFORD,CA,PATHOLOGY,5T32CA009151-24,CA009151,UNITED STATES,T32,183983,False,LESTER S. GORELIC,National Cancer Institute,1975-07-01T04:00:00Z,2000-04-30T04:00:00Z,,,POSTDOCTORAL RESEARCH TRAINING IN TUMOR BIOLOGY,,TERESA S WANG,1894227
8,2700155,,1998,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,INTERNAL MEDICINE/MEDICINE,5T32AR007048-23,AR007048,UNITED STATES,T32,79674,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,2002-04-30T04:00:00Z,,,DISEASES OF BONE AND CALCIUM METABOLISM,,LEONARD JOHN DEFTOS,1872997
9,2547255,,1998,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,PSYCHOLOGY,2T32MH014257-24,MH014257,UNITED STATES,T32,164894,False,DELLA M. HANN,National Institute of Mental Health,1975-07-01T04:00:00Z,2003-06-30T04:00:00Z,,,QUANTITATIVE METHODS FOR BEHAVIORAL RESEARCH,,LAWRENCE E JONES,1871718
10,2243045,,1994,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,BIOLOGY,5T32MH014277-20,MH014277,UNITED STATES,T32,126861,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,RESEARCH TRAINING IN BIOLOGICAL SCIENCES,,GERRY S OXFORD,1871141
11,2166386,,1994,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,PHYSIOLOGY,3T32GM007258-19S1,GM007258,UNITED STATES,T32,100811,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,INTERGRATIVE BIOLOGY:  FROM CELLS TO ORGANISMS,,ALFRED L GOLDBERG,1876808
12,2166365,,1994,NEW YORK UNIVERSITY,NEW YORK,NY,ANATOMY/CELL BIOLOGY,5T32GM007238-20,GM007238,UNITED STATES,T32,133311,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GRADUATE PROGRAM IN CELLULAR & MOLECULAR BIOLOGY,,DAVID D SABATINI,1871376
13,2166274,,1994,TULANE UNIVERSITY OF LOUISIANA,NEW ORLEANS,LA,PHARMACOLOGY,5T32GM007177-18,GM007177,UNITED STATES,T32,84698,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,JAMES W FISHER,1955621
14,2129470,,1994,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,DENTISTRY,5T32DE007034-19,DE007034,UNITED STATES,T32,243551,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,DE8907,,TRAINING PROGRAM IN PERIODONTAL DISEASE,,Robert J Genco,1883720
15,2129450,,1994,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,DENTISTRY,5T32DE007010-19,DE007010,UNITED STATES,T32,250419,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,DE8907,,RESEARCH TRAINING IN PERIODONTAL DISEASES,,T. HOWARD HOWELL,1967091
16,2077680,,1994,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,5T32AR007108-20,AR007108,UNITED STATES,T32,156928,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN RHEUMATOLOGY,,MART  MANNIK,1862432
17,2077665,,1994,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32AR007093-19,AR007093,UNITED STATES,T32,28789,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,DERMATOLOGY TRAINING PROGRAM,,RUSSELL P. HALL,1969553
18,2134631,,1994,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,3T32DK007130-21S1,DK007130,UNITED STATES,T32,35820,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGY,,DAVID H. ALPERS,1863717
19,2134580,,1994,THOMAS JEFFERSON UNIVERSITY,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32DK007084-19,DK007084,UNITED STATES,T32,51297,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1996-03-31T05:00:00Z,,,RESEARCH TRAINING IN HEMATOLOGY,,SANDOR S SHAPIRO,1879114
20,2134574,,1994,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,5T32DK007074-21,DK007074,UNITED STATES,T32,236276,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITION,,THOMAS A BRASITUS,1863643
21,2134566,,1994,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,3T32DK007066-19S1,DK007066,UNITED STATES,T32,37756,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,UNIVERSITY OF PENNSYLVANIA TRAINING IN GASTROENTEROLOGY,,PETER G TRABER,1877185
22,2134556,,1994,YALE UNIVERSITY,NEW HAVEN,CT,INTERNAL MEDICINE/MEDICINE,2T32DK007058-20,DK007058,UNITED STATES,T32,174244,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1999-06-30T04:00:00Z,,,DIABETES MELLITUS & DISORDERS OF METABOLISM,,ROBERT S SHERWIN,1882029
23,2134530,,1994,UNIVERSITY OF COLORADO DENVER,AURORA,CO,INTERNAL MEDICINE/MEDICINE,3T32DK007038-20S1,DK007038,UNITED STATES,T32,38350,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,GASTROINTESTINAL DISEASE,,WILLIAM R BROWN,1870124
24,2134480,,1994,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,INTERNAL MEDICINE/MEDICINE,5T32DK007007-20,DK007007,UNITED STATES,T32,208008,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TRAINING PROGRAM IN DIGESTIVE DISEASES & NUTRITION,,ROBERT K OCKNER,1863701
25,2085427,,1994,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PATHOLOGY,5T32CA009437-13,CA009437,UNITED STATES,T32,236974,False,,National Cancer Institute,1975-07-01T04:00:00Z,1997-05-31T04:00:00Z,,,MOLECULAR TRAINING PROGRAM IN CANCER RESEARCH,,LAWRENCE A LOEB,1860313
26,2084921,,1994,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,PATHOLOGY,5T32CA009141-19,CA009141,UNITED STATES,T32,305595,False,,National Cancer Institute,1975-07-01T04:00:00Z,1996-03-31T05:00:00Z,,,PHD PROGRAM IN IMMUNOLOGY,,MARTIN E DORF,1860771
27,2084779,,1994,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,PHYSIOLOGY,5T32CA009067-20,CA009067,UNITED STATES,T32,166583,False,,National Cancer Institute,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,RADIATION BIOPHYSICS & BIOENGINEERING IN ONCOLOGY,,HONG  JIANG,6667542
28,2084770,,1994,YESHIVA UNIVERSITY,BRONX,NY,GENETICS,5T32CA009060-19,CA009060,UNITED STATES,T32,165968,False,,National Cancer Institute,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,TRAINING IN VIRAL ONCOLOGY AND TUMOR BIOLOGY,,FRANK  LILLY,1969004
29,2084731,,1994,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,INTERNAL MEDICINE/MEDICINE,5T32CA009041-20,CA009041,UNITED STATES,T32,246823,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,EXPERIMENTAL BIOLOGY OF CANCER: HORMONES  & GROWTH,,CHARLES S NICOLL,1964063
30,2077640,,1994,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,INTERNAL MEDICINE/MEDICINE,5T32AR007055-21,AR007055,UNITED STATES,T32,144180,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BASIC AND CLINICAL RHEUMATOLOGY,,Peter E Lipsky,1862417
31,2134552,,1995,STANFORD UNIVERSITY,STANFORD,CA,INTERNAL MEDICINE/MEDICINE,2T32DK007056-22,DK007056,UNITED STATES,T32,159981,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING GRANT IN ACADEMIC GASTROENTEROLOGY,,Harry Bernard Greenberg,6605673
32,2134542,,1995,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PITTSBURGH,PA,INTERNAL MEDICINE/MEDICINE,2T32DK007052-22,DK007052,UNITED STATES,T32,165032,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,FREDERICK R DERUBERTIS,1888258
33,2134521,,1995,MASSACHUSETTS GENERAL HOSPITAL,BOSTON,MA,,2T32DK007028-21,DK007028,UNITED STATES,T32,270583,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETES,,JOSEPH  AVRUCH,1888259
34,2134494,,1995,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32DK007012-20,DK007012,UNITED STATES,T32,135200,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,ENDOCRINOLOGY AND DIABETES TRAINING PROGRAM,,MARC KENNETH DREZNER,1877789
35,2134634,,1996,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,INTERNAL MEDICINE/MEDICINE,5T32DK007130-23,DK007130,UNITED STATES,T32,135985,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGY,,DAVID H. ALPERS,1863717
36,2134576,,1996,UNIVERSITY OF CHICAGO,CHICAGO,IL,INTERNAL MEDICINE/MEDICINE,5T32DK007074-23,DK007074,UNITED STATES,T32,251185,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITION,,THOMAS A BRASITUS,1863643
37,2134571,,1996,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,INTERNAL MEDICINE/MEDICINE,5T32DK007066-22,DK007066,UNITED STATES,T32,191787,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN GASTROINTESTINAL SCIENCES,,PETER G TRABER,1877185
38,2134553,,1996,STANFORD UNIVERSITY,STANFORD,CA,INTERNAL MEDICINE/MEDICINE,5T32DK007056-23,DK007056,UNITED STATES,T32,139151,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING GRANT IN ACADEMIC GASTROENTEROLOGY,,Harry Bernard Greenberg,6605673
39,2134495,,1996,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,2T32DK007012-21,DK007012,UNITED STATES,T32,153258,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,ENDOCRINOLOGY AND DIABETES TRAINING PROGRAM,,MARC KENNETH DREZNER,1877789
40,2166174,,1995,COLUMBIA UNIVERSITY HEALTH SCIENCES,NEW YORK,NY,GENETICS,5T32GM007088-21,GM007088,UNITED STATES,T32,205419,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,PREDOCTORAL TRAINING GRANT IN GENETICS AND DEVELOPMENT,,MARIAN B CARLSON,1887807
41,2161174,,1995,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,HOUSTON,TX,OTHER HEALTH PROFESSIONS,2T32EY007024-16A2,EY007024,UNITED STATES,T32,72422,False,,National Eye Institute,1975-07-01T04:00:00Z,1999-12-31T05:00:00Z,,,HOUSTON AREA VISION TRAINING PROGRAM,,Dianna Ammons Johnson,1890831
42,2243021,,1995,YALE UNIVERSITY,NEW HAVEN,CT,PUBLIC HEALTH & PREV MEDICINE,2T32MH014235-21,MH014235,UNITED STATES,T32,209527,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
43,2156011,,1995,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,PATHOLOGY,2T32ES007017-21,ES007017,UNITED STATES,T32,317716,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,ENVIRONMENTAL PATHOLOGY,,David G. Kaufman,7944001
44,2166490,,1995,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,BIOCHEMISTRY,5T32GM007323-21,GM007323,UNITED STATES,T32,205741,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CHEMICAL BASES OF CELL AND MOLECULAR BIOLOGY,,IRIS  GOLDSTEIN,6666298
45,2166475,,1995,PRINCETON UNIVERSITY,PRINCETON,NJ,BIOCHEMISTRY,2T32GM007312-21,GM007312,UNITED STATES,T32,439075,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1998-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,THOMAS E SHENK,1894197
46,2166430,,1995,UNIVERSITY OF CHICAGO,CHICAGO,IL,BIOCHEMISTRY,2T32GM007281-21,GM007281,UNITED STATES,T32,992880,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,MEDICAL SCIENTIST NATIONAL RESEARCH SERVICE AWARD,,Jose Ramon Quintans,1955225
47,2166342,,1995,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,ANATOMY/CELL BIOLOGY,5T32GM007226-21,GM007226,UNITED STATES,T32,311551,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CELLULAR AND DEVELOPMENTAL BIOLOGY,,MARC Wallace KIRSCHNER,1863369
48,2166265,,1995,DUKE UNIVERSITY,DURHAM,NC,PATHOLOGY,5T32GM007171-21,GM007171,UNITED STATES,T32,749040,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,Salvatore V Pizzo,1871037
49,2166245,,1995,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,NONE,3T32GM007145-20S1,GM007145,UNITED STATES,T32,66220,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,PREDOCTORAL TRAINING IN PHARMACEUTICAL SCIENCES,,WAYNE K ANDERSON,1965586
0,2166365,,1994,NEW YORK UNIVERSITY,NEW YORK,NY,ANATOMY/CELL BIOLOGY,5T32GM007238-20,GM007238,UNITED STATES,T32,133311,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GRADUATE PROGRAM IN CELLULAR & MOLECULAR BIOLOGY,,DAVID D SABATINI,1871376
1,2166274,,1994,TULANE UNIVERSITY OF LOUISIANA,NEW ORLEANS,LA,PHARMACOLOGY,5T32GM007177-18,GM007177,UNITED STATES,T32,84698,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,JAMES W FISHER,1955621
2,2166230,,1994,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007134-20,GM007134,UNITED STATES,T32,136798,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-09-30T04:00:00Z,,,REGULATION & EXPRESSION OF BIOLOGICAL PROCESSES,,G. WESLEY HATFIELD,1859692
3,2166168,,1994,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,PEDIATRICS,5T32GM007085-18,GM007085,UNITED STATES,T32,103449,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING IN MEDICAL GENETICS,,Charles J Epstein,1865075
4,2077680,,1994,UNIVERSITY OF WASHINGTON,SEATTLE,WA,INTERNAL MEDICINE/MEDICINE,5T32AR007108-20,AR007108,UNITED STATES,T32,156928,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN RHEUMATOLOGY,,MART  MANNIK,1862432
5,2077665,,1994,DUKE UNIVERSITY,DURHAM,NC,INTERNAL MEDICINE/MEDICINE,5T32AR007093-19,AR007093,UNITED STATES,T32,28789,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,DERMATOLOGY TRAINING PROGRAM,,RUSSELL P. HALL,1969553
6,2077640,,1994,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,INTERNAL MEDICINE/MEDICINE,5T32AR007055-21,AR007055,UNITED STATES,T32,144180,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BASIC AND CLINICAL RHEUMATOLOGY,,Peter E Lipsky,1862417
7,2085427,,1994,UNIVERSITY OF WASHINGTON,SEATTLE,WA,PATHOLOGY,5T32CA009437-13,CA009437,UNITED STATES,T32,236974,False,,National Cancer Institute,1975-07-01T04:00:00Z,1997-05-31T04:00:00Z,,,MOLECULAR TRAINING PROGRAM IN CANCER RESEARCH,,LAWRENCE A LOEB,1860313
8,2084921,,1994,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,PATHOLOGY,5T32CA009141-19,CA009141,UNITED STATES,T32,305595,False,,National Cancer Institute,1975-07-01T04:00:00Z,1996-03-31T05:00:00Z,,,PHD PROGRAM IN IMMUNOLOGY,,MARTIN E DORF,1860771
9,2084779,,1994,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,PHYSIOLOGY,5T32CA009067-20,CA009067,UNITED STATES,T32,166583,False,,National Cancer Institute,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,RADIATION BIOPHYSICS & BIOENGINEERING IN ONCOLOGY,,HONG  JIANG,6667542
10,2084770,,1994,YESHIVA UNIVERSITY,BRONX,NY,GENETICS,5T32CA009060-19,CA009060,UNITED STATES,T32,165968,False,,National Cancer Institute,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,TRAINING IN VIRAL ONCOLOGY AND TUMOR BIOLOGY,,FRANK  LILLY,1969004
11,2084731,,1994,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,INTERNAL MEDICINE/MEDICINE,5T32CA009041-20,CA009041,UNITED STATES,T32,246823,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,EXPERIMENTAL BIOLOGY OF CANCER: HORMONES  & GROWTH,,CHARLES S NICOLL,1964063
12,3534792,,1992,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32DK007116-18,DK007116,UNITED STATES,T32,52172,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-12-31T05:00:00Z,,,PEDIATRIC ENDOCRINOLOGY AND METABOLISM,,CLAUDE J MIGEON,1966818
13,3534705,,1992,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5T32DK007074-19,DK007074,UNITED STATES,T32,220915,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITION,,THOMAS A BRASITUS,1863643
14,3534688,,1992,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32DK007061-19,DK007061,UNITED STATES,T32,160287,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
15,3534662,,1992,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,5T32DK007053-19,DK007053,UNITED STATES,T32,192136,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
16,3534613,,1992,MASSACHUSETTS GENERAL HOSPITAL,BOSTON,MA,,5T32DK007028-18,DK007028,UNITED STATES,T32,263138,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETES,,JOSEPH  AVRUCH,1888259
17,3534532,,1992,"MONTEFIORE MEDICAL CENTER (BRONX, NY)",NEW YORK,NY,,5T32DK007004-19,DK007004,UNITED STATES,T32,98402,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,INVESTIGATIVE ENDOCRINOLOGY,,MARTIN I SURKS,1966587
18,3534840,,1992,UNIVERSITY OF CHICAGO,CHICAGO,IL,,3T32DK007134-15S1,DK007134,UNITED STATES,T32,7020,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,RESEARCH TRAINING GRANT IN HEMATOLOGY,,HARVEY M GOLOMB,1865143
19,3534783,,1992,UNIVERSITY OF UTAH,SALT LAKE CITY,UT,,5T32DK007115-18,DK007115,UNITED STATES,T32,134779,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN HEMATOLOGY,,M P HEILBRUN,1877163
20,3532620,,1992,STANFORD UNIVERSITY,STANFORD,CA,,5T32CA009151-18,CA009151,UNITED STATES,T32,124806,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TUMOR BIOLOGY,,MICHAEL R LIEBER,1867499
21,3532311,,1992,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32CA009041-18,CA009041,UNITED STATES,T32,279996,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,EXPERIMENTAL BIOLOGY OF CANCER--HORMONES AND GROWTH,,CHARLES S NICOLL,1964063
22,3534748,,1992,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32DK007100-19,DK007100,UNITED STATES,T32,120938,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GRADUATE TRAINING IN GASTROENTEROLOGY AND HEPATOLOGY,,BURTON  COMBES,1898627
23,3531767,,1992,YALE UNIVERSITY,NEW HAVEN,CT,,5T32AR007016-19,AR007016,UNITED STATES,T32,142510,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,DERMATOLOGY RESEARCH TRAINING PROGRAM,,RICHARD Leslie EDELSON,1894263
24,2243018,,1992,YALE UNIVERSITY,NEW HAVEN,CT,PUBLIC HEALTH & PREV MEDICINE,5T32MH014235-18,MH014235,UNITED STATES,T32,206024,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
25,3543472,,1990,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32NS007027-15,NS007027,UNITED STATES,T32,141813,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,PHILIP R. DODGE,2401559
26,3541934,,1990,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32MH014275-16,MH014275,UNITED STATES,T32,116015,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,RESEARCH TRAINING--BIOLOGICAL SCIENCES,,WILLIAM H. MORSE,1961057
27,3541900,,1990,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,5T32MH014257-16,MH014257,UNITED STATES,T32,114110,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,QUANTITATIVE METHODS FOR BEHAVIORAL RESEARCH,,LAWRENCE E JONES,1871718
28,3541877,,1990,YALE UNIVERSITY,NEW HAVEN,CT,,2T32MH014235-16,MH014235,UNITED STATES,T32,212352,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
29,3541297,,1990,CHILDREN'S HOSPITAL BOSTON,BOSTON,MA,,2T32HL007574-09,HL007574,UNITED STATES,T32,317196,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PATHOPHYSIOLOGY OF HUMAN BLOOD CELLS,,SAMUEL E LUX,1865623
30,3540141,,1990,WAKE FOREST UNIVERSITY,WINSTON-SALEM,NC,,2T32HL007115-16,HL007115,UNITED STATES,T32,265558,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CARDIOVASCULAR PATHOLOGY,,Richard W ST CLAIR,1884537
31,3540067,,1990,UNIVERSITY OF MISSOURI-COLUMBIA,COLUMBIA,MO,,2T32HL007094-16,HL007094,UNITED STATES,T32,165978,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-05-31T04:00:00Z,,,CARDIOVASCULAR/RENAL PHYSIOL--PHARMACOL/BIOCHEMISTRY,,ALLAN W JONES,1962966
32,3540036,,1990,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32HL007088-16,HL007088,UNITED STATES,T32,517420,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MOLECULAR HEMATOLOGY,,PHILIP W MAJERUS,1893529
33,3539945,,1990,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32HL007038-16,HL007038,UNITED STATES,T32,111798,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TRANSFUSION MEDICINE,,  CHAPLIN,3737160
34,3539866,,1990,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32HL007014-15,HL007014,UNITED STATES,T32,142020,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RESPIRATORY DISEASE--BASIC AND CLINICAL RESEARCH,,DONALD F TIERNEY,1963091
35,3538823,,1990,YESHIVA UNIVERSITY,BRONX,NY,,5T32HD007053-15,HD007053,UNITED STATES,T32,158049,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,1992-07-31T04:00:00Z,,,HUMAN DEVELOPMENTAL BIOLOGY,,GEORGE J SCHWARTZ,1898609
36,3537230,,1990,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,2T32GM007309-16,GM007309,UNITED STATES,T32,1190143,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,DAVID  VALLE,3102760
37,3537222,,1990,NEW YORK UNIVERSITY,NEW YORK,NY,,2T32GM007308-16,GM007308,UNITED STATES,T32,1028054,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING,,DAVID D SABATINI,1871376
38,3537219,,1990,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32GM007306-16,GM007306,UNITED STATES,T32,266781,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,Christopher A. Walsh,3140152
39,3537120,,1990,YESHIVA UNIVERSITY,BRONX,NY,,2T32GM007260-16A1,GM007260,UNITED STATES,T32,172768,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,SUSAN BAND HORWITZ,1868745
40,3537107,,1990,UNIVERSITY OF OREGON,EUGENE,OR,,5T32GM007257-16,GM007257,UNITED STATES,T32,139419,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,SYSTEMS PHYSIOLOGY TRAINING PROGRAM,,RUSSELL D FERNALD,1882475
41,3537043,,1990,INDIANA UNIVERSITY BLOOMINGTON,BLOOMINGTON,IN,,5T32GM007227-16,GM007227,UNITED STATES,T32,121371,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,Thomas  Blumenthal,1873663
42,3536992,,1990,YALE UNIVERSITY,NEW HAVEN,CT,,2T32GM007205-16,GM007205,UNITED STATES,T32,1008629,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING,,HOWARD  RASMUSSEN,1888202
43,3536865,,1990,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,2T32GM007145-16,GM007145,UNITED STATES,T32,90338,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PHARMACEUTICAL SCIENCES,,DAVID J TRIGGLE,1957314
44,3536849,,1990,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,2T32GM007135-16,GM007135,UNITED STATES,T32,325142,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MOLECULAR BIOLOGY,,WILLIAM B WOOD,1871377
45,3536823,,1990,YESHIVA UNIVERSITY,BRONX,NY,,5T32GM007128-16,GM007128,UNITED STATES,T32,204059,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,GENETICS AND BIOCHEMISTRY OF CELLULAR REGULATION,,JULIUS  MARMUR,1964923
46,3536728,,1990,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32GM007085-14,GM007085,UNITED STATES,T32,98100,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING IN MEDICAL GENETICS,,Charles J Epstein,1865075
47,3536674,,1990,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,2T32GM007057-16,GM007057,UNITED STATES,T32,240831,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING,,LAWRENCE P SCHRAMM,1890370
48,3536633,,1990,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,2T32GM007037-16,GM007037,UNITED STATES,T32,158262,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING,,Ronald Vitt Maier,1898321
49,3536365,,1990,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5T32EY007022-15,EY007022,UNITED STATES,T32,275742,False,,National Eye Institute,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,TRAINING PROGRAM IN VISION RESEARCH,,MATHEW  ALPERN,1966008
0,3538749,,1992,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5T32HD007009-18,HD007009,UNITED STATES,T32,273980,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GROWTH AND DEVELOPMENT,,NANCY B SCHWARTZ,1871366
1,3537220,,1992,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32GM007306-18,GM007306,UNITED STATES,T32,269922,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,Christopher A. Walsh,3140152
2,3537195,,1992,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,5T32GM007283-18,GM007283,UNITED STATES,T32,435873,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,THOMAS G EBREY,1872346
3,3537109,,1992,UNIVERSITY OF OREGON,EUGENE,OR,,5T32GM007257-18,GM007257,UNITED STATES,T32,106193,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,SYSTEMS PHYSIOLOGY TRAINING PROGRAM,,JANIS CHRISTINE WEEKS,1887121
4,3537101,,1992,CASE WESTERN RESERVE UNIVERSITY,CLEVELAND,OH,,5T32GM007250-17,GM007250,UNITED STATES,T32,681212,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1994-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING,,STEVEN G YOUNKIN,1878104
5,3537060,,1992,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,5T32GM007229-18,GM007229,UNITED STATES,T32,609714,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CELL AND MOLECULAR BIOLOGY,,LEE D PEACHEY,1870979
6,3536990,,1992,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32GM007200-18,GM007200,UNITED STATES,T32,1061213,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,NATIONAL RESEARCH SERVICE AWARD - MEDICAL SCIENTIST,,STUART A KORNFELD,1866204
7,3536901,,1992,DUKE UNIVERSITY,DURHAM,NC,,2T32GM007171-18,GM007171,UNITED STATES,T32,665353,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING,,Salvatore V Pizzo,1871037
8,3536858,,1992,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,2T32GM007143-16,GM007143,UNITED STATES,T32,134192,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,SYSTEMS AND INTEGRATIVE BIOLOGY,,JAMES E HEATH,1965587
9,3536839,,1992,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5T32GM007133-18,GM007133,UNITED STATES,T32,330580,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,GENETICS,,WILLIAM Franklin DOVE,1880473
10,3536824,,1992,YESHIVA UNIVERSITY,BRONX,NY,,5T32GM007128-18,GM007128,UNITED STATES,T32,214870,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,GENETICS AND BIOCHEMISTRY OF CELLULAR REGULATION,,JULIUS  MARMUR,1964923
11,3536712,,1992,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32GM007067-18,GM007067,UNITED STATES,T32,584544,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,PHILIP D STAHL,1878747
12,3536656,,1992,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32GM007040-18,GM007040,UNITED STATES,T32,119598,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIS,,KEN  MCCARTHYS,3594297
13,3536325,,1992,BAYLOR COLLEGE OF MEDICINE,HOUSTON,TX,,5T32EY007001-17,EY007001,UNITED STATES,T32,111523,False,,National Eye Institute,1975-07-01T04:00:00Z,1996-01-31T05:00:00Z,,,VISUAL SCIENCES,,ROBERT E ANDERSON,1859630
14,3534688,,1992,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32DK007061-19,DK007061,UNITED STATES,T32,160287,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
15,3534662,,1992,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,5T32DK007053-19,DK007053,UNITED STATES,T32,192136,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
16,3534613,,1992,MASSACHUSETTS GENERAL HOSPITAL,BOSTON,MA,,5T32DK007028-18,DK007028,UNITED STATES,T32,263138,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETES,,JOSEPH  AVRUCH,1888259
17,3534532,,1992,"MONTEFIORE MEDICAL CENTER (BRONX, NY)",NEW YORK,NY,,5T32DK007004-19,DK007004,UNITED STATES,T32,98402,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,INVESTIGATIVE ENDOCRINOLOGY,,MARTIN I SURKS,1966587
18,3534840,,1992,UNIVERSITY OF CHICAGO,CHICAGO,IL,,3T32DK007134-15S1,DK007134,UNITED STATES,T32,7020,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,RESEARCH TRAINING GRANT IN HEMATOLOGY,,HARVEY M GOLOMB,1865143
19,3534783,,1992,UNIVERSITY OF UTAH,SALT LAKE CITY,UT,,5T32DK007115-18,DK007115,UNITED STATES,T32,134779,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN HEMATOLOGY,,M P HEILBRUN,1877163
20,3532620,,1992,STANFORD UNIVERSITY,STANFORD,CA,,5T32CA009151-18,CA009151,UNITED STATES,T32,124806,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TUMOR BIOLOGY,,MICHAEL R LIEBER,1867499
21,3534792,,1992,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32DK007116-18,DK007116,UNITED STATES,T32,52172,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-12-31T05:00:00Z,,,PEDIATRIC ENDOCRINOLOGY AND METABOLISM,,CLAUDE J MIGEON,1966818
22,2166273,,1993,TULANE UNIVERSITY OF LOUISIANA,NEW ORLEANS,LA,PHARMACOLOGY,5T32GM007177-17,GM007177,UNITED STATES,T32,101403,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1997-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,JAMES W FISHER,1955621
23,2166229,,1993,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,MICROBIOLOGY/IMMUN/VIROLOGY,5T32GM007134-19,GM007134,UNITED STATES,T32,141205,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,REGULATION & EXPRESSION OF BIOLOGICAL PROCESSES,,G. WESLEY HATFIELD,1859692
24,2166172,,1993,COLUMBIA UNIV NEW YORK MORNINGSIDE,NEW YORK,NY,GENETICS,5T32GM007088-19,GM007088,UNITED STATES,T32,196732,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,PREDOCTORAL TRAINING GRANT IN GENETICS AND DEVELOPMENT,,MARIAN B CARLSON,1887807
25,2166143,,1993,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,PHARMACOLOGY,5T32GM007062-19,GM007062,UNITED STATES,T32,120984,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,MECHANISMS OF DRUG ACTION AND DISPOSITION,,ALFRED G GILMAN,1861865
26,2161150,,1993,BAYLOR COLLEGE OF MEDICINE,HOUSTON,TX,OPHTHALMOLOGY,5T32EY007001-18,EY007001,UNITED STATES,T32,159147,False,,National Eye Institute,1975-07-01T04:00:00Z,1996-01-31T05:00:00Z,,,RESEARCH TRAINING IN VISUAL SCIENCES,,ROBERT E ANDERSON,1859630
27,2166369,,1993,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,5T32GM007240-19,GM007240,UNITED STATES,T32,304438,False,,"National Institute of General Medical Sciences,National Human Genome Research Institute",1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GENETIC MECHANISMS AND REGULATION,,IMMO E SCHEFFLER,1964303
28,3534705,,1992,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5T32DK007074-19,DK007074,UNITED STATES,T32,220915,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIGESTIVE DISEASES AND NUTRITION,,THOMAS A BRASITUS,1863643
29,3534748,,1992,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32DK007100-19,DK007100,UNITED STATES,T32,120938,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GRADUATE TRAINING IN GASTROENTEROLOGY AND HEPATOLOGY,,BURTON  COMBES,1898627
30,3532311,,1992,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32CA009041-18,CA009041,UNITED STATES,T32,279996,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,EXPERIMENTAL BIOLOGY OF CANCER--HORMONES AND GROWTH,,CHARLES S NICOLL,1964063
31,3531767,,1992,YALE UNIVERSITY,NEW HAVEN,CT,,5T32AR007016-19,AR007016,UNITED STATES,T32,142510,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,DERMATOLOGY RESEARCH TRAINING PROGRAM,,RICHARD Leslie EDELSON,1894263
32,3538819,,1991,YESHIVA UNIVERSITY,BRONX,NY,,3T32HD007053-15S1,HD007053,UNITED STATES,T32,20667,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,1992-07-31T04:00:00Z,,,HUMAN DEVELOPMENTAL BIOLOGY,,GEORGE J SCHWARTZ,1898609
33,3537271,,1991,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,2T32GM007315-16A1,GM007315,UNITED STATES,T32,266075,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY AT MICHIGAN,,Wesley A. Dunnick,1860337
34,3537267,,1991,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32GM007313-17,GM007313,UNITED STATES,T32,524586,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CELL AND MOLECULAR BIOLOGY,,ERNEST PETER GEIDUSCHEK,1876894
35,3537100,,1991,CASE WESTERN RESERVE UNIVERSITY,CLEVELAND,OH,,5T32GM007250-16,GM007250,UNITED STATES,T32,681212,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1994-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,LESLIE T. WEBSTER,2411381
36,3536967,,1991,UNIVERSITY OF CHICAGO,CHICAGO,IL,,2T32GM007197-17,GM007197,UNITED STATES,T32,401540,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,GENETICS AND REGULATION,,ROCHELLE E ESPOSITO,1898429
37,3536945,,1991,DUKE UNIVERSITY,DURHAM,NC,,5T32GM007184-17,GM007184,UNITED STATES,T32,557380,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,ORGANIZATION AND FUNCTION OF CELLULAR STRUCTURES,,ROBERT L HILL,1876863
38,3536932,,1991,UNIVERSITY OF CHICAGO,CHICAGO,IL,,2T32GM007183-17,GM007183,UNITED STATES,T32,824810,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,MOLECULAR AND CELLULAR BIOLOGY,,EDWIN W. TAYLOR,1898278
39,3536854,,1991,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5T32GM007135-17,GM007135,UNITED STATES,T32,341182,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MOLECULAR BIOLOGY,,WILLIAM B WOOD,1871377
40,3536846,,1991,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,,5T32GM007134-17,GM007134,UNITED STATES,T32,139010,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,REGULATION AND EXPRESSION OF BIOLOGICAL PROCESSES,,G. WESLEY HATFIELD,1859692
41,3536795,,1991,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007108-17,GM007108,UNITED STATES,T32,172029,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,NEUROBIOLOGY,,WAYNE E. CRILL,1901429
42,3536695,,1991,UNIVERSITY OF COLORADO DENVER,AURORA,CO,,5T32GM007063-17,GM007063,UNITED STATES,T32,111237,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CLINICAL PHARMACOLOGY,,ALAN S. NIES,2402537
43,3536679,,1991,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32GM007057-17,GM007057,UNITED STATES,T32,244070,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING,,LAWRENCE P SCHRAMM,1890370
44,3536381,,1991,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32EY007026-17,EY007026,UNITED STATES,T32,151770,False,,National Eye Institute,1975-07-01T04:00:00Z,1995-09-29T04:00:00Z,,,VISION RESEARCH,,GORDON Lee FAIN,1896909
45,3534814,,1991,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32DK007126-18,DK007126,UNITED STATES,T32,228605,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RENAL DISEASE,,Marc Randall Hammerman,1888256
46,3534782,,1991,UNIVERSITY OF UTAH,SALT LAKE CITY,UT,,5T32DK007115-17,DK007115,UNITED STATES,T32,119565,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN HEMATOLOGY,,M P HEILBRUN,1877163
47,3534670,,1991,STANFORD UNIVERSITY,STANFORD,CA,,5T32DK007056-18,DK007056,UNITED STATES,T32,178544,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GASTROENTEROLOGY,,GARY M GRAY,3806119
48,3534541,,1991,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,5T32DK007006-18,DK007006,UNITED STATES,T32,178631,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RENAL RESEARCH,,ERIC Grant NEILSON,1864468
49,3534265,,1991,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,2T32DE007034-16,DE007034,UNITED STATES,T32,219515,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,DE8907,,PERIODONTAL DISEASES,,Robert J Genco,1883720
0,2243021,,1995,YALE UNIVERSITY,NEW HAVEN,CT,PUBLIC HEALTH & PREV MEDICINE,2T32MH014235-21,MH014235,UNITED STATES,T32,209527,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
1,3534617,,1994,UNIVERSITY OF COLORADO DENVER,AURORA,CO,,3T32DK007038-18S2,DK007038,UNITED STATES,T32,1620,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,GASTROINTESTINAL DISEASE,,WILLIAM R BROWN,1870124
2,2683945,,1998,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,DENTISTRY,5T32DE007034-23,DE007034,UNITED STATES,T32,214050,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,DE94004,,TRAINING IN FUNDAMENTAL AND APPLIED ORAL HEALTH RESEARCH,,Robert J Genco,1883720
3,2654684,,1998,UNIVERSITY OF IOWA,IOWA CITY,IA,PHARMACOLOGY,5T32GM007069-24,GM007069,UNITED STATES,T32,98306,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIENCES,,Gerald F Gebhart,1887127
4,2654683,,1998,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,PHYSIOLOGY,5T32GM007067-24,GM007067,UNITED STATES,T32,623915,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,,TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,Kendall J Blumer,1887704
5,2654682,,1998,STANFORD UNIVERSITY,STANFORD,CA,INTERNAL MEDICINE/MEDICINE,5T32GM007065-24,GM007065,UNITED STATES,T32,121511,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2000-06-30T04:00:00Z,,,TRAINING PROGRAM IN CLINICAL PHARMACOLOGY,,TERRENCE FRANCIS BLASCHKE,1955228
6,2654678,,1998,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,BIOCHEMISTRY,5T32GM007048-24,GM007048,UNITED STATES,T32,168632,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,2001-06-30T04:00:00Z,,"This proposal requests support or 15 trainees to continue a                     
multidisciplinary program o predoctoral training in neuroscience at the         
University of California, Berkeley. The goal of the training program is to      
teach graduate students to become productive research scientists and            
teachers across the broad disciplines of neuroscience. The 36                   
participating faculty are drawn from across the entire Berkeley campus and      
represent neuroscience research from the molecular and cellular, to neural      
systems, computation, and cognition. Participating departments include the      
Department of Molecular and Cell Biology (including the Divisions of            
Neurobiology, Cell and Developmental Biology, Genetics, and Biochemistry        
and Molecular Biology), Psychology, Vision Science Optometry, chemistry,        
Electrical Engineering and Computer Science, and Environmental Science.         
Students can be admitted to the program through the Ph.D. programs of any       
of the participating departments.                                               
                                                                                
The program is designed to provide training across the entire range of          
neuroscience through required course work and lab experience. During year       
01, students are exposed to the entire field in a survey course, and are        
required to spend 3 consecutive 10 week periods rotating through different      
laboratories of their choice across the campus. Students also attend            
presentations by faculty members describing research opportunities, the         
annual Neuroscience Program Retreat, and the weekly Neuroscience Seminar        
Series. At the end of the third rotation, students select a laboratory in       
which to conduct their thesis research. During year 02, students begin to       
concentrate on their research; they also take lecture/seminar courses and       
begin to acquire teaching experience by serving as a teaching assistant.        
At the end of the second year, students take their oral qualifying exams.       
In years 3-5, students concentrate on their research projects, continue to      
teach and take advanced seminar courses in areas of relevance to their          
thesis topic.                                                                   
                                                                                
Applicants to the program typically have outstanding undergraduate records      
in the biological, chemical or physical sciences. Admission is based on         
evaluation of previous scholastic achievement, prior research performance,      
scores on GRE tests, statement of purpose and letters of recommendation.        
Only candidates in the top 20% are accepted. The training record of this        
program over the past 10 years indicates that almost 95% of the trainees        
have one on to productive careers in biomedical research.                       
",TRAINING PROGRAM IN NEUROBIOLOGY,,Carla J Shatz,1933620
7,3531787,,1988,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32AR007048-15,AR007048,UNITED STATES,T32,111394,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DISEASES OF BONE AND CALCIUM METABOLISM,,LEONARD JOHN DEFTOS,1872997
8,3531770,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,3T32AR007019-13S1,AR007019,UNITED STATES,T32,14036,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DERMATOLOGY,,GEORGE F. ODLAND,2406369
9,3531758,,1988,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,5T32AR007014-13,AR007014,UNITED STATES,T32,12327,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RHEUMATOLOGY,,ALAN S. COHEN,2417435
10,3543463,,1988,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32NS007009-14,NS007009,UNITED STATES,T32,69687,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,RICHARD E ZIGMOND,1878378
11,3540186,,1988,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32HL007149-13,HL007149,UNITED STATES,T32,122804,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1991-05-31T04:00:00Z,,,HEMATOLOGY AND ONCOLOGY,,HAROLD Ross ROBERTS,1867473
12,3540077,,1988,LOUISIANA STATE UNIV HSC NEW ORLEANS,NEW ORLEANS,LA,,5T32HL007098-14,HL007098,UNITED STATES,T32,174972,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-05-31T04:00:00Z,,,CARDIOVASCULAR DYNAMICS AND METABOLISM,,JOHN J SPITZER,1864289
13,3540020,,1988,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32HL007081-14,HL007081,UNITED STATES,T32,361740,False,Karin Fredriksson Lidman,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-05-31T04:00:00Z,,,MULTIDISCIPLINARY HEART AND VASCULAR DISEASES,,BURTON E SOBEL,1899514
14,3539965,,1988,TUFTS MEDICAL CENTER,BOSTON,MA,,5T32HL007053-14,HL007053,UNITED STATES,T32,131005,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,"BIOCHEMISTRY, METABOLISM, AND IMMUNOLOGY OF THE LUNG",,Barry  Fanburg,1859077
15,3539922,,1988,STANFORD UNIVERSITY,STANFORD,CA,,5T32HL007034-14,HL007034,UNITED STATES,T32,246160,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-05-31T04:00:00Z,,,CARDIOVASCULAR DISEASE PREVENTION,,John W Farquhar,1897167
16,3539864,,1988,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32HL007014-13,HL007014,UNITED STATES,T32,118481,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RESPIRATORY DISEASE--BASIC AND CLINICAL RESEARCH,,DONALD F TIERNEY,1963091
17,3537274,,1988,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5T32GM007315-14,GM007315,UNITED STATES,T32,275555,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,MYRON  LEVINE,1970176
18,3537249,,1988,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,,5T32GM007311-14,GM007311,UNITED STATES,T32,71335,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,SYNTHESIS AND STRUCTURE OF BIOLOGICAL MACROMOLECULES,,BARBARA A HAMKALO,2183249
19,3537225,,1988,NEW YORK UNIVERSITY,NEW YORK,NY,,5T32GM007308-14,GM007308,UNITED STATES,T32,889000,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,DAVID D SABATINI,1871376
20,3537134,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007266-14,GM007266,UNITED STATES,T32,292402,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1989-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,LAWRENCE A LOEB,1860313
21,3537123,,1988,YESHIVA UNIVERSITY,BRONX,NY,,5T32GM007260-14,GM007260,UNITED STATES,T32,110593,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,SUSAN BAND HORWITZ,1868745
22,3537057,,1988,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,5T32GM007229-14,GM007229,UNITED STATES,T32,444243,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,LEE D PEACHEY,1870979
23,3537034,,1988,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32GM007226-14,GM007226,UNITED STATES,T32,305755,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,CELLULAR AND DEVELOPMENTAL BIOLOGY,,MORRIS J KARNOVSKY,1891211
24,3537009,,1988,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5T32GM007215-14,GM007215,UNITED STATES,T32,882162,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,WILLIAM S. REZNIKOFF,1964688
25,3536987,,1988,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32GM007200-14,GM007200,UNITED STATES,T32,879941,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,CARL  FRIEDEN,1888217
26,3536935,,1988,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5T32GM007183-14,GM007183,UNITED STATES,T32,656483,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR AND CELLULAR BIOLOGY,,EDWIN W. TAYLOR,1898278
27,3536900,,1988,DUKE UNIVERSITY,DURHAM,NC,,2T32GM007171-14,GM007171,UNITED STATES,T32,600536,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,Salvatore V Pizzo,1871037
28,3536852,,1988,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5T32GM007135-14,GM007135,UNITED STATES,T32,261829,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR BIOLOGY,,LAWRENCE M GOLD,1880336
29,3536793,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007108-14,GM007108,UNITED STATES,T32,124671,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,NEUROBIOLOGY,,WAYNE E. CRILL,1901429
30,3536768,,1988,UNIVERSITY OF GEORGIA (UGA),ATHENS,GA,,5T32GM007103-14,GM007103,UNITED STATES,T32,135162,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,GENETICS,,Sidney R. Kushner,1859383
31,3536685,,1988,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32GM007062-14,GM007062,UNITED STATES,T32,93029,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,FACTORS INFLUENCING DRUG ACTIVITY AND DISTRIBUTION,,ALFRED G GILMAN,1861865
32,3536661,,1988,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32GM007048-14,GM007048,UNITED STATES,T32,117727,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,NEUROBIOLOGY,,FRANK S WERBLIN,1872348
33,3536645,,1988,WEST VIRGINIA UNIVERSITY,MORGANTOWN,WV,,5T32GM007039-14,GM007039,UNITED STATES,T32,96706,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,WILLIAM W FLEMING,1881749
34,3536636,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007037-14,GM007037,UNITED STATES,T32,101046,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAUMA AND BURNS,,CHARLES J CARRICO,1955195
35,3536371,,1988,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,HOUSTON,TX,,5T32EY007024-12,EY007024,UNITED STATES,T32,151679,False,,National Eye Institute,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,PHYSIOLOGY AND NEUROCHEMISTRY OF VISION,,HARRY G SPERLING,1965799
36,3535909,,1988,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32ES007017-14,ES007017,UNITED STATES,T32,213375,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,ENVIRONMENTAL PATHOLOGY,,JOE W GRISHAM,1888703
37,3534775,,1988,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32DK007114-15,DK007114,UNITED STATES,T32,59193,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING PROGRAM IN HEMATOLOGY,,ADEL A YUNIS,1978786
38,3534761,,1988,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32DK007109-13,DK007109,UNITED STATES,T32,62721,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,"ENDOCRINE, DIABETES, AND METABOLISM TRAINING PROGRAM",,SIMEON  MARGOLIS,2401550
39,3534745,,1988,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32DK007100-15,DK007100,UNITED STATES,T32,106041,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING IN GASTROENTEROLOGY AND LIVER DISEASES,,BURTON  COMBES,1898627
40,3532707,,1988,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32CA009179-14,CA009179,UNITED STATES,T32,180751,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGY,,MARIAN E KOSHLAND,1970246
41,3534651,,1988,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PITTSBURGH,PA,,5T32DK007052-15,DK007052,UNITED STATES,T32,56815,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,ALAN G ROBINSON,1874549
42,3534546,,1988,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32DK007007-14,DK007007,UNITED STATES,T32,205546,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN DISGESTIVE DISEASES AND NUTRITION,,ROBERT K OCKNER,1863701
43,3534529,,1988,"MONTEFIORE MEDICAL CENTER (BRONX, NY)",NEW YORK,NY,,5T32DK007004-15,DK007004,UNITED STATES,T32,81547,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INVESTIGATIVE ENDOCRINOLOGY,,MARTIN I SURKS,1966587
44,3534269,,1988,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,5T32DE007034-14,DE007034,UNITED STATES,T32,105232,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PERIODONTAL DISEASES,,Robert J Genco,1883720
45,3534236,,1988,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,,5T32DE007014-14,DE007014,UNITED STATES,T32,94984,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,DE8404,,DENTISTRY,,LOUISE J MESSER,2063875
46,3543490,,1989,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32NS007044-15,NS007044,UNITED STATES,T32,128514,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROSCIENCES,,WOLFGANG F NONNER,6424763
47,3541950,,1989,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32MH014277-15,MH014277,UNITED STATES,T32,112298,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RESEARCH TRAINING IN BIOLOGICAL SCIENCES,,GERRY S OXFORD,1871141
48,3541921,,1989,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32MH014268-15,MH014268,UNITED STATES,T32,89014,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,COGNITION - INFORMATION PROCESSING AND DEVELOPMENT,,GEORGE  MANDLER,3806951
49,3540212,,1989,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5T32HL007152-15,HL007152,UNITED STATES,T32,99069,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,HEMATOLOGY,,MARSHALL A LICHTMAN,1957689
0,3534692,,1987,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,5T32DK007066-13,DK007066,UNITED STATES,T32,199287,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MECHANISMS OF GASTROINTESTINAL DISEASE,,FRANK P. BROOKS,2402748
1,3536349,,1987,MEDICAL COLLEGE OF WISCONSIN,MILWAUKEE,WI,,5T32EY007016-13,EY007016,UNITED STATES,T32,115881,False,,John E. Fogarty International Center for Advanced Study in the Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,VISION RESEARCH TRAINING,,HENRY Francis EDELHAUSER,1891300
2,3536322,,1987,BAYLOR COLLEGE OF MEDICINE,HOUSTON,TX,,5T32EY007001-13,EY007001,UNITED STATES,T32,168260,False,,National Eye Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN VISUAL SCIENCES,,ROBERT E ANDERSON,1859630
3,3535908,,1987,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32ES007017-13,ES007017,UNITED STATES,T32,193969,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,ENVIRONMENTAL PATHOLOGY,,JOE W GRISHAM,1888703
4,3534567,,1987,"MAYO CLINIC COLL OF MEDICINE, ROCHESTER",ROCHESTER,MN,,5T32DK007013-13,DK007013,UNITED STATES,T32,111784,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,KIDNEY DISEASES RESEARCH TRAINING PROGRAM,,THOMAS P DOUSA,1860268
5,3534545,,1987,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32DK007007-13,DK007007,UNITED STATES,T32,214548,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN DISGESTIVE DISEASES AND NUTRITION,,ROBERT K OCKNER,1863701
6,3534268,,1987,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,5T32DE007034-13,DE007034,UNITED STATES,T32,268100,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN PERIODONTAL DISEASES,,Robert J Genco,1883720
7,3534250,,1987,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32DE007023-13,DE007023,UNITED STATES,T32,146663,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,ORAL BIOLOGY TRAINING SALIVARY SECRETIONS,,Kenneth T Izutsu,1877343
8,3532522,,1987,UNIVERSITY OF FLORIDA,GAINESVILLE,FL,,5T32CA009126-13,CA009126,UNITED STATES,T32,73114,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING IN THE CELL BIOLOGY AND IMMUNOBIOLOGY OF CANCER,,RICHARD T SMITH,1969274
9,3532381,,1987,UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,HOUSTON,TX,,5T32CA009070-13,CA009070,UNITED STATES,T32,88121,False,,National Cancer Institute,1975-07-01T04:00:00Z,1989-06-30T04:00:00Z,,,TRAINING PROGRAM IN PEDIATRIC HEMATOLOGY/ONCOLOGY,,JAN  VAN EYS,3740849
10,3532307,,1987,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32CA009041-13,CA009041,UNITED STATES,T32,228615,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,EXPERIMENTAL BIOLOGY OF CANCER:  HORMONES & GROWTH CONTR,,Satyabrata  Nandi,9596267
11,3531769,,1987,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,3T32AR007019-12S1,AR007019,UNITED STATES,T32,1076,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DERMATOLOGY,,GEORGE F. ODLAND,2406369
12,3451618,,1987,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,3R25CA017978-10S1,CA017978,UNITED STATES,R25,33307,False,,National Cancer Institute,1975-07-01T04:00:00Z,1988-09-30T04:00:00Z,,"This five year project, designed to meet the oncology education needs of
undergraduate Medical students at the State University of New York at
Buffalo, builds upon an existing program developed over the past five
years.  It is placed largely outside the core curriculum and complementary
to it.  Students will obtain factual knowledge of basic cancer biology and
an appreciation for how research, epidemiology, prevention, and nutrition
influence the clinical management of cancer patients.

In this proposal, year programs are comprised of a series of special
Oncology selectives, electives, and student assistantships.  An inter-year
program, of direct benefit to all students will include restructuring of
the Buffalo Cancer Syllabus, an Oncology Resource library, and
self-instructional module development.  Integration of nutrition,
epidemiology and prevention concepts, in all programs, will be a major
goal.  Systematic evaluation will be carried out.

The first year program consists of selectives and case presentations which
may accommodate at least one-third of the entering Freshman class.  The
selectives, one in general oncology, one in cancer prevention, will consist
of seminars and group discussions focusing on issues such as basic biology,
clinical presentation, prevention, epidemiology, and nutrition in cancer.
Interdisciplinary case presentations will be open to all students.  The
second year program will consist of student assistantships in the summers
preceding or following the sophomore year and will focus on research
methodologies applied to both the basic and clinical investigation of
cancer.  The third year program will build upon established cancer, and
cancer prevention, selectives in which students are exposed to basic
research and clinical problems that directly inter-relate.  To attract
senior students, the fourth year program will consist of oncology electives
reorganized to present relevant meterial.  A new oncology elective will
focus on the care of the ambulatory cancer patient, including various
support needs and community resources.  This new elective will be
coordinated with a number of community support and a cancer prevention
program coordinated through a regional HMO.

The Buffalo Cancer Syllabus, developed during the previous grant, will be
modified to meet the special needs of junior and senior medical students
and special nutrition, prevention, and epidemiology sections will be
developed.  An oncology education resource library will be developed for
use by students and faculty.
",PROFESSIONAL ONCOLOGY EDUCATION PROGRAM,,JOHN R WRIGHT,3617951
13,3532297,,1987,INSTITUTE FOR CANCER RESEARCH,PHILADELPHIA,PA,,5T32CA009035-13,CA009035,UNITED STATES,T32,259171,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN CANCER RESEARCH,,JEROME J FREED,1969275
14,3531794,,1987,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32AR007055-14,AR007055,UNITED STATES,T32,123993,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,BASIC AND CLINICAL RHEUMATOLOGY,,Peter E Lipsky,1862417
15,3543457,,1991,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32NS007000-17,NS007000,UNITED STATES,T32,183123,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,NEUROVIROLOGY AND NEUROIMMUNOLOGY,,JUSTIN C. MCARTHUR,6235512
16,3541302,,1991,CHILDREN'S HOSPITAL BOSTON,BOSTON,MA,,5T32HL007574-10,HL007574,UNITED STATES,T32,324648,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PATHOPHYSIOLOGY OF HUMAN BLOOD CELLS,,SAMUEL E LUX,1865623
17,3540183,,1991,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,2T32HL007149-16,HL007149,UNITED STATES,T32,200831,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,HEMATOLOGY AND ONCOLOGY,,HAROLD Ross ROBERTS,1867473
18,3540163,,1991,UNIVERSITY OF IOWA,IOWA CITY,IA,,5T32HL007121-17,HL007121,UNITED STATES,T32,517721,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,INTERDISCIPLINARY CARDIOVASCULAR RESEARCH,,FRANCOIS M ABBOUD,1864622
19,3540155,,1991,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32HL007118-17,HL007118,UNITED STATES,T32,354831,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MULTIDISCIPLINARY RESPIRATORY DISEASES,,Joseph D Brain,1889196
20,3540129,,1991,NORTHWESTERN UNIVERSITY,CHICAGO,IL,,2T32HL007113-16,HL007113,UNITED STATES,T32,92268,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1996-05-31T04:00:00Z,,,"CV EPIDEMIOLOGY, BIOSTATISTICS, NUTRITION, PREVENTION",,Alan R Dyer,6361771
21,3540072,,1991,UNIVERSITY OF MISSOURI-COLUMBIA,COLUMBIA,MO,,5T32HL007094-17,HL007094,UNITED STATES,T32,179037,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-05-31T04:00:00Z,,,CARDIOVASCULAR/RENAL PHYSIOL--PHARMACOL/BIOCHEMISTRY,,ALLAN W JONES,1962966
22,3540049,,1991,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32HL007089-17,HL007089,UNITED STATES,T32,348930,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-05-31T04:00:00Z,,,CARDIOVASCULAR BIOENGINEERING SCIENCE,,SHU  CHIEN,1876594
23,3543472,,1990,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32NS007027-15,NS007027,UNITED STATES,T32,141813,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,PHILIP R. DODGE,2401559
24,3541934,,1990,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32MH014275-16,MH014275,UNITED STATES,T32,116015,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,RESEARCH TRAINING--BIOLOGICAL SCIENCES,,WILLIAM H. MORSE,1961057
25,3541900,,1990,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,5T32MH014257-16,MH014257,UNITED STATES,T32,114110,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,QUANTITATIVE METHODS FOR BEHAVIORAL RESEARCH,,LAWRENCE E JONES,1871718
26,3541877,,1990,YALE UNIVERSITY,NEW HAVEN,CT,,2T32MH014235-16,MH014235,UNITED STATES,T32,212352,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGY,,STANISLAV V. KASL,1872648
27,3541297,,1990,CHILDREN'S HOSPITAL BOSTON,BOSTON,MA,,2T32HL007574-09,HL007574,UNITED STATES,T32,317196,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PATHOPHYSIOLOGY OF HUMAN BLOOD CELLS,,SAMUEL E LUX,1865623
28,3532547,,1990,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,2T32CA009135-16,CA009135,UNITED STATES,T32,604343,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,EXPERIMENTAL ONCOLOGY,,WILLIAM M. SUGDEN,1884478
29,3538823,,1990,YESHIVA UNIVERSITY,BRONX,NY,,5T32HD007053-15,HD007053,UNITED STATES,T32,158049,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,1992-07-31T04:00:00Z,,,HUMAN DEVELOPMENTAL BIOLOGY,,GEORGE J SCHWARTZ,1898609
30,3540141,,1990,WAKE FOREST UNIVERSITY,WINSTON-SALEM,NC,,2T32HL007115-16,HL007115,UNITED STATES,T32,265558,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CARDIOVASCULAR PATHOLOGY,,Richard W ST CLAIR,1884537
31,3540067,,1990,UNIVERSITY OF MISSOURI-COLUMBIA,COLUMBIA,MO,,2T32HL007094-16,HL007094,UNITED STATES,T32,165978,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-05-31T04:00:00Z,,,CARDIOVASCULAR/RENAL PHYSIOL--PHARMACOL/BIOCHEMISTRY,,ALLAN W JONES,1962966
32,3540036,,1990,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32HL007088-16,HL007088,UNITED STATES,T32,517420,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MOLECULAR HEMATOLOGY,,PHILIP W MAJERUS,1893529
33,3539945,,1990,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32HL007038-16,HL007038,UNITED STATES,T32,111798,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TRANSFUSION MEDICINE,,  CHAPLIN,3737160
34,3539866,,1990,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32HL007014-15,HL007014,UNITED STATES,T32,142020,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RESPIRATORY DISEASE--BASIC AND CLINICAL RESEARCH,,DONALD F TIERNEY,1963091
35,3537230,,1990,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,2T32GM007309-16,GM007309,UNITED STATES,T32,1190143,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,DAVID  VALLE,3102760
36,3537222,,1990,NEW YORK UNIVERSITY,NEW YORK,NY,,2T32GM007308-16,GM007308,UNITED STATES,T32,1028054,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING,,DAVID D SABATINI,1871376
37,3537219,,1990,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32GM007306-16,GM007306,UNITED STATES,T32,266781,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,Christopher A. Walsh,3140152
38,3537120,,1990,YESHIVA UNIVERSITY,BRONX,NY,,2T32GM007260-16A1,GM007260,UNITED STATES,T32,172768,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,SUSAN BAND HORWITZ,1868745
39,3537107,,1990,UNIVERSITY OF OREGON,EUGENE,OR,,5T32GM007257-16,GM007257,UNITED STATES,T32,139419,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1993-06-30T04:00:00Z,,,SYSTEMS PHYSIOLOGY TRAINING PROGRAM,,RUSSELL D FERNALD,1882475
40,3537043,,1990,INDIANA UNIVERSITY BLOOMINGTON,BLOOMINGTON,IN,,5T32GM007227-16,GM007227,UNITED STATES,T32,121371,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,Thomas  Blumenthal,1873663
41,3536992,,1990,YALE UNIVERSITY,NEW HAVEN,CT,,2T32GM007205-16,GM007205,UNITED STATES,T32,1008629,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING,,HOWARD  RASMUSSEN,1888202
42,3536865,,1990,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,2T32GM007145-16,GM007145,UNITED STATES,T32,90338,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PHARMACEUTICAL SCIENCES,,DAVID J TRIGGLE,1957314
43,3536849,,1990,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,2T32GM007135-16,GM007135,UNITED STATES,T32,325142,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MOLECULAR BIOLOGY,,WILLIAM B WOOD,1871377
44,3536823,,1990,YESHIVA UNIVERSITY,BRONX,NY,,5T32GM007128-16,GM007128,UNITED STATES,T32,204059,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,GENETICS AND BIOCHEMISTRY OF CELLULAR REGULATION,,JULIUS  MARMUR,1964923
45,3536728,,1990,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32GM007085-14,GM007085,UNITED STATES,T32,98100,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING IN MEDICAL GENETICS,,Charles J Epstein,1865075
46,3536674,,1990,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,2T32GM007057-16,GM007057,UNITED STATES,T32,240831,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING,,LAWRENCE P SCHRAMM,1890370
47,3536633,,1990,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,2T32GM007037-16,GM007037,UNITED STATES,T32,158262,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING,,Ronald Vitt Maier,1898321
48,3536365,,1990,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5T32EY007022-15,EY007022,UNITED STATES,T32,275742,False,,National Eye Institute,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,TRAINING PROGRAM IN VISION RESEARCH,,MATHEW  ALPERN,1966008
49,3536358,,1990,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32EY007021-15,EY007021,UNITED STATES,T32,248730,False,,National Eye Institute,1975-07-01T04:00:00Z,1992-04-30T04:00:00Z,,,OPHTHALMOLOGY,,DOUGLAS R ANDERSON,1880345
0,3534754,,1990,UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,SAN ANTONIO,TX,,5T32DK007103-15,DK007103,UNITED STATES,T32,89914,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1991-12-31T05:00:00Z,,,TRAINING PROGRAM IN ACADEMIC NEPHROLOGY,,HANNA E ABBOUD,1898637
1,3534740,,1990,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,2T32DK007100-17,DK007100,UNITED STATES,T32,164700,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GRADUATE TRAINING IN GASTROENTEROLOGY AND HEPATOLOGY,,BURTON  COMBES,1898627
2,3534682,,1990,VANDERBILT UNIVERSITY,NASHVILLE,TN,,2T32DK007061-17,DK007061,UNITED STATES,T32,205307,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,JAMES M. MAY,1877106
3,3534655,,1990,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,2T32DK007053-17,DK007053,UNITED STATES,T32,180293,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,DAVID J SALANT,1883548
4,3534615,,1990,UNIVERSITY OF COLORADO DENVER,AURORA,CO,,2T32DK007038-16A1,DK007038,UNITED STATES,T32,117684,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-08-31T04:00:00Z,,,GASTROINTESTINAL DISEASE,,WILLIAM R BROWN,1870124
5,3532595,,1990,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32CA009141-15,CA009141,UNITED STATES,T32,295866,False,,National Cancer Institute,1975-07-01T04:00:00Z,1991-03-31T05:00:00Z,,,IMMUNOLOGY,,MARTIN E DORF,1860771
6,3530640,,1990,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32AI007008-12,AI007008,UNITED STATES,T32,71390,False,,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,1994-06-30T04:00:00Z,,,TRAINING PROGRAM IN PEDIATRIC ALLERGY,,E R STIEHM,1956267
7,3543463,,1988,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32NS007009-14,NS007009,UNITED STATES,T32,69687,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,RICHARD E ZIGMOND,1878378
8,3540186,,1988,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32HL007149-13,HL007149,UNITED STATES,T32,122804,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1991-05-31T04:00:00Z,,,HEMATOLOGY AND ONCOLOGY,,HAROLD Ross ROBERTS,1867473
9,3540077,,1988,LOUISIANA STATE UNIV HSC NEW ORLEANS,NEW ORLEANS,LA,,5T32HL007098-14,HL007098,UNITED STATES,T32,174972,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-05-31T04:00:00Z,,,CARDIOVASCULAR DYNAMICS AND METABOLISM,,JOHN J SPITZER,1864289
10,3540020,,1988,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32HL007081-14,HL007081,UNITED STATES,T32,361740,False,Karin Fredriksson Lidman,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-05-31T04:00:00Z,,,MULTIDISCIPLINARY HEART AND VASCULAR DISEASES,,BURTON E SOBEL,1899514
11,3539965,,1988,TUFTS MEDICAL CENTER,BOSTON,MA,,5T32HL007053-14,HL007053,UNITED STATES,T32,131005,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,"BIOCHEMISTRY, METABOLISM, AND IMMUNOLOGY OF THE LUNG",,Barry  Fanburg,1859077
12,3539922,,1988,STANFORD UNIVERSITY,STANFORD,CA,,5T32HL007034-14,HL007034,UNITED STATES,T32,246160,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-05-31T04:00:00Z,,,CARDIOVASCULAR DISEASE PREVENTION,,John W Farquhar,1897167
13,3539864,,1988,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32HL007014-13,HL007014,UNITED STATES,T32,118481,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RESPIRATORY DISEASE--BASIC AND CLINICAL RESEARCH,,DONALD F TIERNEY,1963091
14,3537274,,1988,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5T32GM007315-14,GM007315,UNITED STATES,T32,275555,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,MYRON  LEVINE,1970176
15,3537249,,1988,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,,5T32GM007311-14,GM007311,UNITED STATES,T32,71335,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,SYNTHESIS AND STRUCTURE OF BIOLOGICAL MACROMOLECULES,,BARBARA A HAMKALO,2183249
16,3537225,,1988,NEW YORK UNIVERSITY,NEW YORK,NY,,5T32GM007308-14,GM007308,UNITED STATES,T32,889000,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,DAVID D SABATINI,1871376
17,3537134,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007266-14,GM007266,UNITED STATES,T32,292402,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1989-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,LAWRENCE A LOEB,1860313
18,3537123,,1988,YESHIVA UNIVERSITY,BRONX,NY,,5T32GM007260-14,GM007260,UNITED STATES,T32,110593,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,SUSAN BAND HORWITZ,1868745
19,3537057,,1988,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,5T32GM007229-14,GM007229,UNITED STATES,T32,444243,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,LEE D PEACHEY,1870979
20,3537034,,1988,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32GM007226-14,GM007226,UNITED STATES,T32,305755,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,CELLULAR AND DEVELOPMENTAL BIOLOGY,,MORRIS J KARNOVSKY,1891211
21,3537009,,1988,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5T32GM007215-14,GM007215,UNITED STATES,T32,882162,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,WILLIAM S. REZNIKOFF,1964688
22,3536987,,1988,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32GM007200-14,GM007200,UNITED STATES,T32,879941,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,CARL  FRIEDEN,1888217
23,3536935,,1988,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5T32GM007183-14,GM007183,UNITED STATES,T32,656483,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR AND CELLULAR BIOLOGY,,EDWIN W. TAYLOR,1898278
24,3536900,,1988,DUKE UNIVERSITY,DURHAM,NC,,2T32GM007171-14,GM007171,UNITED STATES,T32,600536,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,Salvatore V Pizzo,1871037
25,3536852,,1988,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5T32GM007135-14,GM007135,UNITED STATES,T32,261829,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR BIOLOGY,,LAWRENCE M GOLD,1880336
26,3536793,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007108-14,GM007108,UNITED STATES,T32,124671,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,NEUROBIOLOGY,,WAYNE E. CRILL,1901429
27,3536768,,1988,UNIVERSITY OF GEORGIA (UGA),ATHENS,GA,,5T32GM007103-14,GM007103,UNITED STATES,T32,135162,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,GENETICS,,Sidney R. Kushner,1859383
28,3536685,,1988,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32GM007062-14,GM007062,UNITED STATES,T32,93029,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,FACTORS INFLUENCING DRUG ACTIVITY AND DISTRIBUTION,,ALFRED G GILMAN,1861865
29,3536661,,1988,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32GM007048-14,GM007048,UNITED STATES,T32,117727,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,NEUROBIOLOGY,,FRANK S WERBLIN,1872348
30,3536645,,1988,WEST VIRGINIA UNIVERSITY,MORGANTOWN,WV,,5T32GM007039-14,GM007039,UNITED STATES,T32,96706,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES,,WILLIAM W FLEMING,1881749
31,3536636,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007037-14,GM007037,UNITED STATES,T32,101046,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAUMA AND BURNS,,CHARLES J CARRICO,1955195
32,3531787,,1988,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32AR007048-15,AR007048,UNITED STATES,T32,111394,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DISEASES OF BONE AND CALCIUM METABOLISM,,LEONARD JOHN DEFTOS,1872997
33,3531770,,1988,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,3T32AR007019-13S1,AR007019,UNITED STATES,T32,14036,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DERMATOLOGY,,GEORGE F. ODLAND,2406369
34,3531758,,1988,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,5T32AR007014-13,AR007014,UNITED STATES,T32,12327,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RHEUMATOLOGY,,ALAN S. COHEN,2417435
35,3536371,,1988,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,HOUSTON,TX,,5T32EY007024-12,EY007024,UNITED STATES,T32,151679,False,,National Eye Institute,1975-07-01T04:00:00Z,1992-06-30T04:00:00Z,,,PHYSIOLOGY AND NEUROCHEMISTRY OF VISION,,HARRY G SPERLING,1965799
36,3535909,,1988,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32ES007017-14,ES007017,UNITED STATES,T32,213375,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,ENVIRONMENTAL PATHOLOGY,,JOE W GRISHAM,1888703
37,3534775,,1988,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32DK007114-15,DK007114,UNITED STATES,T32,59193,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING PROGRAM IN HEMATOLOGY,,ADEL A YUNIS,1978786
38,3534761,,1988,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32DK007109-13,DK007109,UNITED STATES,T32,62721,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,"ENDOCRINE, DIABETES, AND METABOLISM TRAINING PROGRAM",,SIMEON  MARGOLIS,2401550
39,3534745,,1988,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32DK007100-15,DK007100,UNITED STATES,T32,106041,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING IN GASTROENTEROLOGY AND LIVER DISEASES,,BURTON  COMBES,1898627
40,3534651,,1988,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PITTSBURGH,PA,,5T32DK007052-15,DK007052,UNITED STATES,T32,56815,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN DIABETES AND ENDOCRINOLOGY,,ALAN G ROBINSON,1874549
41,3534546,,1988,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32DK007007-14,DK007007,UNITED STATES,T32,205546,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN DISGESTIVE DISEASES AND NUTRITION,,ROBERT K OCKNER,1863701
42,3534529,,1988,"MONTEFIORE MEDICAL CENTER (BRONX, NY)",NEW YORK,NY,,5T32DK007004-15,DK007004,UNITED STATES,T32,81547,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INVESTIGATIVE ENDOCRINOLOGY,,MARTIN I SURKS,1966587
43,3534269,,1988,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,5T32DE007034-14,DE007034,UNITED STATES,T32,105232,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PERIODONTAL DISEASES,,Robert J Genco,1883720
44,3534236,,1988,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,,5T32DE007014-14,DE007014,UNITED STATES,T32,94984,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,DE8404,,DENTISTRY,,LOUISE J MESSER,2063875
45,3532707,,1988,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32CA009179-14,CA009179,UNITED STATES,T32,180751,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR IMMUNOLOGY AND TUMOR BIOLOGY,,MARIAN E KOSHLAND,1970246
46,3543490,,1989,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32NS007044-15,NS007044,UNITED STATES,T32,128514,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROSCIENCES,,WOLFGANG F NONNER,6424763
47,3541950,,1989,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32MH014277-15,MH014277,UNITED STATES,T32,112298,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,RESEARCH TRAINING IN BIOLOGICAL SCIENCES,,GERRY S OXFORD,1871141
48,3541921,,1989,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32MH014268-15,MH014268,UNITED STATES,T32,89014,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,COGNITION - INFORMATION PROCESSING AND DEVELOPMENT,,GEORGE  MANDLER,3806951
49,3540212,,1989,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5T32HL007152-15,HL007152,UNITED STATES,T32,99069,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,HEMATOLOGY,,MARSHALL A LICHTMAN,1957689
0,3534833,,1989,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32DK007130-16,DK007130,UNITED STATES,T32,128627,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CLINICAL/LABORATORY TRAINING ACADEMIC GASTROENTEROLOGIST,,DAVID H. ALPERS,1863717
1,3534776,,1989,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32DK007114-16,DK007114,UNITED STATES,T32,58296,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING PROGRAM IN HEMATOLOGY,,ADEL A YUNIS,1978786
2,3541302,,1991,CHILDREN'S HOSPITAL BOSTON,BOSTON,MA,,5T32HL007574-10,HL007574,UNITED STATES,T32,324648,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PATHOPHYSIOLOGY OF HUMAN BLOOD CELLS,,SAMUEL E LUX,1865623
3,3540183,,1991,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,2T32HL007149-16,HL007149,UNITED STATES,T32,200831,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,HEMATOLOGY AND ONCOLOGY,,HAROLD Ross ROBERTS,1867473
4,3540163,,1991,UNIVERSITY OF IOWA,IOWA CITY,IA,,5T32HL007121-17,HL007121,UNITED STATES,T32,517721,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,INTERDISCIPLINARY CARDIOVASCULAR RESEARCH,,FRANCOIS M ABBOUD,1864622
5,3540155,,1991,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32HL007118-17,HL007118,UNITED STATES,T32,354831,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MULTIDISCIPLINARY RESPIRATORY DISEASES,,Joseph D Brain,1889196
6,3540129,,1991,NORTHWESTERN UNIVERSITY,CHICAGO,IL,,2T32HL007113-16,HL007113,UNITED STATES,T32,92268,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1996-05-31T04:00:00Z,,,"CV EPIDEMIOLOGY, BIOSTATISTICS, NUTRITION, PREVENTION",,Alan R Dyer,6361771
7,3540072,,1991,UNIVERSITY OF MISSOURI-COLUMBIA,COLUMBIA,MO,,5T32HL007094-17,HL007094,UNITED STATES,T32,179037,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-05-31T04:00:00Z,,,CARDIOVASCULAR/RENAL PHYSIOL--PHARMACOL/BIOCHEMISTRY,,ALLAN W JONES,1962966
8,3540049,,1991,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32HL007089-17,HL007089,UNITED STATES,T32,348930,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1995-05-31T04:00:00Z,,,CARDIOVASCULAR BIOENGINEERING SCIENCE,,SHU  CHIEN,1876594
9,3538819,,1991,YESHIVA UNIVERSITY,BRONX,NY,,3T32HD007053-15S1,HD007053,UNITED STATES,T32,20667,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-07-01T04:00:00Z,1992-07-31T04:00:00Z,,,HUMAN DEVELOPMENTAL BIOLOGY,,GEORGE J SCHWARTZ,1898609
10,3537271,,1991,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,2T32GM007315-16A1,GM007315,UNITED STATES,T32,266075,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY AT MICHIGAN,,Wesley A. Dunnick,1860337
11,3537267,,1991,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32GM007313-17,GM007313,UNITED STATES,T32,524586,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CELL AND MOLECULAR BIOLOGY,,ERNEST PETER GEIDUSCHEK,1876894
12,3537100,,1991,CASE WESTERN RESERVE UNIVERSITY,CLEVELAND,OH,,5T32GM007250-16,GM007250,UNITED STATES,T32,681212,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1994-06-30T04:00:00Z,,,MEDICAL SCIENTIST TRAINING PROGRAM,,LESLIE T. WEBSTER,2411381
13,3536967,,1991,UNIVERSITY OF CHICAGO,CHICAGO,IL,,2T32GM007197-17,GM007197,UNITED STATES,T32,401540,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,GENETICS AND REGULATION,,ROCHELLE E ESPOSITO,1898429
14,3536945,,1991,DUKE UNIVERSITY,DURHAM,NC,,5T32GM007184-17,GM007184,UNITED STATES,T32,557380,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,ORGANIZATION AND FUNCTION OF CELLULAR STRUCTURES,,ROBERT L HILL,1876863
15,3536932,,1991,UNIVERSITY OF CHICAGO,CHICAGO,IL,,2T32GM007183-17,GM007183,UNITED STATES,T32,824810,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,MOLECULAR AND CELLULAR BIOLOGY,,EDWIN W. TAYLOR,1898278
16,3536854,,1991,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5T32GM007135-17,GM007135,UNITED STATES,T32,341182,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,MOLECULAR BIOLOGY,,WILLIAM B WOOD,1871377
17,3536846,,1991,UNIVERSITY OF CALIFORNIA IRVINE,IRVINE,CA,,5T32GM007134-17,GM007134,UNITED STATES,T32,139010,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,REGULATION AND EXPRESSION OF BIOLOGICAL PROCESSES,,G. WESLEY HATFIELD,1859692
18,3536795,,1991,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32GM007108-17,GM007108,UNITED STATES,T32,172029,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,NEUROBIOLOGY,,WAYNE E. CRILL,1901429
19,3536695,,1991,UNIVERSITY OF COLORADO DENVER,AURORA,CO,,5T32GM007063-17,GM007063,UNITED STATES,T32,111237,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,CLINICAL PHARMACOLOGY,,ALAN S. NIES,2402537
20,3536679,,1991,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32GM007057-17,GM007057,UNITED STATES,T32,244070,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BIOMEDICAL ENGINEERING,,LAWRENCE P SCHRAMM,1890370
21,3536381,,1991,UNIVERSITY OF CALIFORNIA LOS ANGELES,LOS ANGELES,CA,,5T32EY007026-17,EY007026,UNITED STATES,T32,151770,False,,National Eye Institute,1975-07-01T04:00:00Z,1995-09-29T04:00:00Z,,,VISION RESEARCH,,GORDON Lee FAIN,1896909
22,3534814,,1991,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32DK007126-18,DK007126,UNITED STATES,T32,228605,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RENAL DISEASE,,Marc Randall Hammerman,1888256
23,3534782,,1991,UNIVERSITY OF UTAH,SALT LAKE CITY,UT,,5T32DK007115-17,DK007115,UNITED STATES,T32,119565,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RESEARCH TRAINING IN HEMATOLOGY,,M P HEILBRUN,1877163
24,3534670,,1991,STANFORD UNIVERSITY,STANFORD,CA,,5T32DK007056-18,DK007056,UNITED STATES,T32,178544,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,GASTROENTEROLOGY,,GARY M GRAY,3806119
25,3534541,,1991,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,5T32DK007006-18,DK007006,UNITED STATES,T32,178631,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RENAL RESEARCH,,ERIC Grant NEILSON,1864468
26,3534265,,1991,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,2T32DE007034-16,DE007034,UNITED STATES,T32,219515,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,DE8907,,PERIODONTAL DISEASES,,Robert J Genco,1883720
27,3532619,,1991,STANFORD UNIVERSITY,STANFORD,CA,,5T32CA009151-17,CA009151,UNITED STATES,T32,169982,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,TUMOR BIOLOGY,,MICHAEL R LIEBER,1867499
28,3532370,,1991,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,5T32CA009067-17,CA009067,UNITED STATES,T32,209232,False,,National Cancer Institute,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,RADIATION BIOPHYSICS AND BIOENGINEERING IN ONCOLOGY,,William D. O'Brien,1880196
29,3531827,,1991,DUKE UNIVERSITY,DURHAM,NC,,2T32AR007093-16A1,AR007093,UNITED STATES,T32,71954,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1996-06-30T04:00:00Z,,,DERMATOLOGY TRAINING PROGRAM,,RUSSELL P. HALL,1969553
30,3531797,,1991,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,5T32AR007055-18,AR007055,UNITED STATES,T32,145800,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,BASIC AND CLINICAL RHEUMATOLOGY,,Peter E Lipsky,1862417
31,3529955,,1991,MOUNT SINAI SCHOOL OF MEDICINE OF CUNY,NEW YORK,NY,,5T32AA007275-13,AA007275,UNITED STATES,T32,180063,False,,National Institute on Alcohol Abuse and Alcoholism,1975-07-01T04:00:00Z,1995-06-30T04:00:00Z,,,PATHOGENESIS AND TREATMENT OF ALCOHOL INDUCED DISEASES,,CHARLES S LIEBER,1878147
32,3543459,,1985,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,2T32NS007009-11,NS007009,UNITED STATES,T32,86804,False,,National Institute of Neurological Disorders and Stroke,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DEVELOPMENTAL NEUROLOGY,,RICHARD E ZIGMOND,1878378
33,3541930,,1985,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32MH014275-11,MH014275,UNITED STATES,T32,121622,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1988-06-30T04:00:00Z,,,RESEARCH TRAINING - BIOLOGICAL SCIENCES,,WILLIAM H. MORSE,1961057
34,3541926,,1985,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5T32MH014274-11,MH014274,UNITED STATES,T32,116068,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1988-06-30T04:00:00Z,,,NEURO-BEHAVIORAL SCIENCES RESEARCH TRAINING PROGRAM,,LEWIS S SEIDEN,1862803
35,3541915,,1985,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,2T32MH014268-11,MH014268,UNITED STATES,T32,83947,False,,National Institute of Mental Health,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,COGNITION - INFORMATION PROCESSING AND DEVELOPMENT,,GEORGE  MANDLER,3806951
36,3540207,,1985,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,2T32HL007152-11,HL007152,UNITED STATES,T32,176001,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING IN HEMATOLOGY RESEARCH,,MARSHALL A LICHTMAN,1957689
37,3540190,,1985,CHILDREN'S HOSPITAL OF PHILADELPHIA,PHILADELPHIA,PA,,2T32HL007150-11,HL007150,UNITED STATES,T32,65724,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RED CELL HEMOGLOBIN RESEARCH TRAINING PROGRAM,,ELIAS  SCHWARTZ,1895546
38,3540165,,1985,VANDERBILT UNIVERSITY,NASHVILLE,TN,,2T32HL007123-11,HL007123,UNITED STATES,T32,283798,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PATHOPHYSIOLOGY OF THE PULMONARY MICROCIRCULATION:,,KENNETH L BRIGHAM,1861587
39,3540157,,1985,UNIVERSITY OF IOWA,IOWA CITY,IA,,2T32HL007121-11,HL007121,UNITED STATES,T32,395761,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INTERDISCIPLINARY CARDIOVASCULAR RESEARCH FELLOWSHIP,,FRANCOIS M ABBOUD,1864622
40,3540120,,1985,"MAYO CLINIC COLL OF MEDICINE, ROCHESTER",ROCHESTER,MN,,2T32HL007111-11,HL007111,UNITED STATES,T32,178000,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CARDIOVASOLOGY,,ROBERT G TANCREDI,3173245
41,3540104,,1985,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,2T32HL007107-11,HL007107,UNITED STATES,T32,96941,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING IN RESEARCH ON BLOOD AND BLOOD DISEASES,,MEHRAN  GOULIAN,1963088
42,3540066,,1985,UNIVERSITY OF MISSOURI-COLUMBIA,COLUMBIA,MO,,2T32HL007094-11,HL007094,UNITED STATES,T32,131043,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CARDIOVASCULAR AND RENAL PHYSIOLOGY PHARMACOLOGY AND BIO,,ALLAN W JONES,1962966
43,3540058,,1985,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,2T32HL007093-11,HL007093,UNITED STATES,T32,221076,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,HEMATOLOGY RESEARCH TRAINING,,JOHN W ADAMSON,1957867
44,3540009,,1985,YESHIVA UNIVERSITY,BRONX,NY,,2T32HL007071-11,HL007071,UNITED STATES,T32,129101,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CARDIOVASCULAR PHYSIOLOGY AND PATHOPHYSIOLOGY,,RONALD S ARONSON,3403575
45,3539910,,1985,WEILL MEDICAL COLLEGE OF CORNELL UNIV,NEW YORK,NY,,2T32HL007029-11,HL007029,UNITED STATES,T32,123129,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INSTITUTIONAL RESEARCH FELLOWSHIP AWARD IN HEMATOLOGY,,Ralph Louis Nachman,9676555
46,3539904,,1985,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32HL007028-10,HL007028,UNITED STATES,T32,70301,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1986-06-30T04:00:00Z,,,"NUTRITION, LIPID METABOLISM, AND ARTERIOSCLEROSIS",,EDWIN L BIERMAN,1865624
47,3539877,,1985,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,2T32HL007022-11A1,HL007022,UNITED STATES,T32,176163,False,,National Heart Lung and Blood Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARD,,KENNETH M MOSER,1862990
48,3537261,,1985,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,2T32GM007313-11,GM007313,UNITED STATES,T32,345806,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELL AND MOLECULAR BIOLOGY,,ERNEST PETER GEIDUSCHEK,1876894
49,3537204,,1985,YESHIVA UNIVERSITY,BRONX,NY,,2T32GM007288-11,GM007288,UNITED STATES,T32,810983,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1988-06-30T04:00:00Z,,,MEDICAL SCIENTIST PROGRAM,,STEPHEN G BAUM,3806400
0,3537103,,1985,UNIVERSITY OF OREGON,EUGENE,OR,,5T32GM007257-11,GM007257,UNITED STATES,T32,78821,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1988-06-30T04:00:00Z,,,SYSTEMS PHYSIOLOGY TRAINING PROGRAM,,RUSSELL D FERNALD,1882475
1,3537077,,1985,NEW YORK UNIVERSITY,NEW YORK,NY,,2T32GM007238-11,GM007238,UNITED STATES,T32,84839,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE PROGRAM IN CELLULAR AND MOLECULAR BIOLOGY,,DAVID D SABATINI,1871376
2,3536999,,1985,PURDUE UNIVERSITY WEST LAFAYETTE,WEST LAFAYETTE,IN,,2T32GM007211-11,GM007211,UNITED STATES,T32,103181,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR MECHANISMS OF CELL FUNCTIONS,,PETER T GILHAM,1876812
3,3536931,,1985,UNIVERSITY OF CHICAGO,CHICAGO,IL,,2T32GM007183-11,GM007183,UNITED STATES,T32,631616,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MOLECULAR AND CELLULAR BIOLOGY,,EDWIN W. TAYLOR,1898278
4,3536915,,1985,TULANE UNIVERSITY OF LOUISIANA,NEW ORLEANS,LA,,2T32GM007177-11,GM007177,UNITED STATES,T32,88028,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,JAMES W FISHER,1955621
5,3536899,,1985,DUKE UNIVERSITY,DURHAM,NC,,2T32GM007171-11,GM007171,UNITED STATES,T32,622743,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1988-06-30T04:00:00Z,,,MEDICAL SCIENTIST,,ROBERT L HILL,1876863
6,3536725,,1985,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32GM007085-10,GM007085,UNITED STATES,T32,83153,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1987-06-30T04:00:00Z,,,POSTDOCTORAL TRAINING IN MEDICAL GENETICS,,Charles J Epstein,1865075
7,3536657,,1985,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,2T32GM007048-11,GM007048,UNITED STATES,T32,111457,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE GROUP IN NEUROBIOLOGY,,FRANK S WERBLIN,1872348
8,3536615,,1985,ALBANY MEDICAL COLLEGE,ALBANY,NY,,2T32GM007033-11,GM007033,UNITED STATES,T32,123465,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,BASIC AND CLINICAL SCIENCE TRAUMA RESEARCH TRAINING,,THOMAS G SABA,1895251
9,3534247,,1985,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,2T32DE007023-11,DE007023,UNITED STATES,T32,150412,False,,NIH Office of the Director,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,ORAL BIOLOGY TRAINING SALIVARY SECRETIONS,,Kenneth T Izutsu,1877343
10,3532613,,1985,STANFORD UNIVERSITY,STANFORD,CA,,2T32CA009151-11,CA009151,UNITED STATES,T32,170328,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,POSTDOCTORAL RESEARCH TRAINING IN TUMOR BIOLOGY,,David  Korn,8844274
11,3532451,,1985,UNIVERSITY OF TENNESSEE KNOXVILLE,KNOXVILLE,TN,,2T32CA009104-11,CA009104,UNITED STATES,T32,84671,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING IN CARCINOGENESIS RESEARCH,,FRANCIS T KENNEY,3173401
12,3532364,,1985,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,2T32CA009067-11,CA009067,UNITED STATES,T32,105205,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RADIATION BIOPHYSICS & BIOENGINEERING IN ONCOLOGY,,HOWARD S DUCOFF,3755393
13,3531575,,1985,SCRIPPS CLINIC AND RESEARCH FOUNDATION,SAN DIEGO,CA,,2T32AM007144-12,AM007144,UNITED STATES,T32,155610,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING IN CLINICAL IMMUNOLOGY,,DENNIS  CARSON,1863886
14,3531574,,1985,WEILL MEDICAL COLLEGE OF CORNELL UNIV,NEW YORK,NY,,5T32AM007142-12,AM007142,UNITED STATES,T32,42345,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1988-06-30T04:00:00Z,,,BIOMEDICAL RESEARCH PROGRAM IN DIGESTIVE DISEASES,,DAVID  ZAKIM,1966816
15,3531573,,1985,UNIVERSITY OF FLORIDA,GAINESVILLE,FL,,5T32AM007141-11,AM007141,UNITED STATES,T32,67504,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1986-06-30T04:00:00Z,,,INVESTIGATIVE MUSCULOSKELETAL PATHOLOGY,,WILLIAM F. ENNEKING,2418114
16,3531567,,1985,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,2T32AM007129-12,AM007129,UNITED STATES,T32,150582,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENDOCRINOLOGY & METABOLISM,,JUDSON J VAN WYK,3723876
17,3531564,,1985,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,2T32AM007120-11,AM007120,UNITED STATES,T32,247361,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
18,3531558,,1985,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,3T32AM007113-11S1,AM007113,UNITED STATES,T32,34607,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1986-06-30T04:00:00Z,,,GASTROENTEROLOGY,,DAVID R SAUNDERS,3805711
19,3531550,,1985,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,2T32AM007100-12,AM007100,UNITED STATES,T32,118800,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING IN GASTROENTEROLOGY AND LIVER DISEASES,,BURTON  COMBES,1898627
20,3531546,,1985,DUKE UNIVERSITY,DURHAM,NC,,2T32AM007093-11,AM007093,UNITED STATES,T32,54302,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DEMATOLOGY TRAINING PROGRAM,,SHELDON R PINNELL,1877794
21,3531528,,1985,UNIVERSITY OF TEXAS SW MED CTR/DALLAS,DALLAS,TX,,2T32AM007055-12,AM007055,UNITED STATES,T32,111005,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,BASIC AND CLINICAL RHEUMATOLOGY,,Peter E Lipsky,1862417
22,3531527,,1985,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,2T32AM007053-12,AM007053,UNITED STATES,T32,169144,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,NORMAN G LEVINSKY,2434115
23,3531514,,1985,MASSACHUSETTS GENERAL HOSPITAL,BOSTON,MA,,2T32AM007028-11,AM007028,UNITED STATES,T32,269140,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETES,,JOSEPH  AVRUCH,1888259
24,3531511,,1985,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,2T32AM007019-11,AM007019,UNITED STATES,T32,123528,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DERMATOLOGY,,GEORGE F. ODLAND,2406369
25,3531505,,1985,"MAYO CLINIC COLL OF MEDICINE, ROCHESTER",ROCHESTER,MN,,2T32AM007013-11,AM007013,UNITED STATES,T32,112208,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,KIDNEY DISEASES RESEARCH TRAINING PROGRAM,,THOMAS P DOUSA,1860268
26,3531500,,1985,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,2T32AM007006-12,AM007006,UNITED STATES,T32,150527,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RENAL PATHOPHYSIOLOGY IN CARDIAC AND RENAL DISEASE,,ZALMAN S AGUS,3735324
27,3530630,,1985,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32AI007007-10,AI007007,UNITED STATES,T32,59153,False,,National Institute of Allergy and Infectious Diseases,1975-07-01T04:00:00Z,1987-05-31T04:00:00Z,,,PEDIATRIC ALLERGY AND IMMUNOLOGY,,Jerry A Winkelstein,1899134
28,3537272,,1986,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5T32GM007315-12,GM007315,UNITED STATES,T32,218772,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY AT MICHIGAN,,MYRON  LEVINE,1970176
29,3537223,,1986,NEW YORK UNIVERSITY,NEW YORK,NY,,5T32GM007308-12,GM007308,UNITED STATES,T32,805074,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,MEDICAL SCIENTIST NATIONAL RESEARCH SERVICE AWARD,,MICHAEL L SHELANSKI,1871427
30,3537198,,1986,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,,5T32GM007287-12,GM007287,UNITED STATES,T32,1200787,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCES,,DAVID  BOTSTEIN,1871621
31,3537121,,1986,YESHIVA UNIVERSITY,BRONX,NY,,5T32GM007260-12,GM007260,UNITED STATES,T32,103311,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN PHARMACOLOGICAL SCIENCES,,SUSAN BAND HORWITZ,1868745
32,3537087,,1986,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5T32GM007240-12,GM007240,UNITED STATES,T32,204902,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GENETIC MECHANISMS AND REGULATION,,DAN L. LINDSLEY,2405328
33,3537063,,1986,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32GM007231-12,GM007231,UNITED STATES,T32,577931,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,CELLULAR AND MOLECULAR BIOLOGY,,DENNIS A POWERS,1973914
34,3536960,,1986,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32GM007196-12,GM007196,UNITED STATES,T32,224818,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,REGULATION OF GENE EXPRESSION IN PROKARYOTES AND EUKARYO,,JONATHAN  BECKWITH,1863254
35,3536919,,1986,TULANE UNIVERSITY OF LOUISIANA,NEW ORLEANS,LA,,5T32GM007177-12,GM007177,UNITED STATES,T32,88348,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PHARMACOLOGICAL SCIENCES TRAINING PROGRAM,,JAMES W FISHER,1955621
36,3536659,,1986,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,5T32GM007048-12,GM007048,UNITED STATES,T32,102182,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE GROUP IN NEUROBIOLOGY,,FRANK S WERBLIN,1872348
37,3536651,,1986,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32GM007040-12,GM007040,UNITED STATES,T32,68038,False,,National Institute of General Medical Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARD,,RONALD G THURMAN,1884355
38,3536347,,1986,MEDICAL COLLEGE OF WISCONSIN,MILWAUKEE,WI,,3T32EY007016-11S1,EY007016,UNITED STATES,T32,4606,False,,John E. Fogarty International Center for Advanced Study in the Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,VISION RESEARCH TRAINING,,HENRY Francis EDELHAUSER,1891300
39,3536336,,1986,PURDUE UNIVERSITY WEST LAFAYETTE,WEST LAFAYETTE,IN,,5T32EY007008-12,EY007008,UNITED STATES,T32,192830,False,,National Eye Institute,1975-07-01T04:00:00Z,1990-07-31T04:00:00Z,,,"RESEARCH TRAINING:  VISUAL PHYSIOLOGY, CHEMISTRY, AND MO",,SANFORD E OSTROY,1965650
40,3535924,,1986,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,,5T32ES007020-12,ES007020,UNITED STATES,T32,331755,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING GRANT IN ENVIRONMENTAL TOXICOLOGY,,GERALD N WOGAN,1893869
41,3534802,,1986,WASHINGTON UNIVERSITY,SAINT LOUIS,MO,,5T32DK007120-12,DK007120,UNITED STATES,T32,240144,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DIABETES AND RELATED METABOLIC DISEASES,,Marshall Alan PERMUTT,6365732
42,3534773,,1986,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,,5T32DK007114-13,DK007114,UNITED STATES,T32,55454,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,GRADUATE TRAINING PROGRAM IN HEMATOLOGY,,ADEL A YUNIS,1978786
43,3534759,,1986,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32DK007109-11,DK007109,UNITED STATES,T32,57892,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,"ENDOCRINE, DIABETES, AND METABOLISM TRAINING PROGRAM",,SIMEON  MARGOLIS,2401550
44,3534731,,1986,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5T32DK007092-12,DK007092,UNITED STATES,T32,113608,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INVESTIGATIVE DIABETES ENDOCRINOLOGY AND METABOLISM,,DEAN H. LOCKWOOD,2401536
45,3534723,,1986,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,,5T32DK007087-13,DK007087,UNITED STATES,T32,139802,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY,,ROBERT L VERNIER,3735531
46,3534706,,1986,VANDERBILT UNIVERSITY,NASHVILLE,TN,,2T32DK007083-12A1,DK007083,UNITED STATES,T32,82025,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1991-08-31T04:00:00Z,,,TRAINING IN NUTRITION,,CONRAD  WAGNER,1877290
47,3534657,,1986,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,5T32DK007053-13,DK007053,UNITED STATES,T32,170801,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,NORMAN G LEVINSKY,2434115
48,3534642,,1986,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32DK007047-13,DK007047,UNITED STATES,T32,98421,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,KIDNEY AND MEMBRANE PHYSIOLOGY AND DISEASE,,CARL W GOTTSCHALK,1981835
49,3534557,,1986,DUKE UNIVERSITY,DURHAM,NC,,2T32DK007012-11A1,DK007012,UNITED STATES,T32,86598,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,ENDOCRINOLOGY AND DIABETES TRAINING PROGRAM,,MARC KENNETH DREZNER,1877789
0,3534759,,1986,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5T32DK007109-11,DK007109,UNITED STATES,T32,57892,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,"ENDOCRINE, DIABETES, AND METABOLISM TRAINING PROGRAM",,SIMEON  MARGOLIS,2401550
1,3534731,,1986,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5T32DK007092-12,DK007092,UNITED STATES,T32,113608,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,INVESTIGATIVE DIABETES ENDOCRINOLOGY AND METABOLISM,,DEAN H. LOCKWOOD,2401536
2,3534723,,1986,UNIVERSITY OF MINNESOTA TWIN CITIES,MINNEAPOLIS,MN,,5T32DK007087-13,DK007087,UNITED STATES,T32,139802,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PREFACULTY TRAINING IN PEDIATRIC NEPHROLOGY,,ROBERT L VERNIER,3735531
3,3534706,,1986,VANDERBILT UNIVERSITY,NASHVILLE,TN,,2T32DK007083-12A1,DK007083,UNITED STATES,T32,82025,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1991-08-31T04:00:00Z,,,TRAINING IN NUTRITION,,CONRAD  WAGNER,1877290
4,3534657,,1986,BOSTON UNIVERSITY MEDICAL CAMPUS,BOSTON,MA,,5T32DK007053-13,DK007053,UNITED STATES,T32,170801,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN NEPHROLOGY,,NORMAN G LEVINSKY,2434115
5,3534642,,1986,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5T32DK007047-13,DK007047,UNITED STATES,T32,98421,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,KIDNEY AND MEMBRANE PHYSIOLOGY AND DISEASE,,CARL W GOTTSCHALK,1981835
6,3534557,,1986,DUKE UNIVERSITY,DURHAM,NC,,2T32DK007012-11A1,DK007012,UNITED STATES,T32,86598,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,ENDOCRINOLOGY AND DIABETES TRAINING PROGRAM,,MARC KENNETH DREZNER,1877789
7,3534544,,1986,UNIVERSITY OF CALIFORNIA SAN FRANCISCO,SAN FRANCISCO,CA,,5T32DK007007-12,DK007007,UNITED STATES,T32,222860,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN DISGESTIVE DISEASES AND NUTRITION,,ROBERT K OCKNER,1863701
8,3535924,,1986,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,,5T32ES007020-12,ES007020,UNITED STATES,T32,331755,False,,National Institute of Environmental Health Sciences,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING GRANT IN ENVIRONMENTAL TOXICOLOGY,,GERALD N WOGAN,1893869
9,3534226,,1986,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5T32DE007010-12,DE007010,UNITED STATES,T32,305119,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RESEARCH TRAINING IN PERIODONTAL DISEASES,,RAY C WILLIAMS,1967092
10,3534206,,1986,UNIVERSITY OF SOUTHERN CALIFORNIA,LOS ANGELES,CA,,2T32DE007006-11,DE007006,UNITED STATES,T32,63133,False,,National Institute of Dental and Craniofacial Research,1975-07-01T04:00:00Z,1991-06-30T04:00:00Z,,,TRAINING PROGRAM IN CRANIOFACIAL BIOLOGY,,Michael  Melnick,3095428
11,3532550,,1986,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5T32CA009135-12,CA009135,UNITED STATES,T32,452767,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,PREDOCTORAL TRAINING IN EXPERIMENTAL ONCOLOGY,,"Henry C Pitot, Jr.",1882191
12,3532521,,1986,UNIVERSITY OF FLORIDA,GAINESVILLE,FL,,5T32CA009126-12,CA009126,UNITED STATES,T32,103563,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING IN THE CELL BIOLOGY AND IMMUNOBIOLOGY OF CANCER,,RICHARD T SMITH,1969274
13,3532447,,1986,UNIVERSITY OF UTAH,SALT LAKE CITY,UT,,5T32CA009097-12,CA009097,UNITED STATES,T32,66754,False,,National Cancer Institute,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,RADIATION BIOLOGY AND EXPERIMENTAL ONCOLOGY TRAINING,,LYLE A. DETHLEFSEN,2402753
14,3531871,,1986,SCRIPPS CLINIC AND RESEARCH FOUNDATION,SAN DIEGO,CA,,5T32AR007144-13,AR007144,UNITED STATES,T32,138689,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING IN CLINICAL IMMUNOLOGY,,DENNIS  CARSON,1863886
15,3531771,,1986,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5T32AR007019-12,AR007019,UNITED STATES,T32,113561,False,,National Institute of Arthritits and Musculoskeletal and Skin Diseases,1975-07-01T04:00:00Z,1990-06-30T04:00:00Z,,,DERMATOLOGY,,GEORGE F. ODLAND,2406369
16,3451620,,1986,STATE UNIVERSITY OF NEW YORK AT BUFFALO,BUFFALO,NY,,5R25CA017978-10,CA017978,UNITED STATES,R25,50177,False,,National Cancer Institute,1975-07-01T04:00:00Z,1988-09-30T04:00:00Z,,"This five year project, designed to meet the oncology education needs of
undergraduate Medical students at the State University of New York at
Buffalo, builds upon an existing program developed over the past five
years.  It is placed largely outside the core curriculum and complementary
to it.  Students will obtain factual knowledge of basic cancer biology and
an appreciation for how research, epidemiology, prevention, and nutrition
influence the clinical management of cancer patients.

In this proposal, year programs are comprised of a series of special
Oncology selectives, electives, and student assistantships.  An inter-year
program, of direct benefit to all students will include restructuring of
the Buffalo Cancer Syllabus, an Oncology Resource library, and
self-instructional module development.  Integration of nutrition,
epidemiology and prevention concepts, in all programs, will be a major
goal.  Systematic evaluation will be carried out.

The first year program consists of selectives and case presentations which
may accommodate at least one-third of the entering Freshman class.  The
selectives, one in general oncology, one in cancer prevention, will consist
of seminars and group discussions focusing on issues such as basic biology,
clinical presentation, prevention, epidemiology, and nutrition in cancer.
Interdisciplinary case presentations will be open to all students.  The
second year program will consist of student assistantships in the summers
preceding or following the sophomore year and will focus on research
methodologies applied to both the basic and clinical investigation of
cancer.  The third year program will build upon established cancer, and
cancer prevention, selectives in which students are exposed to basic
research and clinical problems that directly inter-relate.  To attract
senior students, the fourth year program will consist of oncology electives
reorganized to present relevant meterial.  A new oncology elective will
focus on the care of the ambulatory cancer patient, including various
support needs and community resources.  This new elective will be
coordinated with a number of community support and a cancer prevention
program coordinated through a regional HMO.

The Buffalo Cancer Syllabus, developed during the previous grant, will be
modified to meet the special needs of junior and senior medical students
and special nutrition, prevention, and epidemiology sections will be
developed.  An oncology education resource library will be developed for
use by students and faculty.
",PROFESSIONAL ONCOLOGY EDUCATION PROGRAM,,JOHN R WRIGHT,3312956
17,9387260,,2017,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,3T32ES007028-42S1,ES007028,UNITED STATES,T32,5415,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2017-06-30T04:00:00Z,PA16287,"DESCRIPTION (provided by applicant)   
   
Funds are requested to support eight pre-doctoral (Ph.D. candidates) and six postdoctoral trainees in the Training Program in Environmental Toxicology, the long-standing training component of the Center in Molecular Toxicology at Vanderbilt University. This interdisciplinary program provides research career training in molecular aspects of toxicology related to environmental health. Because the field is inherently interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural biology, analytical technology, functional genomics, pathogen-host interactions, disease pathology, and exposure science. The faculty preceptors have appointments in the departments of Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Neurology, Pathology/Microbiology/Immunology, Pediatrics, and Pharmacology, all of whom train doctoral students and postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations, dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive feature of the Program is hands-on training on diverse technology platforms through a highly developed and open system of research facility cores at Vanderbilt. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the medical school departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program in Biomedical and Biological Sciences or the Quantitative and Chemical Biology Program, where they spend the first 9 months in a common core curriculum and do laboratory rotations. Graduate students are supported for the first year by these programs. Students then are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training program support begins in the second year. Both pre-doctoral and postdoctoral trainees are selected by the Training Program Advisory Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes 18 faculty members who are all Investigators in the Center in Molecular Toxicology. Major research areas in the Center include oxidative damage, DNA damage and repair, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, neurotoxicology, respiratory disease pathophysiology, systems biology, and pathogen-host interactions. Graduates from the program have been highly successful in academia, industry, and other professional settings and include leaders in the field.",Training Program in Environmental Toxicology,"Public Health Relevance: This interdisciplinary program has a long-standing and successful history of training scientists for careers in molecular toxicology as applied to environmental health.  The trainees have gone on to productive careers in academia, industry, and government institutes. Trainees receive a strong, broad background in basic science with opportunities to specialize in specific sub-disciplines of basic and translational research.",Aaron B Bowman,2625423
18,6498222,,2002,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-28,ES007028,UNITED STATES,T32,520537,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2004-06-30T04:00:00Z,,"Application is made for continued funding of a long-standing training program associated with the Center in Molecular Toxicology at Vanderbilt University. Funds are requested to support ten predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees plus two summer medical students. The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Cell Biology, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program obtain degrees through Biochemistry, Cell Biology, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center. In the other four (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations. In the current system, graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution). Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress. Another aspect of this grant is the summer medical student training program, with students drawn from both the classes at Vanderbilt and Meharry Medical College. The list of preceptors includes fourteen faculty who are either Center Investigators or are associated with the Center in some other way. Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mechanisms of mutagenesis, regulation of gene expression, and environmental pathology. Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area. ",TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
19,2156047,,1995,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,2T32ES007028-21,ES007028,UNITED STATES,T32,192424,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1999-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
20,2654581,,1998,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-24,ES007028,UNITED STATES,T32,277909,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1999-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
21,2156048,,1996,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-22,ES007028,UNITED STATES,T32,229628,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1999-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
22,3535941,,1990,VANDERBILT UNIVERSITY,NASHVILLE,TN,,2T32ES007028-16,ES007028,UNITED STATES,T32,248315,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1995-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
23,8666611,,2014,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,2T32ES007028-40,ES007028,UNITED STATES,T32,599378,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"   
DESCRIPTION (provided by applicant)   
   
Funds are requested to support eight pre-doctoral (Ph.D. candidates) and six postdoctoral trainees in the Training Program in Environmental Toxicology, the long-standing training component of the Center in Molecular Toxicology at Vanderbilt University. This interdisciplinary program provides research career training in molecular aspects of toxicology related to environmental health. Because the field is inherently interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural biology, analytical technology, functional genomics, pathogen-host interactions, disease pathology, and exposure science. The faculty preceptors have appointments in the departments of Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Neurology, Pathology/Microbiology/Immunology, Pediatrics, and Pharmacology, all of whom train doctoral students and postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations, dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive feature of the Program is hands-on training on diverse technology platforms through a highly developed and open system of research facility cores at Vanderbilt. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the medical school departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program in Biomedical and Biological Sciences or the Quantitative and Chemical Biology Program, where they spend the first 9 months in a common core curriculum and do laboratory rotations. Graduate students are supported for the first year by these programs. Students then are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training program support begins in the second year. Both pre-doctoral and postdoctoral trainees are selected by the Training Program Advisory Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes 18 faculty members who are all Investigators in the Center in Molecular Toxicology. Major research areas in the Center include oxidative damage, DNA damage and repair, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, neurotoxicology, respiratory disease pathophysiology, systems biology, and pathogen-host interactions. Graduates from the program have been highly successful in academia, industry, and other professional settings and include leaders in the field.   
   
",Training Program in Environmental Toxicology,"Public Health Relevance: This interdisciplinary program has a long-standing and successful history of training scientists for careers in molecular toxicology as applied to environmental health.  The trainees have gone on to productive careers in academia, industry, and government institutes. Trainees receive a strong, broad background in basic science with opportunities to specialize in specific sub-disciplines of basic and translational research.   
   
      

",Aaron B Bowman,2625423
24,9100784,,2016,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-42,ES007028,UNITED STATES,T32,683696,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant)   
   
Funds are requested to support eight pre-doctoral (Ph.D. candidates) and six postdoctoral trainees in the Training Program in Environmental Toxicology, the long-standing training component of the Center in Molecular Toxicology at Vanderbilt University. This interdisciplinary program provides research career training in molecular aspects of toxicology related to environmental health. Because the field is inherently interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural biology, analytical technology, functional genomics, pathogen-host interactions, disease pathology, and exposure science. The faculty preceptors have appointments in the departments of Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Neurology, Pathology/Microbiology/Immunology, Pediatrics, and Pharmacology, all of whom train doctoral students and postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations, dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive feature of the Program is hands-on training on diverse technology platforms through a highly developed and open system of research facility cores at Vanderbilt. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the medical school departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program in Biomedical and Biological Sciences or the Quantitative and Chemical Biology Program, where they spend the first 9 months in a common core curriculum and do laboratory rotations. Graduate students are supported for the first year by these programs. Students then are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training program support begins in the second year. Both pre-doctoral and postdoctoral trainees are selected by the Training Program Advisory Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes 18 faculty members who are all Investigators in the Center in Molecular Toxicology. Major research areas in the Center include oxidative damage, DNA damage and repair, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, neurotoxicology, respiratory disease pathophysiology, systems biology, and pathogen-host interactions. Graduates from the program have been highly successful in academia, industry, and other professional settings and include leaders in the field.",Training Program in Environmental Toxicology,"Public Health Relevance: This interdisciplinary program has a long-standing and successful history of training scientists for careers in molecular toxicology as applied to environmental health.  The trainees have gone on to productive careers in academia, industry, and government institutes. Trainees receive a strong, broad background in basic science with opportunities to specialize in specific sub-disciplines of basic and translational research.",Aaron B Bowman,2625423
25,9702312,,2019,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,2T32ES007028-45,ES007028,UNITED STATES,T32,789802,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2024-06-30T04:00:00Z,PA18403,"Project Summary
Funds are requested to support eight predoctoral (Ph.D. candidates) and six postdoctoral trainees in the
Training Program in Environmental Toxicology, a long-standing research training program in molecular
toxicology at Vanderbilt University. This interdisciplinary program provides research career training
in molecular aspects of toxicology related to environmental health. Because the field is inherently
interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural
biology, analytical technology, microphysiological systems, functional genomics, pathogen-host interactions,
disease pathology, and exposure science. The faculty preceptors have appointments in the departments of
Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Pathology, Microbiology &
Immunology, Obstetrics & Gynecology, Pediatrics and Physics all of whom have trained doctoral students and
postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations,
dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive
feature of the program is hands-on training on diverse technology platforms through a highly developed and
open system of research facility cores at Vanderbilt. A fraction of our graduate students are recruited through
specific departments, while most matriculate through one of two umbrella programs: the Interdisciplinary
Graduate Program in Biomedical and Biological Sciences (IGP) or the Quantitative and Chemical Biology
Program (QCB). The students then spend their first 9 months in a common core curriculum and do laboratory
rotations. Graduate students are supported for the first year by these programs or departments. Students then
are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training
program support begins in the second year. Both predoctoral and postdoctoral trainees are selected by the
Training Program Executive Committee composed of the Director, Associate Director and the Internal Advisory
Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors
includes 17 faculty with diverse research interests and substantively well support research programs with the
average current year direct costs available being over $1 million per investigators. Major research areas
represented by our faculty preceptors include (1) Xenobiotic metabolism, detoxication, and enzymology; (2)
Oxidative stress and inflammation; (3) DNA damage, genome maintenance, and replication; (4) Translational
toxicology; (5) Host-pathogen-environment interactions; (6) Systems biology and developmental toxicology;
and newly represented this cycle (7) Organs-on-chips and microphysiological systems. Graduates from the
program have been highly successful in academia, industry, and other professional settings and include
leaders in the field.",Training Program in Environmental Toxicology,"Project Narrative
This interdisciplinary program has a long-standing and successful history of training scientists for careers in
molecular toxicology as applied to environmental health. Our trainees have gone on to productive careers in
academia, industry, and government institutes. Trainees receive a strong, broad background in basic science
with opportunities to specialize in specific subdisciplines of basic and translational research.",F PETER Guengerich,1894180
26,6350763,,2001,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-27,ES007028,UNITED STATES,T32,465850,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2004-06-30T04:00:00Z,,"Application is made for continued funding of a long-standing training program associated with the Center in Molecular Toxicology at Vanderbilt University. Funds are requested to support ten predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees plus two summer medical students. The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Cell Biology, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program obtain degrees through Biochemistry, Cell Biology, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center. In the other four (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations. In the current system, graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution). Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress. Another aspect of this grant is the summer medical student training program, with students drawn from both the classes at Vanderbilt and Meharry Medical College. The list of preceptors includes fourteen faculty who are either Center Investigators or are associated with the Center in some other way. Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mechanisms of mutagenesis, regulation of gene expression, and environmental pathology. Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area. ",TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
27,7460640,,2008,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-34,ES007028,UNITED STATES,T32,592790,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2009-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):   
Application is made for continued funding of a long-standing program associated with the Center in Molecular Toxicology at Vanderbilt University.  Funds are requested to support eight predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees.  The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows.  Graduate students in the program obtain degrees through Biochemistry, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning the operation and application of instrumental systems in research.  Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center.  In the other three (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations.  
Graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution).  Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress.  The list of preceptors includes sixteen faculty, who are all Center investigators.  Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mutagenesis, mechanisms of cell signaling, and structural biology relevant to toxicology.  Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area.",Training Program in Environmental Toxicology,,F PETER Guengerich,1894180
28,2331532,,1997,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-23,ES007028,UNITED STATES,T32,240578,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1999-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
29,7253920,,2007,VANDERBILT UNIVERSITY MED CTR,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-33,ES007028,UNITED STATES,T32,648134,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2009-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):   
Application is made for continued funding of a long-standing program associated with the Center in Molecular Toxicology at Vanderbilt University.  Funds are requested to support eight predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees.  The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows.  Graduate students in the program obtain degrees through Biochemistry, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning the operation and application of instrumental systems in research.  Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center.  In the other three (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations.  
Graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution).  Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress.  The list of preceptors includes sixteen faculty, who are all Center investigators.  Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mutagenesis, mechanisms of cell signaling, and structural biology relevant to toxicology.  Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area.",Training Program in Environmental Toxicology,,F PETER Guengerich,1894180
30,6916457,,2005,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-31,ES007028,UNITED STATES,T32,607050,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2009-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):   
Application is made for continued funding of a long-standing program associated with the Center in Molecular Toxicology at Vanderbilt University.  Funds are requested to support eight predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees.  The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows.  Graduate students in the program obtain degrees through Biochemistry, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning the operation and application of instrumental systems in research.  Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center.  In the other three (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations.  
Graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution).  Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress.  The list of preceptors includes sixteen faculty, who are all Center investigators.  Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mutagenesis, mechanisms of cell signaling, and structural biology relevant to toxicology.  Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area.",Training Program in Environmental Toxicology,,F PETER Guengerich,1894180
31,3535945,,1987,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32ES007028-13,ES007028,UNITED STATES,T32,148110,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
32,3535946,,1988,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32ES007028-14,ES007028,UNITED STATES,T32,165703,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1990-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
33,2156045,,1993,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-19,ES007028,UNITED STATES,T32,204511,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1995-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
34,3535943,,1991,VANDERBILT UNIVERSITY,NASHVILLE,TN,,3T32ES007028-17S1,ES007028,UNITED STATES,T32,3124,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1995-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
35,3535944,,1986,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32ES007028-12,ES007028,UNITED STATES,T32,125811,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
36,7628737,,2009,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,2T32ES007028-35,ES007028,UNITED STATES,T32,528702,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2014-06-30T04:00:00Z,PA06468,"  
DESCRIPTION (provided by applicant)  
  
Application is made for continued funding of a long-standing program associated with the Center in Molecular Toxicology at Vanderbilt University.  Funds are requested to support eight pre-doctoral trainees (Ph.D. candidates) and six postdoctoral trainees (those having a Ph.D., M.D., D.V.M., etc.). This interdisciplinary program emphasizes molecular aspects of toxicology related to environmental health. The faculty is drawn from individuals with appointments in Biochemistry, Biological Sciences, Chemistry, Medicine, Pathology, Pediatrics, and Pharmacology, all of whom train postdoctoral fellows.  Graduate students in the program obtain degrees through Biochemistry, Biological Sciences, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research.  
  
Graduate students are recruited to the Departments of Biological Sciences and Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the other three (biomedical) departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program or the Chemical and Physical Biology Program, where they spend the first 9 months in a relatively common core curriculum and do four laboratory rotations. Graduate students are recruited into toxicology from these first year pools (the initial year is supported by the institution). Both pre-doctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes twenty-two faculties who are all Center investigators. Major research areas in the Center include oxidative damage, DNA damage and genetic instability, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, and neurotoxicology.  Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area.  
  
  
BACKGROUND  
  
This toxicology program at Vanderbilt began in the 1970s.  The focus of the training has changed over the years. Initially, the focus was on practical toxicology of pesticides, metals, and other hazardous chemicals.  During the 1970s, the focus moved to biochemical toxicology.  Since the 1980s, the emphasis has been on molecular toxicology with a recent focus on the integration of clinical themes.  Originally, the Training Program was housed in the Department of Biochemistry.  However, over time the program became interdepartmental.  Currently, there are 22 mentors for this Training Program with primary appointments within the Departments of Biochemistry, Biological Sciences, Chemistry, Pathology, Pediatrics, Pharmacology, and Medicine. The Training Program has a long history of training individuals who go on to have productive careers in academia, research institutes, and industry.   
  
    

",Training Program in Environmental Toxicology,,F PETER Guengerich,1894180
37,8880211,,2015,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-41,ES007028,UNITED STATES,T32,662930,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant)   
   
Funds are requested to support eight pre-doctoral (Ph.D. candidates) and six postdoctoral trainees in the Training Program in Environmental Toxicology, the long-standing training component of the Center in Molecular Toxicology at Vanderbilt University. This interdisciplinary program provides research career training in molecular aspects of toxicology related to environmental health. Because the field is inherently interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural biology, analytical technology, functional genomics, pathogen-host interactions, disease pathology, and exposure science. The faculty preceptors have appointments in the departments of Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Neurology, Pathology/Microbiology/Immunology, Pediatrics, and Pharmacology, all of whom train doctoral students and postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations, dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive feature of the Program is hands-on training on diverse technology platforms through a highly developed and open system of research facility cores at Vanderbilt. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the medical school departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program in Biomedical and Biological Sciences or the Quantitative and Chemical Biology Program, where they spend the first 9 months in a common core curriculum and do laboratory rotations. Graduate students are supported for the first year by these programs. Students then are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training program support begins in the second year. Both pre-doctoral and postdoctoral trainees are selected by the Training Program Advisory Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes 18 faculty members who are all Investigators in the Center in Molecular Toxicology. Major research areas in the Center include oxidative damage, DNA damage and repair, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, neurotoxicology, respiratory disease pathophysiology, systems biology, and pathogen-host interactions. Graduates from the program have been highly successful in academia, industry, and other professional settings and include leaders in the field.",Training Program in Environmental Toxicology,"Public Health Relevance: This interdisciplinary program has a long-standing and successful history of training scientists for careers in molecular toxicology as applied to environmental health.  The trainees have gone on to productive careers in academia, industry, and government institutes. Trainees receive a strong, broad background in basic science with opportunities to specialize in specific sub-disciplines of basic and translational research.",Aaron B Bowman,2625423
38,8501451,,2013,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-39,ES007028,UNITED STATES,T32,595959,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2014-06-30T04:00:00Z,PA06468,"See instructions):
 Application is made for continued funding of a long-standing programassociated withthe Center in Molecular
 Toxicology at Vanderbilt University. Funds are requested to support eight predoctoral trainees (Ph.D.
 candidates) and six postdoctoral trainees (those having a Ph.D., M.D., D.V.M., etc.). This interdisciplinary
 program emphasizes molecular aspects of toxicology related to environmental health. The faculty is drawn
 from individuals with appointments in Biochemistry, Biological Sciences, Chemistry, Medicine, Pathology,
 Pediatrics, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program
 obtain degrees through Biochemistry, Biological Sciences, Chemistry, Pathology, or Pharmacology.
 Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in
 seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation
 and application of instrumental systems in research.
Graduate students are recruited to the Departments of Biological Sciences and Chemistry through
departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the other three
(biomedical) departments, graduate students are initially recruited into either the Interdisciplinary Graduate
Program or the Chemical and Physical Biology Program, where they spend the first 9 months in a relatively
common core curriculum and do four laboratory rotations. Graduate students are recruited into Toxicology
from these first year pools (theinitial year is supported by the institution). Both predoctoral and postdoctoral
trainees are selected by the Center's Steering Committee, with guidelines to ensure distribution of
trainees and monitoring of progress. The list of preceptors includes twenty-two faculty who are all Center
Investigators. Major research areas in the Center include oxidative damage, DMA damage and genetic
instability, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles,
and neurotoxicology. Molecular toxicology is recognized as a strong program, and the institution has
continued its commitment to making Vanderbilt a leading center for training in this area.
 RELEVANCE (See instructions):
 This interdisciplinary program has a long-standing and successful history of training individuals in the
 molecular aspects of environmental toxicology. Many former trainees of the program have gone on to
 productive careers in academia, industry, and government institutes. Pre- and postdoctoraltrainees receive
 a strong background in basic science with opportunities to participate in clinical and translational research.
 The ultimate goal of this program is to train future scientists in areas relevant to improving human health.",Training Program in Environmental Toxicology,,Daniel C Liebler,1895831
39,6604029,,2003,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-29,ES007028,UNITED STATES,T32,551762,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2004-06-30T04:00:00Z,,"Application is made for continued funding of a long-standing training program associated with the Center in Molecular Toxicology at Vanderbilt University. Funds are requested to support ten predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees plus two summer medical students. The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Cell Biology, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program obtain degrees through Biochemistry, Cell Biology, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center. In the other four (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations. In the current system, graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution). Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress. Another aspect of this grant is the summer medical student training program, with students drawn from both the classes at Vanderbilt and Meharry Medical College. The list of preceptors includes fourteen faculty who are either Center Investigators or are associated with the Center in some other way. Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mechanisms of mutagenesis, regulation of gene expression, and environmental pathology. Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area. ",TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
40,6150679,,2000,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-26,ES007028,UNITED STATES,T32,495417,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2004-06-30T04:00:00Z,,"Application is made for continued funding of a long-standing training program associated with the Center in Molecular Toxicology at Vanderbilt University. Funds are requested to support ten predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees plus two summer medical students. The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Cell Biology, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program obtain degrees through Biochemistry, Cell Biology, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center. In the other four (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations. In the current system, graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution). Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress. Another aspect of this grant is the summer medical student training program, with students drawn from both the classes at Vanderbilt and Meharry Medical College. The list of preceptors includes fourteen faculty who are either Center Investigators or are associated with the Center in some other way. Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mechanisms of mutagenesis, regulation of gene expression, and environmental pathology. Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area. ",TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
41,3535948,,1991,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32ES007028-17,ES007028,UNITED STATES,T32,275554,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1995-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
42,3535947,,1989,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32ES007028-15,ES007028,UNITED STATES,T32,166418,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1990-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
43,9527144,,2018,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-44,ES007028,UNITED STATES,T32,628475,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant)   
   
Funds are requested to support eight pre-doctoral (Ph.D. candidates) and six postdoctoral trainees in the Training Program in Environmental Toxicology, the long-standing training component of the Center in Molecular Toxicology at Vanderbilt University. This interdisciplinary program provides research career training in molecular aspects of toxicology related to environmental health. Because the field is inherently interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural biology, analytical technology, functional genomics, pathogen-host interactions, disease pathology, and exposure science. The faculty preceptors have appointments in the departments of Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Neurology, Pathology/Microbiology/Immunology, Pediatrics, and Pharmacology, all of whom train doctoral students and postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations, dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive feature of the Program is hands-on training on diverse technology platforms through a highly developed and open system of research facility cores at Vanderbilt. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the medical school departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program in Biomedical and Biological Sciences or the Quantitative and Chemical Biology Program, where they spend the first 9 months in a common core curriculum and do laboratory rotations. Graduate students are supported for the first year by these programs. Students then are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training program support begins in the second year. Both pre-doctoral and postdoctoral trainees are selected by the Training Program Advisory Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes 18 faculty members who are all Investigators in the Center in Molecular Toxicology. Major research areas in the Center include oxidative damage, DNA damage and repair, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, neurotoxicology, respiratory disease pathophysiology, systems biology, and pathogen-host interactions. Graduates from the program have been highly successful in academia, industry, and other professional settings and include leaders in the field.",Training Program in Environmental Toxicology,"Public Health Relevance: This interdisciplinary program has a long-standing and successful history of training scientists for careers in molecular toxicology as applied to environmental health.  The trainees have gone on to productive careers in academia, industry, and government institutes. Trainees receive a strong, broad background in basic science with opportunities to specialize in specific sub-disciplines of basic and translational research.",F PETER Guengerich,1894180
44,8104994,,2011,VANDERBILT UNIVERSITY,Nashville,TN,PEDIATRICS,5T32ES007028-37,ES007028,UNITED STATES,T32,579727,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2014-06-30T04:00:00Z,PA06468,"  
DESCRIPTION (provided by applicant)  
  
Application is made for continued funding of a long-standing program associated with the Center in Molecular Toxicology at Vanderbilt University.  Funds are requested to support eight pre-doctoral trainees (Ph.D. candidates) and six postdoctoral trainees (those having a Ph.D., M.D., D.V.M., etc.). This interdisciplinary program emphasizes molecular aspects of toxicology related to environmental health. The faculty is drawn from individuals with appointments in Biochemistry, Biological Sciences, Chemistry, Medicine, Pathology, Pediatrics, and Pharmacology, all of whom train postdoctoral fellows.  Graduate students in the program obtain degrees through Biochemistry, Biological Sciences, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research.  
  
Graduate students are recruited to the Departments of Biological Sciences and Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the other three (biomedical) departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program or the Chemical and Physical Biology Program, where they spend the first 9 months in a relatively common core curriculum and do four laboratory rotations. Graduate students are recruited into toxicology from these first year pools (the initial year is supported by the institution). Both pre-doctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes twenty-two faculties who are all Center investigators. Major research areas in the Center include oxidative damage, DNA damage and genetic instability, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, and neurotoxicology.  Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area.  
  
  
BACKGROUND  
  
This toxicology program at Vanderbilt began in the 1970s.  The focus of the training has changed over the years. Initially, the focus was on practical toxicology of pesticides, metals, and other hazardous chemicals.  During the 1970s, the focus moved to biochemical toxicology.  Since the 1980s, the emphasis has been on molecular toxicology with a recent focus on the integration of clinical themes.  Originally, the Training Program was housed in the Department of Biochemistry.  However, over time the program became interdepartmental.  Currently, there are 22 mentors for this Training Program with primary appointments within the Departments of Biochemistry, Biological Sciences, Chemistry, Pathology, Pediatrics, Pharmacology, and Medicine. The Training Program has a long history of training individuals who go on to have productive careers in academia, research institutes, and industry.   
  
    

",Training Program in Environmental Toxicology,,Michael  Aschner,1889672
45,9939545,,2020,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-46,ES007028,UNITED STATES,T32,493067,True,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2024-06-30T04:00:00Z,PA18403,"Project Summary
Funds are requested to support eight predoctoral (Ph.D. candidates) and six postdoctoral trainees in the
Training Program in Environmental Toxicology, a long-standing research training program in molecular
toxicology at Vanderbilt University. This interdisciplinary program provides research career training
in molecular aspects of toxicology related to environmental health. Because the field is inherently
interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural
biology, analytical technology, microphysiological systems, functional genomics, pathogen-host interactions,
disease pathology, and exposure science. The faculty preceptors have appointments in the departments of
Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Pathology, Microbiology &
Immunology, Obstetrics & Gynecology, Pediatrics and Physics all of whom have trained doctoral students and
postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations,
dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive
feature of the program is hands-on training on diverse technology platforms through a highly developed and
open system of research facility cores at Vanderbilt. A fraction of our graduate students are recruited through
specific departments, while most matriculate through one of two umbrella programs: the Interdisciplinary
Graduate Program in Biomedical and Biological Sciences (IGP) or the Quantitative and Chemical Biology
Program (QCB). The students then spend their first 9 months in a common core curriculum and do laboratory
rotations. Graduate students are supported for the first year by these programs or departments. Students then
are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training
program support begins in the second year. Both predoctoral and postdoctoral trainees are selected by the
Training Program Executive Committee composed of the Director, Associate Director and the Internal Advisory
Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors
includes 17 faculty with diverse research interests and substantively well support research programs with the
average current year direct costs available being over $1 million per investigators. Major research areas
represented by our faculty preceptors include (1) Xenobiotic metabolism, detoxication, and enzymology; (2)
Oxidative stress and inflammation; (3) DNA damage, genome maintenance, and replication; (4) Translational
toxicology; (5) Host-pathogen-environment interactions; (6) Systems biology and developmental toxicology;
and newly represented this cycle (7) Organs-on-chips and microphysiological systems. Graduates from the
program have been highly successful in academia, industry, and other professional settings and include
leaders in the field.",Training Program in Environmental Toxicology,"Project Narrative
This interdisciplinary program has a long-standing and successful history of training scientists for careers in
molecular toxicology as applied to environmental health. Our trainees have gone on to productive careers in
academia, industry, and government institutes. Trainees receive a strong, broad background in basic science
with opportunities to specialize in specific subdisciplines of basic and translational research.",F PETER Guengerich,1894180
46,7097319,,2006,VANDERBILT UNIVERSITY MEDICAL CENTER,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-32,ES007028,UNITED STATES,T32,642583,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2009-06-30T04:00:00Z,,,Training Program in Environmental Toxicology,,F PETER Guengerich,1894180
47,2802895,,1999,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,2T32ES007028-25,ES007028,UNITED STATES,T32,441054,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2004-06-30T04:00:00Z,,"Application is made for continued funding of a long-standing training program associated with the Center in Molecular Toxicology at Vanderbilt University. Funds are requested to support ten predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees plus two summer medical students. The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Cell Biology, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program obtain degrees through Biochemistry, Cell Biology, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation and application of instrumental systems in research. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center. In the other four (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations. In the current system, graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution). Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress. Another aspect of this grant is the summer medical student training program, with students drawn from both the classes at Vanderbilt and Meharry Medical College. The list of preceptors includes fourteen faculty who are either Center Investigators or are associated with the Center in some other way. Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mechanisms of mutagenesis, regulation of gene expression, and environmental pathology. Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area. ",TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
48,8296312,,2012,VANDERBILT UNIVERSITY,Nashville,TN,PEDIATRICS,5T32ES007028-38,ES007028,UNITED STATES,T32,572806,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2014-06-30T04:00:00Z,PA06468,"See instructions):
 Application is made for continued funding of a long-standing programassociated withthe Center in Molecular
 Toxicology at Vanderbilt University. Funds are requested to support eight predoctoral trainees (Ph.D.
 candidates) and six postdoctoral trainees (those having a Ph.D., M.D., D.V.M., etc.). This interdisciplinary
 program emphasizes molecular aspects of toxicology related to environmental health. The faculty is drawn
 from individuals with appointments in Biochemistry, Biological Sciences, Chemistry, Medicine, Pathology,
 Pediatrics, and Pharmacology, all of whom train postdoctoral fellows. Graduate students in the program
 obtain degrees through Biochemistry, Biological Sciences, Chemistry, Pathology, or Pharmacology.
 Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in
 seminars, journal clubs, and joint research meetings. There is also much opportunity for learning operation
 and application of instrumental systems in research.
Graduate students are recruited to the Departments of Biological Sciences and Chemistry through
departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the other three
(biomedical) departments, graduate students are initially recruited into either the Interdisciplinary Graduate
Program or the Chemical and Physical Biology Program, where they spend the first 9 months in a relatively
common core curriculum and do four laboratory rotations. Graduate students are recruited into Toxicology
from these first year pools (theinitial year is supported by the institution). Both predoctoral and postdoctoral
trainees are selected by the Center's Steering Committee, with guidelines to ensure distribution of
trainees and monitoring of progress. The list of preceptors includes twenty-two faculty who are all Center
Investigators. Major research areas in the Center include oxidative damage, DMA damage and genetic
instability, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles,
and neurotoxicology. Molecular toxicology is recognized as a strong program, and the institution has
continued its commitment to making Vanderbilt a leading center for training in this area.
 RELEVANCE (See instructions):
 This interdisciplinary program has a long-standing and successful history of training individuals in the
 molecular aspects of environmental toxicology. Many former trainees of the program have gone on to
 productive careers in academia, industry, and government institutes. Pre- and postdoctoraltrainees receive
 a strong background in basic science with opportunities to participate in clinical and translational research.
 The ultimate goal of this program is to train future scientists in areas relevant to improving human health.",Training Program in Environmental Toxicology,,Daniel C Liebler,1895831
49,9306918,,2017,VANDERBILT UNIVERSITY,Nashville,TN,BIOCHEMISTRY,5T32ES007028-43,ES007028,UNITED STATES,T32,749212,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2019-06-30T04:00:00Z,PA11184,"DESCRIPTION (provided by applicant)   
   
Funds are requested to support eight pre-doctoral (Ph.D. candidates) and six postdoctoral trainees in the Training Program in Environmental Toxicology, the long-standing training component of the Center in Molecular Toxicology at Vanderbilt University. This interdisciplinary program provides research career training in molecular aspects of toxicology related to environmental health. Because the field is inherently interdisciplinary, research training in the program spans chemistry, biochemistry, chemical biology, structural biology, analytical technology, functional genomics, pathogen-host interactions, disease pathology, and exposure science. The faculty preceptors have appointments in the departments of Biochemistry, Biological Sciences, Biomedical Informatics, Chemistry, Medicine, Neurology, Pathology/Microbiology/Immunology, Pediatrics, and Pharmacology, all of whom train doctoral students and postdoctoral fellows. Training is achieved through basic and specialized coursework, research rotations, dissertation research, and participation in seminars, journal clubs, and joint research meetings. A distinctive feature of the Program is hands-on training on diverse technology platforms through a highly developed and open system of research facility cores at Vanderbilt. Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center in Molecular Toxicology. In the medical school departments, graduate students are initially recruited into either the Interdisciplinary Graduate Program in Biomedical and Biological Sciences or the Quantitative and Chemical Biology Program, where they spend the first 9 months in a common core curriculum and do laboratory rotations. Graduate students are supported for the first year by these programs. Students then are recruited into the Training Program in Environmental Toxicology from these first-year pools, and training program support begins in the second year. Both pre-doctoral and postdoctoral trainees are selected by the Training Program Advisory Committee, with guidelines to ensure distribution of trainees and monitoring of progress. The list of preceptors includes 18 faculty members who are all Investigators in the Center in Molecular Toxicology. Major research areas in the Center include oxidative damage, DNA damage and repair, maintenance of genomic integrity, enzymatic biotransformation and reactions of electrophiles, neurotoxicology, respiratory disease pathophysiology, systems biology, and pathogen-host interactions. Graduates from the program have been highly successful in academia, industry, and other professional settings and include leaders in the field.",Training Program in Environmental Toxicology,"Public Health Relevance: This interdisciplinary program has a long-standing and successful history of training scientists for careers in molecular toxicology as applied to environmental health.  The trainees have gone on to productive careers in academia, industry, and government institutes. Trainees receive a strong, broad background in basic science with opportunities to specialize in specific sub-disciplines of basic and translational research.",Aaron B Bowman,2625423
0,6750525,,2004,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,2T32ES007028-30,ES007028,UNITED STATES,T32,618820,False,Carol A. Shreffler,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,2009-06-30T04:00:00Z,,"DESCRIPTION (provided by applicant):   
Application is made for continued funding of a long-standing program associated with the Center in Molecular Toxicology at Vanderbilt University.  Funds are requested to support eight predoctoral (Ph.D. candidates) and six postdoctoral (already having a Ph.D., M.D., D.V.M., etc.) trainees.  The program emphasizes molecular aspects of toxicology and is interdisciplinary. The faculty is drawn from individuals with appointments in Biochemistry, Chemistry, Medicine, Pathology, and Pharmacology, all of whom train postdoctoral fellows.  Graduate students in the program obtain degrees through Biochemistry, Chemistry, Pathology, or Pharmacology. Considerable emphasis is placed upon research rotations, the thesis research itself, and participation in seminars, journal clubs, and joint research meetings. There is also much opportunity for learning the operation and application of instrumental systems in research.  Graduate students are recruited to the Department of Chemistry through departmental mechanisms, with assistance from the Center.  In the other three (biomedical) departments, graduate students are initially recruited into the Interdisciplinary Graduate Program, where they spend the first 9 months in a relatively common core curriculum and do three laboratory rotations.  
Graduate students are recruited into Toxicology from these first year pools (the initial year is supported by the institution).  Both predoctoral and postdoctoral trainees are selected by the Center's Steering Committee, with guidelines to insure distribution of trainees and monitoring of progress.  The list of preceptors includes sixteen faculty, who are all Center investigators.  Major research areas in the Center include enzymatic oxidation and conjugation, oxidative damage, DNA damage and mutagenesis, mechanisms of cell signaling, and structural biology relevant to toxicology.  Molecular toxicology is recognized as a strong program, and the institution has continued its commitment to making Vanderbilt a leading center for training in this area.",Training Program in Environmental Toxicology,,F PETER Guengerich,1894180
1,2156046,,1994,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32ES007028-20,ES007028,UNITED STATES,T32,173390,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1995-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
2,3535949,,1992,VANDERBILT UNIVERSITY,NASHVILLE,TN,,5T32ES007028-18,ES007028,UNITED STATES,T32,230424,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1995-06-30T04:00:00Z,,,ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
3,3535940,,1985,VANDERBILT UNIVERSITY,NASHVILLE,TN,,2T32ES007028-11,ES007028,UNITED STATES,T32,120682,False,,National Institute of Environmental Health Sciences,1975-07-10T04:00:00Z,1990-06-30T04:00:00Z,,,TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGY,,F PETER Guengerich,1894180
4,6921358,,2005,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-30,NS007044,UNITED STATES,T32,286219,False,Stephen J Korn,National Institute of Neurological Disorders and Stroke,1975-07-15T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Adapted From The Abstract Provided By Applicant): This is a
renewal application for a longstanding training program that is now focussed,
providing pre-doctoral and post-doctoral trainees with intensive research
experience in the areas of synapses, ion channels and transduction, while
ensuring that the trainees have a thorough grounding in the basic
neurosciences. The approaches involve the use of advanced molecular biological,
physical, chemical, electrical, mathematical, and computational techniques to
study fundamental questions in these closely related areas of cellular and
molecular neuroscience. Pre-doctoral trainees will enter the program after
taking an interdisciplinary group of graduate courses and specialized courses
tailored to their needs and after selecting a mentor on the training faculty.
Under the mentors direction they will design and execute an original research
project, culminating in a Ph.D. degree. Post-doctoral trainees are offered a
choice of research topics from which they develop their own independent
projects. All trainees receive much individual attention from program faculty
and are exposed to a variety of pertinent research activities. Trainees give
research presentations and participate in seminars and journal clubs with a
large and closely interacting group of neuroscientists. The trainees also take
part in career and ethics workshops and gain supervised teaching experience.
The aim of this training program is to produce a cadre of highly qualified
scientists, capable of working at the forefront of their respective research
areas, while being broadly knowledgeable in basic neuroscience and able to
communicate effectively. The trainees will be qualified for diverse advanced
positions in the biomedical sciences, ranging from academic to those in private
industry and government. Accepted trainees must have strong academic
credentials, with a clear interest in scientific inquiry. Support is requested
for 2 pre-doctoral, 2 post-doctoral, and 4 shortterm (summer medical student)
trainees. The neuroscience training program is conducted by 19 faculty members,
each actively involved in teaching and research. These faculty have advanced
laboratories, and are well funded through individual research grants. Primary
research and training facilities are in the Medical Science Building at the
Univ. of Miami School of Medicine.","Synapses, Channels, and Transduction in Neuroscience",,Kenneth J Muller,7684521
5,6608029,,2003,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-28,NS007044,UNITED STATES,T32,38552,False,EDMUND M TALLEY,National Institute of Neurological Disorders and Stroke,1975-07-15T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Adapted From The Abstract Provided By Applicant): This is a
renewal application for a longstanding training program that is now focussed,
providing pre-doctoral and post-doctoral trainees with intensive research
experience in the areas of synapses, ion channels and transduction, while
ensuring that the trainees have a thorough grounding in the basic
neurosciences. The approaches involve the use of advanced molecular biological,
physical, chemical, electrical, mathematical, and computational techniques to
study fundamental questions in these closely related areas of cellular and
molecular neuroscience. Pre-doctoral trainees will enter the program after
taking an interdisciplinary group of graduate courses and specialized courses
tailored to their needs and after selecting a mentor on the training faculty.
Under the mentors direction they will design and execute an original research
project, culminating in a Ph.D. degree. Post-doctoral trainees are offered a
choice of research topics from which they develop their own independent
projects. All trainees receive much individual attention from program faculty
and are exposed to a variety of pertinent research activities. Trainees give
research presentations and participate in seminars and journal clubs with a
large and closely interacting group of neuroscientists. The trainees also take
part in career and ethics workshops and gain supervised teaching experience.
The aim of this training program is to produce a cadre of highly qualified
scientists, capable of working at the forefront of their respective research
areas, while being broadly knowledgeable in basic neuroscience and able to
communicate effectively. The trainees will be qualified for diverse advanced
positions in the biomedical sciences, ranging from academic to those in private
industry and government. Accepted trainees must have strong academic
credentials, with a clear interest in scientific inquiry. Support is requested
for 2 pre-doctoral, 2 post-doctoral, and 4 shortterm (summer medical student)
trainees. The neuroscience training program is conducted by 19 faculty members,
each actively involved in teaching and research. These faculty have advanced
laboratories, and are well funded through individual research grants. Primary
research and training facilities are in the Medical Science Building at the
Univ. of Miami School of Medicine.","Synapses, Channels, and Transduction in Neuroscience",,Kenneth J Muller,7684521
6,6314378,,2001,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,2T32NS007044-26,NS007044,UNITED STATES,T32,173140,False,EDMUND M TALLEY,National Institute of Neurological Disorders and Stroke,1975-07-15T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Adapted From The Abstract Provided By Applicant): This is a
renewal application for a longstanding training program that is now focussed,
providing pre-doctoral and post-doctoral trainees with intensive research
experience in the areas of synapses, ion channels and transduction, while
ensuring that the trainees have a thorough grounding in the basic
neurosciences. The approaches involve the use of advanced molecular biological,
physical, chemical, electrical, mathematical, and computational techniques to
study fundamental questions in these closely related areas of cellular and
molecular neuroscience. Pre-doctoral trainees will enter the program after
taking an interdisciplinary group of graduate courses and specialized courses
tailored to their needs and after selecting a mentor on the training faculty.
Under the mentors direction they will design and execute an original research
project, culminating in a Ph.D. degree. Post-doctoral trainees are offered a
choice of research topics from which they develop their own independent
projects. All trainees receive much individual attention from program faculty
and are exposed to a variety of pertinent research activities. Trainees give
research presentations and participate in seminars and journal clubs with a
large and closely interacting group of neuroscientists. The trainees also take
part in career and ethics workshops and gain supervised teaching experience.
The aim of this training program is to produce a cadre of highly qualified
scientists, capable of working at the forefront of their respective research
areas, while being broadly knowledgeable in basic neuroscience and able to
communicate effectively. The trainees will be qualified for diverse advanced
positions in the biomedical sciences, ranging from academic to those in private
industry and government. Accepted trainees must have strong academic
credentials, with a clear interest in scientific inquiry. Support is requested
for 2 pre-doctoral, 2 post-doctoral, and 4 shortterm (summer medical student)
trainees. The neuroscience training program is conducted by 19 faculty members,
each actively involved in teaching and research. These faculty have advanced
laboratories, and are well funded through individual research grants. Primary
research and training facilities are in the Medical Science Building at the
Univ. of Miami School of Medicine.","Synapses, Channels, and Transduction in Neuroscience",,Kenneth J Muller,7684521
7,6768657,,2004,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-29,NS007044,UNITED STATES,T32,246721,False,EDMUND M TALLEY,National Institute of Neurological Disorders and Stroke,1975-07-15T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Adapted From The Abstract Provided By Applicant): This is a
renewal application for a longstanding training program that is now focussed,
providing pre-doctoral and post-doctoral trainees with intensive research
experience in the areas of synapses, ion channels and transduction, while
ensuring that the trainees have a thorough grounding in the basic
neurosciences. The approaches involve the use of advanced molecular biological,
physical, chemical, electrical, mathematical, and computational techniques to
study fundamental questions in these closely related areas of cellular and
molecular neuroscience. Pre-doctoral trainees will enter the program after
taking an interdisciplinary group of graduate courses and specialized courses
tailored to their needs and after selecting a mentor on the training faculty.
Under the mentors direction they will design and execute an original research
project, culminating in a Ph.D. degree. Post-doctoral trainees are offered a
choice of research topics from which they develop their own independent
projects. All trainees receive much individual attention from program faculty
and are exposed to a variety of pertinent research activities. Trainees give
research presentations and participate in seminars and journal clubs with a
large and closely interacting group of neuroscientists. The trainees also take
part in career and ethics workshops and gain supervised teaching experience.
The aim of this training program is to produce a cadre of highly qualified
scientists, capable of working at the forefront of their respective research
areas, while being broadly knowledgeable in basic neuroscience and able to
communicate effectively. The trainees will be qualified for diverse advanced
positions in the biomedical sciences, ranging from academic to those in private
industry and government. Accepted trainees must have strong academic
credentials, with a clear interest in scientific inquiry. Support is requested
for 2 pre-doctoral, 2 post-doctoral, and 4 shortterm (summer medical student)
trainees. The neuroscience training program is conducted by 19 faculty members,
each actively involved in teaching and research. These faculty have advanced
laboratories, and are well funded through individual research grants. Primary
research and training facilities are in the Medical Science Building at the
Univ. of Miami School of Medicine.","Synapses, Channels, and Transduction in Neuroscience",,Kenneth J Muller,7684521
8,6530960,,2002,UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,MIAMI,FL,PHYSIOLOGY,5T32NS007044-27,NS007044,UNITED STATES,T32,190723,False,EDMUND M TALLEY,National Institute of Neurological Disorders and Stroke,1975-07-15T04:00:00Z,2006-06-30T04:00:00Z,,"DESCRIPTION (Adapted From The Abstract Provided By Applicant): This is a
renewal application for a longstanding training program that is now focussed,
providing pre-doctoral and post-doctoral trainees with intensive research
experience in the areas of synapses, ion channels and transduction, while
ensuring that the trainees have a thorough grounding in the basic
neurosciences. The approaches involve the use of advanced molecular biological,
physical, chemical, electrical, mathematical, and computational techniques to
study fundamental questions in these closely related areas of cellular and
molecular neuroscience. Pre-doctoral trainees will enter the program after
taking an interdisciplinary group of graduate courses and specialized courses
tailored to their needs and after selecting a mentor on the training faculty.
Under the mentors direction they will design and execute an original research
project, culminating in a Ph.D. degree. Post-doctoral trainees are offered a
choice of research topics from which they develop their own independent
projects. All trainees receive much individual attention from program faculty
and are exposed to a variety of pertinent research activities. Trainees give
research presentations and participate in seminars and journal clubs with a
large and closely interacting group of neuroscientists. The trainees also take
part in career and ethics workshops and gain supervised teaching experience.
The aim of this training program is to produce a cadre of highly qualified
scientists, capable of working at the forefront of their respective research
areas, while being broadly knowledgeable in basic neuroscience and able to
communicate effectively. The trainees will be qualified for diverse advanced
positions in the biomedical sciences, ranging from academic to those in private
industry and government. Accepted trainees must have strong academic
credentials, with a clear interest in scientific inquiry. Support is requested
for 2 pre-doctoral, 2 post-doctoral, and 4 shortterm (summer medical student)
trainees. The neuroscience training program is conducted by 19 faculty members,
each actively involved in teaching and research. These faculty have advanced
laboratories, and are well funded through individual research grants. Primary
research and training facilities are in the Medical Science Building at the
Univ. of Miami School of Medicine.","Synapses, Channels, and Transduction in Neuroscience",,Kenneth J Muller,7684521
9,3310561,,1987,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5R01HD006707-16,HD006707,UNITED STATES,R01,230646,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1988-07-31T04:00:00Z,,"Our long-term objective is to achieve an understanding of the molecular
properties of the estrogen receptor and its role in regulating normal and
abnormal uterine growth and reproductive function.  We have described the
mechanism by which estradiol-binding modulates the equilibrium between the
nonactive and the active states of the estrogen receptor.  The estrogen
receptor exists in two forms or states:  the nonactive, 4S monomer, which
has a lower affinity for estradiol and rapid estradiol dissociation
kinetics; and the activated, 5S receptor dimer, which has a higher affinity
for estradiol and slower estradiol dissociation kinetics.  Equilibrium
between these two forms of the estrogen receptor induces a posibively
cooperative equilibrium binding of estradiol.  Since there is only limited
information on several crucial aspects of the biochemistry of the estrogen
receptor, we propose:  1) A careful kinetic and thermodynamic analysis of
the interactions between the receptor and tritiated and nontriatiated
potent agonists (estradiol, diethylstilbestrol), weak estrogens (estrone,
estroil) and estrogenic antagonists (clomiphene, tamoxifen,
hydroxytamoxifen, and LY117018).  The relationship between the receptor's
binding kinetics with each of these compounds and their biological activity
will be compared.  2) Characterization and kinetics of the DNA binding
properties of activated as compared with nonactivated forms of the estrogen
receptor.  The role of estrogen-binding by the receptor on the receptor's
DNA binding interactions will be investigated.  3) Estrogen affinity
chromatography will be used to purify the estrogen receptor from calf
uteri, and its molecular properties will then be described.  4) Monoclonal
antibodies will be prepared as a probe for the receptor's biochemistry.
",THE UTERINE ESTROGEN BINDING PROTEINS,,Thomas A Gasiewicz,1859131
10,3224318,,1989,IOWA STATE UNIVERSITY,AMES,IA,,2R01DK001549-32A1,DK001549,UNITED STATES,R01,146823,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1994-03-30T05:00:00Z,,"A series of spectoscopic, chemical and crystallographic studies will be
conducted on three highly purified vitamin B6-dependent enzymes:  cytosolic
aspartate aminotransferase of pig hearts (AspAT), tryptophanase of
Escherichia coli and glutamate decarboxylase of E. coli.  The goals will
be to provide understanding of basic mechanisms of pyridoxal phosphate-
dependent catalysis and to assist in the design of useful enzyme-activated
inhibitors.  (1) We will conduct a series of microspectrophotometric
measurements on crystals of aspartate aminotransferase.  We will measure
binding constants within crystals for inhibitors and natural substrates.
(2) We will collaborate in determining structures of substrate and
inhibitor complexes of this enzyme.  We will make special efforts to
stabilize the erythro-3-hydroxyaspartate complex and to deduce its
structure.  (3) We will separate individual species of the self-inactivated
beta subform of AspAT by isoelectric focusing and will crystallize at least
the major species and some other less abundant forms.  This homogeneous
beta form will be analyzed by X-ray diffraction and will be used by us in
microspectrophotometry for a variety of experiments.  We will characterize
an addition major compound released from the inactivated subunit of the
beta subform by heating.  (4) The 6-fluoro derivatives of pyridoxal and
pyridoxamine phosphates, incorporated in to the active sites of AspAT,
tryptophanase, and bacterial glutamate decarboxylase, will be studied by
19F NMR spectroscopy.  (5) We will try to crystallize AspAT inhibited by
enzyme-activated inhibitors including beta-methyleneaspartate, serine
sulfate, and acetylenic GABA.  This should allow us to see directly the
structures of different types of inhibited enzyme.  The resulting knowledge
will be important for rational design of drugs for inhibition of other
transaminases.  We also propose to do modeling of inhibitor action using
an Evans & Sutherland graphics terminal.  We will try series of
spectroscopic studies on tryptophanase and glutamate decarboxylase aimed
at elucidating the structures of intermediate species.  We will also
attempt to obtain crystals of these enzymes suitable for X-ray studies.
(7) We will conduct nonenzymic studies on formation of Al3+ -stabilized
quinonoid species in methanol and we will compare rates of alpha hydrogen
removal in model systems with pyridoxal phosphate, its N-methyl derivatives
and with 6-fluoropyridoxal phosphate.
",MECHANISMS & INHIBITORS OF PYRIDOXAL-DEPENDENT ENZYMES,,DAVID E METZLER,3619902
11,3269564,,1993,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5R01GM019199-21,GM019199,UNITED STATES,R01,259466,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",PROCESSING OF DNA BY HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
12,2133536,,1993,IOWA STATE UNIVERSITY,AMES,IA,BIOCHEMISTRY,5R01DK001549-36,DK001549,UNITED STATES,R01,151457,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"A series of spectoscopic, chemical and crystallographic studies will be
conducted on three highly purified vitamin B6-dependent enzymes:  cytosolic
aspartate aminotransferase of pig hearts (AspAT), tryptophanase of
Escherichia coli and glutamate decarboxylase of E. coli.  The goals will
be to provide understanding of basic mechanisms of pyridoxal phosphate-
dependent catalysis and to assist in the design of useful enzyme-activated
inhibitors.  (1) We will conduct a series of microspectrophotometric
measurements on crystals of aspartate aminotransferase.  We will measure
binding constants within crystals for inhibitors and natural substrates.
(2) We will collaborate in determining structures of substrate and
inhibitor complexes of this enzyme.  We will make special efforts to
stabilize the erythro-3-hydroxyaspartate complex and to deduce its
structure.  (3) We will separate individual species of the self-inactivated
beta subform of AspAT by isoelectric focusing and will crystallize at least
the major species and some other less abundant forms.  This homogeneous
beta form will be analyzed by X-ray diffraction and will be used by us in
microspectrophotometry for a variety of experiments.  We will characterize
an addition major compound released from the inactivated subunit of the
beta subform by heating.  (4) The 6-fluoro derivatives of pyridoxal and
pyridoxamine phosphates, incorporated in to the active sites of AspAT,
tryptophanase, and bacterial glutamate decarboxylase, will be studied by
19F NMR spectroscopy.  (5) We will try to crystallize AspAT inhibited by
enzyme-activated inhibitors including beta-methyleneaspartate, serine
sulfate, and acetylenic GABA.  This should allow us to see directly the
structures of different types of inhibited enzyme.  The resulting knowledge
will be important for rational design of drugs for inhibition of other
transaminases.  We also propose to do modeling of inhibitor action using
an Evans & Sutherland graphics terminal.  We will try series of
spectroscopic studies on tryptophanase and glutamate decarboxylase aimed
at elucidating the structures of intermediate species.  We will also
attempt to obtain crystals of these enzymes suitable for X-ray studies.
(7) We will conduct nonenzymic studies on formation of Al3+ -stabilized
quinonoid species in methanol and we will compare rates of alpha hydrogen
removal in model systems with pyridoxal phosphate, its N-methyl derivatives
and with 6-fluoropyridoxal phosphate.
",MECHANISMS & INHIBITORS OF PYRIDOXAL-DEPENDENT ENZYMES,,DAVID E METZLER,3619902
13,3310564,,1992,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5R01HD006707-20,HD006707,UNITED STATES,R01,260537,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1993-03-31T05:00:00Z,,"The long-term objectives of this research program are to elucidate
the estrogen-, antiestrogen- and DNA-binding mechanisms and
activities of the estrogen receptor; and the application of these
basic studies to the regulation and function of reproductive
tissues and the control of estrogen-dependent cancers.  The
immediate specific aims are:  (1) to determine whether the affinity
of the estrogen receptor for its estrogen responsive element (ERE),
a specific nucleotide sequence of the prolactin gene, controls the
selectivity of the receptor for specific genes.  The in vitro
affinity of the estrogen receptor for the ERE and the in vivo
response to estradiol will be measured after site-directed in vitro
mutagenesis of the ERE.  The affinity of the receptor for the DNA
will be measured by the gel mobility assay.  The ERE's will be
linked to the thymidine kinase promoter linked to the
chloramphenicol acetyltransferase gene.  The plasmid constructs
will be transfected into GH3 cells and responsiveness to estradiol
measured.  (2) The affinity of the antiestrogen receptor complexes
for the ERE and mutant EREs will be measured to determine whether
the antiestrogens change the interaction and selectivity of the
receptor, so that the receptor interacts with other genes.  (3)
Isolate and characterize DNA-binding protein(s) that bind at or
near the ERE of the prolactin gene whose binding is dependent
upon/or modified by the presence of the purified estrogen receptor.
(4) Identify and characterize the in vivo phosphorylation sites of
the estrogen receptor in calf uteri and MCF-7 cells. Determine the
effects of receptor phosphorylation on the receptor's estrogen-
and DNA-binding activities.  Such information could provide insight
into the fundamental mechanisms of steroid hormone action.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
14,3269563,,1992,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5R01GM019199-20,GM019199,UNITED STATES,R01,247515,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",PROCESSING OF DNA BY HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
15,3267905,,1986,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,2R01GM006590-27,GM006590,UNITED STATES,R01,229552,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-11-30T05:00:00Z,,"A systematic analysis of the structure, function and regulation of the
pyruvate, Alpha-ketoglutarate, and branched chain Alpha-keto acid
dehydrogenase multienzyme complexes will be continued.  The specific aims
are (1) to purify the branched chain Alpha-keto acid dehydrogenase
phosphatase from bovine kidney to homogeneity, determine its subunit
composition, and further characterize its regulation; (2) to purify and
characterize the branched chain Alpha-keto acid dehydrogenase kinase from
bovine kidney; (3) to further characterize pyruvate dehydrogenase
phosphatase and pyruvate dehydrogenase kinase from bovine kidney and heart;
(4) to separate the two different subunits comprising the pyruvate
dehydrogenase component of the mammalian pyruvate dehydrogenase complex and
determine the function of each subunit; (5) to continue structural studies
on the Alpha-keto acid dehydrogenase complexes, subcomplexes and component
enzymes thereof, using limited proteolysis, electron microscopy and X-ray
diffraction.  The mitochondrial pyruvate and branched chain Alpha-keto acid
dehydrogenase complexes occupy key positions in metabolism, and their
activities are under metabolic and hormonal control.  Regulation of the
flux of carbon through the pyruvate dehydrogenase complex plays an
essential role in the control of energy metabolism.  The branched chain
Alpha-keto acids derived from the branched chain amino acids, valine,
leucine and isoleucine, represent an important source of carbon for
cellular energy generation, carbohydrate biosynthesis and ketone body
production in various tissues.  Elucidation of the structure and catalytic
and regulatory properties of the isolated Alpha-keto acid dehydrogenase
complexes and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Also, analysis
of inherited and acquired disorders of pyruvate and branched chain amino
acid metabolism that have been reported rests on knowledge of normal
metabolism of these substances.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
16,3150684,,1985,IOWA STATE UNIVERSITY,AMES,IA,,2R01AM001549-29,AM001549,UNITED STATES,R01,99072,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1988-08-31T04:00:00Z,,"We propose to continue collaboration with Dr. Arthur Arnone at the
University of Iowa and with Dr. Marvin Makinen at the University of Chicago
on X-ray diffraction and polarized optical spectroscopic studies of
crystalline cytosolic aspartate aminotransferase (glutamate-oxaloacetate
transaminase) of pig hearts.  The aim will be to understand the dynamic
behavior of the coenzyme and protein during various stages of catalysis by
this important heart enzyme.  Among the features to be studied is a major
conformational change of the protein that accompanies the binding of
substrates or inhibitors.  We will attempt to precisely define the details
of the catalytic process and the role of the protein as a ""solvent"" for the
reaction.  We will continue to study the action of serine sulfate,
Beta-methyleneaspartate, vinylglycine and other ""suicide inactivators"" of
vitamin B6-dependent enzymes.  We will prepare crystalline derivatives with
which it should be possible to see directly the structure of three
different types of inhibited enzyme.  This knowledge will be important for
rational design of drugs for inhibition of other transaminases.  We will
attempt to determine the structure of the inhibited active site of the
naturally occurring Beta subform which is only partially active.  This will
involve characterization of compounds released by heating the inactivated
subunits and isolation and chemical characterization of peptides carrying a
covalently bonded inhibitor or modified substrate.  The possible biological
and medical significance of the presence in tissues of large amounts of
partially inactivated enzyme will be considered.  We will continue studies
of a series of analogs of pyridoxal phosphate with aspartate
aminotransferase and glutamate decarboxylase.  Among these are analogs that
do not permit transimination and 6-fluropyridoxal phosphate, a compound
with interesting electronic properties and with a good NMR signal that can
be seen when bound to enzymes.  We will study further the formation of
fluorescent pyrrolopyridines with pyridoxal 5 foot-sulfate.  We will
continue nonenzymatic studies of Schiff bases, especially of diamines using
both proton NMR and computer-assisted spectroscopic analysis.  All of these
studies have a direct relevance to a large group of important vitamin
B6-dependent enzymes.
",THE ACTION OF B VITAMINS IN ENZYMIC CATALYSIS,,DAVID E METZLER,3226632
17,3224320,,1986,IOWA STATE UNIVERSITY,AMES,IA,,5R01DK001549-30,DK001549,UNITED STATES,R01,92612,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1988-08-31T04:00:00Z,,"We propose to continue collaboration with Dr. Arthur Arnone at the
University of Iowa and with Dr. Marvin Makinen at the University of Chicago
on X-ray diffraction and polarized optical spectroscopic studies of
crystalline cytosolic aspartate aminotransferase (glutamate-oxaloacetate
transaminase) of pig hearts.  The aim will be to understand the dynamic
behavior of the coenzyme and protein during various stages of catalysis by
this important heart enzyme.  Among the features to be studied is a major
conformational change of the protein that accompanies the binding of
substrates or inhibitors.  We will attempt to precisely define the details
of the catalytic process and the role of the protein as a ""solvent"" for the
reaction.  We will continue to study the action of serine sulfate,
Beta-methyleneaspartate, vinylglycine and other ""suicide inactivators"" of
vitamin B6-dependent enzymes.  We will prepare crystalline derivatives with
which it should be possible to see directly the structure of three
different types of inhibited enzyme.  This knowledge will be important for
rational design of drugs for inhibition of other transaminases.  We will
attempt to determine the structure of the inhibited active site of the
naturally occurring Beta subform which is only partially active.  This will
involve characterization of compounds released by heating the inactivated
subunits and isolation and chemical characterization of peptides carrying a
covalently bonded inhibitor or modified substrate.  The possible biological
and medical significance of the presence in tissues of large amounts of
partially inactivated enzyme will be considered.  We will continue studies
of a series of analogs of pyridoxal phosphate with aspartate
aminotransferase and glutamate decarboxylase.  Among these are analogs that
do not permit transimination and 6-fluropyridoxal phosphate, a compound
with interesting electronic properties and with a good NMR signal that can
be seen when bound to enzymes.  We will study further the formation of
fluorescent pyrrolopyridines with pyridoxal 5 foot-sulfate.  We will
continue nonenzymatic studies of Schiff bases, especially of diamines using
both proton NMR and computer-assisted spectroscopic analysis.  All of these
studies have a direct relevance to a large group of important vitamin
B6-dependent enzymes.
",THE ACTION OF B VITAMINS IN ENZYMIC CATALYSIS,,DAVID E METZLER,3226632
18,2166088,,1994,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,CHEMISTRY,5R01GM006590-35,GM006590,UNITED STATES,R01,229090,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-08-31T04:00:00Z,,"     This research project is directed toward elucidating the
structure, function and regulation of the alpha-keto acid
dehydrogenase multienzyme complexes from eukaryotic,and prokaryotic
cells.  During the next five-year period emphasis will be placed on
structure-function studies of eukaryotic pyruvate dehydrogenase
(PDH) complexes, particularly the PDH complex from Saccharomyces
cerevisiae, using biochemical, molecular genetic, and X-ray
crystallographic approaches.  The specific aims are (1) to conduct
structure-function Analyses, including collaborative X-ray
crystallography, of S. cerevisiae dihydrolipoamide acetyltransferase
(E 2p) and its structural domains using recombinant proteins; (2)
to continue to elucidate the nature and function of the protein X
component of the yeast PDH complex, using biochemical and molecular
genetic approaches; (3) to conduct collaborative X-ray
crystallographic analysis and site-directed mutagenesis of
dihydrolipoamide dehydrogenase (E3); (4) to clone the yeast gene
encoding the beta subunit of pyruvate dehydrogenase (El) and
overexpress E1alpha and E1beta for functional studies; (5) to purify
to homogeneity and further characterize the protein kinase which
modulates the activity of the bovine branched-chain alpha-keto acid
dehydrogenase complex; (6) to clone and sequence cDNAs encoding the
two subunits of the regulatory enzyme PDH phosphatase.  The
alpha-keto acid dehydrogenase multienzyme complexes play central
roles in cellular metabolism, are major sites of regulation, and are
clinically important.  In !mammalian cells, these multienzyme
complexes are located within mitochondria, an organelle that is the
major source of energy for cellular functions.  Regulation of the
flux of carbon through the PDH complex plays an essential role in
the control of energy metabolism.  PDH phosphatase is one of the
target enzymes of insulin action.  The branched-chain alpha-keto
acids represent an important source of carbon for cellular energy
generation, carbohydrate biosynthesis, and ketone body production
in various tissues.  Elucidation of the structure and catalytic and
regulatory properties of the alpha-keto acid dehydrogenase complexes
and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Inherited
and acquired disorders of pyruvate and branched-chain amino acid
metabolism have been reported.  Analysis of the etiology of these
disorders rests on knowledge of normal metabolism of 'the alpha-keto
acids.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
19,6018253,,1999,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,CHEMISTRY,5R01GM006590-39,GM006590,UNITED STATES,R01,237463,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,2001-06-30T04:00:00Z,,"DESCRIPTION:  This research project is directed toward elucidating the          
structure, function, and regulation of the mammalian pyruvate dehydrogenase     
(PDH) multi-enzyme complex.  The PDH complex is localized to the                
mitochondria, where it plays a critical role in regulating cellular fuel        
utilization.  The activity of the mammalian PDH complex is regulated            
primarily by phosphorylation and dephosphorylation, catalyzed by a specific     
PDH kinase and a PDH phosphatase, respectively.  PDH phosphatase (PDP) is a     
heterodimer consisting of a Mg2+-dependent and Ca2+-stimulated catalytic        
subunit (PDPc) and a flavoprotein (PDPr).  PDH phosphatase activity is          
stimulated by insulin in several tissues, particularly in adipose tissue.  A    
critical outstanding issue is how the signal is transferred from the insulin    
receptor in the plasma membrane to the PDH phosphatase within the               
mitochondrial membrane-matrix compartment.  Recent observations suggest that    
PDPr may be involved in this signaling pathway.  The proposed studies seek      
to elucidate the nature and regulation of the mammalian PDH phosphatase and     
the macromolecular organization of the Saccharomyces cerevisiae PDH complex,    
which is a good model for the mammalian PDH complex.  The specific aims are:    
(1) elucidate the nature and function of the regulatory subunit (PDPr) of       
bovine PDH phosphatase and (2) determine the number and localization of         
binding sites for the E3-binding protein and for pyruvate dehydrogenase (E1)    
on the icosahedral acetyltransferase (E2) and the functional significance of    
this localization.  The role(s) of PDPr on the catalytic activity, substrate    
specificity, and divalent cation requirements of PDP will be assessed using     
recombinant PDPc and PDPr and native PDH phosphatase:  the function, if any     
of FAD in PDPr will be determined and the domain structure of PDPr will be      
delineated.  Enzymic assays, equilibrium dialysis, limited proteolysis, and     
deletion mutagenesis will be used.  Protein-protein interaction between E2,     
E3BP, and E1 will be assessed by protein engineering and binding studies in     
conjunction with cryoelectron microscopy and image reconstruction.              
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
20,3310558,,1990,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,3R01HD006707-18S1,HD006707,UNITED STATES,R01,93060,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1992-11-30T05:00:00Z,,"The long-term objectives of this research program are to elucidate
the estrogen-, antiestrogen- and DNA-binding mechanisms and
activities of the estrogen receptor; and the application of these
basic studies to the regulation and function of reproductive
tissues and the control of estrogen-dependent cancers.  The
immediate specific aims are:  (1) to determine whether the affinity
of the estrogen receptor for its estrogen responsive element (ERE),
a specific nucleotide sequence of the prolactin gene, controls the
selectivity of the receptor for specific genes.  The in vitro
affinity of the estrogen receptor for the ERE and the in vivo
response to estradiol will be measured after site-directed in vitro
mutagenesis of the ERE.  The affinity of the receptor for the DNA
will be measured by the gel mobility assay.  The ERE's will be
linked to the thymidine kinase promoter linked to the
chloramphenicol acetyltransferase gene.  The plasmid constructs
will be transfected into GH3 cells and responsiveness to estradiol
measured.  (2) The affinity of the antiestrogen receptor complexes
for the ERE and mutant EREs will be measured to determine whether
the antiestrogens change the interaction and selectivity of the
receptor, so that the receptor interacts with other genes.  (3)
Isolate and characterize DNA-binding protein(s) that bind at or
near the ERE of the prolactin gene whose binding is dependent
upon/or modified by the presence of the purified estrogen receptor.
(4) Identify and characterize the in vivo phosphorylation sites of
the estrogen receptor in calf uteri and MCF-7 cells. Determine the
effects of receptor phosphorylation on the receptor's estrogen-
and DNA-binding activities.  Such information could provide insight
into the fundamental mechanisms of steroid hormone action.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
21,3267914,,1993,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,5R01GM006590-34,GM006590,UNITED STATES,R01,219815,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"     This research project is directed toward elucidating the
structure, function and regulation of the alpha-keto acid
dehydrogenase multienzyme complexes from eukaryotic,and prokaryotic
cells.  During the next five-year period emphasis will be placed on
structure-function studies of eukaryotic pyruvate dehydrogenase
(PDH) complexes, particularly the PDH complex from Saccharomyces
cerevisiae, using biochemical, molecular genetic, and X-ray
crystallographic approaches.  The specific aims are (1) to conduct
structure-function Analyses, including collaborative X-ray
crystallography, of S. cerevisiae dihydrolipoamide acetyltransferase
(E 2p) and its structural domains using recombinant proteins; (2)
to continue to elucidate the nature and function of the protein X
component of the yeast PDH complex, using biochemical and molecular
genetic approaches; (3) to conduct collaborative X-ray
crystallographic analysis and site-directed mutagenesis of
dihydrolipoamide dehydrogenase (E3); (4) to clone the yeast gene
encoding the beta subunit of pyruvate dehydrogenase (El) and
overexpress E1alpha and E1beta for functional studies; (5) to purify
to homogeneity and further characterize the protein kinase which
modulates the activity of the bovine branched-chain alpha-keto acid
dehydrogenase complex; (6) to clone and sequence cDNAs encoding the
two subunits of the regulatory enzyme PDH phosphatase.  The
alpha-keto acid dehydrogenase multienzyme complexes play central
roles in cellular metabolism, are major sites of regulation, and are
clinically important.  In !mammalian cells, these multienzyme
complexes are located within mitochondria, an organelle that is the
major source of energy for cellular functions.  Regulation of the
flux of carbon through the PDH complex plays an essential role in
the control of energy metabolism.  PDH phosphatase is one of the
target enzymes of insulin action.  The branched-chain alpha-keto
acids represent an important source of carbon for cellular energy
generation, carbohydrate biosynthesis, and ketone body production
in various tissues.  Elucidation of the structure and catalytic and
regulatory properties of the alpha-keto acid dehydrogenase complexes
and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Inherited
and acquired disorders of pyruvate and branched-chain amino acid
metabolism have been reported.  Analysis of the etiology of these
disorders rests on knowledge of normal metabolism of 'the alpha-keto
acids.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
22,3267912,,1990,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,5R01GM006590-31,GM006590,UNITED STATES,R01,198475,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-11-30T05:00:00Z,,"A systematic analysis of the structure, function and regulation of the
pyruvate, Alpha-ketoglutarate, and branched chain Alpha-keto acid
dehydrogenase multienzyme complexes will be continued.  The specific aims
are (1) to purify the branched chain Alpha-keto acid dehydrogenase
phosphatase from bovine kidney to homogeneity, determine its subunit
composition, and further characterize its regulation; (2) to purify and
characterize the branched chain Alpha-keto acid dehydrogenase kinase from
bovine kidney; (3) to further characterize pyruvate dehydrogenase
phosphatase and pyruvate dehydrogenase kinase from bovine kidney and heart;
(4) to separate the two different subunits comprising the pyruvate
dehydrogenase component of the mammalian pyruvate dehydrogenase complex and
determine the function of each subunit; (5) to continue structural studies
on the Alpha-keto acid dehydrogenase complexes, subcomplexes and component
enzymes thereof, using limited proteolysis, electron microscopy and X-ray
diffraction.  The mitochondrial pyruvate and branched chain Alpha-keto acid
dehydrogenase complexes occupy key positions in metabolism, and their
activities are under metabolic and hormonal control.  Regulation of the
flux of carbon through the pyruvate dehydrogenase complex plays an
essential role in the control of energy metabolism.  The branched chain
Alpha-keto acids derived from the branched chain amino acids, valine,
leucine and isoleucine, represent an important source of carbon for
cellular energy generation, carbohydrate biosynthesis and ketone body
production in various tissues.  Elucidation of the structure and catalytic
and regulatory properties of the isolated Alpha-keto acid dehydrogenase
complexes and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Also, analysis
of inherited and acquired disorders of pyruvate and branched chain amino
acid metabolism that have been reported rests on knowledge of normal
metabolism of these substances.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
23,3267910,,1988,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,5R01GM006590-29,GM006590,UNITED STATES,R01,180267,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-11-30T05:00:00Z,,"A systematic analysis of the structure, function and regulation of the
pyruvate, Alpha-ketoglutarate, and branched chain Alpha-keto acid
dehydrogenase multienzyme complexes will be continued.  The specific aims
are (1) to purify the branched chain Alpha-keto acid dehydrogenase
phosphatase from bovine kidney to homogeneity, determine its subunit
composition, and further characterize its regulation; (2) to purify and
characterize the branched chain Alpha-keto acid dehydrogenase kinase from
bovine kidney; (3) to further characterize pyruvate dehydrogenase
phosphatase and pyruvate dehydrogenase kinase from bovine kidney and heart;
(4) to separate the two different subunits comprising the pyruvate
dehydrogenase component of the mammalian pyruvate dehydrogenase complex and
determine the function of each subunit; (5) to continue structural studies
on the Alpha-keto acid dehydrogenase complexes, subcomplexes and component
enzymes thereof, using limited proteolysis, electron microscopy and X-ray
diffraction.  The mitochondrial pyruvate and branched chain Alpha-keto acid
dehydrogenase complexes occupy key positions in metabolism, and their
activities are under metabolic and hormonal control.  Regulation of the
flux of carbon through the pyruvate dehydrogenase complex plays an
essential role in the control of energy metabolism.  The branched chain
Alpha-keto acids derived from the branched chain amino acids, valine,
leucine and isoleucine, represent an important source of carbon for
cellular energy generation, carbohydrate biosynthesis and ketone body
production in various tissues.  Elucidation of the structure and catalytic
and regulatory properties of the isolated Alpha-keto acid dehydrogenase
complexes and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Also, analysis
of inherited and acquired disorders of pyruvate and branched chain amino
acid metabolism that have been reported rests on knowledge of normal
metabolism of these substances.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
24,3269560,,1987,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5R01GM019199-16,GM019199,UNITED STATES,R01,197578,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-07-31T04:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",THE GENETIC APPARATUS OF HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
25,3267909,,1987,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,5R01GM006590-28,GM006590,UNITED STATES,R01,176705,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-11-30T05:00:00Z,,"A systematic analysis of the structure, function and regulation of the
pyruvate, Alpha-ketoglutarate, and branched chain Alpha-keto acid
dehydrogenase multienzyme complexes will be continued.  The specific aims
are (1) to purify the branched chain Alpha-keto acid dehydrogenase
phosphatase from bovine kidney to homogeneity, determine its subunit
composition, and further characterize its regulation; (2) to purify and
characterize the branched chain Alpha-keto acid dehydrogenase kinase from
bovine kidney; (3) to further characterize pyruvate dehydrogenase
phosphatase and pyruvate dehydrogenase kinase from bovine kidney and heart;
(4) to separate the two different subunits comprising the pyruvate
dehydrogenase component of the mammalian pyruvate dehydrogenase complex and
determine the function of each subunit; (5) to continue structural studies
on the Alpha-keto acid dehydrogenase complexes, subcomplexes and component
enzymes thereof, using limited proteolysis, electron microscopy and X-ray
diffraction.  The mitochondrial pyruvate and branched chain Alpha-keto acid
dehydrogenase complexes occupy key positions in metabolism, and their
activities are under metabolic and hormonal control.  Regulation of the
flux of carbon through the pyruvate dehydrogenase complex plays an
essential role in the control of energy metabolism.  The branched chain
Alpha-keto acids derived from the branched chain amino acids, valine,
leucine and isoleucine, represent an important source of carbon for
cellular energy generation, carbohydrate biosynthesis and ketone body
production in various tissues.  Elucidation of the structure and catalytic
and regulatory properties of the isolated Alpha-keto acid dehydrogenase
complexes and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Also, analysis
of inherited and acquired disorders of pyruvate and branched chain amino
acid metabolism that have been reported rests on knowledge of normal
metabolism of these substances.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
26,2194992,,1995,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,PUBLIC HEALTH & PREV MEDICINE,5R01HD006707-23,HD006707,UNITED STATES,R01,268806,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1997-03-31T05:00:00Z,,"The estrogens are essential hormones for regulating normal development,
 growth and reproductive functions.  The estrogens, as well as the
 estrogenic antagonists mediate their biological actions by their
 interactions with the estrogen receptor.  The estrogen receptor in turn
 regulates the transcriptional activity of estrogen responsive genes by
 its interactions with specific DNA sequence of these genes referred to as
 the estrogen responsive elements (ERE).  The long term goal of this
 research program is to elucidate the mechanism of estrogen and estrogenic
 antagonist interactions with the estrogen receptor, and to gain insight
 into the structure-function relationship of the receptor.  The estrogen
 receptor is phosphorylated in an estrogen dependent manner immediately
 before or after binding to an ERE and as a consequence the gene's
 transcriptional activity is promoted.  A major gap in our knowledge and
 the focus of this research program is to describe the mechanism(s) by
 which the estrogen dependent phosphorylation of the estrogen receptor
 regulates the receptor's transcriptional function.  Our working model is
 that as a consequence of phosphorylation of the estrogen receptor the
 receptor affinity for its ERE is increased and/or changes the
 conformation of the estrogen receptor-ERE complexes in such a way to
 promote transcriptional activity.  We will identify which crucial
 serine(s) of the estrogen receptor is (are) phosphorylated in an estrogen
 dependent manner We intend to characterize and identify the specific
 protein kinase responsible for the phosphorylation of the receptor.  The
 in vivo transcriptional activity of the crucial serine(s) that is
 phosphorylated will be assessed using site-directed mutagenesis of the
 specific serine(s).  We will determine whether phosphorylation of the
 estrogen receptor influences its interaction with the ERE to antagonists
 to promote transcriptional activation. The ability of estrogens and
 estrogenic antagonists to phosphorylate the crucial serine(s) will be
 determined by [32p] labeling  of the estrogen receptor in MCF-7 cells
 followed by receptor purification and SDS-gel electrophoresis.  HPLC
 isolation of the [32p]labeled tryptic peptide(s) and gas-phase
 microsequencing of the peptide(s) will be used to identify the crucial
 serine(s) that is phosphorylated in a hormone dependent manner.  These
 studies will provide a test of our model and an important insight into a
 key step by which the estrogen receptor regulates gene transcription.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
27,2734312,,1998,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,CHEMISTRY,5R01GM006590-38,GM006590,UNITED STATES,R01,228435,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,2000-06-30T04:00:00Z,,"DESCRIPTION:  This research project is directed toward elucidating the          
structure, function, and regulation of the mammalian pyruvate dehydrogenase     
(PDH) multi-enzyme complex.  The PDH complex is localized to the                
mitochondria, where it plays a critical role in regulating cellular fuel        
utilization.  The activity of the mammalian PDH complex is regulated            
primarily by phosphorylation and dephosphorylation, catalyzed by a specific     
PDH kinase and a PDH phosphatase, respectively.  PDH phosphatase (PDP) is a     
heterodimer consisting of a Mg2+-dependent and Ca2+-stimulated catalytic        
subunit (PDPc) and a flavoprotein (PDPr).  PDH phosphatase activity is          
stimulated by insulin in several tissues, particularly in adipose tissue.  A    
critical outstanding issue is how the signal is transferred from the insulin    
receptor in the plasma membrane to the PDH phosphatase within the               
mitochondrial membrane-matrix compartment.  Recent observations suggest that    
PDPr may be involved in this signaling pathway.  The proposed studies seek      
to elucidate the nature and regulation of the mammalian PDH phosphatase and     
the macromolecular organization of the Saccharomyces cerevisiae PDH complex,    
which is a good model for the mammalian PDH complex.  The specific aims are:    
(1) elucidate the nature and function of the regulatory subunit (PDPr) of       
bovine PDH phosphatase and (2) determine the number and localization of         
binding sites for the E3-binding protein and for pyruvate dehydrogenase (E1)    
on the icosahedral acetyltransferase (E2) and the functional significance of    
this localization.  The role(s) of PDPr on the catalytic activity, substrate    
specificity, and divalent cation requirements of PDP will be assessed using     
recombinant PDPc and PDPr and native PDH phosphatase:  the function, if any     
of FAD in PDPr will be determined and the domain structure of PDPr will be      
delineated.  Enzymic assays, equilibrium dialysis, limited proteolysis, and     
deletion mutagenesis will be used.  Protein-protein interaction between E2,     
E3BP, and E1 will be assessed by protein engineering and binding studies in     
conjunction with cryoelectron microscopy and image reconstruction.              
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
28,2166091,,1996,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,CHEMISTRY,2R01GM006590-36A2,GM006590,UNITED STATES,R01,208704,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,2000-06-30T04:00:00Z,,,BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
29,3269558,,1991,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,2R01GM019199-19A1,GM019199,UNITED STATES,R01,243784,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",PROCESSING OF DNA BY HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
30,3310557,,1993,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,2R01HD006707-21,HD006707,UNITED STATES,R01,212418,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1996-11-30T05:00:00Z,,"The estrogens are essential hormones for regulating normal development,
growth and reproductive functions.  The estrogens, as well as the
estrogenic antagonists mediate their biological actions by their
interactions with the estrogen receptor.  The estrogen receptor in turn
regulates the transcriptional activity of estrogen responsive genes by
its interactions with specific DNA sequence of these genes referred to as
the estrogen responsive elements (ERE).  The long term goal of this
research program is to elucidate the mechanism of estrogen and estrogenic
antagonist interactions with the estrogen receptor, and to gain insight
into the structure-function relationship of the receptor.  The estrogen
receptor is phosphorylated in an estrogen dependent manner immediately
before or after binding to an ERE and as a consequence the gene's
transcriptional activity is promoted.  A major gap in our knowledge and
the focus of this research program is to describe the mechanism(s) by
which the estrogen dependent phosphorylation of the estrogen receptor
regulates the receptor's transcriptional function.  Our working model is
that as a consequence of phosphorylation of the estrogen receptor the
receptor affinity for its ERE is increased and/or changes the
conformation of the estrogen receptor-ERE complexes in such a way to
promote transcriptional activity.  We will identify which crucial
serine(s) of the estrogen receptor is (are) phosphorylated in an estrogen
dependent manner We intend to characterize and identify the specific
protein kinase responsible for the phosphorylation of the receptor.  The
in vivo transcriptional activity of the crucial serine(s) that is
phosphorylated will be assessed using site-directed mutagenesis of the
specific serine(s).  We will determine whether phosphorylation of the
estrogen receptor influences its interaction with the ERE to antagonists
to promote transcriptional activation. The ability of estrogens and
estrogenic antagonists to phosphorylate the crucial serine(s) will be
determined by [32p] labeling  of the estrogen receptor in MCF-7 cells
followed by receptor purification and SDS-gel electrophoresis.  HPLC
isolation of the [32p]labeled tryptic peptide(s) and gas-phase
microsequencing of the peptide(s) will be used to identify the crucial
serine(s) that is phosphorylated in a hormone dependent manner.  These
studies will provide a test of our model and an important insight into a
key step by which the estrogen receptor regulates gene transcription.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
31,3269562,,1989,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5R01GM019199-18,GM019199,UNITED STATES,R01,214996,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-07-31T04:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",GENETIC APPARATUS OF HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
32,3310562,,1989,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5R01HD006707-18,HD006707,UNITED STATES,R01,278605,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1992-11-30T05:00:00Z,,"The long-term objectives of this research program are to elucidate
the estrogen-, antiestrogen- and DNA-binding mechanisms and
activities of the estrogen receptor; and the application of these
basic studies to the regulation and function of reproductive
tissues and the control of estrogen-dependent cancers.  The
immediate specific aims are:  (1) to determine whether the affinity
of the estrogen receptor for its estrogen responsive element (ERE),
a specific nucleotide sequence of the prolactin gene, controls the
selectivity of the receptor for specific genes.  The in vitro
affinity of the estrogen receptor for the ERE and the in vivo
response to estradiol will be measured after site-directed in vitro
mutagenesis of the ERE.  The affinity of the receptor for the DNA
will be measured by the gel mobility assay.  The ERE's will be
linked to the thymidine kinase promoter linked to the
chloramphenicol acetyltransferase gene.  The plasmid constructs
will be transfected into GH3 cells and responsiveness to estradiol
measured.  (2) The affinity of the antiestrogen receptor complexes
for the ERE and mutant EREs will be measured to determine whether
the antiestrogens change the interaction and selectivity of the
receptor, so that the receptor interacts with other genes.  (3)
Isolate and characterize DNA-binding protein(s) that bind at or
near the ERE of the prolactin gene whose binding is dependent
upon/or modified by the presence of the purified estrogen receptor.
(4) Identify and characterize the in vivo phosphorylation sites of
the estrogen receptor in calf uteri and MCF-7 cells. Determine the
effects of receptor phosphorylation on the receptor's estrogen-
and DNA-binding activities.  Such information could provide insight
into the fundamental mechanisms of steroid hormone action.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
33,3224323,,1991,IOWA STATE UNIVERSITY,AMES,IA,,5R01DK001549-34,DK001549,UNITED STATES,R01,137218,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1994-03-30T05:00:00Z,,"A series of spectoscopic, chemical and crystallographic studies will be
conducted on three highly purified vitamin B6-dependent enzymes:  cytosolic
aspartate aminotransferase of pig hearts (AspAT), tryptophanase of
Escherichia coli and glutamate decarboxylase of E. coli.  The goals will
be to provide understanding of basic mechanisms of pyridoxal phosphate-
dependent catalysis and to assist in the design of useful enzyme-activated
inhibitors.  (1) We will conduct a series of microspectrophotometric
measurements on crystals of aspartate aminotransferase.  We will measure
binding constants within crystals for inhibitors and natural substrates.
(2) We will collaborate in determining structures of substrate and
inhibitor complexes of this enzyme.  We will make special efforts to
stabilize the erythro-3-hydroxyaspartate complex and to deduce its
structure.  (3) We will separate individual species of the self-inactivated
beta subform of AspAT by isoelectric focusing and will crystallize at least
the major species and some other less abundant forms.  This homogeneous
beta form will be analyzed by X-ray diffraction and will be used by us in
microspectrophotometry for a variety of experiments.  We will characterize
an addition major compound released from the inactivated subunit of the
beta subform by heating.  (4) The 6-fluoro derivatives of pyridoxal and
pyridoxamine phosphates, incorporated in to the active sites of AspAT,
tryptophanase, and bacterial glutamate decarboxylase, will be studied by
19F NMR spectroscopy.  (5) We will try to crystallize AspAT inhibited by
enzyme-activated inhibitors including beta-methyleneaspartate, serine
sulfate, and acetylenic GABA.  This should allow us to see directly the
structures of different types of inhibited enzyme.  The resulting knowledge
will be important for rational design of drugs for inhibition of other
transaminases.  We also propose to do modeling of inhibitor action using
an Evans & Sutherland graphics terminal.  We will try series of
spectroscopic studies on tryptophanase and glutamate decarboxylase aimed
at elucidating the structures of intermediate species.  We will also
attempt to obtain crystals of these enzymes suitable for X-ray studies.
(7) We will conduct nonenzymic studies on formation of Al3+ -stabilized
quinonoid species in methanol and we will compare rates of alpha hydrogen
removal in model systems with pyridoxal phosphate, its N-methyl derivatives
and with 6-fluoropyridoxal phosphate.
",MECHANISMS & INHIBITORS OF PYRIDOXAL-DEPENDENT ENZYMES,,DAVID E METZLER,3226632
34,3267908,,1985,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,3R01GM006590-26S1,GM006590,UNITED STATES,R01,50964,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1985-11-30T05:00:00Z,,"A systematic analysis of the structure, function, and regulation of the
pyruvate, alpha-ketoglutarate, and branched chain alpha-keto acid dehydrogenase
complexes from microorganisms and mammalian tissues will be continued.  The two
regulatory enzymes, pyruvate dehydrogenase kinase and pyruvate dehydrogenase
phosphatase, will be further characterized with respect to subunit structure and
function.  These enzymes, which regulate the activity of the mammalian pyruvate
dehydrogenase complex by phosphorylation and dephosphorylation, have been
obtained in a homogeneous state.  Systematic studies will be continued on
structural and mechanistic similarities and differences between the alpha-keto
acid dehydrogenase complexes, using electron microscopy, limited proteolysis and
X-ray diffraction.

",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
35,2444414,,1997,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,CHEMISTRY,5R01GM006590-37,GM006590,UNITED STATES,R01,219753,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,2000-06-30T04:00:00Z,,"DESCRIPTION:  This research project is directed toward elucidating the          
structure, function, and regulation of the mammalian pyruvate dehydrogenase     
(PDH) multi-enzyme complex.  The PDH complex is localized to the                
mitochondria, where it plays a critical role in regulating cellular fuel        
utilization.  The activity of the mammalian PDH complex is regulated            
primarily by phosphorylation and dephosphorylation, catalyzed by a specific     
PDH kinase and a PDH phosphatase, respectively.  PDH phosphatase (PDP) is a     
heterodimer consisting of a Mg2+-dependent and Ca2+-stimulated catalytic        
subunit (PDPc) and a flavoprotein (PDPr).  PDH phosphatase activity is          
stimulated by insulin in several tissues, particularly in adipose tissue.  A    
critical outstanding issue is how the signal is transferred from the insulin    
receptor in the plasma membrane to the PDH phosphatase within the               
mitochondrial membrane-matrix compartment.  Recent observations suggest that    
PDPr may be involved in this signaling pathway.  The proposed studies seek      
to elucidate the nature and regulation of the mammalian PDH phosphatase and     
the macromolecular organization of the Saccharomyces cerevisiae PDH complex,    
which is a good model for the mammalian PDH complex.  The specific aims are:    
(1) elucidate the nature and function of the regulatory subunit (PDPr) of       
bovine PDH phosphatase and (2) determine the number and localization of         
binding sites for the E3-binding protein and for pyruvate dehydrogenase (E1)    
on the icosahedral acetyltransferase (E2) and the functional significance of    
this localization.  The role(s) of PDPr on the catalytic activity, substrate    
specificity, and divalent cation requirements of PDP will be assessed using     
recombinant PDPc and PDPr and native PDH phosphatase:  the function, if any     
of FAD in PDPr will be determined and the domain structure of PDPr will be      
delineated.  Enzymic assays, equilibrium dialysis, limited proteolysis, and     
deletion mutagenesis will be used.  Protein-protein interaction between E2,     
E3BP, and E1 will be assessed by protein engineering and binding studies in     
conjunction with cryoelectron microscopy and image reconstruction.              
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
36,2173426,,1994,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,BIOCHEMISTRY,5R01GM019199-22,GM019199,UNITED STATES,R01,266248,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1996-03-31T05:00:00Z,,,PROCESSING OF DNA BY HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
37,3224324,,1992,IOWA STATE UNIVERSITY,AMES,IA,,5R01DK001549-35,DK001549,UNITED STATES,R01,143329,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1994-03-30T05:00:00Z,,"A series of spectoscopic, chemical and crystallographic studies will be
conducted on three highly purified vitamin B6-dependent enzymes:  cytosolic
aspartate aminotransferase of pig hearts (AspAT), tryptophanase of
Escherichia coli and glutamate decarboxylase of E. coli.  The goals will
be to provide understanding of basic mechanisms of pyridoxal phosphate-
dependent catalysis and to assist in the design of useful enzyme-activated
inhibitors.  (1) We will conduct a series of microspectrophotometric
measurements on crystals of aspartate aminotransferase.  We will measure
binding constants within crystals for inhibitors and natural substrates.
(2) We will collaborate in determining structures of substrate and
inhibitor complexes of this enzyme.  We will make special efforts to
stabilize the erythro-3-hydroxyaspartate complex and to deduce its
structure.  (3) We will separate individual species of the self-inactivated
beta subform of AspAT by isoelectric focusing and will crystallize at least
the major species and some other less abundant forms.  This homogeneous
beta form will be analyzed by X-ray diffraction and will be used by us in
microspectrophotometry for a variety of experiments.  We will characterize
an addition major compound released from the inactivated subunit of the
beta subform by heating.  (4) The 6-fluoro derivatives of pyridoxal and
pyridoxamine phosphates, incorporated in to the active sites of AspAT,
tryptophanase, and bacterial glutamate decarboxylase, will be studied by
19F NMR spectroscopy.  (5) We will try to crystallize AspAT inhibited by
enzyme-activated inhibitors including beta-methyleneaspartate, serine
sulfate, and acetylenic GABA.  This should allow us to see directly the
structures of different types of inhibited enzyme.  The resulting knowledge
will be important for rational design of drugs for inhibition of other
transaminases.  We also propose to do modeling of inhibitor action using
an Evans & Sutherland graphics terminal.  We will try series of
spectroscopic studies on tryptophanase and glutamate decarboxylase aimed
at elucidating the structures of intermediate species.  We will also
attempt to obtain crystals of these enzymes suitable for X-ray studies.
(7) We will conduct nonenzymic studies on formation of Al3+ -stabilized
quinonoid species in methanol and we will compare rates of alpha hydrogen
removal in model systems with pyridoxal phosphate, its N-methyl derivatives
and with 6-fluoropyridoxal phosphate.
",MECHANISMS & INHIBITORS OF PYRIDOXAL-DEPENDENT ENZYMES,,DAVID E METZLER,3226632
38,3267907,,1991,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,2R01GM006590-32A1,GM006590,UNITED STATES,R01,201933,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"     This research project is directed toward elucidating the
structure, function and regulation of the alpha-keto acid
dehydrogenase multienzyme complexes from eukaryotic,and prokaryotic
cells.  During the next five-year period emphasis will be placed on
structure-function studies of eukaryotic pyruvate dehydrogenase
(PDH) complexes, particularly the PDH complex from Saccharomyces
cerevisiae, using biochemical, molecular genetic, and X-ray
crystallographic approaches.  The specific aims are (1) to conduct
structure-function Analyses, including collaborative X-ray
crystallography, of S. cerevisiae dihydrolipoamide acetyltransferase
(E 2p) and its structural domains using recombinant proteins; (2)
to continue to elucidate the nature and function of the protein X
component of the yeast PDH complex, using biochemical and molecular
genetic approaches; (3) to conduct collaborative X-ray
crystallographic analysis and site-directed mutagenesis of
dihydrolipoamide dehydrogenase (E3); (4) to clone the yeast gene
encoding the beta subunit of pyruvate dehydrogenase (El) and
overexpress E1alpha and E1beta for functional studies; (5) to purify
to homogeneity and further characterize the protein kinase which
modulates the activity of the bovine branched-chain alpha-keto acid
dehydrogenase complex; (6) to clone and sequence cDNAs encoding the
two subunits of the regulatory enzyme PDH phosphatase.  The
alpha-keto acid dehydrogenase multienzyme complexes play central
roles in cellular metabolism, are major sites of regulation, and are
clinically important.  In !mammalian cells, these multienzyme
complexes are located within mitochondria, an organelle that is the
major source of energy for cellular functions.  Regulation of the
flux of carbon through the PDH complex plays an essential role in
the control of energy metabolism.  PDH phosphatase is one of the
target enzymes of insulin action.  The branched-chain alpha-keto
acids represent an important source of carbon for cellular energy
generation, carbohydrate biosynthesis, and ketone body production
in various tissues.  Elucidation of the structure and catalytic and
regulatory properties of the alpha-keto acid dehydrogenase complexes
and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Inherited
and acquired disorders of pyruvate and branched-chain amino acid
metabolism have been reported.  Analysis of the etiology of these
disorders rests on knowledge of normal metabolism of 'the alpha-keto
acids.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
39,3269559,,1986,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5R01GM019199-15,GM019199,UNITED STATES,R01,178694,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-07-31T04:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",THE GENETIC APPARATUS OF HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
40,3269556,,1985,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,2R01GM019199-14,GM019199,UNITED STATES,R01,182690,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-07-31T04:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",THE GENETIC APPARATUS OF HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
41,2194991,,1994,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,PUBLIC HEALTH & PREV MEDICINE,5R01HD006707-22,HD006707,UNITED STATES,R01,220915,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1997-03-31T05:00:00Z,,"The estrogens are essential hormones for regulating normal development,
growth and reproductive functions.  The estrogens, as well as the
estrogenic antagonists mediate their biological actions by their
interactions with the estrogen receptor.  The estrogen receptor in turn
regulates the transcriptional activity of estrogen responsive genes by
its interactions with specific DNA sequence of these genes referred to as
the estrogen responsive elements (ERE).  The long term goal of this
research program is to elucidate the mechanism of estrogen and estrogenic
antagonist interactions with the estrogen receptor, and to gain insight
into the structure-function relationship of the receptor.  The estrogen
receptor is phosphorylated in an estrogen dependent manner immediately
before or after binding to an ERE and as a consequence the gene's
transcriptional activity is promoted.  A major gap in our knowledge and
the focus of this research program is to describe the mechanism(s) by
which the estrogen dependent phosphorylation of the estrogen receptor
regulates the receptor's transcriptional function.  Our working model is
that as a consequence of phosphorylation of the estrogen receptor the
receptor affinity for its ERE is increased and/or changes the
conformation of the estrogen receptor-ERE complexes in such a way to
promote transcriptional activity.  We will identify which crucial
serine(s) of the estrogen receptor is (are) phosphorylated in an estrogen
dependent manner We intend to characterize and identify the specific
protein kinase responsible for the phosphorylation of the receptor.  The
in vivo transcriptional activity of the crucial serine(s) that is
phosphorylated will be assessed using site-directed mutagenesis of the
specific serine(s).  We will determine whether phosphorylation of the
estrogen receptor influences its interaction with the ERE to antagonists
to promote transcriptional activation. The ability of estrogens and
estrogenic antagonists to phosphorylate the crucial serine(s) will be
determined by [32p] labeling  of the estrogen receptor in MCF-7 cells
followed by receptor purification and SDS-gel electrophoresis.  HPLC
isolation of the [32p]labeled tryptic peptide(s) and gas-phase
microsequencing of the peptide(s) will be used to identify the crucial
serine(s) that is phosphorylated in a hormone dependent manner.  These
studies will provide a test of our model and an important insight into a
key step by which the estrogen receptor regulates gene transcription.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
42,2194993,,1996,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,PUBLIC HEALTH & PREV MEDICINE,5R01HD006707-24,HD006707,UNITED STATES,R01,281340,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1998-06-30T04:00:00Z,,,UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
43,3224322,,1990,IOWA STATE UNIVERSITY,AMES,IA,,5R01DK001549-33,DK001549,UNITED STATES,R01,136947,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1994-03-30T05:00:00Z,,"A series of spectoscopic, chemical and crystallographic studies will be
conducted on three highly purified vitamin B6-dependent enzymes:  cytosolic
aspartate aminotransferase of pig hearts (AspAT), tryptophanase of
Escherichia coli and glutamate decarboxylase of E. coli.  The goals will
be to provide understanding of basic mechanisms of pyridoxal phosphate-
dependent catalysis and to assist in the design of useful enzyme-activated
inhibitors.  (1) We will conduct a series of microspectrophotometric
measurements on crystals of aspartate aminotransferase.  We will measure
binding constants within crystals for inhibitors and natural substrates.
(2) We will collaborate in determining structures of substrate and
inhibitor complexes of this enzyme.  We will make special efforts to
stabilize the erythro-3-hydroxyaspartate complex and to deduce its
structure.  (3) We will separate individual species of the self-inactivated
beta subform of AspAT by isoelectric focusing and will crystallize at least
the major species and some other less abundant forms.  This homogeneous
beta form will be analyzed by X-ray diffraction and will be used by us in
microspectrophotometry for a variety of experiments.  We will characterize
an addition major compound released from the inactivated subunit of the
beta subform by heating.  (4) The 6-fluoro derivatives of pyridoxal and
pyridoxamine phosphates, incorporated in to the active sites of AspAT,
tryptophanase, and bacterial glutamate decarboxylase, will be studied by
19F NMR spectroscopy.  (5) We will try to crystallize AspAT inhibited by
enzyme-activated inhibitors including beta-methyleneaspartate, serine
sulfate, and acetylenic GABA.  This should allow us to see directly the
structures of different types of inhibited enzyme.  The resulting knowledge
will be important for rational design of drugs for inhibition of other
transaminases.  We also propose to do modeling of inhibitor action using
an Evans & Sutherland graphics terminal.  We will try series of
spectroscopic studies on tryptophanase and glutamate decarboxylase aimed
at elucidating the structures of intermediate species.  We will also
attempt to obtain crystals of these enzymes suitable for X-ray studies.
(7) We will conduct nonenzymic studies on formation of Al3+ -stabilized
quinonoid species in methanol and we will compare rates of alpha hydrogen
removal in model systems with pyridoxal phosphate, its N-methyl derivatives
and with 6-fluoropyridoxal phosphate.
",MECHANISMS & INHIBITORS OF PYRIDOXAL-DEPENDENT ENZYMES,,DAVID E METZLER,3226632
44,3267913,,1992,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,5R01GM006590-33,GM006590,UNITED STATES,R01,210465,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1995-03-31T05:00:00Z,,"     This research project is directed toward elucidating the
structure, function and regulation of the alpha-keto acid
dehydrogenase multienzyme complexes from eukaryotic,and prokaryotic
cells.  During the next five-year period emphasis will be placed on
structure-function studies of eukaryotic pyruvate dehydrogenase
(PDH) complexes, particularly the PDH complex from Saccharomyces
cerevisiae, using biochemical, molecular genetic, and X-ray
crystallographic approaches.  The specific aims are (1) to conduct
structure-function Analyses, including collaborative X-ray
crystallography, of S. cerevisiae dihydrolipoamide acetyltransferase
(E 2p) and its structural domains using recombinant proteins; (2)
to continue to elucidate the nature and function of the protein X
component of the yeast PDH complex, using biochemical and molecular
genetic approaches; (3) to conduct collaborative X-ray
crystallographic analysis and site-directed mutagenesis of
dihydrolipoamide dehydrogenase (E3); (4) to clone the yeast gene
encoding the beta subunit of pyruvate dehydrogenase (El) and
overexpress E1alpha and E1beta for functional studies; (5) to purify
to homogeneity and further characterize the protein kinase which
modulates the activity of the bovine branched-chain alpha-keto acid
dehydrogenase complex; (6) to clone and sequence cDNAs encoding the
two subunits of the regulatory enzyme PDH phosphatase.  The
alpha-keto acid dehydrogenase multienzyme complexes play central
roles in cellular metabolism, are major sites of regulation, and are
clinically important.  In !mammalian cells, these multienzyme
complexes are located within mitochondria, an organelle that is the
major source of energy for cellular functions.  Regulation of the
flux of carbon through the PDH complex plays an essential role in
the control of energy metabolism.  PDH phosphatase is one of the
target enzymes of insulin action.  The branched-chain alpha-keto
acids represent an important source of carbon for cellular energy
generation, carbohydrate biosynthesis, and ketone body production
in various tissues.  Elucidation of the structure and catalytic and
regulatory properties of the alpha-keto acid dehydrogenase complexes
and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Inherited
and acquired disorders of pyruvate and branched-chain amino acid
metabolism have been reported.  Analysis of the etiology of these
disorders rests on knowledge of normal metabolism of 'the alpha-keto
acids.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
45,3310556,,1988,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,2R01HD006707-17,HD006707,UNITED STATES,R01,267424,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1992-07-31T04:00:00Z,,"The long-term objectives of this research program are to elucidate
the estrogen-, antiestrogen- and DNA-binding mechanisms and
activities of the estrogen receptor; and the application of these
basic studies to the regulation and function of reproductive
tissues and the control of estrogen-dependent cancers.  The
immediate specific aims are:  (1) to determine whether the affinity
of the estrogen receptor for its estrogen responsive element (ERE),
a specific nucleotide sequence of the prolactin gene, controls the
selectivity of the receptor for specific genes.  The in vitro
affinity of the estrogen receptor for the ERE and the in vivo
response to estradiol will be measured after site-directed in vitro
mutagenesis of the ERE.  The affinity of the receptor for the DNA
will be measured by the gel mobility assay.  The ERE's will be
linked to the thymidine kinase promoter linked to the
chloramphenicol acetyltransferase gene.  The plasmid constructs
will be transfected into GH3 cells and responsiveness to estradiol
measured.  (2) The affinity of the antiestrogen receptor complexes
for the ERE and mutant EREs will be measured to determine whether
the antiestrogens change the interaction and selectivity of the
receptor, so that the receptor interacts with other genes.  (3)
Isolate and characterize DNA-binding protein(s) that bind at or
near the ERE of the prolactin gene whose binding is dependent
upon/or modified by the presence of the purified estrogen receptor.
(4) Identify and characterize the in vivo phosphorylation sites of
the estrogen receptor in calf uteri and MCF-7 cells. Determine the
effects of receptor phosphorylation on the receptor's estrogen-
and DNA-binding activities.  Such information could provide insight
into the fundamental mechanisms of steroid hormone action.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
46,3269561,,1988,UNIVERSITY OF COLORADO AT BOULDER,BOULDER,CO,,5R01GM019199-17,GM019199,UNITED STATES,R01,208426,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-07-31T04:00:00Z,,"We propose to continue our analysis of the organization of genes and other
sequences in chromosomes of hypotrichous ciliates and the extensive
changes, including especially excision of all genes from chromosomes and
destruction of most of the sequences of the genome, that occur when a
macronucleus is produced from a micronucleus after cell mating.  The work
consists of 8 projects.  (1) Cloning of DNA intermediates during genome
processing to determine the pathway of processing, time of removal of
intron-like sequences from genes, time of addition of telomeres to
gene-sized molecules, and sequencing of micronuclear DNA, polytene DNA, and
DNA of intermediate fragments to search for sequences that may signal
processing.  (2) Analysis of the arrangement of genes in micronuclear DNA
will be continued.  (3) Micronuclear and macronuclear versions of genes
will be compared to test how general is the occurrence of removal of
intron-like sequences from genes during macronuclear development.  This
includes a search for sequence commonalities among the intron-like
sequences and a study of multiple versions of genes.  (4) Macronuclear
genes will be analyzed for intron presence.  If the intron-like sequences
removed during macronuclear development represent introns, macronuclear DNA
may totally lack introns.  (5) Macronuclear genes will be sequenced to
identify commonalities that may give insight about macronuclear gene
function.  (6) Sequencing genes that flank will be compared among different
species to test the degree of sequence instability of these ""non-essential""
regions.  Sequences of macronuclear rDNA molecules of different species
will be compared to measure the degree of constraint on sequence
divergences on non-transcribed, transcribed non-coding, and coding regions
of the gene-sized molecules.  (7) We will determine whether regulation of
expression of the gene for heat shock 70 protein is transcriptional or
translational as part of the question of transcriptional control in
hypotrichs.  (8) The structure of micronuclear chromosomal telomeres will
be determined through cloning and the protein(s) that binds to the
telomeres of macronuclear gene-sized molecules characterized.
",THE GENETIC APPARATUS OF HYPOTRICHOUS CILIATES,,DAVID M PRESCOTT,1903088
47,3310563,,1991,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5R01HD006707-19,HD006707,UNITED STATES,R01,248557,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1992-11-30T05:00:00Z,,"The long-term objectives of this research program are to elucidate
the estrogen-, antiestrogen- and DNA-binding mechanisms and
activities of the estrogen receptor; and the application of these
basic studies to the regulation and function of reproductive
tissues and the control of estrogen-dependent cancers.  The
immediate specific aims are:  (1) to determine whether the affinity
of the estrogen receptor for its estrogen responsive element (ERE),
a specific nucleotide sequence of the prolactin gene, controls the
selectivity of the receptor for specific genes.  The in vitro
affinity of the estrogen receptor for the ERE and the in vivo
response to estradiol will be measured after site-directed in vitro
mutagenesis of the ERE.  The affinity of the receptor for the DNA
will be measured by the gel mobility assay.  The ERE's will be
linked to the thymidine kinase promoter linked to the
chloramphenicol acetyltransferase gene.  The plasmid constructs
will be transfected into GH3 cells and responsiveness to estradiol
measured.  (2) The affinity of the antiestrogen receptor complexes
for the ERE and mutant EREs will be measured to determine whether
the antiestrogens change the interaction and selectivity of the
receptor, so that the receptor interacts with other genes.  (3)
Isolate and characterize DNA-binding protein(s) that bind at or
near the ERE of the prolactin gene whose binding is dependent
upon/or modified by the presence of the purified estrogen receptor.
(4) Identify and characterize the in vivo phosphorylation sites of
the estrogen receptor in calf uteri and MCF-7 cells. Determine the
effects of receptor phosphorylation on the receptor's estrogen-
and DNA-binding activities.  Such information could provide insight
into the fundamental mechanisms of steroid hormone action.
",UTERINE ESTROGEN-BINDING PROTEINS,,Thomas A Gasiewicz,1859131
48,3267911,,1989,UNIVERSITY OF TEXAS AUSTIN,AUSTIN,TX,,5R01GM006590-30,GM006590,UNITED STATES,R01,195208,False,,National Institute of General Medical Sciences,1975-08-01T04:00:00Z,1990-11-30T05:00:00Z,,"A systematic analysis of the structure, function and regulation of the
pyruvate, Alpha-ketoglutarate, and branched chain Alpha-keto acid
dehydrogenase multienzyme complexes will be continued.  The specific aims
are (1) to purify the branched chain Alpha-keto acid dehydrogenase
phosphatase from bovine kidney to homogeneity, determine its subunit
composition, and further characterize its regulation; (2) to purify and
characterize the branched chain Alpha-keto acid dehydrogenase kinase from
bovine kidney; (3) to further characterize pyruvate dehydrogenase
phosphatase and pyruvate dehydrogenase kinase from bovine kidney and heart;
(4) to separate the two different subunits comprising the pyruvate
dehydrogenase component of the mammalian pyruvate dehydrogenase complex and
determine the function of each subunit; (5) to continue structural studies
on the Alpha-keto acid dehydrogenase complexes, subcomplexes and component
enzymes thereof, using limited proteolysis, electron microscopy and X-ray
diffraction.  The mitochondrial pyruvate and branched chain Alpha-keto acid
dehydrogenase complexes occupy key positions in metabolism, and their
activities are under metabolic and hormonal control.  Regulation of the
flux of carbon through the pyruvate dehydrogenase complex plays an
essential role in the control of energy metabolism.  The branched chain
Alpha-keto acids derived from the branched chain amino acids, valine,
leucine and isoleucine, represent an important source of carbon for
cellular energy generation, carbohydrate biosynthesis and ketone body
production in various tissues.  Elucidation of the structure and catalytic
and regulatory properties of the isolated Alpha-keto acid dehydrogenase
complexes and their component enzymes is a necessary prerequisite to
understanding the in vivo regulation of their activities.  Also, analysis
of inherited and acquired disorders of pyruvate and branched chain amino
acid metabolism that have been reported rests on knowledge of normal
metabolism of these substances.
",BIOCHEMISTRY OF ALPHA-KETO ACID DEHYDROGENASE COMPLEXES,,LESTER J REED,1887908
49,3224321,,1987,IOWA STATE UNIVERSITY,AMES,IA,,5R01DK001549-31,DK001549,UNITED STATES,R01,102729,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-08-01T04:00:00Z,1988-08-31T04:00:00Z,,"We propose to continue collaboration with Dr. Arthur Arnone at the
University of Iowa and with Dr. Marvin Makinen at the University of Chicago
on X-ray diffraction and polarized optical spectroscopic studies of
crystalline cytosolic aspartate aminotransferase (glutamate-oxaloacetate
transaminase) of pig hearts.  The aim will be to understand the dynamic
behavior of the coenzyme and protein during various stages of catalysis by
this important heart enzyme.  Among the features to be studied is a major
conformational change of the protein that accompanies the binding of
substrates or inhibitors.  We will attempt to precisely define the details
of the catalytic process and the role of the protein as a ""solvent"" for the
reaction.  We will continue to study the action of serine sulfate,
Beta-methyleneaspartate, vinylglycine and other ""suicide inactivators"" of
vitamin B6-dependent enzymes.  We will prepare crystalline derivatives with
which it should be possible to see directly the structure of three
different types of inhibited enzyme.  This knowledge will be important for
rational design of drugs for inhibition of other transaminases.  We will
attempt to determine the structure of the inhibited active site of the
naturally occurring Beta subform which is only partially active.  This will
involve characterization of compounds released by heating the inactivated
subunits and isolation and chemical characterization of peptides carrying a
covalently bonded inhibitor or modified substrate.  The possible biological
and medical significance of the presence in tissues of large amounts of
partially inactivated enzyme will be considered.  We will continue studies
of a series of analogs of pyridoxal phosphate with aspartate
aminotransferase and glutamate decarboxylase.  Among these are analogs that
do not permit transimination and 6-fluropyridoxal phosphate, a compound
with interesting electronic properties and with a good NMR signal that can
be seen when bound to enzymes.  We will study further the formation of
fluorescent pyrrolopyridines with pyridoxal 5 foot-sulfate.  We will
continue nonenzymatic studies of Schiff bases, especially of diamines using
both proton NMR and computer-assisted spectroscopic analysis.  All of these
studies have a direct relevance to a large group of important vitamin
B6-dependent enzymes.
",THE ACTION OF B VITAMINS IN ENZYMIC CATALYSIS,,DAVID E METZLER,3226632
0,3310559,,1985,UNIVERSITY OF ROCHESTER,ROCHESTER,NY,,5R01HD006707-14,HD006707,UNITED STATES,R01,214337,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-08-01T04:00:00Z,1988-07-31T04:00:00Z,,"Our long-term objective is to achieve an understanding of the molecular
properties of the estrogen receptor and its role in regulating normal and
abnormal uterine growth and reproductive function.  We have described the
mechanism by which estradiol-binding modulates the equilibrium between the
nonactive and the active states of the estrogen receptor.  The estrogen
receptor exists in two forms or states:  the nonactive, 4S monomer, which
has a lower affinity for estradiol and rapid estradiol dissociation
kinetics; and the activated, 5S receptor dimer, which has a higher affinity
for estradiol and slower estradiol dissociation kinetics.  Equilibrium
between these two forms of the estrogen receptor induces a posibively
cooperative equilibrium binding of estradiol.  Since there is only limited
information on several crucial aspects of the biochemistry of the estrogen
receptor, we propose:  1) A careful kinetic and thermodynamic analysis of
the interactions between the receptor and tritiated and nontriatiated
potent agonists (estradiol, diethylstilbestrol), weak estrogens (estrone,
estroil) and estrogenic antagonists (clomiphene, tamoxifen,
hydroxytamoxifen, and LY117018).  The relationship between the receptor's
binding kinetics with each of these compounds and their biological activity
will be compared.  2) Characterization and kinetics of the DNA binding
properties of activated as compared with nonactivated forms of the estrogen
receptor.  The role of estrogen-binding by the receptor on the receptor's
DNA binding interactions will be investigated.  3) Estrogen affinity
chromatography will be used to purify the estrogen receptor from calf
uteri, and its molecular properties will then be described.  4) Monoclonal
antibodies will be prepared as a probe for the receptor's biochemistry.
",THE UTERINE ESTROGEN BINDING PROTEINS,,Thomas A Gasiewicz,1859131
1,8579413,,2013,YALE UNIVERSITY,NEW HAVEN,CT,NONE,2R01GM014642-46A1,GM014642,UNITED STATES,R01,416250,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2016-05-31T04:00:00Z,PA11260,,Synthesis and Assembly of Flagellar Proteins,"A major resurgence in research on cilia and flagella (synonymous terms) occurred following the discovery of
Intraflagellar Transport (IFT) and the demonstration that it is essential for the assembly and maintenance of all
eukaryotic cilia. Abnormalities in ciliary assembly has, in turn, been shown to underlie many human diseases
called ciliopathies, including polycystic kidney disease and blindness. The proposed research will provide new
insights into cilia assembly, focusing on how ciliary proteins are transported to the cilia for assembly, as well as
identifying new proteins involved in gating proteins into and out of cilia.",JOEL L ROSENBAUM,1955194
2,7760650,,2010,YALE UNIVERSITY,NEW HAVEN,CT,BIOCHEMISTRY,5R01GM014642-43,GM014642,UNITED STATES,R01,701323,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2013-01-31T05:00:00Z,PA07070,"  
DESCRIPTION (provided by applicant): IFT, Intraflagellar Transport, discovered in Chlamydomonas in our laboratory, is essential for the assembly and maintenance of almost all eukaryotic cilia and flagella. Studies of the genes involved in IFT and its mechanism have led to new findings on the role of cilia/flagella (interchangeable terms) in many pathologies where the role of cilia was heretofore unsuspected. Because ciliary signaling processes, and their receptors on the ciliary membrane, are key to many of these pathologies, the proposed research is directed at determining how channels/receptors are targeted to the flagellar membrane, and to the flagellar axoneme through a proposed flagellar pore structure, and how IFT is involved in this transit process. We will determine, for the first time, the high resolution ultrastructure of the IFT particles both in situ and as isolated particles with Cryo-EM. Because there is mounting evidence, from our laboratory and others, that the cilium is involved in the control of the cell cycle, one of our most important goals is to determine the molecular interactions between one of the IFT polypeptides, a small G protein, and the cell cycle. Finally, one of our initial aims, 40 years ago, in establishing systems of cilia and flagellar regeneration, was to study how the cell recognizes the lack of its flagella and up-regulates hundreds of genes rapidly after flagellar detachment; we will determine what cytoplasmic factors are responsible for this transcriptional up-regulation.  
  
PUBLIC HEALTH RELEVANCE: This proposal extends our study of intraflagellar transport (IFT) and how this motility process participates in the assembly and maintenance of eukaryotic cilia/flagella. Studies on the genes and mechanisms underlying IFT have led to new insight into the role of cilia in many pathologies where this role was heretofore unsuspected. Among these are situs inversus, retinal degeneration, developmental diseases of bone, muscle and connective tissue, cystic diseases of the kidney, liver and pancreas, as well as syndromes that include obesity and diabetes. The proposed research is directed at basic cell and molecular aspects of IFT which have not yet been well-researched.  
    

",Synthesis and Assembly of Flagellar Proteins,"
PROJECT NARRATIVE
 This proposal extends our study of intraflagellar transport (IFT) and how this motility
process participates in the assembly and maintenance of eukaryotic cilia/flagella.
Studies on the genes and mechanisms underlying IFT have led to new insight into the
role of cilia in many pathologies where this role was heretofore unsuspected. Among
these are situs inversus, retinal degeneration, developmental diseases of bone, muscle
and connective tissue, cystic diseases of the kidney, liver and pancreas, as well as
syndromes that include obesity and diabetes. The proposed research is directed at basic
cell and molecular aspects of IFT which have not yet been well-researched.",JOEL L ROSENBAUM,1955194
3,8895962,,2015,YALE UNIVERSITY,NEW HAVEN,CT,NONE,5R01GM014642-48,GM014642,UNITED STATES,R01,166500,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2018-05-31T04:00:00Z,PA11260,"Defects in cilia have been linked to human pathologies based on aberrant motility (e.g. infertility, respiratory
infections) and/or abnormal signaling (e.g. polycystic kidney disease, blindness). Such ciliopathies can
result from improper assembly of cilia; therefore, understanding how ciliary precursors are brought to the
cilium and into the ciliary compartment may shed new light on their role in disease. How essential
structural components are delivered from their site of synthesis to the ciliary axoneme, is a mystery. To
address this issue a novel preparation of vesicles has been isolated during flagellar assembly from the
cytoplasm of Chlamydomonas, a pivotal organism for the study of assembly and function of cilia. These
vesicles carry ciliary membrane proteins (e.g. CrPKD2) as well as components of the ciliary axoneme,
including tubulin and radial spoke proteins. Combining high resolution imaging, proteomics and RNAi
knockdown, the hypothesis that axonemal proteins are transported to the cilium via peripheral
attachment to vesicles targeted to the periciliary membrane is being tested. Once at the base of the
cilium, the flagellar transition zone (TZ) is involved in determining which proteins enter/exit the flagellar
compartment. Many proteins involved in ciliopathies are found in the TZ. To further characterize the
composition of the TZ, TZs of Chlamydomonas have been isolated and analyzed by mass spectrometry.
Endosomal Sorting Complexes Required for Transport (ESCRT) proteins, which are involved in membrane
dynamics, were identified in this analysis, heralding a previously unknown function of the TZ, which will be
studied. These proteins may be involved in removing ubiquitinated proteins from the cilium, the release of
ciliary membrane into the surrounding milieu, or in the severing of the organelle from the cell - three poorly
understood processes known to occur in cilia. Additional newly identified proteins of the TZ that are
conserved in humans will be studied to provide new insights into the role of cilia function and human
disease.",Synthesis and Assembly of Flagellar Proteins,"A major resurgence in research on cilia and flagella (synonymous terms) occurred following the discovery of
Intraflagellar Transport (IFT) and the demonstration that it is essential for the assembly and maintenance of all
eukaryotic cilia. Abnormalities in ciliary assembly has, in turn, been shown to underlie many human diseases
called ciliopathies, including polycystic kidney disease and blindness. The proposed research will provide new
insights into cilia assembly, focusing on how ciliary proteins are transported to the cilia for assembly, as well as
identifying new proteins involved in gating proteins into and out of cilia.",JOEL L ROSENBAUM,1955194
4,8053815,,2011,BROWN UNIVERSITY,PROVIDENCE,RI,BIOCHEMISTRY,5R01GM019756-39,GM019756,UNITED STATES,R01,657271,False,Michael T. Bender,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2014-03-31T04:00:00Z,PA07070,"  
DESCRIPTION (provided by applicant): ABSTRACT:  The long-term goal of this grant proposal is to understand at an atomic level how the ribosome functions during protein synthesis. We will take a multidisciplinary approach utilizing genetic, biochemical and structural methods to study the bacterial ribosome. Our first aim is to examine ribosome structural dynamics during decoding of mRNA and its inhibition by antibiotics. We will use X-ray crystallography to obtain high-resolution structures of mutant Thermus thermophilus 30S subunits that reveal new conformational states. We will examine the effects of the mutations on the accuracy and kinetics of decoding. Our second aim is to probe a pathway by which codon recognition is signaled via ribosomal protein S12 and aminoacyl-tRNA to EF-Tu to activate GTP hydrolysis, a key step in the tRNA selection process. These experiments are designed to provide fundamental insights into ribosome structure and function, including new conformational states of the ribosome, to aid in understanding the decoding process. The ability to solve structures of ribosomes with antibiotic-resistance mutations will aid in understanding the mechanisms of antibiotic action and resistance, and has particular clinical relevance for the rational design of drugs to fight resistant microbial pathogens.  
  
PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE: The goal of this project is to further our understanding of the molecular mechanisms of protein synthesis at the atomic level, using the methods of structural biology, genetics and biochemistry. Protein synthesis in bacteria is the target of over half of all antibiotics, and modifications and mutations in components involved of this process can lead to antibiotic resistance, one of the most pressing medical problems of our time. Deciphering the molecular basis for antibiotic resistance will provide important information needed for the rational design of novel antimicrobial agents effective against antibiotic resistant microorganisms. A more comprehensive examination of the structural basis for protein synthesis will also provide important insights into one of the most fundamental processes found in all forms of life.  
    

",Polysomes & Subunits: Structure-Function Relationships,"
PROJECT NARRATIVE
The goal of this project is to further our understanding of the molecular mechanisms of protein synthesis at
the atomic level, using the methods of structural biology, genetics and biochemistry. Protein synthesis in
bacteria is the target of over half of all antibiotics, and modifications and mutations in components involved
of this process can lead to antibiotic resistance, one of the most pressing medical problems of our time.
Deciphering the molecular basis for antibiotic resistance will provide important information needed for the
rational design of novel antimicrobial agents effective against antibiotic resistant microorganisms. A more
comprehensive examination of the structural basis for protein synthesis will also provide important insights
into one of the most fundamental processes found in all forms of life.",ALBERT E DAHLBERG,1965233
5,8080845,,2011,VANDERBILT UNIVERSITY,Nashville,TN,PEDIATRICS,5T32HD007043-35,HD007043,UNITED STATES,T32,135029,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2013-04-30T04:00:00Z,PA02109,"  
DESCRIPTION (provided by applicant):  The primary objective of the proposed training program in reproductive biology (RBTP) is to continue offering predoctoral and postdoctoral training to individuals who demonstrate potential for developing into independent investigators in the field of reproductive biology. The renewal application by including multidisciplinary interests expands the horizon of training for students. This will better prepare their career paths in the 21st century and present them with opportunities to make significant scientific contribution to reproductive biology. This renewal application focuses on the current excitement in scientific innovations, opportunities and advances in biomedical sciences with evolving technologies. The proposed RBTP has been developed within the current mission of the NIH roadmap to multidisciplinary approaches to research endeavors. This mission can best be accomplished if students are trained in an environment where specific biological problems are addressed using contemporary knowledge in developmental biology, physiological genomics, proteomics, signal transduction, and molecular and cellular biology. The present environment at Vanderbilt is highly conducive to such training due to a broad based interactive group of 13 investigators spanning several departments and thematic areas, and the recent establishment of genomics, proteomics, lipidomics and imaging centers on the campus with state-of-the-art facilities. Training will occur with major emphasis in: 1) gametogenesis, sperm functions and fertilization, (Greenstein, Olson, Drummond-Barbosa and Waterman); 2) uterine biology (Das, Dey, Ong and Paria); 3) embryogenesis, development and implantation (Das, Dey, Chiang, Lee and Paria); and 4) genetic regulation of gonadotropin secretion (Phillips). These areas of research training require the infusion and active participation of preceptors who are experts in developmental biology, signal transductions, genomics and proteomics (Lee, Caprioli, and Sealy).  
    

",Reproductive Biology: Training for the 21st Century,,KEVIN G OSTEEN,1890741
6,7233991,,2007,UNIVERSITY OF MICHIGAN,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-33,HD007048,UNITED STATES,T32,262883,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2010-04-30T04:00:00Z,,"DESCRIPTION (provided by applicant): This longstanding training program, now administered through the Department of Obstetrics and Gynecology, will provide four predoctoral students and three postdoctoral fellows, including physicians, with a broad and in-depth experience in reproductive sciences involving human beings and animals. This will be accomplished by the strong and closely integrated multi-departmental Reproductive Sciences Program (RSP) involving the resources of 28 faculty members in several departments and colleges. Qualified trainees are accepted after competitive review. Predoctoral fellows must first be accepted into the Rackham School of Graduate Studies; once in the RSP, they will participate in the Program-sponsored course in reproductive sciences and in other targeted courses designed to stimulate considerations about translational research. Postdoctoral fellows will submit an individual NRSA application and interact with both clinical and sociological fellows interested in the fields of women's and men s health. All fellows will be involved in various investigative projects, seminars, workshops, and courses. The training program furnishes flexible, individualized, rigorous training that will enable the trainee to acquire a broad, critical understanding of current concepts in reproductive sciences, including translational research, and an intimate knowledge of modern sophisticated, methodological approaches. Hands-on training will be accomplished primarily in the various research and clinical laboratories of RSP faculty mentors and co-mentors. The interdisciplinary traditions and culture of the Program will continue through several activities including the weekly noon RSP Fellows and Faculty Seminar Series, RSP Poster Day, RSP Trainee Consultants, and interactive sessions with clinical researchers. These trainee functions provide an opportunity for critical review of research progress, experimental designs, and future research plans, and they lead to national exposure. Fellows will have access to several University-supported core facilities that provide essential instruction, reagents, space and equipment. RSP graduates are able to pursue an independent career in one or more disciplines: anatomy, animal science, biochemistry, cell and molecular biology, neurosciences including behavior and neuroendocrinology, men's health, obstetrics and gynecology, pediatrics, pharmacology, physiology, toxicology, veterinary medicine, women's health and zoology. Special expertise may be obtained in several subspecialties: electron microscopy, histology, histochemistry, immunoendocrinology, regulatory biology, hormone action, contraceptive biology, neuroendocrinology, membrane biology, general endocrinology, developmental biology, gene expression, data analysis, recombinant DNA technology, biological rhythms, epidemiology, and clinical investigation.",Training Program in Reproductive Endocrinology,,GARY DANIEL SMITH,1859945
7,7209750,,2007,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,5R01GM022395-32,GM022395,UNITED STATES,R01,295832,False,Susan R. Haynes,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2010-03-31T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  One of the most dramatic advances in biomedical research in the past 15 years has been the demonstration that human disorders can be studied in model organisms. This is a tribute to the investment of our country in basic biology. Genetic organisms such as yeast, Drosophila, C. elegans, and the mouse have led the way, but the organism par excellence for the study of thyroid hormone, one of the most important hormones for human health, is the amphibian, Xenopus laevis. Although vertebrates in all of the various phyla including humans require thyroid hormone (TH) to complete their life cycle, by far the most dramatic example is the role of TH in amphibian metamorphosis. TH is required absolutely for all of the remarkable changes that convert a tadpole into a frog. Many features of TH biology are identical in all vertebrates. However, the ease with which the model amphibian organism, X. laevis can be raised in the laboratory, the ability to manipulate TH levels, and the abundance of the material all make X. laevis the best model organism to study the action of TH. The mere addition of TH to the rearing water induces all of the events of metamorphosis. TH controls cell death, cell proliferation, and the remodeling of organs. Modem genetic methods are being applied to X. laevis with great success beginning with the new sperm mediated transgenesis technique of Kroll and Amaya. By expressing genes or mutant genes that interfere with metamorphosis in specific cell types the TH-controlled developmental program of a single cell type can be inhibited or activated selectively. The expression of detrimental gene products can be activated in cells at precise times in development utilizing controllable promoters. This wonderful old biological problem that previously could only be described by scientists is now yielding to modem molecular methods.   
      

",AMPHIBIAN METAMORPHOSIS: A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
8,7283130,,2007,UNIVERSITY OF CALIFORNIA,LA JOLLA,CA,BIOLOGY,5R01GM018386-38,GM018386,UNITED STATES,R01,721388,False,Peter  Preusch,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2009-08-31T04:00:00Z,,"  
DESCRIPTION (provided by applicant): This research program deals with basic mechanisms of transcription and with transcriptional regulation of the activities of genes. Its implications for human health relate to the development application of precise and specific interventions in gene expression that are based on a broad and fundamental understanding of transcription mechanisms as well as their associated protein-protein and protein-nucleic acid interactions.  The proposed experiments deal with two transcription systems. Projects dealing with eukaryotic nuclear RNA polymerase III pursue the following objectives: 1) precisely delineate the major binding site for the Bdp1 subunit of the transcription factor (TF)IIIB; 2) devise a perfectly symmetric (i.e. palindromic) DNA site for TFIIIB; 3) explore new TBP-Brf1 fusion proteins in assembly of transcriptionally functional TFIIIB; 4) probe the structure of transcription initiating promoter complexes and transcript-elongating transcription complexes by RNA protein cross-linking to answer specific questions about the role of the Brf1 subunit of TFIIIB in initiation of transcription, transcript elongation, rapid polymerase recycling and coupling between transcription and post-transcriptional RNA processing; 5) probe the structure of the RNA polymerase III surface by protein-protein cross-linking to answer specific questions about the locations of five specified subunits and about the TFIIIB-polymerase III contact surface; 6) use chromatin immunoprecipitation (CHIP) to determine occupancy of selected RNA polymerase III-transcribed genes by TFIIIB, TFIIIC and RNA polymerase III, as well as kinetics of change of occupancy upon selective disruption of RNA polymerase III transcription; 7) dissect the mechanism that directs DNA transposition by the retrovirus-like Ty3 transposable element to RNA polymerase III promoters by interaction with TFIIIB (in collaboration); 8) analyze RNA polymerase III transcription through obstructing nucleosomes (in collaboration).  A parallel group of projects deals with a regulatory system that couples transcription to concurrent genome replication in bacteria. The activator of this regulatory system is a sliding clamp protein; a specific RNA polymerase-bound co-activator is also required. The principal projects pursue the following objectives: 1) determine the mode of attachment of the co-activator to RNA polymerase and associated protein secondary structure changes; 2) determine whether the co-activator functions only in initiation of transcription or whether it remains attached to RNA polymerase throughout transcription; 3) dissect the architecture of this transcription regulatory system and its relationship to the architecture and function of bacterial sigma initiation factors by means of an extensive series of recombinant constructions, targeted mutagenesis and protein domain fusions.      

",Nucleic Acids and Neucleoproteins,,ERNEST PETER GEIDUSCHEK,1876894
9,6539523,,2002,CORNELL UNIVERSITY ITHACA,ITHACA,NY,BIOCHEMISTRY,5R01NS008527-31,NS008527,UNITED STATES,R01,392500,False,EDMUND M TALLEY,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,2005-03-31T05:00:00Z,,"
 DESCRIPTION (adapted from applicant's abstract): The long-term objective is an     
 understanding of the mechanism of protein-mediated reactions on cell surfaces      
 by using newly developed pre-steady-state transient kinetic techniques. The        
 proteins are the neurotransmitter receptors at the junction between about          
 10(12) cells of the mammalian nervous system and the transport proteins that       
 remove the neurotransmitters from these junctions, thus terminating the            
 reactions. The specific aims are to determine the reaction mechanisms of these     
 proteins. What are the rate and equilibrium constants of the reactions and how     
 are they affected by disease-causing mutations of the proteins, therapeutically    
 useful compounds, and abused drugs? The principal investigator will investigate    
 the excitatory nicotinic acetylcholine and glutamate receptors, the inhibitory     
 gamma-aminobutyric acid (GABA) receptor, and the dopamine transporter. Among       
 the compounds that inhibit or activate these proteins are the anti-convulsant      
 MK-801, the abused drug cocaine, neurosteroids, and combinatorially synthesized    
 RNA ligands that inhibit or prevent inhibition. The principal investigator will    
 investigate the mechanism of a GABA receptor reported to function abnormally in    
 the hippocampus of epilepsy-prone rats. Once one understands the mechanisms one    
 can explore the selection of compounds that counteract receptor malfunction.       
 Health Relatedness of the Project: Neurotransmitter receptors regulate             
 intercellular communication in the central nervous system and provide the          
 mechanism by which environmental information is received, stored, and              
 transmitted. They are implicated in nervous system diseases (e.g., epilepsy,       
 Parkinson's) and are the targets of therapeutic agents (for instance               
 anti-convulsants, tranquilizers) and abused drugs. An understanding of their       
 effects on the protein-mediated reaction mechanisms can lead to the rational       
 clinical treatment of diseases and the design of improved drugs. Research          
 Design: The principal investigator will use both the steady-state                  
 single-channel current-recording technique and the pre-steady-state kinetic        
 techniques newly developed by this laboratory. The new transient kinetic           
 techniques for use with membrane-bound proteins are suitable for studying          
 reactions on cell surfaces in the us-ms time region. Receptors are equilibrated    
 with a photolabile, biologically inert neurotransmitter precursor before           
 photolysis releases the neurotransmitter in us, thereby initiating the             
 reaction. The resulting whole-cell current due to opening of receptor-channels     
 or dopamine uptake is recorded and analyzed. Using combinatorially synthesized     
 RNA ligands for specific sites on the membrane-bound proteins, the principal       
 investigator will test predictions arising from the mechanism based on the         
 kinetic measurements. The ligands are isolated by a technique developed by the     
 principal investigator's laboratory.                                               
                                                                                    
",CHEMICAL REACTIONS IN TRANSMISSION OF NERVE IMPULSES,,GEORGE Paul HESS,1879144
10,6632946,,2003,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,INTERNAL MEDICINE/MEDICINE,5P30CA014051-32,CA014051,UNITED STATES,P30,2482124,False,Hasnaa  Shafik,National Cancer Institute,1975-09-01T04:00:00Z,2005-04-30T04:00:00Z,,"The Cancer Center at NIT is a Basic Cancer Center comprising three integrated research programs involving more than two dozen laboratories at NIT. Most laboratories are located in three buildings of the Biology Department (Cancer Center, Biology building, Whitehead Institute) and share many common research facilities. Research programs focus on the underlying cell and molecular biology of cell behavior with particular emphasis on issues related to cancer; control of cell proliferation, cell cycle and cell survival, gene expression, cell adhesion and migration, tumor progression, angiogenesis and metastasis. There is a strong emphasis on the use of genetics and molecular genetics to discover genes controlling these processes and/or altered in cancer using human genomics and genetic studies in model organisms (mice, zebrafish, invertebrates and yeast). Three programs in Molecular Genetics & Immunology, Tumor Suppressors, Cell Cycle & Checkpoints, and Cell Biology, Development & Differentiation unite the center members; each is headed by a leader in the field. The major budget requests are to fund shared facilities (Biopolymers, Cell Sorter, Computing Glassware, Histology, Media Preparation, Microarray Technologies, Microscopy, Monoclonal Antibodies, Shared Research Resources, Transgenic Mouse Facility) and infrastructure that support and enhance the scientific research of the center and for developmental funds to foster new directions and initiatives in cancer research. No funds are requested for senior leadership or staff investigator salaries. ",CANCER CENTER SUPPORT (CORE) GRANT,,TYLER E. JACKS,3128332
11,6518805,,2003,FRED HUTCHINSON CANCER RESEARCH CENTER,SEATTLE,WA,,5R01GM017709-32,GM017709,UNITED STATES,R01,572795,False,Irene A. Eckstrand,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2005-12-31T05:00:00Z,,"It has been widely appreciated that biological systems resist environmental, stochastic, and genetic perturbations. This phenomenon has been termed homeostasis, buffering, robustness and canalization. It is becoming possible to investigate these concepts at a molecular level. Recent results indicate that molecular circuits are designed to minimize the phenotypic consequences of perturbation, a process we will term ""buffering"". We propose to develop paradigms and methods for understanding how genetic variation is buffered using the DNA replication and dNTP synthesis circuits of the yeast, Saccharomyces cerevisiae as test cases. Understanding such buffering mechanisms is important to three broad areas of biology: (1) how genetic variation, the material of evolution, is accumulated in a species; (2) which genes influence the phenotypic expression of genetic variability, for example in the highly variable presentation of human disease in different individuals; and (3) the design principles of biological systems. Our specific aims are the following: 1. Design and employ methods to control the quantity of specific essential proteins in the DNA replication machinery and dNTP biosynthesis pathway. 2. Comprehensively identify the nonessential proteins that influence the capacity of the cell to withstand reduced expression of key essential proteins. 3. Compare the buffering capacity contributed by specific proteins quantitatively and assign them to different epistasis groups. 4. Explore differences among natural isolates of S. cerevisiae in their buffering mechanisms. ",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,LELAND H HARTWELL,6249948
12,7118663,,2006,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,5R01GM018386-37,GM018386,UNITED STATES,R01,723571,False,Catherine D. Lewis,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2008-08-31T04:00:00Z,,"  
DESCRIPTION (provided by applicant): This research program deals with basic mechanisms of transcription and with transcriptional regulation of the activities of genes. Its implications for human health relate to the development application of precise and specific interventions in gene expression that are based on a broad and fundamental understanding of transcription mechanisms as well as their associated protein-protein and protein-nucleic acid interactions.  The proposed experiments deal with two transcription systems. Projects dealing with eukaryotic nuclear RNA polymerase III pursue the following objectives: 1) precisely delineate the major binding site for the Bdp1 subunit of the transcription factor (TF)IIIB; 2) devise a perfectly symmetric (i.e. palindromic) DNA site for TFIIIB; 3) explore new TBP-Brf1 fusion proteins in assembly of transcriptionally functional TFIIIB; 4) probe the structure of transcription initiating promoter complexes and transcript-elongating transcription complexes by RNA protein cross-linking to answer specific questions about the role of the Brf1 subunit of TFIIIB in initiation of transcription, transcript elongation, rapid polymerase recycling and coupling between transcription and post-transcriptional RNA processing; 5) probe the structure of the RNA polymerase III surface by protein-protein cross-linking to answer specific questions about the locations of five specified subunits and about the TFIIIB-polymerase III contact surface; 6) use chromatin immunoprecipitation (CHIP) to determine occupancy of selected RNA polymerase III-transcribed genes by TFIIIB, TFIIIC and RNA polymerase III, as well as kinetics of change of occupancy upon selective disruption of RNA polymerase III transcription; 7) dissect the mechanism that directs DNA transposition by the retrovirus-like Ty3 transposable element to RNA polymerase III promoters by interaction with TFIIIB (in collaboration); 8) analyze RNA polymerase III transcription through obstructing nucleosomes (in collaboration).  A parallel group of projects deals with a regulatory system that couples transcription to concurrent genome replication in bacteria. The activator of this regulatory system is a sliding clamp protein; a specific RNA polymerase-bound co-activator is also required. The principal projects pursue the following objectives: 1) determine the mode of attachment of the co-activator to RNA polymerase and associated protein secondary structure changes; 2) determine whether the co-activator functions only in initiation of transcription or whether it remains attached to RNA polymerase throughout transcription; 3) dissect the architecture of this transcription regulatory system and its relationship to the architecture and function of bacterial sigma initiation factors by means of an extensive series of recombinant constructions, targeted mutagenesis and protein domain fusions.      

",Nucleic Acids and Neucleoproteins,,ERNEST PETER GEIDUSCHEK,1876894
13,6450197,,2001,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOCHEMISTRY,3R01DK014575-31S1,DK014575,UNITED STATES,R01,220844,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,2001-11-30T05:00:00Z,,"Our goal is to understand the molecular basis of two control mechanisms         
that contribute to the onset of obesity and its complications, notably          
NIDDM. These mechanisms include: l.  control of expression of the obese         
(leptin) gene in the adipocyte, and 2. transcriptional control of the           
stearoylCoA desaturase genes (SCD1 and SCD2) in the adipocyte and               
hepatocyte.                                                                     
                                                                                
Leptin, a secretory protein expressed only by adipose tissue, regulates         
appetite (via receptors in the hypothalamus) and energy metabolism.  The        
3T3-L1 adipocyte system, pioneered in this laboratory, will be used as a        
cell culture model that mimics adipocytes in vivo. Our studies show that        
leptin is expressed/secreted by 3T3-L1 adipocytes and its expression is         
dramatically regulated in vivo by changes in physiological state. We have       
cloned/sequenced the regulatory 5' flanking region of the gene for use in       
the studies proposed. We plan to:                                               
                                                                                
* characterize the factors that regulate expression of the leptin gene and      
its mRNA, and                                                                   
                                                                                
* identify critical cis-regulatory elements within the leptin gene              
promoter that control its expression. We will identify and characterize         
the cognate trans-acting nuclear factors that interact with the cis-            
elements and determine how these interactions regulate transcription.           
                                                                                
The SCD genes catalyze delta9 cis-desaturation of fatty acids, and thereby      
determine the degree of unsaturation and functional properties of membrane      
phospholipids and storage/secretory triacylglycerols). Expression of the        
SCD1 and SCD2 genes is induced during adipocyte differentiation and is          
feed-back inhibited by polyunsaturated fatty acids (notably arachidonate)       
in certain cell types. We have cloned, sequenced and characterized the          
mouse SCD1 and SCD2 genes.  A preadipocyte -repressive element (or PRE)         
and its binding protein (PRE-BP1) was discovered that maintains the SCD2        
gene in the repressed state prior to differentiation. A similar, but            
distinct, element and binding protein have been identified for the SCD1         
gene. We plan to:                                                               
                                                                                
* sequence, express and characterize PRE-BP1 (SCD2) and the PRE-BP for the      
SCD1 gene.                                                                      
                                                                                
* investigate their site-specific binding interactions and                      
repression/derepression mechanisms and role in negative-feedback control        
by arachidonate, and                                                            
                                                                                
* determine the physiological basis (preadipocyte differentiation,              
negative feedback, etc.) for derepression and repression of the SCD1 and        
SCD2 genes.                                                                     
",REGULATION OF LIPOGENESIS,,M DANIEL LANE,1878591
14,2897555,,1999,EMORY UNIVERSITY,ATLANTA,GA,PHARMACOLOGY,5K05DA000008-25,DA000008,UNITED STATES,K05,98739,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,PA91102,"This is a renewal application for a NIDA Research Scientist Award. A            
program of research is proposed for studying behavioral effects of two          
types of drugs of significant clinical, social, and theoretical                 
importance: 1) opioids, some of which have long represented a serious           
abuse problem; 2) caffeine, the most widely consumed behaviorally-active        
drug in the world, which has features that make it a convenient model           
""drug of abuse"". The proposed experiments will be supported by two              
research grants from NIDA.                                                      
                                                                                
The basic research strategy is to use behavioral methodologies as               
bioassays of drug interactions with their neuronal substrates in order to       
identify and characterize components of drug action that might be relevant      
to potential for abuse and to related phenomena, such as tolerance and          
physical dependence. Representative compounds will be studied over a range      
of doses in several complementary behavioral procedures, such as drug           
discrimination, locomotor activity, autotitration of reinforcement              
threshold for electrical stimulation of the brain, and drug-induced             
turning. Established collaborations with faculty colleagues will bring          
additional methodologies to bear on the research questions of interest.         
Most experiments will be performed on rats, some on squirrel monkeys.           
This approach will help in the interpretation of experimental findings by       
indicating their generality with respect to pharmacological, behavioral,        
and species variables.                                                          
                                                                                
The proposed experiments will address several hypotheses. Among them are:       
1)Brain opioid systems can, under some conditions, modulate brain dopamine      
systems and behavioral effects of drugs that are mediated by dopamine. 2)       
Single-dose opioid agonist-induced sensitization to effects of antagonists      
is a model of acute physical dependence. 3) Discriminative effects of low       
and high doses of caffeine model, respectively, positive and negative mood      
states induced by caffeine in humans. 4) Brain dopamine systems mediate         
some behavioral effects of caffeine and tolerance to those effects,             
sometimes as a result of adenosine-receptor blockade.                           
                                                                                
Several pre- and postdoctral trainees will participate in this research         
program each year. An important goal will be to provide them with               
technical and, most important, intellectual skills necessary for careers        
in research on the behavioral pharmacology of drugs of abuse.                   
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS AND CAFFEINE,,STEPHEN G HOLTZMAN,1868593
15,2891504,,1999,CORNELL UNIVERSITY ITHACA,ITHACA,NY,BIOCHEMISTRY,5R01NS008527-28,NS008527,UNITED STATES,R01,268129,False,EDMUND M TALLEY,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,2001-03-31T05:00:00Z,,"The long-term objective is elucidation of the chemical mechanism of             
neurotransmitter receptor-mediated reactions in the membrane of nerve and       
muscle cells. Techniques developed by this group enable one to study            
elementary steps of the reactions, information needed to understand the         
regulation of signal transmission between the approximately 10(12) cells        
in the human nervous system. Specific aims are to: 1. Determine reaction        
mechanisms of excitatory acetylcholine and glutamate and inhibitory GABA        
and glycine receptors. The knowledge gained is required to account for          
the integration of excitatory and inhibitory signals by a single cell.          
2. Understand the modification of receptor function by therapeutic              
agents, abused drugs, and combinatorially synthesized RNA polymers.             
Receptors in cells and genetically engineered forms expressed in X.             
laevis oocytes will be used to understand how these compounds affect            
receptor mechanisms. 3. Understand the integrated action of a known             
circuit of neurons controlling a measurable behavioral response,                
pharyngeal pumping, in the nematode C elegans. Neurotransmitters secreted       
by specific cells and responding receptors in target cells will be              
identified. Health Relatedness of the Project: Neurotransmitter receptors       
regulate intercellular communication in the central nervous system and          
provide the mechanism by which environmental information is received,           
stored, and transmitted. They are implicated in nervous system diseases         
(Alzheimer's, Parkinson's) and are the targets of therapeutic agents (for       
instance, Prozac(TM), tranquilizers) and abused drugs. Understanding how        
receptor-mediated reaction mechanisms are modified is required for              
rational clinical treatment of diseases and the design of improved drugs.       
Research Design: Rapid reaction techniques, newly developed by this group       
and suitable for studying reactions on cell surfaces in the mu s-ms time        
region, will be used. Receptors are equilibrated with a photolabile,            
biologically inert neurotransmitter precursor before photolysis releases        
the neurotransmitter in mu s, thereby initiating the reaction. The              
resulting whole-cell current due to opening of receptor-channels is             
recorded and analyzed. This technique is used in combination with a cell-       
flow technique with a 5-ms time resolution. This approach overcomes the         
limitations of previous techniques with inadequate time resolution that         
has hampered research in this area during the last 40 years and can be          
used with intact single cells, oocytes, and circuits of cells.                  
",CHEMICAL REACTIONS IN TRANSMISSION OF NERVE IMPULSES,,GEORGE Paul HESS,1879144
16,3269051,,1989,ROCKEFELLER UNIVERSITY,NEW YORK,NY,,5R01GM017132-20,GM017132,UNITED STATES,R01,329692,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-11-30T05:00:00Z,,"The long range objectives of this study are to characterize molecules
associated with the microtubules of eukaryotic flagella that are
responsible for the function and assembly of these organelles.  The study
is based on application of morphological, genetical, and biochemical
techniques to a model organism, the unicellular alga Chlamydomonas
reinhardtii.  Mutant strains under analysis include those affecting
flagellar function and assembly.  A subset of assembly mutants are
clustered on a linkage group showing unique meiotic behavior.  In one class
of these, the uni mutants, the defect appears to interrupt assembly of the
basal body transition zone.  Efforts will be made to identify a cellular
DNA encoding these functions.  Independent efforts will be made to obtain
genomic clones encoding the several large subunit polypeptides of four
axonemal dyneins.  Phosphorylation of a set of polypeptides involved in
controlling transitions between two different bending forms of flagella
will be studied using in vitro phosphorylation methods as well as reversion
analysis of mutants.  The latter technique will also be used to study
components required for stability of central microtubules.
",BIOCHEMICAL GENETICS OF MICROTUBULES,,DAVID J LUCK,1965380
17,3268082,,1989,YALE UNIVERSITY,NEW HAVEN,CT,,5R01GM009966-28,GM009966,UNITED STATES,R01,858954,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The studies described here continue and extend our research in the area of
somatic cell genetics.  We shall continue to refine gene mapping
procedures, especially to increase the resolution of the physical map by
gene transfer.  A new aspect of our research will be the analysis of the
molecular mechanisms of growth and differentiation.  Using somatic cell
genetic approaches, we have cloned genes tht are regulated in respect to
the resting or proliferating states of cells.  These are thymidine kinase,
transferrin receptor, surface antigen 4F2, and surface antigen S11.  The
genes are being characterized structurally and in terms of their kinetics
of transcriptional expression during the culture cycle and the cell cycle.
We propose to determine the molecular mechanisms of transcriptional control
in this gene set.  Another new research program involves mouse and human
DNA sequences that show a high degree of homology with the Drosophila
homeotic genes Antennapedia and Ultrabithorax.  We have cloned a number of
such sequences and propose experiments by which their biological
significance can be evaluated.  If our hypothesis is correct that these
genes regulate pattern formation in mammals, then we shall have a genetic
approach to studying mechanisms of morphogenesis in higher organisms.  In
another new system (sr = segregation regulation), we shall investigate
genetic factors located on the mammalian X chromosome that control
chromosome segregation in hybrid cells.  We postulate that this system
represents a hitherto unrecognized mechanism that mediates intercellular
recognition in somatic cell populations.  A primary objective will be the
purification and recombinant DNA cloning of these sr genes.  We believe the
pursuit of these projects will provide useful and significant insights into
the genetic mechanisms controlling mammalian cell growth, differentiation,
and morphogenesis.
",GENETIC ANALYSIS OF SOMATIC CELL POPULATION,,FRANK H RUDDLE,1862461
18,3393835,,1987,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5R01NS008841-19,NS008841,UNITED STATES,R01,176590,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1991-08-31T04:00:00Z,,"The major objective of the proposed research is to study the properties and
physiological function of the enzymes catalyzing the formation of
phosphatidic acid, the key precursor of glycerides and phosphoglycerides.
Detailed studies will be made on the enzymes of the acyl dihydroxyacetone
phosphate (acyl DHAP) pathway, namely DHAP acyltransferase, alkyl DHAP
synthase and acyl/alkyl DHAP reductase.  The acyl DHAP pathway has been
shown to play a role in the biosynthesis of glycerolipids, especially the
containing ether linkages (glycerol-ether lipids and plasmalogens).  In
recent years, a number of discoveries such as the presence of acyl DHAP
pathway enzymes in microbodies (peroxisomes and microperoxisomes), the
demonstration that in patients with Zellweger cerebrohepatorenal syndrome
both the microbodies and glycerol-ether lipids are absent, and the
discovery that an ether lipid (platelet activating factor), has a potent
biomessenger role, all point towards the importance of the acyl DHAP
pathway in lipid metabolism.  In the proposed studies, our aim is to purify
the membrane-bound acyl DHAP pathway enzymes to homogeneity and study in
detail their properties and reaction mechanisms.  Attempts will be made to
raise specific antibodies against these enzymes and then to use these
antibodies to estimate and to localize the enzymes in different tissues.
The activity of these enzymes under different physiological conditions and
the contributions of the acyl DHAP pathway to the biosynthesis of non-ether
glycerolipids will be studied.  Different analogs of acyl/alkyl DHAP will
be chemically synthesized to test their possible use as inhibitors or
substrates for different enzymes.  The role of ether lipids will be
investigated by studying their distribution, turnover, and transport in
different systems.  The incorporation of exogenously added ether lipid
precursors to membrane lipids of skin fibroblasts from Zellweger syndrome
patients and in whole animals will also be studied.  The deficiency of
different acyl DHAP pathway enzymes in the cultured fibroblasts from
patients suffering from Zellweger syndrome, neonatal adrenoleukodystrophy
and related diseases will be studied in detail.
",METABOLISM OF PHOSPHATIDIC ACID AND ITS ANALOGS IN LIVER,,AMIYA K HAJRA,1901432
19,3374548,,1987,UNIVERSITY OF CHICAGO,CHICAGO,IL,,5R01MH004151-28,MH004151,UNITED STATES,R01,363739,False,,National Institute of Mental Health,1975-09-01T04:00:00Z,1988-08-31T04:00:00Z,,"A series of seven studies on sleep is proposed:  1.  A study of behavioral and
functional characteristics of a rat state characterized by low EEG, low EMG, and
high theta amplitudes aims to clarify where this state belongs relative to
wakefulness and sleep stages.  2.  To increase our understanding of underlying
oscillators, we propose to compare relationships among circadian rhythms of
sleep, temperature, and activity in the rat under several light:dark schedules.
3.  To understand why diurnal sleep rhythms changes with age, we propose to
compare the rhythms of young and old rats under ""normal"" and phase reversed
lighting schedules and during ""free-runs"".  4.  To develop measures of sleep
intensity, we propose to compare frequency and amplitude characteristics of the
sleep EEG following sleep deprivation with baseline recordings.  5.  We propose
to develop improved techniques for sleep depriving animals through the use of an
automated system that delivers stimuli contingent upon an animal's state.  6.
To understand the large individual differences in EEG slow wave activity during
sleep, we propose to examine how they are correlated with a number of
physiological, psychological, and sleep parameters.  7.  We propose to describe
the visual characteristics of dreams by having subjects choose photographs which
match the visual characteristics of their own dreams.  We also propose to
determine how these visual characteristics are related to phasic events during
sleep.
",THE PSYCHOLOGY AND PHYSIOLOGY OF SLEEP,,ALLAN  RECHTSCHAFFEN,1891083
20,3374526,,1989,UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,CHAMPAIGN,IL,,5R01MH001206-34,MH001206,UNITED STATES,R01,59706,False,,National Institute of Mental Health,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"This ongoing research program is organized into three distinct but related
areas.  The general aim of the first area is to elucidate and describe
selective attentional mechanisms as they operate in visual information
processing.  Ongoing and proposed research is directed toward attention
effects at early levels in stimulus processing, stimulus selection and the
role of competing responses, sustained attention, and the spatial
characteristics of the distribution of attentional resources in the visual
field.  Among the methodologies used, response competition paradigms, cost
benefit analysis, and reaction time measures play a major role.

A second area of research is to refine a new set of measures that analyze
the microstructure of the responses that are used to signify choice in
reaction time tasks.  In recently completed pilot studies, these measures
have shown high promise of reflecting differences in information processing
that are not revealed in the usual latency measures.

A third research direction uses a response competition paradigm to
determine the extent and nature of the relationships and content that is
retrieved upon semantic processing of a word.
",ATTENTION AND VISUAL INFORMATION PROCESSING,,CHARLES W ERIKSEN,1961188
21,3268668,,1988,YALE UNIVERSITY,NEW HAVEN,CT,,5R01GM014642-21,GM014642,UNITED STATES,R01,331452,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1991-07-31T04:00:00Z,,"Detachment of the flagella of the bi-flagellate alga Chlamydomonas results
in the regeneration of two 12Mu flagella in 90 min.  Deflagellation induces
a large increase in the synthesis and accumulation of flagellar protein
mRNAs.  These mRNAs rapidly fall back to pre-deflagellation levels once
regeneration is complete, and this is due both to a decrease in synthesis
and a shortening of mRNA half-life.  Only detachment of the flagella is
required for these events, as they will occur normally if flagellar
regeneration is blocked (colchicine).  The system is ideal for
investigating the signals responsible for the coordinate control of gene
transcription, translational controls, and problems of organelle protein
assembly.  Transcriptional control of the alpha-tubulin genes is being
investigated by injecting constructs of the tubulin gene promotor DNA and
chloramphenicol acetyl transferase gene (CAT) into the Xenopus oocyte
nucleus and assaying for CAT.  Proteins isolated from Chlamydomonas nuclei
or cytoplasm are being coinjected with the constructs; they are identified
as putative transcriptional control proteins by in vitro protein/DNA
binding studies using DNA from the alpha-tubulin promotor region.  In
addition to the alpha and beta tubulin genes which have already been cloned
and sequenced, we are isolating genes for radial link and dynein-ATPase
peptides by use of polyclonal antibodies to these proteins and a lambda
gt11 expression vector containing Chlamydomonas genomic DNA.  The radial
link genes and their 5' flanking regions will be sequenced and analyzed for
commonalities.  Radial link genes will also be used in studies on the
transformation of paralyzed radial link mutants to the motile wild-type.
Since tubulin mRNA half-life decreases upon completion of regeneration, the
stability of radiolabeled in vitro-synthesized (SP6) tubulin mRNA will be
examined in the reticulocyte lysate and by injection of the mRNA into
Xenopus oocyte cytoplasm.  Both flagellar alpha-tubulin mRNAs appear to be
synthesized in response to deflagellation, but only one is used for
flagellar protein synthesis.  This apparent translational control will be
analyzed using in vitro-synthesized tubulin mRNAs and the reticulocyte
lysate; we will determine if the alpha tubulin mRNA which is not used for
flagellar tubulin synthesis is used for the synthesis of mitotic tubulin.
Other evidence suggests that the amount of tubulin dimers in the cell can
control the amount of tubulin mRNA present.  We will experimentally vary
the amount of tubulin dimers in the pool and analyze the changes in tubulin
mRNA synthesis and accumulation.  The mechanism by which this control might
be exerted will be investigated by RNA/protein cross linking studies.
There is no feed back control between the amount of mRNA synthesized in
responses to deflagellation and the amount already present.  In studies on
flagellar protein assembly, we will determine the role of the alpha-tubulin
acetylation which occurs at the time of tubulin assembly at the flagellar
tip.  The possible role of acetylation in microtubule assembly/disassembly
in vitro will be investigated as will be the calcium sensitivity of
acetylated microtubules.  The flagellar dynein-ATPase is prefabricated in
the cytoplasm during flagellar regeneration and we will use dynein mutants
to describe the steps in the assembly of the dynein polypeptides.
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
22,3269722,,1988,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5R01GM019670-16,GM019670,UNITED STATES,R01,261959,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The proposed research will study three critical problems in the field of
molecular genetics:  the mechanism of ""illegitimate"" recombination
catalyzed by transposable elements, the mechanism of transcription
initiation and the mechanism of translation initiation.  Transposable
elements are genetic entities that are widespread throughout nature which
can catalyze numerous types of genome rearrangements and thus have been
implicated in germline mutations (important for evolution) and somatic cell
mutations (important in oncogenesis).  Our projects will use genetic and
biochemical approaches to elucidate the molecular mechanism of illegitimate
recombination encoded by one model system--the bacterial transposon Tn5.
Transcription initiation is the first step in gene expression.  We will be
studying how promoter structure (the DNA sequence recognized by RNA
polymerase) affects this process.  We will also be examining how regulatory
protein-DNA interactions and competitive RNA polymerase-DNA interactions
modulate this process.  Translation initiation is also a crucial step in
gene expression in which the rate of protein systhesis from a particular
mRNA is modualted.  The structure (both 1 degree and 2 degree) of the mRNA
is an important determinant of the rate of this process.  We will analyze
mutations affecting the structure of the lacZ mRNA in an attempt to
understand this event.
",GENETIC REGULATION AND TRANSPOSITION,,WILLIAM S. REZNIKOFF,1964688
23,3335649,,1988,UNIVERSITY OF IOWA,IOWA CITY,IA,,5R01HL018629-14,HL018629,UNITED STATES,R01,116021,False,,National Heart Lung and Blood Institute,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"Most studies on myocardial hypertrophy during hypertension are based on
young animals, a limitation which precludes an adequate understanding of
the heart's response to the more common adult onset of hypertension.  Our
previous work suggests that age and the duration of hypertension play
important roles in modulating left ventricular hypertrophy and its
associated changes.  Accordingly, the proposed research will test the
hypothesis that when the onset and progression of hypertension occur during
middle or late life the left ventricle develops structural and functional
abnormalities which are exacerbated by prolonged periods of hypertension.
We will study two age groups of rats with renovascular (Goldblatt, two
kidney, one clip) hypertension of either 3 or 6 mos. duration.  To test the
hypothesis that some left ventricular abnormalities may not be reversible
when hypertension develops late in life we will also study animals
following the reversal of hypertension with antihypertensive therapy.  Left
ventricular performance will be assessed by measuring indices of cardiac
output during acutely increased preload.  To delineate specific alterations
in subcellular components of the myocardial cell which may underlie
functional changes, electron and light microscopy and morphometry will be
employed, and the subepi- and subendo-cardial regions of the left ventricle
compared.  Because it is recognized that the coronary vasculature and
circulation may be adversely affected by hypertension and/or myocardial
hypertrophy, regional and total myocardial perfusion will be measured at
rest and during maximal vasodilation, and coronary reserve estimated.  As a
corollary to the perfusion studies the extensiveness of the capillary bed
and the structure of the coronary arteries will be evaluated by microscopy
and image analysis.  To determine whether any of the alterations
characteristic of hypertension and its reversal are model dependent, we
will also employ rats with mineralcorticoid hypertension in some of the
experiments.  These studies will provide new and basic insights regarding
the impact of age and the duration of hypertension on the heart.
",INFLUENCE OF AGING AND HYPERTENSION ON THE MYOCARDIUM,,ROBERT J TOMANEK,1887413
24,3224959,,1988,GEORGE WASHINGTON UNIVERSITY,WASHINGTON,DC,,5R01DK013048-20,DK013048,UNITED STATES,R01,90552,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-11-30T05:00:00Z,,"In this program I will continue the study of sulfur amino acid metabolism in
mammals.  Three broad approaches will be utilized.  We have developed assays for
six of the enzymes involved in the conversion of methionine to homocysteine
(S-adenosylmethionine synthetase, S-adenosylhomocysteine hydrolase), the
conversion of homocysteine to cysteine (cystathionine synthase, cystathionase)
and the remethylation of homocysteine (betaine homocysteine methyltransferase
and N5 methyltetrahydrofolate homocysteine methyltransferase).  Employing these
assays, we will evaluate the effect of dietary and hormonal factors on the
tissue (liver and other organs) content of the various enzymes.  Concurrently,
the enzymes will be purified and their kinetic properties determined with
particular reference to regulation by intermediates of the pathway as well as by
other normal and abnormal metabolites.  Finally, I will attempt to correlate
these in vitro evaluations of the regulation of enzyme content and activity with
a study of the effect of the same dietary and hormonal factors on the metabolism
of methionine in the intact rat liver.  In the latter experiments, we will use
techniques of isolated organ perfusion as well as studies in the whole animal.
Due to the essential role of methionine in human nutrition, these studies have a
broad relevance.  They are particularly significant in the areas of (1)
Homocystinuria and other disorders of sulfur amino acid metabolism; (2)
Alcoholic liver disease which in the experimental animal is reversed, in part,
by methionine; (3) chronic liver disease of many etiologies which are associated
with hypermethioninemia and possibly (4) Neuropsychiatric disorders.

",SULFUR AMINO ACID METABOLISM IN MAMMALS,,JAMES D FINKELSTEIN,1966713
25,3224642,,1988,UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,HOUSTON,TX,,5R01DK009801-24,DK009801,UNITED STATES,R01,194478,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The long term objective of this project is the definition of the chemistry
of the glycoprotein hormones, particularly the gonadotropins from the
pituitary and chorion.  It is proposed to continue conventional sequencing
studies on eCG and eLH (in progress-Specific Aim 1), and to use this
methodology to reinvestigate hFSHBeta and pFSHBeta sequences to resolve
some remaining questions about their proposed sequences (Specific Aim 3).
Studies of functional group proximity on LH will be done using
bi-functional crosslinking reagents of specified length, enzymatic
degradation, and amino acid sequencing of the isolated peptides to identify
specific peptides involved in the crosslink (Specific Aim 4).  This will
require HPLC peptide mapping and location of the unaffected peptides for
which considerable information has already been generated.  Methodology for
detection of sulfate esters at the nanomole level with precision and
accuracy will be developed in order to compare the carbohydrate termination
groups (sulfate ester or sialic acid) for equine or human pituitary and
chorionic glycoprotein hormones (Specific Aim 5).  These are the only
species with well characterized chorionic gonadotropins.

It is proposed to examine the gene sequence of the equine LH and CG beta
subunit using recombinant DNA methodology (Specific Aim 2) since important
differences have been shown for the gene products in the equine compared to
the human.  The gene sequences are known for the human in these two
instances.  The determination of the equine sequences will be through
selection of recombinant clones for eLHBeta or eCGBeta from an equine
cosmid genomic DNA library with human cDNA clones.

Subsequent to the foregoing recombinant DNA study the sequence of the
rabbit LHBeta gene would be determined (Specific Aim 6) since this gene
product also has some unusual properties.

Specific Aim 7 involves collaborative studies to improve embryo transplants
in cattle.  Our role will be to produce FSH preparations free of LH.
",CHEMISTRY OF LUTEINIZING AND RELATED HORMONES,,DARRELL N. WARD,2418685
26,3226279,,1987,UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,FARMINGTON,CT,,5R01DK019167-12,DK019167,UNITED STATES,R01,168264,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1989-06-30T04:00:00Z,,"Iron uptake for heme and hemoglobin synthesis in erythropoietic cells
occurs by receptor-mediated endocytosis of transferrin.  The purpose of
these studies is to define and characterize the nature of events which are
implicated in transferrin-mediated iron delivery and its regulation in rat
reticulocytes and to determine how and if heme synthesis regulate the iron
delivery mechanism to control iron uptake.  Biochemical and functional
studies of the iron delivery process seek to determine the extent to which
iron uptake is dependent upon calcium influx or its mobilization from
intracellular stores, the role of protein kinase C, and the significance of
phosphorylation of receptor, membrane, and membrane-associated proteins in
the control of iron delivery.  Analysis of the mechanism of action of
dansylcadaverine, a potent inhibitor of transferrin-mediated iron delivery,
will be performed to determine the molecular basis of its effects on iron
uptake, particularly with emphasis upon the possible role of
metalloendoproteases in receptor-mediated membrane flow.  The long-term
objective of these studies is to determine the mutual co-ordination of
hemoglobin synthesis and iron metabolism in developing red blood cells.
The results of these studies may have significant implications in our
understanding of human red cell disorders which are characterized by
aberrant iron metabolism.
",IRON METABOLISM IN ERYTHROPOIETIC CELLS,,JOSEPH A GRASSO,3716219
27,3225238,,1987,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5R01DK014575-19,DK014575,UNITED STATES,R01,247866,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The GOALS of the proposed research are:  To determine how the major
constituents (apoproteins, triacylglycerol, cholesterol, and phospholipids)
of very low density lipoprotein are assembled and translocated and to
determine how these processes and subsequent secretion are regulated.  To
determine the mechanism(s) by which acetyl-CoA carboxylase--the key
regulatory enzyme of fatty synthesis, hence de novo lipogenesis--is
controlled.

The estrogen-induced chick hepatocyte in monolayer culture, a system
developed in this laboratory, will serve as experimental model.  The chick
hepatocyte is ideally suited for studies on VLDL synthesis and secretion,
since the liver accounts for nearly all de novo fatty acid synthesis in the
chick, as it dies in man, and provides the major fraction of the fatty
acids utilized by other tissues (including adipose tissue) in the form of
VLDL -triacylglycerol, and since VLDL output of the hepatocyte in culture
can be increased 10-20-fold by prior hormone treatment.  We have already
amassed a large body of background information with this system.

The sequence of events will be determined by which apoproteins and lipids
are assembled to form the nascent VLDL particle.

The intracellular sites of these events will be identified and
characterized.

Using puromycin-induced nascent chain release, the interaction of segments
of the apo-B polypeptide and specific VLDL lipids will be established.

A cell-free system will be developed that is capable of assembling,
processing and translocating nascent VLDL.

This cell-free system will be used to investigate the minimal requirements
of and the mechanisms of key steps in the VLDL assembly/processing pathway.

cDNA clones which encode the mRNA for apo-B will be isolated and sequenced.

The regulatory mechanisms for the synthesis, assembly, translocation and
secretion of VLDL will be investigated.

The effect of the phosphorylation state of acetyl-CoA carboxylase on the
kinetics of its citrate-induced activation and polymerization and the state
of its protomerpolymer equilibrium will be determined.
",REGULATION OF LIPOGENESIS AND VLDL SYNTHESIS/ASSEMBLY,,M DANIEL LANE,1878591
28,3224728,,1987,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,,5R01DK011011-21,DK011011,UNITED STATES,R01,229082,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1991-06-30T04:00:00Z,,"The objective is to investigate the biochemical and molecular mechanisms
that regulate expression of specific differentiated functions in a model
system of dispersed cells in culture.  Studies will focus on:

1. Analyis of the acute actions of a regulatory peptide:
thyrotropin-releasing hormone (TRH) as a prototype.  Experiments will use
clonal strains of pituitary cells and will examine the nature of the
biochemical linkage between the TRH receptor and polyphosphatidylinositol
hydrolysis, the mechanisms used by the cell for mobilization of
intracellulr Ca2+, characterization of membrane cation channels, and the
roles of protein kinase C and protein phosphorylation in acute actions of
TRH on hormone (prolactin (PRL) and growth hormone (GH)) secretion.

2. Actions of tumor-promoting phorbol esters on differentiated functions.
Phorbol esters will be localized in cells by a new immunohistochemical
approach, and the mechanisms by which phorbol esters modulate plasma
membrane receptors and regulate acute protein secretion (PRL and GH) will
be investigated.  3.  Regulation of specific protein synthesis.  Using a
highly differentiated cell culture system in which the biosynthesis of PRL
and GH is controlled by hormones, Ca2+, and tumor promoters, I shall
investigate the biochemical and molecular mechanisms by which phorbol
esters and TRH regulate the biosynthesis of PRL and GH, and the role of
Ca2+ in the regulatory pathway.  The results of these studies will
contribute new knowledge on the details of regulation of 2 important
protein hormones; this fundamental knowledge can be expected to contribute
to the better understanding of certain disorders of growth (including
cancer) and reproductive function.
",DIFFERENTIATED FUNCTIONS IN DISPERSED CELL CULTURE,,ARMEN H TASHJIAN,1888218
29,3269721,,1987,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5R01GM019670-15,GM019670,UNITED STATES,R01,256772,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The proposed research will study three critical problems in the field of
molecular genetics:  the mechanism of ""illegitimate"" recombination
catalyzed by transposable elements, the mechanism of transcription
initiation and the mechanism of translation initiation.  Transposable
elements are genetic entities that are widespread throughout nature which
can catalyze numerous types of genome rearrangements and thus have been
implicated in germline mutations (important for evolution) and somatic cell
mutations (important in oncogenesis).  Our projects will use genetic and
biochemical approaches to elucidate the molecular mechanism of illegitimate
recombination encoded by one model system--the bacterial transposon Tn5.
Transcription initiation is the first step in gene expression.  We will be
studying how promoter structure (the DNA sequence recognized by RNA
polymerase) affects this process.  We will also be examining how regulatory
protein-DNA interactions and competitive RNA polymerase-DNA interactions
modulate this process.  Translation initiation is also a crucial step in
gene expression in which the rate of protein systhesis from a particular
mRNA is modualted.  The structure (both 1 degree and 2 degree) of the mRNA
is an important determinant of the rate of this process.  We will analyze
mutations affecting the structure of the lacZ mRNA in an attempt to
understand this event.
",GENETIC REGULATION AND TRANSPOSITION,,WILLIAM S. REZNIKOFF,1964688
30,3269270,,1987,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5R01GM018386-18,GM018386,UNITED STATES,R01,314734,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"This research program deals with transcription and transcriptional
regulation in one prokaryotic and one eukaryotic system.

T4:  The focus is on the enzymology of T4 late gene regulation, using
defined and specifically constructed T4 late transcription units, located
in plasmids.  We propose these principal research topics:  1) Analysis of
the roles of T4-specific RNA polymerase-binding proteins in T4 late
promoter selection, RNA chain initiation, elongation and termination, and
discrimination against other promoters; 2) Analysis of T4 late promoter
specificity and selectivity by in vitro mutagenesis and synthesis of
synthetic promoters; 3) Analysis of the coupling between DNA replication
and T4 late gene activity in vitro.

S cerevisiae RNA polymerase III:  The focus is on the mechanism of specific
transcription, on the assembly of stable transcription complexes and on the
process of RNA chain formation in a transcription unit with internal
promoters.  Transcription components, including transcription factors, will
be purified.  The interaction of the large DNA-binding transcription factor
with the internal promoters of tRNA genes will be further analyzed.
Quantitative analysis of equilibrium binding constants for factor-DNA
complexes will be undertaken.  Complexes of the transcription factor with
different promoters will be examined by electron microscopy.  In a second
series of studies, the interactions of a second transcription factor with
these large transcription factor-DNA complexes will be analyzed in terms of
DNA binding site, nature of bound proteins, stability and shape.  In a
third series of experiments complete transcription complexes, containing
RNA polymerase III, will be assembled; DNA binding site, shape and
stability will again be analyzed.  RNA chain elongation will be analyzed,
particularly from the point of view of the interaction of proteins with the
internal promoter.  Some experiments on the regulation of synthesis of
transcription factor proteins in yeast are proposed.
",NUCLEIC ACIDS AND NUCLEOPROTEINS,,ERNEST PETER GEIDUSCHEK,1876894
31,3269049,,1987,ROCKEFELLER UNIVERSITY,NEW YORK,NY,,5R01GM017132-18,GM017132,UNITED STATES,R01,312945,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-11-30T05:00:00Z,,"The long range objectives of this study are to characterize molecules
associated with the microtubules of eukaryotic flagella that are
responsible for the function and assembly of these organelles.  The study
is based on application of morphological, genetical, and biochemical
techniques to a model organism, the unicellular alga Chlamydomonas
reinhardtii.  Mutant strains under analysis include those affecting
flagellar function and assembly.  A subset of assembly mutants are
clustered on a linkage group showing unique meiotic behavior.  In one class
of these, the uni mutants, the defect appears to interrupt assembly of the
basal body transition zone.  Efforts will be made to identify a cellular
DNA encoding these functions.  Independent efforts will be made to obtain
genomic clones encoding the several large subunit polypeptides of four
axonemal dyneins.  Phosphorylation of a set of polypeptides involved in
controlling transitions between two different bending forms of flagella
will be studied using in vitro phosphorylation methods as well as reversion
analysis of mutants.  The latter technique will also be used to study
components required for stability of central microtubules.
",BIOCHEMICAL GENETICS OF MICROTUBULES,,DAVID J LUCK,1965380
32,3224783,,1989,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5R01DK011356-23,DK011356,UNITED STATES,R01,175511,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"This grant proposal concerns mechanisms by which red blood cells achieve
and maintain their content of water and small ions.  The experiments are
divided into two parts.  The first involves dog red blood cells, in which
movements of sodium, calcium, protons, and potassium across the membrane
are strongly dependent on cell volume.  The proposed work seeks to examine
the nature of the stimulus-response coupling, so as to clarify how certain
membrane transporters are turned on and off by minor degrees of cell
shrinkage or swelling.  Methods will involve the use of cross-linking
agents, membrane-expanding treatments, and selective proteolyic digestion
to influence the relationship between cell volume and ion transport.
Membrane protein separations will be performed by gel electrophoresis,
using cells that have had specific transporters ""turned on"" or ""turned off""
by volume manipulation.  Net and isotopic flux measurements will be used to
monitor transport.

The second project is a one-year, preliminary study designed to evaluate,
by the techniques of electron probe microanalysis, a unifying hypothesis
that would explain the generation of dense, viscous red blood cells in
sickle cell disease, hereditary spherocytosis, and other hemolytic states.
The hypothesis states that red blood cells in all these conditions are
subject to fragmentation or budding.  The vesicles that bud off the cells
are believed to be richer in water and salts and poorer in hemoglobin
content than the parent cells, thus leaving the latter dense, viscous, and
poorly deformable.  The work proposed here involves a one year feasibility
study during which red blood cell fragments produced in vitro would be
assayed for ion, water, and hemoglobin content by standard techniques of
atomic absorption and/or flame photometry.  The same fragments would be
subjected to electron probe microanalysis, to determine whether the method
has the sensitivity and specificity to approach the problem with blood
samples from patients.  The hypothesis cannot be evaluated in the blood of
patients in any other way than by electron probe microanalysis:  this is
because cell fragments in the circulation may originate from platelets,
leukocytes, and possibly other non-red cell sources.  Only by combining the
techniques of electron microscopy and microanalysis can one be sure of the
origin of the fragments in which quantitative elemental determinations are
to be made.
",ION TRANSFER AND METABOLISM IN MAMMALIAN RED BLOOD CELLS,,JOHN C PARKER,3173154
33,3101367,,1987,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,,5P30CA014051-16,CA014051,UNITED STATES,P30,1625828,False,,National Cancer Institute,1975-09-01T04:00:00Z,1990-04-30T04:00:00Z,,"This is a request for five years of core support beginning September 1, 1980
following the termination of NCI Grant CA 14051.  The Cancer Center Support
(Core) Grant is requested to provide funds for shared facilities and services,
including research salaries for professional staff (the faculty members who as a
group operate the program of the Center), centralized services, shared
equipment, developmental funds, and administration.

Research will be carried out in three main areas of Cancer Biology: 1) Cancer
Virology - this group, led by five faculty members, concentrates primarily on
the identification of cancer-inducing genes and their products.  2) Cancer
Immunology - this program, led by three faculty members, places its major effort
in the study of the mechanism by which killer T lymphocytes destroy foreign or
cancer cells in vivo and in vitro.  3) Cancer Cell Biology, with four faculty
members, explores the biochemical changes that occur on the cell surface and in
the cytoskeleton as a result of mailignant transformation.

This Core Grant will aid further development of the Center by providing partial
support for initial research costs of two new faculty members:  a replacement in
the Immunology Group and an addition to the Cell Biology Group.  Development
funds are also requested for the support of exploratory projects in the initial
phase, prior to application for peer-reviewed funding.

",CANCER CENTER SUPPORT (CORE) GRANT,,Phillip A Sharp,7355826
34,3075292,,1987,EMORY UNIVERSITY,ATLANTA,GA,,5K05DA000008-13,DA000008,UNITED STATES,K05,56121,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"This is an application for an ADAMHA Research Scientist Award.  A program
of research is proposed for characterizing the behavioral effects of two
types of drugs of major clinical, social, and theoretical importance:
opioids, which have long represented a significant abuse problem, and
caffeine, which is the most widely consumed behaviorally-active compound in
this country.  A theme central to the entire research program is that
through systematic and comprehensive behavioral studies it will be possible
to characterize the bases of drug actions at the neuronal level.

Representative opioid alkaloids--agonists, agonist/antagonists, and
antagonists--will be studied in several behavioral procedures, notably,
drug discrimination, food-reinforced operant responding (punishment
paradigm), and locomotor activity, and in at least two animal species, rat
and squirrel monkey for optimal assessment of the generality of
experimental findings.  Emphasis will be placed on clarifying the role of
endogenous opioid peptides in the diverseness of the behavioral effects of
opioid alkaloids.  Behavioral effects of peptides will be determined after
central administration, their effects compared to those of prototypic
alkaloids, and interactions studied between peptides administered centrally
and alkaloids administered systemically.

The effects of chronic caffeine administration will be characterized by an
integrated behavioral and neurochemical approach.  Most studies will be
performed on rats receiving caffeine daily by scheduled access to water
bottles containing the drug.  Matched controls will receive drug-free tap
water.  Rate and extent of tolerance development, and time course for loss
of tolerance to caffeine-induced stimulation of motor activity will be
determined as a function of daily drug dosage.  Pharmacologic (i.e.,
alkylxanthine and nonxanthine drugs) and behavioral (i.e., food-reinforced
operant responding) variables in tolerance to caffeine will also be
assessed.  Changes in various measures of the functional state of brain
catecholamine and adenosine systems will be determined in parallel with the
behavioral changes as a first step toward identifying the cellular
mechanisms that underlie tolerance to caffeine.
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS AND CAFFEINE,,STEPHEN G HOLTZMAN,1868593
35,3163849,,1987,COLORADO STATE UNIVERSITY-FORT COLLINS,FORT COLLINS,CO,,5R01CA013899-15,CA013899,UNITED STATES,R01,451927,False,,National Cancer Institute,1975-09-01T04:00:00Z,1991-06-30T04:00:00Z,,"The objective of this research is to evaluate the factors of dose
fractionation and treatment volume which influence late complications
following radiation therapy.  Increased knowledge of the pathogenesis of
late effects including better definition of dose limiting cells will
provide a better understanding of the effects of altered fractionation
schemes and treatment volume.  Isoeffect curves for response of canine
heart and mediastinal structures including the esophagus and trachea will
be generated by exposing those tissues to a range of total doses given a
range of doses per fraction.  Sequential studies will be done using
noninvasive endoscopic, radiographic, electrocardiographic and
echocardiographic techniques.  Histologic analyses will be done two years
after irradiation for comparison with functional studies and provide
information on the pathogenesis of late effects.  The volume effect will be
evaluated by irradiating variable lengths of spinal cords of dogs.
Electrophysiologic measurements will be made sequentially and histologic
analyses done two years following irradiation.  If a volume effect is
found, additional studies will be done with smaller doses per fraction to
determine the influence of fractionation on volume effect.  These studies
will show quantitatively how tissues respond to the different methods of
irradiation and the histologic analyses will contribute to the description
of pathogenesis of late effects.  The isoeffect curves generated may
provide directions for adjusting fraction size and dose delivery and
indicate how those alterations may be additionally influenced by volume
irradiated.
",RADIATION REPAIR OF NORMAL MAMMALIAN TISSUE,,EDWARD L GILLETTE,1969200
36,3484142,,1988,STANFORD UNIVERSITY,STANFORD,CA,,5R37GM013235-22,GM013235,UNITED STATES,R37,462115,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1992-06-30T04:00:00Z,,"The advent and widespread application of the recombinant DNA
methodology during the past twelve years has greatly extended
our understanding of the molecular basis of heredity.  More
significantly, the emergence of a new molecular paradigm -
reverse genetics, which relies on the ability to specifically modify
the structure of genes in vitro and to test their biological
properties, has revolutionized the experimental approaches in
molecular genetics.  The ability to construct minichromosomes
with novel arrangements of genetic elements also provides
vectors for the isolation of genes as well as substrates for the
analysis of specific genetic reactions.  Our proposal, which applies
this approach to explore the basic mechanisms of gene regulation
in the establishment of immune responsiveness and of genetic
recombination, aims

(1)  identify the factors and mechanisms that limit the
epression of antibody genes to only lymphoid cells;
(2)  isolate and characterize the human gene whose
dysfunction is responsible for galactosemia;
(3)  understand the mechanisms responsible for non-
homologous, homologous and non-reciprocal modes of
genetic recombination, especially those which permit the
rejoining of broken DNA;
(4)  develop genetic approaches to effect a replacement or
repair of chromosomal DNA sequences;
(5)  developing vectors which can deliver genes to only
specific types of cells.

It is anticipated that the information we develop will advance our
unerstanding of the molecular basis of disease and provide novel
approaches to their prevention, treatment and cure.
",MECHANISMS & REGULATION OF GENE EXPRESSION,,PAUL  BERG,1965506
37,7113842,,2006,BROWN UNIVERSITY,PROVIDENCE,RI,BIOCHEMISTRY,5R01GM019756-35,GM019756,UNITED STATES,R01,640349,False,Marcus M. Rhoades,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2009-08-31T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  The long term objective of this grant proposal is to understand how the ribosome functions at the atomic level during protein synthesis. Our approach includes developing genetic and biochemical systems in the extreme thermophile Thermus thermophilus to construct and isolate mutants in rRNA, ribosomal proteins and translation factors. Our first aim is to characterize wild-type T. thermophilus ribosomes in solution by structure probing and determine modified residues by mass spectrometry. This will serve as the baseline for subsequent analysis of mutants in rRNA and ribosomal proteins. Selected mutants will be identified for crystallization attempts. A second aim is to investigate the nature of interactions between the ribosome and elongation factors EF-Tu and EF-G during accommodation and translocation. Selected functional sites in both subunits will be probed. A model for conformational change during translocation will be evaluated as will the mechanism of translocation inhibition by tuberactinomycin antibiotics. A third aim will probe our collection of mutants in the peptidyltransferase active site of 23S rRNA of T. thermophilus to characterize functions in addition to peptide bond formation associated with this region, including translocation, decoding and peptide release. Fast kinetic experiments will be used to evaluate the mutants and test a model of accommodation, and the peptide antibiotic negamycin will be examined for its role in termination. These experiments should provide fundamental insights into ribosome structure-function relationships, different conformational states of the ribosome during translation and the mode of action of and resistance to clinically useful antibiotics.      

",Polysomes & Subunits: Structure-Function Relationships,,ALBERT E DAHLBERG,1965233
38,6773983,,2004,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-30,HD007048,UNITED STATES,T32,280107,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2005-04-30T04:00:00Z,,,TRAINING PROGRAM IN REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
39,6628737,,2003,YALE UNIVERSITY,NEW HAVEN,CT,PHYSIOLOGY,5R37GM014642-36,GM014642,UNITED STATES,R37,536411,False,James F. Deatherage,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-01-31T05:00:00Z,,"In the bi-flagellate alga Chlamydomonas, flagellar detachment signals           
the immediate, coordinate upregulation of over 200 genes encoding               
flagellar proteins, and, within minutes, the synthesis of these proteins        
and their assembly into new flagella.  This project is directed toward          
determining (a) where in the cytoplasm the mRNAs encoding these                 
flagellar proteins are located and where these proteins are synthesized;        
(b) to what extent these polypeptides are pre-assembled in the cytoplasm        
prior to entering the nascent flagella; (c) how these proteins are              
targeted to the flagella; (d) the role of the basal body/centriole in           
this targeting process; and (e) how, once in the flagella, the                  
precursors are transported to the assembly site at the flagellar tips.          
Using a variety of assembly mutants, these studies examine the                  
synthesis, assembly and transport of flagellar radial spokes, which are         
complexes composed of 17 polypeptides that pre-assemble in the                  
cytoplasm, yet function solely in the flagella.  Studies on transport           
focus on intraflagellar transport (IFT), a motility characterized by the        
rapid anterograde and retrograde movement of particles between the              
flagellar membrane and axoneme.  IFT particles are composed of ca. 15           
polypeptides, the genes for which are being cloned.  Mutations in C.            
elegans homologues of 3 of these polypeptides have been identified that         
result in defects in assembly of cilia found on sensory dendrites.              
Likewise, mutations in the microtubule motors that power anterograde and        
retrograde IFT in Chlamydomonas and their homologues in C. elegans              
result in the inability to assemble functional flagella or sensory              
cilia.  IFT is, therefore, one of the only microtubule-based motilities         
in which mutants are available in both the anterograde and retrograde           
transport of defined, isolable particles.  Particles, ultrastructurally         
similar to IFT particles, are found in the connecting cilium of                 
vertebrate retinal rod inner-outer segments, and kinesins, homologous           
to those associated with IFT, have been localized to this region. These         
observations suggest that IFT is universally required for assembly and          
maintenance of both motile and non-motile sensory cilia and, therefore,         
may be involved in male fertility, the assembly and maintenance of              
respiratory and oviduct cilia, and diseases of the retinal rod and cone         
outer segments.                                                                 
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
40,7053310,,2006,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,5R01GM022395-31,GM022395,UNITED STATES,R01,304668,False,Susan R. Haynes,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2008-03-31T04:00:00Z,,"  
DESCRIPTION (provided by applicant):  One of the most dramatic advances in biomedical research in the past 15 years has been the demonstration that human disorders can be studied in model organisms. This is a tribute to the investment of our country in basic biology. Genetic organisms such as yeast, Drosophila, C. elegans, and the mouse have led the way, but the organism par excellence for the study of thyroid hormone, one of the most important hormones for human health, is the amphibian, Xenopus laevis. Although vertebrates in all of the various phyla including humans require thyroid hormone (TH) to complete their life cycle, by far the most dramatic example is the role of TH in amphibian metamorphosis. TH is required absolutely for all of the remarkable changes that convert a tadpole into a frog. Many features of TH biology are identical in all vertebrates. However, the ease with which the model amphibian organism, X. laevis can be raised in the laboratory, the ability to manipulate TH levels, and the abundance of the material all make X. laevis the best model organism to study the action of TH. The mere addition of TH to the rearing water induces all of the events of metamorphosis. TH controls cell death, cell proliferation, and the remodeling of organs. Modem genetic methods are being applied to X. laevis with great success beginning with the new sperm mediated transgenesis technique of Kroll and Amaya. By expressing genes or mutant genes that interfere with metamorphosis in specific cell types the TH-controlled developmental program of a single cell type can be inhibited or activated selectively. The expression of detrimental gene products can be activated in cells at precise times in development utilizing controllable promoters. This wonderful old biological problem that previously could only be described by scientists is now yielding to modem molecular methods.   
      

",AMPHIBIAN METAMORPHOSIS: A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
41,6286216,,2001,FRED HUTCHINSON CANCER RESEARCH CENTER,SEATTLE,WA,,2R01GM017709-31,GM017709,UNITED STATES,R01,515837,False,Irene A. Eckstrand,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2005-12-31T05:00:00Z,,"It has been widely appreciated that biological systems resist environmental, stochastic, and genetic perturbations. This phenomenon has been termed homeostasis, buffering, robustness and canalization. It is becoming possible to investigate these concepts at a molecular level. Recent results indicate that molecular circuits are designed to minimize the phenotypic consequences of perturbation, a process we will term ""buffering"". We propose to develop paradigms and methods for understanding how genetic variation is buffered using the DNA replication and dNTP synthesis circuits of the yeast, Saccharomyces cerevisiae as test cases. Understanding such buffering mechanisms is important to three broad areas of biology: (1) how genetic variation, the material of evolution, is accumulated in a species; (2) which genes influence the phenotypic expression of genetic variability, for example in the highly variable presentation of human disease in different individuals; and (3) the design principles of biological systems. Our specific aims are the following: 1. Design and employ methods to control the quantity of specific essential proteins in the DNA replication machinery and dNTP biosynthesis pathway. 2. Comprehensively identify the nonessential proteins that influence the capacity of the cell to withstand reduced expression of key essential proteins. 3. Compare the buffering capacity contributed by specific proteins quantitatively and assign them to different epistasis groups. 4. Explore differences among natural isolates of S. cerevisiae in their buffering mechanisms. ",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,LELAND H HARTWELL,6249948
42,6832169,,2005,FRED HUTCHINSON CANCER RESEARCH CENTER,SEATTLE,WA,,5R01GM017709-34,GM017709,UNITED STATES,R01,607166,False,Irene A. Eckstrand,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2007-12-31T05:00:00Z,,"It has been widely appreciated that biological systems resist environmental, stochastic, and genetic perturbations. This phenomenon has been termed homeostasis, buffering, robustness and canalization. It is becoming possible to investigate these concepts at a molecular level. Recent results indicate that molecular circuits are designed to minimize the phenotypic consequences of perturbation, a process we will term ""buffering"". We propose to develop paradigms and methods for understanding how genetic variation is buffered using the DNA replication and dNTP synthesis circuits of the yeast, Saccharomyces cerevisiae as test cases. Understanding such buffering mechanisms is important to three broad areas of biology: (1) how genetic variation, the material of evolution, is accumulated in a species; (2) which genes influence the phenotypic expression of genetic variability, for example in the highly variable presentation of human disease in different individuals; and (3) the design principles of biological systems. Our specific aims are the following: 1. Design and employ methods to control the quantity of specific essential proteins in the DNA replication machinery and dNTP biosynthesis pathway. 2. Comprehensively identify the nonessential proteins that influence the capacity of the cell to withstand reduced expression of key essential proteins. 3. Compare the buffering capacity contributed by specific proteins quantitatively and assign them to different epistasis groups. 4. Explore differences among natural isolates of S. cerevisiae in their buffering mechanisms. ",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,LELAND H HARTWELL,6249948
43,6191384,,2000,EMORY UNIVERSITY,ATLANTA,GA,PHARMACOLOGY,2K05DA000008-26,DA000008,UNITED STATES,K05,119264,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,2005-08-31T04:00:00Z,PA95051,"                                                                           
 DESCRIPTION: (Applicant's Abstract)            
 Continued career development will come from a combination of new research projects 
and new questions from older projects, leading to new methods and to new 
as well as continuing collaborations. This will be facilitated by the thriving                
 neuroscience community at Emory University, which includes many principal          
 investigators conducting research on issues related to drug abuse, and by the      
 recent expansion of faculty and breadth of research within the Dept. of            
 Pharmacology. The proposed research focuses on the behavioral pharmacology of      
 opioids and, to a smaller extent, cocaine, and reflects current grant support      
 from NIDA. Specific aims include testing hypotheses about acute opioid             
 dependence in rats and squirrel monkeys and the functional state of endogenous     
 opioid systems in adult rats that had undergone daily maternal separation          
 during the early postnatal period. Trainees at various academic levels -           
 undergraduate, pre- and postdoctoral - will participate in this research           
 program each year. An important goal will be to provide them with the              
 intellectual skills needed for a career of research on the behavioral              
 pharmacology of drugs of abuse. In addition, the Candidate will continue to        
 engage in nonresearch activities that contribute to overall career development,    
 such as teaching neurobehavioral pharmacology, membership on journal editorial     
 boards and government advisory committees, and holding elected office in           
 scientific organizations.                                                          
                                                                                    
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS,,STEPHEN G HOLTZMAN,1868593
44,6469946,,2002,IOWA STATE UNIVERSITY,AMES,IA,BIOCHEMISTRY,2R01NS010546-36,NS010546,UNITED STATES,R01,341852,False,Tom P. Jacobs,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,2007-04-30T04:00:00Z,,"
 DESCRIPTION (provided by applicant): The proposed research focuses on enzymes      
 that play central roles in the regulation of glycolysis and gluconeogenesis.       
 Metabolite flux through the glycolytic and gluconeogenic pathways in liver         
 determines the level of serum glucose. Hence, a thorough understanding of          
 regulatory phenomena associated with glycolysis and gluconeogenesis should         
 facilitate the development of new therapies in the treatment of diabetes. The      
 goal here is a complete description of the dynamics of ligand interactions and     
 the molecular mechanisms of catalytic/regulatory actions associated with human     
 hexokinase I and porcine fructose-i 6-bisphosphatase. Hexokinase I is broadly      
 distributed amongst tissues, and is the predominant isoform in the brain and       
 the red blood cell. The isoform of fructose-1,6-bisphosphatase under               
 investigation here predominates in liver. An engineered form of hexokinase I       
 will permit the determination by NMR spectroscopy of the equilibrium constant      
 governing its central kinetic complex. Specific mutants at ligand binding sites    
 should reveal key factors governing interactions between hexokinase I and the      
 mitochondrion. A proposed model for the allosteric regulation of catalysis in      
 hexokinase I will be tested by directed mutation. Predicted outcomes of            
 specific mutations will be verified by steady-state kinetics and structure         
 determinations by X-ray diffraction. Novel constructs of fructose-I                
 ,6-bisphosphatase, which combine subunits of different functional properties       
 into a single tetramer, should reveal the basis of cooperative phenomena in        
 ligand binding and kinetics. Stopped-flow fluorescence of an engineered            
 fructose-1 ,6-bisphosphatase should determine whether the enzyme under             
 conditions of kinetics assays exists in an oligomeric state other than that of     
 a tetramer. Molecular models for allosteric inhibition, ligand binding             
 synergism, and catalysis proposed for fructose-1 ,6-bisphosphatase will be         
 tested by directed mutations and follow-up investigations in fluorescence          
 spectroscopy, steady state kinetics, NMR spectroscopy and structure                
 determinations from single crystals. Finally, the significance and                 
 physiological relevance of a newly discovered allosteric effector site on          
 fructose-1,6-bisphosphatase will be investigated by techniques of steady-state     
 kinetics, fluorescence spectroscopy, NMR spectroscopy, directed mutation and       
 X-ray crystallography.                                                             
                                                                                    
",Regulatory Enzymes of Glycolysis and Gluconeogenesis,,HERBERT Jerome FROMM,1894874
45,6378230,,2001,EMORY UNIVERSITY,ATLANTA,GA,PHARMACOLOGY,5K05DA000008-27,DA000008,UNITED STATES,K05,119264,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,2005-08-31T04:00:00Z,PA95051,"                                                                           
 DESCRIPTION: (Applicant's Abstract)            
 Continued career development will come from a combination of new research projects 
and new questions from older projects, leading to new methods and to new 
as well as continuing collaborations. This will be facilitated by the thriving                
 neuroscience community at Emory University, which includes many principal          
 investigators conducting research on issues related to drug abuse, and by the      
 recent expansion of faculty and breadth of research within the Dept. of            
 Pharmacology. The proposed research focuses on the behavioral pharmacology of      
 opioids and, to a smaller extent, cocaine, and reflects current grant support      
 from NIDA. Specific aims include testing hypotheses about acute opioid             
 dependence in rats and squirrel monkeys and the functional state of endogenous     
 opioid systems in adult rats that had undergone daily maternal separation          
 during the early postnatal period. Trainees at various academic levels -           
 undergraduate, pre- and postdoctoral - will participate in this research           
 program each year. An important goal will be to provide them with the              
 intellectual skills needed for a career of research on the behavioral              
 pharmacology of drugs of abuse. In addition, the Candidate will continue to        
 engage in nonresearch activities that contribute to overall career development,    
 such as teaching neurobehavioral pharmacology, membership on journal editorial     
 boards and government advisory committees, and holding elected office in           
 scientific organizations.                                                          
                                                                                    
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS,,STEPHEN G HOLTZMAN,1868593
46,6385294,,2001,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,5R01GM022395-26,GM022395,UNITED STATES,R01,359660,False,Judith H. Greenberg,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-03-31T05:00:00Z,,"Amphibian metamorphosis involves the growth and differentiation, cell death and resorption, or remodeling of most tadpole tissue to become a frog. These changes are controlled by thyroid hormone (TH). Metamorphosis is a remarkably tractable developmental system since the diverse changes can be induced precociously with exogenous TH or inhibited pharmacologically with well known ""goitrogens"" added to the rearing water. Many features of TH physiology are the same in all vertebrates including the negative feedback loop between the thyroid gland the pituitary, the remarkable similarity in the TH receptors (TR), their RCR partners, and the DNA elements (TRE) to which these receptors bind. We have developed a three phase strategy to study individual programs of metamorphosis. First, we identified genes that are up- and down-regulated by TH in the tail, limb, intestine, and a cultured cell by means of a subtractive hybridization method that has the added power of estimating the number of genes in each program. We have concentrated our attention on the simplest program, tail resorption, in which we isolated about half of the TH-induced up- and down-regulated genes (17 and 4, respectively) clues about their possible roles in the resorption program. This grant application deals with the third phase which is underway, namely assaying genes for functional role in metamorphosis. The recent discovery of a transgenesis method for Xenopus laevis has provided us with such an assay. The function of the TH response gene in metamorphoses can be assessed as well as the various receptors, co-activators, and o-repressors that are presumed to play a role in the ability of TH to alter gene expression. Of special interest is an examination of the role of unliganded thyroid receptor in suppressing metamorphic changes. The participation of various hormones other than TH that have been implicated in amphibian metamorphosis is being assessed. The molecular explanation for many well documented biological features of metamorphosis such as the onset of competence to respond to TH, the different chronology of tissue response to the hormone (heterochrony) can be studied from a new perspective. We have already observed instructive phenotypes by over-expressing genes that inhibit metamorphosis. Strategies are described that can take advantage of these phenotypes and elucidate developmental pathways. ",AMPHIBIAN METAMORPHOSIS--A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
47,2770819,,1999,FRED HUTCHINSON CANCER RESEARCH CENTER,SEATTLE,WA,,5R37GM017709-29,GM017709,UNITED STATES,R37,516407,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2001-02-28T05:00:00Z,,"The events of the mitotic cell cycle are organized into dependent pathways      
in somatic cells and microorganisms: late events do not occur unless early      
events are completed.  The RAD9 checkpoint, consisting of five gene             
products, assures the dependence of mitosis upon the completion of DNA          
replication.  The RAD9 checkpoint increases the fidelity of the unperturbed     
mitotic cell cycle and maintains viability in the presence of intrinsic or      
extrinsic perturbations to DNA.  We assume that the RAD9 pathway transduces     
a signal from incompletely replicated or damaged DNA to inhibit a component     
of the mitotic spindle, the target.  In this project period we seek to:  1)     
Identify new checkpoints that we believe to be responsible for enforcing        
other dependent relationships in the mitotic cycle and for ensuring the         
high fidelity of mitotic chromosome transmission using the logic and            
methods developed in our study of the RAD9 pathway.  2) Order that RAD9         
(and newly discovered checkpoint pathways) using dominant mutations and         
epistasis tests. 3) Elucidate the nature of the target of the RAD9              
pathways) using dominant mutations and epistasis tests.  3) Elucidate the       
nature of the target of the RAD9 pathway (and other pathways) by isolating      
suppressors of the dominant mutations.  4) Identify a signal of the RAD9        
pathway by locating the substrate of CDC13, a gene product that acts at a       
specific site near the end of the chromosome.  5) Elucidate the pathways of     
sister chromatid exchange which occur during cell cycle arrest at the RAD9      
checkpoint.  This work should increase our understanding of functions that      
insure the fidelity of the mitotic cell cycle and contribute to our insight     
into the origins of the cancer cell, a cell in which the loss of mitotic        
fidelity is likely to be causal in the disease.                                 
",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,LELAND H HARTWELL,6249948
48,2749738,,1999,YALE UNIVERSITY,NEW HAVEN,CT,PHYSIOLOGY,2R37GM014642-32,GM014642,UNITED STATES,R37,481699,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-01-31T05:00:00Z,,"In the bi-flagellate alga Chlamydomonas, flagellar detachment signals           
the immediate, coordinate upregulation of over 200 genes encoding               
flagellar proteins, and, within minutes, the synthesis of these proteins        
and their assembly into new flagella.  This project is directed toward          
determining (a) where in the cytoplasm the mRNAs encoding these                 
flagellar proteins are located and where these proteins are synthesized;        
(b) to what extent these polypeptides are pre-assembled in the cytoplasm        
prior to entering the nascent flagella; (c) how these proteins are              
targeted to the flagella; (d) the role of the basal body/centriole in           
this targeting process; and (e) how, once in the flagella, the                  
precursors are transported to the assembly site at the flagellar tips.          
Using a variety of assembly mutants, these studies examine the                  
synthesis, assembly and transport of flagellar radial spokes, which are         
complexes composed of 17 polypeptides that pre-assemble in the                  
cytoplasm, yet function solely in the flagella.  Studies on transport           
focus on intraflagellar transport (IFT), a motility characterized by the        
rapid anterograde and retrograde movement of particles between the              
flagellar membrane and axoneme.  IFT particles are composed of ca. 15           
polypeptides, the genes for which are being cloned.  Mutations in C.            
elegans homologues of 3 of these polypeptides have been identified that         
result in defects in assembly of cilia found on sensory dendrites.              
Likewise, mutations in the microtubule motors that power anterograde and        
retrograde IFT in Chlamydomonas and their homologues in C. elegans              
result in the inability to assemble functional flagella or sensory              
cilia.  IFT is, therefore, one of the only microtubule-based motilities         
in which mutants are available in both the anterograde and retrograde           
transport of defined, isolable particles.  Particles, ultrastructurally         
similar to IFT particles, are found in the connecting cilium of                 
vertebrate retinal rod inner-outer segments, and kinesins, homologous           
to those associated with IFT, have been localized to this region. These         
observations suggest that IFT is universally required for assembly and          
maintenance of both motile and non-motile sensory cilia and, therefore,         
may be involved in male fertility, the assembly and maintenance of              
respiratory and oviduct cilia, and diseases of the retinal rod and cone         
outer segments.                                                                 
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
49,6080318,,2000,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,2T32HD007048-26,HD007048,UNITED STATES,T32,162243,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2005-04-30T04:00:00Z,,,TRAINING PROGRAM IN REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
0,2684679,,1998,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,5R01GM022395-23,GM022395,UNITED STATES,R01,430174,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-03-31T05:00:00Z,,"Amphibian metamorphosis is a complex series of changes in gene expression       
that affect every tissue and organ of the tadpole.  The process is              
controlled entirely by thyroid hormone (TH).  The goal of this project is       
to understand at a molecular level how one hormone can initiate so many         
different developmental programs and to elucidate the molecular details of      
a few of these programs.  The experimental strategy has three phases:           
first, the isolation of up and down regulated gene in several programs,         
second, the identification of regulated genes by sequencing and comparison      
with the public data base, and third, the determination of the role of          
these genes in the developmental program.  During the past 5 years we have      
completed the first two phases, and in this proposal we outline functional      
assays for the many genes that we have identified.  In the course of these      
experiments it has become apparent that amphibian metamorphosis is a            
superb model system for the study of TH action at the molecular level.          
These studies will provide information relevant to the various questions        
addressed by researchers who have used exclusively mammals and chickens as      
their experimental organisms.  The hormone receptors are the same, and the      
general pattern of their expression is similar.  The well known negative        
feedback loop between the thyroid and pituitary glands in mammals actually      
develops during metamorphosis.  The amphibian system is far easier to           
manipulate than chickens and mammals as will become evident from the body       
of this application.  Because of the accessibility of the system and our        
development of a powerful subtractive hybridization method (the ""gene           
expression screen""), large numbers of TH regulated genes have been              
identified in tadpoles far in excess of all the TH regulated genes              
combined that have been found in other organisms.  This prompts a               
reexamination of the thyroid response elements (TRE) and some classic           
questions about the molecular basis of TH action.  In addition, TH induced      
metamorphosis provides a novel way to study vertebrate organogenesis since      
the characteristic organ changes can be induced at will by the                  
experimenter simply by adding exogenous hormone to a competent tadpole.         
In Th-induced metamorphosis the expression of a predetermined program is        
studied.  However, we are now analyzing two related complex developmental       
systems designed to find genes that set up the programs.  These two             
systems are tail regeneration and the homeotic transformation from tail to      
limb induced by retinoic acid.  These systems are examples of important         
biological events controlled by changes in gene expression that are not         
subject to genetic analysis but can be studied by this three phase              
approach.  The affect of any hormone on its target tissue, the action of        
drugs that work by affecting gene expression, and the comparison of genes       
expressed in a variety of diseased versus normal tissues are candidates         
for this kind of analysis.                                                      
",AMPHIBIAN METAMORPHOSIS--A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
1,2654900,,1998,YALE UNIVERSITY,NEW HAVEN,CT,BIOLOGY,5R01GM014642-31,GM014642,UNITED STATES,R01,450013,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1999-01-31T05:00:00Z,,"In the biflagellate alga Chlamydomonas, flagellar detachment signals the        
immediate and coordinate upregulation of over 150 genes encoding flagellar      
proteins.  Synthesis of flagellar proteins rapidly ensues and, within           
minutes, new flagellar assembly is initiated.  To understand the process of     
organelle assembly we will study the synthesis and assembly of the              
flagellar radical spokes.  These structures, found only in the flagella,        
are required for flagellar motility; they are attached to the A-tubules of      
the outer doublet microtubules and are composed of 17 radial spoke              
polypeptides (RSPs) assembled into separable head and stalk domains.  We        
have cloned and sequenced the genes for several of these polypeptides,          
successfully using them to rescue mutants defective in spoke assembly.          
                                                                                
Chlamydomonas is a polarized cell with the flagella at one end.  With RSP       
antibodies and RSP cDNAs, we will determine by immunoelectron microscopy        
and in situ hybridization the site of RSP synthesis in the cytoplasm and        
subsequent route to the flagella.  We will also determine if the 17 RSPs        
form cytoplasmic pre-assembly aggregates prior to their transport to the        
flagellum.  To examine the assembly of spoke proteins onto the axoneme,         
RSPs obtained from cytoplasmic and flagellar extracts will be assembled         
onto axonemes isolated from mutants lacking entire spokes or spoke heads.       
We will continue to characterize the axonemal binding domain of RSP3 in         
vivo by testing the ability of mutagenized RSP3 to enter the flagellum,         
bind the axoneme, and target fusion proteins to the flagellar compartment.      
To determine how the RSPs and other flagellar proteins are transported to       
their assembly site at the flagellar tip, we will identify the molecular        
motors responsible for a newly-described motility beneath the flagellar         
membrane, IFT (Intraflagellar Transport).  In addition, we will use             
biochemical and genetic procedures, including our probes for RSPs and other     
flagellar proteins, to determine the nature of the cargo being carried by       
these motors.                                                                   
                                                                                
While investigating motors that may power IFT, we have determined that a        
kinesin-like protein (Klpl), the cDNA of which we have cloned and               
sequenced, is localized to only one of the two central pair microtubules of     
the flagellar axoneme.  We will clone and sequence the other kinesins we        
have identified in Chlamydomonas flagella and localize these proteins with      
specific antibody probes.  Since the central-pair microtubules are thought      
to rotate during flagellar beating, we will examine Klpl motility in vitro      
assays, testing for directionality and the ability to rotate microtubules.      
Proteins that interact with Klpl will be identified by non-denaturing           
immunoprecipitation with the Klpl antibody.  In addition, Klpl cDNAs will       
be mutagenized in vitro, and expressed in Chlamydomonas, to determine the       
functional role of this kinesin in vivo.                                        
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
2,2770013,,1998,EMORY UNIVERSITY,ATLANTA,GA,PHARMACOLOGY,5K05DA000008-24,DA000008,UNITED STATES,K05,98739,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,PA91102,"This is a renewal application for a NIDA Research Scientist Award. A            
program of research is proposed for studying behavioral effects of two          
types of drugs of significant clinical, social, and theoretical                 
importance: 1) opioids, some of which have long represented a serious           
abuse problem; 2) caffeine, the most widely consumed behaviorally-active        
drug in the world, which has features that make it a convenient model           
""drug of abuse"". The proposed experiments will be supported by two              
research grants from NIDA.                                                      
                                                                                
The basic research strategy is to use behavioral methodologies as               
bioassays of drug interactions with their neuronal substrates in order to       
identify and characterize components of drug action that might be relevant      
to potential for abuse and to related phenomena, such as tolerance and          
physical dependence. Representative compounds will be studied over a range      
of doses in several complementary behavioral procedures, such as drug           
discrimination, locomotor activity, autotitration of reinforcement              
threshold for electrical stimulation of the brain, and drug-induced             
turning. Established collaborations with faculty colleagues will bring          
additional methodologies to bear on the research questions of interest.         
Most experiments will be performed on rats, some on squirrel monkeys.           
This approach will help in the interpretation of experimental findings by       
indicating their generality with respect to pharmacological, behavioral,        
and species variables.                                                          
                                                                                
The proposed experiments will address several hypotheses. Among them are:       
1)Brain opioid systems can, under some conditions, modulate brain dopamine      
systems and behavioral effects of drugs that are mediated by dopamine. 2)       
Single-dose opioid agonist-induced sensitization to effects of antagonists      
is a model of acute physical dependence. 3) Discriminative effects of low       
and high doses of caffeine model, respectively, positive and negative mood      
states induced by caffeine in humans. 4) Brain dopamine systems mediate         
some behavioral effects of caffeine and tolerance to those effects,             
sometimes as a result of adenosine-receptor blockade.                           
                                                                                
Several pre- and postdoctral trainees will participate in this research         
program each year. An important goal will be to provide them with               
technical and, most important, intellectual skills necessary for careers        
in research on the behavioral pharmacology of drugs of abuse.                   
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS AND CAFFEINE,,STEPHEN G HOLTZMAN,1868593
3,2609006,,1998,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32HD007043-24,HD007043,UNITED STATES,T32,137949,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,,"REPRODUCTIVE BIOLOGY, BIOCHEMISTRY AND ENDOCRINOLOGY",,FRANK  CHYTIL,1863160
4,2391294,,1997,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,BIOCHEMISTRY,5R01DK014575-28,DK014575,UNITED STATES,R01,300752,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,2001-03-31T05:00:00Z,,"Our goal is to understand the molecular basis of two control mechanisms         
that contribute to the onset of obesity and its complications, notably          
NIDDM. These mechanisms include: l.  control of expression of the obese         
(leptin) gene in the adipocyte, and 2. transcriptional control of the           
stearoylCoA desaturase genes (SCD1 and SCD2) in the adipocyte and               
hepatocyte.                                                                     
                                                                                
Leptin, a secretory protein expressed only by adipose tissue, regulates         
appetite (via receptors in the hypothalamus) and energy metabolism.  The        
3T3-L1 adipocyte system, pioneered in this laboratory, will be used as a        
cell culture model that mimics adipocytes in vivo. Our studies show that        
leptin is expressed/secreted by 3T3-L1 adipocytes and its expression is         
dramatically regulated in vivo by changes in physiological state. We have       
cloned/sequenced the regulatory 5' flanking region of the gene for use in       
the studies proposed. We plan to:                                               
                                                                                
* characterize the factors that regulate expression of the leptin gene and      
its mRNA, and                                                                   
                                                                                
* identify critical cis-regulatory elements within the leptin gene              
promoter that control its expression. We will identify and characterize         
the cognate trans-acting nuclear factors that interact with the cis-            
elements and determine how these interactions regulate transcription.           
                                                                                
The SCD genes catalyze delta9 cis-desaturation of fatty acids, and thereby      
determine the degree of unsaturation and functional properties of membrane      
phospholipids and storage/secretory triacylglycerols). Expression of the        
SCD1 and SCD2 genes is induced during adipocyte differentiation and is          
feed-back inhibited by polyunsaturated fatty acids (notably arachidonate)       
in certain cell types. We have cloned, sequenced and characterized the          
mouse SCD1 and SCD2 genes.  A preadipocyte -repressive element (or PRE)         
and its binding protein (PRE-BP1) was discovered that maintains the SCD2        
gene in the repressed state prior to differentiation. A similar, but            
distinct, element and binding protein have been identified for the SCD1         
gene. We plan to:                                                               
                                                                                
* sequence, express and characterize PRE-BP1 (SCD2) and the PRE-BP for the      
SCD1 gene.                                                                      
                                                                                
* investigate their site-specific binding interactions and                      
repression/derepression mechanisms and role in negative-feedback control        
by arachidonate, and                                                            
                                                                                
* determine the physiological basis (preadipocyte differentiation,              
negative feedback, etc.) for derepression and repression of the SCD1 and        
SCD2 genes.                                                                     
",REGULATION OF LIPOGENESIS,,M DANIEL LANE,1878591
5,2391834,,1997,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,5R01GM022395-22,GM022395,UNITED STATES,R01,413956,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-03-31T05:00:00Z,,"Amphibian metamorphosis is a complex series of changes in gene expression       
that affect every tissue and organ of the tadpole.  The process is              
controlled entirely by thyroid hormone (TH).  The goal of this project is       
to understand at a molecular level how one hormone can initiate so many         
different developmental programs and to elucidate the molecular details of      
a few of these programs.  The experimental strategy has three phases:           
first, the isolation of up and down regulated gene in several programs,         
second, the identification of regulated genes by sequencing and comparison      
with the public data base, and third, the determination of the role of          
these genes in the developmental program.  During the past 5 years we have      
completed the first two phases, and in this proposal we outline functional      
assays for the many genes that we have identified.  In the course of these      
experiments it has become apparent that amphibian metamorphosis is a            
superb model system for the study of TH action at the molecular level.          
These studies will provide information relevant to the various questions        
addressed by researchers who have used exclusively mammals and chickens as      
their experimental organisms.  The hormone receptors are the same, and the      
general pattern of their expression is similar.  The well known negative        
feedback loop between the thyroid and pituitary glands in mammals actually      
develops during metamorphosis.  The amphibian system is far easier to           
manipulate than chickens and mammals as will become evident from the body       
of this application.  Because of the accessibility of the system and our        
development of a powerful subtractive hybridization method (the ""gene           
expression screen""), large numbers of TH regulated genes have been              
identified in tadpoles far in excess of all the TH regulated genes              
combined that have been found in other organisms.  This prompts a               
reexamination of the thyroid response elements (TRE) and some classic           
questions about the molecular basis of TH action.  In addition, TH induced      
metamorphosis provides a novel way to study vertebrate organogenesis since      
the characteristic organ changes can be induced at will by the                  
experimenter simply by adding exogenous hormone to a competent tadpole.         
In Th-induced metamorphosis the expression of a predetermined program is        
studied.  However, we are now analyzing two related complex developmental       
systems designed to find genes that set up the programs.  These two             
systems are tail regeneration and the homeotic transformation from tail to      
limb induced by retinoic acid.  These systems are examples of important         
biological events controlled by changes in gene expression that are not         
subject to genetic analysis but can be studied by this three phase              
approach.  The affect of any hormone on its target tissue, the action of        
drugs that work by affecting gene expression, and the comparison of genes       
expressed in a variety of diseased versus normal tissues are candidates         
for this kind of analysis.                                                      
",AMPHIBIAN METAMORPHOSIS--A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
6,2414067,,1997,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,NONE,5P30CA014051-26,CA014051,UNITED STATES,P30,1272880,False,,National Cancer Institute,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,"The Center for Cancer Research (CCR) at MIT was established twenty years        
ago to conduct basic research in areas relevant to cancer. The CCR is an        
autonomous administrative unit with its own assigned space (53,343 sq. ft)      
and faculty slots under the control of the CCR Director, who reports to         
the Dean of Science. The CCR currently has 13 Staff Investigators and 6         
Affiliate Investigators. The CCR has a total staff of 170-180 researchers       
and the Affiliate labs represent more than 100 additional people. The CCR       
has its own administrative office responsible for management of the CCSG        
and research grants of the CCR, and of shared research facilities which         
include Biopolymers, Cell Sorter, Glassware, Media Preparation,                 
Quantitation & Computing, Research Microscopy & Photography, and                
Transgenic Animal & Histology facilities. The established research              
programs in the CCR are Molecular Genetics, Cell & Developmental Biology,       
and Immunology and the strengths of the CCR research lie in basic cell and      
molecular biology and, in recent years, the application of transgenic           
mouse methods the generate animal models of cancer and other diseases.          
Areas of emphasis include the discovery and analyses of oncogenes and           
tumor suppressor genes and other disease genes, regulation of gene              
transcription and RNA splicing, cell adhesion in normal and pathological        
situations, structure and function of the cytoskeleton, processing of cell      
surface proteins, antigen processing and presentation, and T & B cell           
development. In addition to its strengths in basic research, the CCR            
performs an important role in training future researchers in biomedical         
science, including undergraduate and graduate students, postdoctoral and        
clinical fellows. Extensive collaborations exist with medical schools,          
hospitals and the biotechnology/pharmaceutical industries. Thus, the            
research in the CCR has a major impact both on the fundamental                  
understanding of cancer and on translation to and from the clinical arena.      
",CANCER CENTER SUPPORT (CORE) GRANT,,RICHARD O HYNES,1894213
7,6078645,,1999,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-25,HD007048,UNITED STATES,T32,206831,False,DONNA L VOGEL,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,,TRAINING PROGRAM IN REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
8,2262237,,1996,IOWA STATE UNIVERSITY,AMES,IA,BIOCHEMISTRY,5R01NS010546-30,NS010546,UNITED STATES,R01,185548,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1997-08-31T04:00:00Z,,,REGULATORY ENZYMES OF GLYCOLYSIS AND GLUCONEOGENESIS,,HERBERT Jerome FROMM,1894874
9,2260718,,1996,CORNELL UNIVERSITY ITHACA,ITHACA,NY,BIOCHEMISTRY,5R01NS008527-25,NS008527,UNITED STATES,R01,231149,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1997-03-31T05:00:00Z,,,CHEMICAL REACTIONS IN TRANSMISSION OF NERVE IMPULSES,,GEORGE Paul HESS,1879144
10,2195050,,1996,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32HD007043-22,HD007043,UNITED STATES,T32,172169,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2000-06-30T04:00:00Z,,,"REPRODUCTIVE BIOLOGY, BIOCHEMISTRY AND ENDOCRINOLOGY",,FRANK  CHYTIL,1863160
11,2173926,,1996,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,2R01GM022395-21A1,GM022395,UNITED STATES,R01,398964,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-03-31T05:00:00Z,,,AMPHIBIAN METAMORPHOSIS--A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
12,2128916,,1996,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,INTERNAL MEDICINE/MEDICINE,5R37DE003658-32,DE003658,UNITED STATES,R37,299816,False,,National Institute of Dental and Craniofacial Research,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,,GENETIC POLYMORPHISMS OF SALIVA,,EDWIN A AZEN,1877361
13,2136667,,1996,HARVARD UNIVERSITY (MEDICAL SCHOOL),BOSTON,MA,OTHER BASIC SCIENCES,2R01DK011011-29,DK011011,UNITED STATES,R01,259704,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1999-03-31T05:00:00Z,,,REGULATION OF THE THYROTROPIN-RELEASING HORMONE RECEPTOR,,ARMEN H TASHJIAN,1888218
14,2684609,,1998,HARVARD UNIVERSITY,CAMBRIDGE,MA,CHEMISTRY,5R01GM006920-38,GM006920,UNITED STATES,R01,287164,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1999-12-31T05:00:00Z,,"Our objectives are to establish the basis for activity and allosteric           
regulation of enzymes, using three-dimensional structures as determined by      
X-ray diffraction methods.  Structures are established of complexes of the      
enzymes with substrate analogues, allosteric effectors, inhibitors, and         
other molecules and ions, including mutants and other modified forms of         
the enzymes.  The allosteric enzymes under study are fructose-1, 6-             
bisphosphatase (FBPase), aspartate transcarbamylase (ATCase), and               
chorismate mutase (CMase) from Saccharomyces cerevisiae.  We will also          
continue studies of the non-allosteric enzyme leucine aminopeptidase (LAP       
and pepA).  The LAP structure at 1.6 angstroms guides us in the two-metal       
mechanism of FBPase.                                                            
                                                                                
In the allosteric enzymes, structural studies are continued of binding of       
various ligands in order to elucidate the mechanisms and pathways for the       
transmission of conformational information from the allosteric sites to         
the active sites.  Although many such studies have been completed for           
FBPase and ATCase, the detailed pathways for informational transfer are         
not yet established.  At this early stage both T and R structures are           
known for allosteric CMase.                                                     
                                                                                
The structural basis for design of an analogue of the allosteric inhibitor      
(AMP) of FBPase is being established in order to develop a drug for             
treatment of Type II diabetes.  A highly specific analogue (K(d)=0.1            
microM) of AMP (K(d)=1 microM) has been obtained as an inhibitor for            
FBPase, an enzyme which is elevated in Type II diabetes; the method             
consisted of repeated consecutive cycles of structures of FBPase bound to       
the inhibitor followed by model building of a newly designed inhibitor          
from the X-ray results, followed by chemical synthesis.  Active site            
inhibitors can be designed from structures for ATCase (control pyrimidine       
synthesis), CMase (to make herbicides, bacteriocides or fungicides), and        
leucine aminopeptidase (to control protein degradation and hormone              
processing).                                                                    
",STRUCTURE/FUNCTION OF BIOLOGICALLY ACTIVE MOLECULES,,WILLIAM N LIPSCOMB,1965589
15,2518843,,1997,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,5R37GM018386-28,GM018386,UNITED STATES,R37,570853,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"This research program deals with mechanisms of transcription and                
transcriptional regulation. One major project area focusses on the              
mechanism for coupling the expression of certain viral genes to DNA             
replication during the development of the bacterial virus T4, a process         
that is now known to involve transcriptional enhancer mechanisms. The           
principal research topics are: 1) the role of DNA connectivity in the           
enhancement (i.e. whether enhancing interactions occur in a                     
three-dimensional space or whether they require tracking along DNA); 2) the     
effects of assembling replication proteins into replisome on their ability      
to enhance transcription and the effects of ongoing replication on              
enhancement; 3) figuring out how transcriptional enhancement works at the       
molecular level by mapping protein-protein and protein-DNA interactions at      
the promoter and at the enhancer. These four broad topics will be pursued       
by various in vitro methods, including transcription kinetics, various          
footprinting techniques, photocrosslinking of protein to DNA, other             
crosslinking methods and other methods of analyzing the binding of proteins     
to DNA in assemblies of moderate complexity. A fourth topic involves            
certain in vivo correlates of the preceding analysis.                           
                                                                                
The second project area consists of several research topics involving           
transcription by RNA polymerase III. It is now clear that only one              
transcription factor of the yeast RNA polymerase III, TFIIIB, is essential      
for positioning the enzyme at the start site for transcription. One             
research topic analyzes this minimal transcription initiation system in         
kinetic and structural terms, using normal and mutant promoters. A second       
research topic involves the use of photochemical methods, including the use     
of a newly developed photocrosslinking reagent, to analyze the structure of     
transcription complexes and to map protein-protein as well as protein-DNA       
interactions along an entire transcription unit. A third research topic         
involves kinetic and structural analysis of RNA chain elongation and            
termination by RNA polymerase III.                                              
                                                                                
The connecting thread of these two lines of research is their common focus      
on a molecular understanding of transcription and its regulation and on         
processes such as promoter finding, promoter opening, modulations of            
promoter strength by protein-protein and protein-DNA interactions, RNA          
chain elongation and termination that are common to transcription in all        
organisms and all types of cells.                                               
",NUCLEIC ACIDS NUCLEOPROTEINS,,ERNEST PETER GEIDUSCHEK,1876894
16,2518103,,1997,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,INTERNAL MEDICINE/MEDICINE,5R37DE003658-33,DE003658,UNITED STATES,R37,311810,False,,National Institute of Dental and Craniofacial Research,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"1.  Salivary protein genetic polymorphisms.  The long term objective is to      
better understand the mutation mechanisms that produce such an abundant         
variety of polymorphic forms in the saliva.  The specific aim is to             
biochemically characterize mutant forms of proline-rich and histatin            
proteins by cloning and sequencing the genomic DNA of specific alleles at       
PRP and His loci.  It is possible that genetic variation of salivary            
proteins, by altering the oral microenvironment, may relate to different        
disease susceptibilities among individuals.                                     
                                                                                
2.  Cell culture of Macaque and human salivary gland epithelia.  The long       
term objective is to determine the intra and extracellular factors that         
regulate the expression of salivary-type genes coding for proline-rich          
proteins (PRPs), histatins, statherin and cystatins.  These studies would       
be greatly enhanced by the availability of transformed salivary gland           
epithelial cell lines.  The specific aim is to determine the conditions         
for primary cell culture of Macaque and human salivary gland epithelial         
cells and to transform them in order to establish permanent cell lines          
that express salivary-type genes.  Perhaps this may lead to a better            
understanding of salivary-type gene regulation, and the principles so-          
derived might be used to manipulate and favorably alter the oral                
microenvironment in ways conductive to oral health.                             
                                                                                
3.  Application of molecular techniques to the study of taste transduction      
in the mouse.  The long term objective is to better understand the              
molecular basis of taste transduction.  We have two specific aims:  a. To       
prove directly by transgenic mouse experiments the role of salivary and         
von Ebner's gland secreted PRPs in the perception of bitter taste.  Such a      
role is strongly supported by previous genetic evidence.  b. To establish       
a taste cell-specific cDNA library in the mouse as an important resource        
in identifying molecules that play a role in transducing taste.  These          
studies may increase understanding of the relationships between the             
chemical senses and the oral environment.                                       
",GENETIC POLYMORPHISMS OF SALIVA,,EDWIN A AZEN,1877361
17,3103262,,1993,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5P40RR000200-30,RR000200,UNITED STATES,P40,374469,False,,National Center for Research Resources,1975-09-01T04:00:00Z,1994-08-31T04:00:00Z,,"We seek renewal of the animal resource laboratory i the Unit for
Laboratory Animal Medicine at the University of Michigan.  The long term
objectives are to enhance the University of Michigan animal research
programs, foster the humane treatment of laboratory animals through
excellent professional care, and contribute new knowledge to comparative
medicine.  The specific aims are:  1) to operate a diagnostic laboratory
for protecting animal health, ensuring humane treatment of animals and
improving the quality of animals used in research; 2) to conduct
research on diseases that are identified by the diagnostic laboratory
and that ar deemed to merit further clinical or experimental study 3) to
conduct pilot research on the pathogenesis and immunobiology of rabbit
pasteurellosis; 4) to develop and characterize animal models of human
diseases and to problems of human biology such as diabetes mellitus,
wound repair, cryptosporidiosis and aging; 5) to develop an animal model
for gene therapy utilizing herpes simplex in a gene delivery system; and
6) to facilitate training in laboratory animal medicine and comparative
medicine through provision of case studies and teaching materials.  The
methods to be used are those of clinical medicine, clinical and anatomic
pathology, immunology, immunogenetics and other relevant disciplines.
",A UNIVERSITY RESOURCE IN LABORATORY ANIMAL MEDICINE,,DANIEL H RINGLER,1957422
18,3482730,,1993,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,,5R37DE003658-29,DE003658,UNITED STATES,R37,256392,False,,National Institute of Dental and Craniofacial Research,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"1.  Salivary protein genetic polymorphisms.  The long term objective is to
better understand the mutation mechanisms that produce such an abundant
variety of polymorphic forms in the saliva.  The specific aim is to
biochemically characterize mutant forms of proline-rich and histatin
proteins by cloning and sequencing the genomic DNA of specific alleles at
PRP and His loci.  It is possible that genetic variation of salivary
proteins, by altering the oral microenvironment, may relate to different
disease susceptibilities among individuals.

2.  Cell culture of Macaque and human salivary gland epithelia.  The long
term objective is to determine the intra and extracellular factors that
regulate the expression of salivary-type genes coding for proline-rich
proteins (PRPs), histatins, statherin and cystatins.  These studies would
be greatly enhanced by the availability of transformed salivary gland
epithelial cell lines.  The specific aim is to determine the conditions
for primary cell culture of Macaque and human salivary gland epithelial
cells and to transform them in order to establish permanent cell lines
that express salivary-type genes.  Perhaps this may lead to a better
understanding of salivary-type gene regulation, and the principles so-
derived might be used to manipulate and favorably alter the oral
microenvironment in ways conductive to oral health.

3.  Application of molecular techniques to the study of taste transduction
in the mouse.  The long term objective is to better understand the
molecular basis of taste transduction.  We have two specific aims:  a. To
prove directly by transgenic mouse experiments the role of salivary and
von Ebner's gland secreted PRPs in the perception of bitter taste.  Such a
role is strongly supported by previous genetic evidence.  b. To establish
a taste cell-specific cDNA library in the mouse as an important resource
in identifying molecules that play a role in transducing taste.  These
studies may increase understanding of the relationships between the
chemical senses and the oral environment.
",GENETIC POLYMORPHISMS OF SALIVA,,EDWIN A AZEN,1877361
19,2195047,,1993,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32HD007043-19,HD007043,UNITED STATES,T32,155621,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,1995-06-30T04:00:00Z,,,"REPRODUCTIVE BIOLOGY, BIOCHEMISTRY, AND ENDOCRINOLOGY",,FRANK  CHYTIL,1863160
20,2086201,,1995,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,NONE,2P30CA014051-24,CA014051,UNITED STATES,P30,1501615,False,,National Cancer Institute,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,"The Center for Cancer Research (CCR) at MIT was established twenty years
 ago to conduct basic research in areas relevant to cancer. The CCR is an
 autonomous administrative unit with its own assigned space (53,343 sq. ft)
 and faculty slots under the control of the CCR Director, who reports to
 the Dean of Science. The CCR currently has 13 Staff Investigators and 6
 Affiliate Investigators. The CCR has a total staff of 170-180 researchers
 and the Affiliate labs represent more than 100 additional people. The CCR
 has its own administrative office responsible for management of the CCSG
 and research grants of the CCR, and of shared research facilities which
 include Biopolymers, Cell Sorter, Glassware, Media Preparation,
 Quantitation & Computing, Research Microscopy & Photography, and
 Transgenic Animal & Histology facilities. The established research
 programs in the CCR are Molecular Genetics, Cell & Developmental Biology,
 and Immunology and the strengths of the CCR research lie in basic cell and
 molecular biology and, in recent years, the application of transgenic
 mouse methods the generate animal models of cancer and other diseases.
 Areas of emphasis include the discovery and analyses of oncogenes and
 tumor suppressor genes and other disease genes, regulation of gene
 transcription and RNA splicing, cell adhesion in normal and pathological
 situations, structure and function of the cytoskeleton, processing of cell
 surface proteins, antigen processing and presentation, and T & B cell
 development. In addition to its strengths in basic research, the CCR
 performs an important role in training future researchers in biomedical
 science, including undergraduate and graduate students, postdoctoral and
 clinical fellows. Extensive collaborations exist with medical schools,
 hospitals and the biotechnology/pharmaceutical industries. Thus, the
 research in the CCR has a major impact both on the fundamental
 understanding of cancer and on translation to and from the clinical arena.
",CANCER CENTER SUPPORT (CORE) GRANT,,RICHARD O HYNES,1894213
21,2128915,,1995,UNIVERSITY OF WISCONSIN MADISON,MADISON,WI,INTERNAL MEDICINE/MEDICINE,4R37DE003658-31,DE003658,UNITED STATES,R37,288286,False,,National Institute of Dental and Craniofacial Research,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"1.  Salivary protein genetic polymorphisms.  The long term objective is to
 better understand the mutation mechanisms that produce such an abundant
 variety of polymorphic forms in the saliva.  The specific aim is to
 biochemically characterize mutant forms of proline-rich and histatin
 proteins by cloning and sequencing the genomic DNA of specific alleles at
 PRP and His loci.  It is possible that genetic variation of salivary
 proteins, by altering the oral microenvironment, may relate to different
 disease susceptibilities among individuals.
 
 2.  Cell culture of Macaque and human salivary gland epithelia.  The long
 term objective is to determine the intra and extracellular factors that
 regulate the expression of salivary-type genes coding for proline-rich
 proteins (PRPs), histatins, statherin and cystatins.  These studies would
 be greatly enhanced by the availability of transformed salivary gland
 epithelial cell lines.  The specific aim is to determine the conditions
 for primary cell culture of Macaque and human salivary gland epithelial
 cells and to transform them in order to establish permanent cell lines
 that express salivary-type genes.  Perhaps this may lead to a better
 understanding of salivary-type gene regulation, and the principles so-
 derived might be used to manipulate and favorably alter the oral
 microenvironment in ways conductive to oral health.
 
 3.  Application of molecular techniques to the study of taste transduction
 in the mouse.  The long term objective is to better understand the
 molecular basis of taste transduction.  We have two specific aims:  a. To
 prove directly by transgenic mouse experiments the role of salivary and
 von Ebner's gland secreted PRPs in the perception of bitter taste.  Such a
 role is strongly supported by previous genetic evidence.  b. To establish
 a taste cell-specific cDNA library in the mouse as an important resource
 in identifying molecules that play a role in transducing taste.  These
 studies may increase understanding of the relationships between the
 chemical senses and the oral environment.
",GENETIC POLYMORPHISMS OF SALIVA,,EDWIN A AZEN,1877361
22,2173929,,1995,CALIFORNIA INSTITUTE OF TECHNOLOGY,PASADENA,CA,CHEMISTRY,4R37GM022432-21,GM022432,UNITED STATES,R37,521743,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"Two membrane proteins with important and well-defined physiological
 functions in cellular respiration (cytochrome c oxidase from beef heart and
 yeast mitochondria; HCO3-/Cl- anion exchange protein from human red blood
 cells) are under study to relate their biological functions to their
 chemical structures and three-dimensional structures in the membrane.
 
 (1) Work toward elucidation of the structure of the metal sites of
 cytochrome c oxidase, their spatial distribution and functional role in
 electron transfer, dioxygen reduction and energy conservation will be
 continued.  Particular emphasis will be devoted to the ligands of CuB, the
 nature of the ""pulsed"" enzyme, the electronic structures of the two
 dioxygen intermediates at the three-electron level of reduction, the
 sequence of intramolecular electron transfer, redox interactions among the
 metal sites and their role in the energy conservation process, and the site
 of redox-linked proton translocation in the protein.  A hypothesis of
 redox-linked proton-translocation based on the concept of electron-gating
 will be tested and the details extended or refined as necessary.  (2)
 Similarly, the structure of the anion transport sites of the Cl-/HCO3-
 anion exchange protein is being studied by 35Cl/37Cl nuclear magnetic
 resonance (NMR) spectroscopy and amino acid-specific modification
 experiments, followed by chemical analysis by HPLC.  The goals are to
 develop a molecular picture describing the anion translocation event, the
 structure of the transport site(s), their location(s) in the primary
 sequence of the protein and relative to the membrane, and the minimal
 structure containing the intact anion transport machinery.  (3) To
 investigate the interactions of these proteins with the lipids in the
 membranes in which they are embedded, purified cytochrome c oxidase as well
 as the HCO3-/Cl- exchange protein are being reconstituted into lipid
 membranes of well-defined chemical compositions.  The state of aggregation
 of the intramembraneous particles in the reconstituted membranes is being
 visualized by freeze-fracture electron microscopy, and the protein
 distributions thus derived are correlated with the motional state of the
 bilayer inferred from magnetic resonance experiments to provide insights on
 the nature of the lipid deformations induced by the membrane proteins in
 their immediate surroundings.  These studies on lipid-mediated
 protein-protein forces are designed to develop an understanding of the
 significance of protein-lipid interactions in biological function.
",MEMBRANE PROTEINS--STRUCTURE AND FUNCTION,,SUNNEY I. CHAN,2401834
23,2172021,,1994,ROCKEFELLER UNIVERSITY,NEW YORK,NY,ANATOMY/CELL BIOLOGY,5R01GM017132-25,GM017132,UNITED STATES,R01,402859,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"Centrioles are complex microtubule structures.  They are present at the
mitotic spindle poles of many eukaryotic cells.  In interphase cells they
define the centrosphere; an organizing center for microtubules.  In cells
bearing cilia or flagella they form the proximal region of the basal body,
a nucleating structure for microtubules of the flagellar axonemes.  It is
proposed to study the function and replication of centrioles/basal bodies
in the model system Chlamydomonas reinhardtii.  In this organism a number
of mutants affecting basal body function and assembly are clustered on an
unusual linkage group that has Mendelian segregation patterns but gives a
circular linkage map.  The physical counterpart of this linkage group is a
6-9 megabase linear DNA that has been localized to basal bodies.  In its
mitotic and meiotic cycle Chlamydomonas manifests the classical motifs to
centriolar morphogenesis:  replicative formation, de novo origin and
interconversion to basal bodies.  The proposed studies focus on the basal
body associated DNA.  It is proposed to study further the structure of this
DNA to understand the origin of the circular genetic map and to determine
its localization in the cell at times in the meiotic cycle when
centriole/basal bodies are absent.  A major effort will be made to clone
and characterize unique sequence segments of this DNA corresponding to a
limited region of the genetic map.  The proposed studies are strongly
supported by features of the model system.  Lineages derived from
interspecific crosses with C. smithii make restriction fragment length
polymorphism linkage mapping efficient.  The basal body associated DNA can
be isolated as a chromosome by pulsed field gel electrophoresis thus
providing an enriched source of DNA fragments.  The linkage group segment
to be analyzed has already been indexed by ten phenotypic markers and six
molecular markers.  Methods have been devised to synchronize events in the
meiotic and mitotic life cycles for isolation of RNAs.  The proposed
transcription analysis, testing of homology to DNAs from other cells, and
DNA sequence analysis are expected to reveal the function of this DNA and
indicate whether it is a feature of other centriole/basal body containing
cells.
",BIOCHEMICAL GENETICS OF MICROTUBULES,,DAVID J LUCK,1965380
24,2170819,,1994,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,HERSHEY,PA,BIOCHEMISTRY,5R01GM016329-27,GM016329,UNITED STATES,R01,329094,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"The objectives of this project are to study recombinational processes which
lead to rearrangement of the enteric bacterial chromosome.  Chromosomal
rearrangements are of importance because they allow types of genetic
variation that cannot be obtained by other routes.  Rearrangements may take
the form of duplications, deletions, transpositions or inversions.  Our
efforts will be focused on those structures within the chromosome which are
prone to participating in rearrangements, on the consequences to cell
fitness of these rearrangements and on the pressures which may exist for
conserving the gross gene organization of the chromosome.

Earlier studies of missense suppression in Escherichia coli demonstrated
that certain aspects of the genetics of missense suppressors had their
basis in chromosomal rearrangement.  In one instance, suppressor
instability was related to the fact that the suppressor gene was in a
tandem duplication, which allowed both the suppressor and its essential
wild type allele to coexist.  The duplications were produced by crossover
between different rRNA operons, seven of which occur in the enteric
bacterial chromosome.  These redundant rrn operons are ""hot spots"" for not
only duplications, but also deletions, inversions and transpositions.  In a
second instance, the strength of a missense suppressor was enhanced through
the amplification of the gene for glycyl-tRNA synthetase.  This
amplification involved unequal crossover between two members of a complex
family of imperfectly homologous genes called the rhs family.  This project
focuses on these two types of natural ""hot spots"" for rearrangement, the
rrn family and the rhs family.  Highest priority is to be devoted to the
rhs loci.  They are to be analyzed as to their structure, function, map
position, origins and the degree to which they participate in and are
altered by recombinational processes.  Another area of high priority is an
extension of our analysis of unequal recombination between the redundant
rrn operons.  The consequences of unequal crossover between rrn operons,
the factors which mitigate against the establishment or rrn mediated
rearrangements in evolution, and ""gene conversion"" events between rrn
operons with limited sequence differences will be studied.  A third area of
interest is the nature of chromosomal rearrangements that are prevalent in
E. coli by S. typhimunrium crosses.
",GENETICS AND BIOCHEMISTRY OF MISSENCE SUPPRESSION,,CHARLES W HILL,1876912
25,2169176,,1994,YALE UNIVERSITY,NEW HAVEN,CT,BIOLOGY,5R01GM014642-27,GM014642,UNITED STATES,R01,388304,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-01-31T05:00:00Z,,"Flagella regeneration in the bi-flagellate alga Chlamydomonas is being used
as a model system in which to define general principles underlying cell
organelle formation.  When the flagella are detached, transcription of
genes for flagellar proteins is rapidly induced followed by translation of
mRNAs for flagellar proteins and, within minutes, assembly of a new
flagellum begins.  We will investigate these processes studying,
specifically, the synthesis and assembly of the flagellar radial spoke
proteins.  The spokes are attached to the A-tubules of the flagellar outer
doublet microtubules, have a head and stalk which are composed of 17
polypeptides, and are required for motility.  There are paralyzed mutants
in several of these polypeptides and the genes for 5 have been cloned.
Transformation can be used to rescue the paralyzed mutants back to
motility.  In vitro mutagenesis and transformation will be used to
determine the radial spoke gene sequences responsible for (a) gene up-
regulation following flagellar detachment, (b) targeting of radial spoke
proteins to the flagellum, and (c) assembly of the proteins onto the outer
doublet microtubules.  Phosphorylation of radial spoke proteins is
necessary for assembly of functional radial spokes.  By use of mutants
lacking a flagellar protein kinase, as well as in vitro mutagenesis and
transformation, the role of radial spoke protein phosphorylation in either
the targeting of proteins to the flagellum or their assembly onto the
axoneme will be determined.  Extracts from wild-type and radial spoke
mutant cells will be used to assemble radial spokes onto spokeless axonemes
in vitro.  Assembly will be determined by electron microscopy, gold-labeled
antibody localization, and sedimentation of labeled spoke proteins with the
doublet microtubules.  These studies will help determine the order of
assembly of radial spoke proteins, in a manner similar to that used to
analyze T-4 phage morphogenesis.  To determine how the flagellar proteins
find their way to the end of the cell where flagellar assembly occurs, the
site of radial spoke protein synthesis in the cytoplasm will be
investigated on the ultrastructural level using gold-labeled antibodies and
in situ RNA hybridization.

Almost all of the flagellar alpha-tubulin is acetylated and the hypothesis
that acetylation plays a role in the attachment of microtubule-associated
proteins/structures to the microtubules will be tested by use of acetylated
and unacetylated microtubules in an in vitro assembly system with
microtubule-associated proteins/structures.  Assembly will be analyzed by
sedimentation of labeled associated proteins with the microtubules and by
electron microscopy.
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
26,2168629,,1994,STANFORD UNIVERSITY,STANFORD,CA,BIOCHEMISTRY,5R37GM013235-28,GM013235,UNITED STATES,R37,529172,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1997-06-30T04:00:00Z,,"The advent and widespread application of the recombinant DNA
methodology during the past twelve years has greatly extended
our understanding of the molecular basis of heredity.  More
significantly, the emergence of a new molecular paradigm -
reverse genetics, which relies on the ability to specifically modify
the structure of genes in vitro and to test their biological
properties, has revolutionized the experimental approaches in
molecular genetics.  The ability to construct minichromosomes
with novel arrangements of genetic elements also provides
vectors for the isolation of genes as well as substrates for the
analysis of specific genetic reactions.  Our proposal, which applies
this approach to explore the basic mechanisms of gene regulation
in the establishment of immune responsiveness and of genetic
recombination, aims

(1)  identify the factors and mechanisms that limit the
epression of antibody genes to only lymphoid cells;
(2)  isolate and characterize the human gene whose
dysfunction is responsible for galactosemia;
(3)  understand the mechanisms responsible for non-
homologous, homologous and non-reciprocal modes of
genetic recombination, especially those which permit the
rejoining of broken DNA;
(4)  develop genetic approaches to effect a replacement or
repair of chromosomal DNA sequences;
(5)  developing vectors which can deliver genes to only
specific types of cells.

It is anticipated that the information we develop will advance our
unerstanding of the molecular basis of disease and provide novel
approaches to their prevention, treatment and cure.
",MECHANISMS AND REGULATION OF GENE EXPRESSION,,PAUL  BERG,1965506
27,2195049,,1995,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,2T32HD007043-21,HD007043,UNITED STATES,T32,172225,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2000-06-30T04:00:00Z,,,"REPRODUCTIVE BIOLOGY, BIOCHEMISTRY AND ENDOCRINOLOGY",,FRANK  CHYTIL,1863160
28,3334109,,1992,CASE WESTERN RESERVE UNIVERSITY,CLEVELAND,OH,,5R01HL001661-41,HL001661,UNITED STATES,R01,285860,False,,National Heart Lung and Blood Institute,1975-09-01T04:00:00Z,1995-03-31T05:00:00Z,,"DESCRIPTION:  (Adapted from investigator's abstract).  The objective of
this project is to continue examination of the processes of blood
coagulation and related phenomena with an increasing emphasis on the
regulatory role of blood cells and endothelial cells.  Our focus will be on
regulation of the initial steps of clotting via the intrinsic pathway of
thrombin formation, particularly upon control of the activation of Hageman
factor (factor XII).  Our immediate goal is to elucidate the role of
inhibitors of the activation of this clotting factor that are derived from
vascular endothelial cells.  We will also explore the importance of
metallic ions in activation of Hageman factor.  These and related projects
aim at an understanding of hemorrhagic and thrombolytic states.

As always, vigorous attempts will be made to learn more about the
physiology of hemostasis and thrombosis through study of suitable patients.
",HEMOSTATIC MECHANISMS,,OSCAR D RATNOFF,1963165
29,3484418,,1993,CALIFORNIA INSTITUTE OF TECHNOLOGY,PASADENA,CA,,5R37GM022432-19,GM022432,UNITED STATES,R37,468013,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"Two membrane proteins with important and well-defined physiological
functions in cellular respiration (cytochrome c oxidase from beef heart and
yeast mitochondria; HCO3-/Cl- anion exchange protein from human red blood
cells) are under study to relate their biological functions to their
chemical structures and three-dimensional structures in the membrane.

(1) Work toward elucidation of the structure of the metal sites of
cytochrome c oxidase, their spatial distribution and functional role in
electron transfer, dioxygen reduction and energy conservation will be
continued.  Particular emphasis will be devoted to the ligands of CuB, the
nature of the ""pulsed"" enzyme, the electronic structures of the two
dioxygen intermediates at the three-electron level of reduction, the
sequence of intramolecular electron transfer, redox interactions among the
metal sites and their role in the energy conservation process, and the site
of redox-linked proton translocation in the protein.  A hypothesis of
redox-linked proton-translocation based on the concept of electron-gating
will be tested and the details extended or refined as necessary.  (2)
Similarly, the structure of the anion transport sites of the Cl-/HCO3-
anion exchange protein is being studied by 35Cl/37Cl nuclear magnetic
resonance (NMR) spectroscopy and amino acid-specific modification
experiments, followed by chemical analysis by HPLC.  The goals are to
develop a molecular picture describing the anion translocation event, the
structure of the transport site(s), their location(s) in the primary
sequence of the protein and relative to the membrane, and the minimal
structure containing the intact anion transport machinery.  (3) To
investigate the interactions of these proteins with the lipids in the
membranes in which they are embedded, purified cytochrome c oxidase as well
as the HCO3-/Cl- exchange protein are being reconstituted into lipid
membranes of well-defined chemical compositions.  The state of aggregation
of the intramembraneous particles in the reconstituted membranes is being
visualized by freeze-fracture electron microscopy, and the protein
distributions thus derived are correlated with the motional state of the
bilayer inferred from magnetic resonance experiments to provide insights on
the nature of the lipid deformations induced by the membrane proteins in
their immediate surroundings.  These studies on lipid-mediated
protein-protein forces are designed to develop an understanding of the
significance of protein-lipid interactions in biological function.
",MEMBRANE PROTEIN--STRUCTURE AND FUNCTION,,SUNNEY I. CHAN,2401834
30,3163852,,1990,COLORADO STATE UNIVERSITY-FORT COLLINS,FORT COLLINS,CO,,5R01CA013899-18,CA013899,UNITED STATES,R01,380392,False,,National Cancer Institute,1975-09-01T04:00:00Z,1992-04-30T04:00:00Z,,"The objective of this research is to evaluate the factors of dose
fractionation and treatment volume which influence late complications
following radiation therapy.  Increased knowledge of the pathogenesis of
late effects including better definition of dose limiting cells will
provide a better understanding of the effects of altered fractionation
schemes and treatment volume.  Isoeffect curves for response of canine
heart and mediastinal structures including the esophagus and trachea will
be generated by exposing those tissues to a range of total doses given a
range of doses per fraction.  Sequential studies will be done using
noninvasive endoscopic, radiographic, electrocardiographic and
echocardiographic techniques.  Histologic analyses will be done two years
after irradiation for comparison with functional studies and provide
information on the pathogenesis of late effects.  The volume effect will be
evaluated by irradiating variable lengths of spinal cords of dogs.
Electrophysiologic measurements will be made sequentially and histologic
analyses done two years following irradiation.  If a volume effect is
found, additional studies will be done with smaller doses per fraction to
determine the influence of fractionation on volume effect.  These studies
will show quantitatively how tissues respond to the different methods of
irradiation and the histologic analyses will contribute to the description
of pathogenesis of late effects.  The isoeffect curves generated may
provide directions for adjusting fraction size and dose delivery and
indicate how those alterations may be additionally influenced by volume
irradiated.
",RADIATION REPAIR OF NORMAL MAMMALIAN TISSUE,,EDWARD L GILLETTE,1969200
31,3394264,,1990,IOWA STATE UNIVERSITY,AMES,IA,,5R01NS010546-24,NS010546,UNITED STATES,R01,105952,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1992-08-31T04:00:00Z,,"The long-term objective of this application is to determine how fructose
1,6-bisphosphatase (FBPase), a key regulatory enzyme in gluconeogenesis,
functions as a catalyst and is controlled at the molecular level.
Experiments are to be conducted with the enzyme from mammalian brain and
liver tissue.

Although brain is not a gluconeogenic tissue, it does contain FBPase.
Because the substrate for this enzyme is the product of a key step in brain
glycolysis involving the enzyme phosphofructokinase, coordinated regulation
of these two enzymes is essential to brain tissue viability.  Brain FBPase
is somewhat unique among mammalian FBPases for two reasons:  it does not
require exogenous metal ion for activity, and it is not inhibited by AMP.
One of the aims of this application is to investigate the regulation of the
brain enzyme as well as its mechanism of action.

The role of exogenous metal ion in FBPase enzymology is not clearly
understood.  Attempts will be made to evaluate the role of exogenous metal
in catalysis and regulation from kinetic experiments in the
nonphysiological direction in the presence and absence of AMP.

Liver FBPase has two or three tightly associated metal ions per monomeric
subunit.  The enzyme itself is a tetramer.  The function of these metals
will be investigated using a variety of techniques, including nuclear
magnetic resonance spectroscopy.  The metals may facilitate catalysis by
binding to the oxygen atoms at the 1-phosphate position of the substrate,
thereby aiding nucleophilic attack by a hydroxyl ion on the phosphorous
atom.  On the other hand, they may simply tether the substrate to the
enzyme by hydrogen bonding a liganded water molecule to the substrate, or
they may merely provide the enzyme with the proper conformation for
catalysis.  Answers to these questions may be provided by replacing the
natural metal Zn2+, with the paramagnetic ion Mn2+.  By taking advantage of
the fact that paramagnetic ions can effectively relax diamagnetic nuclei,
and that this effect is distance dependent, it is possible to measure the
distance from the metal binding site to a particular nucleus, such as the
1-P of the substrate.  A knowledge of these distances may provide insights
into the role of the metals in catalysis.  It is also possible using this
technique to obtain information on how physiologically important
regulators, such as AMP and fructose 2,6-bisphosphatate, function at the
molecular level to inhibit FBPase.
",MECHANISM AND REGULATION OF BRAIN AND LIVER PHOSPHATASES,,HERBERT Jerome FROMM,1894874
32,3334760,,1990,TUFTS MEDICAL CENTER,BOSTON,MA,,2R01HL014456-19,HL014456,UNITED STATES,R01,344126,False,,National Heart Lung and Blood Institute,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"It is now generally accepted that angiotension converting enzyme (ACE)
participates in regulation of vasoactivity and may be important in such
varied cellular functions as modulation of inflammation, metabolism of
neuropeptides, airway reactivity, electrolyte absorption, granuloma
formation and spermatogenesis or reproduction.  We have begun to identify
intracellular mechanisms for regulation of synthesis of ACE by bovine
endothelial cells in culture; intracellular Ca2+ and cAMP appear to be
important components of this regulation that is also under hormonal (T3,
T4, dexamethasone, aldosterone) control.  We now wish to further explore
regulation of ACE synthesis in bovine and human endothelial cells and will
also extend these studies to macrophages, monocytes and fibroblasts.  The
mechanism by which hypoxia elevates cellular ACE will be evaluated.  A
factor we have found to be produced by smooth muscle cells that stimulates
ACE synthesis by endothelial cells will be studied.  In addition to Ca2+
and cAMP, possible influence of ACE synthesis of inositol polyphosphates
will be explored and possible intermediate effects on protein
phosphorylations through kinase actions will be examined.  We will continue
to assess ACE by enzymatic activity, but will also utilize our newly
developed ELISA for measuring ACE antigen in cells and radiolabeling with
[35S] methionine for turnover studies that should better define kinetics of
our observations.  Synthetic cDNA probes will be developed by polymerase
chain reaction for measurement of ACE mRNA in human and bovine cells and
tissue.  This methodology will be applied to assessments of the role of
transcriptional processes for various factors that influence cellular ACE.
We believe the proposed studies should provide the first composite
understanding of regulation of ACE at the cellular and molecular level and
may allow new insights for the regulation of this important enzyme in more
intact organ systems.
",LUNG METABOLISM--ENZYMES IN THE PULMONARY CIRCULATION,,Barry  Fanburg,1859077
33,3224785,,1992,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5R01DK011356-26,DK011356,UNITED STATES,R01,212733,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"This project deals with the mechanisms that allow cells to keep their water
content at a constant level. It focuses on the receptors that perceive
changes in cell water, the membrane transporters that correct perturbations
in cell water, and the signaling systems that link the receptors with the
transporters. The aims of the project are to identify the receptor(s), to
study how volume-activated transport systems are coordinated, and to study
how volume is regulated in vivo. Red cells are selected for study because
of their anatomical simplicity. The experiments involve measurements of
water, ions, and metabolic intermediates in red cells plus radioisotopic
labeling and separation of red cell membrane proteins. The in vivo work
entails the administration of an antimetabolite, hydroxyurea, to
experimental animals. The red cells of human subjects who are being treated
with hydroxyurea for myeloproliferative disorders will also be studied. The
clinical importance of this work is that changes in cell water content are
a common and potentially lethal manifestation of many disease states,
including brain injury, sickle cell disease, and acute renal failure.
",ION TRANSFER AND METABOLISM IN MAMMALIAN RED BLOOD CELLS,,JOHN C PARKER,3173154
34,3484221,,1992,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5R37GM017709-23,GM017709,UNITED STATES,R37,355090,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"The events of the mitotic cell cycle are organized into dependent pathways
in somatic cells and microorganisms: late events do not occur unless early
events are completed.  The RAD9 checkpoint, consisting of five gene
products, assures the dependence of mitosis upon the completion of DNA
replication.  The RAD9 checkpoint increases the fidelity of the unperturbed
mitotic cell cycle and maintains viability in the presence of intrinsic or
extrinsic perturbations to DNA.  We assume that the RAD9 pathway transduces
a signal from incompletely replicated or damaged DNA to inhibit a component
of the mitotic spindle, the target.  In this project period we seek to:  1)
Identify new checkpoints that we believe to be responsible for enforcing
other dependent relationships in the mitotic cycle and for ensuring the
high fidelity of mitotic chromosome transmission using the logic and
methods developed in our study of the RAD9 pathway.  2) Order that RAD9
(and newly discovered checkpoint pathways) using dominant mutations and
epistasis tests. 3) Elucidate the nature of the target of the RAD9
pathways) using dominant mutations and epistasis tests.  3) Elucidate the
nature of the target of the RAD9 pathway (and other pathways) by isolating
suppressors of the dominant mutations.  4) Identify a signal of the RAD9
pathway by locating the substrate of CDC13, a gene product that acts at a
specific site near the end of the chromosome.  5) Elucidate the pathways of
sister chromatid exchange which occur during cell cycle arrest at the RAD9
checkpoint.  This work should increase our understanding of functions that
insure the fidelity of the mitotic cell cycle and contribute to our insight
into the origins of the cancer cell, a cell in which the loss of mitotic
fidelity is likely to be causal in the disease.
",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,STANLEY  FIELDS,1871181
35,3394260,,1992,IOWA STATE UNIVERSITY,AMES,IA,,2R01NS010546-26,NS010546,UNITED STATES,R01,178909,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1997-08-31T04:00:00Z,,"How enzymes catalyze reactions and are regulated at the molecular level are
fundamental questions in contemporary biology.  We propose to address these
questions by investigation of two highly regulated enzymes of carbohydrate
metabolism, human brain hexokinase (HKI) and porcine liver fructose-1, 6-
bisphosphatase (FBPase).  HKI is believed to be the pacemaker of glycolysis
in brain tissue, whereas FBPase is a crucial control step in
gluconeogenesis.  Thus these enzymes are related in the sense that one is
involved in glucose utilization, whereas the other is critical to the
synthesis of blood glucose.

Brain which only comprises 2-3% of total mammalian body weight utilizes
approximately 25% of the circulating blood glucose and about 20% of the
oxygen consumed by the body.  In cerebral tissue, under normal
physiological conditions, glucose phosphorylation is mediated by HKI, and
it is then metabolized via the Krebs cycle to synthesize ATP which is
required in large quantities for brain metabolism.  Human HKI was recently
cloned and expressed in Escherichia coli in our laboratory.  In order to
gain insights into the putative glucose and ATP binding domains, the
regulatory sites, and the N-terminal amino acid sequence responsible for
HKI binding to the mitochondrial pore structure, studies involving site-
specific mutagenesis will be undertaken.  NMR spectroscopy will be used in
conjunction with the mutagenesis experiments to investigate the mechanism
of the HKI reaction, its molecular mechanism of regulation, and structure-
function relationships of the enzyme.

The 3-dimensional structure of FBPase is currently available.  Analysis of
this model can be used to evaluate the structure-function relationships
that exist at the active and allosteric sites of this enzyme from site-
specific mutagenesis studies.  We will clone and express the pig kidney
FBPase gene in E. coli as a prerequisite to doing the site-directed
mutagenesis studies.  Our goal will be to evaluate the kinetic and
regulatory properties of the mutant and wild-type enzymes and to use this
information to elucidate the structure-function relationships of liver
FBPase.
",REGULATORY ENZYMES OF GLYCOLYSIS AND GLUCONEOGENESIS,,HERBERT Jerome FROMM,1894874
36,2260748,,1994,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,PSYCHIATRY,5R01NS008841-24,NS008841,UNITED STATES,R01,155850,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1995-11-30T05:00:00Z,,"The long-term objectives of this research are to elucidate the metabolic
relationships between lipids and to study the enzymatic control of
membrane lipid biogenesis.  The specific objective of this proposal is
to characterize the enzymes of the acyl dihydroxyacetone phosphate (acyl
DHAP) pathway which catalyze the biosynthesis of the key membrane lipid
precursors, phosphatidic acid and its ether analog.  Several recent
discoveries, such as the presence of acyl DHAP pathway enzymes in
microbodies (peroxisomes and microperoxisomes), the identification of a
number of congenital peroxisomal disorders which result in a deficiency
of tissue ether lipids, and the recognition of biomessenger and second
messenger roles for ether lipids, have emphasized the importance of the
acyl DHAP pathway enzymes in membrane lipid biogenesis.  Two of these
enzymes, DHAP acyltransferase and alkyl DHAP synthase, are deficient in
a number of genetic diseases involving peroxisomal disorders, such as
Zellweger cerebrohepatorenal syndrome (ZS), Rhizomelic chondrodysplasia
punctata (RCDP), neonatal adrenoleukodystrophy, infantile Refsum disease,
etc.  Individuals with these diseases suffer from progressive
neurological disorders and mental retardation, and are diagnosed by the
deficiency of their cellular DHAP acyltransferase.  In this application
we intend to make thorough studies of the molecular properties and
cellular regulation of two of these acyl DHAP pathway enzymes.  The
following specific aims are proposed:

  1) To purify the key membrane-bound enzyme, DHAP acyltransferase
(DHAPAT), to homogeneity.  Following purification, the properties,
catalytic reaction mechanisms, and regulation of its activity by membrane
lipids will be investigated.  2) To generate specific antibodies against
DHAPAT and acyl/alkyl DHAP reductase (which has already been purified to
homogeneity), which will be used to study the tissue distribution and
subcellular localization of the enzymes, the developmental profile of the
enzymes in brain, and to detect the presence of mutant enzymes in
peroxisomal genetic diseases, such as ZS and RCDP. 3) To study the
molecular properties, regulation and biogenesis of acyl/alkyl DHAP
reductase by determining its primary structure by cloning and sequencing
the corresponding cDNA.

The results obtained from these studies will not only enhance our
understanding of membrane lipid biogenesis and the function of ether
lipids, but will also provide knowledge regarding the molecular defects
in aberrant peroxisomal lipid synthesis that may lead to treatments for
diseases involving these disorders.
",METABOLISM OF PHOSPHATIDIC ACID & ANALOGS IN LIVER/BRAIN,,AMIYA K HAJRA,1901432
37,2086725,,1994,STATE UNIVERSITY NEW YORK STONY BROOK,STONY BROOK,NY,GENETICS,4R37CA018808-20,CA018808,UNITED STATES,R37,291555,False,,National Cancer Institute,1975-09-01T04:00:00Z,1997-05-31T04:00:00Z,,"The overall objective of this proposal is to define the molecular
mechanisms by which SV40 T antigen regulates viral DNA replication.
T antigen carries out a number of important and related regulatory
functions in the course of infection.  Our goals are to understand
the nature of these functions, to relate these functions to one
another, and to determine how the structure of T antigen is
organized to accomplish these functions.  The activities on which
we focus on this application are the binding of T antigen to the
origin of replication, the denaturation of origin duplex DNA, the
role of T antigen in guiding cellular replication proteins to the
origin, the nicking of origin DNA, and the switch of T antigen from
initiation to helicase functions in DNA replication.  We think that
each of these steps in the replication of SV40 may be accomplished
by distinct functions of T antigen.  This information may establish
general principles that are applicable to other replicons.  The
initiation of DNA replication is one of the most perfectly
regulated processes in eukaryotic cells and is crucial to the
control of cellular growth.  We have the following specific aims:

1. To characterize further the structure and function of the
origin of replication.  We will construct insertion mutations
between domains that we have previously identified to probe the
spatial relationships among the domains, and we will isolate
mutations in T antigen that suppress base substitution mutations
in T antigen-binding regions of the origin to identify protein-DNA
contact regions.

2. To analyze T antigen-induced events at the origin of
replication.  We will  use established DNase, DMS and KMn04
footprinting techniques.  We will also focus on a newly discovered,
T antigen-associated nuclease activity directed at the AT domain
of the core origin and on the interactions of T antigen with
cellular replication proteins.

3. To characterize the domain structure of T antigen.  We will
use a two-stage saturation mutagenesis of the ""zinc finger"",tsA,
origin binding, origin unwinding, nuclease-association, and
helicase domains of T antigen and we will select for second-site
mutations in T antigen or in the origin of replication that
suppresses first-site mutations in each functional domain of T
antigen.
",TUMOR VIRUS--PROTEIN FUNCTION AND DNA REPLICATION,,PETER J TEGTMEYER,1955330
38,2172756,,1995,UNIVERSITY OF WASHINGTON,SEATTLE,WA,GENETICS,4R37GM017709-26,GM017709,UNITED STATES,R37,408518,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1996-08-31T04:00:00Z,,"The events of the mitotic cell cycle are organized into dependent pathways
 in somatic cells and microorganisms: late events do not occur unless early
 events are completed.  The RAD9 checkpoint, consisting of five gene
 products, assures the dependence of mitosis upon the completion of DNA
 replication.  The RAD9 checkpoint increases the fidelity of the unperturbed
 mitotic cell cycle and maintains viability in the presence of intrinsic or
 extrinsic perturbations to DNA.  We assume that the RAD9 pathway transduces
 a signal from incompletely replicated or damaged DNA to inhibit a component
 of the mitotic spindle, the target.  In this project period we seek to:  1)
 Identify new checkpoints that we believe to be responsible for enforcing
 other dependent relationships in the mitotic cycle and for ensuring the
 high fidelity of mitotic chromosome transmission using the logic and
 methods developed in our study of the RAD9 pathway.  2) Order that RAD9
 (and newly discovered checkpoint pathways) using dominant mutations and
 epistasis tests. 3) Elucidate the nature of the target of the RAD9
 pathways) using dominant mutations and epistasis tests.  3) Elucidate the
 nature of the target of the RAD9 pathway (and other pathways) by isolating
 suppressors of the dominant mutations.  4) Identify a signal of the RAD9
 pathway by locating the substrate of CDC13, a gene product that acts at a
 specific site near the end of the chromosome.  5) Elucidate the pathways of
 sister chromatid exchange which occur during cell cycle arrest at the RAD9
 checkpoint.  This work should increase our understanding of functions that
 insure the fidelity of the mitotic cell cycle and contribute to our insight
 into the origins of the cancer cell, a cell in which the loss of mitotic
 fidelity is likely to be causal in the disease.
",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,STANLEY  FIELDS,1871181
39,3268665,,1991,YALE UNIVERSITY,NEW HAVEN,CT,,2R01GM014642-24,GM014642,UNITED STATES,R01,360154,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-01-31T05:00:00Z,,"Flagella regeneration in the bi-flagellate alga Chlamydomonas is being used
as a model system in which to define general principles underlying cell
organelle formation.  When the flagella are detached, transcription of
genes for flagellar proteins is rapidly induced followed by translation of
mRNAs for flagellar proteins and, within minutes, assembly of a new
flagellum begins.  We will investigate these processes studying,
specifically, the synthesis and assembly of the flagellar radial spoke
proteins.  The spokes are attached to the A-tubules of the flagellar outer
doublet microtubules, have a head and stalk which are composed of 17
polypeptides, and are required for motility.  There are paralyzed mutants
in several of these polypeptides and the genes for 5 have been cloned.
Transformation can be used to rescue the paralyzed mutants back to
motility.  In vitro mutagenesis and transformation will be used to
determine the radial spoke gene sequences responsible for (a) gene up-
regulation following flagellar detachment, (b) targeting of radial spoke
proteins to the flagellum, and (c) assembly of the proteins onto the outer
doublet microtubules.  Phosphorylation of radial spoke proteins is
necessary for assembly of functional radial spokes.  By use of mutants
lacking a flagellar protein kinase, as well as in vitro mutagenesis and
transformation, the role of radial spoke protein phosphorylation in either
the targeting of proteins to the flagellum or their assembly onto the
axoneme will be determined.  Extracts from wild-type and radial spoke
mutant cells will be used to assemble radial spokes onto spokeless axonemes
in vitro.  Assembly will be determined by electron microscopy, gold-labeled
antibody localization, and sedimentation of labeled spoke proteins with the
doublet microtubules.  These studies will help determine the order of
assembly of radial spoke proteins, in a manner similar to that used to
analyze T-4 phage morphogenesis.  To determine how the flagellar proteins
find their way to the end of the cell where flagellar assembly occurs, the
site of radial spoke protein synthesis in the cytoplasm will be
investigated on the ultrastructural level using gold-labeled antibodies and
in situ RNA hybridization.

Almost all of the flagellar alpha-tubulin is acetylated and the hypothesis
that acetylation plays a role in the attachment of microtubule-associated
proteins/structures to the microtubules will be tested by use of acetylated
and unacetylated microtubules in an in vitro assembly system with
microtubule-associated proteins/structures.  Assembly will be analyzed by
sedimentation of labeled associated proteins with the microtubules and by
electron microscopy.
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
40,3484416,,1991,CALIFORNIA INSTITUTE OF TECHNOLOGY,PASADENA,CA,,5R37GM022432-17,GM022432,UNITED STATES,R37,427091,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"Two membrane proteins with important and well-defined physiological
functions in cellular respiration (cytochrome c oxidase from beef heart and
yeast mitochondria; HCO3-/Cl- anion exchange protein from human red blood
cells) are under study to relate their biological functions to their
chemical structures and three-dimensional structures in the membrane.

(1) Work toward elucidation of the structure of the metal sites of
cytochrome c oxidase, their spatial distribution and functional role in
electron transfer, dioxygen reduction and energy conservation will be
continued.  Particular emphasis will be devoted to the ligands of CuB, the
nature of the ""pulsed"" enzyme, the electronic structures of the two
dioxygen intermediates at the three-electron level of reduction, the
sequence of intramolecular electron transfer, redox interactions among the
metal sites and their role in the energy conservation process, and the site
of redox-linked proton translocation in the protein.  A hypothesis of
redox-linked proton-translocation based on the concept of electron-gating
will be tested and the details extended or refined as necessary.  (2)
Similarly, the structure of the anion transport sites of the Cl-/HCO3-
anion exchange protein is being studied by 35Cl/37Cl nuclear magnetic
resonance (NMR) spectroscopy and amino acid-specific modification
experiments, followed by chemical analysis by HPLC.  The goals are to
develop a molecular picture describing the anion translocation event, the
structure of the transport site(s), their location(s) in the primary
sequence of the protein and relative to the membrane, and the minimal
structure containing the intact anion transport machinery.  (3) To
investigate the interactions of these proteins with the lipids in the
membranes in which they are embedded, purified cytochrome c oxidase as well
as the HCO3-/Cl- exchange protein are being reconstituted into lipid
membranes of well-defined chemical compositions.  The state of aggregation
of the intramembraneous particles in the reconstituted membranes is being
visualized by freeze-fracture electron microscopy, and the protein
distributions thus derived are correlated with the motional state of the
bilayer inferred from magnetic resonance experiments to provide insights on
the nature of the lipid deformations induced by the membrane proteins in
their immediate surroundings.  These studies on lipid-mediated
protein-protein forces are designed to develop an understanding of the
significance of protein-lipid interactions in biological function.
",MEMBRANE PROTEIN--STRUCTURE AND FUNCTION,,SUNNEY I. CHAN,2401834
41,3484145,,1991,STANFORD UNIVERSITY,STANFORD,CA,,5R37GM013235-25,GM013235,UNITED STATES,R37,448671,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1992-06-30T04:00:00Z,,"The advent and widespread application of the recombinant DNA
methodology during the past twelve years has greatly extended
our understanding of the molecular basis of heredity.  More
significantly, the emergence of a new molecular paradigm -
reverse genetics, which relies on the ability to specifically modify
the structure of genes in vitro and to test their biological
properties, has revolutionized the experimental approaches in
molecular genetics.  The ability to construct minichromosomes
with novel arrangements of genetic elements also provides
vectors for the isolation of genes as well as substrates for the
analysis of specific genetic reactions.  Our proposal, which applies
this approach to explore the basic mechanisms of gene regulation
in the establishment of immune responsiveness and of genetic
recombination, aims

(1)  identify the factors and mechanisms that limit the
epression of antibody genes to only lymphoid cells;
(2)  isolate and characterize the human gene whose
dysfunction is responsible for galactosemia;
(3)  understand the mechanisms responsible for non-
homologous, homologous and non-reciprocal modes of
genetic recombination, especially those which permit the
rejoining of broken DNA;
(4)  develop genetic approaches to effect a replacement or
repair of chromosomal DNA sequences;
(5)  developing vectors which can deliver genes to only
specific types of cells.

It is anticipated that the information we develop will advance our
unerstanding of the molecular basis of disease and provide novel
approaches to their prevention, treatment and cure.
",MECHANISMS AND REGULATION OF GENE EXPRESSION,,PAUL  BERG,1965506
42,3224784,,1991,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5R01DK011356-25,DK011356,UNITED STATES,R01,201062,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"This project deals with the mechanisms that allow cells to keep their water
content at a constant level. It focuses on the receptors that perceive
changes in cell water, the membrane transporters that correct perturbations
in cell water, and the signaling systems that link the receptors with the
transporters. The aims of the project are to identify the receptor(s), to
study how volume-activated transport systems are coordinated, and to study
how volume is regulated in vivo. Red cells are selected for study because
of their anatomical simplicity. The experiments involve measurements of
water, ions, and metabolic intermediates in red cells plus radioisotopic
labeling and separation of red cell membrane proteins. The in vivo work
entails the administration of an antimetabolite, hydroxyurea, to
experimental animals. The red cells of human subjects who are being treated
with hydroxyurea for myeloproliferative disorders will also be studied. The
clinical importance of this work is that changes in cell water content are
a common and potentially lethal manifestation of many disease states,
including brain injury, sickle cell disease, and acute renal failure.
",ION TRANSFER AND METABOLISM IN MAMMALIAN RED BLOOD CELLS,,JOHN C PARKER,3173154
43,3538808,,1990,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,2T32HD007048-16,HD007048,UNITED STATES,T32,125233,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,1995-06-30T04:00:00Z,,,REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
44,3484085,,1990,YALE UNIVERSITY,NEW HAVEN,CT,,2R37GM009966-29,GM009966,UNITED STATES,R37,775903,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"Our research focuses on three interrelated problems: (1) gene mapping of
developmentally relevant genes, (2) transcriptional regulation of the
transferrin receptor (TR) gene, and (3) the developmental role of the A-
type homeobox genes in man and the laboratory mouse.  Gene mapping will be
used to determine if the linkage relationships of epigenetically relevant
genes are conserved evolutionarily, and whether these linkage patterns are
functionally significant.  TR will be treated as a model system to study
mechanisms which control cell division, and genes such as TR that are
activated in dividing cells.  The homeobox genes encode transcription
factors which control the expression of genes relevant to the
developmental process.  Studies will be carried out to determine how these
genes regulate themselves, how they respond to ""input"" genes, and how they
control the coordinated patterns of expression of ""target"" genes.  We see
these three projects as interrelated, and we believe all three will
contribute to a better understanding of the developmental process in
mammals.
",GENETIC ANALYSIS OF SOMATIC CELL POPULATION,,FRANK H RUDDLE,1862461
45,3538815,,1992,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,5T32HD007048-18,HD007048,UNITED STATES,T32,159476,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,1995-06-30T04:00:00Z,,,REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
46,3075290,,1990,EMORY UNIVERSITY,ATLANTA,GA,,2K05DA000008-16,DA000008,UNITED STATES,K05,82693,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"A program of research is proposed for studying behavioral effects of two
types of drugs of major clinical, social , and theoretical important:  1)
opioids, which have long represented a significant abuse problem; 2)
caffeine, which is the most widely consumed behaviorally-active compound in
the world, and which has many of the characteristics of a drug of abuse.

The basic strategy of this research program is to use behavioral
methodologies to study interactions of drugs with their neuronal
substrates.  The objective is to identify and characterize components of
drug action that may be relevant to potential for abuse and to related
phenomena, such as tolerance and physical dependence.  The neuronal
substrates of drug action will be characterized with receptor-selective
agonists, antagonists, and tolerance and cross-tolerance.  Representative
compounds will be studied over a range of doses in several behavioral
procedures, such as drug discrimination, food-reinforced operant
responding, locomotor activity, and autotitration of reinforcement
threshold for electrical brain stimulation.  Experiments will be performed
on rats and, often, on squirrel monkeys.  This approach will help in
assessing the generality  of experimental findings with respect to
pharmacological, behavioral, and species variables.

The proposed experiments will address a number of hypotheses.  Among these
are:  1) Endogenous opioid peptides can modulate the behavioral effects of
exogenously administered opioid drugs; 2) Similar components of drug action
mediate discriminative stimulus, reinforcing stimulus, and subjective drug
effects; 3) The discriminative stimulus effects of low and high doses of
caffeine differ qualitatively from each other and reflect components of
drug action that underlie, respectively, positive and negative mood states
in humans.
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS & CAFFEINE,,STEPHEN G HOLTZMAN,1868593
47,3393829,,1986,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,,2R01NS008841-18,NS008841,UNITED STATES,R01,153582,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1991-08-31T04:00:00Z,,"The major objective of the proposed research is to study the properties and
physiological function of the enzymes catalyzing the formation of
phosphatidic acid, the key precursor of glycerides and phosphoglycerides.
Detailed studies will be made on the enzymes of the acyl dihydroxyacetone
phosphate (acyl DHAP) pathway, namely DHAP acyltransferase, alkyl DHAP
synthase and acyl/alkyl DHAP reductase.  The acyl DHAP pathway has been
shown to play a role in the biosynthesis of glycerolipids, especially the
containing ether linkages (glycerol-ether lipids and plasmalogens).  In
recent years, a number of discoveries such as the presence of acyl DHAP
pathway enzymes in microbodies (peroxisomes and microperoxisomes), the
demonstration that in patients with Zellweger cerebrohepatorenal syndrome
both the microbodies and glycerol-ether lipids are absent, and the
discovery that an ether lipid (platelet activating factor), has a potent
biomessenger role, all point towards the importance of the acyl DHAP
pathway in lipid metabolism.  In the proposed studies, our aim is to purify
the membrane-bound acyl DHAP pathway enzymes to homogeneity and study in
detail their properties and reaction mechanisms.  Attempts will be made to
raise specific antibodies against these enzymes and then to use these
antibodies to estimate and to localize the enzymes in different tissues.
The activity of these enzymes under different physiological conditions and
the contributions of the acyl DHAP pathway to the biosynthesis of non-ether
glycerolipids will be studied.  Different analogs of acyl/alkyl DHAP will
be chemically synthesized to test their possible use as inhibitors or
substrates for different enzymes.  The role of ether lipids will be
investigated by studying their distribution, turnover, and transport in
different systems.  The incorporation of exogenously added ether lipid
precursors to membrane lipids of skin fibroblasts from Zellweger syndrome
patients and in whole animals will also be studied.  The deficiency of
different acyl DHAP pathway enzymes in the cultured fibroblasts from
patients suffering from Zellweger syndrome, neonatal adrenoleukodystrophy
and related diseases will be studied in detail.
",METABOLISM OF PHOSPHATIDIC ACID AND ITS ANALOGS IN LIVER,,AMIYA K HAJRA,1901432
48,3394261,,1985,IOWA STATE UNIVERSITY,AMES,IA,,5R01NS010546-20,NS010546,UNITED STATES,R01,88741,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1986-08-31T04:00:00Z,,"How enzymes function as catalysts and how they are regulated at the
molecular and hormonal level is of fundamental importance to the
biologist.  The studies proposed in this application involve the
investigation of enzymes involved in glycolysis and gluconeogenesis and
their regulation.  In the case of glycolysis, experiments will be centered
around two isozymes, brain and muscle hexokinase.  The activity of the
latter phosphotransferase has been shown to decrease in
streptozotocin-induced diabetes and returns to normal upon the
administration of insulin.  We have shown that the rate of degradation of
muscle hexokinase in the diabetic rat is three times greater than in the
normal animal.  We propose to investigate the rates of synthesis and
degradation in insulin treated diabetic animals and the rate of synthesis
of muscle hexokinase in normal and diabetic animals.  Brain hexokinase is
the pacemaker of glycolysis in the brain and red blood cells, and its
activity is controlled by its products and inorganic phosphate.  We plan to
investigate the mechanism of brain hexokinase regulation using kinetic and
nuclear magnetic resonance techniques.  The gluconeogenic enzyme we propose
to investigate is fructose 1,6-bisphosphatase.  It has recently been
demonstrated that fructose 2,6-bisphosphate is a potent inhibitor of the
phosphatase and an activator of the glycolytic enzyme,
phosphofructokinase.  We have preliminary evidence showing how the
inhibitor affects the activity of fructose 1,6-bisphosphatase at the
molecular level and we plan to pursue these investigations using nuclear
magnetic resonance procedures.  In addition, we expect to investigate the
kinetic mechanism of action of the enzyme responsible for the biosynthesis
of the inhibitor, fructose-6-P 2 kinase, and finally, we propose to study
its regulation using kinetic protocols.  The same procedures will be used
to investigate the mechanism and regulation of fructose 1,6-bisphosphatase.
",REGULATION OF BRAIN AND TUMOR PHOSPHOTRANSFERASES,,HERBERT Jerome FROMM,1894874
49,3271135,,1985,CALIFORNIA INSTITUTE OF TECHNOLOGY,PASADENA,CA,,2R01GM022432-11,GM022432,UNITED STATES,R01,372652,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"Two membrane proteins with important and well-defined physiological
functions in cellular respiration (cytochrome c oxidase from beef heart and
yeast mitochondria; HCO3-/Cl- anion exchange protein from human red blood
cells) are under study to relate their biological functions to their
chemical structures and three-dimensional structures in the membrane.

(1) Work toward elucidation of the structure of the metal sites of
cytochrome c oxidase, their spatial distribution and functional role in
electron transfer, dioxygen reduction and energy conservation will be
continued.  Particular emphasis will be devoted to the ligands of CuB, the
nature of the ""pulsed"" enzyme, the electronic structures of the two
dioxygen intermediates at the three-electron level of reduction, the
sequence of intramolecular electron transfer, redox interactions among the
metal sites and their role in the energy conservation process, and the site
of redox-linked proton translocation in the protein.  A hypothesis of
redox-linked proton-translocation based on the concept of electron-gating
will be tested and the details extended or refined as necessary.  (2)
Similarly, the structure of the anion transport sites of the Cl-/HCO3-
anion exchange protein is being studied by 35Cl/37Cl nuclear magnetic
resonance (NMR) spectroscopy and amino acid-specific modification
experiments, followed by chemical analysis by HPLC.  The goals are to
develop a molecular picture describing the anion translocation event, the
structure of the transport site(s), their location(s) in the primary
sequence of the protein and relative to the membrane, and the minimal
structure containing the intact anion transport machinery.  (3) To
investigate the interactions of these proteins with the lipids in the
membranes in which they are embedded, purified cytochrome c oxidase as well
as the HCO3-/Cl- exchange protein are being reconstituted into lipid
membranes of well-defined chemical compositions.  The state of aggregation
of the intramembraneous particles in the reconstituted membranes is being
visualized by freeze-fracture electron microscopy, and the protein
distributions thus derived are correlated with the motional state of the
bilayer inferred from magnetic resonance experiments to provide insights on
the nature of the lipid deformations induced by the membrane proteins in
their immediate surroundings.  These studies on lipid-mediated
protein-protein forces are designed to develop an understanding of the
significance of protein-lipid interactions in biological function.
",STUDIES OF LIPID-LIPID AND LIPID-PROTEIN INTERACTIONS,,SUNNEY I. CHAN,2401834
0,3269047,,1985,ROCKEFELLER UNIVERSITY,NEW YORK,NY,,3R01GM017132-16S1,GM017132,UNITED STATES,R01,55266,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1985-11-30T05:00:00Z,,"The major objectives of this study are to develop and characterize a series of
flagellar defective mutants of Chlamydomonas reinhardtii which will be useful in
studying molecular mechanisms of flagellar motility and flagellar assembly.
Flagellar proteins of mutants with defective axonemal structures will be
analyzed and compared with wild-type counterparts to obtain knowledge of the
molecular composition of axonemal accessory structures such as radial spokes and
central pair complexes.  Similar analyses will be carried out in mutants with
abnormal flagellar motility.  At the same time wild-type flagella will be
analyzed for biochemical functions, with attempts to isolate protein kinases,
dynein ATPases, accessory proteins which stabilize microtubules, etc.  The
protein composition of the purified enzymes will be analyzed and compared with
the protein compositions of mutant axonemes to correlate biochemical functions
with specific structures or specific defects of flagellar function.  In selected
cases, where a number of independent genes are found to affect a single
structure or a specific function, attempts will be made to indentify the gene
product.  Flagellar function will be analyzed by stroboscopic darkfield
microscopy.
",BIOCHEMICAL GENETICS OF MICROTUBULES,,DAVID J LUCK,1965380
1,3150763,,1985,UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,HOUSTON,TX,,2R01AM009801-21,AM009801,UNITED STATES,R01,184197,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The long term objective of this project is the definition of the chemistry
of the glycoprotein hormones, particularly the gonadotropins from the
pituitary and chorion.  It is proposed to continue conventional sequencing
studies on eCG and eLH (in progress-Specific Aim 1), and to use this
methodology to reinvestigate hFSHBeta and pFSHBeta sequences to resolve
some remaining questions about their proposed sequences (Specific Aim 3).
Studies of functional group proximity on LH will be done using
bi-functional crosslinking reagents of specified length, enzymatic
degradation, and amino acid sequencing of the isolated peptides to identify
specific peptides involved in the crosslink (Specific Aim 4).  This will
require HPLC peptide mapping and location of the unaffected peptides for
which considerable information has already been generated.  Methodology for
detection of sulfate esters at the nanomole level with precision and
accuracy will be developed in order to compare the carbohydrate termination
groups (sulfate ester or sialic acid) for equine or human pituitary and
chorionic glycoprotein hormones (Specific Aim 5).  These are the only
species with well characterized chorionic gonadotropins.

It is proposed to examine the gene sequence of the equine LH and CG beta
subunit using recombinant DNA methodology (Specific Aim 2) since important
differences have been shown for the gene products in the equine compared to
the human.  The gene sequences are known for the human in these two
instances.  The determination of the equine sequences will be through
selection of recombinant clones for eLHBeta or eCGBeta from an equine
cosmid genomic DNA library with human cDNA clones.

Subsequent to the foregoing recombinant DNA study the sequence of the
rabbit LHBeta gene would be determined (Specific Aim 6) since this gene
product also has some unusual properties.

Specific Aim 7 involves collaborative studies to improve embryo transplants
in cattle.  Our role will be to produce FSH preparations free of LH.
",CHEMISTRY OF LUTEINIZING AND RELATED HORMONES,,DARRELL N. WARD,2418685
2,3269139,,1986,UNIVERSITY OF WASHINGTON,SEATTLE,WA,,5R01GM017709-17,GM017709,UNITED STATES,R01,245627,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The precise replication and segregation of eukaryotic chromosomes during
mitotic cell division is undoubtedly a highly complicated process requiring
the participation of hundreds of gene products.  Our goals are to define as
many as possible of the genes involved in mitotic chromosome transmission
in Saccharomyces cerevisiae, to locate the chromosomal domains upon which
these gene products act, and to determine what role the proteins play.  We
have developed novel strategies to accomplish these goals by exploiting
decreases in the fidelity of chromosome replication or segregation which
result from deficient, excess, or abberrant gene product expression.  The
decrease in fidelity is signalled either by an increase in the rate of
chromosome loss or in mitotic recombination.  In order to more effectively
exploit fidelity changes we will investigate the relationship between DNA
damage and mitotic recombination and we will develop minichromosome
substrates with which to define the chromosomal domains where gene products
function.

Mitotic cell division requires rigid integration of the assembly and
function of the mitotic spindle, with the replication and segregation of
sister chromatids.  Our ultimate goal is to understand how these
sophisticated biosynthetic and morphogenetic events are coordinated to
produce identical sister cells at mitosis and the reduction of chromosome
number in meiosis.  We will seek to determine the molecular nature of the
events that occur at the telomere and centromere of the chromosome in
response to the activity of CDC13, 17 and 15 gene products respectively.
This information will permit us to determine how the order of gene product
function is achieved at particular steps: either by provision of active
gene product or by availability of the substrate on the chromosome at the
appropriate time and place.
",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,STANLEY  FIELDS,1871181
3,3268079,,1986,YALE UNIVERSITY,NEW HAVEN,CT,,5R01GM009966-25,GM009966,UNITED STATES,R01,743691,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The studies described here continue and extend our research in the area of
somatic cell genetics.  We shall continue to refine gene mapping
procedures, especially to increase the resolution of the physical map by
gene transfer.  A new aspect of our research will be the analysis of the
molecular mechanisms of growth and differentiation.  Using somatic cell
genetic approaches, we have cloned genes tht are regulated in respect to
the resting or proliferating states of cells.  These are thymidine kinase,
transferrin receptor, surface antigen 4F2, and surface antigen S11.  The
genes are being characterized structurally and in terms of their kinetics
of transcriptional expression during the culture cycle and the cell cycle.
We propose to determine the molecular mechanisms of transcriptional control
in this gene set.  Another new research program involves mouse and human
DNA sequences that show a high degree of homology with the Drosophila
homeotic genes Antennapedia and Ultrabithorax.  We have cloned a number of
such sequences and propose experiments by which their biological
significance can be evaluated.  If our hypothesis is correct that these
genes regulate pattern formation in mammals, then we shall have a genetic
approach to studying mechanisms of morphogenesis in higher organisms.  In
another new system (sr = segregation regulation), we shall investigate
genetic factors located on the mammalian X chromosome that control
chromosome segregation in hybrid cells.  We postulate that this system
represents a hitherto unrecognized mechanism that mediates intercellular
recognition in somatic cell populations.  A primary objective will be the
purification and recombinant DNA cloning of these sr genes.  We believe the
pursuit of these projects will provide useful and significant insights into
the genetic mechanisms controlling mammalian cell growth, differentiation,
and morphogenesis.
",GENETIC ANALYSIS OF SOMATIC CELL POPULATION,,FRANK H RUDDLE,1862461
4,3225237,,1986,JOHNS HOPKINS UNIVERSITY,BALTIMORE,MD,,5R01DK014575-18,DK014575,UNITED STATES,R01,211438,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The GOALS of the proposed research are:  To determine how the major
constituents (apoproteins, triacylglycerol, cholesterol, and phospholipids)
of very low density lipoprotein are assembled and translocated and to
determine how these processes and subsequent secretion are regulated.  To
determine the mechanism(s) by which acetyl-CoA carboxylase--the key
regulatory enzyme of fatty synthesis, hence de novo lipogenesis--is
controlled.

The estrogen-induced chick hepatocyte in monolayer culture, a system
developed in this laboratory, will serve as experimental model.  The chick
hepatocyte is ideally suited for studies on VLDL synthesis and secretion,
since the liver accounts for nearly all de novo fatty acid synthesis in the
chick, as it dies in man, and provides the major fraction of the fatty
acids utilized by other tissues (including adipose tissue) in the form of
VLDL -triacylglycerol, and since VLDL output of the hepatocyte in culture
can be increased 10-20-fold by prior hormone treatment.  We have already
amassed a large body of background information with this system.

The sequence of events will be determined by which apoproteins and lipids
are assembled to form the nascent VLDL particle.

The intracellular sites of these events will be identified and
characterized.

Using puromycin-induced nascent chain release, the interaction of segments
of the apo-B polypeptide and specific VLDL lipids will be established.

A cell-free system will be developed that is capable of assembling,
processing and translocating nascent VLDL.

This cell-free system will be used to investigate the minimal requirements
of and the mechanisms of key steps in the VLDL assembly/processing pathway.

cDNA clones which encode the mRNA for apo-B will be isolated and sequenced.

The regulatory mechanisms for the synthesis, assembly, translocation and
secretion of VLDL will be investigated.

The effect of the phosphorylation state of acetyl-CoA carboxylase on the
kinetics of its citrate-induced activation and polymerization and the state
of its protomerpolymer equilibrium will be determined.
",REGULATION OF LIPOGENESIS AND VLDL SYNTHESIS/ASSEMBLY,,M DANIEL LANE,1878591
5,3226275,,1986,UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,FARMINGTON,CT,,2R01DK019167-11,DK019167,UNITED STATES,R01,160635,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1989-06-30T04:00:00Z,,"Iron uptake for heme and hemoglobin synthesis in erythropoietic cells
occurs by receptor-mediated endocytosis of transferrin.  The purpose of
these studies is to define and characterize the nature of events which are
implicated in transferrin-mediated iron delivery and its regulation in rat
reticulocytes and to determine how and if heme synthesis regulate the iron
delivery mechanism to control iron uptake.  Biochemical and functional
studies of the iron delivery process seek to determine the extent to which
iron uptake is dependent upon calcium influx or its mobilization from
intracellular stores, the role of protein kinase C, and the significance of
phosphorylation of receptor, membrane, and membrane-associated proteins in
the control of iron delivery.  Analysis of the mechanism of action of
dansylcadaverine, a potent inhibitor of transferrin-mediated iron delivery,
will be performed to determine the molecular basis of its effects on iron
uptake, particularly with emphasis upon the possible role of
metalloendoproteases in receptor-mediated membrane flow.  The long-term
objective of these studies is to determine the mutual co-ordination of
hemoglobin synthesis and iron metabolism in developing red blood cells.
The results of these studies may have significant implications in our
understanding of human red cell disorders which are characterized by
aberrant iron metabolism.
",IRON METABOLISM IN ERYTHROPOIETIC CELLS,,JOSEPH A GRASSO,3716219
6,3224325,,1986,COLUMBIA UNIV NEW YORK MORNINGSIDE,NEW YORK,NY,,5R01DK001940-29,DK001940,UNITED STATES,R01,239366,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The long-term objectives of this proposal include continued efforts to
design improved antagonists of the neurohypophysial hormones and to use
them as pharmacological probes of the actions of endogenous
neurohypophysial hormones.  Specific aims include attempts to modify
existing antagonists of the antidiuretic action of vasopressin to attain
greater potency, specificity and stability.  Systematic substitutions and
deletions will be made and the resulting analogs will be tested for
activities by multiple bioassays.  Oxytocin antagonists will also be
modified in the hopes of improving potency and specificity.  In addition,
antagonists and agonists will be iodinated to provide potentially useful
radioactive ligands for receptor studies.  Agonists and antagonists will be
used as pharmacological tools to characterize the brainstem receptors that
mediate vasopressin's actions on cardiovascular reflexes.  If better
oxytocin antagonists are designed they will be used to explore the possible
involvement of endogenous oxytocin in initiation of labor.  Antagonists of
the antidiuretic response promise to become useful therapeutic agents for
treating water retention in a variety of circumstances.  Oxytocin
antagonists could be useful for treating uterine hypermotility and,
possibly, premature labor.
",NEUROHYPOPHYSIAL CONTROL OF WATER EXCRETION,,WILBUR H. SAWYER,2417499
7,3224780,,1986,UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,CHAPEL HILL,NC,,5R01DK011356-20,DK011356,UNITED STATES,R01,156991,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"This grant proposal concerns mechanisms by which red blood cells achieve
and maintain their content of water and small ions.  The experiments are
divided into two parts.  The first involves dog red blood cells, in which
movements of sodium, calcium, protons, and potassium across the membrane
are strongly dependent on cell volume.  The proposed work seeks to examine
the nature of the stimulus-response coupling, so as to clarify how certain
membrane transporters are turned on and off by minor degrees of cell
shrinkage or swelling.  Methods will involve the use of cross-linking
agents, membrane-expanding treatments, and selective proteolyic digestion
to influence the relationship between cell volume and ion transport.
Membrane protein separations will be performed by gel electrophoresis,
using cells that have had specific transporters ""turned on"" or ""turned off""
by volume manipulation.  Net and isotopic flux measurements will be used to
monitor transport.

The second project is a one-year, preliminary study designed to evaluate,
by the techniques of electron probe microanalysis, a unifying hypothesis
that would explain the generation of dense, viscous red blood cells in
sickle cell disease, hereditary spherocytosis, and other hemolytic states.
The hypothesis states that red blood cells in all these conditions are
subject to fragmentation or budding.  The vesicles that bud off the cells
are believed to be richer in water and salts and poorer in hemoglobin
content than the parent cells, thus leaving the latter dense, viscous, and
poorly deformable.  The work proposed here involves a one year feasibility
study during which red blood cell fragments produced in vitro would be
assayed for ion, water, and hemoglobin content by standard techniques of
atomic absorption and/or flame photometry.  The same fragments would be
subjected to electron probe microanalysis, to determine whether the method
has the sensitivity and specificity to approach the problem with blood
samples from patients.  The hypothesis cannot be evaluated in the blood of
patients in any other way than by electron probe microanalysis:  this is
because cell fragments in the circulation may originate from platelets,
leukocytes, and possibly other non-red cell sources.  Only by combining the
techniques of electron microscopy and microanalysis can one be sure of the
origin of the fragments in which quantitative elemental determinations are
to be made.
",ION TRANSFER AND METABOLISM IN MAMMALIAN RED BLOOD CELLS,,JOHN C PARKER,3173154
8,3164876,,1986,UNIVERSITY OF PENNSYLVANIA,PHILADELPHIA,PA,,2R01CA018194-11A1,CA018194,UNITED STATES,R01,116852,False,,National Cancer Institute,1975-09-01T04:00:00Z,1991-07-31T04:00:00Z,,"That the intracellular controls which regulate the emergence of a normal
definitive muscle, cartilage, or pigment cell may produce neoplastic cells
when they malfunction has been discussed since Boveri's time over 60 years
ago.  To this end, the impact of TPA, EMS, pp60 v-src, and BrUdR on the
differentiation programs of primary cultured myogenic, chondrogenic, and
melanogenic cells is studied.  These 4 pleiotropic molecules, each having a
different initial intracellular target, share one remarkable property -
they selectively, but reversibly block transcription of that subset of
genes which define the treated cell's differentiation program.  These
conclusions derive from following (a) the synthesis of cell-specific
proteins, and (b) the accumulation of these cell-specific mRNAs in the
treated cells.  The vulnerability of a normal cell's differentiation
program to these agents cannot be ascribed to a generalized cytotoxicity
reaction, but may be analogous to the transcriptional response of
heat-shocked cells.  The semi-autonomy of a cell's differentiation program
in the context of the regulation of ""household"" molecules is striking.
These experiments also provide unusually favorable models for the study of
normal myofibrillogenesis and chondrogenesis, as well as the role of
c-oncogenes in the regulation of proliferation and/or cell diversification.

Our common model for normal cell diversification and transformation
postulates that the lineage-dependent activation of cell-specific subsets
of genes active in early compartments of a given lineage, are inactive in
later compartments.  To test this, 0-16 hour chick blastodisc cells were
dissociated and cultured at low density.  They demonstrate that hours prior
to gastrulation, and well before putative ""cell-cell,
epithelial-mesenchymal inductive interactions"", blastodisc cells have been
channeled into different, transitory, founder cells for multi-, bi-, and
unipotential lineages.  These findings suggest that early and late stages
of diversification reflect genetically pre-programmed intracellular
changes, rather than changes primarily induced by exogenous molecules.
These conclusions are also consistent with the proposition that the unique
phenotypic properties of any given type of transformed cell must be
pre-determined by the differentiation program of its normal progenitor cell.
",CONVERSION OF EMBRYONIC CELLS INTO TRANSFORMED CELLS,,HOWARD  HOLTZER,2090933
9,3444448,,1985,UNIVERSITY OF CALIFORNIA BERKELEY,BERKELEY,CA,,2R22AI012522-31,AI012522,UNITED STATES,R22,216058,False,,National Institute of Allergy and Infectious Diseases,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"In spite of the many dramatic advances being made in medical care, diseases
related to the genus Mycobacteria continue to plague largeareas of the
world.  The long-range objective of this research program is to contribute
to our understanding of the fundamental physiology of mycobacteria with the
belief that this understanding can lead to improved procedures for treating
and controlling tuberculosis and leprosy.  The core of the program is
centered on the fact that mycobacteria have an unusual lipid metabolism,
which enhances their pathogenicity by providing an impervious cell wall
that is resistant to macrophage attack, and which lipid metabolism is
facilitated by the novel ability of mycobacteria to synthesize and use
complex carbohydrates as lipid carriers.  The specific carbohydrates are
called polymethylpolysaccharides and were discovered and characterized in
the laboratory of the applicant.  The polymethylpolysaccharides, composed
of a 3-0-methylmannose polysaccharide and a 6-0-methylglucose
lipopolysaccharide, act as lipid carriers by coiling up around the extended
fatty acid chain and forming a water-soluble 1:1 complex with the included
lipid.  This unusual interaction is due to the inherently hydrophobic
nature of the interior of a coiled Alpha 1 greater than 4-glycan, but it is
also enhanced by the increase in nonpolar character provided by the methyl
ehter groups.  The immediate aims of this proposal are (1) to delineate the
pathways for biosynthesis and degradation of the 6-0-methylglucose
lipopolysaccharide, (2) to define in more detail the nature of the
complexation between polymethylpolysaccharide and lipid, (3) to explore
approaches to the chemical synthesis of analogs of the
polymethylpolysaccharides that may have useful lipid-binding properties,
and (4) to investigate the structure, biosynthesis and immunochemistry of a
new mycobacterial glycolipid.  Part 1 of this proposal will deal with the
incorporation of radiolabeled compounds into precursor intermediates of the
polysaccharide and with the characterization of products of enzymic
degradation of the intact methylglucose polysaccharide; part 2 will involve
studies of polysaccharide-lipid complex formation by fast atom bombardment
mass spectrometry, by 1H nuclear magnetic resonance, and by X-ray
crystallography; part 3 is concerned with chemical modification of amylose
to yield oligosaccharides with lipid-binding properties; and part 4 will
make use of classical methods of carbohydrate characterization and
immunochemistry.
",COMPLEX CARBOHYDRATES IN MYCOBACTERIUM SPECIES,,CLINTON E BALLOU,3755714
10,3334759,,1985,TUFTS MEDICAL CENTER,BOSTON,MA,,2R01HL014456-14,HL014456,UNITED STATES,R01,256136,False,,National Heart Lung and Blood Institute,1975-09-01T04:00:00Z,1990-08-31T04:00:00Z,,"The pulmonary vasculature contains enzymes that are resonsible for
alterations in components of the pulmonary circulation, thereby changing
the composition of the systemic and bronchial blood flow.
Angiotensin-1-converting enzymes is an endothelial cell surface enzyme with
which we have had considerable experience and which we wish to continue to
study in the present proposal.  A two-step immunoabsorbent and
chromatography system will be used to purify ACE from human plasma, lung,
testes and kidney.  Physical (e.g., molecular weight and isoelectric point)
and chemical (e.g., peptide, carbohydrate and amino acid anylyses)
properties of ACE from these different human sources will be compared.  ACE
from endothelial cells, macrophages, fibroblasts and monocytes and
associated culture media will be assessed by electrophoretic and
immunoblotting techniques with which isoenzymes of ACE can be discerned.
These studies will allow comparisons between cellular, organ and
circulating ACE.  The turnover of protein and carbohydrate components of
ACE in cell culture and in vivo will be studied by immunoprecipitation
techniques, utilizing antibody prepared against purified ACE.  Factors
regulating the synthesis, degradation and release of ACE will be evaluated
in cell culture with initial emphasis placed on hormonal regulation, the
role of the sugar moiety and possible feedback inhibition by product
formation.  Similar assessments of regulation will be done in vivo with a
rat model.  Since it is recognized that ACE activity is elevated in sera of
patients with sarcoidosis, possible unique properties of ACE in sera of
patients with sarcoidosis will be evaluated by isoelectric focusing and
immunoblotting, and the ELISA method we have developed will be used to
compare absolute quantity of enzyme with serum enzymatic activity in these
patients.  Measurement and characterization of ACE and factors regulating
its synthesis and release will be studied in peripheral blood monocytes and
alveolar macrophages of patients with sarcoidosis.  With these studies we
hope to gain a broader understanding of structural properties of human ACE
and, in particular, of that from the lung; to evaluate the regulation of
the synthesis, release and general metabolism of ACE; and to determine the
utility of new approaches to studies of this enzyme in sarcoidosis.
",LUNG METABOLISM--ENZYMES IN THE PULMONARY CIRCULATION,,Barry  Fanburg,1859077
11,3334595,,1985,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,,5R01HL013172-16,HL013172,UNITED STATES,R01,118524,False,,National Heart Lung and Blood Institute,1975-09-01T04:00:00Z,1987-08-31T04:00:00Z,,"Using computerized axial tomography scans of full chest and full chest
fluoroscopic magnetic tape recordings, we will measure regional changes in lung
volume, mass, and weighted mass.  These studies are to determine the effects of
trauma and operative injury on chest cage and diaphragmatic motion and
gravitational force for fluid filtration and lung expansion.

These studies are coordinated with clinical studies to determine optimum
treatment of acute post-trauma respiratory insufficiency with the goal of
developing decision logic to control therapy; in animals, to assess the effects
of gravity and hemodilution on the Starling forces.
",HEART AND LUNG INTERACTION IN POST-TRAUMA LUNG EDEMA,,RICHARD M PETERS,3753735
12,3150701,,1985,YALE UNIVERSITY,NEW HAVEN,CT,,5R01AM003688-25,AM003688,UNITED STATES,R01,243754,False,,National Institute of Diabetes and Digestive and Kidney Diseases,1975-09-01T04:00:00Z,1986-08-31T04:00:00Z,,"This work concerns the biogenesis of plasmalemma utilizing the basolateral
membrane of the secretory cells of the salt gland as a model system.  Salt
stress causes a great amplification of this membrane and withdrawal of the
stress results in rapid membrane resorption.  Hypothetically, plasma membrane
biogenesis occurs as an assembly line process involving functionally specialized
compartments of the cell within which the Golgi is central to assembly.  The
process, the synthesis and assembly of phospholipid shall be studied by
biochemical techniques that determine the lipid content and phospholipid
synthetic enzyme activity of fractions and whole gland.  Cytochemically, methods
to localize many of the enzymes concerned with phospholipid synthesis will be
developed as well as organo metallic analogues of lipids as tracers.  The
synthesis and assembly of enzymatic proteins shall also be studied, using NaK
ATPase as a marker.  These studies will use fractionation, gel profiles of
fractions, pulse chase and immunochemistry with antibodies to the enzyme.  The
cytochemistry of NaK ATPase shall be further pursued as well as other membrane
enzymes for both the apical and basolateral membrane.  On destressing the
ultrastructure biochemistry and cytochemistry of the resorption of the
basolateral plasma membrane will be studies with emphasis on endocytosis,
lysosomes and the Golgi.  The experiments also lend opportunity to examine the
possibility of recycling.  Although these experiments will use whole gland,
slices and fractions, we also use minilobules obtained of collagenase digestion
and from this develop single cell system in culture.  Finally control of
membrane biogenesis will be examined, focusing on the probability that the
initial signal is a cholinergic stimulus and the second involves a cyclic
nucleotide.  The latter experiments shall present an opportunity to induce
secretory cells to produce new protein and phospholipid in vitro.

",BIOGENESIS AND DEGRADATION OF PLASMA MEMBRANES,,RUSSELL J BARRNETT,3734865
13,3124595,,1985,UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,FARMINGTON,CT,,2R01AI009648-16,AI009648,UNITED STATES,R01,234941,False,,National Institute of Allergy and Infectious Diseases,1975-09-01T04:00:00Z,1988-08-31T04:00:00Z,,"The long term objectives of this application are to define, in molecular
terms, the initial biochemical and physiological responses of the
neutrophil to chemotactic agents.  In this work, particular stress is laid
on delineating the nature and role of the cellular enzymes activated in
these responses.  The initial aim is to refine the model of the
formylpeptide receptor of the rabbit neutrophil previously described and
extend it from the portion accommodating tripeptides to the area
accommodating tetrapeptides.  Efforts to obtain highly active specific
antagonists of the formylpeptide receptor will continue.  The study of the
interrelationships of two series of boc methyl esters with fMet-Leu-Phe and
other chemotactic factors on granule enzyme secretion, chemotaxis and other
neutrophil functions will be continued.  Particular attention will be paid
to obtaining evidence testing the working hypothesis that the inhibition of
the secretory activity of the boc methyl esters by fMet-Leu-Phe is due to
the evocation of two inhibitory signals, one from the reaction of
fMet-Leu-Phe with the neutrophil, the other from the action of the boc
methyl ester.  Attempts will be made to establish that DFP inhibits the
activation by chemotactic factor of the Na+, K+-ATPase by interfering with
the activation of a serine esterase.  For this purpose, use will be made of
the uptake of H3[DFP].  In addition, the mechanisms by which chemotactic
factors activate the phospholipase A2 of isolated plasma membranes of
neutrophils will be further studied.  To this end, the effects of
deoxycholate and various combinations of chemotactic factors acting at
separate receptors will be investigated.  In addition, attempts will be
made to see whether chemotactic factors can increase the acyl-transferase
activity of isolated plasma membranes and relate the increased activity and
the activation of phospholipase A2-A2 to change in the endogenous
phospholipids of the same membranes.
",IMMUNOLOGICALLY ACTIVATED ENZYME SYSTEMS OF CELLS,,ELMER L BECKER,1964500
14,3101364,,1985,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,,2P30CA014051-14,CA014051,UNITED STATES,P30,1725187,False,,National Cancer Institute,1975-09-01T04:00:00Z,1988-04-30T04:00:00Z,,"This is a request for five years of core support beginning September 1, 1980
following the termination of NCI Grant CA 14051.  The Cancer Center Support
(Core) Grant is requested to provide funds for shared facilities and services,
including research salaries for professional staff (the faculty members who as a
group operate the program of the Center), centralized services, shared
equipment, developmental funds, and administration.

Research will be carried out in three main areas of Cancer Biology: 1) Cancer
Virology - this group, led by five faculty members, concentrates primarily on
the identification of cancer-inducing genes and their products.  2) Cancer
Immunology - this program, led by three faculty members, places its major effort
in the study of the mechanism by which killer T lymphocytes destroy foreign or
cancer cells in vivo and in vitro.  3) Cancer Cell Biology, with four faculty
members, explores the biochemical changes that occur on the cell surface and in
the cytoskeleton as a result of mailignant transformation.

This Core Grant will aid further development of the Center by providing partial
support for initial research costs of two new faculty members:  a replacement in
the Immunology Group and an addition to the Cell Biology Group.  Development
funds are also requested for the support of exploratory projects in the initial
phase, prior to application for peer-reviewed funding.

",CANCER CENTER SUPPORT (CORE) GRANT,,Phillip A Sharp,7355826
15,8743210,,2014,YALE UNIVERSITY,NEW HAVEN,CT,NONE,5R01GM014642-47,GM014642,UNITED STATES,R01,416250,False,JOSEPH G GINDHART,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2016-05-31T04:00:00Z,PA11260,"Defects in cilia have been linked to human pathologies based on aberrant motility (e.g. infertility, respiratory
infections) and/or abnormal signaling (e.g. polycystic kidney disease, blindness). Such ciliopathies can
result from improper assembly of cilia; therefore, understanding how ciliary precursors are brought to the
cilium and into the ciliary compartment may shed new light on their role in disease. How essential
structural components are delivered from their site of synthesis to the ciliary axoneme, is a mystery. To
address this issue a novel preparation of vesicles has been isolated during flagellar assembly from the
cytoplasm of Chlamydomonas, a pivotal organism for the study of assembly and function of cilia. These
vesicles carry ciliary membrane proteins (e.g. CrPKD2) as well as components of the ciliary axoneme,
including tubulin and radial spoke proteins. Combining high resolution imaging, proteomics and RNAi
knockdown, the hypothesis that axonemal proteins are transported to the cilium via peripheral
attachment to vesicles targeted to the periciliary membrane is being tested. Once at the base of the
cilium, the flagellar transition zone (TZ) is involved in determining which proteins enter/exit the flagellar
compartment. Many proteins involved in ciliopathies are found in the TZ. To further characterize the
composition of the TZ, TZs of Chlamydomonas have been isolated and analyzed by mass spectrometry.
Endosomal Sorting Complexes Required for Transport (ESCRT) proteins, which are involved in membrane
dynamics, were identified in this analysis, heralding a previously unknown function of the TZ, which will be
studied. These proteins may be involved in removing ubiquitinated proteins from the cilium, the release of
ciliary membrane into the surrounding milieu, or in the severing of the organelle from the cell - three poorly
understood processes known to occur in cilia. Additional newly identified proteins of the TZ that are
conserved in humans will be studied to provide new insights into the role of cilia function and human
disease.",Synthesis and Assembly of Flagellar Proteins,"A major resurgence in research on cilia and flagella (synonymous terms) occurred following the discovery of
Intraflagellar Transport (IFT) and the demonstration that it is essential for the assembly and maintenance of all
eukaryotic cilia. Abnormalities in ciliary assembly has, in turn, been shown to underlie many human diseases
called ciliopathies, including polycystic kidney disease and blindness. The proposed research will provide new
insights into cilia assembly, focusing on how ciliary proteins are transported to the cilia for assembly, as well as
identifying new proteins involved in gating proteins into and out of cilia.",JOEL L ROSENBAUM,1955194
16,8450936,,2013,BROWN UNIVERSITY,PROVIDENCE,RI,BIOCHEMISTRY,5R01GM019756-41,GM019756,UNITED STATES,R01,634268,False,Michael T. Bender,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2015-03-31T04:00:00Z,PA07070,"  
DESCRIPTION (provided by applicant): ABSTRACT:  The long-term goal of this grant proposal is to understand at an atomic level how the ribosome functions during protein synthesis. We will take a multidisciplinary approach utilizing genetic, biochemical and structural methods to study the bacterial ribosome. Our first aim is to examine ribosome structural dynamics during decoding of mRNA and its inhibition by antibiotics. We will use X-ray crystallography to obtain high-resolution structures of mutant Thermus thermophilus 30S subunits that reveal new conformational states. We will examine the effects of the mutations on the accuracy and kinetics of decoding. Our second aim is to probe a pathway by which codon recognition is signaled via ribosomal protein S12 and aminoacyl-tRNA to EF-Tu to activate GTP hydrolysis, a key step in the tRNA selection process. These experiments are designed to provide fundamental insights into ribosome structure and function, including new conformational states of the ribosome, to aid in understanding the decoding process. The ability to solve structures of ribosomes with antibiotic-resistance mutations will aid in understanding the mechanisms of antibiotic action and resistance, and has particular clinical relevance for the rational design of drugs to fight resistant microbial pathogens.  
  
",Polysomes & Subunits: Structure-Function Relationships,"PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE: The goal of this project is to further our understanding of the molecular mechanisms of protein synthesis at the atomic level, using the methods of structural biology, genetics and biochemistry. Protein synthesis in bacteria is the target of over half of all antibiotics, and modifications and mutations in components involved of this process can lead to antibiotic resistance, one of the most pressing medical problems of our time. Deciphering the molecular basis for antibiotic resistance will provide important information needed for the rational design of novel antimicrobial agents effective against antibiotic resistant microorganisms. A more comprehensive examination of the structural basis for protein synthesis will also provide important insights into one of the most fundamental processes found in all forms of life.  
    

",ALBERT E DAHLBERG,1965233
17,6894185,,2005,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,2T32HD007048-31,HD007048,UNITED STATES,T32,308913,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2010-04-30T04:00:00Z,,"DESCRIPTION (provided by applicant): This longstanding training program, now administered through the Department of Obstetrics and Gynecology, will provide four predoctoral students and three postdoctoral fellows, including physicians, with a broad and in-depth experience in reproductive sciences involving human beings and animals. This will be accomplished by the strong and closely integrated multi-departmental Reproductive Sciences Program (RSP) involving the resources of 28 faculty members in several departments and colleges. Qualified trainees are accepted after competitive review. Predoctoral fellows must first be accepted into the Rackham School of Graduate Studies; once in the RSP, they will participate in the Program-sponsored course in reproductive sciences and in other targeted courses designed to stimulate considerations about translational research. Postdoctoral fellows will submit an individual NRSA application and interact with both clinical and sociological fellows interested in the fields of women's and men s health. All fellows will be involved in various investigative projects, seminars, workshops, and courses. The training program furnishes flexible, individualized, rigorous training that will enable the trainee to acquire a broad, critical understanding of current concepts in reproductive sciences, including translational research, and an intimate knowledge of modern sophisticated, methodological approaches. Hands-on training will be accomplished primarily in the various research and clinical laboratories of RSP faculty mentors and co-mentors. The interdisciplinary traditions and culture of the Program will continue through several activities including the weekly noon RSP Fellows and Faculty Seminar Series, RSP Poster Day, RSP Trainee Consultants, and interactive sessions with clinical researchers. These trainee functions provide an opportunity for critical review of research progress, experimental designs, and future research plans, and they lead to national exposure. Fellows will have access to several University-supported core facilities that provide essential instruction, reagents, space and equipment. RSP graduates are able to pursue an independent career in one or more disciplines: anatomy, animal science, biochemistry, cell and molecular biology, neurosciences including behavior and neuroendocrinology, men's health, obstetrics and gynecology, pediatrics, pharmacology, physiology, toxicology, veterinary medicine, women's health and zoology. Special expertise may be obtained in several subspecialties: electron microscopy, histology, histochemistry, immunoendocrinology, regulatory biology, hormone action, contraceptive biology, neuroendocrinology, membrane biology, general endocrinology, developmental biology, gene expression, data analysis, recombinant DNA technology, biological rhythms, epidemiology, and clinical investigation.",Training Program in Reproductive Endocrinology,,DOUGLAS L FOSTER,1863159
18,7059319,,2006,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-32,HD007048,UNITED STATES,T32,309731,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2010-04-30T04:00:00Z,,,Training Program in Reproductive Endocrinology,,GARY DANIEL SMITH,1859945
19,2518887,,1997,CALIFORNIA INSTITUTE OF TECHNOLOGY,PASADENA,CA,NONE,5R37GM022432-23,GM022432,UNITED STATES,R37,546253,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"Two membrane proteins with important and well-defined physiological             
functions in cellular respiration (cytochrome c oxidase from beef heart and     
yeast mitochondria; HCO3-/Cl- anion exchange protein from human red blood       
cells) are under study to relate their biological functions to their            
chemical structures and three-dimensional structures in the membrane.           
                                                                                
(1) Work toward elucidation of the structure of the metal sites of              
cytochrome c oxidase, their spatial distribution and functional role in         
electron transfer, dioxygen reduction and energy conservation will be           
continued.  Particular emphasis will be devoted to the ligands of CuB, the      
nature of the ""pulsed"" enzyme, the electronic structures of the two             
dioxygen intermediates at the three-electron level of reduction, the            
sequence of intramolecular electron transfer, redox interactions among the      
metal sites and their role in the energy conservation process, and the site     
of redox-linked proton translocation in the protein.  A hypothesis of           
redox-linked proton-translocation based on the concept of electron-gating       
will be tested and the details extended or refined as necessary.  (2)           
Similarly, the structure of the anion transport sites of the Cl-/HCO3-          
anion exchange protein is being studied by 35Cl/37Cl nuclear magnetic           
resonance (NMR) spectroscopy and amino acid-specific modification               
experiments, followed by chemical analysis by HPLC.  The goals are to           
develop a molecular picture describing the anion translocation event, the       
structure of the transport site(s), their location(s) in the primary            
sequence of the protein and relative to the membrane, and the minimal           
structure containing the intact anion transport machinery.  (3) To              
investigate the interactions of these proteins with the lipids in the           
membranes in which they are embedded, purified cytochrome c oxidase as well     
as the HCO3-/Cl- exchange protein are being reconstituted into lipid            
membranes of well-defined chemical compositions.  The state of aggregation      
of the intramembraneous particles in the reconstituted membranes is being       
visualized by freeze-fracture electron microscopy, and the protein              
distributions thus derived are correlated with the motional state of the        
bilayer inferred from magnetic resonance experiments to provide insights on     
the nature of the lipid deformations induced by the membrane proteins in        
their immediate surroundings.  These studies on lipid-mediated                  
protein-protein forces are designed to develop an understanding of the          
significance of protein-lipid interactions in biological function.              
",MEMBRANE PROTEINS--STRUCTURE AND FUNCTION,,SUNNEY I. CHAN,2401834
20,2770826,,1998,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,5R37GM018386-29,GM018386,UNITED STATES,R37,592271,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"This research program deals with mechanisms of transcription and                
transcriptional regulation. One major project area focusses on the              
mechanism for coupling the expression of certain viral genes to DNA             
replication during the development of the bacterial virus T4, a process         
that is now known to involve transcriptional enhancer mechanisms. The           
principal research topics are: 1) the role of DNA connectivity in the           
enhancement (i.e. whether enhancing interactions occur in a                     
three-dimensional space or whether they require tracking along DNA); 2) the     
effects of assembling replication proteins into replisome on their ability      
to enhance transcription and the effects of ongoing replication on              
enhancement; 3) figuring out how transcriptional enhancement works at the       
molecular level by mapping protein-protein and protein-DNA interactions at      
the promoter and at the enhancer. These four broad topics will be pursued       
by various in vitro methods, including transcription kinetics, various          
footprinting techniques, photocrosslinking of protein to DNA, other             
crosslinking methods and other methods of analyzing the binding of proteins     
to DNA in assemblies of moderate complexity. A fourth topic involves            
certain in vivo correlates of the preceding analysis.                           
                                                                                
The second project area consists of several research topics involving           
transcription by RNA polymerase III. It is now clear that only one              
transcription factor of the yeast RNA polymerase III, TFIIIB, is essential      
for positioning the enzyme at the start site for transcription. One             
research topic analyzes this minimal transcription initiation system in         
kinetic and structural terms, using normal and mutant promoters. A second       
research topic involves the use of photochemical methods, including the use     
of a newly developed photocrosslinking reagent, to analyze the structure of     
transcription complexes and to map protein-protein as well as protein-DNA       
interactions along an entire transcription unit. A third research topic         
involves kinetic and structural analysis of RNA chain elongation and            
termination by RNA polymerase III.                                              
                                                                                
The connecting thread of these two lines of research is their common focus      
on a molecular understanding of transcription and its regulation and on         
processes such as promoter finding, promoter opening, modulations of            
promoter strength by protein-protein and protein-DNA interactions, RNA          
chain elongation and termination that are common to transcription in all        
organisms and all types of cells.                                               
",NUCLEIC ACIDS NUCLEOPROTEINS,,ERNEST PETER GEIDUSCHEK,1876894
21,2609007,,1998,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-24,HD007048,UNITED STATES,T32,158586,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,,TRAINING PROGRAM IN REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
22,6150962,,2000,YALE UNIVERSITY,NEW HAVEN,CT,PHYSIOLOGY,5R37GM014642-33,GM014642,UNITED STATES,R37,494777,False,James F. Deatherage,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-01-31T05:00:00Z,,"In the bi-flagellate alga Chlamydomonas, flagellar detachment signals           
the immediate, coordinate upregulation of over 200 genes encoding               
flagellar proteins, and, within minutes, the synthesis of these proteins        
and their assembly into new flagella.  This project is directed toward          
determining (a) where in the cytoplasm the mRNAs encoding these                 
flagellar proteins are located and where these proteins are synthesized;        
(b) to what extent these polypeptides are pre-assembled in the cytoplasm        
prior to entering the nascent flagella; (c) how these proteins are              
targeted to the flagella; (d) the role of the basal body/centriole in           
this targeting process; and (e) how, once in the flagella, the                  
precursors are transported to the assembly site at the flagellar tips.          
Using a variety of assembly mutants, these studies examine the                  
synthesis, assembly and transport of flagellar radial spokes, which are         
complexes composed of 17 polypeptides that pre-assemble in the                  
cytoplasm, yet function solely in the flagella.  Studies on transport           
focus on intraflagellar transport (IFT), a motility characterized by the        
rapid anterograde and retrograde movement of particles between the              
flagellar membrane and axoneme.  IFT particles are composed of ca. 15           
polypeptides, the genes for which are being cloned.  Mutations in C.            
elegans homologues of 3 of these polypeptides have been identified that         
result in defects in assembly of cilia found on sensory dendrites.              
Likewise, mutations in the microtubule motors that power anterograde and        
retrograde IFT in Chlamydomonas and their homologues in C. elegans              
result in the inability to assemble functional flagella or sensory              
cilia.  IFT is, therefore, one of the only microtubule-based motilities         
in which mutants are available in both the anterograde and retrograde           
transport of defined, isolable particles.  Particles, ultrastructurally         
similar to IFT particles, are found in the connecting cilium of                 
vertebrate retinal rod inner-outer segments, and kinesins, homologous           
to those associated with IFT, have been localized to this region. These         
observations suggest that IFT is universally required for assembly and          
maintenance of both motile and non-motile sensory cilia and, therefore,         
may be involved in male fertility, the assembly and maintenance of              
respiratory and oviduct cilia, and diseases of the retinal rod and cone         
outer segments.                                                                 
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
23,6128898,,2000,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,2R01GM022395-25,GM022395,UNITED STATES,R01,376040,False,Judith H. Greenberg,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-03-31T05:00:00Z,,"Amphibian metamorphosis involves the growth and differentiation, cell death and resorption, or remodeling of most tadpole tissue to become a frog. These changes are controlled by thyroid hormone (TH). Metamorphosis is a remarkably tractable developmental system since the diverse changes can be induced precociously with exogenous TH or inhibited pharmacologically with well known ""goitrogens"" added to the rearing water. Many features of TH physiology are the same in all vertebrates including the negative feedback loop between the thyroid gland the pituitary, the remarkable similarity in the TH receptors (TR), their RCR partners, and the DNA elements (TRE) to which these receptors bind. We have developed a three phase strategy to study individual programs of metamorphosis. First, we identified genes that are up- and down-regulated by TH in the tail, limb, intestine, and a cultured cell by means of a subtractive hybridization method that has the added power of estimating the number of genes in each program. We have concentrated our attention on the simplest program, tail resorption, in which we isolated about half of the TH-induced up- and down-regulated genes (17 and 4, respectively) clues about their possible roles in the resorption program. This grant application deals with the third phase which is underway, namely assaying genes for functional role in metamorphosis. The recent discovery of a transgenesis method for Xenopus laevis has provided us with such an assay. The function of the TH response gene in metamorphoses can be assessed as well as the various receptors, co-activators, and o-repressors that are presumed to play a role in the ability of TH to alter gene expression. Of special interest is an examination of the role of unliganded thyroid receptor in suppressing metamorphic changes. The participation of various hormones other than TH that have been implicated in amphibian metamorphosis is being assessed. The molecular explanation for many well documented biological features of metamorphosis such as the onset of competence to respond to TH, the different chronology of tissue response to the hormone (heterochrony) can be studied from a new perspective. We have already observed instructive phenotypes by over-expressing genes that inhibit metamorphosis. Strategies are described that can take advantage of these phenotypes and elucidate developmental pathways. ",AMPHIBIAN METAMORPHOSIS--A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
24,6125209,,2000,YALE UNIVERSITY,NEW HAVEN,CT,PHYSIOLOGY,5R01GM009966-37,GM009966,UNITED STATES,R01,386821,False,Judith H. Greenberg,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2001-11-30T05:00:00Z,,"DESCRIPTION (adapted from investigator's abstract):  A major problem in         
developmental biology concerns the specification of identities along linear     
axes.  Axial development frequently involves serial structures, as for          
example somites, which develop differentially depending on their position.      
Seemingly diverse developmental processes such as the formation of the          
cranial nerves, vertebrae, limbs, and the urogenital system all share the       
feature of axial specification that may involve common underlying               
developmental mechanisms.  There is growing support for this integrative        
concept based primarily on the discovery of the homeobox genes which are        
highly conserved throughout multicellular organisms and involved in axial       
specification.  The Principal Investigator will examine the molecular basis     
of homeobox gene activation associated with the specification of                
developmental identity.  Hoxc-8 was chosen because it is representative of      
the medial class of Hox genes and because a wealth of information exists for    
this gene.  Three major approaches to the analysis of Hoxc-8, all of which      
involve different aspects of its transcriptional control, will be taken.        
The first will identify enhancer motifs using reporter constructs in            
transgenic mice.  Experience has shown this approach to be reliable,            
efficient, and rapid.  The transgenic system will be combined with the use      
of YACs containing the mouse Hoxc cluster, and a novel clasper vector that      
permits the precise dissection of YACs by recombination.  These new tools       
facilitate the detection of enhancer elements operating at substantial          
distances from the promoter, enhancer sharing between Hox genes, and genetic    
complementation.  The second will characterize transcription factors            
regulating the expression of Hox genes by interaction with the defined          
enhancer motifs.  Attention will be given to the combinational interaction      
of these proteins, a possibility underlined by their preliminary findings.      
The third will investigate functional aspects of Hoxc-8 enhancers at the        
molecular level using in vivo ligation-mediated PCR footprinting, using         
embryonic tissues, transgenic mice, and transformed cell populations.           
",DEVELOPMENTAL REGULATION OF HOX GENE EXPRESSION,,FRANK H RUDDLE,1862461
25,6350004,,2001,SALK INSTITUTE FOR BIOLOGICAL STUDIES,LA JOLLA,CA,,5R01CA013884-28,CA013884,UNITED STATES,R01,387451,False,,National Cancer Institute,1975-09-01T04:00:00Z,2004-01-31T05:00:00Z,,"Our long-term objective is to understand cell transformation by DNA tumor       
viruses. The transforming proteins of these viruses exert their effects,        
at least in part, by associating with cellular proteins involved in growth      
regulation. We will study nature and functional consequences of the             
association of the polyoma middle T antigen (mT) with protein phosphatase       
2A (PP2A), pp60c-src and phosphatidylinositol-3 (PI-3) kinase, using a          
combination of genetic analysis of mT and biochemical analysis of cellular      
growth control signalling pathways. We will study mechanisms by which mT        
transactivates cellular growth control genes, including c-fos and c-jun,        
and will explore the involvement of ras and raf in mT-mediated                  
transactivation and cell transformation. Neuroblastoma cells express a          
neuronal form of pp60c-src, with an altered Src homology 3 (SH3) domain.        
We will seek to identify proteins that bind differentially to the SH3           
domains of the neuronal and fibroblastic forms of pp60c-src, to increase        
our understanding of mechanisms by which pp60c-src affects cell growth and      
differentiation. Finally we will study mechanisms of transactivation by         
p53, the association of p53 with the cellular protein, MDM2, and cell           
cycle control by p53, with emphasis on the possible role of                     
phosphorylation in these processes.                                             
",VIRAL GENE FUNCTIONS AND REGULATION OF CELL GROWTH,,Walter  Eckhart,1864017
26,6351138,,2001,YALE UNIVERSITY,NEW HAVEN,CT,PHYSIOLOGY,5R37GM014642-34,GM014642,UNITED STATES,R37,508246,False,James F. Deatherage,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-01-31T05:00:00Z,,"In the bi-flagellate alga Chlamydomonas, flagellar detachment signals           
the immediate, coordinate upregulation of over 200 genes encoding               
flagellar proteins, and, within minutes, the synthesis of these proteins        
and their assembly into new flagella.  This project is directed toward          
determining (a) where in the cytoplasm the mRNAs encoding these                 
flagellar proteins are located and where these proteins are synthesized;        
(b) to what extent these polypeptides are pre-assembled in the cytoplasm        
prior to entering the nascent flagella; (c) how these proteins are              
targeted to the flagella; (d) the role of the basal body/centriole in           
this targeting process; and (e) how, once in the flagella, the                  
precursors are transported to the assembly site at the flagellar tips.          
Using a variety of assembly mutants, these studies examine the                  
synthesis, assembly and transport of flagellar radial spokes, which are         
complexes composed of 17 polypeptides that pre-assemble in the                  
cytoplasm, yet function solely in the flagella.  Studies on transport           
focus on intraflagellar transport (IFT), a motility characterized by the        
rapid anterograde and retrograde movement of particles between the              
flagellar membrane and axoneme.  IFT particles are composed of ca. 15           
polypeptides, the genes for which are being cloned.  Mutations in C.            
elegans homologues of 3 of these polypeptides have been identified that         
result in defects in assembly of cilia found on sensory dendrites.              
Likewise, mutations in the microtubule motors that power anterograde and        
retrograde IFT in Chlamydomonas and their homologues in C. elegans              
result in the inability to assemble functional flagella or sensory              
cilia.  IFT is, therefore, one of the only microtubule-based motilities         
in which mutants are available in both the anterograde and retrograde           
transport of defined, isolable particles.  Particles, ultrastructurally         
similar to IFT particles, are found in the connecting cilium of                 
vertebrate retinal rod inner-outer segments, and kinesins, homologous           
to those associated with IFT, have been localized to this region. These         
observations suggest that IFT is universally required for assembly and          
maintenance of both motile and non-motile sensory cilia and, therefore,         
may be involved in male fertility, the assembly and maintenance of              
respiratory and oviduct cilia, and diseases of the retinal rod and cone         
outer segments.                                                                 
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
27,6329803,,2001,VANDERBILT UNIVERSITY,NASHVILLE,TN,BIOCHEMISTRY,5T32HD007043-27,HD007043,UNITED STATES,T32,205458,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2005-04-30T04:00:00Z,,,"REPRODUCTIVE BIOLOGY, BIOCHEMISTRY AND ENDOCRINOLOGY",,DAVID E ONG,1863687
28,6134315,,1999,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,NONE,3P30CA014051-28S1,CA014051,UNITED STATES,P30,203000,False,Hasnaa  Shafik,National Cancer Institute,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,"The Center for Cancer Research (CCR) at MIT was established twenty years        
ago to conduct basic research in areas relevant to cancer. The CCR is an        
autonomous administrative unit with its own assigned space (53,343 sq. ft)      
and faculty slots under the control of the CCR Director, who reports to         
the Dean of Science. The CCR currently has 13 Staff Investigators and 6         
Affiliate Investigators. The CCR has a total staff of 170-180 researchers       
and the Affiliate labs represent more than 100 additional people. The CCR       
has its own administrative office responsible for management of the CCSG        
and research grants of the CCR, and of shared research facilities which         
include Biopolymers, Cell Sorter, Glassware, Media Preparation,                 
Quantitation & Computing, Research Microscopy & Photography, and                
Transgenic Animal & Histology facilities. The established research              
programs in the CCR are Molecular Genetics, Cell & Developmental Biology,       
and Immunology and the strengths of the CCR research lie in basic cell and      
molecular biology and, in recent years, the application of transgenic           
mouse methods the generate animal models of cancer and other diseases.          
Areas of emphasis include the discovery and analyses of oncogenes and           
tumor suppressor genes and other disease genes, regulation of gene              
transcription and RNA splicing, cell adhesion in normal and pathological        
situations, structure and function of the cytoskeleton, processing of cell      
surface proteins, antigen processing and presentation, and T & B cell           
development. In addition to its strengths in basic research, the CCR            
performs an important role in training future researchers in biomedical         
science, including undergraduate and graduate students, postdoctoral and        
clinical fellows. Extensive collaborations exist with medical schools,          
hospitals and the biotechnology/pharmaceutical industries. Thus, the            
research in the CCR has a major impact both on the fundamental                  
understanding of cancer and on translation to and from the clinical arena.      
",CANCER CENTER SUPPORT,,RICHARD O HYNES,1894213
29,2115833,,1995,EMORY UNIVERSITY,ATLANTA,GA,PHARMACOLOGY,2K05DA000008-21,DA000008,UNITED STATES,K05,101655,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,PA91102,"This is a renewal application for a NIDA Research Scientist Award. A
 program of research is proposed for studying behavioral effects of two
 types of drugs of significant clinical, social, and theoretical
 importance: 1) opioids, some of which have long represented a serious
 abuse problem; 2) caffeine, the most widely consumed behaviorally-active
 drug in the world, which has features that make it a convenient model
 ""drug of abuse"". The proposed experiments will be supported by two
 research grants from NIDA.
 
 The basic research strategy is to use behavioral methodologies as
 bioassays of drug interactions with their neuronal substrates in order to
 identify and characterize components of drug action that might be relevant
 to potential for abuse and to related phenomena, such as tolerance and
 physical dependence. Representative compounds will be studied over a range
 of doses in several complementary behavioral procedures, such as drug
 discrimination, locomotor activity, autotitration of reinforcement
 threshold for electrical stimulation of the brain, and drug-induced
 turning. Established collaborations with faculty colleagues will bring
 additional methodologies to bear on the research questions of interest.
 Most experiments will be performed on rats, some on squirrel monkeys.
 This approach will help in the interpretation of experimental findings by
 indicating their generality with respect to pharmacological, behavioral,
 and species variables.
 
 The proposed experiments will address several hypotheses. Among them are:
 1)Brain opioid systems can, under some conditions, modulate brain dopamine
 systems and behavioral effects of drugs that are mediated by dopamine. 2)
 Single-dose opioid agonist-induced sensitization to effects of antagonists
 is a model of acute physical dependence. 3) Discriminative effects of low
 and high doses of caffeine model, respectively, positive and negative mood
 states induced by caffeine in humans. 4) Brain dopamine systems mediate
 some behavioral effects of caffeine and tolerance to those effects,
 sometimes as a result of adenosine-receptor blockade.
 
 Several pre- and postdoctral trainees will participate in this research
 program each year. An important goal will be to provide them with
 technical and, most important, intellectual skills necessary for careers
 in research on the behavioral pharmacology of drugs of abuse.
",BEHAVIORAL PHARMACOLOGY OF OPIOIDS AND CAFFEINE,,STEPHEN G HOLTZMAN,1868593
30,2173260,,1995,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,4R37GM018386-26,GM018386,UNITED STATES,R37,558618,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,"This research program deals with mechanisms of transcription and
 transcriptional regulation. One major project area focusses on the
 mechanism for coupling the expression of certain viral genes to DNA
 replication during the development of the bacterial virus T4, a process
 that is now known to involve transcriptional enhancer mechanisms. The
 principal research topics are: 1) the role of DNA connectivity in the
 enhancement (i.e. whether enhancing interactions occur in a
 three-dimensional space or whether they require tracking along DNA); 2) the
 effects of assembling replication proteins into replisome on their ability
 to enhance transcription and the effects of ongoing replication on
 enhancement; 3) figuring out how transcriptional enhancement works at the
 molecular level by mapping protein-protein and protein-DNA interactions at
 the promoter and at the enhancer. These four broad topics will be pursued
 by various in vitro methods, including transcription kinetics, various
 footprinting techniques, photocrosslinking of protein to DNA, other
 crosslinking methods and other methods of analyzing the binding of proteins
 to DNA in assemblies of moderate complexity. A fourth topic involves
 certain in vivo correlates of the preceding analysis.
 
 The second project area consists of several research topics involving
 transcription by RNA polymerase III. It is now clear that only one
 transcription factor of the yeast RNA polymerase III, TFIIIB, is essential
 for positioning the enzyme at the start site for transcription. One
 research topic analyzes this minimal transcription initiation system in
 kinetic and structural terms, using normal and mutant promoters. A second
 research topic involves the use of photochemical methods, including the use
 of a newly developed photocrosslinking reagent, to analyze the structure of
 transcription complexes and to map protein-protein as well as protein-DNA
 interactions along an entire transcription unit. A third research topic
 involves kinetic and structural analysis of RNA chain elongation and
 termination by RNA polymerase III.
 
 The connecting thread of these two lines of research is their common focus
 on a molecular understanding of transcription and its regulation and on
 processes such as promoter finding, promoter opening, modulations of
 promoter strength by protein-protein and protein-DNA interactions, RNA
 chain elongation and termination that are common to transcription in all
 organisms and all types of cells.
",NUCLEIC ACIDS NUCLEOPROTEINS,,ERNEST PETER GEIDUSCHEK,1876894
31,2169177,,1995,YALE UNIVERSITY,NEW HAVEN,CT,BIOLOGY,2R01GM014642-28,GM014642,UNITED STATES,R01,423692,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1999-01-31T05:00:00Z,,"In the biflagellate alga Chlamydomonas, flagellar detachment signals the
 immediate and coordinate upregulation of over 150 genes encoding flagellar
 proteins.  Synthesis of flagellar proteins rapidly ensues and, within
 minutes, new flagellar assembly is initiated.  To understand the process of
 organelle assembly we will study the synthesis and assembly of the
 flagellar radical spokes.  These structures, found only in the flagella,
 are required for flagellar motility; they are attached to the A-tubules of
 the outer doublet microtubules and are composed of 17 radial spoke
 polypeptides (RSPs) assembled into separable head and stalk domains.  We
 have cloned and sequenced the genes for several of these polypeptides,
 successfully using them to rescue mutants defective in spoke assembly.
 
 Chlamydomonas is a polarized cell with the flagella at one end.  With RSP
 antibodies and RSP cDNAs, we will determine by immunoelectron microscopy
 and in situ hybridization the site of RSP synthesis in the cytoplasm and
 subsequent route to the flagella.  We will also determine if the 17 RSPs
 form cytoplasmic pre-assembly aggregates prior to their transport to the
 flagellum.  To examine the assembly of spoke proteins onto the axoneme,
 RSPs obtained from cytoplasmic and flagellar extracts will be assembled
 onto axonemes isolated from mutants lacking entire spokes or spoke heads.
 We will continue to characterize the axonemal binding domain of RSP3 in
 vivo by testing the ability of mutagenized RSP3 to enter the flagellum,
 bind the axoneme, and target fusion proteins to the flagellar compartment.
 To determine how the RSPs and other flagellar proteins are transported to
 their assembly site at the flagellar tip, we will identify the molecular
 motors responsible for a newly-described motility beneath the flagellar
 membrane, IFT (Intraflagellar Transport).  In addition, we will use
 biochemical and genetic procedures, including our probes for RSPs and other
 flagellar proteins, to determine the nature of the cargo being carried by
 these motors.
 
 While investigating motors that may power IFT, we have determined that a
 kinesin-like protein (Klpl), the cDNA of which we have cloned and
 sequenced, is localized to only one of the two central pair microtubules of
 the flagellar axoneme.  We will clone and sequence the other kinesins we
 have identified in Chlamydomonas flagella and localize these proteins with
 specific antibody probes.  Since the central-pair microtubules are thought
 to rotate during flagellar beating, we will examine Klpl motility in vitro
 assays, testing for directionality and the ability to rotate microtubules.
 Proteins that interact with Klpl will be identified by non-denaturing
 immunoprecipitation with the Klpl antibody.  In addition, Klpl cDNAs will
 be mutagenized in vitro, and expressed in Chlamydomonas, to determine the
 functional role of this kinesin in vivo.
",SYNTHESIS AND ASSEMBLY OF FLAGELLAR PROTEINS,,JOEL L ROSENBAUM,1955194
32,2170820,,1995,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,HERSHEY,PA,BIOCHEMISTRY,2R01GM016329-28,GM016329,UNITED STATES,R01,291101,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1999-08-31T04:00:00Z,,"DESCRIPTION:  Most if not all genomes contain genes that occur in several
 copies.  The existence of such multigene families poses several special
 genetic problems  that fall into three overlapping categories.  The first
 relates to the specific role in the cell of each individual gene, the
 second  concerns the exchange of information between copies, while the
 third relates  to the promotion of chromosomal rearrangement through the
 provision of large  homologies.  All three have major implications for
 genome evolution.  This  project addresses these problems through the
 study of an unusual family of composite genetic elements that
 collectively comprise nearly 1% of the  chromosome of Escherichia coli
 K-12.  This Rhs element family is interesting  from several perspectives.
 They serve as paradigms of complex multigene  families which clearly
 interact through recombination.  They are a completely  novel class of
 accessory genetic element whose behavior is still largely not
 understood.  Finally, and possibly most importantly, their novel
 structure and  occurrence in independent E. coli suggest they may have
 a fundamentally  important role in the success of E. coli populations.
 The most prominent  feature of an Rhs element is a large open reading
 frame that encodes a protein  predicted to be in excess of 150 kDa.  This
 large ORF is a mosaic, being  composed of a 3.7 kb core and a shorter
 core-extension.  The cores are highly  conserved among different Rhs
 elements, while the core-extensions are highly  divergent.  The
 association of core-extensions with particular elements varies  in
 independent E. coli in a fashion that correlates with the clonal
 structure  of natural populations.  The degree of this correlation is
 unprecedented among  accessory genetic elements.  Properties predicted
 from the core protein's  primary sequence suggest that this protein may
 function on the cell surface.  The specific aims of the project address
 the functions of these elements, the  control of their expression and
 their genetic behavior in natural populations  of E. coli.
",ORGANIZATION AND REORGANIZATION OF THE E COLI GENOME,,CHARLES W HILL,1876912
33,2262236,,1995,IOWA STATE UNIVERSITY,AMES,IA,BIOCHEMISTRY,5R01NS010546-29,NS010546,UNITED STATES,R01,177777,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1997-08-31T04:00:00Z,,"How enzymes catalyze reactions and are regulated at the molecular level are
 fundamental questions in contemporary biology.  We propose to address these
 questions by investigation of two highly regulated enzymes of carbohydrate
 metabolism, human brain hexokinase (HKI) and porcine liver fructose-1, 6-
 bisphosphatase (FBPase).  HKI is believed to be the pacemaker of glycolysis
 in brain tissue, whereas FBPase is a crucial control step in
 gluconeogenesis.  Thus these enzymes are related in the sense that one is
 involved in glucose utilization, whereas the other is critical to the
 synthesis of blood glucose.
 
 Brain which only comprises 2-3% of total mammalian body weight utilizes
 approximately 25% of the circulating blood glucose and about 20% of the
 oxygen consumed by the body.  In cerebral tissue, under normal
 physiological conditions, glucose phosphorylation is mediated by HKI, and
 it is then metabolized via the Krebs cycle to synthesize ATP which is
 required in large quantities for brain metabolism.  Human HKI was recently
 cloned and expressed in Escherichia coli in our laboratory.  In order to
 gain insights into the putative glucose and ATP binding domains, the
 regulatory sites, and the N-terminal amino acid sequence responsible for
 HKI binding to the mitochondrial pore structure, studies involving site-
 specific mutagenesis will be undertaken.  NMR spectroscopy will be used in
 conjunction with the mutagenesis experiments to investigate the mechanism
 of the HKI reaction, its molecular mechanism of regulation, and structure-
 function relationships of the enzyme.
 
 The 3-dimensional structure of FBPase is currently available.  Analysis of
 this model can be used to evaluate the structure-function relationships
 that exist at the active and allosteric sites of this enzyme from site-
 specific mutagenesis studies.  We will clone and express the pig kidney
 FBPase gene in E. coli as a prerequisite to doing the site-directed
 mutagenesis studies.  Our goal will be to evaluate the kinetic and
 regulatory properties of the mutant and wild-type enzymes and to use this
 information to elucidate the structure-function relationships of liver
 FBPase.
",REGULATORY ENZYMES OF GLYCOLYSIS AND GLUCONEOGENESIS,,HERBERT Jerome FROMM,1894874
34,2260749,,1995,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,PSYCHIATRY,5R01NS008841-25,NS008841,UNITED STATES,R01,165279,False,,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,1996-11-30T05:00:00Z,,,METABOLISM OF PHOSPHATIDIC ACID & ANALOGS IN LIVER/BRAIN,,AMIYA K HAJRA,1901432
35,2086727,,1996,STATE UNIVERSITY NEW YORK STONY BROOK,STONY BROOK,NY,GENETICS,5R37CA018808-22,CA018808,UNITED STATES,R37,310720,False,,National Cancer Institute,1975-09-01T04:00:00Z,1997-12-31T05:00:00Z,,,TUMOR VIRUS--PROTEIN FUNCTION AND DNA REPLICATION,,PETER J TEGTMEYER,1955330
36,2086202,,1996,MASSACHUSETTS INSTITUTE OF TECHNOLOGY,CAMBRIDGE,MA,NONE,5P30CA014051-25,CA014051,UNITED STATES,P30,1954521,False,,National Cancer Institute,1975-09-01T04:00:00Z,2000-04-30T04:00:00Z,,,CANCER CENTER SUPPORT (CORE) GRANT,,RICHARD O HYNES,1894213
37,2195053,,1994,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-20,HD007048,UNITED STATES,T32,144257,False,,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,1995-06-30T04:00:00Z,,,REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
38,2173487,,1994,BROWN UNIVERSITY,PROVIDENCE,RI,BIOCHEMISTRY,5R01GM019756-23,GM019756,UNITED STATES,R01,394962,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1997-08-31T04:00:00Z,,"The objective of this research proposal is to further the understanding
of the catalytic role of rRNA in the process of translation.  Our goal
is to define regions in E. coli rRNA which are involved in particular
functions during the different stages of protein synthesis.  The
primary approach of the laboratory involves mutagenesis of rRNA by in
vitro and in vivo methods using a plasmid-borne rrnB operon.  Plasmids,
particular cell strains and mutagenic techniques have been developed
to permit the isolation of lethal as well as nonlethal mutations in
sufficient quantities for analysis.  Structural and functional features
of the mutants will be characterized by a variety of biochemical and
genetic systems.  Four major topics of translation will be
investigated, in each of which rRNA has a central functional role.  The
four areas include I. Fidelity of translation; functional interactions
between tRNA and rRNA.  Mutants will be constructed by site-directed
mutagenesis or selected for by systems such as TrpE91, following random
mutagenesis, to study functional interactions between selected regions
of tRNA and rRNA.  II. Interactions between mRNA and rRNA at initiation
and termination.  Translational enhancers will be identified and
characterized as will sites of functional interaction between mRNA and
rRNA at termination.  III. Peptidyl transferase activity in 23S rRNA.
Mutations will be constructed at important functional sites involving
tRNA and rRNA interactions in domain V of 23S rRNA.  IV.  The role of
4.5S rRNA, 16S, and 23S rRNA in transport of nascent proteins across
the cell membrane.  Mutations will be constructed at putative
functional sites in 4.5S rRNA and the rRNAs, and effects on transport
will be studied.  It is anticipated that these studies will contribute
to our understanding of the functional role of rRNA by defining in
detail structural and functional features of particular regions of the
rRNAs and their contributions to the overall process of protein
synthesis.
",POLYSOMES & SUBUNITS--STRUCTURE-FUNCTION RELATIONSHIPS,,ALBERT E DAHLBERG,1965233
39,2173259,,1994,UNIVERSITY OF CALIFORNIA SAN DIEGO,LA JOLLA,CA,BIOLOGY,5R37GM018386-25,GM018386,UNITED STATES,R37,506132,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"This research program deals with mechanisms of transcription and
transcriptional regulation. One major project area focusses on the
mechanism for coupling the expression of certain viral genes to DNA
replication during the development of the bacterial virus T4, a process
that is now known to involve transcriptional enhancer mechanisms. The
principal research topics are: 1) the role of DNA connectivity in the
enhancement (i.e. whether enhancing interactions occur in a
three-dimensional space or whether they require tracking along DNA); 2) the
effects of assembling replication proteins into replisome on their ability
to enhance transcription and the effects of ongoing replication on
enhancement; 3) figuring out how transcriptional enhancement works at the
molecular level by mapping protein-protein and protein-DNA interactions at
the promoter and at the enhancer. These four broad topics will be pursued
by various in vitro methods, including transcription kinetics, various
footprinting techniques, photocrosslinking of protein to DNA, other
crosslinking methods and other methods of analyzing the binding of proteins
to DNA in assemblies of moderate complexity. A fourth topic involves
certain in vivo correlates of the preceding analysis.

The second project area consists of several research topics involving
transcription by RNA polymerase III. It is now clear that only one
transcription factor of the yeast RNA polymerase III, TFIIIB, is essential
for positioning the enzyme at the start site for transcription. One
research topic analyzes this minimal transcription initiation system in
kinetic and structural terms, using normal and mutant promoters. A second
research topic involves the use of photochemical methods, including the use
of a newly developed photocrosslinking reagent, to analyze the structure of
transcription complexes and to map protein-protein as well as protein-DNA
interactions along an entire transcription unit. A third research topic
involves kinetic and structural analysis of RNA chain elongation and
termination by RNA polymerase III.

The connecting thread of these two lines of research is their common focus
on a molecular understanding of transcription and its regulation and on
processes such as promoter finding, promoter opening, modulations of
promoter strength by protein-protein and protein-DNA interactions, RNA
chain elongation and termination that are common to transcription in all
organisms and all types of cells.
",NUCLEIC ACIDS NUCLEOPROTEINS,,ERNEST PETER GEIDUSCHEK,1876894
40,2172755,,1994,UNIVERSITY OF WASHINGTON,SEATTLE,WA,GENETICS,5R37GM017709-25,GM017709,UNITED STATES,R37,377326,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1995-08-31T04:00:00Z,,"The events of the mitotic cell cycle are organized into dependent pathways
in somatic cells and microorganisms: late events do not occur unless early
events are completed.  The RAD9 checkpoint, consisting of five gene
products, assures the dependence of mitosis upon the completion of DNA
replication.  The RAD9 checkpoint increases the fidelity of the unperturbed
mitotic cell cycle and maintains viability in the presence of intrinsic or
extrinsic perturbations to DNA.  We assume that the RAD9 pathway transduces
a signal from incompletely replicated or damaged DNA to inhibit a component
of the mitotic spindle, the target.  In this project period we seek to:  1)
Identify new checkpoints that we believe to be responsible for enforcing
other dependent relationships in the mitotic cycle and for ensuring the
high fidelity of mitotic chromosome transmission using the logic and
methods developed in our study of the RAD9 pathway.  2) Order that RAD9
(and newly discovered checkpoint pathways) using dominant mutations and
epistasis tests. 3) Elucidate the nature of the target of the RAD9
pathways) using dominant mutations and epistasis tests.  3) Elucidate the
nature of the target of the RAD9 pathway (and other pathways) by isolating
suppressors of the dominant mutations.  4) Identify a signal of the RAD9
pathway by locating the substrate of CDC13, a gene product that acts at a
specific site near the end of the chromosome.  5) Elucidate the pathways of
sister chromatid exchange which occur during cell cycle arrest at the RAD9
checkpoint.  This work should increase our understanding of functions that
insure the fidelity of the mitotic cell cycle and contribute to our insight
into the origins of the cancer cell, a cell in which the loss of mitotic
fidelity is likely to be causal in the disease.
",GENETIC ANALYSIS OF THE EUKARYOTIC CELL CYCLE,,STANLEY  FIELDS,1871181
41,2086726,,1995,STATE UNIVERSITY NEW YORK STONY BROOK,STONY BROOK,NY,GENETICS,5R37CA018808-21,CA018808,UNITED STATES,R37,298018,False,,National Cancer Institute,1975-09-01T04:00:00Z,1997-05-31T04:00:00Z,,"The overall objective of this proposal is to define the molecular
 mechanisms by which SV40 T antigen regulates viral DNA replication.
 T antigen carries out a number of important and related regulatory
 functions in the course of infection.  Our goals are to understand
 the nature of these functions, to relate these functions to one
 another, and to determine how the structure of T antigen is
 organized to accomplish these functions.  The activities on which
 we focus on this application are the binding of T antigen to the
 origin of replication, the denaturation of origin duplex DNA, the
 role of T antigen in guiding cellular replication proteins to the
 origin, the nicking of origin DNA, and the switch of T antigen from
 initiation to helicase functions in DNA replication.  We think that
 each of these steps in the replication of SV40 may be accomplished
 by distinct functions of T antigen.  This information may establish
 general principles that are applicable to other replicons.  The
 initiation of DNA replication is one of the most perfectly
 regulated processes in eukaryotic cells and is crucial to the
 control of cellular growth.  We have the following specific aims:
 
 1. To characterize further the structure and function of the
 origin of replication.  We will construct insertion mutations
 between domains that we have previously identified to probe the
 spatial relationships among the domains, and we will isolate
 mutations in T antigen that suppress base substitution mutations
 in T antigen-binding regions of the origin to identify protein-DNA
 contact regions.
 
 2. To analyze T antigen-induced events at the origin of
 replication.  We will  use established DNase, DMS and KMn04
 footprinting techniques.  We will also focus on a newly discovered,
 T antigen-associated nuclease activity directed at the AT domain
 of the core origin and on the interactions of T antigen with
 cellular replication proteins.
 
 3. To characterize the domain structure of T antigen.  We will
 use a two-stage saturation mutagenesis of the ""zinc finger"",tsA,
 origin binding, origin unwinding, nuclease-association, and
 helicase domains of T antigen and we will select for second-site
 mutations in T antigen or in the origin of replication that
 suppresses first-site mutations in each functional domain of T
 antigen.
",TUMOR VIRUS--PROTEIN FUNCTION AND DNA REPLICATION,,PETER J TEGTMEYER,1955330
42,2173930,,1996,CALIFORNIA INSTITUTE OF TECHNOLOGY,PASADENA,CA,CHEMISTRY,5R37GM022432-22,GM022432,UNITED STATES,R37,537901,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,,,MEMBRANE PROTEINS--STRUCTURE AND FUNCTION,,SUNNEY I. CHAN,2401834
43,2115834,,1996,EMORY UNIVERSITY,ATLANTA,GA,PHARMACOLOGY,5K05DA000008-22,DA000008,UNITED STATES,K05,100440,False,,National Institute on Drug Abuse,1975-09-01T04:00:00Z,2000-08-31T04:00:00Z,PA91102,,BEHAVIORAL PHARMACOLOGY OF OPIOIDS AND CAFFEINE,,STEPHEN G HOLTZMAN,1868593
44,2170821,,1996,PENNSYLVANIA STATE UNIV HERSHEY MED CTR,HERSHEY,PA,BIOCHEMISTRY,5R01GM016329-29,GM016329,UNITED STATES,R01,297202,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,1999-08-31T04:00:00Z,,,ORGANIZATION AND REORGANIZATION OF THE E COLI GENOME,,CHARLES W HILL,1876912
45,6427928,,2002,YALE UNIVERSITY,NEW HAVEN,CT,PHYSIOLOGY,2R01GM009966-38A1,GM009966,UNITED STATES,R01,392400,False,Judith H. Greenberg,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2005-11-30T05:00:00Z,,"The Hox and the Distalless (Dlx) gene complexes play a major role in establishing pattern formation over the anterior/posterior axis (A/P) of the body and over the proximal/distal (P/D) axis of the limbs in mammals.  The Hox genes regulate A/P axis patterning from the tail to the hind brain/midbrain junction, while the Dlx genes regulate patterning from the hindbrain to the forebrain.  The Hox and Dlx clusters are linked chromosomally with a one megabase interval separating the two clusters.  The expression of the Hox and Dlx genes is regulated by transcription factors and morphogens such as retinoic acid that bind enhancers and other protein binding sites in non-coding domains within the gene clusters.  The protein binding sites have been shown to exert important cis regulatory control with respect to the orderly activation and display of Hox and Dlx genes over the A/P body and (P/D) limb axes.  Little is known about the number, location, composition, and function of these control domains.  Our previous reports on the early enhancer (EE) of the Hoxc8 gene provide the most detailed information of one such site, but much remains to be learned even about the EE, not to mention the myriad of additional sites.  In this grant application, we describe our plan to investigate in greater detail the stucture and function of Hox and Dlx cis- regulatory sites.  We will concentrate on two domains with which we have had experience, namely the Hoxc8 (40 kb) and Dlx3/7 (80 kb) regions.  New methods of our design will be used to locate, describe, and mutate control motifs in these domains.  An important new aspect of our research is the identification and functional analysis of transcription factor proteins that bind to control motifs.  We view enhancer elements as the ultimate target of developmental signaling pathways.  The enhancer in its complexity can be viewed as a decoding device to integrate multiple signals and to elicit appropriate gene expression responses in competent cells.  Knowledge regarding enhancer sequence, protein binding domains, and the specific transcription factors binding the enhancers will contribute to our understanding of the epigenetic function of these motifs.  We believe an in depth investigation of non-coding control elements in the Hoxc8 and Dlx3/7 domains will provide insightful information relevant to the entire clusters with respect to their control of developmental patterning and their role in the evolutionary diversification of body plans.",Developmental Regulation of Hox and D1x Gene Expression,,FRANK H RUDDLE,1862461
46,6490010,,2002,HARVARD UNIVERSITY,CAMBRIDGE,MA,CHEMISTRY,5R01GM006920-41,GM006920,UNITED STATES,R01,300090,False,,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2003-12-31T05:00:00Z,,"This project, Structural and Function of Biologically Active Molecules, is focussed on activity of three allosteric enzymes: fructose-1,6 bisphosphatase (FBPase) in the gluconeogenic pathway, yeast chorismate mutase (CMase) in the pathway to tyrosine and phenylalanine and aspartate transcarbamylase ATCase in the pyrimidine biosynthetic pathway. FBPase levels are elevated in Type 2 diabetics.  Starting from the three-dimensional structures of the T (less active) form and R (more active) forms, attempts are in progress to develop analogues of AMP, the allosteric inhibitor, in order to lower levels of glucose in diabetics.  The stages use cycles of synthesis, structure of the enzyme-inhibitor complex by X-ray diffraction, model building and redesign for new synthesis. Inhibitors highly specific for FBPase have been found in the 20nM range for Kd, substantially more strongly bound than AMP (Kd = 1 mu M).  Other aspects of structure-function studies of FBPase include establishing the catalytic and regulatory mechanism, especially the roles of the divalent metal cations. Also, as a result of structure determinations active site inhibitors for allosteric (CMase can be designed as herbicides, bacteriocides or fungicides which are harmless to humans who do not make this enzyme.  Likewise inhibitors of ATCase, such as PALA (N-phosphonyl-L-aspartate) can be improved upon for control of the pyrimidine pathway in certain cancers.  These two regulatory enzymes merit further study, proposed here, in order to understand the structural basis for aspects of allosteric regulation not explainable using the present day models, such as the concerted or sequential models. ",STRUCTURE AND FUNCTION OF BIOLOGICALLY ACTIVE MOLECULES,,WILLIAM N LIPSCOMB,1965589
47,6635805,,2003,"CARNEGIE INSTITUTION OF WASHINGTON, D.C.",WASHINGTON,DC,,5R01GM022395-28,GM022395,UNITED STATES,R01,372455,False,Judith H. Greenberg,National Institute of General Medical Sciences,1975-09-01T04:00:00Z,2004-03-31T05:00:00Z,,"Amphibian metamorphosis involves the growth and differentiation, cell death and resorption, or remodeling of most tadpole tissue to become a frog. These changes are controlled by thyroid hormone (TH). Metamorphosis is a remarkably tractable developmental system since the diverse changes can be induced precociously with exogenous TH or inhibited pharmacologically with well known ""goitrogens"" added to the rearing water. Many features of TH physiology are the same in all vertebrates including the negative feedback loop between the thyroid gland the pituitary, the remarkable similarity in the TH receptors (TR), their RCR partners, and the DNA elements (TRE) to which these receptors bind. We have developed a three phase strategy to study individual programs of metamorphosis. First, we identified genes that are up- and down-regulated by TH in the tail, limb, intestine, and a cultured cell by means of a subtractive hybridization method that has the added power of estimating the number of genes in each program. We have concentrated our attention on the simplest program, tail resorption, in which we isolated about half of the TH-induced up- and down-regulated genes (17 and 4, respectively) clues about their possible roles in the resorption program. This grant application deals with the third phase which is underway, namely assaying genes for functional role in metamorphosis. The recent discovery of a transgenesis method for Xenopus laevis has provided us with such an assay. The function of the TH response gene in metamorphoses can be assessed as well as the various receptors, co-activators, and o-repressors that are presumed to play a role in the ability of TH to alter gene expression. Of special interest is an examination of the role of unliganded thyroid receptor in suppressing metamorphic changes. The participation of various hormones other than TH that have been implicated in amphibian metamorphosis is being assessed. The molecular explanation for many well documented biological features of metamorphosis such as the onset of competence to respond to TH, the different chronology of tissue response to the hormone (heterochrony) can be studied from a new perspective. We have already observed instructive phenotypes by over-expressing genes that inhibit metamorphosis. Strategies are described that can take advantage of these phenotypes and elucidate developmental pathways. ",AMPHIBIAN METAMORPHOSIS--A DEVELOPMENTAL PROGRAM,,DONALD D BROWN,1898460
48,6764136,,2004,IOWA STATE UNIVERSITY,AMES,IA,BIOCHEMISTRY,5R01NS010546-38,NS010546,UNITED STATES,R01,341452,False,Tom P. Jacobs,National Institute of Neurological Disorders and Stroke,1975-09-01T04:00:00Z,2007-04-30T04:00:00Z,,"
 DESCRIPTION (provided by applicant): The proposed research focuses on enzymes      
 that play central roles in the regulation of glycolysis and gluconeogenesis.       
 Metabolite flux through the glycolytic and gluconeogenic pathways in liver         
 determines the level of serum glucose. Hence, a thorough understanding of          
 regulatory phenomena associated with glycolysis and gluconeogenesis should         
 facilitate the development of new therapies in the treatment of diabetes. The      
 goal here is a complete description of the dynamics of ligand interactions and     
 the molecular mechanisms of catalytic/regulatory actions associated with human     
 hexokinase I and porcine fructose-i 6-bisphosphatase. Hexokinase I is broadly      
 distributed amongst tissues, and is the predominant isoform in the brain and       
 the red blood cell. The isoform of fructose-1,6-bisphosphatase under               
 investigation here predominates in liver. An engineered form of hexokinase I       
 will permit the determination by NMR spectroscopy of the equilibrium constant      
 governing its central kinetic complex. Specific mutants at ligand binding sites    
 should reveal key factors governing interactions between hexokinase I and the      
 mitochondrion. A proposed model for the allosteric regulation of catalysis in      
 hexokinase I will be tested by directed mutation. Predicted outcomes of            
 specific mutations will be verified by steady-state kinetics and structure         
 determinations by X-ray diffraction. Novel constructs of fructose-I                
 ,6-bisphosphatase, which combine subunits of different functional properties       
 into a single tetramer, should reveal the basis of cooperative phenomena in        
 ligand binding and kinetics. Stopped-flow fluorescence of an engineered            
 fructose-1 ,6-bisphosphatase should determine whether the enzyme under             
 conditions of kinetics assays exists in an oligomeric state other than that of     
 a tetramer. Molecular models for allosteric inhibition, ligand binding             
 synergism, and catalysis proposed for fructose-1 ,6-bisphosphatase will be         
 tested by directed mutations and follow-up investigations in fluorescence          
 spectroscopy, steady state kinetics, NMR spectroscopy and structure                
 determinations from single crystals. Finally, the significance and                 
 physiological relevance of a newly discovered allosteric effector site on          
 fructose-1,6-bisphosphatase will be investigated by techniques of steady-state     
 kinetics, fluorescence spectroscopy, NMR spectroscopy, directed mutation and       
 X-ray crystallography.                                                             
                                                                                    
",Regulatory Enzymes of Glycolysis and Gluconeogenesis,,HERBERT Jerome FROMM,1894874
49,6636753,,2003,UNIVERSITY OF MICHIGAN AT ANN ARBOR,ANN ARBOR,MI,OBSTETRICS & GYNECOLOGY,5T32HD007048-29,HD007048,UNITED STATES,T32,209668,False,SUSAN  TAYMANS,Eunice Kennedy Shriver National Institute of Child Health and Human Development,1975-09-01T04:00:00Z,2005-04-30T04:00:00Z,,,TRAINING PROGRAM IN REPRODUCTIVE ENDOCRINOLOGY,,DOUGLAS L FOSTER,1863159
